data_1dby_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dby _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.61 -169.51 46.04 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.97 141.34 52.01 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.66 165.61 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.884 0.85 . . . . 0.0 110.565 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -146.69 176.84 9.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.819 2.047 . . . . 0.0 105.866 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -39.29 -57.97 1.28 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.849 0.86 . . . . 0.0 112.504 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.67 -58.61 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.822 1.249 . . . . 0.0 112.015 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -67.14 -35.66 80.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.347 0.659 . . . . 0.0 111.645 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -46.12 -47.28 17.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.531 1.533 . . . . 0.0 110.996 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -49.42 -55.28 13.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.107 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.5 -62.02 1.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.933 0.893 . . . . 0.0 111.653 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.83 -27.46 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 125.715 1.606 . . . . 0.0 113.077 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.46 -74.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.567 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.54 -42.31 70.76 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.048 1.295 . . . . 0.0 113.17 -172.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.78 17.07 11.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.727 0.811 . . . . 0.0 111.958 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.9 p -72.99 149.69 43.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.44 1.018 . . . . 0.0 111.892 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.5 p -92.51 -58.77 2.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.43 1.492 . . . . 0.0 108.992 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.67 162.91 63.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.3 1.44 . . . . 0.0 109.058 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.07 164.32 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.518 2.145 . . . . 0.0 112.383 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 t -145.48 144.13 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.66 97.41 5.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.06 119.52 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -94.2 111.67 23.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -78.49 109.92 13.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -123.84 -171.42 2.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.826 0.85 . . . . 0.0 111.157 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.7 151.4 2.84 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.64 1.176 . . . . 0.0 108.137 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.51 -33.47 98.04 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.457 2.105 . . . . 0.0 112.759 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -74.47 -14.15 60.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.528 -0.732 . . . . 0.0 111.018 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.45 82.8 8.13 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.123 -0.986 . . . . 0.0 111.304 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.27 -58.03 2.96 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.732 1.158 . . . . 0.0 113.864 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.71 -40.37 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 CA-C-N 119.748 1.774 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -58.53 -52.08 67.15 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -55.95 -48.5 75.66 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.86 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -74.48 -22.26 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.884 0.765 . . . . 0.0 111.741 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.4 mm -81.69 -34.51 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.496 1.043 . . . . 0.0 110.805 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.05 -45.44 4.66 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.207 1.803 . . . . 0.0 115.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -62.52 -40.48 38.29 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.983 1.789 . . . . 0.0 109.821 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.91 -48.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.716 1.207 . . . . 0.0 107.762 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.2 t -52.09 -51.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.905 0.882 . . . . 0.0 108.823 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.0 -57.78 10.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.08 -43.68 87.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.882 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.26 -49.4 76.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.26 72.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.447 -0.783 . . . . 0.0 111.668 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -48.99 83.24 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -55.19 -47.86 74.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -83.53 59.11 4.92 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.309 1.528 . . . . 0.0 111.379 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 155.35 13.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.925 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 68.51 -55.1 0.53 Allowed 'General case' 0 C--N 1.338 0.099 0 C-N-CA 129.024 2.929 . . . . 0.0 113.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -82.84 -53.16 6.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -81.1 99.28 8.42 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.671 -171.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -79.66 87.38 5.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.24 152.36 32.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.856 -1.152 . . . . 0.0 108.805 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.84 166.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 121.752 -0.592 . . . . 0.0 109.745 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -130.31 121.33 25.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.63 1.172 . . . . 0.0 109.381 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.6 tp -108.43 118.9 37.97 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.859 1.264 . . . . 0.0 110.085 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -73.87 112.98 10.5 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 m -69.74 -28.54 65.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.374 1.47 . . . . 0.0 111.498 -173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.6 -40.64 48.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.174 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -83.01 -27.23 30.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.28 2.232 . . . . 0.0 112.162 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.8 m -132.34 62.15 61.49 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.216 1.406 . . . . 0.0 109.718 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.03 -33.65 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 1 C-N-CA 125.509 4.139 . . . . 0.0 109.97 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -30.07 -73.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.332 2.253 . . . . 0.0 111.964 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -35.4 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.328 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.21 76.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -68.2 -47.23 68.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.146 0.978 . . . . 0.0 109.554 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -55.9 -43.34 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.69 -34.81 45.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.018 0.527 . . . . 0.0 111.247 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 56.35 1.07 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.4 mt -122.02 146.36 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.84 1.656 . . . . 0.0 107.638 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -149.35 -64.23 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.26 144.87 56.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 pt -143.54 156.31 60.15 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.11 141.61 57.54 Favored 'Cis proline' 0 N--CA 1.454 -0.812 0 CA-C-N 120.007 1.038 . . . . 0.0 113.528 3.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -133.91 101.25 5.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.11 100.54 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.374 1.47 . . . . 0.0 107.646 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtt -88.25 148.1 24.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.54 139.43 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 C-N-CA 125.659 1.584 . . . . 0.0 107.671 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -129.21 144.59 51.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.41 -27.03 13.38 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.318 0.386 . . . . 0.0 111.22 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.7 87.95 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 -63.15 2.8 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.554 0.597 . . . . 0.0 112.178 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -79.88 154.6 28.24 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.608 0.763 . . . . 0.0 110.701 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -71.27 158.05 37.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.51 1.124 . . . . 0.0 109.72 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.96 -58.18 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.714 1.206 . . . . 0.0 110.176 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -141.79 177.68 8.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.695 1.198 . . . . 0.0 110.112 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.7 m -156.38 132.74 10.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.282 1.033 . . . . 0.0 109.546 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.3 mt -109.46 144.26 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -130.19 142.58 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 173.61 47.26 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.792 0.71 . . . . 0.0 112.49 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.26 156.1 35.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.797 0.439 . . . . 0.0 109.92 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.66 156.67 38.86 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.028 0.931 . . . . 0.0 109.059 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -82.99 139.35 9.56 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.174 2.582 . . . . 0.0 107.171 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -48.58 -45.27 37.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 0.0 112.672 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -45.66 67.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.985 0.421 . . . . 0.0 110.626 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -65.15 -45.98 82.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.1 mt -56.2 -52.42 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 t -48.86 -58.51 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 124.609 1.163 . . . . 0.0 109.429 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.14 -47.46 83.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.494 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.0 m -56.06 -43.4 77.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.485 1.114 . . . . 0.0 110.11 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.94 -52.04 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 121.387 -0.82 . . . . 0.0 109.095 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -52.63 -47.34 67.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.62 0.768 . . . . 0.0 112.745 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.67 -23.78 65.09 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.944 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 118.809 0.731 . . . . 0.0 109.686 179.002 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.5 167.37 50.14 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.781 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.06 128.21 56.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.68 165.44 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 122.482 1.134 . . . . 0.0 111.604 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -142.89 172.14 13.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.784 2.434 . . . . 0.0 106.023 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -39.26 -49.87 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.99 1.716 . . . . 0.0 112.371 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.57 -74.08 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.227 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 p -50.31 -42.08 52.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.591 1.156 . . . . 0.0 111.826 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -39.93 -42.84 1.41 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.679 1.992 . . . . 0.0 111.15 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -61.88 -58.84 6.39 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 111.76 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -62.09 -32.74 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.323 0.649 . . . . 0.0 111.403 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -93.12 -30.24 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.898 0.879 . . . . 0.0 113.255 -170.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.95 -72.43 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 124.626 1.17 . . . . 0.0 109.828 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.4 mt -46.98 -55.84 7.43 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.981 0.912 . . . . 0.0 111.584 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.49 7.97 8.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 113.175 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -71.29 143.14 50.44 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 120.027 1.285 . . . . 0.0 110.615 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -81.87 -60.5 2.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.652 1.181 . . . . 0.0 108.73 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.04 162.43 64.55 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.186 0.995 . . . . 0.0 109.484 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.02 160.31 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.901 2.4 . . . . 0.0 113.713 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 t -143.06 147.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.174 1.39 . . . . 0.0 108.417 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.36 110.84 13.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.06 139.85 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -111.72 120.46 42.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.21 113.89 17.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -127.27 -172.15 2.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.764 0.793 . . . . 0.0 110.279 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.45 152.52 4.02 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -52.76 -42.87 60.21 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.579 2.186 . . . . 0.0 112.614 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -69.07 -12.81 62.01 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.768 -0.582 . . . . 0.0 112.269 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -77.82 80.78 4.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.797 -1.189 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.93 -56.49 3.78 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.354 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.92 -29.93 88.06 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.945 1.763 . . . . 0.0 112.414 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.26 -48.34 57.27 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -48.32 50.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.657 0.783 . . . . 0.0 111.647 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.25 -20.65 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.877 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.4 pt -90.02 -28.88 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 121.126 1.784 . . . . 0.0 110.264 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.43 -47.37 4.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.36 -39.4 57.16 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.332 2.021 . . . . 0.0 110.216 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.85 -46.34 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.08 -42.18 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.76 -65.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.421 0.688 . . . . 0.0 111.927 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -42.35 78.13 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.275 1.398 . . . . 0.0 111.727 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mt -62.77 -26.23 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.553 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.93 90.82 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.7 1.136 . . . . 0.0 109.016 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -47.49 90.83 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -58.35 -50.66 72.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -97.25 33.19 2.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.387 0.675 . . . . 0.0 112.349 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -60.27 168.83 1.85 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.607 0.718 . . . . 0.0 111.307 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 71.9 -58.55 0.58 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 127.377 2.271 . . . . 0.0 111.743 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.4 -50.15 11.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.866 -174.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.9 105.84 16.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.105 0.562 . . . . 0.0 110.108 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.15 98.96 6.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.0 t -79.32 137.34 37.3 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.559 -0.713 . . . . 0.0 110.47 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.16 163.71 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.524 0.678 . . . . 0.0 112.195 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -133.86 118.53 18.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.406 1.482 . . . . 0.0 109.595 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tp -99.5 124.17 44.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.63 109.05 7.79 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -67.39 -36.82 82.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.008 1.323 . . . . 0.0 111.243 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -66.4 -38.34 87.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.37 1.068 . . . . 0.0 110.106 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.83 -25.43 32.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.162 1.785 . . . . 0.0 111.363 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.2 t -122.6 52.73 4.32 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.461 1.504 . . . . 0.0 112.636 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.29 -25.94 71.79 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.135 3.224 . . . . 0.0 110.45 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -54.62 -63.26 1.21 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.702 0.801 . . . . 0.0 108.911 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.75 -51.23 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.794 0.838 . . . . 0.0 109.061 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.86 -47.99 21.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.228 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -67.37 -48.83 66.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.533 0.733 . . . . 0.0 110.797 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.55 -46.98 73.73 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.539 0.736 . . . . 0.0 111.203 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -79.56 -31.17 41.9 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.162 0.585 . . . . 0.0 111.166 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.84 52.1 3.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mm -73.54 84.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 122.192 0.996 . . . . 0.0 109.345 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -78.42 76.38 4.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m 94.31 166.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.391 2.676 . . . . 0.0 110.383 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.9 pt -136.21 153.68 76.75 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.169 0.988 . . . . 0.0 108.544 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.06 145.83 76.44 Favored 'Cis proline' 0 N--CA 1.453 -0.858 0 CA-C-N 120.31 1.146 . . . . 0.0 112.772 1.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 m -139.45 113.17 8.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.58 138.16 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 mtt -129.85 143.89 51.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.5 t -107.76 139.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 126.045 1.738 . . . . 0.0 107.065 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -126.62 134.48 50.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.64 -26.67 13.73 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.69 67.95 0.25 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.35 -56.89 3.71 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.89 157.66 26.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.844 0.857 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -65.76 160.63 22.54 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.87 1.668 . . . . 0.0 111.482 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.0 t -129.61 -66.23 0.81 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.471 1.508 . . . . 0.0 109.541 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -138.27 172.72 12.49 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.818 1.247 . . . . 0.0 110.007 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.6 t -160.47 153.49 21.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.041 0.936 . . . . 0.0 109.819 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.4 mm -134.54 146.24 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.76 142.16 42.54 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 126.379 1.872 . . . . 0.0 108.25 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.92 155.05 16.69 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.316 0.484 . . . . 0.0 111.998 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.95 52.37 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.549 1.14 . . . . 0.0 112.588 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.7 145.69 63.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.44 147.47 68.33 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.24 1.293 . . . . 0.0 111.426 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -58.1 -34.68 70.45 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.59 55.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.247 0.93 . . . . 0.0 110.992 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -49.48 77.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.237 1.015 . . . . 0.0 109.007 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 mm -58.26 -49.68 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.693 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.39 -53.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.45 1.1 . . . . 0.0 109.21 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.09 -48.89 72.94 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.3 m -60.8 -36.74 79.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.233 0.613 . . . . 0.0 111.441 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.81 -53.71 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 121.206 -0.934 . . . . 0.0 108.826 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -53.44 -42.24 66.92 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.412 1.085 . . . . 0.0 110.86 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -49.83 -45.89 50.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.309 0.644 . . . . 0.0 110.404 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.089 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 110.774 -0.084 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.1 -178.47 44.68 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.5 136.86 54.64 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.86 166.7 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.635 1.207 . . . . 0.0 112.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -149.15 172.71 14.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.298 2.639 . . . . 0.0 105.269 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -38.01 -50.12 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.85 2.06 . . . . 0.0 111.687 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.34 -72.22 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 111.572 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -58.64 -33.95 70.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 112.292 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -42.57 -44.64 4.25 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.603 1.961 . . . . 0.0 111.051 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -54.05 -55.61 25.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.504 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.33 -46.11 56.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.344 0.658 . . . . 0.0 111.858 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -85.07 -19.48 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.884 1.274 . . . . 0.0 114.085 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.6 -51.64 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.611 1.096 . . . . 0.0 112.044 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.32 -52.07 25.5 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.938 -0.476 . . . . 0.0 111.543 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -79.12 -9.12 59.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 m -55.73 135.4 51.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.636 1.174 . . . . 0.0 112.852 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 p -79.87 -62.03 1.81 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.805 1.242 . . . . 0.0 109.725 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.93 157.25 76.53 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -54.42 157.62 11.47 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.711 2.274 . . . . 0.0 113.931 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.27 118.45 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.547 1.539 . . . . 0.0 110.676 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.55 91.64 7.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.67 1.188 . . . . 0.0 108.417 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 p -99.27 125.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -99.41 121.31 40.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.57 0.748 . . . . 0.0 109.199 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -79.77 116.51 19.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -133.31 -170.67 2.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.915 0.486 . . . . 0.0 110.662 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.43 151.08 4.35 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -54.58 -40.05 85.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.71 2.273 . . . . 0.0 113.147 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -68.7 -16.62 63.88 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.451 0.568 . . . . 0.0 111.348 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -77.61 79.55 4.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.31 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.57 -57.34 4.53 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.66 -34.55 15.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.423 3.415 . . . . 0.0 114.244 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.01 -54.41 6.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.97 0.891 . . . . 0.0 108.638 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.9 tpt85 -47.42 -49.11 25.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.197 0.999 . . . . 0.0 111.381 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.31 -26.58 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.776 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 pt -87.75 -26.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.194 1.816 . . . . 0.0 110.514 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -46.18 4.05 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.75 -40.98 26.32 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.103 1.868 . . . . 0.0 110.378 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.32 -52.06 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.116 1.366 . . . . 0.0 107.879 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.16 -47.21 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 0.0 108.868 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -68.09 -55.5 12.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -60.59 -32.83 71.92 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.491 0.587 . . . . 0.0 109.483 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.61 -49.27 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.09 -33.87 67.74 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.85 -0.531 . . . . 0.0 110.537 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.05 -56.26 26.32 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.1 -41.45 62.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.078 0.439 . . . . 0.0 110.679 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -98.32 25.97 5.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.272 1.029 . . . . 0.0 113.304 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 169.3 2.0 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.446 0.641 . . . . 0.0 111.97 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 73.82 -53.71 0.69 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.784 2.033 . . . . 0.0 111.28 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -78.44 -54.97 5.6 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.61 114.21 27.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.5 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -78.42 163.33 25.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.8 t -145.56 146.13 31.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.42 168.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.482 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -136.0 107.42 6.88 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.685 1.194 . . . . 0.0 109.611 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -87.57 117.16 26.18 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -73.37 104.15 4.28 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.628 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.7 m -56.37 -46.74 79.9 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.309 1.844 . . . . 0.0 112.023 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.9 -36.7 82.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.26 1.824 . . . . 0.0 110.479 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -84.65 -26.01 28.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.459 1.904 . . . . 0.0 111.116 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -122.01 54.61 5.34 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.855 1.662 . . . . 0.0 111.905 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.6 -24.84 76.85 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 124.098 3.198 . . . . 0.0 111.02 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -51.83 -71.66 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.046 0.938 . . . . 0.0 109.089 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -53.48 -48.34 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.648 1.179 . . . . 0.0 109.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.29 -51.32 46.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.855 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -70.66 -43.99 67.99 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.573 0.749 . . . . 0.0 110.878 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.1 -47.67 68.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.564 0.745 . . . . 0.0 110.303 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -79.35 -31.09 42.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.95 48.08 5.93 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 pt -74.38 97.96 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.072 0.939 . . . . 0.0 109.894 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 69.08 4.68 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 109.208 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t 101.6 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 129.48 3.112 . . . . 0.0 109.506 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -143.59 161.01 48.9 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.3 1.84 . . . . 0.0 109.318 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -68.57 157.01 88.94 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 120.697 1.285 . . . . 0.0 113.054 2.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -152.07 102.59 2.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -79.86 131.96 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.7 mtt -125.54 136.79 53.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -96.02 101.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -89.01 148.62 23.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 33.94 1.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.625 0.578 . . . . 0.0 110.728 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 105.57 3.0 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.69 -70.93 0.9 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.524 1.059 . . . . 0.0 113.025 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -101.53 169.84 8.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.055 0.931 . . . . 0.0 112.189 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -84.09 165.09 18.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.334 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.79 -58.88 1.92 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.16 1.384 . . . . 0.0 108.911 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -133.18 176.29 8.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.112 1.365 . . . . 0.0 109.434 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 t -158.76 160.89 36.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.083 0.553 . . . . 0.0 110.706 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.3 mt -138.15 122.92 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.03 139.73 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.988 0.915 . . . . 0.0 109.404 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.0 153.92 14.76 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 121.47 0.483 . . . . 0.0 113.133 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.52 73.69 1.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.991 -0.711 . . . . 0.0 111.307 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.74 148.18 72.26 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.96 157.07 11.25 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.03 2.487 . . . . 0.0 113.948 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -51.94 -45.78 64.48 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.68 0.792 . . . . 0.0 111.646 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.66 64.58 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.277 0.631 . . . . 0.0 110.355 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -48.13 78.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.41 -57.08 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.8 t -48.96 -61.27 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.994 1.318 . . . . 0.0 109.872 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -52.8 -46.49 67.68 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.344 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.8 m -63.18 -44.54 95.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.622 0.369 . . . . 0.0 110.919 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.23 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 121.207 -0.933 . . . . 0.0 108.882 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -55.58 -54.05 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -47.3 -49.79 23.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.45 1.1 . . . . 0.0 110.166 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.613 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.28 -171.94 25.03 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 169.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 141.51 45.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -139.87 173.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 122.801 1.286 . . . . 0.0 110.895 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.98 171.08 18.38 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.323 2.649 . . . . 0.0 104.627 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -39.17 -53.64 1.84 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 112.832 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -52.78 63.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.312 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -73.58 -35.54 65.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.273 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -39.43 -48.16 1.91 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.601 2.36 . . . . 0.0 110.535 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -42.62 -70.44 0.11 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.169 0.988 . . . . 0.0 112.206 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.6 -47.68 80.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.533 1.133 . . . . 0.0 111.602 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.68 -37.18 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.521 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.17 -65.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.056 0.943 . . . . 0.0 110.99 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -62.8 -59.43 4.87 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -172.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.49 41.39 0.47 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.879 -0.513 . . . . 0.0 111.66 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -90.31 168.86 11.58 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -97.18 -71.65 0.67 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.542 1.537 . . . . 0.0 107.904 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.21 157.63 75.39 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.81 159.59 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.0 1.8 . . . . 0.0 114.961 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.18 127.88 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.942 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tt -103.34 104.82 14.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.031 1.732 . . . . 0.0 107.522 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.02 126.47 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.93 115.88 31.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -79.1 111.74 15.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -128.21 -174.32 3.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 122.111 0.958 . . . . 0.0 110.015 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.7 140.01 2.11 Favored Pre-proline 0 N--CA 1.451 -0.38 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -39.2 -54.47 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.362 2.708 . . . . 0.0 117.393 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -57.79 -20.89 38.73 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.819 0.736 . . . . 0.0 112.549 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 85.91 0.83 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.367 0.667 . . . . 0.0 112.13 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.2 -55.04 4.42 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.322 0.963 . . . . 0.0 113.816 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.01 -36.06 98.31 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.2 1.933 . . . . 0.0 110.959 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -66.44 -49.34 67.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -55.4 -46.31 76.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.456 0.302 . . . . 0.0 111.094 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.88 -30.4 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.128 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 tp -84.69 -35.97 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 120.619 1.554 . . . . 0.0 112.437 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.44 -49.16 4.94 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -60.32 -34.27 93.73 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.835 2.356 . . . . 0.0 110.766 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.84 -47.95 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.366 1.066 . . . . 0.0 108.379 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.58 -51.17 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -57.45 -55.28 36.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.404 . . . . 0.0 110.994 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.37 -50.84 72.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.739 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -51.13 -52.34 18.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.32 73.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.72 -41.21 97.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -66.85 -50.84 61.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -83.71 59.94 5.45 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.456 1.122 . . . . 0.0 109.878 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -46.1 -67.36 0.29 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.965 2.106 . . . . 0.0 111.988 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.92 -57.96 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.097 1.359 . . . . 0.0 114.202 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -78.9 -54.59 5.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.36 117.62 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.85 -163.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -91.34 116.37 28.79 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.754 1.221 . . . . 0.0 110.55 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.3 t -78.47 142.35 37.56 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.329 -0.857 . . . . 0.0 109.665 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.2 164.3 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -137.22 115.82 12.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.073 0.949 . . . . 0.0 109.58 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.45 118.23 34.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.87 0.868 . . . . 0.0 109.508 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -71.81 107.33 4.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.9 m -59.33 -43.06 92.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.092 1.757 . . . . 0.0 111.545 -173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.63 -35.87 82.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.909 0.884 . . . . 0.0 110.316 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.81 -24.71 30.89 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.425 1.49 . . . . 0.0 111.514 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 49.74 2.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.507 1.923 . . . . 0.0 113.23 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.13 -25.56 37.33 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.629 3.552 . . . . 0.0 109.713 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -51.26 -54.72 23.21 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.031 0.932 . . . . 0.0 109.189 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.9 -57.11 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.753 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.39 -45.1 65.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.427 0.691 . . . . 0.0 112.168 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -65.93 -48.74 70.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.996 0.519 . . . . 0.0 109.927 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.91 -38.12 69.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.529 0.332 . . . . 0.0 110.609 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.62 -23.49 45.87 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.14 40.11 11.93 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.203 0.906 . . . . 0.0 111.634 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.03 169.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.494 1.118 . . . . 0.0 109.089 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -154.25 -58.39 0.12 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.893 0.877 . . . . 0.0 109.386 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 147.93 30.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.38 155.54 60.97 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.65 142.32 69.41 Favored 'Cis proline' 0 N--CA 1.453 -0.855 0 CA-C-N 120.134 1.084 . . . . 0.0 112.322 1.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -137.05 102.48 4.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.03 134.71 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 33.5 mtt -128.33 123.52 34.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.5 t -95.88 141.54 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -127.1 158.3 37.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.332 1.453 . . . . 0.0 107.913 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 42.62 1.18 Allowed 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.335 1.022 . . . . 0.0 110.726 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.2 97.17 2.28 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.49 -73.19 0.77 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.428 0.537 . . . . 0.0 112.213 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.84 160.54 26.06 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.315 1.055 . . . . 0.0 111.847 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.95 143.75 28.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.512 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.2 t -88.38 -70.29 0.65 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.283 1.033 . . . . 0.0 108.289 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -150.79 -175.37 5.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.588 1.555 . . . . 0.0 109.256 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -143.73 162.42 36.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.916 1.286 . . . . 0.0 109.719 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.3 mt -139.24 140.78 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.33 138.72 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.78 153.72 25.95 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 121.888 0.716 . . . . 0.0 112.116 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.97 78.01 3.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.246 0.618 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -78.28 152.25 78.76 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.26 153.23 22.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.592 2.194 . . . . 0.0 113.995 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -46.6 -50.25 17.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.278 1.831 . . . . 0.0 110.654 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.2 -47.25 75.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.933 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -62.54 -46.21 89.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.568 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.1 mt -54.68 -55.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 t -52.33 -59.03 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.218 0.607 . . . . 0.0 110.042 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -49.47 -52.14 31.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.436 0.694 . . . . 0.0 110.338 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 45.4 m -61.7 -45.37 94.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.214 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.06 -56.24 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 118.739 0.699 . . . . 0.0 109.583 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -62.72 -43.76 97.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.932 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -51.24 -54.4 26.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.258 0.623 . . . . 0.0 109.552 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.649 -176.095 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.03 157.1 36.07 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.987 1.28 . . . . 0.0 113.285 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.3 114.85 20.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.14 164.54 20.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 122.806 1.289 . . . . 0.0 110.13 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -143.21 174.75 10.43 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.348 1.859 . . . . 0.0 106.691 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -53.41 2.1 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.957 1.303 . . . . 0.0 113.229 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.94 -59.65 2.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.136 0.974 . . . . 0.0 111.46 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -59.11 -34.43 72.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.563 0.745 . . . . 0.0 111.682 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -45.42 -48.29 13.67 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 126.039 1.736 . . . . 0.0 110.541 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -55.15 -53.64 53.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.632 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -53.64 54.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 0.0 112.347 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -75.15 -39.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.875 1.27 . . . . 0.0 113.302 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.61 -66.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.18 0.992 . . . . 0.0 110.903 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.06 -59.2 5.73 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 121.217 0.532 . . . . 0.0 110.877 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -78.87 40.55 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.355 0.662 . . . . 0.0 111.227 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.1 t -90.29 -169.44 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.834 0.854 . . . . 0.0 109.328 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -131.58 -66.14 0.73 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.191 2.196 . . . . 0.0 106.71 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.86 157.0 79.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.02 161.03 7.03 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.391 2.061 . . . . 0.0 112.617 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.28 139.32 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -114.11 117.15 30.44 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.77 115.94 51.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -90.3 111.95 23.33 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -78.76 112.64 16.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -125.36 -173.84 2.92 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.096 0.951 . . . . 0.0 110.265 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.72 152.49 4.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -55.33 -32.02 79.46 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.393 2.062 . . . . 0.0 113.544 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -78.98 -6.42 56.26 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.3 0.955 . . . . 0.0 111.737 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.17 88.22 6.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.827 -1.171 . . . . 0.0 111.192 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.11 -63.52 0.91 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.639 1.114 . . . . 0.0 113.706 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.36 -47.24 23.07 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.959 2.439 . . . . 0.0 112.63 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 77.7 m -54.27 -44.43 71.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.261 0.624 . . . . 0.0 109.854 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -54.76 -50.11 69.22 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -81.94 -19.68 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.594 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.2 mt -78.78 -38.88 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.842 0.857 . . . . 0.0 109.224 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.85 -49.26 5.72 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.893 2.077 . . . . 0.0 115.553 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.83 -37.24 79.4 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.345 2.03 . . . . 0.0 110.109 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.48 -43.65 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.7 t -55.67 -45.38 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -56.43 -63.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.557 0.743 . . . . 0.0 109.831 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.92 -37.55 76.93 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.684 0.675 . . . . 0.0 112.04 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -52.25 -36.44 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.632 0.773 . . . . 0.0 110.01 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.59 -39.2 76.27 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.333 0.515 . . . . 0.0 110.988 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.14 -50.4 34.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -53.36 -44.5 68.59 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -115.12 37.43 3.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.656 0.782 . . . . 0.0 112.803 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.98 162.2 2.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.906 0.882 . . . . 0.0 111.176 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 72.77 -61.81 0.49 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.314 2.245 . . . . 0.0 111.353 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -78.0 -32.08 51.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -170.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 tp -125.38 102.9 7.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.88 94.86 5.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.43 132.2 37.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 118.589 -0.719 . . . . 0.0 109.317 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.11 176.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.022 0.828 . . . . 0.0 111.793 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -131.13 122.93 27.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.723 2.009 . . . . 0.0 110.943 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -104.31 120.15 40.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.607 1.563 . . . . 0.0 109.818 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -74.89 107.61 7.09 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 m -66.76 -33.66 76.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.491 1.516 . . . . 0.0 111.427 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.29 -38.92 78.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.58 -27.85 31.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.762 2.025 . . . . 0.0 111.519 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -119.84 52.28 2.16 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.579 1.552 . . . . 0.0 112.431 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -65.98 -30.08 48.48 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 125.49 4.127 . . . . 0.0 109.747 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.83 -62.17 2.07 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -55.73 -47.06 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.388 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.3 -47.42 55.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.194 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -65.74 -46.05 80.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.161 0.585 . . . . 0.0 110.515 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -54.45 -45.8 73.18 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.978 0.511 . . . . 0.0 110.638 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -79.48 -30.93 42.26 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.21 43.29 3.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 123.915 0.769 . . . . 0.0 111.22 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.38 88.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -77.29 -23.24 51.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.2 p -157.24 175.08 14.5 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 pt -146.62 154.4 48.24 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.08 133.94 26.37 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 CA-C-N 120.92 1.364 . . . . 0.0 113.445 1.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -139.98 104.83 4.95 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.571 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.0 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.78 153.27 34.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.74 133.15 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.218 1.007 . . . . 0.0 108.669 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -128.81 141.98 51.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 133.77 18.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.53 41.75 98.85 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -172.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.19 -47.47 2.63 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 124.451 1.024 . . . . 0.0 114.075 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -79.62 157.26 27.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.044 0.938 . . . . 0.0 111.964 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -88.24 156.07 19.41 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 127.296 2.238 . . . . 0.0 112.83 -172.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.83 -80.28 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.665 0.386 . . . . 0.0 111.626 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -74.71 152.84 39.07 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.107 0.48 . . . . 0.0 111.99 -170.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.7 m -132.94 110.88 10.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.969 2.508 . . . . 0.0 106.005 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.47 123.86 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -78.83 146.85 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.93 -137.72 0.69 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 71.53 -46.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.945 1.298 . . . . 0.0 110.687 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.08 148.49 75.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.18 68.75 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.526 1.484 . . . . 0.0 111.696 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -50.62 -37.41 40.22 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.227 1.011 . . . . 0.0 111.27 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.55 -41.73 21.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.508 0.595 . . . . 0.0 111.192 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -47.21 84.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.708 0.803 . . . . 0.0 108.869 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 mt -63.27 -40.29 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.825 1.25 . . . . 0.0 110.072 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.8 t -57.89 -58.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.921 1.288 . . . . 0.0 108.143 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.01 -46.63 68.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.233 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 m -60.39 -51.98 67.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.189 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.77 -44.15 93.18 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.34 -0.85 . . . . 0.0 110.854 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -50.46 -39.73 48.76 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.869 0.868 . . . . 0.0 111.558 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -59.64 -29.25 67.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.294 -0.254 . . . . 0.0 111.399 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 CA--C 1.529 0.156 0 C-N-CA 123.691 0.797 . . . . 0.0 109.995 179.225 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.88 179.68 44.27 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.33 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.67 137.46 54.45 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.14 164.02 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 118.972 0.806 . . . . 0.0 111.158 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.02 169.9 17.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 173.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -38.92 -45.26 1.16 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.352 1.861 . . . . 0.0 112.41 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.09 -74.14 0.12 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.028 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -48.81 -38.9 23.48 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.499 1.12 . . . . 0.0 111.564 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -38.95 -47.36 1.44 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.364 2.266 . . . . 0.0 110.591 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -48.3 -64.67 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.96 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.08 -38.55 75.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.126 1.37 . . . . 0.0 111.911 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 p -83.0 -47.86 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.293 1.037 . . . . 0.0 113.424 -172.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.85 -57.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.726 0.81 . . . . 0.0 110.886 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.48 -57.0 6.47 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.57 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.39 45.53 0.67 Allowed 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.444 -0.785 . . . . 0.0 111.221 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 p -90.52 164.72 14.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.545 1.138 . . . . 0.0 111.128 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.5 p -104.98 -68.62 0.85 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.623 1.569 . . . . 0.0 107.162 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.0 162.93 62.73 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.034 1.333 . . . . 0.0 108.035 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.27 167.9 2.33 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.799 1.666 . . . . 0.0 112.294 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -146.28 120.27 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.574 1.549 . . . . 0.0 109.215 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -97.72 102.79 14.64 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -98.21 109.73 24.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.362 0.665 . . . . 0.0 109.801 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -87.77 117.72 26.8 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -79.19 112.6 16.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -126.31 -173.74 2.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.843 0.83 . . . . 0.0 111.008 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.66 156.76 3.43 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.41 -36.42 78.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.315 2.01 . . . . 0.0 109.991 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -76.68 -3.56 38.58 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.708 0.803 . . . . 0.0 111.738 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.4 t -63.69 -60.42 3.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.714 1.143 . . . . 0.0 111.659 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 -86.02 0.52 Allowed Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.069 -1.406 . . . . 0.0 110.761 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.97 -46.13 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.415 2.744 . . . . 0.0 111.843 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.0 m -46.13 -46.53 17.19 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.374 1.47 . . . . 0.0 111.41 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -67.87 -44.08 77.92 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.656 0.783 . . . . 0.0 110.797 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.97 -13.13 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.875 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.59 -38.49 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.062 1.345 . . . . 0.0 108.491 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -37.95 -47.38 2.71 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.905 2.082 . . . . 0.0 114.721 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.13 -39.97 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.828 1.686 . . . . 0.0 109.918 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -74.91 -47.52 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.629 1.972 . . . . 0.0 109.505 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -38.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.601 -1.312 . . . . 0.0 109.568 175.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.86 -54.25 24.21 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 119.286 -0.387 . . . . 0.0 110.822 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.08 -41.89 89.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.32 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mm -55.3 -46.49 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.27 -51.09 57.32 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.16 -54.21 13.02 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -61.73 -54.0 48.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.678 0.752 . . . . 0.0 112.916 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -83.21 -8.06 59.53 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -37.31 -58.49 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.501 1.921 . . . . 0.0 113.5 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.21 -39.91 60.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.952 1.301 . . . . 0.0 112.802 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -91.32 -37.47 13.24 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.887 1.275 . . . . 0.0 113.301 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.03 145.5 18.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.84 1.256 . . . . 0.0 108.446 -168.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -93.82 154.67 17.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.997 1.719 . . . . 0.0 109.678 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 147.01 49.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.83 167.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.133 0.424 . . . . 0.0 111.021 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -135.54 113.65 11.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.661 1.185 . . . . 0.0 111.545 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.9 tt -94.87 116.53 28.84 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.126 0.971 . . . . 0.0 109.57 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -75.88 111.38 11.19 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -66.53 -29.23 69.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.366 1.466 . . . . 0.0 111.85 -173.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.69 -38.31 54.67 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.915 1.286 . . . . 0.0 109.787 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -80.91 -25.94 37.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.044 1.737 . . . . 0.0 110.782 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 m -117.33 51.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.916 2.087 . . . . 0.0 112.232 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -63.78 -31.0 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 125.598 4.198 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -58.4 -64.24 0.99 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.19 -44.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.851 0.357 . . . . 0.0 110.073 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.79 64.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -67.78 -44.46 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.226 0.61 . . . . 0.0 110.628 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.73 -45.85 70.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 110.222 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -79.56 -33.2 42.01 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.79 50.11 2.18 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.85 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.777 0.831 . . . . 0.0 109.351 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -26.31 43.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.905 0.882 . . . . 0.0 110.812 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.9 m -160.24 160.17 32.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.833 1.253 . . . . 0.0 107.781 -171.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 pt -143.35 160.7 50.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.956 1.702 . . . . 0.0 107.566 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.7 154.57 79.46 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 CA-C-N 121.426 1.545 . . . . 0.0 113.838 3.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.6 m -151.14 104.04 3.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.8 mt -91.12 118.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.9 mtt -103.86 129.52 51.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.7 t -91.18 115.76 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.47 166.18 12.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.822 1.249 . . . . 0.0 108.626 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.28 -161.0 0.71 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.06 102.86 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.33 1.443 . . . . 0.0 114.656 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.27 -64.35 2.07 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.75 1.167 . . . . 0.0 114.963 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.43 177.74 4.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.479 1.133 . . . . 0.0 113.706 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -87.72 155.92 19.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.041 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.6 t -103.59 -69.15 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.823 1.249 . . . . 0.0 108.994 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.42 177.96 8.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 108.39 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -152.87 149.29 28.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.892 -0.505 . . . . 0.0 109.975 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -121.52 104.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.955 2.102 . . . . 0.0 107.026 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.4 mt -89.49 137.38 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.05 1.34 . . . . 0.0 107.799 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.64 150.0 25.42 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 121.697 0.609 . . . . 0.0 112.284 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.42 64.18 2.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.954 0.901 . . . . 0.0 112.031 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.29 150.66 74.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.21 149.25 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.728 1.619 . . . . 0.0 112.1 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -45.69 66.72 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.95 -43.72 14.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.206 0.602 . . . . 0.0 111.515 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -51.43 67.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.993 0.917 . . . . 0.0 108.931 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.0 -52.19 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 123.829 0.852 . . . . 0.0 109.775 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.28 -57.3 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.267 0.94 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -55.28 -49.28 72.52 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.807 0.336 . . . . 0.0 110.286 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.5 m -57.23 -45.98 83.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.725 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.79 -52.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 120.915 -1.116 . . . . 0.0 109.267 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.02 -38.34 65.03 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.731 1.212 . . . . 0.0 111.721 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -54.7 -33.5 61.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.505 0.322 . . . . 0.0 110.88 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 . . . . . 0 CA--C 1.536 0.427 0 C-N-CA 125.354 1.462 . . . . 0.0 113.145 -174.055 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.38 167.47 54.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.392 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.04 132.16 50.58 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -131.39 173.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 122.074 0.94 . . . . 0.0 110.043 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -155.66 178.28 10.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.309 2.244 . . . . 0.0 105.48 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -45.7 -55.95 5.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.993 0.815 . . . . 0.0 111.699 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.31 -57.79 4.29 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.833 1.653 . . . . 0.0 112.623 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 p -74.06 -47.0 39.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.863 0.865 . . . . 0.0 111.293 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -39.66 -48.7 2.17 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.229 2.212 . . . . 0.0 110.739 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -40.03 -53.83 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.708 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -87.27 -47.83 8.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.366 1.079 . . . . 0.0 110.695 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.28 -32.89 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.217 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -109.95 -64.56 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.02 1.328 . . . . 0.0 111.603 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.23 -71.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.312 0.505 . . . . 0.0 111.14 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.43 53.64 2.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.905 0.882 . . . . 0.0 108.8 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.1 p -90.8 -129.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.024 0.929 . . . . 0.0 109.56 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.1 p -161.54 -78.04 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.05 163.71 58.65 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -50.17 163.13 0.64 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.814 2.343 . . . . 0.0 114.043 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 t -146.45 141.54 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 108.784 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.01 97.53 5.14 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.96 129.85 47.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -102.32 116.67 33.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.21 108.66 12.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -124.49 -175.5 3.28 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 123.716 0.635 . . . . 0.0 110.475 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.53 142.07 1.35 Allowed Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.922 0.889 . . . . 0.0 111.077 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.73 108.72 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.228 1.952 . . . . 0.0 108.468 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 137.85 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 1 C-N-CA 131.756 4.022 . . . . 0.0 105.846 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.7 t -74.93 83.02 2.2 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.54 -58.96 2.84 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.249 0.928 . . . . 0.0 112.25 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -48.54 -34.14 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.967 3.111 . . . . 0.0 113.86 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.41 -46.23 17.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -50.91 -50.24 57.86 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.275 1.43 . . . . 0.0 111.119 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.97 -32.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.5 mm -76.35 -36.86 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.551 1.141 . . . . 0.0 111.95 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.76 -48.49 5.42 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.8 -36.46 61.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.656 2.238 . . . . 0.0 110.179 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.86 -45.23 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.17 -48.17 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -59.92 -53.07 62.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.04 -39.69 95.5 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.775 -1.203 . . . . 0.0 110.402 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mt -56.8 -44.4 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.86 -52.82 55.92 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.73 49.06 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -62.99 -43.3 99.16 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -117.08 8.93 13.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -39.65 -46.53 1.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.731 2.012 . . . . 0.0 112.199 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -29.91 -58.81 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.874 2.469 . . . . 0.0 113.508 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -112.29 -31.72 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.343 1.057 . . . . 0.0 112.342 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.46 105.47 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.125 0.57 . . . . 0.0 111.055 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -78.66 91.08 4.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.2 t -79.5 136.44 36.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.997 -1.064 . . . . 0.0 110.328 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.96 173.27 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.522 0.729 . . . . 0.0 111.551 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -139.93 113.07 8.25 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.726 1.21 . . . . 0.0 111.127 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.81 126.84 38.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.738 0.699 . . . . 0.0 110.753 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -77.64 108.97 11.21 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 m -70.87 -33.22 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.754 1.622 . . . . 0.0 111.55 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.4 -40.33 93.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.221 1.01 . . . . 0.0 109.346 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -84.61 -24.16 29.27 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.177 2.191 . . . . 0.0 112.141 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 m -134.97 61.98 50.02 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 120.821 -1.174 . . . . 0.0 111.735 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.06 -23.25 34.18 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 124.962 3.774 . . . . 0.0 109.921 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -42.97 -72.64 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.614 1.565 . . . . 0.0 110.931 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.0 t -52.18 -48.4 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.033 1.333 . . . . 0.0 109.899 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -41.81 66.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.939 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.5 m -74.8 -43.5 54.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.015 . . . . 0.0 110.566 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -54.84 -48.31 73.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.316 0.646 . . . . 0.0 109.938 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -79.44 -33.0 42.84 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.56 56.7 4.12 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.3 pt -67.49 142.28 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.492 0.663 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -79.6 71.7 6.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.6 t 65.33 -157.28 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.616 1.166 . . . . 0.0 109.384 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 153.04 69.96 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.313 1.045 . . . . 0.0 110.103 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.24 145.07 82.33 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 CA-C-N 119.536 0.87 . . . . 0.0 112.515 2.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.1 m -136.08 106.66 6.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.65 105.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.928 1.691 . . . . 0.0 106.54 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.6 mtp -103.62 127.53 51.04 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.46 134.03 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -120.65 136.73 54.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 173.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.464 ' CG ' ' H ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -107.43 -101.3 0.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 81' ' ' LYS . . . -71.85 73.15 0.84 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.61 -59.94 3.33 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.328 0.966 . . . . 0.0 112.975 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -86.09 173.27 9.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.36 0.6 . . . . 0.0 112.279 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.21 152.92 10.09 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.948 1.699 . . . . 0.0 113.411 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 t -130.54 -56.87 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.666 1.987 . . . . 0.0 109.058 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.05 166.95 21.54 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.397 1.079 . . . . 0.0 110.632 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 m -152.75 95.5 2.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.817 1.647 . . . . 0.0 106.618 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.33 141.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.3 mt -133.22 142.96 40.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 155.94 32.19 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 71.96 1.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.099 -0.648 . . . . 0.0 111.67 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -79.13 153.66 77.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.43 154.46 53.27 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.343 2.028 . . . . 0.0 114.424 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -45.38 -53.49 8.55 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.364 1.866 . . . . 0.0 109.47 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.49 -55.79 4.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.727 1.211 . . . . 0.0 110.132 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -59.19 -53.39 58.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 110.539 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 80.8 mt -51.87 -58.67 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.88 -60.29 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.976 1.31 . . . . 0.0 109.907 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -49.23 -49.14 44.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.269 0.486 . . . . 0.0 111.163 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.7 m -61.53 -57.72 10.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 p -63.51 -45.06 98.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 118.561 -1.256 . . . . 0.0 111.257 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -50.96 -49.76 59.39 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.765 1.626 . . . . 0.0 110.741 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -51.72 -48.84 63.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.719 175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -173.2 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.436 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.2 168.16 54.73 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.31 131.65 56.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.82 162.83 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 122.167 0.984 . . . . 0.0 110.488 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -142.72 176.59 8.93 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.407 1.883 . . . . 0.0 106.338 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -39.22 -58.84 1.11 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.653 1.181 . . . . 0.0 112.383 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -54.62 -58.09 8.87 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.851 1.661 . . . . 0.0 113.09 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -67.2 -46.38 74.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.3 1.84 . . . . 0.0 110.558 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -40.15 -51.5 2.64 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 126.84 2.056 . . . . 0.0 111.212 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -44.08 -52.5 7.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.664 0.745 . . . . 0.0 110.931 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.66 -58.06 3.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.606 0.717 . . . . 0.0 111.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.33 -43.6 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.565 -169.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.68 -61.54 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.518 1.127 . . . . 0.0 111.348 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -70.68 -63.03 1.17 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.929 0.786 . . . . 0.0 110.508 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -79.92 52.63 1.53 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.619 0.645 . . . . 0.0 111.48 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 p -89.02 155.36 19.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.783 1.633 . . . . 0.0 110.322 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -87.1 -73.77 0.46 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.66 162.01 64.59 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.58 166.88 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.323 2.016 . . . . 0.0 114.18 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.14 149.02 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.362 1.865 . . . . 0.0 110.466 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 tt -126.87 102.03 6.84 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 170.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.0 p -107.08 123.6 62.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.116 1.325 . . . . 0.0 108.789 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -93.59 115.29 27.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -79.61 104.07 9.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -116.61 -169.91 1.72 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.315 1.046 . . . . 0.0 110.24 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.49 148.73 1.55 Allowed Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 124.595 1.158 . . . . 0.0 107.923 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.03 -37.71 95.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.559 2.173 . . . . 0.0 112.85 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -72.73 -18.7 61.49 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.904 -0.497 . . . . 0.0 111.052 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.69 83.59 6.43 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.057 -1.027 . . . . 0.0 109.715 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.29 -59.53 1.82 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.52 1.057 . . . . 0.0 113.457 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.99 -48.61 20.74 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.694 2.263 . . . . 0.0 111.546 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.4 m -55.74 -50.49 70.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -58.13 -49.93 75.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.332 1.053 . . . . 0.0 111.536 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.73 -22.47 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.722 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.0 mt -82.56 -30.13 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 119.847 1.203 . . . . 0.0 109.435 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.35 -41.69 2.64 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.937 1.695 . . . . 0.0 115.223 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.76 -40.89 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.323 2.015 . . . . 0.0 109.809 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.14 -35.33 34.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 C-N-CA 118.153 -1.419 . . . . 0.0 108.136 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.7 t -52.73 -43.65 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.15 -58.36 8.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.094 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.36 -42.2 77.4 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.558 0.617 . . . . 0.0 111.884 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.98 -36.5 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 122.838 0.455 . . . . 0.0 109.962 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.68 -46.97 80.86 Favored 'General case' 0 C--O 1.223 -0.342 0 O-C-N 121.913 -0.492 . . . . 0.0 110.193 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.9 -42.68 99.63 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.76 -44.06 90.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.55 15.63 8.84 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -39.43 -51.15 2.13 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.132 1.373 . . . . 0.0 113.7 -174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -44.7 -46.65 10.44 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.081 1.752 . . . . 0.0 112.774 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -98.56 -37.76 9.42 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.92 0.888 . . . . 0.0 112.266 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.4 tp -116.16 112.07 21.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.101 -167.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -79.96 93.65 5.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 49.9 t -79.13 134.16 36.72 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.494 -0.754 . . . . 0.0 109.685 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.64 167.9 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.166 0.586 . . . . 0.0 111.758 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -135.27 116.4 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.034 1.334 . . . . 0.0 110.077 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -98.86 120.83 39.96 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 109.585 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -75.42 103.31 5.5 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.672 0.749 . . . . 0.0 110.265 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -81.96 48.33 1.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.451 1.9 . . . . 0.0 111.27 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -145.5 -47.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.59 -26.43 34.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.86 2.064 . . . . 0.0 109.821 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.4 m -133.05 60.38 49.0 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.006 -1.059 . . . . 0.0 113.813 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.87 -23.78 16.07 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 125.186 3.924 . . . . 0.0 108.716 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -37.38 -69.25 0.12 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.356 1.862 . . . . 0.0 111.099 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -35.68 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.183 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.63 81.24 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 m -72.41 -45.21 60.71 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.095 0.958 . . . . 0.0 109.965 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -54.97 -46.04 75.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.35 0.66 . . . . 0.0 110.386 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.98 -34.76 43.92 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.365 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.23 54.77 1.24 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.516 0.579 . . . . 0.0 111.859 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.6 mt -77.69 121.41 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -79.0 -35.46 42.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.02 0.528 . . . . 0.0 111.537 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.9 m -158.73 168.82 25.84 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.1 pt -124.82 154.56 70.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.34 149.69 82.19 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 CA-C-N 120.287 1.138 . . . . 0.0 112.277 2.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -144.04 106.04 4.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.61 116.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.5 mtt -105.76 134.93 48.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -99.47 140.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -127.99 161.1 29.94 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 54.56 0.81 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.521 1.138 . . . . 0.0 110.488 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.18 98.35 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.48 -73.08 1.17 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.103 0.858 . . . . 0.0 112.066 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -94.58 165.21 12.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.825 1.298 . . . . 0.0 113.131 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -77.32 142.35 39.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.265 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 41.7 t -89.08 -65.22 1.04 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.227 1.011 . . . . 0.0 108.643 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -151.28 -174.75 4.92 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.091 1.756 . . . . 0.0 108.166 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.2 t -154.23 166.72 32.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.364 0.666 . . . . 0.0 109.585 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.0 mt -136.02 118.63 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.95 141.0 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 109.027 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.64 163.33 38.3 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.836 0.731 . . . . 0.0 111.569 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.34 142.97 57.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.08 0.552 . . . . 0.0 110.739 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.69 153.54 36.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 124.123 0.969 . . . . 0.0 108.525 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.72 145.29 20.2 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 N-CA-C 105.586 -2.505 . . . . 0.0 105.586 168.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -56.29 -33.41 65.5 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.321 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.88 -42.87 6.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.662 0.785 . . . . 0.0 110.62 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.1 m -75.3 -44.42 45.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.978 0.511 . . . . 0.0 110.018 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.5 mt -54.42 -47.45 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 123.51 0.724 . . . . 0.0 110.08 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -57.15 -55.28 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.439 0.695 . . . . 0.0 109.714 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -56.61 -45.49 81.45 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.889 -0.507 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.3 m -66.34 -43.24 86.65 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.073 0.549 . . . . 0.0 111.752 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.71 -43.62 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 121.024 -1.048 . . . . 0.0 108.878 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.26 -47.75 80.61 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -54.1 -52.0 62.38 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.473 0.709 . . . . 0.0 109.919 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 122.613 0.365 . . . . 0.0 111.791 -178.28 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.06 166.16 44.63 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.32 126.98 55.84 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.52 164.43 30.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 122.271 1.034 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -148.9 179.84 7.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.321 1.848 . . . . 0.0 106.832 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -39.05 -59.05 1.04 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.362 1.465 . . . . 0.0 112.213 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.99 -69.14 0.25 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.546 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -51.59 -39.03 57.18 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.248 1.019 . . . . 0.0 112.11 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -44.74 -48.22 10.79 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.197 1.399 . . . . 0.0 111.045 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -50.29 -51.25 46.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.412 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -74.76 -56.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.428 0.633 . . . . 0.0 111.38 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.7 t -66.86 -23.97 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.078 1.751 . . . . 0.0 113.368 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.51 -75.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.574 0.75 . . . . 0.0 110.524 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.37 -47.06 66.37 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.667 0.667 . . . . 0.0 112.781 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.14 15.03 16.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.423 1.089 . . . . 0.0 112.085 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.34 147.93 27.64 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.034 0.834 . . . . 0.0 111.407 -173.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.2 p -80.01 -61.91 1.84 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.345 1.458 . . . . 0.0 111.753 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.45 160.25 75.57 Favored Pre-proline 0 C--O 1.233 0.185 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.79 159.88 3.27 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.245 1.963 . . . . 0.0 110.403 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.05 149.26 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 123.768 0.827 . . . . 0.0 109.599 -173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.67 98.97 4.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.68 119.29 45.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -95.29 114.04 25.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -79.58 112.37 16.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -128.14 -172.04 2.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.817 0.818 . . . . 0.0 110.526 -174.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.27 151.7 4.71 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 124.516 1.126 . . . . 0.0 108.108 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.62 -31.98 93.26 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.375 2.05 . . . . 0.0 113.266 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -79.47 -7.23 58.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.107 0.867 . . . . 0.0 111.405 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.6 t -81.31 83.63 6.83 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.078 -1.013 . . . . 0.0 112.551 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.93 -58.02 2.78 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.551 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.22 -20.19 66.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 CA-C-N 119.634 1.717 . . . . 0.0 113.064 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.8 m -81.15 -49.82 10.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -45.17 -50.21 11.55 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.778 0.831 . . . . 0.0 111.153 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -65.82 -25.75 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.387 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 pt -90.23 -29.05 4.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 CA-C-N 120.689 1.586 . . . . 0.0 110.255 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.02 4.28 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.96 -28.39 24.36 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 122.276 1.849 . . . . 0.0 109.848 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -71.41 -41.42 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -55.94 -46.74 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.38 -54.73 39.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.69 -41.15 94.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.638 1.563 . . . . 0.0 110.669 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.9 mm -60.36 -41.99 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -50.71 67.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.925 0.784 . . . . 0.0 109.302 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.81 -49.7 34.11 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.14 -58.89 4.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -85.38 -0.03 53.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -171.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -39.0 -49.12 1.69 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.549 1.54 . . . . 0.0 113.163 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -46.87 -59.95 2.74 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.859 1.664 . . . . 0.0 112.593 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -83.48 -30.03 27.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.799 1.24 . . . . 0.0 112.579 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.67 110.89 10.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 -168.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.81 95.59 6.07 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.3 t -79.26 140.18 37.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.572 -0.705 . . . . 0.0 109.29 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.82 165.4 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.835 0.854 . . . . 0.0 109.906 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -133.56 116.95 16.52 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.708 1.203 . . . . 0.0 109.268 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 tt -99.1 123.39 43.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.017 0.436 . . . . 0.0 110.385 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.99 108.82 9.14 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.9 m -68.99 -29.82 68.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 124.876 1.27 . . . . 0.0 111.692 -174.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.58 -43.26 66.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.91 0.862 . . . . 0.0 110.177 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -81.19 -27.4 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.299 1.84 . . . . 0.0 111.666 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.2 m -134.0 61.89 54.09 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 121.04 -1.037 . . . . 0.0 110.679 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.14 -35.9 31.31 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.899 3.733 . . . . 0.0 108.861 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -33.55 -69.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.11 2.164 . . . . 0.0 111.058 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.8 t -55.48 -51.45 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.744 1.218 . . . . 0.0 110.057 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.32 -37.03 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.122 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 m -74.6 -45.23 46.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.53 1.132 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.99 -43.28 73.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.421 0.688 . . . . 0.0 109.629 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -78.97 -32.71 45.42 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.385 -0.341 . . . . 0.0 110.952 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.45 51.1 2.42 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 111.675 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.0 mt -84.05 113.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.075 0.95 . . . . 0.0 108.676 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.45 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -79.65 -26.86 40.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 113.532 -175.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 m -161.08 167.11 26.96 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 pt -129.53 151.92 78.78 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 146.88 83.0 Favored 'Cis proline' 0 N--CA 1.453 -0.894 0 CA-C-N 119.923 1.008 . . . . 0.0 113.277 1.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.6 m -139.61 114.4 9.4 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.3 mt -104.55 102.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.8 mtt -87.86 131.92 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.44 143.31 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -134.31 158.93 42.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.964 0.906 . . . . 0.0 109.716 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 146.72 28.52 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.554 2.342 . . . . 0.0 104.73 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.92 55.12 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.117 -1.516 . . . . 0.0 111.768 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.1 -52.58 2.95 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 122.258 -0.554 . . . . 0.0 113.525 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -79.67 163.66 24.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.539 1.161 . . . . 0.0 113.409 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -67.67 148.04 51.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.863 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 t -115.11 -63.41 1.46 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.355 1.462 . . . . 0.0 109.125 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -138.3 -177.7 4.96 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 109.771 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -155.22 131.82 10.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.941 0.896 . . . . 0.0 109.455 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.0 mm -104.33 153.28 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.74 142.02 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.154 0.981 . . . . 0.0 108.596 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.31 158.24 20.14 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 121.531 0.517 . . . . 0.0 112.54 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.92 70.18 1.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.53 . . . . 0.0 111.146 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -78.5 153.43 78.8 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.71 147.22 50.91 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.619 1.546 . . . . 0.0 112.208 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -62.05 -39.19 91.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.391 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -48.86 37.12 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -59.56 -51.12 71.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 109.204 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.1 mt -54.96 -58.38 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.039 0.535 . . . . 0.0 109.878 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.2 t -49.67 -55.98 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.886 1.274 . . . . 0.0 110.673 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -48.23 74.25 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -61.38 -41.41 97.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.459 0.303 . . . . 0.0 111.191 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.18 -49.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -57.75 -46.56 84.33 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.509 0.724 . . . . 0.0 110.048 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -51.85 -52.05 52.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.736 0.814 . . . . 0.0 109.482 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.01 -177.44 39.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.86 136.9 54.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.41 165.49 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.616 0.722 . . . . 0.0 111.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -145.55 172.09 13.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.784 2.034 . . . . 0.0 106.063 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -39.09 -48.12 1.63 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.936 1.694 . . . . 0.0 112.663 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.52 -74.0 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.105 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -52.86 -36.33 58.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.512 1.125 . . . . 0.0 111.951 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -41.06 -46.73 2.99 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 126.258 1.823 . . . . 0.0 111.376 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -49.48 -48.02 48.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.789 1.236 . . . . 0.0 111.086 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -85.12 -57.64 3.01 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.779 0.832 . . . . 0.0 111.157 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.77 -38.58 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.651 1.18 . . . . 0.0 112.163 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -104.91 -59.52 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 112.305 -174.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 mt -66.57 -71.34 0.2 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.162 0.437 . . . . 0.0 110.982 -174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -79.57 52.77 1.46 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.101 0.476 . . . . 0.0 111.483 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 p -90.67 159.29 16.47 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.11 1.764 . . . . 0.0 111.301 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -91.72 -69.87 0.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.243 1.417 . . . . 0.0 107.736 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 m -78.75 154.41 78.32 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.29 163.81 16.47 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.748 0.965 . . . . 0.0 110.194 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.47 113.72 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.667 1.187 . . . . 0.0 111.348 -171.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.32 105.64 13.56 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.85 116.04 45.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 109.762 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -89.44 112.27 23.36 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -78.71 112.93 16.32 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -130.12 -172.52 2.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.575 0.75 . . . . 0.0 110.754 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.5 148.82 3.51 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.967 1.307 . . . . 0.0 107.772 172.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.15 -45.35 41.67 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.702 2.268 . . . . 0.0 112.809 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -64.56 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.031 -0.418 . . . . 0.0 111.96 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.4 t -76.31 84.44 3.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.626 -0.671 . . . . 0.0 110.913 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.53 -54.12 5.77 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.996 0.808 . . . . 0.0 112.883 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -27.78 71.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.365 2.043 . . . . 0.0 112.767 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.4 m -77.15 -53.67 7.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -45.04 -47.2 11.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.981 1.712 . . . . 0.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -71.9 -25.96 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.02 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.6 pt -86.88 -26.43 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 121.267 1.849 . . . . 0.0 110.083 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.14 -45.72 3.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.367 1.467 . . . . 0.0 114.795 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -68.11 -33.17 25.9 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.708 2.272 . . . . 0.0 109.979 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -38.76 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 127.053 2.141 . . . . 0.0 107.901 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.25 -45.69 95.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.92 -52.92 63.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.844 0.457 . . . . 0.0 110.205 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -50.69 -49.85 56.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.434 0.561 . . . . 0.0 109.955 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.91 -38.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.58 -33.73 64.17 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.026 0.376 . . . . 0.0 110.277 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.58 -56.56 7.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.94 -47.53 21.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -106.69 21.95 16.66 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -48.62 -40.4 27.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.958 0.903 . . . . 0.0 111.274 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.48 -68.35 0.19 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.37 1.468 . . . . 0.0 112.4 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -89.94 -14.64 33.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.16 135.04 33.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.683 1.129 . . . . 0.0 113.102 -167.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -79.94 151.63 29.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.1 t -137.34 136.75 38.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.8 166.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 112.069 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -128.3 116.13 19.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.081 1.352 . . . . 0.0 109.542 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.8 tp -97.73 115.97 29.02 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.57 0.748 . . . . 0.0 109.983 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -71.1 110.42 5.76 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -64.21 -43.67 94.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 111.4 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.11 -33.68 76.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.584 0.754 . . . . 0.0 110.403 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -82.44 -25.03 33.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 0.0 111.104 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -125.88 54.9 11.44 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 113.034 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.18 -30.83 45.96 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.789 2.993 . . . . 0.0 108.616 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -43.64 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.13 1.772 . . . . 0.0 110.991 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.4 t -50.57 -51.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -39.09 74.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.044 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -70.35 -45.19 66.62 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.014 0.526 . . . . 0.0 109.656 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.58 -42.35 74.65 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.2 -23.97 43.46 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.747 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.85 10.62 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.041 0.829 . . . . 0.0 111.072 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -70.23 128.9 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.88 -45.03 21.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.325 0.65 . . . . 0.0 111.386 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 m -156.48 171.28 20.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.06 154.39 68.1 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.17 149.59 89.81 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 CA-C-N 119.787 0.96 . . . . 0.0 112.118 1.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -135.57 101.18 4.71 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.0 mt -90.61 114.57 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.6 mtm -126.16 150.34 48.35 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.2 t -108.51 139.73 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.5 168.26 12.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.333 1.021 . . . . 0.0 109.994 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 156.78 2.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.979 2.112 . . . . 0.0 106.7 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 37.57 49.96 1.83 Allowed Glycine 0 CA--C 1.535 1.343 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.96 64.55 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.667 -1.074 . . . . 0.0 115.621 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -147.75 172.21 14.45 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.515 1.657 . . . . 0.0 111.099 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -85.76 161.66 19.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.834 1.254 . . . . 0.0 109.412 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 53.1 t -131.16 -63.1 0.86 Allowed 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 126.231 1.813 . . . . 0.0 109.826 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -113.66 162.3 16.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.394 1.078 . . . . 0.0 110.433 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -154.77 131.43 10.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.334 1.454 . . . . 0.0 107.854 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -140.57 113.46 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -99.11 139.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.8 148.26 22.54 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.407 1.004 . . . . 0.0 110.804 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 75.48 1.0 Allowed 'General case' 0 C--N 1.339 0.12 0 O-C-N 122.033 -0.686 . . . . 0.0 110.875 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.9 m -78.73 145.26 66.31 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.33 157.63 39.59 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.972 1.781 . . . . 0.0 113.027 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -42.1 -51.01 4.7 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.372 1.469 . . . . 0.0 110.028 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.08 -44.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 111.861 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -69.17 -48.44 62.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 70.2 mt -54.41 -54.3 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -46.59 -64.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 127.802 2.441 . . . . 0.0 109.271 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -55.6 -49.08 73.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.512 0.196 . . . . 0.0 111.297 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.4 m -56.85 -52.07 66.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.845 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.03 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.918 0.781 . . . . 0.0 110.515 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -52.7 -36.73 57.76 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.368 0.667 . . . . 0.0 112.015 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -46.92 -46.39 21.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.048 0.452 . . . . 0.0 110.49 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 124.146 0.978 . . . . 0.0 111.195 -174.336 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.34 177.69 18.09 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.52 141.77 50.49 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 m -142.07 171.72 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 123.137 1.446 . . . . 0.0 112.674 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.38 169.56 19.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.977 3.311 . . . . 0.0 105.055 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -38.43 -50.39 1.52 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.702 2.401 . . . . 0.0 112.753 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.17 -70.02 0.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.726 0.774 . . . . 0.0 110.577 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -53.25 -38.7 63.23 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.601 1.16 . . . . 0.0 112.415 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -42.97 -46.75 5.55 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.864 2.066 . . . . 0.0 111.5 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -54.26 -55.38 28.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.72 -54.25 17.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.468 0.707 . . . . 0.0 111.516 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.31 -31.17 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.261 1.424 . . . . 0.0 112.79 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.24 -72.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.549 0.739 . . . . 0.0 111.024 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.1 mt -53.79 -41.03 66.81 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -172.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -93.12 13.23 21.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.009 0.924 . . . . 0.0 112.512 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 t -73.71 142.97 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.514 1.052 . . . . 0.0 111.888 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 p -79.64 -61.31 2.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.045 1.338 . . . . 0.0 108.636 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.86 155.14 80.62 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -57.23 161.32 11.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.64 1.56 . . . . 0.0 112.56 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 t -141.1 143.07 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.411 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tt -120.08 102.35 8.47 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.378 1.871 . . . . 0.0 106.689 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t -97.77 127.41 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -103.08 124.87 49.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -79.68 106.69 11.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -118.62 -176.13 3.03 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.872 1.32 . . . . 0.0 111.66 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.79 152.08 6.3 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.49 -42.68 12.11 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.857 1.342 . . . . 0.0 111.665 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -58.25 -18.75 28.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.796 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.8 t -77.97 88.72 4.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.707 1.139 . . . . 0.0 109.773 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.54 -63.07 1.04 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.187 1.375 . . . . 0.0 113.538 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -49.47 -47.29 23.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.39 2.726 . . . . 0.0 112.358 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.5 m -58.75 -53.6 56.58 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -53.25 -54.47 35.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.854 1.262 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -75.79 -27.37 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.652 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.78 -26.87 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.754 1.161 . . . . 0.0 109.796 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.79 -46.2 4.64 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -63.28 -35.68 61.23 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.675 2.25 . . . . 0.0 110.373 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 t -68.69 -44.28 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 t -58.07 -44.37 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.53 -60.81 3.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 122.828 0.451 . . . . 0.0 111.035 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.51 -33.87 71.91 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.435 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mt -56.8 -43.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.17 -47.7 76.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.042 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.28 -60.68 5.53 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 120.191 1.36 . . . . 0.0 110.69 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -48.17 -55.74 9.63 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.616 1.566 . . . . 0.0 110.717 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.39 58.88 4.74 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 123.447 1.594 . . . . 0.0 110.313 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -48.31 138.18 10.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.227 1.811 . . . . 0.0 110.115 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.73 -56.2 0.62 Allowed 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.565 2.346 . . . . 0.0 112.968 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.1 -9.44 58.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -166.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -141.62 108.87 5.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.974 1.261 . . . . 0.0 112.214 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -93.78 111.75 23.49 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.68 138.31 38.23 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.811 -1.18 . . . . 0.0 108.135 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.15 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -133.93 106.53 7.32 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.359 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.11 120.03 30.14 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 111.254 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.29 106.75 8.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.3 m -68.87 -31.97 71.3 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.231 1.413 . . . . 0.0 111.453 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.87 -41.5 87.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.438 1.095 . . . . 0.0 109.309 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.51 -28.68 26.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.004 2.122 . . . . 0.0 111.99 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.4 t -127.13 53.21 9.55 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.399 1.48 . . . . 0.0 112.208 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -62.78 -27.14 75.21 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.306 3.337 . . . . 0.0 108.825 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -40.37 -60.05 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.628 1.571 . . . . 0.0 110.263 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.8 -50.78 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.171 0.988 . . . . 0.0 110.167 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.08 64.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.426 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -68.63 -44.91 73.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.898 0.879 . . . . 0.0 110.397 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -56.38 -42.0 77.16 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.644 0.778 . . . . 0.0 110.332 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -78.47 -34.18 47.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.39 45.89 2.46 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.415 1.007 . . . . 0.0 111.588 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.76 -179.16 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 125.938 1.695 . . . . 0.0 108.33 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -158.62 -63.66 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.559 0.744 . . . . 0.0 109.593 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 m -54.94 154.64 5.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 110.223 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 pt -143.2 157.92 59.28 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.175 1.39 . . . . 0.0 107.3 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.27 156.28 84.78 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 120.766 1.309 . . . . 0.0 112.958 2.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -160.46 115.74 2.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -98.65 148.46 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.9 mtt -136.24 133.0 36.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.7 t -99.46 139.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -132.82 144.86 50.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 136.88 15.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 46.14 94.64 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -171.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.01 -59.65 2.66 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.908 0.766 . . . . 0.0 114.006 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -81.44 168.29 18.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -67.73 155.37 39.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.235 1.814 . . . . 0.0 112.96 -173.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.0 t -116.17 -72.38 0.69 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.965 2.106 . . . . 0.0 109.651 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -146.07 172.01 14.04 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.299 1.44 . . . . 0.0 110.246 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.5 m -116.41 146.58 42.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.63 1.972 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.82 -175.43 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.54 153.14 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.36 -153.57 5.83 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 51.48 42.48 29.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.947 0.899 . . . . 0.0 111.828 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.46 153.16 65.39 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.074 1.35 . . . . 0.0 107.477 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.36 160.43 32.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.103 1.868 . . . . 0.0 111.676 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -50.53 -43.57 56.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.807 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.41 -44.71 55.21 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.235 0.614 . . . . 0.0 111.111 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.3 m -65.84 -50.96 62.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -55.41 -52.78 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.392 0.677 . . . . 0.0 109.499 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.42 -58.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.428 1.491 . . . . 0.0 109.595 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -55.31 -47.41 75.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.689 0.677 . . . . 0.0 110.992 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.1 m -60.92 -43.83 98.03 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 119.591 -0.242 . . . . 0.0 111.448 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -72.5 -45.75 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.967 0.803 . . . . 0.0 109.829 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -51.54 -45.56 63.03 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.12 0.968 . . . . 0.0 110.772 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -48.24 -44.32 33.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.964 0.506 . . . . 0.0 110.316 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.176 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.41 -172.64 35.13 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.24 140.58 52.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.88 167.81 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.153 0.978 . . . . 0.0 111.793 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 8' ' ' ASP . 8.1 t-20 -143.5 172.76 12.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.844 2.058 . . . . 0.0 106.389 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 76.5 m-20 -38.82 -46.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.195 1.798 . . . . 0.0 112.381 -177.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.46 -76.19 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.719 0.408 . . . . 0.0 110.768 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.0 p -46.94 -39.82 13.07 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.271 1.429 . . . . 0.0 112.194 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -39.42 -47.9 1.86 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.526 1.93 . . . . 0.0 111.487 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.774 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -71.23 -45.73 62.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.507 0.67 . . . . 0.0 111.261 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.79 -37.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.031 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -106.33 -73.93 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.883 0.873 . . . . 0.0 110.78 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.9 mt -52.06 -54.53 29.11 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.865 0.466 . . . . 0.0 111.86 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -81.03 11.73 3.86 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -65.6 152.43 44.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.82 1.191 . . . . 0.0 109.614 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 p -79.33 -64.69 1.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.12 155.12 77.41 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.27 165.01 1.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.904 2.403 . . . . 0.0 112.608 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -144.72 143.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.449 1.099 . . . . 0.0 111.588 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -104.52 130.13 52.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.899 1.68 . . . . 0.0 107.67 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.61 111.28 27.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 118.918 0.781 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -89.69 116.28 27.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' CD2' ' CD1' ' A' ' 71' ' ' ILE . 15.9 m-85 -79.75 114.53 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -129.44 -173.48 3.02 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.565 0.698 . . . . 0.0 111.664 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.64 156.59 8.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -59.44 -40.52 66.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.206 1.938 . . . . 0.0 110.658 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -72.24 -10.25 59.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.881 0.472 . . . . 0.0 111.515 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.36 82.29 3.11 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.8 -1.187 . . . . 0.0 110.157 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.2 -61.21 1.01 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.825 1.202 . . . . 0.0 113.529 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.05 -41.3 78.36 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.387 2.058 . . . . 0.0 112.43 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 81.4 m -55.22 -47.66 75.02 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -56.2 -52.32 64.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.729 0.412 . . . . 0.0 111.482 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -73.24 -30.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.91 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.85 -23.08 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.951 0.9 . . . . 0.0 110.361 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.0 -46.54 5.17 Favored Pre-proline 0 CA--C 1.549 0.919 0 O-C-N 119.914 -1.741 . . . . 0.0 115.061 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.92 -37.58 64.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.466 2.111 . . . . 0.0 110.173 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.41 -49.08 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.8 t -49.96 -44.76 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.67 -61.92 1.61 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.36 -40.22 81.65 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.532 -0.73 . . . . 0.0 112.256 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.77 -38.42 75.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.21 -52.3 64.34 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -43.58 -53.43 6.06 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.897 0.76 . . . . 0.0 111.572 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -47.95 -35.4 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.24 1.016 . . . . 0.0 112.869 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -120.33 27.03 8.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.447 1.499 . . . . 0.0 112.673 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -39.67 -53.14 2.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.879 1.271 . . . . 0.0 113.799 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.04 -53.22 59.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 122.181 0.991 . . . . 0.0 112.33 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -79.43 -20.29 47.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.822 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 tp -144.8 114.68 7.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.051 0.387 . . . . 0.0 111.988 -170.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.2 168.09 20.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.3 t -145.65 141.45 28.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.988 -1.07 . . . . 0.0 110.273 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.21 161.8 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.893 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -127.62 109.38 11.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.452 1.101 . . . . 0.0 109.492 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tp -87.9 121.59 30.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.238 0.542 . . . . 0.0 110.426 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -74.58 105.46 5.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.9 m -65.21 -35.94 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.916 1.686 . . . . 0.0 111.03 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.92 -39.56 94.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.511 1.124 . . . . 0.0 109.539 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.37 -21.7 30.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.804 1.642 . . . . 0.0 110.702 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.1 m -120.96 51.11 2.22 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 114.597 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.53 -27.39 61.78 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.487 2.791 . . . . 0.0 109.68 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -54.28 -75.83 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.849 0.86 . . . . 0.0 109.933 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.63 -44.01 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.036 0.935 . . . . 0.0 110.343 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.63 80.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.76 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.4 p -70.74 -39.58 73.23 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.681 0.392 . . . . 0.0 110.27 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.73 -41.66 77.88 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.106 0.562 . . . . 0.0 109.928 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.29 -31.52 48.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.07 47.19 4.22 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.41 ' CD1' ' CD2' ' A' ' 26' ' ' PHE . 58.6 mt -72.62 114.67 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -29.74 44.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.305 0.242 . . . . 0.0 111.006 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 m -159.84 157.99 30.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.959 0.904 . . . . 0.0 108.619 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 pt -119.52 150.74 50.51 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.46 77.21 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.126 1.081 . . . . 0.0 114.05 3.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 m -143.06 113.34 7.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.08 119.96 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 mtt -105.22 159.23 16.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.904 0.882 . . . . 0.0 109.247 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 81.8 t -126.5 130.63 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -116.77 147.53 41.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.892 1.677 . . . . 0.0 108.36 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.8 53.1 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.435 0.636 . . . . 0.0 109.582 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.09 85.99 1.74 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.16 -67.32 1.17 Allowed Glycine 0 CA--C 1.527 0.827 0 CA-C-N 117.388 0.594 . . . . 0.0 112.884 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -79.85 163.69 24.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.258 1.023 . . . . 0.0 111.428 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -90.13 150.06 22.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.072 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.1 t -91.23 -51.4 5.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.23 -178.88 6.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 109.519 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -157.67 143.13 17.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.404 1.482 . . . . 0.0 107.816 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.21 153.35 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.119 0.968 . . . . 0.0 109.456 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.0 mt -79.92 141.86 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -138.57 2.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.37 42.34 31.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.806 0.803 . . . . 0.0 111.236 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.88 151.1 67.63 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.95 151.52 64.92 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.86 1.706 . . . . 0.0 112.836 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -45.08 46.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.409 1.484 . . . . 0.0 110.801 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -43.13 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.653 0.781 . . . . 0.0 111.133 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -49.55 74.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.815 . . . . 0.0 109.055 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.66 -52.37 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 123.951 0.9 . . . . 0.0 108.754 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.2 t -53.65 -59.25 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.104 0.962 . . . . 0.0 109.32 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -50.62 -42.36 55.98 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.705 0.402 . . . . 0.0 111.016 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -60.99 -59.49 5.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.8 -45.78 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.91 0.884 . . . . 0.0 111.62 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.47 -39.61 4.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.981 1.713 . . . . 0.0 113.193 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.69 -49.22 78.39 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.286 0.634 . . . . 0.0 110.593 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 N--CA 1.446 -0.641 0 C-N-CA 124.911 1.284 . . . . 0.0 110.257 -172.516 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.15 174.05 54.68 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.46 132.84 56.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.4 164.47 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 122.513 1.149 . . . . 0.0 111.208 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.63 169.31 18.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.998 2.519 . . . . 0.0 105.487 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -40.43 -52.99 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.079 1.352 . . . . 0.0 111.318 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.12 -53.23 56.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.048 . . . . 0.0 112.308 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 p -78.67 -31.4 46.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.344 0.658 . . . . 0.0 112.002 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -42.59 -43.54 3.82 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 127.548 2.339 . . . . 0.0 110.335 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -50.72 -67.68 0.23 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.358 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -42.6 98.91 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.226 1.01 . . . . 0.0 112.352 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.66 -43.9 16.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.971 -168.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.3 t -99.2 -54.03 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.399 1.08 . . . . 0.0 111.307 -174.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -69.17 -57.77 4.94 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.756 0.707 . . . . 0.0 110.283 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.6 51.55 1.28 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.173 0.989 . . . . 0.0 110.112 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 p -90.06 154.69 19.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.766 1.226 . . . . 0.0 112.64 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -100.94 -71.37 0.71 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.023 1.729 . . . . 0.0 107.405 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.7 m -79.19 158.95 73.84 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.56 159.81 12.85 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.565 1.51 . . . . 0.0 109.97 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 t -138.7 119.03 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.064 0.945 . . . . 0.0 110.419 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -94.41 110.35 22.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.375 1.07 . . . . 0.0 108.179 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.76 113.46 40.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -86.24 113.88 22.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.3 113.09 17.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.4 p-90 -129.18 -174.71 3.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.79 0.805 . . . . 0.0 111.016 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.77 154.14 5.23 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.888 1.275 . . . . 0.0 108.17 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.98 -42.1 15.32 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.821 2.348 . . . . 0.0 110.45 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 30.8 p-90 -66.39 -17.95 65.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.893 0.477 . . . . 0.0 111.215 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.9 t -75.37 97.59 3.65 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.545 -0.722 . . . . 0.0 110.248 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -32.01 -68.87 0.13 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.908 2.194 . . . . 0.0 115.062 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.13 -44.37 12.58 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.879 1.839 . . . . 0.0 110.8 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.4 m -47.22 -50.37 21.16 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.291 0.636 . . . . 0.0 109.998 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -46.26 -50.4 16.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.045 1.338 . . . . 0.0 111.618 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -90.15 -13.56 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 tp -85.62 -27.86 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.468 1.031 . . . . 0.0 109.561 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.55 -48.3 4.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -62.56 -36.98 61.56 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.56 2.173 . . . . 0.0 110.337 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 t -63.13 -51.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -50.77 -46.05 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.255 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.89 -62.17 1.88 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.617 0.367 . . . . 0.0 111.187 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.19 -30.16 68.0 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.02 0.827 . . . . 0.0 113.161 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -26.15 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 118.048 -1.461 . . . . 0.0 109.387 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.11 73.92 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.042 -1.036 . . . . 0.0 109.757 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.69 -42.36 95.39 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -57.65 -39.37 76.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.058 0.429 . . . . 0.0 109.955 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -78.86 53.76 1.44 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.637 -0.664 . . . . 0.0 112.456 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -62.09 -44.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.8 108.82 3.11 Favored 'General case' 0 N--CA 1.443 -0.812 1 N-CA-C 100.163 -4.014 . . . . 0.0 100.163 162.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -72.67 107.93 5.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.471 -2.15 . . . . 0.0 113.822 -153.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.13 121.98 37.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 108.879 -3.782 . . . . 0.0 105.828 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.89 149.74 32.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.08 138.56 53.71 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.12 165.37 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.006 0.522 . . . . 0.0 109.968 -176.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -132.13 111.9 11.85 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 110.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.86 116.12 28.74 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 124.796 1.238 . . . . 0.0 109.391 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -74.38 109.59 7.99 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -66.25 -33.11 75.02 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 111.289 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.71 -38.44 76.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.745 0.818 . . . . 0.0 110.179 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.96 -29.77 32.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.814 1.646 . . . . 0.0 111.598 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 t -124.27 55.65 10.22 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.571 1.548 . . . . 0.0 111.644 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -65.15 -29.34 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 124.377 3.385 . . . . 0.0 108.593 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -47.3 -69.33 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.6 t -54.5 -56.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.746 0.819 . . . . 0.0 109.928 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.23 -47.59 62.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -63.36 -49.89 72.09 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.816 -0.552 . . . . 0.0 109.849 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.07 -40.23 66.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.502 0.721 . . . . 0.0 110.642 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -78.96 -23.37 44.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.833 1.253 . . . . 0.0 111.814 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.3 28.69 19.27 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.561 1.077 . . . . 0.0 112.182 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -81.45 80.52 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -78.48 -3.19 42.22 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.761 -1.108 . . . . 0.0 112.288 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 m -155.96 157.34 36.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.5 pt -145.85 157.72 50.44 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.879 1.672 . . . . 0.0 106.637 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.79 147.02 87.06 Favored 'Cis proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.147 1.445 . . . . 0.0 113.329 1.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.7 m -156.72 120.41 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -97.06 116.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 125.354 1.462 . . . . 0.0 107.154 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.2 mtt -99.15 147.84 24.69 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.652 1.115 . . . . 0.0 108.696 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.56 105.45 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -89.47 124.04 34.13 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 4.69 18.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.758 0.823 . . . . 0.0 112.102 -175.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.91 100.46 0.36 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.1 -73.45 1.52 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-N 117.489 0.644 . . . . 0.0 111.874 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -102.12 172.64 6.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.981 0.912 . . . . 0.0 111.594 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -78.6 162.24 26.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.213 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.8 t -120.4 -66.61 1.04 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.675 1.19 . . . . 0.0 108.208 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -126.36 -169.16 1.97 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.27 1.028 . . . . 0.0 109.585 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -156.81 167.7 29.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.573 1.149 . . . . 0.0 108.069 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.88 133.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.1 mt -78.87 142.01 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.64 -157.12 7.51 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.039 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.8 54.62 9.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 109.95 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.42 158.04 74.18 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 125.633 1.573 . . . . 0.0 108.495 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.88 143.21 44.88 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 105.613 -2.495 . . . . 0.0 105.613 167.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.73 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.26 -56.41 8.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -55.22 -46.13 75.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.069 0.948 . . . . 0.0 110.605 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -49.09 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.05 -45.52 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.596 0.759 . . . . 0.0 109.543 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -42.93 87.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.488 1.04 . . . . 0.0 109.119 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.4 m -61.32 -46.77 88.92 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.438 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -48.75 78.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 O-C-N 121.829 -0.545 . . . . 0.0 109.709 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.03 -48.36 76.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -43.68 64.87 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.823 -0.548 . . . . 0.0 109.898 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.5 m-30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.456 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.57 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.24 -173.62 36.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.277 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.26 136.83 45.78 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.7 168.2 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 121.916 0.865 . . . . 0.0 109.459 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.75 175.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 106.27 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -47.33 -47.11 25.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.871 0.868 . . . . 0.0 112.156 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.39 -72.2 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.775 0.83 . . . . 0.0 110.714 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -52.57 -33.42 45.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.428 1.091 . . . . 0.0 112.422 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -41.48 -46.43 3.48 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.297 1.439 . . . . 0.0 110.199 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -56.47 -60.85 2.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.613 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -63.64 -31.63 72.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.516 0.726 . . . . 0.0 112.702 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.8 t -95.16 -48.1 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.277 0.631 . . . . 0.0 112.065 -171.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -94.22 -53.13 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.034 1.334 . . . . 0.0 111.713 -175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.02 -58.57 3.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.871 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.23 50.11 1.03 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.278 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 p -90.43 145.75 24.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.769 1.228 . . . . 0.0 112.218 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -93.44 -65.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -79.25 160.77 69.95 Favored Pre-proline 0 C--O 1.232 0.167 0 C-N-CA 124.608 1.163 . . . . 0.0 108.835 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -55.65 162.55 6.38 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.577 1.518 . . . . 0.0 110.692 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.63 144.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.878 1.671 . . . . 0.0 110.128 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 tt -124.91 100.81 6.77 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.427 1.891 . . . . 0.0 106.181 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.19 116.93 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -88.79 116.16 26.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -79.17 108.83 12.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -122.3 -169.15 1.84 Allowed 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 124.184 0.993 . . . . 0.0 111.017 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.02 150.8 2.02 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -57.61 -40.31 81.2 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.026 1.818 . . . . 0.0 111.291 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -67.06 -16.54 64.41 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.836 0.454 . . . . 0.0 111.585 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.1 t -74.69 85.01 2.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.227 -0.921 . . . . 0.0 111.176 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.71 -60.57 1.2 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.317 0.96 . . . . 0.0 113.563 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.48 -50.38 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.022 2.481 . . . . 0.0 112.61 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.06 -45.08 91.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -56.19 -50.29 71.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.556 1.143 . . . . 0.0 110.256 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.08 -37.85 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.437 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 pt -77.37 -25.29 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 120.083 1.31 . . . . 0.0 111.895 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.51 -47.56 4.69 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -62.22 -37.75 60.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.743 2.295 . . . . 0.0 110.484 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.96 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.5 -43.03 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -57.92 -66.14 0.52 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.1 0.409 . . . . 0.0 110.107 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -59.07 -29.52 67.38 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mm -50.8 -34.06 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.486 0.584 . . . . 0.0 109.983 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.4 74.85 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.525 1.057 . . . . 0.0 111.053 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.1 -24.61 76.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.57 -53.55 9.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 117.754 0.777 . . . . 0.0 108.911 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -79.78 58.66 2.88 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.71 -40.97 92.79 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 103.339 -2.837 . . . . 0.0 103.339 164.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.91 110.16 3.22 Favored 'General case' 0 N--CA 1.439 -1.018 1 N-CA-C 98.78 -4.526 . . . . 0.0 98.78 162.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -73.36 125.24 27.4 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 124.822 2.249 . . . . 0.0 115.586 -151.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.5 tp -134.55 120.4 19.61 Favored 'General case' 0 C--N 1.314 -0.962 1 CA-C-N 107.867 -4.242 . . . . 0.0 108.054 164.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.24 94.04 7.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.14 130.34 35.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.834 -0.541 . . . . 0.0 109.565 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.67 174.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.706 0.802 . . . . 0.0 111.934 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -144.08 113.45 6.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.014 1.325 . . . . 0.0 111.283 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.0 tt -98.9 125.62 44.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.849 0.833 . . . . 0.0 110.6 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -71.74 105.24 3.66 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.906 1.283 . . . . 0.0 113.874 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -81.21 45.84 0.88 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.859 -1.151 . . . . 0.0 111.027 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -152.09 -48.94 0.11 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -82.98 -19.04 37.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.737 2.015 . . . . 0.0 110.2 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -137.33 61.4 32.24 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.834 1.254 . . . . 0.0 111.915 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.8 -24.6 8.49 Favored 'Trans proline' 0 N--CA 1.446 -1.304 1 C-N-CA 125.492 4.128 . . . . 0.0 110.317 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -47.62 -68.69 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.765 1.226 . . . . 0.0 110.276 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.79 -43.3 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.094 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.72 70.06 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.249 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.2 m -70.13 -45.95 65.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.583 0.753 . . . . 0.0 109.713 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.18 -45.83 75.81 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.977 0.511 . . . . 0.0 110.749 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -79.43 -30.3 42.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.352 0.261 . . . . 0.0 111.534 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.17 54.39 2.15 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.9 mm -69.75 92.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.859 0.838 . . . . 0.0 108.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -78.04 82.12 4.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t 73.21 -175.81 0.16 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.357 1.863 . . . . 0.0 109.498 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.6 pt -145.38 157.06 53.33 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.22 . . . . 0.0 108.455 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.33 138.23 44.0 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 120.62 1.257 . . . . 0.0 111.85 1.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -134.63 98.25 4.01 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -89.53 109.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.2 mmt -97.16 143.57 27.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 64.4 t -114.13 133.51 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.15 161.21 31.6 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.91 77.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.951 0.405 . . . . 0.0 110.163 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.46 1.36 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.632 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.48 -56.52 3.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 123.836 0.732 . . . . 0.0 112.738 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -79.36 155.01 28.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 122.245 1.021 . . . . 0.0 111.893 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.12 130.47 36.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.649 1.979 . . . . 0.0 108.155 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.6 t -89.31 -57.99 2.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.269 1.028 . . . . 0.0 110.109 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.94 166.89 22.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.595 1.158 . . . . 0.0 111.869 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -142.25 126.15 17.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.251 2.22 . . . . 0.0 105.191 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -128.6 103.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -100.52 138.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.183 1.393 . . . . 0.0 109.555 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.81 156.15 21.94 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.953 0.787 . . . . 0.0 112.563 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.66 51.89 0.2 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.11 1.364 . . . . 0.0 113.148 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.91 148.77 69.18 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.81 156.06 64.19 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.356 1.37 . . . . 0.0 111.71 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.78 -46.04 29.99 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.894 1.277 . . . . 0.0 111.007 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.17 -41.89 3.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.776 0.831 . . . . 0.0 111.525 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.268 1.027 . . . . 0.0 109.153 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.47 -52.64 50.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 C-N-CA 124.431 1.092 . . . . 0.0 108.878 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.5 t -53.2 -58.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.783 1.233 . . . . 0.0 109.567 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.39 -50.11 68.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.449 -0.157 . . . . 0.0 110.911 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.2 m -60.4 -55.74 29.94 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.471 0.177 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -41.54 85.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 O-C-N 121.383 -0.823 . . . . 0.0 110.374 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -45.64 90.38 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -53.67 -42.2 67.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.856 -0.527 . . . . 0.0 109.781 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.744 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.365 0.126 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.85 -168.05 12.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.01 147.02 50.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.54 168.16 21.46 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 CA-C-O 122.038 0.923 . . . . 0.0 111.46 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.32 170.34 16.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.364 2.666 . . . . 0.0 105.93 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -39.93 -50.78 2.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.768 1.627 . . . . 0.0 110.964 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.95 -73.45 0.09 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.243 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 p -52.76 -36.43 57.88 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.274 1.03 . . . . 0.0 112.49 -174.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -40.02 -46.19 2.06 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.928 1.691 . . . . 0.0 110.841 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -49.78 -62.49 1.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.999 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.32 -39.84 71.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.284 0.634 . . . . 0.0 111.879 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.22 -40.01 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.953 -169.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.88 -60.21 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 123.892 0.877 . . . . 0.0 110.706 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -65.07 -68.15 0.38 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.626 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.98 34.98 0.2 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.862 0.865 . . . . 0.0 112.664 -171.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -91.21 143.49 26.6 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.993 0.917 . . . . 0.0 109.5 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.06 -60.91 2.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.4 1.08 . . . . 0.0 108.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.9 m -78.74 155.83 77.97 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -56.39 160.54 10.97 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.203 1.935 . . . . 0.0 114.351 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.23 118.56 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.536 1.134 . . . . 0.0 111.506 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.45 88.01 5.78 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 124.841 1.257 . . . . 0.0 109.593 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.22 133.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 O-C-N 121.157 -0.965 . . . . 0.0 109.259 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.54 121.49 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.924 0.89 . . . . 0.0 108.645 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -79.79 108.67 13.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -123.29 -173.72 2.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 122.275 1.035 . . . . 0.0 110.296 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 152.63 9.78 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.43 -44.97 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-N 120.542 1.229 . . . . 0.0 111.756 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.412 ' CH2' HD11 ' A' ' 74' ' ' ILE . 17.1 p-90 -56.12 -20.7 18.55 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.463 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.7 t -77.46 84.84 3.85 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.585 -0.697 . . . . 0.0 109.412 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.98 -57.94 1.96 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.586 1.089 . . . . 0.0 113.147 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.9 -25.33 69.1 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.089 1.86 . . . . 0.0 113.01 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.9 m -77.2 -50.67 12.43 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -49.14 -50.76 35.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.564 1.546 . . . . 0.0 111.41 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.2 pt -64.81 -39.84 87.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.467 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 pt -76.83 -26.69 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.563 1.074 . . . . 0.0 111.667 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -48.46 4.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.97 -38.03 60.93 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.357 2.038 . . . . 0.0 110.357 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.57 -39.74 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.5 t -52.77 -40.69 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.96 -58.5 4.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.701 0.4 . . . . 0.0 111.054 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.59 -47.59 81.72 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.683 -0.636 . . . . 0.0 111.996 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.97 -38.5 60.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.23 -43.42 98.91 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.421 -0.799 . . . . 0.0 109.301 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.02 -50.49 58.72 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.3 -53.37 44.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.527 0.663 . . . . 0.0 110.222 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -82.08 51.17 1.71 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.126 0.965 . . . . 0.0 112.015 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -41.6 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.935 2.494 . . . . 0.0 111.509 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.19 -54.43 46.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -78.13 -40.54 37.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.37 128.39 37.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 118.204 -1.398 . . . . 0.0 114.387 -152.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -83.11 163.14 21.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.1 t -142.72 145.8 33.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.57 168.42 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.577 -175.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -137.87 112.44 8.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.294 1.038 . . . . 0.0 108.702 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.7 tp -98.2 120.49 38.7 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.2 1.0 . . . . 0.0 109.725 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -73.23 109.99 7.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -67.49 -35.76 79.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.795 1.238 . . . . 0.0 111.086 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.51 -39.69 92.15 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -80.21 -33.52 38.08 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.877 1.671 . . . . 0.0 112.005 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.0 t -120.9 55.56 4.65 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.625 1.57 . . . . 0.0 111.937 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.34 -24.67 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.06 3.173 . . . . 0.0 110.598 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -54.15 -67.54 0.25 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.803 0.841 . . . . 0.0 109.773 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -53.21 -51.1 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 124.2 1.0 . . . . 0.0 109.202 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.47 -48.19 37.93 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.208 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -66.47 -46.65 75.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.018 0.527 . . . . 0.0 110.627 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.55 -45.5 77.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -79.43 -31.17 42.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.589 0.356 . . . . 0.0 111.488 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.59 43.94 3.04 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.655 0.645 . . . . 0.0 111.627 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mm -73.52 90.64 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -77.47 -20.53 54.27 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.3 m -156.18 165.01 37.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.412 HD11 ' CH2' ' A' ' 30' ' ' TRP . 26.7 pt -129.87 153.47 80.93 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.82 165.36 70.35 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.302 1.144 . . . . 0.0 111.954 0.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -156.74 113.55 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.77 115.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.9 mtt -111.56 134.84 52.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.58 115.77 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.79 162.48 15.21 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 0.0 109.619 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.41 151.55 9.75 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.71 1.204 . . . . 0.0 107.899 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.04 45.6 14.74 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.969 1.147 . . . . 0.0 115.969 170.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.06 0.31 60.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.94 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -129.94 159.38 36.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.737 1.769 . . . . 0.0 111.922 -176.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 138.59 31.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.81 1.644 . . . . 0.0 107.989 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.4 t -114.81 -82.25 0.61 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.003 0.921 . . . . 0.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -92.73 163.53 13.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.086 0.554 . . . . 0.0 110.866 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -157.5 122.61 4.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.773 1.229 . . . . 0.0 109.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.93 137.2 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.42 143.6 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 109.743 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.98 165.52 40.19 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 123.37 0.419 . . . . 0.0 112.328 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.63 131.17 45.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.308 0.643 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.3 153.77 41.25 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.8 138.97 27.01 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 104.714 -2.841 . . . . 0.0 104.714 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -56.14 -33.92 65.63 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.389 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.27 -37.3 7.11 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.542 1.064 . . . . 0.0 112.237 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.6 m -70.78 -41.68 71.36 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.499 -0.751 . . . . 0.0 109.302 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.0 mt -61.71 -44.23 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -54.36 -55.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -52.64 -43.5 65.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.966 0.348 . . . . 0.0 110.787 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -59.09 -40.2 84.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.33 -50.74 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.084 -1.01 . . . . 0.0 108.971 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -51.61 -47.48 63.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.047 0.939 . . . . 0.0 112.873 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -25.69 60.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 N--CA 1.453 -0.322 0 CA-C-N 118.44 0.564 . . . . 0.0 109.704 179.159 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.426 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.41 -179.01 51.49 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.43 137.62 54.81 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.89 164.98 32.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 122.299 1.047 . . . . 0.0 111.379 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -144.11 168.74 19.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.853 2.061 . . . . 0.0 105.731 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -39.63 -45.67 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.31 -70.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.432 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -59.57 -33.47 71.48 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.475 1.11 . . . . 0.0 112.336 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -42.17 -46.67 4.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 126.778 2.031 . . . . 0.0 111.265 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -47.45 -48.41 26.65 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.753 1.221 . . . . 0.0 110.651 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -82.33 -63.1 1.45 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.061 0.934 . . . . 0.0 111.268 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.97 -31.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.889 -169.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.21 -59.81 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.004 0.522 . . . . 0.0 111.865 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.38 -71.03 0.26 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.464 0.575 . . . . 0.0 110.041 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.88 48.41 0.83 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.723 0.809 . . . . 0.0 111.212 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 p -90.38 148.37 22.86 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.653 1.581 . . . . 0.0 109.129 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -83.62 -68.03 0.74 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 m -79.49 158.95 73.11 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.274 1.03 . . . . 0.0 108.66 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.12 164.9 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.486 2.124 . . . . 0.0 113.082 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.81 148.95 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.902 2.081 . . . . 0.0 109.207 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -131.68 105.56 7.6 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.19 122.91 52.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.618 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -97.73 117.69 32.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.52 112.13 16.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -126.14 -176.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.202 1.001 . . . . 0.0 110.335 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.89 148.29 3.13 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -53.21 -45.27 42.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.164 . . . . 0.0 112.513 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -67.07 -20.62 65.85 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.776 -0.578 . . . . 0.0 111.898 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.04 85.09 2.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.117 0.871 . . . . 0.0 110.404 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -34.45 -62.96 0.48 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.492 1.52 . . . . 0.0 114.374 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.57 -43.48 50.52 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 119.633 1.716 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.8 m -59.73 -45.37 92.4 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -55.22 -53.64 53.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.787 1.235 . . . . 0.0 110.542 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 pt -69.71 -29.71 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.36 -0.353 . . . . 0.0 111.397 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.1 mt -74.27 -35.32 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.253 0.621 . . . . 0.0 111.471 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.51 -48.03 6.68 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -61.72 -36.71 73.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.483 2.122 . . . . 0.0 109.75 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.77 -45.11 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.75 -43.75 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -66.05 -48.84 69.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.859 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.93 -41.08 99.37 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.829 -1.169 . . . . 0.0 109.65 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.6 mt -56.82 -44.44 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.68 -50.34 68.48 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.41 -45.21 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.93 -46.58 81.04 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -111.91 23.76 13.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -56.16 168.59 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.916 1.286 . . . . 0.0 112.317 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 71.3 -52.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 127.657 2.383 . . . . 0.0 111.199 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -80.19 -50.22 10.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.249 0.547 . . . . 0.0 110.094 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -102.0 106.4 17.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.652 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -78.66 90.04 4.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 49.1 t -78.32 137.9 38.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.53 163.09 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 123.161 0.585 . . . . 0.0 110.12 -175.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -127.57 115.21 18.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.483 1.113 . . . . 0.0 109.614 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tp -91.49 119.06 31.12 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.271 0.628 . . . . 0.0 109.562 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.17 107.1 6.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -67.99 -35.98 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.198 1.399 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.59 -38.82 92.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.701 1.201 . . . . 0.0 109.871 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.5 -25.08 33.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.719 2.008 . . . . 0.0 111.036 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 m -121.46 53.61 3.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 113.93 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.11 -25.82 73.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.061 3.174 . . . . 0.0 109.367 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -50.85 -70.38 0.09 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.896 1.279 . . . . 0.0 109.68 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.8 t -51.41 -50.63 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.059 1.344 . . . . 0.0 109.184 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.82 -47.88 51.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.251 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 m -72.15 -43.35 64.78 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.92 0.888 . . . . 0.0 111.236 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.91 -48.34 70.25 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.286 0.635 . . . . 0.0 110.03 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -79.55 -35.63 39.55 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.21 53.41 9.09 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 pt -57.31 142.11 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.497 1.119 . . . . 0.0 111.775 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -79.91 70.26 6.43 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.0 t 64.52 -160.15 0.29 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -139.51 150.23 62.89 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.78 143.29 73.5 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.985 1.03 . . . . 0.0 113.798 3.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m -140.44 110.04 6.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.82 134.15 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.1 mtt -124.86 128.44 48.67 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.657 1.183 . . . . 0.0 108.881 176.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.77 131.58 45.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -119.94 134.23 55.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 173.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.49 25.48 10.17 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.109 0.964 . . . . 0.0 110.597 -178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.21 123.26 5.22 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.43 -64.99 3.15 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.885 0.842 . . . . 0.0 113.376 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -126.22 172.73 9.82 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.244 1.018 . . . . 0.0 111.93 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -67.46 164.86 17.86 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.179 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -128.7 -57.37 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.815 1.646 . . . . 0.0 108.813 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -140.11 171.29 14.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.565 1.546 . . . . 0.0 109.729 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -160.08 147.83 16.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.5 150.4 33.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.08 144.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.62 162.41 37.85 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.603 0.557 . . . . 0.0 112.565 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.76 131.26 38.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.553 0.741 . . . . 0.0 110.534 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.37 149.5 48.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.05 155.48 33.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.676 2.251 . . . . 0.0 114.003 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -46.03 -52.47 11.82 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.404 1.482 . . . . 0.0 109.771 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.83 -45.85 50.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.281 0.633 . . . . 0.0 110.612 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -49.19 68.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -53.04 -58.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.9 t -52.42 -55.5 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 110.318 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.09 -47.43 78.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.506 0.594 . . . . 0.0 110.967 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.3 m -59.87 -42.27 93.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.96 0.504 . . . . 0.0 110.575 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.19 -57.18 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -45.32 -58.54 3.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.933 1.293 . . . . 0.0 111.342 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -18.59 25.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 . . . . . 0 CA--C 1.534 0.356 0 CA-C-N 120.013 1.279 . . . . 0.0 110.722 175.639 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.02 166.79 52.12 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.907 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.51 119.65 37.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.56 161.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.734 0.813 . . . . 0.0 109.671 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -138.04 171.7 14.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -39.82 -45.46 1.79 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.001 1.32 . . . . 0.0 111.468 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.68 -77.76 0.06 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.253 0.621 . . . . 0.0 110.974 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.7 p -46.69 -38.65 10.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.133 1.373 . . . . 0.0 112.744 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -39.71 -46.39 1.86 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.522 1.529 . . . . 0.0 110.819 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -48.76 -56.79 7.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.519 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.34 -33.57 49.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.871 -0.518 . . . . 0.0 112.017 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.4 t -92.5 -26.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -169.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.91 -51.25 4.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 124.747 1.219 . . . . 0.0 111.519 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.63 -61.86 1.69 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -77.51 33.22 0.16 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.932 . . . . 0.0 112.1 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 m -91.09 132.65 35.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.42 1.088 . . . . 0.0 111.133 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 p -78.79 -53.29 7.27 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.711 1.604 . . . . 0.0 107.158 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.94 152.56 79.91 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.02 166.61 29.09 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 N-CA-C 108.658 -1.324 . . . . 0.0 108.658 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.488 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -152.48 134.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.423 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tt -99.06 115.35 28.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.987 1.715 . . . . 0.0 108.864 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.0 t -100.91 114.16 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.72 116.51 24.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -78.64 110.77 14.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 9.0 p-90 -124.17 -172.71 2.6 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.792 0.806 . . . . 0.0 112.111 -172.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.42 151.84 2.55 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 125.239 1.416 . . . . 0.0 107.426 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.55 -42.11 35.5 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.552 2.168 . . . . 0.0 110.044 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.405 ' CH2' HD12 ' A' ' 74' ' ' ILE . 34.6 p-90 -67.35 -17.32 64.7 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.355 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.9 t -80.02 87.52 5.41 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.208 -0.933 . . . . 0.0 110.794 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.49 -61.63 1.49 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.521 1.058 . . . . 0.0 113.712 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.73 -19.94 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.096 1.864 . . . . 0.0 113.21 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.0 m -82.75 -50.79 8.31 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -50.2 -47.4 54.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.567 1.547 . . . . 0.0 110.832 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.21 -18.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.929 -0.558 . . . . 0.0 112.415 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -88.74 -28.32 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.464 1.029 . . . . 0.0 110.052 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.08 -47.31 3.83 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.704 1.602 . . . . 0.0 113.266 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.25 -38.26 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.948 1.766 . . . . 0.0 110.884 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.4 t -69.75 -57.4 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.707 1.203 . . . . 0.0 109.452 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 p -54.02 -42.86 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.96 -56.24 23.45 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.59 -0.693 . . . . 0.0 112.427 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.38 -41.39 89.24 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 122.008 -0.433 . . . . 0.0 110.435 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -55.67 -44.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.34 -53.6 54.09 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -44.65 -44.43 8.38 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.249 0.452 . . . . 0.0 112.422 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.76 -41.84 96.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -121.92 9.76 10.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -39.85 -41.4 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.008 2.123 . . . . 0.0 113.752 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.84 -40.7 2.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.46 1.904 . . . . 0.0 112.991 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -132.47 -54.26 0.95 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.6 tp -83.44 170.83 14.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.488 ' CB ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.36 93.75 2.96 Favored 'General case' 0 N--CA 1.433 -1.323 2 N-CA-C 122.993 4.442 . . . . 0.0 122.993 -164.05 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 11.1 t -151.2 122.2 7.65 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 118.96 -2.338 . . . . 0.0 114.794 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.08 165.68 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.599 1.16 . . . . 0.0 110.202 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 27' ' ' TRP . 7.4 mtmp? -132.73 122.81 25.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.732 1.213 . . . . 0.0 111.576 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -104.82 120.51 41.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.829 0.823 . . . . 0.0 110.21 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -69.45 109.51 4.26 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 124.775 1.23 . . . . 0.0 113.42 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -82.61 47.59 1.2 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 0.0 110.347 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.19 -46.59 0.1 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.43 -23.01 35.04 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.669 1.988 . . . . 0.0 109.705 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.47 53.24 5.65 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 112.542 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.55 -38.78 7.76 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.88 3.72 . . . . 0.0 109.493 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -49.46 -67.31 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.892 1.277 . . . . 0.0 110.528 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.09 -45.53 88.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.93 -39.77 66.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.059 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -72.73 -41.55 65.06 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 124.144 0.978 . . . . 0.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -55.39 -43.23 75.02 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.09 -32.29 44.61 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.89 35.24 6.86 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.12 1.343 . . . . 0.0 111.622 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.5 mt -80.84 62.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.329 1.452 . . . . 0.0 109.37 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -81.59 57.73 3.45 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.551 -0.718 . . . . 0.0 110.355 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 163.3 150.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.963 2.505 . . . . 0.0 107.585 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.405 HD12 ' CH2' ' A' ' 30' ' ' TRP . 13.3 pt -152.85 155.24 32.13 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.12 134.53 28.6 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.362 1.165 . . . . 0.0 112.857 1.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 m -132.8 106.21 7.6 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mt -94.75 130.51 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.138 1.375 . . . . 0.0 107.698 -177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.5 mtt -130.62 152.22 50.22 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.46 141.35 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.22 167.28 20.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 110.623 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.65 152.2 3.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.746 2.018 . . . . 0.0 106.712 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.21 41.25 8.07 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.484 1.038 . . . . 0.0 115.675 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.5 11.49 68.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.103 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -138.38 167.85 21.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.441 1.62 . . . . 0.0 110.421 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.44 160.2 25.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.546 0.738 . . . . 0.0 110.139 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.3 t -115.94 -53.7 2.54 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 125.569 1.548 . . . . 0.0 109.455 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 -177.0 5.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.724 1.21 . . . . 0.0 108.834 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.9 t -158.35 151.8 23.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 0.0 109.48 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.3 mm -135.84 155.88 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 127.549 2.34 . . . . 0.0 105.55 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.1 mt -138.95 145.48 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.01 155.13 20.75 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.46 135.58 45.76 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.65 152.31 68.22 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.63 160.09 47.28 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.007 1.805 . . . . 0.0 112.409 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -43.41 -51.34 6.57 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 126.136 1.774 . . . . 0.0 111.276 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.95 -45.93 60.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.847 0.459 . . . . 0.0 110.948 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 m -66.28 -48.02 71.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.1 mt -55.72 -55.52 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.34 -51.84 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.496 0.718 . . . . 0.0 110.147 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.81 -46.86 81.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.996 0.816 . . . . 0.0 110.445 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.1 m -57.31 -43.32 83.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.294 0.638 . . . . 0.0 109.782 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 t -62.98 -58.91 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.996 0.816 . . . . 0.0 109.213 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -44.16 -51.89 7.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.835 1.254 . . . . 0.0 112.289 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -26.28 30.19 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 CA--C 1.536 0.404 0 O-C-N 121.379 -0.825 . . . . 0.0 111.328 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.41 111.6 4.1 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 112.2 -0.36 . . . . 0.0 112.2 -177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.65 115.5 19.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.55 165.07 12.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.282 1.039 . . . . 0.0 111.361 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -138.2 170.89 15.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.451 2.3 . . . . 0.0 106.408 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -38.81 -52.86 1.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.219 1.808 . . . . 0.0 111.428 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.69 -73.34 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.567 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -52.28 -38.12 57.44 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.511 1.125 . . . . 0.0 111.769 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -42.91 -45.08 4.84 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.313 1.845 . . . . 0.0 111.356 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -55.55 -51.95 65.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.856 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.11 -50.43 16.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.306 0.574 . . . . 0.0 111.655 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -74.57 -39.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.747 1.219 . . . . 0.0 112.825 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -107.38 -54.67 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 112.763 -170.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -64.53 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.81 49.61 0.78 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 110.432 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -84.13 121.91 28.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.565 1.546 . . . . 0.0 111.373 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.3 p -79.77 -61.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.88 153.88 80.5 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.78 149.86 67.31 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.517 -0.993 . . . . 0.0 109.517 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.455 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -149.96 127.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.38 121.15 30.46 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.29 114.97 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 171.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -99.31 136.83 38.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -87.85 111.9 21.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -117.63 -174.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.66 5.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -56.69 -39.59 90.27 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -70.52 -16.11 62.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.158 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.3 t -73.61 102.3 3.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.216 1.371 . . . . 0.0 111.408 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.8 -62.36 3.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.034 1.302 . . . . 0.0 114.018 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.64 -42.62 35.73 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.137 2.558 . . . . 0.0 111.674 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.7 m -63.14 -50.31 70.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -55.42 -49.76 71.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.134 -0.354 . . . . 0.0 111.098 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.24 -32.9 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.066 -0.969 . . . . 0.0 111.844 -175.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.8 pt -80.51 -28.62 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.646 1.567 . . . . 0.0 111.42 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.54 -49.39 5.13 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.12 -37.34 75.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.983 1.789 . . . . 0.0 110.043 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.56 -44.48 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 108.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.2 t -53.14 -53.28 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.85 -49.3 78.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.769 -0.582 . . . . 0.0 112.184 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.06 -43.63 95.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.968 0.804 . . . . 0.0 109.493 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.1 -41.44 80.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -48.64 76.35 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.27 -44.28 57.77 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -58.52 -53.94 52.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.591 1.195 . . . . 0.0 110.409 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CG ' ' HB3' ' A' ' 52' ' ' LEU . 60.3 m-85 -82.98 53.57 2.47 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.0 -21.59 66.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.861 1.665 . . . . 0.0 108.227 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.16 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 168.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' CE ' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -161.17 110.41 1.61 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 164.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.429 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 7.1 tp -151.02 -177.35 5.96 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 116.858 -1.937 . . . . 0.0 112.067 159.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.455 ' CA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.29 66.26 1.73 Allowed 'General case' 0 N--CA 1.419 -1.996 2 N-CA-C 123.845 4.757 . . . . 0.0 123.845 -157.341 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.32 109.75 9.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 117.742 -1.583 . . . . 0.0 113.81 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.43 163.43 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.464 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -153.76 121.54 5.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.005 0.431 . . . . 0.0 110.256 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.13 118.91 29.18 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.821 0.849 . . . . 0.0 110.243 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -72.49 105.64 4.25 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -69.51 -31.72 70.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.797 1.239 . . . . 0.0 111.567 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.1 -39.2 89.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.931 0.893 . . . . 0.0 109.483 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -86.76 -26.08 24.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.734 2.013 . . . . 0.0 111.722 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 t -126.21 55.96 14.9 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.571 1.548 . . . . 0.0 112.463 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.62 -31.2 70.42 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.508 2.805 . . . . 0.0 108.056 174.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -40.78 -75.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.485 1.914 . . . . 0.0 111.715 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.88 -48.14 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.849 1.26 . . . . 0.0 110.266 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.64 -41.26 69.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.731 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.0 m -72.27 -42.89 65.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 110.389 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -56.04 -42.18 76.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.677 0.391 . . . . 0.0 110.085 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.41 -36.38 45.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.15 45.64 3.01 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.36 0.981 . . . . 0.0 111.219 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.82 130.07 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -79.09 -38.8 35.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 t -163.62 -173.53 3.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 pt -129.42 156.27 78.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 124.558 1.143 . . . . 0.0 109.267 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.99 157.66 82.64 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.127 1.081 . . . . 0.0 112.621 2.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 m -160.99 142.32 11.81 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-O 122.213 1.006 . . . . 0.0 109.679 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HB ' ' N ' ' A' ' 89' ' ' ILE 0.607 0.8 OUTLIER -75.2 13.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 2 N-CA-C 138.996 10.369 . . . . 0.0 138.996 -160.967 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 65.1 mtt -80.87 128.61 33.86 Favored 'General case' 0 C--N 1.318 -0.801 1 CA-C-N 126.526 4.239 . . . . 0.0 114.708 -162.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.6 137.04 33.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -129.29 160.62 32.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.093 0.957 . . . . 0.0 109.744 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.16 167.81 6.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.576 1.95 . . . . 0.0 105.916 172.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 51.34 34.12 32.99 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.81 9.9 66.73 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 117.88 -1.511 . . . . 0.0 115.409 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -147.81 169.14 20.42 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.469 2.134 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.69 149.4 50.06 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 127.765 2.426 . . . . 0.0 109.993 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.59 -80.17 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.028 0.531 . . . . 0.0 111.58 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.59 175.36 7.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.961 0.8 . . . . 0.0 111.49 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.5 p -143.16 116.01 8.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.433 1.093 . . . . 0.0 111.389 -175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.439 ' N ' ' HB ' ' A' ' 77' ' ' ILE . 23.5 mt -118.88 122.57 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.43 1.492 . . . . 0.0 112.934 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.5 mt -84.25 155.95 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 119.327 -2.108 . . . . 0.0 106.32 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.5 -158.33 7.12 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.35 -16.61 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.62 152.84 80.95 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 120.081 1.31 . . . . 0.0 108.883 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.32 131.73 21.03 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 105.172 -2.665 . . . . 0.0 105.172 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -57.89 -29.12 64.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.21 -38.65 18.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.387 0.994 . . . . 0.0 110.474 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -60.01 -51.92 67.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.609 1.164 . . . . 0.0 109.076 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.72 -49.07 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.352 1.461 . . . . 0.0 110.474 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -52.3 -55.25 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -57.91 -50.14 74.35 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.177 -0.327 . . . . 0.0 110.83 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.2 m -55.61 -41.26 73.21 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.116 0.567 . . . . 0.0 111.567 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.72 -45.24 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.888 0.767 . . . . 0.0 110.513 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -54.55 -35.02 62.8 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.422 0.689 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -44.9 -50.99 10.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.462 0.648 . . . . 0.0 109.465 171.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 124.111 0.964 . . . . 0.0 110.923 -176.924 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 121.171 0.51 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.82 140.73 38.82 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.67 92.36 5.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -81.79 161.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.589 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -160.0 -178.95 7.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -38.27 -56.53 1.21 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.0 1.72 . . . . 0.0 112.888 -170.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.05 -71.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.203 0.601 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 p -49.6 -43.41 46.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.891 1.276 . . . . 0.0 111.695 -175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -39.94 -50.85 2.51 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.266 1.826 . . . . 0.0 112.248 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -49.7 -50.45 43.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.947 0.899 . . . . 0.0 111.405 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -79.61 -56.89 3.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.939 0.895 . . . . 0.0 112.058 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.26 -32.05 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 125.449 1.5 . . . . 0.0 113.073 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.29 -52.38 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.133 0.573 . . . . 0.0 112.432 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -73.6 -73.01 0.23 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.631 0.651 . . . . 0.0 111.293 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -79.62 47.09 0.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.206 0.602 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 m -90.42 151.35 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.566 1.147 . . . . 0.0 109.442 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -78.85 -57.06 3.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -78.42 150.98 77.39 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.52 162.61 39.57 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.491 1.461 . . . . 0.0 109.217 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -150.16 134.39 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.186 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -95.12 99.09 11.13 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 126.229 1.812 . . . . 0.0 108.125 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 p -94.9 125.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -94.32 121.51 35.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.54 108.17 12.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -124.35 -172.88 2.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.787 0.803 . . . . 0.0 110.913 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.48 152.26 3.2 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.25 -40.07 78.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.134 1.889 . . . . 0.0 112.455 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -73.2 -12.17 60.78 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.4 t -73.83 86.65 1.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.084 -1.01 . . . . 0.0 110.84 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -31.74 -66.5 0.17 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.299 1.428 . . . . 0.0 115.284 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -59.46 -45.27 27.19 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.001 1.8 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.5 m -56.4 -46.09 80.32 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -57.02 -50.92 71.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.17 1.388 . . . . 0.0 110.329 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.9 pt -68.36 -36.92 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.408 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.82 -25.47 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 120.178 1.354 . . . . 0.0 111.444 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -38.99 -45.81 3.14 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -64.6 -38.19 33.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.855 2.37 . . . . 0.0 110.241 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -39.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.682 1.593 . . . . 0.0 108.522 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.6 t -58.86 -50.93 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -58.92 -52.07 67.33 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.179 0.592 . . . . 0.0 111.865 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.45 -41.63 94.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.12 0.873 . . . . 0.0 110.469 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.14 -44.03 97.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.62 75.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.59 44.52 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -49.11 -54.38 16.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.421 0.688 . . . . 0.0 111.346 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.66 33.66 3.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -51.8 -45.45 63.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -33.35 -50.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.897 2.879 . . . . 0.0 113.401 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -149.88 -58.89 0.2 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.487 1.115 . . . . 0.0 113.5 -170.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 tp -78.59 179.14 7.28 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -155.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' CB ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.23 92.06 2.7 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 123.196 4.517 . . . . 0.0 123.196 -157.097 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 39.6 t -152.97 120.98 6.14 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 119.949 -1.719 . . . . 0.0 112.584 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.59 171.98 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.711 0.804 . . . . 0.0 110.515 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -143.5 114.3 7.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.5 118.45 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.764 0.711 . . . . 0.0 110.195 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.11 106.49 5.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.9 m -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.667 1.587 . . . . 0.0 111.456 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -34.08 77.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.181 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -87.05 -15.37 38.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 110.972 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -138.53 64.34 37.15 Favored Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 120.239 -1.538 . . . . 0.0 112.687 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.75 -26.91 32.25 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.173 3.249 . . . . 0.0 108.582 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -47.37 -70.51 0.09 Allowed 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 125.535 1.534 . . . . 0.0 110.611 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.22 -49.97 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 125.541 1.536 . . . . 0.0 109.481 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.48 -45.79 69.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.524 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.2 m -68.92 -41.57 77.99 Favored 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 123.739 0.815 . . . . 0.0 111.014 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.03 -42.2 76.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.183 0.593 . . . . 0.0 109.724 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.67 -32.92 47.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.15 36.23 5.78 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.261 0.934 . . . . 0.0 110.797 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -74.45 107.72 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -77.73 -27.34 50.51 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.838 0.455 . . . . 0.0 110.923 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -155.34 159.04 39.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.6 pt -115.02 156.86 44.7 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.59 161.73 81.88 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 120.608 1.253 . . . . 0.0 114.175 3.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.9 m -160.63 124.86 3.6 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.82 106.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.665 1.186 . . . . 0.0 108.327 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.7 mtt -103.85 132.01 50.51 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.737 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.1 t -100.71 110.53 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -92.98 143.86 25.82 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 50.61 1.83 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.45 77.98 1.3 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.79 -61.82 2.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.94 0.781 . . . . 0.0 112.201 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.08 163.07 22.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.962 0.905 . . . . 0.0 111.058 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -89.4 151.24 22.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.94 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -109.17 -57.12 2.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.623 . . . . 0.0 107.765 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -124.36 159.48 30.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.798 1.239 . . . . 0.0 109.367 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.1 m -152.4 93.34 1.78 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -103.82 146.87 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.229 1.412 . . . . 0.0 108.46 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.01 151.45 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.32 -158.48 5.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.52 46.56 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.951 0.9 . . . . 0.0 110.504 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.05 153.18 80.27 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.16 139.22 35.01 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 N-CA-C 105.4 -2.577 . . . . 0.0 105.4 170.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -67.11 -19.67 65.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 118.773 -1.171 . . . . 0.0 109.918 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.23 -49.9 68.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.801 1.182 . . . . 0.0 109.221 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -55.86 -48.11 76.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.518 1.127 . . . . 0.0 109.687 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.67 -49.02 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.018 0.527 . . . . 0.0 109.81 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.88 -56.82 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -51.79 -45.65 63.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.369 0.531 . . . . 0.0 110.793 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.2 m -60.41 -33.07 71.98 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.589 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.6 t -76.75 -47.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 120.408 1.458 . . . . 0.0 109.988 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -49.35 -45.04 45.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.079 0.952 . . . . 0.0 111.063 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -53.86 -27.67 31.41 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 CA--C 1.531 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.131 177.865 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.25 175.46 54.66 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.83 136.13 54.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.93 164.36 30.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 122.346 1.07 . . . . 0.0 112.775 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.9 170.26 16.04 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 128.033 2.533 . . . . 0.0 104.433 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -39.12 -46.87 1.49 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.281 1.832 . . . . 0.0 112.735 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.13 -66.28 0.43 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.33 1.052 . . . . 0.0 111.723 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -67.21 -41.59 85.51 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.711 1.204 . . . . 0.0 111.641 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -39.52 -47.84 1.94 Allowed 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 127.524 2.33 . . . . 0.0 110.996 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -41.62 -66.67 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.006 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -42.96 65.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 111.364 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.0 t -73.51 -18.39 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.121 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.15 -51.18 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.333 1.053 . . . . 0.0 112.272 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.71 -70.86 0.43 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.121 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.01 40.22 0.4 Allowed 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.973 -1.08 . . . . 0.0 112.22 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 m -91.12 137.87 32.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.734 1.213 . . . . 0.0 110.645 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 p -78.78 -55.62 5.02 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.404 1.482 . . . . 0.0 108.66 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.93 156.38 79.82 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.59 167.17 19.71 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 N-CA-C 108.871 -1.242 . . . . 0.0 108.871 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -136.7 144.77 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 126.595 1.958 . . . . 0.0 109.21 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -124.69 98.37 5.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 106.494 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.31 120.29 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.183 0.901 . . . . 0.0 110.323 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -90.93 117.21 29.35 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.743 0.817 . . . . 0.0 109.143 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.45 108.67 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -127.41 -174.75 3.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 121.717 0.77 . . . . 0.0 111.075 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.62 149.01 4.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.91 -44.05 52.64 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.526 2.151 . . . . 0.0 112.448 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.5 p-90 -68.83 -18.33 64.15 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.146 -0.346 . . . . 0.0 111.823 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 37.9 t -77.89 85.14 4.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -177.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.21 -60.24 1.38 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.649 1.119 . . . . 0.0 114.088 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.12 -17.24 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.84 1.82 . . . . 0.0 112.509 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -81.43 -48.11 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.07 -49.93 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.308 1.443 . . . . 0.0 110.244 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 pt -63.19 -36.52 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.275 -0.869 . . . . 0.0 112.393 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.1 pt -80.04 -25.32 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.741 1.155 . . . . 0.0 111.401 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.87 -48.27 5.55 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 120.071 1.305 . . . . 0.0 114.497 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.72 -39.37 53.71 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.974 2.449 . . . . 0.0 110.026 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -47.07 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.02 -42.56 90.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.06 -56.28 24.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.02 0.528 . . . . 0.0 110.37 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -62.84 -37.84 88.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.917 -1.114 . . . . 0.0 111.108 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.21 -45.79 67.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.1 -51.89 66.26 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -46.18 -42.52 12.64 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 112.199 -0.361 . . . . 0.0 112.199 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -71.61 -54.54 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.675 0.738 . . . . 0.0 112.351 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -92.47 9.03 36.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -45.33 148.94 0.57 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.318 1.447 . . . . 0.0 111.831 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.1 t70 74.61 -50.09 0.67 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.626 1.97 . . . . 0.0 111.569 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -77.56 -29.02 51.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.73 1.212 . . . . 0.0 111.141 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.76 121.42 13.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.136 1.374 . . . . 0.0 108.319 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -79.45 94.12 5.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -79.45 133.34 36.53 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.279 -0.888 . . . . 0.0 108.978 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.84 168.54 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.301 0.572 . . . . 0.0 112.053 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -134.56 111.1 9.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.341 1.456 . . . . 0.0 109.517 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tt -89.56 118.51 29.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.764 0.792 . . . . 0.0 109.966 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -71.93 100.2 2.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 109.208 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 m -85.36 52.82 2.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.753 1.621 . . . . 0.0 110.081 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -148.28 -46.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -79.93 -25.44 40.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.528 2.331 . . . . 0.0 110.062 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 t -132.58 55.47 17.72 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.06 -23.59 29.25 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.994 3.796 . . . . 0.0 109.264 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -44.55 -58.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.784 1.634 . . . . 0.0 109.211 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.32 -53.25 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.027 0.931 . . . . 0.0 109.967 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.51 -40.32 62.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.975 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 m -69.79 -47.73 61.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.058 0.943 . . . . 0.0 110.567 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.55 -44.68 77.0 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.927 . . . . 0.0 110.437 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.01 -31.93 44.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.83 50.19 3.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.16 139.36 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 109.554 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -41.21 29.02 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.967 0.507 . . . . 0.0 111.403 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -167.11 -170.94 1.63 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.6 pt -130.32 152.65 80.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 124.774 1.23 . . . . 0.0 108.384 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.39 157.04 99.45 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.95 1.018 . . . . 0.0 113.478 2.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -160.15 114.43 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.8 mt -97.38 107.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.9 mtt -97.43 142.62 29.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.108 0.867 . . . . 0.0 109.0 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.22 129.56 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -132.92 162.11 32.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.862 0.865 . . . . 0.0 110.663 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.64 152.94 3.95 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.012 1.325 . . . . 0.0 108.151 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.47 44.8 11.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.55 8.17 70.85 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.837 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -138.39 163.05 32.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.597 1.698 . . . . 0.0 111.031 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -90.17 148.29 23.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.5 t -100.07 -60.69 1.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.266 1.027 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.47 -168.5 1.53 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.013 1.725 . . . . 0.0 107.159 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -150.95 172.16 16.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.599 0.76 . . . . 0.0 109.056 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.29 142.04 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.564 1.546 . . . . 0.0 106.835 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.9 mt -79.71 140.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -145.7 4.06 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.48 38.7 28.67 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.793 0.796 . . . . 0.0 111.232 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.22 157.55 60.8 Favored Pre-proline 0 C--N 1.341 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 111.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -70.5 140.07 39.08 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 163.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -58.0 -25.15 60.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.799 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.3 -44.66 34.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.156 0.889 . . . . 0.0 109.918 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -50.49 73.42 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.467 1.107 . . . . 0.0 109.53 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -52.38 50.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.869 0.868 . . . . 0.0 109.783 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.2 t -53.57 -58.88 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.653 0.661 . . . . 0.0 109.806 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -52.32 -53.07 49.02 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.6 m -53.71 -47.6 70.38 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.156 0.285 . . . . 0.0 111.64 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.63 -50.0 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.543 0.737 . . . . 0.0 109.279 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -57.6 -44.88 85.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.86 -51.5 60.81 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.055 0.942 . . . . 0.0 109.337 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 CA--C 1.532 0.285 0 O-C-N 122.277 -0.265 . . . . 0.0 111.613 -178.925 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.08 163.23 54.05 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.24 44.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.42 162.37 14.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 122.136 0.97 . . . . 0.0 110.572 -178.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -140.61 168.42 19.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.469 2.308 . . . . 0.0 105.778 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -39.87 -49.29 2.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.444 1.497 . . . . 0.0 110.787 176.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.74 -66.8 0.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.436 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -66.16 -41.38 90.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.436 1.095 . . . . 0.0 112.229 -174.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -38.93 -47.51 1.45 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 128.201 2.6 . . . . 0.0 111.237 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -44.41 -59.66 2.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.537 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.12 -46.04 18.81 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.884 0.849 . . . . 0.0 110.844 -176.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.0 -34.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.031 -168.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.29 -59.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.445 1.098 . . . . 0.0 111.657 -172.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.63 -68.02 0.37 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -175.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -79.61 41.69 0.49 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.556 -0.715 . . . . 0.0 111.762 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -90.18 139.6 30.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -78.52 -54.89 5.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -78.85 157.29 76.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.69 152.68 81.05 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 111.758 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 76.5 t -146.74 124.3 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.357 1.063 . . . . 0.0 113.757 -177.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 tt -107.72 123.77 49.02 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 125.35 1.46 . . . . 0.0 108.341 -178.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.07 133.38 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -96.59 123.37 40.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -78.78 110.94 14.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 175.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -123.15 -173.68 2.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.886 0.851 . . . . 0.0 111.045 -176.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.84 157.9 4.36 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 175.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.33 -38.53 84.16 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.136 1.891 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -73.78 -8.68 56.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.947 0.499 . . . . 0.0 111.422 176.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -80.11 85.44 5.67 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.28 -1.512 . . . . 0.0 109.617 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.58 -61.6 1.81 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.675 1.131 . . . . 0.0 113.151 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -49.34 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.798 2.999 . . . . 0.0 112.04 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -57.6 -50.93 71.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.013 0.925 . . . . 0.0 109.304 -178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.25 -45.87 90.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.186 -0.435 . . . . 0.0 112.152 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 pt -67.34 -38.61 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.23 -178.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.84 -23.35 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.66 1.118 . . . . 0.0 111.939 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.51 4.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -176.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.78 -29.41 23.79 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 122.666 1.988 . . . . 0.0 109.866 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -44.44 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.12 -44.49 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -54.3 41.91 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.36 -40.16 81.48 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.979 -1.076 . . . . 0.0 110.302 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.6 mt -58.21 -45.79 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.04 -44.98 64.5 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.455 0.571 . . . . 0.0 109.546 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 -57.1 10.39 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -50.09 -51.18 44.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.573 0.702 . . . . 0.0 111.288 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -88.26 19.94 3.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -56.4 153.1 10.32 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.075 0.852 . . . . 0.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.3 -52.1 0.7 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.799 2.039 . . . . 0.0 111.485 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -78.57 -51.84 9.34 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.41 -158.32 0.89 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -158.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -76.21 82.12 3.01 Favored 'General case' 0 N--CA 1.441 -0.883 2 N-CA-C 127.687 6.18 . . . . 0.0 127.687 -156.729 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.6 t -148.29 121.7 9.07 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.938 -2.351 . . . . 0.0 114.974 172.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.92 167.35 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.382 1.073 . . . . 0.0 109.88 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -134.18 113.48 12.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.853 1.261 . . . . 0.0 109.758 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 tp -93.36 114.77 27.27 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.043 0.937 . . . . 0.0 110.413 -178.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -72.68 109.78 6.55 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.8 m -70.12 -33.51 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.031 1.333 . . . . 0.0 111.18 -174.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.54 -37.96 89.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.483 1.113 . . . . 0.0 109.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -87.35 -27.01 23.09 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.731 2.012 . . . . 0.0 111.758 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.2 t -121.01 52.8 3.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.275 1.83 . . . . 0.0 111.741 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.46 -38.16 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.642 2.894 . . . . 0.0 108.97 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -38.33 -69.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.657 1.983 . . . . 0.0 110.839 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.93 -54.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.746 1.218 . . . . 0.0 109.957 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.18 -37.46 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.835 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -68.69 -48.09 64.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.414 0.685 . . . . 0.0 109.162 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.62 -42.9 75.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 110.009 177.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.51 -25.62 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.49 13.47 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.723 0.678 . . . . 0.0 111.649 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.5 mt -79.85 90.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -10.74 59.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.621 1.169 . . . . 0.0 112.978 -175.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.9 m -159.38 161.98 35.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.2 pt -132.75 154.92 81.64 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.77 161.88 74.81 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.661 1.272 . . . . 0.0 114.424 4.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -160.85 122.04 2.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 174.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.96 99.14 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.967 0.907 . . . . 0.0 108.62 -172.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.3 mtt -96.83 138.86 33.75 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.586 0.63 . . . . 0.0 110.079 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.19 131.1 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.31 167.57 17.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.743 1.617 . . . . 0.0 111.174 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.17 151.67 3.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.752 2.021 . . . . 0.0 105.955 173.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 47.4 42.3 18.46 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 170.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.1 10.33 68.62 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.691 178.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -141.76 170.75 15.14 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.561 1.68 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.89 162.85 17.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.471 1.109 . . . . 0.0 111.262 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 45.2 t -130.53 -50.9 1.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.384 1.874 . . . . 0.0 110.012 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -138.88 167.38 22.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.468 -177.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.7 m -151.81 89.02 1.43 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 126.234 1.814 . . . . 0.0 106.24 175.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.08 -175.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 106.615 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.43 156.65 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.66 -150.16 2.09 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.9 -43.71 0.57 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.466 1.506 . . . . 0.0 112.166 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.86 151.95 79.73 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.03 149.25 53.87 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.621 1.547 . . . . 0.0 112.543 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -59.19 -37.24 76.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.2 -50.47 38.05 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.722 0.409 . . . . 0.0 110.074 175.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -56.86 -48.41 78.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.615 1.166 . . . . 0.0 110.095 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.1 mt -59.41 -53.01 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.43 -53.56 23.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.22 -42.26 63.43 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.328 0.513 . . . . 0.0 111.143 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.1 m -59.94 -47.72 84.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.58 -38.49 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 122.034 -0.417 . . . . 0.0 112.076 -178.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -45.68 -42.49 11.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.699 1.2 . . . . 0.0 112.304 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -45.84 -39.09 8.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.846 1.258 . . . . 0.0 111.734 176.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.452 -0.339 0 C-N-CA 126.972 2.109 . . . . 0.0 110.556 -178.375 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 119.837 -0.125 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.19 148.31 36.99 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 174.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.46 100.81 10.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 171.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 m -103.6 161.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.852 0.834 . . . . 0.0 109.432 -176.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -151.34 172.89 15.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.93 2.092 . . . . 0.0 105.494 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.79 -48.41 15.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.073 0.949 . . . . 0.0 112.317 -176.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.22 -72.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 110.77 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -51.7 -36.58 47.26 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.539 1.135 . . . . 0.0 112.491 -174.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -39.8 -49.67 2.35 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 126.28 1.832 . . . . 0.0 110.863 177.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -49.98 -56.92 8.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.552 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -74.02 -45.15 51.61 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.678 -175.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.3 t -74.91 -43.7 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.574 -168.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.5 t -95.9 -64.65 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.22 1.008 . . . . 0.0 111.007 -173.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -64.31 -59.05 4.85 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.36 41.98 0.41 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.162 0.585 . . . . 0.0 111.312 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -89.75 -171.13 3.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 p -128.2 -65.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.799 2.039 . . . . 0.0 106.973 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.1 158.97 74.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.6 159.84 46.15 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.419 1.185 . . . . 0.0 111.347 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.24 123.95 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.178 1.791 . . . . 0.0 109.007 -177.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.84 101.33 12.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.76 137.76 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -110.74 118.08 35.19 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -78.25 112.29 15.08 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -125.31 -174.82 3.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.172 0.987 . . . . 0.0 111.158 -175.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.41 142.73 1.78 Allowed Pre-proline 0 C--O 1.224 -0.287 0 C-N-CA 126.527 1.931 . . . . 0.0 106.165 171.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -37.98 -53.5 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.148 3.232 . . . . 0.0 117.708 179.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.6 p-90 -61.27 -15.96 40.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.449 0.568 . . . . 0.0 112.458 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -73.0 80.91 1.2 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.191 0.596 . . . . 0.0 111.022 -177.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.15 -56.75 1.8 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.642 1.115 . . . . 0.0 112.691 176.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -50.96 -48.64 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.176 2.584 . . . . 0.0 112.585 177.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.6 m -58.61 -47.51 84.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -61.42 -45.66 93.39 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.3 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.05 -25.47 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.331 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.33 -27.99 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.867 1.667 . . . . 0.0 110.391 174.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -38.68 -45.54 2.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.98 -40.24 73.22 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 CA-C-N 122.346 1.874 . . . . 0.0 109.855 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -74.18 -47.67 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.523 1.129 . . . . 0.0 108.668 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -52.01 -36.08 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.422 1.089 . . . . 0.0 108.165 175.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.1 -58.63 3.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.797 -0.565 . . . . 0.0 110.709 173.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -49.29 -41.46 38.2 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.347 -0.359 . . . . 0.0 111.757 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -52.76 -42.98 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 118.482 0.583 . . . . 0.0 110.433 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.71 66.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.671 0.669 . . . . 0.0 111.171 178.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.93 -46.01 14.85 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 174.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.06 -65.75 0.88 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.355 1.062 . . . . 0.0 113.104 -176.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -82.91 19.16 1.42 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.498 1.119 . . . . 0.0 112.805 -174.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -39.41 -42.02 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 128.204 2.602 . . . . 0.0 112.057 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -36.17 -46.89 0.54 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 127.719 2.408 . . . . 0.0 111.748 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.96 -55.04 1.3 Allowed 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.687 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.35 113.57 21.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -163.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.89 91.48 8.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.7 t -79.23 142.09 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 120.752 -1.218 . . . . 0.0 109.454 -178.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -156.73 176.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.828 0.74 . . . . 0.0 110.744 -178.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -142.13 137.74 31.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.846 0.858 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.87 122.26 45.77 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.71 1.204 . . . . 0.0 112.824 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.66 105.79 5.92 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 122.071 0.939 . . . . 0.0 109.809 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -59.89 -39.8 86.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.665 1.986 . . . . 0.0 111.94 -173.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.33 -38.27 74.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.67 0.788 . . . . 0.0 110.709 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -80.09 -27.17 39.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.27 1.428 . . . . 0.0 110.995 177.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.4 m -134.57 62.83 56.88 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.813 1.245 . . . . 0.0 111.342 -177.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 -34.33 28.95 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 109.533 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -37.25 -69.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.764 2.026 . . . . 0.0 110.663 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -61.01 -45.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 122.822 0.449 . . . . 0.0 110.753 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -37.11 60.24 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.13 0.172 . . . . 0.0 111.049 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.1 m -74.41 -46.42 40.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.248 1.019 . . . . 0.0 109.859 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.04 -45.45 75.22 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.197 0.599 . . . . 0.0 110.501 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -79.27 -33.33 43.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.905 0.482 . . . . 0.0 110.51 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.57 53.58 2.41 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.9 mm -67.52 130.13 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.15 -42.4 26.26 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.934 -0.479 . . . . 0.0 110.783 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.8 m -166.09 174.95 8.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.799 2.04 . . . . 0.0 106.042 179.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 pt -120.35 150.75 52.4 Favored Pre-proline 0 N--CA 1.455 -0.202 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.33 144.8 81.59 Favored 'Cis proline' 0 N--CA 1.457 -0.654 0 CA-C-N 119.905 1.002 . . . . 0.0 113.355 1.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -143.12 111.67 6.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.05 138.77 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.3 mtt -130.51 128.19 40.68 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 173.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.6 97.2 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -79.34 125.99 30.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -137.29 0.31 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.03 77.82 0.42 Allowed Glycine 0 CA--C 1.531 1.031 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.25 -63.3 4.15 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -79.66 167.84 20.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.47 0.708 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -87.36 149.3 24.58 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.59 -55.19 3.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.351 1.06 . . . . 0.0 109.127 170.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -137.18 163.7 30.24 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.577 1.151 . . . . 0.0 112.808 -176.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.3 t -138.71 128.69 25.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 173.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 mt -140.21 137.27 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -78.64 140.03 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 174.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.11 -137.71 0.72 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.12 -31.1 0.21 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.448 1.499 . . . . 0.0 112.44 -177.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.06 149.5 79.87 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -56.95 144.99 87.43 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 120.988 1.125 . . . . 0.0 110.387 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -55.86 -31.6 62.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.341 0.656 . . . . 0.0 110.189 -178.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -37.87 60.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.021 0.828 . . . . 0.0 111.087 175.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -61.64 -49.55 76.12 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.355 1.062 . . . . 0.0 108.341 178.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.77 -43.23 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.569 1.148 . . . . 0.0 109.817 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.92 -55.03 22.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 124.127 0.971 . . . . 0.0 108.865 177.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -55.07 -48.19 73.84 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.994 -0.441 . . . . 0.0 110.289 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -59.76 -44.67 93.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.637 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.68 -44.75 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 CA-C-N 119.067 0.849 . . . . 0.0 110.636 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -46.65 -47.27 20.23 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.342 1.057 . . . . 0.0 110.731 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -44.48 -39.96 5.21 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.567 1.147 . . . . 0.0 111.818 176.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 CA--C 1.533 0.31 0 C-N-CA 124.796 1.238 . . . . 0.0 113.224 -175.538 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.02 157.74 51.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 177.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.55 117.57 33.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -105.58 160.15 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 122.187 0.994 . . . . 0.0 109.87 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -152.1 174.53 13.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.736 2.414 . . . . 0.0 106.774 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -37.72 -58.36 0.9 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 126.549 1.94 . . . . 0.0 112.653 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.26 -67.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -53.67 -45.59 70.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.145 0.978 . . . . 0.0 111.928 -175.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -42.07 -50.42 4.7 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 127.14 2.176 . . . . 0.0 111.447 -178.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -48.52 -48.06 38.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.791 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -81.05 -59.81 2.52 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.367 0.667 . . . . 0.0 111.456 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.31 -31.49 54.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 126.332 1.853 . . . . 0.0 113.116 -172.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.42 -56.51 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.449 0.699 . . . . 0.0 112.009 -173.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.76 -60.0 2.46 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.867 0.758 . . . . 0.0 109.815 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.84 42.32 0.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.9 p -90.16 148.42 22.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.902 -0.499 . . . . 0.0 109.832 -178.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 p -87.57 -62.93 1.39 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.778 1.231 . . . . 0.0 107.964 177.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 151.38 75.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.033 1.333 . . . . 0.0 108.192 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.44 160.49 48.42 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 120.942 1.095 . . . . 0.0 109.585 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -151.14 133.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -172.049 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 tt -92.3 109.46 20.84 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.07 110.14 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -87.15 113.39 22.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -79.11 109.81 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 177.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -130.47 -173.6 3.11 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 121.723 0.773 . . . . 0.0 111.44 -173.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.04 150.73 4.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.72 -40.2 85.73 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.042 1.828 . . . . 0.0 112.422 178.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.403 ' CH2' HD11 ' A' ' 74' ' ' ILE . 41.1 p-90 -70.19 -14.22 62.53 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.904 -0.498 . . . . 0.0 111.789 177.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 84.18 3.54 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.119 -0.988 . . . . 0.0 112.127 -177.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.52 -62.06 1.42 Allowed Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.772 -1.016 . . . . 0.0 114.059 175.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 -23.54 74.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.214 1.942 . . . . 0.0 113.222 -178.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.8 m -77.39 -58.55 3.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -43.45 -52.59 5.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.53 2.332 . . . . 0.0 111.602 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.69 -22.79 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.247 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.88 -27.29 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.488 1.04 . . . . 0.0 110.831 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.71 -44.97 3.9 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 117.023 -1.465 . . . . 0.0 114.005 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.71 -37.25 88.5 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.532 2.155 . . . . 0.0 110.215 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -43.4 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -59.97 -41.95 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -65.05 -48.66 73.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.402 0.681 . . . . 0.0 110.599 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -60.76 -40.44 92.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.354 0.525 . . . . 0.0 109.719 -179.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mt -53.35 -47.29 58.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.88 -52.42 65.2 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.81 -41.72 28.07 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.61 1.1 . . . . 0.0 112.129 178.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.47 -70.27 0.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.335 0.654 . . . . 0.0 110.046 177.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -86.86 48.46 1.65 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.427 1.108 . . . . 0.0 111.28 -174.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -52.02 61.38 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 127.595 2.358 . . . . 0.0 115.011 -168.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -70.08 -72.44 0.2 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.821 0.82 . . . . 0.0 111.834 -177.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -39.47 34.64 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -164.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 tp -105.48 -171.84 1.98 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -155.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 2.7 pptp? -76.34 91.67 3.28 Favored 'General case' 0 N--CA 1.431 -1.389 2 N-CA-C 123.585 4.661 . . . . 0.0 123.585 -160.933 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.4 t -153.82 121.89 6.07 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.492 -1.38 . . . . 0.0 113.2 172.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.59 163.68 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.395 1.478 . . . . 0.0 108.744 173.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 115.08 16.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.514 1.126 . . . . 0.0 110.864 -175.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -92.74 110.22 21.66 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.98 103.83 2.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.231 1.015 . . . . 0.0 108.699 177.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -84.53 54.1 2.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.492 2.317 . . . . 0.0 108.987 -177.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -150.89 -48.67 0.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.23 -26.25 30.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 111.238 172.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.87 53.13 0.94 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.97 2.108 . . . . 0.0 115.042 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.59 -25.75 40.51 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.683 3.589 . . . . 0.0 108.79 174.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -49.14 -70.56 0.09 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.897 1.279 . . . . 0.0 109.951 178.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.6 t -51.56 -49.44 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.232 1.413 . . . . 0.0 108.856 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.89 67.14 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.8 m -69.68 -45.79 67.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.28 0.632 . . . . 0.0 110.335 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.4 -46.05 76.61 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.245 0.618 . . . . 0.0 110.62 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.44 -31.36 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.478 0.311 . . . . 0.0 111.155 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.72 52.46 2.63 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.79 115.61 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -78.4 -33.65 48.63 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.091 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -163.29 -173.39 3.35 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.403 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.3 pt -142.14 149.05 50.71 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.22 139.27 60.45 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 CA-C-N 119.394 0.819 . . . . 0.0 113.304 2.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -130.15 118.89 22.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 102.04 -3.318 . . . . 0.0 102.04 172.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.2 mt -112.49 100.45 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 108.272 -172.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.4 mtt -94.29 138.39 32.34 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.136 0.426 . . . . 0.0 110.287 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.5 104.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.82 147.69 28.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.44 21.57 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.396 1.078 . . . . 0.0 109.618 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.06 127.23 6.04 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.5 -52.06 1.86 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.828 1.68 . . . . 0.0 114.116 178.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -138.48 -179.88 6.06 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.248 1.019 . . . . 0.0 110.649 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 152.71 21.04 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.778 1.231 . . . . 0.0 109.832 176.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -110.82 -71.06 0.78 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.404 1.482 . . . . 0.0 107.883 177.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -96.6 162.91 13.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.693 0.797 . . . . 0.0 109.691 177.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.4 m -153.27 108.58 3.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.347 1.059 . . . . 0.0 108.177 175.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.31 160.65 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -142.98 147.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.67 169.34 45.65 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 121.495 0.497 . . . . 0.0 112.33 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.85 82.71 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.989 0.515 . . . . 0.0 111.122 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.61 151.54 77.29 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.746 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -82.38 149.3 14.88 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.405 2.737 . . . . 0.0 106.76 170.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.01 -42.45 72.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.806 -0.559 . . . . 0.0 112.31 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.54 -51.73 6.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.98 0.912 . . . . 0.0 111.253 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 m -61.5 -50.23 73.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.161 0.584 . . . . 0.0 110.481 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -53.96 -56.37 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.594 0.758 . . . . 0.0 109.016 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -49.88 -64.08 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.741 1.617 . . . . 0.0 108.885 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -51.62 -47.3 63.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.188 0.449 . . . . 0.0 111.824 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -58.35 -45.34 88.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.207 -178.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -44.79 46.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 CA-C-N 119.262 0.937 . . . . 0.0 111.589 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -48.7 -44.33 37.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.244 1.018 . . . . 0.0 110.074 -178.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -44.26 -44.04 7.71 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.125 0.97 . . . . 0.0 111.717 174.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 CA--C 1.531 0.217 0 C-N-CA 125.423 1.489 . . . . 0.0 112.755 -177.955 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.16 -173.56 41.76 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.84 139.25 52.25 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.93 167.98 22.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 122.499 1.142 . . . . 0.0 111.514 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -146.71 175.9 10.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.706 2.402 . . . . 0.0 106.419 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -38.54 -58.78 0.99 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.5 1.52 . . . . 0.0 112.793 -176.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.98 -57.45 11.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.623 1.169 . . . . 0.0 111.908 -177.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -65.11 -40.01 93.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.526 0.73 . . . . 0.0 111.658 -173.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -41.02 -47.13 3.03 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.471 1.908 . . . . 0.0 110.866 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -54.96 -62.99 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.656 178.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -63.21 -32.59 74.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.213 1.005 . . . . 0.0 112.314 -176.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.9 t -92.55 -54.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.19 0.596 . . . . 0.0 111.968 -171.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -83.59 -57.35 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.255 1.022 . . . . 0.0 110.854 -175.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.1 mt -70.23 -54.97 10.51 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.06 0.391 . . . . 0.0 111.238 -174.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -79.44 48.7 0.92 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.73 -0.606 . . . . 0.0 110.622 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 p -90.47 158.51 17.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.21 1.404 . . . . 0.0 111.151 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 p -91.26 -72.05 0.6 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.93 1.292 . . . . 0.0 107.569 176.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -79.39 160.63 69.87 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.22 166.15 1.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.114 1.876 . . . . 0.0 111.771 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 t -138.64 145.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 109.944 -176.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -122.33 105.77 10.49 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 m -101.25 150.9 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 118.626 0.648 . . . . 0.0 109.489 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -115.07 119.9 38.01 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.526 0.73 . . . . 0.0 109.321 174.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -80.76 111.31 17.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -128.84 -173.23 2.92 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.47 0.708 . . . . 0.0 111.608 -174.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.63 154.75 12.4 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.532 1.133 . . . . 0.0 108.158 174.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.46 -43.41 40.21 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.367 2.711 . . . . 0.0 112.07 -176.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -70.9 -13.13 61.91 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.177 0.591 . . . . 0.0 111.262 177.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.23 80.68 3.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.209 -0.932 . . . . 0.0 111.061 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.39 -55.9 4.27 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.907 0.765 . . . . 0.0 112.812 176.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.55 -27.95 78.95 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.55 2.167 . . . . 0.0 112.715 178.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.54 -56.38 4.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -48.71 -48.57 40.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.091 1.357 . . . . 0.0 111.727 -177.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.45 -21.94 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.222 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.4 mm -89.54 -26.58 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 119.461 1.028 . . . . 0.0 110.012 177.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.92 -48.56 5.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.66 -36.88 83.17 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.106 1.871 . . . . 0.0 110.174 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.9 -45.02 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.565 1.146 . . . . 0.0 108.292 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.5 -53.39 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.82 -53.53 57.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.832 0.853 . . . . 0.0 111.943 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.65 -40.48 96.96 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.068 -1.02 . . . . 0.0 110.604 -177.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.5 mt -58.42 -46.7 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.85 68.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.57 -51.44 52.07 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -61.93 -49.22 77.04 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.91 10.43 41.32 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -38.42 -56.94 1.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 126.62 1.968 . . . . 0.0 112.45 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.58 -44.91 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.533 1.933 . . . . 0.0 113.44 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.42 -9.8 19.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.216 1.006 . . . . 0.0 112.458 -176.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -151.08 113.99 4.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -78.65 160.91 27.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 171.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 22.8 t -141.85 142.78 33.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.793 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.06 162.42 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -130.12 111.9 12.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.2 0.6 . . . . 0.0 110.087 -176.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.77 117.21 27.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.572 0.749 . . . . 0.0 109.383 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -74.41 100.94 3.95 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -58.92 -39.71 82.36 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.122 1.769 . . . . 0.0 112.422 -175.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.14 -37.64 75.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.236 1.014 . . . . 0.0 110.343 -173.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -86.34 -28.83 23.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.66 1.584 . . . . 0.0 111.332 177.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -123.43 54.85 7.48 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.464 1.906 . . . . 0.0 110.609 -177.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.71 -40.22 66.42 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.942 3.094 . . . . 0.0 109.006 177.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -29.09 -75.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.404 2.281 . . . . 0.0 111.804 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.7 t -53.37 -49.57 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.049 1.34 . . . . 0.0 109.879 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.92 68.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.949 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -80.3 -42.11 23.65 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.562 1.145 . . . . 0.0 108.957 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.18 -41.39 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -78.64 -30.09 46.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.427 0.691 . . . . 0.0 110.666 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.49 49.32 6.76 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.236 0.922 . . . . 0.0 111.24 176.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -133.28 79.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.661 1.584 . . . . 0.0 109.95 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -31.69 46.67 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.57 145.3 54.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 pt -148.05 154.52 43.12 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.88 140.08 58.76 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 CA-C-N 119.812 0.968 . . . . 0.0 112.273 1.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 m -130.1 107.27 9.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.7 mt -88.78 137.85 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 16.5 mtt -131.59 135.57 47.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.07 141.15 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -127.93 155.45 44.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.949 1.3 . . . . 0.0 108.277 174.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.05 56.42 1.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.884 1.674 . . . . 0.0 107.836 -178.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.49 -153.56 16.93 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 -173.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.2 35.84 1.3 Allowed Glycine 0 CA--C 1.528 0.879 0 O-C-N 121.794 -0.827 . . . . 0.0 114.546 -177.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -151.27 155.26 38.41 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.624 1.569 . . . . 0.0 108.044 177.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -89.84 145.81 24.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.14 1.376 . . . . 0.0 108.323 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.3 t -112.32 -55.85 2.47 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.357 1.063 . . . . 0.0 111.062 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -133.56 170.78 15.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 111.061 -175.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.5 m -156.23 140.62 16.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.115 1.366 . . . . 0.0 108.932 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.4 mm -136.6 153.34 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mt -133.53 144.01 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.97 148.49 24.29 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.028 0.823 . . . . 0.0 112.698 176.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.06 72.76 1.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 110.941 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.4 m -78.91 147.03 69.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -56.66 158.19 17.08 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.901 2.401 . . . . 0.0 114.556 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -46.68 -51.63 15.58 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 125.832 1.653 . . . . 0.0 110.581 177.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.36 -49.42 44.5 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.445 0.698 . . . . 0.0 110.799 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -49.7 73.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.068 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.02 -54.44 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.86 -56.78 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.562 1.145 . . . . 0.0 110.377 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -55.25 -47.47 75.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.3 m -56.92 -44.76 82.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.484 0.714 . . . . 0.0 110.415 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.94 -56.26 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.949 0.795 . . . . 0.0 109.52 176.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -52.51 -45.51 66.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.204 1.002 . . . . 0.0 112.745 -175.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -60.28 -30.75 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.568 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.445 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.56 175.14 54.35 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.878 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.6 129.5 56.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.67 162.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 122.171 0.986 . . . . 0.0 110.094 -177.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -139.34 175.36 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.572 2.349 . . . . 0.0 106.952 175.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -46.9 -55.26 8.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.0 111.521 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.15 -52.27 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.196 1.398 . . . . 0.0 111.442 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 p -75.94 -37.76 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.579 0.751 . . . . 0.0 112.132 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -41.2 -46.56 3.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.767 2.027 . . . . 0.0 110.644 -177.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.34 -50.12 60.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.417 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -78.03 -52.97 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.62 1.2 . . . . 0.0 110.877 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.81 -35.18 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.205 -169.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.3 -59.71 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.3 mt -66.4 -73.57 0.13 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -174.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -82.93 57.95 4.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.726 0.81 . . . . 0.0 108.924 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 p -87.6 -139.5 0.1 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.098 0.959 . . . . 0.0 109.964 -178.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -160.68 -68.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 m -77.79 158.34 78.21 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 104.959 -2.238 . . . . 0.0 104.959 171.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 165.29 21.9 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 N-CA-C 108.55 -1.365 . . . . 0.0 108.55 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.4 146.01 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 125.419 1.488 . . . . 0.0 108.916 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -126.25 103.76 7.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.09 145.08 10.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -113.36 113.21 24.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -78.59 111.26 14.48 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.61 -173.84 2.78 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.716 0.635 . . . . 0.0 110.719 -178.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.38 141.46 0.92 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.754 1.221 . . . . 0.0 110.499 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.07 110.69 3.0 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.445 2.096 . . . . 0.0 108.919 176.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 137.31 -29.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 131.61 3.964 . . . . 0.0 105.684 -173.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.5 t -68.78 88.53 0.37 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.352 0.596 . . . . 0.0 111.933 -177.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -35.65 -67.3 0.34 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.233 1.873 . . . . 0.0 113.388 177.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.28 -46.54 29.82 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 119.6 1.7 . . . . 0.0 112.268 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.3 m -54.22 -42.44 69.8 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.308 0.503 . . . . 0.0 110.293 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -55.57 -53.34 57.59 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 122.802 0.441 . . . . 0.0 111.065 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 pt -74.1 -27.46 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.878 -178.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.24 -38.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 110.683 177.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.64 -48.33 5.15 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -60.36 -37.6 80.72 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.929 2.419 . . . . 0.0 110.435 178.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.49 -45.52 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.32 -44.55 88.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -58.15 -61.46 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.64 0.776 . . . . 0.0 110.011 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.91 -37.51 82.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.633 0.652 . . . . 0.0 111.309 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.41 -40.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 176.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.29 -43.82 92.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.443 0.565 . . . . 0.0 110.097 175.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.36 -39.86 84.08 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.96 -51.14 42.7 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -99.91 10.11 41.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -46.4 147.49 1.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 112.078 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.18 -46.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.945 2.098 . . . . 0.0 111.91 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.87 -19.48 54.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.959 . . . . 0.0 110.709 -178.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.2 tp -155.3 128.83 8.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 107.338 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tmtp? -90.16 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.0 t -79.55 133.91 36.47 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.534 -0.729 . . . . 0.0 109.517 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.28 169.85 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.427 0.632 . . . . 0.0 111.865 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -133.5 131.28 39.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.983 1.713 . . . . 0.0 110.438 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.47 133.89 55.48 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.098 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -81.52 111.15 17.58 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.107 0.956 . . . . 0.0 111.257 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.6 m -84.22 49.86 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.238 2.215 . . . . 0.0 111.13 -174.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.12 -42.15 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -80.7 -24.1 39.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.748 2.019 . . . . 0.0 108.981 169.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -144.18 62.73 10.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.607 1.563 . . . . 0.0 110.985 178.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.26 -26.67 4.03 Favored 'Trans proline' 0 N--CA 1.445 -1.37 1 C-N-CA 126.397 4.732 . . . . 0.0 109.079 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -38.79 -61.26 0.75 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.938 1.695 . . . . 0.0 109.647 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.9 t -56.79 -52.88 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.765 1.226 . . . . 0.0 110.047 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.16 -35.25 64.57 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.501 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 m -73.65 -46.1 48.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.701 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.52 -43.61 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.528 0.731 . . . . 0.0 109.944 177.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.99 -32.53 45.26 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.66 -0.21 . . . . 0.0 110.721 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.87 51.92 2.54 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 123.75 0.69 . . . . 0.0 111.533 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.9 mt -79.92 112.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 -27.42 43.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.118 0.567 . . . . 0.0 112.142 -177.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -157.72 161.89 38.54 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.76 154.88 81.09 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.3 135.18 38.22 Favored 'Cis proline' 0 N--CA 1.449 -1.098 0 CA-C-N 119.282 0.779 . . . . 0.0 113.074 1.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -121.84 102.48 8.22 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 173.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -79.58 137.2 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 175.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.0 mtt -130.22 148.27 52.03 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.34 128.32 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -116.31 144.91 43.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 12.59 3.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.168 -176.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.35 -154.41 25.12 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.25 20.09 0.59 Allowed Glycine 0 CA--C 1.533 1.165 0 CA-C-N 118.041 0.921 . . . . 0.0 114.866 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -153.9 162.58 41.11 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.587 1.555 . . . . 0.0 108.595 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -78.84 -179.48 6.59 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.77 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.8 t -138.9 -66.08 0.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.403 1.081 . . . . 0.0 108.962 177.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -120.94 170.31 9.63 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.601 1.56 . . . . 0.0 109.784 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 t -156.86 152.25 26.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.758 0.823 . . . . 0.0 108.943 178.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.41 150.15 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.794 1.238 . . . . 0.0 107.788 -177.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.7 mt -79.78 119.85 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 171.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.42 86.27 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.135 -0.814 . . . . 0.0 113.973 -173.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.94 66.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.252 1.021 . . . . 0.0 113.017 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.41 154.68 53.44 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 126.06 1.744 . . . . 0.0 106.958 176.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -58.04 155.13 35.3 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.441 2.094 . . . . 0.0 113.952 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.07 -42.54 63.27 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.339 1.056 . . . . 0.0 109.542 177.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.97 -49.0 66.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.948 0.499 . . . . 0.0 109.985 178.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m -61.14 -47.8 84.56 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.1 mm -54.11 -56.73 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -49.32 -58.55 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 125.183 1.393 . . . . 0.0 109.724 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -54.34 -48.31 71.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.881 0.31 . . . . 0.0 111.218 -178.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.0 m -61.36 -38.99 88.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.945 0.498 . . . . 0.0 110.604 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.4 t -65.67 -55.4 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 119.153 0.888 . . . . 0.0 108.778 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -43.86 -57.58 3.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 111.671 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.84 -26.77 15.6 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 CA--C 1.533 0.31 0 O-C-N 121.414 -0.804 . . . . 0.0 110.976 -179.601 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.435 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.02 162.94 42.07 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.592 1.567 . . . . 0.0 113.601 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.65 122.21 35.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 172.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.3 163.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.492 -176.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -149.25 170.5 18.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.469 1.907 . . . . 0.0 107.242 177.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -77.31 80.53 3.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 125.112 2.387 . . . . 0.0 111.713 -176.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 172.76 -76.83 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 2 CA-C-N 107.644 -4.344 . . . . 0.0 107.415 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.7 p -51.8 -39.34 58.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.616 1.167 . . . . 0.0 110.581 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -43.58 -45.54 6.73 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.584 1.553 . . . . 0.0 111.271 175.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -54.17 -52.16 62.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.289 0.566 . . . . 0.0 110.096 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -70.35 -52.5 22.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 111.052 -177.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.6 -46.23 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.721 1.209 . . . . 0.0 112.804 -172.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.2 -61.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.92 0.888 . . . . 0.0 111.169 -174.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -68.04 -56.81 7.53 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.706 -172.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.59 43.75 0.58 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.267 0.485 . . . . 0.0 111.357 -178.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -90.16 -174.62 4.26 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.76 0.79 . . . . 0.0 109.361 177.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.3 p -120.34 -73.34 0.65 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.58 1.952 . . . . 0.0 106.409 176.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.74 158.83 75.11 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.19 159.27 15.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.563 1.509 . . . . 0.0 112.791 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.72 118.0 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.282 1.433 . . . . 0.0 109.778 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -84.96 104.17 14.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.49 116.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -96.06 109.96 22.28 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -78.8 110.89 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -126.69 -174.36 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.082 0.953 . . . . 0.0 111.119 -174.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.06 149.32 3.31 Favored Pre-proline 0 N--CA 1.456 -0.175 0 C-N-CA 124.979 1.312 . . . . 0.0 108.007 172.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.99 -38.34 93.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.706 2.271 . . . . 0.0 113.888 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -76.35 -12.21 60.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.399 0.545 . . . . 0.0 112.111 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 t -77.91 100.46 6.4 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.865 -176.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.92 -64.8 1.37 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.628 1.585 . . . . 0.0 114.544 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.52 -45.44 37.21 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.596 1.698 . . . . 0.0 110.876 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.79 -50.48 63.49 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.22 0.608 . . . . 0.0 109.612 -178.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -56.24 -48.85 75.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.154 0.582 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.46 -29.28 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.776 -177.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 pt -81.7 -24.54 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 120.608 1.549 . . . . 0.0 110.853 176.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.13 -48.61 4.26 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.47 -41.01 35.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.088 1.858 . . . . 0.0 109.97 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.54 -49.67 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.979 1.312 . . . . 0.0 107.926 178.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.7 -44.13 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -56.59 -33.79 66.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -51.07 -35.79 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.308 0.643 . . . . 0.0 109.504 176.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.17 -38.35 70.79 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.313 0.506 . . . . 0.0 110.919 177.144 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.42 -43.4 45.59 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -55.82 -52.15 65.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -107.58 34.09 3.71 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -58.79 161.84 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.806 0.442 . . . . 0.0 110.172 176.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 t70 74.92 -55.44 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.613 1.965 . . . . 0.0 111.429 178.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -77.87 -31.67 51.52 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 -177.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.47 152.24 49.33 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.761 0.824 . . . . 0.0 109.906 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -106.17 152.08 23.92 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 168.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.1 t -132.97 140.41 47.77 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.64 176.4 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 119.033 0.833 . . . . 0.0 109.461 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.72 134.61 26.98 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.442 . . . . 0.0 111.851 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -99.76 119.35 38.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.338 1.855 . . . . 0.0 110.047 -177.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.23 104.06 4.87 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -66.96 -29.64 69.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.684 1.594 . . . . 0.0 111.631 -173.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.2 -42.03 84.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.869 0.842 . . . . 0.0 109.778 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -83.76 -31.63 25.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.281 1.832 . . . . 0.0 111.687 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.1 m -125.85 60.1 31.83 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 -178.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.42 -34.9 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 124.723 3.615 . . . . 0.0 109.779 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -38.46 -72.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.545 1.938 . . . . 0.0 111.626 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.64 -44.78 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 124.026 0.93 . . . . 0.0 110.487 -178.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.15 70.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.538 178.198 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -71.52 -43.8 65.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 109.749 178.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.59 -41.51 77.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.618 0.367 . . . . 0.0 110.437 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -78.19 -33.49 50.06 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.91 47.38 2.1 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.725 0.678 . . . . 0.0 111.827 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.5 mt -78.71 112.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -29.55 47.48 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.12 -0.362 . . . . 0.0 110.908 -177.345 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -160.85 155.01 22.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.58 156.53 38.59 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -66.75 161.23 75.97 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.503 1.215 . . . . 0.0 112.595 2.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -158.37 102.02 1.73 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.4 pt -85.81 133.83 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 174.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.7 mtt -121.25 153.37 37.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.81 117.73 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -112.22 156.39 22.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.144 0.977 . . . . 0.0 109.103 178.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 153.85 8.82 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.363 1.465 . . . . 0.0 107.316 176.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 37.72 9.77 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.005 0.821 . . . . 0.0 114.69 175.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.3 20.51 65.38 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.702 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -141.6 166.03 25.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.332 1.453 . . . . 0.0 109.573 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -90.54 155.22 19.04 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.34 0.656 . . . . 0.0 109.598 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.0 t -108.65 -62.46 1.46 Allowed 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 125.603 1.561 . . . . 0.0 108.941 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.31 179.41 8.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.861 1.265 . . . . 0.0 108.846 177.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 t -155.45 151.4 27.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.631 1.173 . . . . 0.0 109.544 -178.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -146.81 157.25 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.757 1.623 . . . . 0.0 108.208 -179.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -79.6 114.35 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.82 -12.53 21.57 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -174.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.1 63.38 0.33 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.915 . . . . 0.0 111.96 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.97 157.06 58.3 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.434 1.494 . . . . 0.0 107.792 177.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -58.48 155.52 35.79 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.638 2.225 . . . . 0.0 113.729 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.12 -51.81 17.04 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.832 1.653 . . . . 0.0 110.744 178.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -51.88 35.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.598 178.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 m -59.47 -46.51 88.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.776 -0.631 . . . . 0.0 109.874 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.22 -52.02 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.811 0.732 . . . . 0.0 109.366 177.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.3 -57.45 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.055 0.542 . . . . 0.0 109.678 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -53.35 -47.76 69.11 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.984 0.357 . . . . 0.0 110.681 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 m -54.12 -49.29 69.52 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.209 1.003 . . . . 0.0 110.09 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -61.65 -55.18 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.518 -0.739 . . . . 0.0 109.746 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -51.32 -48.41 62.36 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.434 0.693 . . . . 0.0 112.325 -175.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -57.82 -22.29 46.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.782 0.719 . . . . 0.0 112.593 -179.117 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 118.754 0.706 . . . . 0.0 111.404 179.4 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.2 151.28 41.84 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.71 104.47 16.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.89 158.73 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.104 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' A' ' 8' ' ' ASP . 4.8 t-20 -143.26 174.93 10.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 177.337 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.425 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 25.7 t0 -39.37 -49.71 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.329 1.452 . . . . 0.0 112.295 -176.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.33 -78.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.129 177.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 p -45.95 -41.33 11.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.256 1.422 . . . . 0.0 112.632 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -39.71 -46.05 1.81 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.162 1.785 . . . . 0.0 111.38 175.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -49.83 -65.85 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.852 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.78 -35.94 82.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.254 0.622 . . . . 0.0 112.196 -176.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.93 -13.09 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.49 -66.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 119.026 0.83 . . . . 0.0 109.475 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.45 -35.12 69.72 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -93.69 -5.19 49.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.99 0.916 . . . . 0.0 111.817 178.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 m -77.26 132.51 38.71 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.712 -1.243 . . . . 0.0 111.909 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.37 -52.9 7.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.809 1.244 . . . . 0.0 109.553 178.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.59 152.8 83.41 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -64.34 154.51 70.96 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 120.925 1.084 . . . . 0.0 113.049 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -147.85 127.27 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 124.626 1.204 . . . . 0.0 113.541 178.609 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.11 95.49 9.46 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.26 113.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -86.9 114.52 23.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -79.0 102.89 8.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 175.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -120.32 -171.5 2.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 110.519 -173.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.67 152.93 3.97 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -56.59 -35.73 97.36 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.847 1.698 . . . . 0.0 112.237 177.056 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 -76.84 -3.92 40.93 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.798 -0.564 . . . . 0.0 111.985 177.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.7 t -82.06 85.37 6.76 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.587 -1.321 . . . . 0.0 112.125 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.1 -57.88 2.46 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.374 0.988 . . . . 0.0 114.055 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.97 -24.04 53.53 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 120.035 1.917 . . . . 0.0 112.311 -178.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.4 m -66.92 -49.49 65.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.022 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -46.93 -45.55 20.76 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.836 0.854 . . . . 0.0 111.481 -178.01 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -77.48 -19.59 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.794 -177.261 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.16 -22.75 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 121.064 1.756 . . . . 0.0 109.752 171.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.37 -43.03 2.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.421 -1.276 . . . . 0.0 114.041 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.39 -40.96 36.28 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.228 1.952 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.5 t -64.21 -47.66 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.2 t -56.88 -54.58 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -176.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -60.7 -49.78 76.13 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.326 0.65 . . . . 0.0 110.894 -179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -53.85 -52.56 60.03 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -54.34 -43.76 63.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.16 -46.27 65.38 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.68 8.43 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 175.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -39.9 -49.49 2.43 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.235 1.414 . . . . 0.0 112.789 -177.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.24 24.65 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -174.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -40.87 -46.62 2.79 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.133 1.773 . . . . 0.0 112.303 -177.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.19 -44.76 1.25 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.068 2.547 . . . . 0.0 113.4 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -140.22 -55.51 0.53 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.148 0.975 . . . . 0.0 112.832 179.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.57 -169.13 1.59 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.72 -1.582 . . . . 0.0 114.322 -155.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 3.4 pttp -75.79 99.88 4.56 Favored 'General case' 0 N--CA 1.432 -1.354 1 N-CA-C 127.605 6.15 . . . . 0.0 127.605 -153.504 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.3 t -160.02 127.8 4.68 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 120.304 -1.498 . . . . 0.0 112.719 168.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.23 167.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.906 0.882 . . . . 0.0 109.081 171.022 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -136.39 109.31 7.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.352 0.661 . . . . 0.0 110.456 -177.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.47 118.29 31.14 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 122.986 0.514 . . . . 0.0 109.877 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -72.46 111.86 8.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -67.97 -33.71 75.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.615 1.166 . . . . 0.0 111.423 -173.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -67.84 -37.4 81.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.529 1.132 . . . . 0.0 109.322 -179.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.88 -27.82 39.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.504 1.521 . . . . 0.0 111.375 177.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 m -119.19 51.03 1.5 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.67 1.588 . . . . 0.0 114.014 -176.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -60.03 -36.25 90.16 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 124.326 3.351 . . . . 0.0 108.419 175.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -44.34 -72.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.405 1.882 . . . . 0.0 109.93 175.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.76 -50.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.593 1.157 . . . . 0.0 109.738 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.28 -40.92 62.39 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.282 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 m -75.84 -41.12 53.36 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.194 0.998 . . . . 0.0 110.731 179.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.26 -45.2 80.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.148 0.579 . . . . 0.0 109.758 178.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -79.11 -35.22 42.59 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.26 50.74 2.93 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.416 1.008 . . . . 0.0 112.53 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.18 -169.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.248 0.619 . . . . 0.0 110.032 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -158.8 -84.81 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.576 0.75 . . . . 0.0 109.096 177.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -57.57 153.84 12.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 110.351 178.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.1 pt -140.84 155.14 69.23 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.03 140.05 45.43 Favored 'Cis proline' 0 N--CA 1.453 -0.903 0 CA-C-N 120.252 1.126 . . . . 0.0 112.879 2.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 m -127.84 104.84 8.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 173.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.0 mt -101.61 102.6 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.661 1.584 . . . . 0.0 108.244 -173.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.6 mtt -102.26 151.62 22.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.76 130.03 67.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 171.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -121.37 148.73 43.97 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 175.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.61 153.88 13.3 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.18 35.98 80.22 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 118.058 -2.02 . . . . 0.0 108.172 -174.199 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.18 -53.2 1.43 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.58 1.562 . . . . 0.0 113.997 -175.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -79.24 165.84 22.8 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -172.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -80.97 152.8 27.81 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 127.137 2.175 . . . . 0.0 110.833 -178.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.8 t -138.46 -80.39 0.33 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -72.09 149.5 44.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.773 0.321 . . . . 0.0 110.343 178.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.12 75.34 1.29 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.28 1.832 . . . . 0.0 106.72 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.0 mm -81.24 154.21 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.2 mt -138.02 147.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -175.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.39 175.1 48.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.608 0.623 . . . . 0.0 111.567 178.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.66 153.2 44.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.54 156.08 45.43 Favored Pre-proline 0 C--O 1.232 0.165 0 C-N-CA 123.484 0.714 . . . . 0.0 109.207 -178.272 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -73.88 143.97 33.92 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 N-CA-C 105.885 -2.39 . . . . 0.0 105.885 166.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -38.46 76.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.239 0.542 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.57 -52.66 28.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 m -58.86 -49.29 78.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.363 0.665 . . . . 0.0 110.065 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -54.21 -53.09 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.9 t -52.15 -56.73 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.533 0.733 . . . . 0.0 109.254 179.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -52.7 -45.87 67.08 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.264 0.554 . . . . 0.0 111.706 178.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.8 m -58.93 -38.95 80.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.156 -177.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -81.63 -36.2 14.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 119.026 0.83 . . . . 0.0 111.334 178.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -55.75 -35.11 65.84 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -46.48 -37.96 8.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.006 0.522 . . . . 0.0 110.704 171.284 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 127.089 2.156 . . . . 0.0 112.741 -179.169 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.706 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.88 -165.41 31.57 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 176.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.83 141.69 48.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.54 166.08 23.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 122.316 1.055 . . . . 0.0 111.09 -178.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -141.5 169.31 17.84 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -39.33 -46.09 1.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.794 1.638 . . . . 0.0 111.986 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -57.38 -70.55 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.871 177.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.9 p -61.07 -38.2 85.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 112.256 -175.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -39.34 -46.17 1.55 Allowed 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 127.905 2.482 . . . . 0.0 111.107 178.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -42.65 -66.29 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 111.954 175.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -45.05 60.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.933 -174.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.4 t -70.42 -38.26 73.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.001 -171.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -108.69 -69.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.706 -174.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -54.51 -50.78 67.02 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.99 0.359 . . . . 0.0 111.148 -172.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -88.07 17.06 5.3 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.614 -178.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.17 154.21 37.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.12 1.327 . . . . 0.0 111.132 -178.127 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -86.71 -58.63 2.53 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.617 1.567 . . . . 0.0 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.07 161.03 72.33 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.719 1.208 . . . . 0.0 108.01 178.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.41 164.67 8.63 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.659 1.573 . . . . 0.0 109.697 173.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 t -145.88 115.83 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 110.98 -174.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tp -89.06 98.78 11.96 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.32 110.6 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 123.33 0.652 . . . . 0.0 110.549 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -89.11 115.31 26.55 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -80.05 111.39 16.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -131.11 -171.86 2.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.744 0.783 . . . . 0.0 111.035 -173.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.98 150.35 2.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 172.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.4 -42.26 69.31 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.281 1.987 . . . . 0.0 112.177 178.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -66.24 -21.09 66.28 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.077 -0.389 . . . . 0.0 111.757 178.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.0 t -76.26 83.45 3.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.615 -0.678 . . . . 0.0 111.345 -176.166 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.73 -57.18 2.89 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.697 -1.057 . . . . 0.0 113.599 173.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -20.53 67.25 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.977 1.785 . . . . 0.0 112.654 -179.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.2 m -82.06 -59.0 2.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -40.13 -53.0 2.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 127.569 2.347 . . . . 0.0 112.154 -178.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.93 -22.32 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.47 -33.78 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.347 1.059 . . . . 0.0 110.26 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.88 -43.39 3.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 127.311 2.244 . . . . 0.0 115.512 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -67.43 -36.25 20.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.822 1.681 . . . . 0.0 108.86 -179.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -40.2 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 127.166 2.186 . . . . 0.0 107.748 179.032 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.82 -47.77 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.39 -53.19 60.58 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.715 0.406 . . . . 0.0 111.692 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.31 -41.16 96.53 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.16 -0.962 . . . . 0.0 110.813 -179.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.98 -42.8 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.84 -46.84 71.33 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.52 36.83 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 176.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -47.35 -41.75 20.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.546 0.673 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -112.71 31.3 6.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.016 0.926 . . . . 0.0 112.192 -178.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -57.05 154.71 9.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.523 0.678 . . . . 0.0 110.49 -178.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 71.64 -48.45 0.68 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 128.093 2.557 . . . . 0.0 112.028 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -78.37 -13.17 59.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.206 0.457 . . . . 0.0 110.742 179.134 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.62 119.7 6.28 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -80.97 167.73 19.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.6 t -146.9 147.5 30.86 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.93 161.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -125.81 110.61 13.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -89.56 112.43 23.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.38 1.472 . . . . 0.0 109.242 -178.06 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -71.89 107.98 4.93 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.0 m -60.58 -43.18 97.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.147 1.779 . . . . 0.0 111.665 -174.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.21 -33.77 75.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.901 0.881 . . . . 0.0 110.506 -177.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.8 -27.42 36.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.566 1.146 . . . . 0.0 110.425 175.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -122.86 52.81 4.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.914 1.686 . . . . 0.0 113.492 -176.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.23 -31.34 63.97 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.403 3.402 . . . . 0.0 107.985 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -50.43 -60.12 3.32 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.369 1.068 . . . . 0.0 109.457 177.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.59 -55.41 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.8 0.84 . . . . 0.0 109.374 -178.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.43 -45.38 36.19 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.933 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -65.59 -50.23 65.88 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.13 0.572 . . . . 0.0 110.715 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -56.61 -44.06 80.78 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.752 0.421 . . . . 0.0 111.305 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -79.29 -32.22 43.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.607 -0.235 . . . . 0.0 111.579 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.49 60.8 0.98 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.5 mt -129.11 152.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.274 1.43 . . . . 0.0 107.77 -178.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -148.67 -71.08 0.21 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.19 151.11 41.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 pt -146.27 154.77 50.09 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -179.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.74 151.23 74.86 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.656 1.27 . . . . 0.0 113.825 2.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -156.72 100.37 1.92 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 tt -100.7 123.1 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -178.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 mtt -106.02 144.19 33.08 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.413 1.085 . . . . 0.0 110.066 -177.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.9 t -95.87 101.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -95.89 156.36 16.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.178 179.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.31 -154.9 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 171.325 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.56 95.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.301 1.429 . . . . 0.0 114.261 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.02 -76.83 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.919 0.771 . . . . 0.0 113.913 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -79.88 169.71 17.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.097 0.951 . . . . 0.0 113.429 -171.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.59 157.41 17.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.255 171.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 15.9 t -109.36 -60.45 1.77 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.832 1.253 . . . . 0.0 110.113 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -132.86 179.08 6.39 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.602 1.561 . . . . 0.0 109.097 -178.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -160.34 163.78 33.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.979 0.512 . . . . 0.0 110.055 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 mt -137.18 146.53 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.8 mp -135.71 151.1 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.269 1.428 . . . . 0.0 108.52 -174.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.99 152.78 10.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.2 67.92 2.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.707 . . . . 0.0 110.77 -179.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.87 144.3 63.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.75 155.65 13.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.593 2.195 . . . . 0.0 113.896 -178.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -49.28 -43.76 43.37 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.064 0.946 . . . . 0.0 111.323 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.32 65.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 110.625 179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -45.91 86.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.05 -54.68 21.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -50.3 -57.45 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 124.442 1.097 . . . . 0.0 110.187 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -54.73 -47.33 73.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.623 0.249 . . . . 0.0 111.044 -178.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.9 m -64.3 -41.31 96.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.517 0.327 . . . . 0.0 110.86 -179.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.2 t -60.2 -50.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -57.43 -50.77 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -48.01 -50.19 28.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.699 0.8 . . . . 0.0 109.976 176.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.528 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 118.048 -0.977 . . . . 0.0 108.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -45.03 136.88 4.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.842 0.857 . . . . 0.0 112.49 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.44 123.14 20.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.871 1.268 . . . . 0.0 113.764 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.61 -169.51 46.04 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.97 141.34 52.01 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.66 165.61 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.884 0.85 . . . . 0.0 110.565 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -146.69 176.84 9.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.819 2.047 . . . . 0.0 105.866 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -39.29 -57.97 1.28 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.849 0.86 . . . . 0.0 112.504 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.67 -58.61 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.822 1.249 . . . . 0.0 112.015 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -67.14 -35.66 80.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.347 0.659 . . . . 0.0 111.645 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -46.12 -47.28 17.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.531 1.533 . . . . 0.0 110.996 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -49.42 -55.28 13.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.107 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.5 -62.02 1.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.933 0.893 . . . . 0.0 111.653 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.83 -27.46 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 125.715 1.606 . . . . 0.0 113.077 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.46 -74.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.567 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.54 -42.31 70.76 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.048 1.295 . . . . 0.0 113.17 -172.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.78 17.07 11.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.727 0.811 . . . . 0.0 111.958 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.9 p -72.99 149.69 43.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.44 1.018 . . . . 0.0 111.892 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.5 p -92.51 -58.77 2.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.43 1.492 . . . . 0.0 108.992 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.67 162.91 63.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.3 1.44 . . . . 0.0 109.058 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.07 164.32 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.518 2.145 . . . . 0.0 112.383 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 t -145.48 144.13 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.66 97.41 5.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.06 119.52 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -94.2 111.67 23.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -78.49 109.92 13.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -123.84 -171.42 2.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.826 0.85 . . . . 0.0 111.157 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.7 151.4 2.84 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.64 1.176 . . . . 0.0 108.137 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.51 -33.47 98.04 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.457 2.105 . . . . 0.0 112.759 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -74.47 -14.15 60.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.528 -0.732 . . . . 0.0 111.018 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.45 82.8 8.13 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.123 -0.986 . . . . 0.0 111.304 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.27 -58.03 2.96 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.732 1.158 . . . . 0.0 113.864 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.71 -40.37 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 CA-C-N 119.748 1.774 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -58.53 -52.08 67.15 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -55.95 -48.5 75.66 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.86 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -74.48 -22.26 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.884 0.765 . . . . 0.0 111.741 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.4 mm -81.69 -34.51 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.496 1.043 . . . . 0.0 110.805 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.05 -45.44 4.66 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.207 1.803 . . . . 0.0 115.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -62.52 -40.48 38.29 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.983 1.789 . . . . 0.0 109.821 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.91 -48.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.716 1.207 . . . . 0.0 107.762 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.2 t -52.09 -51.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.905 0.882 . . . . 0.0 108.823 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.0 -57.78 10.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.08 -43.68 87.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.882 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.26 -49.4 76.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.26 72.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.447 -0.783 . . . . 0.0 111.668 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -48.99 83.24 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -55.19 -47.86 74.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -83.53 59.11 4.92 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.309 1.528 . . . . 0.0 111.379 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 155.35 13.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.925 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 68.51 -55.1 0.53 Allowed 'General case' 0 C--N 1.338 0.099 0 C-N-CA 129.024 2.929 . . . . 0.0 113.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -82.84 -53.16 6.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -81.1 99.28 8.42 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.671 -171.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -79.66 87.38 5.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.24 152.36 32.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.856 -1.152 . . . . 0.0 108.805 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.84 166.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 121.752 -0.592 . . . . 0.0 109.745 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -130.31 121.33 25.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.63 1.172 . . . . 0.0 109.381 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.6 tp -108.43 118.9 37.97 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.859 1.264 . . . . 0.0 110.085 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -73.87 112.98 10.5 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 m -69.74 -28.54 65.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.374 1.47 . . . . 0.0 111.498 -173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.6 -40.64 48.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.174 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -83.01 -27.23 30.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.28 2.232 . . . . 0.0 112.162 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.8 m -132.34 62.15 61.49 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.216 1.406 . . . . 0.0 109.718 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.03 -33.65 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 1 C-N-CA 125.509 4.139 . . . . 0.0 109.97 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -30.07 -73.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.332 2.253 . . . . 0.0 111.964 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -35.4 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.328 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.21 76.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -68.2 -47.23 68.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.146 0.978 . . . . 0.0 109.554 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -55.9 -43.34 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.69 -34.81 45.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.018 0.527 . . . . 0.0 111.247 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 56.35 1.07 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.4 mt -122.02 146.36 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.84 1.656 . . . . 0.0 107.638 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -149.35 -64.23 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.26 144.87 56.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 pt -143.54 156.31 60.15 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.11 141.61 57.54 Favored 'Cis proline' 0 N--CA 1.454 -0.812 0 CA-C-N 120.007 1.038 . . . . 0.0 113.528 3.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -133.91 101.25 5.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.11 100.54 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.374 1.47 . . . . 0.0 107.646 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtt -88.25 148.1 24.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.54 139.43 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 C-N-CA 125.659 1.584 . . . . 0.0 107.671 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -129.21 144.59 51.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.41 -27.03 13.38 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.318 0.386 . . . . 0.0 111.22 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.7 87.95 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 -63.15 2.8 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.554 0.597 . . . . 0.0 112.178 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -79.88 154.6 28.24 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.608 0.763 . . . . 0.0 110.701 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -71.27 158.05 37.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.51 1.124 . . . . 0.0 109.72 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.96 -58.18 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.714 1.206 . . . . 0.0 110.176 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -141.79 177.68 8.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.695 1.198 . . . . 0.0 110.112 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.7 m -156.38 132.74 10.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.282 1.033 . . . . 0.0 109.546 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.3 mt -109.46 144.26 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -130.19 142.58 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 173.61 47.26 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.792 0.71 . . . . 0.0 112.49 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.26 156.1 35.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.797 0.439 . . . . 0.0 109.92 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.66 156.67 38.86 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.028 0.931 . . . . 0.0 109.059 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -82.99 139.35 9.56 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.174 2.582 . . . . 0.0 107.171 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -48.58 -45.27 37.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 0.0 112.672 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -45.66 67.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.985 0.421 . . . . 0.0 110.626 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -65.15 -45.98 82.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.1 mt -56.2 -52.42 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 t -48.86 -58.51 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 124.609 1.163 . . . . 0.0 109.429 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.14 -47.46 83.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.494 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.0 m -56.06 -43.4 77.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.485 1.114 . . . . 0.0 110.11 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.94 -52.04 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 121.387 -0.82 . . . . 0.0 109.095 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -52.63 -47.34 67.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.62 0.768 . . . . 0.0 112.745 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.67 -23.78 65.09 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.944 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -90.11 -44.8 9.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.809 0.731 . . . . 0.0 109.686 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.5 mp -92.09 -97.09 0.13 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.083 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.17 -45.83 75.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 171.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.92 135.92 38.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 170.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.5 167.37 50.14 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.781 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.06 128.21 56.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.68 165.44 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 122.482 1.134 . . . . 0.0 111.604 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -142.89 172.14 13.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.784 2.434 . . . . 0.0 106.023 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -39.26 -49.87 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.99 1.716 . . . . 0.0 112.371 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.57 -74.08 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.227 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 p -50.31 -42.08 52.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.591 1.156 . . . . 0.0 111.826 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -39.93 -42.84 1.41 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.679 1.992 . . . . 0.0 111.15 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -61.88 -58.84 6.39 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 111.76 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -62.09 -32.74 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.323 0.649 . . . . 0.0 111.403 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -93.12 -30.24 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.898 0.879 . . . . 0.0 113.255 -170.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.95 -72.43 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 124.626 1.17 . . . . 0.0 109.828 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.4 mt -46.98 -55.84 7.43 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.981 0.912 . . . . 0.0 111.584 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.49 7.97 8.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 113.175 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -71.29 143.14 50.44 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 120.027 1.285 . . . . 0.0 110.615 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -81.87 -60.5 2.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.652 1.181 . . . . 0.0 108.73 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.04 162.43 64.55 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.186 0.995 . . . . 0.0 109.484 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.02 160.31 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.901 2.4 . . . . 0.0 113.713 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 t -143.06 147.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.174 1.39 . . . . 0.0 108.417 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.36 110.84 13.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.06 139.85 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -111.72 120.46 42.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.21 113.89 17.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -127.27 -172.15 2.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.764 0.793 . . . . 0.0 110.279 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.45 152.52 4.02 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -52.76 -42.87 60.21 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.579 2.186 . . . . 0.0 112.614 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -69.07 -12.81 62.01 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.768 -0.582 . . . . 0.0 112.269 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -77.82 80.78 4.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.797 -1.189 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.93 -56.49 3.78 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.354 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.92 -29.93 88.06 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.945 1.763 . . . . 0.0 112.414 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.26 -48.34 57.27 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -48.32 50.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.657 0.783 . . . . 0.0 111.647 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.25 -20.65 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.877 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.4 pt -90.02 -28.88 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 121.126 1.784 . . . . 0.0 110.264 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.43 -47.37 4.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.36 -39.4 57.16 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.332 2.021 . . . . 0.0 110.216 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.85 -46.34 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.08 -42.18 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.76 -65.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.421 0.688 . . . . 0.0 111.927 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -42.35 78.13 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.275 1.398 . . . . 0.0 111.727 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mt -62.77 -26.23 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.553 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.93 90.82 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.7 1.136 . . . . 0.0 109.016 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -47.49 90.83 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -58.35 -50.66 72.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -97.25 33.19 2.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.387 0.675 . . . . 0.0 112.349 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -60.27 168.83 1.85 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.607 0.718 . . . . 0.0 111.307 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 71.9 -58.55 0.58 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 127.377 2.271 . . . . 0.0 111.743 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.4 -50.15 11.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.866 -174.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.9 105.84 16.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.105 0.562 . . . . 0.0 110.108 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.15 98.96 6.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.0 t -79.32 137.34 37.3 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.559 -0.713 . . . . 0.0 110.47 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.16 163.71 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.524 0.678 . . . . 0.0 112.195 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -133.86 118.53 18.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.406 1.482 . . . . 0.0 109.595 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tp -99.5 124.17 44.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.63 109.05 7.79 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -67.39 -36.82 82.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.008 1.323 . . . . 0.0 111.243 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -66.4 -38.34 87.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.37 1.068 . . . . 0.0 110.106 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.83 -25.43 32.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.162 1.785 . . . . 0.0 111.363 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.2 t -122.6 52.73 4.32 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.461 1.504 . . . . 0.0 112.636 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.29 -25.94 71.79 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.135 3.224 . . . . 0.0 110.45 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -54.62 -63.26 1.21 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.702 0.801 . . . . 0.0 108.911 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.75 -51.23 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.794 0.838 . . . . 0.0 109.061 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.86 -47.99 21.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.228 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -67.37 -48.83 66.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.533 0.733 . . . . 0.0 110.797 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.55 -46.98 73.73 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.539 0.736 . . . . 0.0 111.203 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -79.56 -31.17 41.9 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.162 0.585 . . . . 0.0 111.166 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.84 52.1 3.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mm -73.54 84.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 122.192 0.996 . . . . 0.0 109.345 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -78.42 76.38 4.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m 94.31 166.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.391 2.676 . . . . 0.0 110.383 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.9 pt -136.21 153.68 76.75 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.169 0.988 . . . . 0.0 108.544 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.06 145.83 76.44 Favored 'Cis proline' 0 N--CA 1.453 -0.858 0 CA-C-N 120.31 1.146 . . . . 0.0 112.772 1.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 m -139.45 113.17 8.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.58 138.16 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 mtt -129.85 143.89 51.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.5 t -107.76 139.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 126.045 1.738 . . . . 0.0 107.065 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -126.62 134.48 50.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.64 -26.67 13.73 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.69 67.95 0.25 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.35 -56.89 3.71 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.89 157.66 26.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.844 0.857 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -65.76 160.63 22.54 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.87 1.668 . . . . 0.0 111.482 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.0 t -129.61 -66.23 0.81 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.471 1.508 . . . . 0.0 109.541 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -138.27 172.72 12.49 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.818 1.247 . . . . 0.0 110.007 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.6 t -160.47 153.49 21.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.041 0.936 . . . . 0.0 109.819 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.4 mm -134.54 146.24 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.76 142.16 42.54 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 126.379 1.872 . . . . 0.0 108.25 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.92 155.05 16.69 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.316 0.484 . . . . 0.0 111.998 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.95 52.37 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.549 1.14 . . . . 0.0 112.588 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.7 145.69 63.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.44 147.47 68.33 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.24 1.293 . . . . 0.0 111.426 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -58.1 -34.68 70.45 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.59 55.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.247 0.93 . . . . 0.0 110.992 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -49.48 77.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.237 1.015 . . . . 0.0 109.007 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 mm -58.26 -49.68 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.693 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.39 -53.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.45 1.1 . . . . 0.0 109.21 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.09 -48.89 72.94 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.3 m -60.8 -36.74 79.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.233 0.613 . . . . 0.0 111.441 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.81 -53.71 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 121.206 -0.934 . . . . 0.0 108.826 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -53.44 -42.24 66.92 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.412 1.085 . . . . 0.0 110.86 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -49.83 -45.89 50.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.309 0.644 . . . . 0.0 110.404 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -77.18 -57.72 3.68 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.04 66.54 8.7 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.917 0.887 . . . . 0.0 108.975 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.185 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.623 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 117.818 -1.086 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -64.77 -40.51 95.39 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 119.533 1.06 . . . . 0.0 110.538 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.84 92.07 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.797 0.839 . . . . 0.0 110.774 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.1 -178.47 44.68 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.5 136.86 54.64 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.86 166.7 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.635 1.207 . . . . 0.0 112.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -149.15 172.71 14.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.298 2.639 . . . . 0.0 105.269 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -38.01 -50.12 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.85 2.06 . . . . 0.0 111.687 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.34 -72.22 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 111.572 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -58.64 -33.95 70.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 112.292 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -42.57 -44.64 4.25 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.603 1.961 . . . . 0.0 111.051 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -54.05 -55.61 25.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.504 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.33 -46.11 56.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.344 0.658 . . . . 0.0 111.858 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -85.07 -19.48 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.884 1.274 . . . . 0.0 114.085 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.6 -51.64 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.611 1.096 . . . . 0.0 112.044 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.32 -52.07 25.5 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.938 -0.476 . . . . 0.0 111.543 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -79.12 -9.12 59.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 m -55.73 135.4 51.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.636 1.174 . . . . 0.0 112.852 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 p -79.87 -62.03 1.81 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.805 1.242 . . . . 0.0 109.725 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.93 157.25 76.53 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -54.42 157.62 11.47 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.711 2.274 . . . . 0.0 113.931 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.27 118.45 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.547 1.539 . . . . 0.0 110.676 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.55 91.64 7.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.67 1.188 . . . . 0.0 108.417 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 p -99.27 125.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -99.41 121.31 40.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.57 0.748 . . . . 0.0 109.199 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -79.77 116.51 19.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -133.31 -170.67 2.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.915 0.486 . . . . 0.0 110.662 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.43 151.08 4.35 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -54.58 -40.05 85.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.71 2.273 . . . . 0.0 113.147 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -68.7 -16.62 63.88 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.451 0.568 . . . . 0.0 111.348 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -77.61 79.55 4.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.31 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.57 -57.34 4.53 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.66 -34.55 15.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.423 3.415 . . . . 0.0 114.244 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.01 -54.41 6.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.97 0.891 . . . . 0.0 108.638 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.9 tpt85 -47.42 -49.11 25.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.197 0.999 . . . . 0.0 111.381 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.31 -26.58 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.776 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 pt -87.75 -26.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.194 1.816 . . . . 0.0 110.514 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -46.18 4.05 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.75 -40.98 26.32 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.103 1.868 . . . . 0.0 110.378 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.32 -52.06 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.116 1.366 . . . . 0.0 107.879 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.16 -47.21 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 0.0 108.868 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -68.09 -55.5 12.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -60.59 -32.83 71.92 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.491 0.587 . . . . 0.0 109.483 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.61 -49.27 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.09 -33.87 67.74 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.85 -0.531 . . . . 0.0 110.537 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.05 -56.26 26.32 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.1 -41.45 62.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.078 0.439 . . . . 0.0 110.679 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -98.32 25.97 5.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.272 1.029 . . . . 0.0 113.304 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 169.3 2.0 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.446 0.641 . . . . 0.0 111.97 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 73.82 -53.71 0.69 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.784 2.033 . . . . 0.0 111.28 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -78.44 -54.97 5.6 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.61 114.21 27.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.5 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -78.42 163.33 25.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.8 t -145.56 146.13 31.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.42 168.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.482 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -136.0 107.42 6.88 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.685 1.194 . . . . 0.0 109.611 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -87.57 117.16 26.18 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -73.37 104.15 4.28 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.628 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.7 m -56.37 -46.74 79.9 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.309 1.844 . . . . 0.0 112.023 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.9 -36.7 82.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.26 1.824 . . . . 0.0 110.479 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -84.65 -26.01 28.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.459 1.904 . . . . 0.0 111.116 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -122.01 54.61 5.34 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.855 1.662 . . . . 0.0 111.905 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.6 -24.84 76.85 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 124.098 3.198 . . . . 0.0 111.02 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -51.83 -71.66 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.046 0.938 . . . . 0.0 109.089 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -53.48 -48.34 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.648 1.179 . . . . 0.0 109.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.29 -51.32 46.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.855 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -70.66 -43.99 67.99 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.573 0.749 . . . . 0.0 110.878 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.1 -47.67 68.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.564 0.745 . . . . 0.0 110.303 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -79.35 -31.09 42.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.95 48.08 5.93 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 pt -74.38 97.96 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.072 0.939 . . . . 0.0 109.894 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 69.08 4.68 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 109.208 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t 101.6 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 129.48 3.112 . . . . 0.0 109.506 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -143.59 161.01 48.9 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.3 1.84 . . . . 0.0 109.318 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -68.57 157.01 88.94 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 120.697 1.285 . . . . 0.0 113.054 2.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -152.07 102.59 2.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -79.86 131.96 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.7 mtt -125.54 136.79 53.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -96.02 101.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -89.01 148.62 23.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 33.94 1.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.625 0.578 . . . . 0.0 110.728 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 105.57 3.0 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.69 -70.93 0.9 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.524 1.059 . . . . 0.0 113.025 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -101.53 169.84 8.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.055 0.931 . . . . 0.0 112.189 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -84.09 165.09 18.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.334 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.79 -58.88 1.92 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.16 1.384 . . . . 0.0 108.911 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -133.18 176.29 8.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.112 1.365 . . . . 0.0 109.434 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 t -158.76 160.89 36.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.083 0.553 . . . . 0.0 110.706 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.3 mt -138.15 122.92 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.03 139.73 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.988 0.915 . . . . 0.0 109.404 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.0 153.92 14.76 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 121.47 0.483 . . . . 0.0 113.133 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.52 73.69 1.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.991 -0.711 . . . . 0.0 111.307 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.74 148.18 72.26 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.96 157.07 11.25 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.03 2.487 . . . . 0.0 113.948 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -51.94 -45.78 64.48 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.68 0.792 . . . . 0.0 111.646 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.66 64.58 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.277 0.631 . . . . 0.0 110.355 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -48.13 78.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.41 -57.08 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.8 t -48.96 -61.27 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.994 1.318 . . . . 0.0 109.872 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -52.8 -46.49 67.68 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.344 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.8 m -63.18 -44.54 95.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.622 0.369 . . . . 0.0 110.919 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.23 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 121.207 -0.933 . . . . 0.0 108.882 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -55.58 -54.05 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -47.3 -49.79 23.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.45 1.1 . . . . 0.0 110.166 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -73.31 -30.94 63.72 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.4 mt -154.8 103.42 2.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.92 1.288 . . . . 0.0 109.639 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.283 0 C-N-CA 129.158 2.983 . . . . 0.0 104.128 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pm0 -52.52 156.3 1.87 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.957 0.903 . . . . 0.0 112.345 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.45 128.43 35.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.493 1.517 . . . . 0.0 114.543 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.28 -171.94 25.03 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 169.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 141.51 45.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -139.87 173.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 122.801 1.286 . . . . 0.0 110.895 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.98 171.08 18.38 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.323 2.649 . . . . 0.0 104.627 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -39.17 -53.64 1.84 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 112.832 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -52.78 63.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.312 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -73.58 -35.54 65.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.273 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -39.43 -48.16 1.91 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.601 2.36 . . . . 0.0 110.535 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -42.62 -70.44 0.11 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.169 0.988 . . . . 0.0 112.206 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.6 -47.68 80.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.533 1.133 . . . . 0.0 111.602 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.68 -37.18 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.521 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.17 -65.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.056 0.943 . . . . 0.0 110.99 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -62.8 -59.43 4.87 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -172.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.49 41.39 0.47 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.879 -0.513 . . . . 0.0 111.66 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -90.31 168.86 11.58 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -97.18 -71.65 0.67 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.542 1.537 . . . . 0.0 107.904 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.21 157.63 75.39 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.81 159.59 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.0 1.8 . . . . 0.0 114.961 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.18 127.88 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.942 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tt -103.34 104.82 14.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.031 1.732 . . . . 0.0 107.522 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.02 126.47 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.93 115.88 31.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -79.1 111.74 15.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -128.21 -174.32 3.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 122.111 0.958 . . . . 0.0 110.015 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.7 140.01 2.11 Favored Pre-proline 0 N--CA 1.451 -0.38 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -39.2 -54.47 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.362 2.708 . . . . 0.0 117.393 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -57.79 -20.89 38.73 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.819 0.736 . . . . 0.0 112.549 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 85.91 0.83 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.367 0.667 . . . . 0.0 112.13 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.2 -55.04 4.42 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.322 0.963 . . . . 0.0 113.816 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.01 -36.06 98.31 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.2 1.933 . . . . 0.0 110.959 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -66.44 -49.34 67.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -55.4 -46.31 76.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.456 0.302 . . . . 0.0 111.094 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.88 -30.4 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.128 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 tp -84.69 -35.97 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 120.619 1.554 . . . . 0.0 112.437 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.44 -49.16 4.94 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -60.32 -34.27 93.73 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.835 2.356 . . . . 0.0 110.766 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.84 -47.95 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.366 1.066 . . . . 0.0 108.379 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.58 -51.17 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -57.45 -55.28 36.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.404 . . . . 0.0 110.994 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.37 -50.84 72.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.739 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -51.13 -52.34 18.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.32 73.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.72 -41.21 97.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -66.85 -50.84 61.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -83.71 59.94 5.45 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.456 1.122 . . . . 0.0 109.878 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -46.1 -67.36 0.29 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.965 2.106 . . . . 0.0 111.988 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.92 -57.96 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.097 1.359 . . . . 0.0 114.202 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -78.9 -54.59 5.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.36 117.62 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.85 -163.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -91.34 116.37 28.79 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.754 1.221 . . . . 0.0 110.55 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.3 t -78.47 142.35 37.56 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.329 -0.857 . . . . 0.0 109.665 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.2 164.3 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -137.22 115.82 12.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.073 0.949 . . . . 0.0 109.58 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.45 118.23 34.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.87 0.868 . . . . 0.0 109.508 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -71.81 107.33 4.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.9 m -59.33 -43.06 92.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.092 1.757 . . . . 0.0 111.545 -173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.63 -35.87 82.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.909 0.884 . . . . 0.0 110.316 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.81 -24.71 30.89 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.425 1.49 . . . . 0.0 111.514 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 49.74 2.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.507 1.923 . . . . 0.0 113.23 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.13 -25.56 37.33 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.629 3.552 . . . . 0.0 109.713 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -51.26 -54.72 23.21 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.031 0.932 . . . . 0.0 109.189 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.9 -57.11 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.753 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.39 -45.1 65.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.427 0.691 . . . . 0.0 112.168 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -65.93 -48.74 70.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.996 0.519 . . . . 0.0 109.927 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.91 -38.12 69.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.529 0.332 . . . . 0.0 110.609 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.62 -23.49 45.87 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.14 40.11 11.93 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.203 0.906 . . . . 0.0 111.634 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.03 169.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.494 1.118 . . . . 0.0 109.089 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -154.25 -58.39 0.12 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.893 0.877 . . . . 0.0 109.386 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 147.93 30.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.38 155.54 60.97 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.65 142.32 69.41 Favored 'Cis proline' 0 N--CA 1.453 -0.855 0 CA-C-N 120.134 1.084 . . . . 0.0 112.322 1.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -137.05 102.48 4.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.03 134.71 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 33.5 mtt -128.33 123.52 34.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.5 t -95.88 141.54 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -127.1 158.3 37.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.332 1.453 . . . . 0.0 107.913 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 42.62 1.18 Allowed 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.335 1.022 . . . . 0.0 110.726 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.2 97.17 2.28 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.49 -73.19 0.77 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.428 0.537 . . . . 0.0 112.213 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.84 160.54 26.06 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.315 1.055 . . . . 0.0 111.847 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.95 143.75 28.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.512 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.2 t -88.38 -70.29 0.65 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.283 1.033 . . . . 0.0 108.289 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -150.79 -175.37 5.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.588 1.555 . . . . 0.0 109.256 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -143.73 162.42 36.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.916 1.286 . . . . 0.0 109.719 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.3 mt -139.24 140.78 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.33 138.72 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.78 153.72 25.95 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 121.888 0.716 . . . . 0.0 112.116 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.97 78.01 3.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.246 0.618 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -78.28 152.25 78.76 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.26 153.23 22.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.592 2.194 . . . . 0.0 113.995 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -46.6 -50.25 17.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.278 1.831 . . . . 0.0 110.654 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.2 -47.25 75.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.933 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -62.54 -46.21 89.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.568 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.1 mt -54.68 -55.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 t -52.33 -59.03 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.218 0.607 . . . . 0.0 110.042 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -49.47 -52.14 31.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.436 0.694 . . . . 0.0 110.338 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 45.4 m -61.7 -45.37 94.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.214 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.06 -56.24 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 118.739 0.699 . . . . 0.0 109.583 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -62.72 -43.76 97.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.932 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -51.24 -54.4 26.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.258 0.623 . . . . 0.0 109.552 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -64.57 -43.91 92.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.649 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.3 mt -118.11 -95.44 0.48 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.045 0.938 . . . . 0.0 110.251 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.077 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 72.08 -67.26 0.27 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.87 140.47 56.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.03 157.1 36.07 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.987 1.28 . . . . 0.0 113.285 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.3 114.85 20.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.14 164.54 20.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 122.806 1.289 . . . . 0.0 110.13 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -143.21 174.75 10.43 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.348 1.859 . . . . 0.0 106.691 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -53.41 2.1 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.957 1.303 . . . . 0.0 113.229 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.94 -59.65 2.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.136 0.974 . . . . 0.0 111.46 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -59.11 -34.43 72.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.563 0.745 . . . . 0.0 111.682 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -45.42 -48.29 13.67 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 126.039 1.736 . . . . 0.0 110.541 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -55.15 -53.64 53.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.632 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -53.64 54.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 0.0 112.347 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -75.15 -39.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.875 1.27 . . . . 0.0 113.302 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.61 -66.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.18 0.992 . . . . 0.0 110.903 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.06 -59.2 5.73 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 121.217 0.532 . . . . 0.0 110.877 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -78.87 40.55 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.355 0.662 . . . . 0.0 111.227 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.1 t -90.29 -169.44 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.834 0.854 . . . . 0.0 109.328 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -131.58 -66.14 0.73 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.191 2.196 . . . . 0.0 106.71 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.86 157.0 79.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.02 161.03 7.03 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.391 2.061 . . . . 0.0 112.617 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.28 139.32 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -114.11 117.15 30.44 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.77 115.94 51.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -90.3 111.95 23.33 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -78.76 112.64 16.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -125.36 -173.84 2.92 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.096 0.951 . . . . 0.0 110.265 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.72 152.49 4.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -55.33 -32.02 79.46 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.393 2.062 . . . . 0.0 113.544 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -78.98 -6.42 56.26 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.3 0.955 . . . . 0.0 111.737 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.17 88.22 6.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.827 -1.171 . . . . 0.0 111.192 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.11 -63.52 0.91 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.639 1.114 . . . . 0.0 113.706 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.36 -47.24 23.07 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.959 2.439 . . . . 0.0 112.63 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 77.7 m -54.27 -44.43 71.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.261 0.624 . . . . 0.0 109.854 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -54.76 -50.11 69.22 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -81.94 -19.68 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.594 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.2 mt -78.78 -38.88 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.842 0.857 . . . . 0.0 109.224 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.85 -49.26 5.72 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.893 2.077 . . . . 0.0 115.553 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.83 -37.24 79.4 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.345 2.03 . . . . 0.0 110.109 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.48 -43.65 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.7 t -55.67 -45.38 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -56.43 -63.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.557 0.743 . . . . 0.0 109.831 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.92 -37.55 76.93 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.684 0.675 . . . . 0.0 112.04 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -52.25 -36.44 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.632 0.773 . . . . 0.0 110.01 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.59 -39.2 76.27 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.333 0.515 . . . . 0.0 110.988 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.14 -50.4 34.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -53.36 -44.5 68.59 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -115.12 37.43 3.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.656 0.782 . . . . 0.0 112.803 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.98 162.2 2.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.906 0.882 . . . . 0.0 111.176 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 72.77 -61.81 0.49 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.314 2.245 . . . . 0.0 111.353 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -78.0 -32.08 51.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -170.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 tp -125.38 102.9 7.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.88 94.86 5.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.43 132.2 37.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 118.589 -0.719 . . . . 0.0 109.317 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.11 176.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.022 0.828 . . . . 0.0 111.793 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -131.13 122.93 27.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.723 2.009 . . . . 0.0 110.943 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -104.31 120.15 40.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.607 1.563 . . . . 0.0 109.818 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -74.89 107.61 7.09 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 m -66.76 -33.66 76.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.491 1.516 . . . . 0.0 111.427 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.29 -38.92 78.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.58 -27.85 31.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.762 2.025 . . . . 0.0 111.519 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -119.84 52.28 2.16 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.579 1.552 . . . . 0.0 112.431 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -65.98 -30.08 48.48 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 125.49 4.127 . . . . 0.0 109.747 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.83 -62.17 2.07 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -55.73 -47.06 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.388 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.3 -47.42 55.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.194 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -65.74 -46.05 80.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.161 0.585 . . . . 0.0 110.515 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -54.45 -45.8 73.18 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.978 0.511 . . . . 0.0 110.638 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -79.48 -30.93 42.26 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.21 43.29 3.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 123.915 0.769 . . . . 0.0 111.22 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.38 88.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -77.29 -23.24 51.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.2 p -157.24 175.08 14.5 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 pt -146.62 154.4 48.24 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.08 133.94 26.37 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 CA-C-N 120.92 1.364 . . . . 0.0 113.445 1.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -139.98 104.83 4.95 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.571 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.0 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.78 153.27 34.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.74 133.15 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.218 1.007 . . . . 0.0 108.669 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -128.81 141.98 51.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 133.77 18.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.53 41.75 98.85 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -172.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.19 -47.47 2.63 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 124.451 1.024 . . . . 0.0 114.075 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -79.62 157.26 27.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.044 0.938 . . . . 0.0 111.964 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -88.24 156.07 19.41 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 127.296 2.238 . . . . 0.0 112.83 -172.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.83 -80.28 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.665 0.386 . . . . 0.0 111.626 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -74.71 152.84 39.07 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.107 0.48 . . . . 0.0 111.99 -170.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.7 m -132.94 110.88 10.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.969 2.508 . . . . 0.0 106.005 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.47 123.86 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -78.83 146.85 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.93 -137.72 0.69 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 71.53 -46.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.945 1.298 . . . . 0.0 110.687 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.08 148.49 75.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.18 68.75 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.526 1.484 . . . . 0.0 111.696 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -50.62 -37.41 40.22 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.227 1.011 . . . . 0.0 111.27 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.55 -41.73 21.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.508 0.595 . . . . 0.0 111.192 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -47.21 84.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.708 0.803 . . . . 0.0 108.869 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 mt -63.27 -40.29 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.825 1.25 . . . . 0.0 110.072 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.8 t -57.89 -58.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.921 1.288 . . . . 0.0 108.143 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.01 -46.63 68.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.233 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 m -60.39 -51.98 67.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.189 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.77 -44.15 93.18 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.34 -0.85 . . . . 0.0 110.854 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -50.46 -39.73 48.76 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.869 0.868 . . . . 0.0 111.558 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -59.64 -29.25 67.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.294 -0.254 . . . . 0.0 111.399 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -91.35 -43.89 9.49 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.691 0.797 . . . . 0.0 109.995 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.44 -107.1 0.15 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.736 0.815 . . . . 0.0 108.856 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.359 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.09 -51.52 45.48 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.74 131.71 41.05 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 167.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.88 179.68 44.27 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.33 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.67 137.46 54.45 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.14 164.02 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 118.972 0.806 . . . . 0.0 111.158 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.02 169.9 17.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 173.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -38.92 -45.26 1.16 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.352 1.861 . . . . 0.0 112.41 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.09 -74.14 0.12 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.028 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -48.81 -38.9 23.48 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.499 1.12 . . . . 0.0 111.564 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -38.95 -47.36 1.44 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.364 2.266 . . . . 0.0 110.591 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -48.3 -64.67 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.96 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.08 -38.55 75.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.126 1.37 . . . . 0.0 111.911 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 p -83.0 -47.86 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.293 1.037 . . . . 0.0 113.424 -172.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.85 -57.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.726 0.81 . . . . 0.0 110.886 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.48 -57.0 6.47 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.57 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.39 45.53 0.67 Allowed 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.444 -0.785 . . . . 0.0 111.221 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 p -90.52 164.72 14.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.545 1.138 . . . . 0.0 111.128 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.5 p -104.98 -68.62 0.85 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.623 1.569 . . . . 0.0 107.162 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.0 162.93 62.73 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.034 1.333 . . . . 0.0 108.035 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.27 167.9 2.33 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.799 1.666 . . . . 0.0 112.294 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -146.28 120.27 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.574 1.549 . . . . 0.0 109.215 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -97.72 102.79 14.64 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -98.21 109.73 24.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.362 0.665 . . . . 0.0 109.801 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -87.77 117.72 26.8 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -79.19 112.6 16.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -126.31 -173.74 2.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.843 0.83 . . . . 0.0 111.008 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.66 156.76 3.43 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.41 -36.42 78.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.315 2.01 . . . . 0.0 109.991 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -76.68 -3.56 38.58 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.708 0.803 . . . . 0.0 111.738 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.4 t -63.69 -60.42 3.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.714 1.143 . . . . 0.0 111.659 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 -86.02 0.52 Allowed Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.069 -1.406 . . . . 0.0 110.761 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.97 -46.13 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.415 2.744 . . . . 0.0 111.843 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.0 m -46.13 -46.53 17.19 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.374 1.47 . . . . 0.0 111.41 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -67.87 -44.08 77.92 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.656 0.783 . . . . 0.0 110.797 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.97 -13.13 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.875 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.59 -38.49 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.062 1.345 . . . . 0.0 108.491 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -37.95 -47.38 2.71 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.905 2.082 . . . . 0.0 114.721 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.13 -39.97 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.828 1.686 . . . . 0.0 109.918 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -74.91 -47.52 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.629 1.972 . . . . 0.0 109.505 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -38.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.601 -1.312 . . . . 0.0 109.568 175.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.86 -54.25 24.21 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 119.286 -0.387 . . . . 0.0 110.822 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.08 -41.89 89.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.32 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mm -55.3 -46.49 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.27 -51.09 57.32 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.16 -54.21 13.02 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -61.73 -54.0 48.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.678 0.752 . . . . 0.0 112.916 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -83.21 -8.06 59.53 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -37.31 -58.49 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.501 1.921 . . . . 0.0 113.5 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.21 -39.91 60.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.952 1.301 . . . . 0.0 112.802 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -91.32 -37.47 13.24 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.887 1.275 . . . . 0.0 113.301 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.03 145.5 18.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.84 1.256 . . . . 0.0 108.446 -168.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -93.82 154.67 17.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.997 1.719 . . . . 0.0 109.678 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 147.01 49.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.83 167.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.133 0.424 . . . . 0.0 111.021 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -135.54 113.65 11.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.661 1.185 . . . . 0.0 111.545 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.9 tt -94.87 116.53 28.84 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.126 0.971 . . . . 0.0 109.57 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -75.88 111.38 11.19 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -66.53 -29.23 69.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.366 1.466 . . . . 0.0 111.85 -173.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.69 -38.31 54.67 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.915 1.286 . . . . 0.0 109.787 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -80.91 -25.94 37.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.044 1.737 . . . . 0.0 110.782 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 m -117.33 51.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.916 2.087 . . . . 0.0 112.232 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -63.78 -31.0 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 125.598 4.198 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -58.4 -64.24 0.99 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.19 -44.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.851 0.357 . . . . 0.0 110.073 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.79 64.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -67.78 -44.46 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.226 0.61 . . . . 0.0 110.628 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.73 -45.85 70.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 110.222 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -79.56 -33.2 42.01 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.79 50.11 2.18 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.85 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.777 0.831 . . . . 0.0 109.351 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.08 -26.31 43.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.905 0.882 . . . . 0.0 110.812 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.9 m -160.24 160.17 32.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.833 1.253 . . . . 0.0 107.781 -171.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 pt -143.35 160.7 50.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.956 1.702 . . . . 0.0 107.566 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.7 154.57 79.46 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 CA-C-N 121.426 1.545 . . . . 0.0 113.838 3.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.6 m -151.14 104.04 3.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.8 mt -91.12 118.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.9 mtt -103.86 129.52 51.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.7 t -91.18 115.76 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.47 166.18 12.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.822 1.249 . . . . 0.0 108.626 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.28 -161.0 0.71 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.06 102.86 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.33 1.443 . . . . 0.0 114.656 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.27 -64.35 2.07 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.75 1.167 . . . . 0.0 114.963 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.43 177.74 4.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.479 1.133 . . . . 0.0 113.706 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -87.72 155.92 19.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.041 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.6 t -103.59 -69.15 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.823 1.249 . . . . 0.0 108.994 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.42 177.96 8.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 108.39 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -152.87 149.29 28.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.892 -0.505 . . . . 0.0 109.975 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -121.52 104.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.955 2.102 . . . . 0.0 107.026 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.4 mt -89.49 137.38 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.05 1.34 . . . . 0.0 107.799 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.64 150.0 25.42 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 121.697 0.609 . . . . 0.0 112.284 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.42 64.18 2.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.954 0.901 . . . . 0.0 112.031 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.29 150.66 74.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.21 149.25 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.728 1.619 . . . . 0.0 112.1 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -45.69 66.72 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.95 -43.72 14.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.206 0.602 . . . . 0.0 111.515 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -51.43 67.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.993 0.917 . . . . 0.0 108.931 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.0 -52.19 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 123.829 0.852 . . . . 0.0 109.775 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.28 -57.3 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.267 0.94 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -55.28 -49.28 72.52 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.807 0.336 . . . . 0.0 110.286 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.5 m -57.23 -45.98 83.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.725 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.79 -52.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 120.915 -1.116 . . . . 0.0 109.267 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.02 -38.34 65.03 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.731 1.212 . . . . 0.0 111.721 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -54.7 -33.5 61.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.505 0.322 . . . . 0.0 110.88 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -105.46 -77.0 0.59 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.354 1.462 . . . . 0.0 113.145 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 mt 67.62 -58.91 0.42 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 129.752 3.221 . . . . 0.0 111.423 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.551 1.54 . . . . 0.0 108.583 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.71 -48.72 53.16 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 170.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.53 138.6 40.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.38 167.47 54.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.392 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.04 132.16 50.58 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -131.39 173.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 122.074 0.94 . . . . 0.0 110.043 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -155.66 178.28 10.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.309 2.244 . . . . 0.0 105.48 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -45.7 -55.95 5.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.993 0.815 . . . . 0.0 111.699 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.31 -57.79 4.29 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.833 1.653 . . . . 0.0 112.623 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 p -74.06 -47.0 39.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.863 0.865 . . . . 0.0 111.293 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -39.66 -48.7 2.17 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.229 2.212 . . . . 0.0 110.739 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -40.03 -53.83 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.708 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -87.27 -47.83 8.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.366 1.079 . . . . 0.0 110.695 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.28 -32.89 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.217 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -109.95 -64.56 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.02 1.328 . . . . 0.0 111.603 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.23 -71.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.312 0.505 . . . . 0.0 111.14 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.43 53.64 2.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.905 0.882 . . . . 0.0 108.8 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.1 p -90.8 -129.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.024 0.929 . . . . 0.0 109.56 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.1 p -161.54 -78.04 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.05 163.71 58.65 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -50.17 163.13 0.64 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.814 2.343 . . . . 0.0 114.043 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 t -146.45 141.54 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 108.784 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.01 97.53 5.14 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.96 129.85 47.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -102.32 116.67 33.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.21 108.66 12.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -124.49 -175.5 3.28 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 123.716 0.635 . . . . 0.0 110.475 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.53 142.07 1.35 Allowed Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.922 0.889 . . . . 0.0 111.077 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.73 108.72 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.228 1.952 . . . . 0.0 108.468 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 137.85 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 1 C-N-CA 131.756 4.022 . . . . 0.0 105.846 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.7 t -74.93 83.02 2.2 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.54 -58.96 2.84 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.249 0.928 . . . . 0.0 112.25 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -48.54 -34.14 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.967 3.111 . . . . 0.0 113.86 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.41 -46.23 17.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -50.91 -50.24 57.86 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.275 1.43 . . . . 0.0 111.119 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.97 -32.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.5 mm -76.35 -36.86 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.551 1.141 . . . . 0.0 111.95 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.76 -48.49 5.42 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.8 -36.46 61.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.656 2.238 . . . . 0.0 110.179 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.86 -45.23 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.17 -48.17 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -59.92 -53.07 62.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.04 -39.69 95.5 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.775 -1.203 . . . . 0.0 110.402 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mt -56.8 -44.4 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.86 -52.82 55.92 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.73 49.06 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -62.99 -43.3 99.16 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -117.08 8.93 13.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -39.65 -46.53 1.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.731 2.012 . . . . 0.0 112.199 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -29.91 -58.81 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.874 2.469 . . . . 0.0 113.508 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -112.29 -31.72 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.343 1.057 . . . . 0.0 112.342 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.46 105.47 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.125 0.57 . . . . 0.0 111.055 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -78.66 91.08 4.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.2 t -79.5 136.44 36.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.997 -1.064 . . . . 0.0 110.328 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.96 173.27 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.522 0.729 . . . . 0.0 111.551 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -139.93 113.07 8.25 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.726 1.21 . . . . 0.0 111.127 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.81 126.84 38.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.738 0.699 . . . . 0.0 110.753 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -77.64 108.97 11.21 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 m -70.87 -33.22 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.754 1.622 . . . . 0.0 111.55 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.4 -40.33 93.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.221 1.01 . . . . 0.0 109.346 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -84.61 -24.16 29.27 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.177 2.191 . . . . 0.0 112.141 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 m -134.97 61.98 50.02 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 120.821 -1.174 . . . . 0.0 111.735 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.06 -23.25 34.18 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 124.962 3.774 . . . . 0.0 109.921 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -42.97 -72.64 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.614 1.565 . . . . 0.0 110.931 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.0 t -52.18 -48.4 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.033 1.333 . . . . 0.0 109.899 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -41.81 66.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.939 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.5 m -74.8 -43.5 54.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.015 . . . . 0.0 110.566 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -54.84 -48.31 73.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.316 0.646 . . . . 0.0 109.938 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -79.44 -33.0 42.84 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.56 56.7 4.12 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.3 pt -67.49 142.28 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.492 0.663 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -79.6 71.7 6.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.6 t 65.33 -157.28 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.616 1.166 . . . . 0.0 109.384 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 153.04 69.96 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.313 1.045 . . . . 0.0 110.103 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.24 145.07 82.33 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 CA-C-N 119.536 0.87 . . . . 0.0 112.515 2.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.1 m -136.08 106.66 6.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.65 105.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.928 1.691 . . . . 0.0 106.54 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.6 mtp -103.62 127.53 51.04 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.46 134.03 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -120.65 136.73 54.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 173.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.464 ' CG ' ' H ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -107.43 -101.3 0.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 81' ' ' LYS . . . -71.85 73.15 0.84 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.61 -59.94 3.33 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.328 0.966 . . . . 0.0 112.975 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -86.09 173.27 9.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.36 0.6 . . . . 0.0 112.279 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.21 152.92 10.09 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.948 1.699 . . . . 0.0 113.411 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 t -130.54 -56.87 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.666 1.987 . . . . 0.0 109.058 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.05 166.95 21.54 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.397 1.079 . . . . 0.0 110.632 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 m -152.75 95.5 2.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.817 1.647 . . . . 0.0 106.618 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.33 141.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.3 mt -133.22 142.96 40.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 155.94 32.19 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 71.96 1.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.099 -0.648 . . . . 0.0 111.67 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -79.13 153.66 77.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.43 154.46 53.27 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.343 2.028 . . . . 0.0 114.424 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -45.38 -53.49 8.55 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.364 1.866 . . . . 0.0 109.47 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.49 -55.79 4.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.727 1.211 . . . . 0.0 110.132 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -59.19 -53.39 58.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 110.539 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 80.8 mt -51.87 -58.67 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.88 -60.29 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.976 1.31 . . . . 0.0 109.907 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -49.23 -49.14 44.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.269 0.486 . . . . 0.0 111.163 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.7 m -61.53 -57.72 10.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 p -63.51 -45.06 98.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 118.561 -1.256 . . . . 0.0 111.257 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -50.96 -49.76 59.39 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.765 1.626 . . . . 0.0 110.741 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -51.72 -48.84 63.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.719 175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -78.09 -76.15 0.2 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -173.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 11.95 -52.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 1 C-N-CA 133.622 4.769 . . . . 0.0 118.457 -169.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.257 0 C-N-CA 127.448 2.299 . . . . 0.0 110.552 -173.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.43 -41.8 98.99 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.51 144.64 27.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.2 168.16 54.73 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.31 131.65 56.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.82 162.83 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 122.167 0.984 . . . . 0.0 110.488 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -142.72 176.59 8.93 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.407 1.883 . . . . 0.0 106.338 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -39.22 -58.84 1.11 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.653 1.181 . . . . 0.0 112.383 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -54.62 -58.09 8.87 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.851 1.661 . . . . 0.0 113.09 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -67.2 -46.38 74.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.3 1.84 . . . . 0.0 110.558 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -40.15 -51.5 2.64 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 126.84 2.056 . . . . 0.0 111.212 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -44.08 -52.5 7.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.664 0.745 . . . . 0.0 110.931 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.66 -58.06 3.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.606 0.717 . . . . 0.0 111.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.33 -43.6 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.565 -169.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.68 -61.54 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.518 1.127 . . . . 0.0 111.348 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -70.68 -63.03 1.17 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.929 0.786 . . . . 0.0 110.508 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -79.92 52.63 1.53 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.619 0.645 . . . . 0.0 111.48 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 p -89.02 155.36 19.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.783 1.633 . . . . 0.0 110.322 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -87.1 -73.77 0.46 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.66 162.01 64.59 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.58 166.88 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.323 2.016 . . . . 0.0 114.18 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.14 149.02 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.362 1.865 . . . . 0.0 110.466 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 tt -126.87 102.03 6.84 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 170.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.0 p -107.08 123.6 62.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.116 1.325 . . . . 0.0 108.789 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -93.59 115.29 27.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -79.61 104.07 9.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -116.61 -169.91 1.72 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.315 1.046 . . . . 0.0 110.24 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.49 148.73 1.55 Allowed Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 124.595 1.158 . . . . 0.0 107.923 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.03 -37.71 95.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.559 2.173 . . . . 0.0 112.85 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -72.73 -18.7 61.49 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.904 -0.497 . . . . 0.0 111.052 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.69 83.59 6.43 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.057 -1.027 . . . . 0.0 109.715 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.29 -59.53 1.82 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.52 1.057 . . . . 0.0 113.457 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.99 -48.61 20.74 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.694 2.263 . . . . 0.0 111.546 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.4 m -55.74 -50.49 70.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -58.13 -49.93 75.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.332 1.053 . . . . 0.0 111.536 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.73 -22.47 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.722 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.0 mt -82.56 -30.13 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 119.847 1.203 . . . . 0.0 109.435 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.35 -41.69 2.64 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.937 1.695 . . . . 0.0 115.223 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.76 -40.89 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.323 2.015 . . . . 0.0 109.809 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.14 -35.33 34.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 C-N-CA 118.153 -1.419 . . . . 0.0 108.136 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.7 t -52.73 -43.65 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.15 -58.36 8.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.094 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.36 -42.2 77.4 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.558 0.617 . . . . 0.0 111.884 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.98 -36.5 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 122.838 0.455 . . . . 0.0 109.962 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.68 -46.97 80.86 Favored 'General case' 0 C--O 1.223 -0.342 0 O-C-N 121.913 -0.492 . . . . 0.0 110.193 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.9 -42.68 99.63 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.76 -44.06 90.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.55 15.63 8.84 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -39.43 -51.15 2.13 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.132 1.373 . . . . 0.0 113.7 -174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -44.7 -46.65 10.44 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.081 1.752 . . . . 0.0 112.774 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -98.56 -37.76 9.42 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.92 0.888 . . . . 0.0 112.266 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.4 tp -116.16 112.07 21.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.101 -167.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -79.96 93.65 5.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 49.9 t -79.13 134.16 36.72 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.494 -0.754 . . . . 0.0 109.685 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.64 167.9 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.166 0.586 . . . . 0.0 111.758 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -135.27 116.4 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.034 1.334 . . . . 0.0 110.077 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -98.86 120.83 39.96 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 109.585 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -75.42 103.31 5.5 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.672 0.749 . . . . 0.0 110.265 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -81.96 48.33 1.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.451 1.9 . . . . 0.0 111.27 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -145.5 -47.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.59 -26.43 34.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.86 2.064 . . . . 0.0 109.821 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.4 m -133.05 60.38 49.0 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.006 -1.059 . . . . 0.0 113.813 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.87 -23.78 16.07 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 125.186 3.924 . . . . 0.0 108.716 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -37.38 -69.25 0.12 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.356 1.862 . . . . 0.0 111.099 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -35.68 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.183 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.63 81.24 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 m -72.41 -45.21 60.71 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.095 0.958 . . . . 0.0 109.965 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -54.97 -46.04 75.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.35 0.66 . . . . 0.0 110.386 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.98 -34.76 43.92 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.365 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.23 54.77 1.24 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.516 0.579 . . . . 0.0 111.859 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.6 mt -77.69 121.41 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -79.0 -35.46 42.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.02 0.528 . . . . 0.0 111.537 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.9 m -158.73 168.82 25.84 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.1 pt -124.82 154.56 70.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.34 149.69 82.19 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 CA-C-N 120.287 1.138 . . . . 0.0 112.277 2.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -144.04 106.04 4.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.61 116.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.5 mtt -105.76 134.93 48.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -99.47 140.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -127.99 161.1 29.94 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 54.56 0.81 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.521 1.138 . . . . 0.0 110.488 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.18 98.35 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.48 -73.08 1.17 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.103 0.858 . . . . 0.0 112.066 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -94.58 165.21 12.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.825 1.298 . . . . 0.0 113.131 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -77.32 142.35 39.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.265 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 41.7 t -89.08 -65.22 1.04 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.227 1.011 . . . . 0.0 108.643 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -151.28 -174.75 4.92 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.091 1.756 . . . . 0.0 108.166 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.2 t -154.23 166.72 32.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.364 0.666 . . . . 0.0 109.585 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.0 mt -136.02 118.63 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.95 141.0 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 109.027 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.64 163.33 38.3 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.836 0.731 . . . . 0.0 111.569 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.34 142.97 57.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.08 0.552 . . . . 0.0 110.739 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.69 153.54 36.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 124.123 0.969 . . . . 0.0 108.525 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.72 145.29 20.2 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 N-CA-C 105.586 -2.505 . . . . 0.0 105.586 168.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -56.29 -33.41 65.5 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.321 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.88 -42.87 6.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.662 0.785 . . . . 0.0 110.62 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.1 m -75.3 -44.42 45.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.978 0.511 . . . . 0.0 110.018 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.5 mt -54.42 -47.45 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 123.51 0.724 . . . . 0.0 110.08 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -57.15 -55.28 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.439 0.695 . . . . 0.0 109.714 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -56.61 -45.49 81.45 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.889 -0.507 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.3 m -66.34 -43.24 86.65 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.073 0.549 . . . . 0.0 111.752 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.71 -43.62 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 121.024 -1.048 . . . . 0.0 108.878 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.26 -47.75 80.61 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -54.1 -52.0 62.38 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.473 0.709 . . . . 0.0 109.919 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -63.06 -41.79 99.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.613 0.365 . . . . 0.0 111.791 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.7 -99.68 0.32 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.875 1.27 . . . . 0.0 109.299 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.354 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 tpp . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.09 -44.48 76.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.09 135.46 41.19 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 169.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.06 166.16 44.63 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.32 126.98 55.84 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.52 164.43 30.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 122.271 1.034 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -148.9 179.84 7.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.321 1.848 . . . . 0.0 106.832 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -39.05 -59.05 1.04 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.362 1.465 . . . . 0.0 112.213 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.99 -69.14 0.25 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.546 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -51.59 -39.03 57.18 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.248 1.019 . . . . 0.0 112.11 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -44.74 -48.22 10.79 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.197 1.399 . . . . 0.0 111.045 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -50.29 -51.25 46.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.412 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -74.76 -56.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.428 0.633 . . . . 0.0 111.38 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.7 t -66.86 -23.97 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.078 1.751 . . . . 0.0 113.368 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.51 -75.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.574 0.75 . . . . 0.0 110.524 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.37 -47.06 66.37 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.667 0.667 . . . . 0.0 112.781 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.14 15.03 16.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.423 1.089 . . . . 0.0 112.085 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.34 147.93 27.64 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.034 0.834 . . . . 0.0 111.407 -173.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.2 p -80.01 -61.91 1.84 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.345 1.458 . . . . 0.0 111.753 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.45 160.25 75.57 Favored Pre-proline 0 C--O 1.233 0.185 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.79 159.88 3.27 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.245 1.963 . . . . 0.0 110.403 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.05 149.26 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 123.768 0.827 . . . . 0.0 109.599 -173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.67 98.97 4.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.68 119.29 45.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -95.29 114.04 25.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -79.58 112.37 16.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -128.14 -172.04 2.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.817 0.818 . . . . 0.0 110.526 -174.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.27 151.7 4.71 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 124.516 1.126 . . . . 0.0 108.108 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.62 -31.98 93.26 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.375 2.05 . . . . 0.0 113.266 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -79.47 -7.23 58.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.107 0.867 . . . . 0.0 111.405 176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.6 t -81.31 83.63 6.83 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.078 -1.013 . . . . 0.0 112.551 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.93 -58.02 2.78 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.551 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.22 -20.19 66.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 CA-C-N 119.634 1.717 . . . . 0.0 113.064 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.8 m -81.15 -49.82 10.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -45.17 -50.21 11.55 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.778 0.831 . . . . 0.0 111.153 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -65.82 -25.75 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.387 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 pt -90.23 -29.05 4.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 CA-C-N 120.689 1.586 . . . . 0.0 110.255 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.02 4.28 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.96 -28.39 24.36 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 122.276 1.849 . . . . 0.0 109.848 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -71.41 -41.42 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -55.94 -46.74 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.38 -54.73 39.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.69 -41.15 94.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.638 1.563 . . . . 0.0 110.669 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.9 mm -60.36 -41.99 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -50.71 67.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.925 0.784 . . . . 0.0 109.302 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.81 -49.7 34.11 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.14 -58.89 4.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -85.38 -0.03 53.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -171.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -39.0 -49.12 1.69 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.549 1.54 . . . . 0.0 113.163 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -46.87 -59.95 2.74 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.859 1.664 . . . . 0.0 112.593 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -83.48 -30.03 27.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.799 1.24 . . . . 0.0 112.579 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.67 110.89 10.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 -168.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.81 95.59 6.07 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.3 t -79.26 140.18 37.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.572 -0.705 . . . . 0.0 109.29 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.82 165.4 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.835 0.854 . . . . 0.0 109.906 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -133.56 116.95 16.52 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.708 1.203 . . . . 0.0 109.268 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 tt -99.1 123.39 43.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.017 0.436 . . . . 0.0 110.385 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.99 108.82 9.14 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.9 m -68.99 -29.82 68.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 124.876 1.27 . . . . 0.0 111.692 -174.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.58 -43.26 66.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.91 0.862 . . . . 0.0 110.177 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -81.19 -27.4 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.299 1.84 . . . . 0.0 111.666 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.2 m -134.0 61.89 54.09 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 121.04 -1.037 . . . . 0.0 110.679 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.14 -35.9 31.31 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.899 3.733 . . . . 0.0 108.861 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -33.55 -69.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.11 2.164 . . . . 0.0 111.058 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.8 t -55.48 -51.45 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.744 1.218 . . . . 0.0 110.057 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.32 -37.03 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.122 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 m -74.6 -45.23 46.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.53 1.132 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.99 -43.28 73.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.421 0.688 . . . . 0.0 109.629 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -78.97 -32.71 45.42 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.385 -0.341 . . . . 0.0 110.952 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.45 51.1 2.42 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 111.675 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.0 mt -84.05 113.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.075 0.95 . . . . 0.0 108.676 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.45 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -79.65 -26.86 40.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 113.532 -175.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 m -161.08 167.11 26.96 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 pt -129.53 151.92 78.78 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 146.88 83.0 Favored 'Cis proline' 0 N--CA 1.453 -0.894 0 CA-C-N 119.923 1.008 . . . . 0.0 113.277 1.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.6 m -139.61 114.4 9.4 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.3 mt -104.55 102.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.8 mtt -87.86 131.92 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.44 143.31 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -134.31 158.93 42.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.964 0.906 . . . . 0.0 109.716 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 146.72 28.52 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.554 2.342 . . . . 0.0 104.73 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.92 55.12 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.117 -1.516 . . . . 0.0 111.768 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.1 -52.58 2.95 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 122.258 -0.554 . . . . 0.0 113.525 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -79.67 163.66 24.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.539 1.161 . . . . 0.0 113.409 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -67.67 148.04 51.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.863 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 t -115.11 -63.41 1.46 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.355 1.462 . . . . 0.0 109.125 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -138.3 -177.7 4.96 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 109.771 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -155.22 131.82 10.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.941 0.896 . . . . 0.0 109.455 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.0 mm -104.33 153.28 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.74 142.02 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.154 0.981 . . . . 0.0 108.596 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.31 158.24 20.14 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 121.531 0.517 . . . . 0.0 112.54 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.92 70.18 1.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.53 . . . . 0.0 111.146 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -78.5 153.43 78.8 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.71 147.22 50.91 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.619 1.546 . . . . 0.0 112.208 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -62.05 -39.19 91.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.391 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -48.86 37.12 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -59.56 -51.12 71.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 109.204 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.1 mt -54.96 -58.38 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.039 0.535 . . . . 0.0 109.878 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.2 t -49.67 -55.98 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.886 1.274 . . . . 0.0 110.673 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -48.23 74.25 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -61.38 -41.41 97.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.459 0.303 . . . . 0.0 111.191 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.18 -49.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -57.75 -46.56 84.33 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.509 0.724 . . . . 0.0 110.048 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -51.85 -52.05 52.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.736 0.814 . . . . 0.0 109.482 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -65.82 -45.4 82.44 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.1 mt -108.16 -98.99 0.37 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.037 1.335 . . . . 0.0 109.894 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.338 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.29 -41.13 98.24 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.05 129.35 34.43 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 168.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.01 -177.44 39.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.86 136.9 54.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.41 165.49 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.616 0.722 . . . . 0.0 111.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -145.55 172.09 13.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.784 2.034 . . . . 0.0 106.063 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -39.09 -48.12 1.63 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.936 1.694 . . . . 0.0 112.663 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.52 -74.0 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.105 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -52.86 -36.33 58.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.512 1.125 . . . . 0.0 111.951 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -41.06 -46.73 2.99 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 126.258 1.823 . . . . 0.0 111.376 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -49.48 -48.02 48.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.789 1.236 . . . . 0.0 111.086 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -85.12 -57.64 3.01 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.779 0.832 . . . . 0.0 111.157 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.77 -38.58 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.651 1.18 . . . . 0.0 112.163 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -104.91 -59.52 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 112.305 -174.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 mt -66.57 -71.34 0.2 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.162 0.437 . . . . 0.0 110.982 -174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -79.57 52.77 1.46 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.101 0.476 . . . . 0.0 111.483 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 p -90.67 159.29 16.47 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.11 1.764 . . . . 0.0 111.301 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -91.72 -69.87 0.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.243 1.417 . . . . 0.0 107.736 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 m -78.75 154.41 78.32 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.29 163.81 16.47 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.748 0.965 . . . . 0.0 110.194 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.47 113.72 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.667 1.187 . . . . 0.0 111.348 -171.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.32 105.64 13.56 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.85 116.04 45.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 109.762 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -89.44 112.27 23.36 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -78.71 112.93 16.32 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -130.12 -172.52 2.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.575 0.75 . . . . 0.0 110.754 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.5 148.82 3.51 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.967 1.307 . . . . 0.0 107.772 172.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.15 -45.35 41.67 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.702 2.268 . . . . 0.0 112.809 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -64.56 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.031 -0.418 . . . . 0.0 111.96 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.4 t -76.31 84.44 3.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.626 -0.671 . . . . 0.0 110.913 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.53 -54.12 5.77 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.996 0.808 . . . . 0.0 112.883 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -27.78 71.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.365 2.043 . . . . 0.0 112.767 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.4 m -77.15 -53.67 7.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -45.04 -47.2 11.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.981 1.712 . . . . 0.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -71.9 -25.96 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.02 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.6 pt -86.88 -26.43 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 121.267 1.849 . . . . 0.0 110.083 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.14 -45.72 3.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.367 1.467 . . . . 0.0 114.795 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -68.11 -33.17 25.9 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.708 2.272 . . . . 0.0 109.979 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -38.76 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 127.053 2.141 . . . . 0.0 107.901 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.25 -45.69 95.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.92 -52.92 63.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.844 0.457 . . . . 0.0 110.205 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -50.69 -49.85 56.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.434 0.561 . . . . 0.0 109.955 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.91 -38.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.58 -33.73 64.17 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.026 0.376 . . . . 0.0 110.277 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.58 -56.56 7.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.94 -47.53 21.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -106.69 21.95 16.66 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -48.62 -40.4 27.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.958 0.903 . . . . 0.0 111.274 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.48 -68.35 0.19 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.37 1.468 . . . . 0.0 112.4 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -89.94 -14.64 33.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.16 135.04 33.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.683 1.129 . . . . 0.0 113.102 -167.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -79.94 151.63 29.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.1 t -137.34 136.75 38.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.8 166.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 112.069 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -128.3 116.13 19.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.081 1.352 . . . . 0.0 109.542 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.8 tp -97.73 115.97 29.02 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.57 0.748 . . . . 0.0 109.983 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -71.1 110.42 5.76 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -64.21 -43.67 94.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 111.4 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.11 -33.68 76.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.584 0.754 . . . . 0.0 110.403 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -82.44 -25.03 33.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 0.0 111.104 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -125.88 54.9 11.44 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 113.034 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.18 -30.83 45.96 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.789 2.993 . . . . 0.0 108.616 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -43.64 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.13 1.772 . . . . 0.0 110.991 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.4 t -50.57 -51.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -39.09 74.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.044 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -70.35 -45.19 66.62 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.014 0.526 . . . . 0.0 109.656 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.58 -42.35 74.65 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.2 -23.97 43.46 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.747 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.85 10.62 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.041 0.829 . . . . 0.0 111.072 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -70.23 128.9 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.88 -45.03 21.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.325 0.65 . . . . 0.0 111.386 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 m -156.48 171.28 20.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.06 154.39 68.1 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.17 149.59 89.81 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 CA-C-N 119.787 0.96 . . . . 0.0 112.118 1.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -135.57 101.18 4.71 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.0 mt -90.61 114.57 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.6 mtm -126.16 150.34 48.35 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.2 t -108.51 139.73 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.5 168.26 12.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.333 1.021 . . . . 0.0 109.994 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 156.78 2.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.979 2.112 . . . . 0.0 106.7 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 37.57 49.96 1.83 Allowed Glycine 0 CA--C 1.535 1.343 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.96 64.55 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.667 -1.074 . . . . 0.0 115.621 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -147.75 172.21 14.45 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.515 1.657 . . . . 0.0 111.099 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -85.76 161.66 19.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.834 1.254 . . . . 0.0 109.412 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 53.1 t -131.16 -63.1 0.86 Allowed 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 126.231 1.813 . . . . 0.0 109.826 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -113.66 162.3 16.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.394 1.078 . . . . 0.0 110.433 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -154.77 131.43 10.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.334 1.454 . . . . 0.0 107.854 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -140.57 113.46 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -99.11 139.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.8 148.26 22.54 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.407 1.004 . . . . 0.0 110.804 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 75.48 1.0 Allowed 'General case' 0 C--N 1.339 0.12 0 O-C-N 122.033 -0.686 . . . . 0.0 110.875 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.9 m -78.73 145.26 66.31 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.33 157.63 39.59 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.972 1.781 . . . . 0.0 113.027 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -42.1 -51.01 4.7 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.372 1.469 . . . . 0.0 110.028 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.08 -44.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 111.861 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -69.17 -48.44 62.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 70.2 mt -54.41 -54.3 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -46.59 -64.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 127.802 2.441 . . . . 0.0 109.271 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -55.6 -49.08 73.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.512 0.196 . . . . 0.0 111.297 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.4 m -56.85 -52.07 66.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.845 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.03 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.918 0.781 . . . . 0.0 110.515 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -52.7 -36.73 57.76 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.368 0.667 . . . . 0.0 112.015 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -46.92 -46.39 21.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.048 0.452 . . . . 0.0 110.49 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -87.95 -42.65 12.33 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.146 0.978 . . . . 0.0 111.195 -174.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 mp -129.26 83.42 2.14 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.554 1.142 . . . . 0.0 109.41 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 117.433 -1.27 . . . . 0.0 109.975 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 118.915 -0.564 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -163.22 178.35 8.28 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.82 143.32 31.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.155 0.982 . . . . 0.0 112.359 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.34 177.69 18.09 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.52 141.77 50.49 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 m -142.07 171.72 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 123.137 1.446 . . . . 0.0 112.674 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.38 169.56 19.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.977 3.311 . . . . 0.0 105.055 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -38.43 -50.39 1.52 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.702 2.401 . . . . 0.0 112.753 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.17 -70.02 0.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.726 0.774 . . . . 0.0 110.577 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -53.25 -38.7 63.23 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.601 1.16 . . . . 0.0 112.415 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -42.97 -46.75 5.55 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.864 2.066 . . . . 0.0 111.5 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -54.26 -55.38 28.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.72 -54.25 17.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.468 0.707 . . . . 0.0 111.516 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.31 -31.17 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.261 1.424 . . . . 0.0 112.79 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.24 -72.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.549 0.739 . . . . 0.0 111.024 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.1 mt -53.79 -41.03 66.81 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -172.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -93.12 13.23 21.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.009 0.924 . . . . 0.0 112.512 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 t -73.71 142.97 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.514 1.052 . . . . 0.0 111.888 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 p -79.64 -61.31 2.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.045 1.338 . . . . 0.0 108.636 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.86 155.14 80.62 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -57.23 161.32 11.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.64 1.56 . . . . 0.0 112.56 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 t -141.1 143.07 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.411 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tt -120.08 102.35 8.47 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.378 1.871 . . . . 0.0 106.689 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t -97.77 127.41 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -103.08 124.87 49.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -79.68 106.69 11.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -118.62 -176.13 3.03 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.872 1.32 . . . . 0.0 111.66 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.79 152.08 6.3 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.49 -42.68 12.11 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.857 1.342 . . . . 0.0 111.665 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -58.25 -18.75 28.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.796 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.8 t -77.97 88.72 4.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.707 1.139 . . . . 0.0 109.773 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.54 -63.07 1.04 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.187 1.375 . . . . 0.0 113.538 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -49.47 -47.29 23.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.39 2.726 . . . . 0.0 112.358 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.5 m -58.75 -53.6 56.58 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -53.25 -54.47 35.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.854 1.262 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -75.79 -27.37 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.652 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.78 -26.87 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.754 1.161 . . . . 0.0 109.796 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.79 -46.2 4.64 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -63.28 -35.68 61.23 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.675 2.25 . . . . 0.0 110.373 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 t -68.69 -44.28 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 t -58.07 -44.37 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.53 -60.81 3.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 122.828 0.451 . . . . 0.0 111.035 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.51 -33.87 71.91 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.435 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mt -56.8 -43.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.17 -47.7 76.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.042 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.28 -60.68 5.53 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 120.191 1.36 . . . . 0.0 110.69 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -48.17 -55.74 9.63 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.616 1.566 . . . . 0.0 110.717 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.39 58.88 4.74 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 123.447 1.594 . . . . 0.0 110.313 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -48.31 138.18 10.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.227 1.811 . . . . 0.0 110.115 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.73 -56.2 0.62 Allowed 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.565 2.346 . . . . 0.0 112.968 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.1 -9.44 58.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -166.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -141.62 108.87 5.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.974 1.261 . . . . 0.0 112.214 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -93.78 111.75 23.49 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.68 138.31 38.23 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.811 -1.18 . . . . 0.0 108.135 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.15 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -133.93 106.53 7.32 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.359 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.11 120.03 30.14 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 111.254 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.29 106.75 8.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.3 m -68.87 -31.97 71.3 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.231 1.413 . . . . 0.0 111.453 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.87 -41.5 87.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.438 1.095 . . . . 0.0 109.309 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.51 -28.68 26.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.004 2.122 . . . . 0.0 111.99 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.4 t -127.13 53.21 9.55 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.399 1.48 . . . . 0.0 112.208 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -62.78 -27.14 75.21 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.306 3.337 . . . . 0.0 108.825 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -40.37 -60.05 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.628 1.571 . . . . 0.0 110.263 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.8 -50.78 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.171 0.988 . . . . 0.0 110.167 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.08 64.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.426 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -68.63 -44.91 73.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.898 0.879 . . . . 0.0 110.397 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -56.38 -42.0 77.16 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.644 0.778 . . . . 0.0 110.332 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -78.47 -34.18 47.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.39 45.89 2.46 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.415 1.007 . . . . 0.0 111.588 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.76 -179.16 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 125.938 1.695 . . . . 0.0 108.33 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -158.62 -63.66 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.559 0.744 . . . . 0.0 109.593 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 m -54.94 154.64 5.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 110.223 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 pt -143.2 157.92 59.28 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.175 1.39 . . . . 0.0 107.3 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.27 156.28 84.78 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 120.766 1.309 . . . . 0.0 112.958 2.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -160.46 115.74 2.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -98.65 148.46 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.9 mtt -136.24 133.0 36.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.7 t -99.46 139.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -132.82 144.86 50.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 136.88 15.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 46.14 94.64 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -171.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.01 -59.65 2.66 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.908 0.766 . . . . 0.0 114.006 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -81.44 168.29 18.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -67.73 155.37 39.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.235 1.814 . . . . 0.0 112.96 -173.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.0 t -116.17 -72.38 0.69 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.965 2.106 . . . . 0.0 109.651 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -146.07 172.01 14.04 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.299 1.44 . . . . 0.0 110.246 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.5 m -116.41 146.58 42.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.63 1.972 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.82 -175.43 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.54 153.14 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.36 -153.57 5.83 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 51.48 42.48 29.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.947 0.899 . . . . 0.0 111.828 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.46 153.16 65.39 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.074 1.35 . . . . 0.0 107.477 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.36 160.43 32.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.103 1.868 . . . . 0.0 111.676 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -50.53 -43.57 56.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.807 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.41 -44.71 55.21 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.235 0.614 . . . . 0.0 111.111 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.3 m -65.84 -50.96 62.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -55.41 -52.78 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.392 0.677 . . . . 0.0 109.499 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.42 -58.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.428 1.491 . . . . 0.0 109.595 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -55.31 -47.41 75.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.689 0.677 . . . . 0.0 110.992 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.1 m -60.92 -43.83 98.03 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 119.591 -0.242 . . . . 0.0 111.448 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -72.5 -45.75 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.967 0.803 . . . . 0.0 109.829 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -51.54 -45.56 63.03 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.12 0.968 . . . . 0.0 110.772 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -48.24 -44.32 33.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.964 0.506 . . . . 0.0 110.316 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -78.88 -41.63 29.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.4 -104.02 0.1 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.132 0.973 . . . . 0.0 109.02 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.364 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -113.54 -34.62 5.5 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.841 0.856 . . . . 0.0 111.352 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.75 95.67 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.547 0.739 . . . . 0.0 111.545 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.41 -172.64 35.13 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.24 140.58 52.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.88 167.81 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.153 0.978 . . . . 0.0 111.793 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 8' ' ' ASP . 8.1 t-20 -143.5 172.76 12.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.844 2.058 . . . . 0.0 106.389 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 76.5 m-20 -38.82 -46.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.195 1.798 . . . . 0.0 112.381 -177.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.46 -76.19 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.719 0.408 . . . . 0.0 110.768 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.0 p -46.94 -39.82 13.07 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.271 1.429 . . . . 0.0 112.194 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -39.42 -47.9 1.86 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.526 1.93 . . . . 0.0 111.487 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.774 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -71.23 -45.73 62.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.507 0.67 . . . . 0.0 111.261 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.79 -37.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.031 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -106.33 -73.93 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.883 0.873 . . . . 0.0 110.78 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.9 mt -52.06 -54.53 29.11 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.865 0.466 . . . . 0.0 111.86 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -81.03 11.73 3.86 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -65.6 152.43 44.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.82 1.191 . . . . 0.0 109.614 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 p -79.33 -64.69 1.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.12 155.12 77.41 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.27 165.01 1.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.904 2.403 . . . . 0.0 112.608 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -144.72 143.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.449 1.099 . . . . 0.0 111.588 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -104.52 130.13 52.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.899 1.68 . . . . 0.0 107.67 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.61 111.28 27.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 118.918 0.781 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -89.69 116.28 27.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' CD2' ' CD1' ' A' ' 71' ' ' ILE . 15.9 m-85 -79.75 114.53 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -129.44 -173.48 3.02 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.565 0.698 . . . . 0.0 111.664 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.64 156.59 8.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -59.44 -40.52 66.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.206 1.938 . . . . 0.0 110.658 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -72.24 -10.25 59.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.881 0.472 . . . . 0.0 111.515 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.36 82.29 3.11 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.8 -1.187 . . . . 0.0 110.157 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.2 -61.21 1.01 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.825 1.202 . . . . 0.0 113.529 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.05 -41.3 78.36 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.387 2.058 . . . . 0.0 112.43 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 81.4 m -55.22 -47.66 75.02 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -56.2 -52.32 64.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.729 0.412 . . . . 0.0 111.482 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -73.24 -30.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.91 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.85 -23.08 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.951 0.9 . . . . 0.0 110.361 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.0 -46.54 5.17 Favored Pre-proline 0 CA--C 1.549 0.919 0 O-C-N 119.914 -1.741 . . . . 0.0 115.061 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.92 -37.58 64.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.466 2.111 . . . . 0.0 110.173 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.41 -49.08 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.8 t -49.96 -44.76 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.67 -61.92 1.61 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.36 -40.22 81.65 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.532 -0.73 . . . . 0.0 112.256 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.77 -38.42 75.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.21 -52.3 64.34 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -43.58 -53.43 6.06 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.897 0.76 . . . . 0.0 111.572 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -47.95 -35.4 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.24 1.016 . . . . 0.0 112.869 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -120.33 27.03 8.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.447 1.499 . . . . 0.0 112.673 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -39.67 -53.14 2.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.879 1.271 . . . . 0.0 113.799 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.04 -53.22 59.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 122.181 0.991 . . . . 0.0 112.33 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -79.43 -20.29 47.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.822 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 tp -144.8 114.68 7.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.051 0.387 . . . . 0.0 111.988 -170.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.2 168.09 20.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 44.3 t -145.65 141.45 28.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.988 -1.07 . . . . 0.0 110.273 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.21 161.8 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.893 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -127.62 109.38 11.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.452 1.101 . . . . 0.0 109.492 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tp -87.9 121.59 30.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.238 0.542 . . . . 0.0 110.426 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -74.58 105.46 5.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.9 m -65.21 -35.94 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.916 1.686 . . . . 0.0 111.03 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.92 -39.56 94.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.511 1.124 . . . . 0.0 109.539 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.37 -21.7 30.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.804 1.642 . . . . 0.0 110.702 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.1 m -120.96 51.11 2.22 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 114.597 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.53 -27.39 61.78 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.487 2.791 . . . . 0.0 109.68 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -54.28 -75.83 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.849 0.86 . . . . 0.0 109.933 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.63 -44.01 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.036 0.935 . . . . 0.0 110.343 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.63 80.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.76 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.4 p -70.74 -39.58 73.23 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.681 0.392 . . . . 0.0 110.27 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.73 -41.66 77.88 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.106 0.562 . . . . 0.0 109.928 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.29 -31.52 48.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.07 47.19 4.22 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.41 ' CD1' ' CD2' ' A' ' 26' ' ' PHE . 58.6 mt -72.62 114.67 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -29.74 44.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.305 0.242 . . . . 0.0 111.006 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 m -159.84 157.99 30.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.959 0.904 . . . . 0.0 108.619 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 pt -119.52 150.74 50.51 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.46 77.21 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.126 1.081 . . . . 0.0 114.05 3.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 m -143.06 113.34 7.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.08 119.96 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 mtt -105.22 159.23 16.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.904 0.882 . . . . 0.0 109.247 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 81.8 t -126.5 130.63 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -116.77 147.53 41.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.892 1.677 . . . . 0.0 108.36 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.8 53.1 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.435 0.636 . . . . 0.0 109.582 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.09 85.99 1.74 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.16 -67.32 1.17 Allowed Glycine 0 CA--C 1.527 0.827 0 CA-C-N 117.388 0.594 . . . . 0.0 112.884 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -79.85 163.69 24.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.258 1.023 . . . . 0.0 111.428 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -90.13 150.06 22.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.072 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.1 t -91.23 -51.4 5.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.23 -178.88 6.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 109.519 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -157.67 143.13 17.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.404 1.482 . . . . 0.0 107.816 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.21 153.35 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.119 0.968 . . . . 0.0 109.456 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.0 mt -79.92 141.86 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -138.57 2.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.37 42.34 31.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.806 0.803 . . . . 0.0 111.236 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.88 151.1 67.63 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.95 151.52 64.92 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.86 1.706 . . . . 0.0 112.836 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -45.08 46.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.409 1.484 . . . . 0.0 110.801 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -43.13 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.653 0.781 . . . . 0.0 111.133 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -49.55 74.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.815 . . . . 0.0 109.055 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.66 -52.37 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 123.951 0.9 . . . . 0.0 108.754 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.2 t -53.65 -59.25 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.104 0.962 . . . . 0.0 109.32 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -50.62 -42.36 55.98 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.705 0.402 . . . . 0.0 111.016 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -60.99 -59.49 5.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.8 -45.78 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.91 0.884 . . . . 0.0 111.62 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.47 -39.61 4.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.981 1.713 . . . . 0.0 113.193 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.69 -49.22 78.39 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.286 0.634 . . . . 0.0 110.593 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -80.33 -62.66 1.61 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.911 1.284 . . . . 0.0 110.257 -172.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.18 63.02 7.79 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.549 -1.691 . . . . 0.0 108.869 179.927 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 119.32 -0.371 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.17 -48.49 65.16 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.46 140.1 30.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 169.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.15 174.05 54.68 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.46 132.84 56.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.4 164.47 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 122.513 1.149 . . . . 0.0 111.208 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.63 169.31 18.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.998 2.519 . . . . 0.0 105.487 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -40.43 -52.99 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.079 1.352 . . . . 0.0 111.318 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.12 -53.23 56.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.048 . . . . 0.0 112.308 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 p -78.67 -31.4 46.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.344 0.658 . . . . 0.0 112.002 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -42.59 -43.54 3.82 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 127.548 2.339 . . . . 0.0 110.335 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -50.72 -67.68 0.23 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.358 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -42.6 98.91 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.226 1.01 . . . . 0.0 112.352 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.66 -43.9 16.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.971 -168.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.3 t -99.2 -54.03 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.399 1.08 . . . . 0.0 111.307 -174.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -69.17 -57.77 4.94 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.756 0.707 . . . . 0.0 110.283 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.6 51.55 1.28 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.173 0.989 . . . . 0.0 110.112 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 p -90.06 154.69 19.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.766 1.226 . . . . 0.0 112.64 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -100.94 -71.37 0.71 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.023 1.729 . . . . 0.0 107.405 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.7 m -79.19 158.95 73.84 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.56 159.81 12.85 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.565 1.51 . . . . 0.0 109.97 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 t -138.7 119.03 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.064 0.945 . . . . 0.0 110.419 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -94.41 110.35 22.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.375 1.07 . . . . 0.0 108.179 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.76 113.46 40.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -86.24 113.88 22.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.3 113.09 17.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.4 p-90 -129.18 -174.71 3.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.79 0.805 . . . . 0.0 111.016 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.77 154.14 5.23 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.888 1.275 . . . . 0.0 108.17 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.98 -42.1 15.32 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.821 2.348 . . . . 0.0 110.45 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 30.8 p-90 -66.39 -17.95 65.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.893 0.477 . . . . 0.0 111.215 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.9 t -75.37 97.59 3.65 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.545 -0.722 . . . . 0.0 110.248 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -32.01 -68.87 0.13 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.908 2.194 . . . . 0.0 115.062 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.13 -44.37 12.58 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.879 1.839 . . . . 0.0 110.8 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.4 m -47.22 -50.37 21.16 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.291 0.636 . . . . 0.0 109.998 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -46.26 -50.4 16.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.045 1.338 . . . . 0.0 111.618 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -90.15 -13.56 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 tp -85.62 -27.86 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.468 1.031 . . . . 0.0 109.561 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.55 -48.3 4.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -62.56 -36.98 61.56 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.56 2.173 . . . . 0.0 110.337 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 t -63.13 -51.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -50.77 -46.05 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.255 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.89 -62.17 1.88 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.617 0.367 . . . . 0.0 111.187 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.19 -30.16 68.0 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.02 0.827 . . . . 0.0 113.161 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -26.15 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 118.048 -1.461 . . . . 0.0 109.387 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.11 73.92 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.042 -1.036 . . . . 0.0 109.757 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.69 -42.36 95.39 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -57.65 -39.37 76.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.058 0.429 . . . . 0.0 109.955 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -78.86 53.76 1.44 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.637 -0.664 . . . . 0.0 112.456 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -62.09 -44.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.8 108.82 3.11 Favored 'General case' 0 N--CA 1.443 -0.812 1 N-CA-C 100.163 -4.014 . . . . 0.0 100.163 162.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -72.67 107.93 5.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.471 -2.15 . . . . 0.0 113.822 -153.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.13 121.98 37.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 108.879 -3.782 . . . . 0.0 105.828 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.89 149.74 32.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.08 138.56 53.71 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.12 165.37 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.006 0.522 . . . . 0.0 109.968 -176.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -132.13 111.9 11.85 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 110.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.86 116.12 28.74 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 124.796 1.238 . . . . 0.0 109.391 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -74.38 109.59 7.99 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -66.25 -33.11 75.02 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 111.289 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.71 -38.44 76.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.745 0.818 . . . . 0.0 110.179 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.96 -29.77 32.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.814 1.646 . . . . 0.0 111.598 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 t -124.27 55.65 10.22 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.571 1.548 . . . . 0.0 111.644 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -65.15 -29.34 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 124.377 3.385 . . . . 0.0 108.593 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -47.3 -69.33 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.6 t -54.5 -56.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.746 0.819 . . . . 0.0 109.928 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.23 -47.59 62.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -63.36 -49.89 72.09 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.816 -0.552 . . . . 0.0 109.849 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.07 -40.23 66.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.502 0.721 . . . . 0.0 110.642 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -78.96 -23.37 44.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.833 1.253 . . . . 0.0 111.814 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.3 28.69 19.27 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.561 1.077 . . . . 0.0 112.182 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -81.45 80.52 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -78.48 -3.19 42.22 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.761 -1.108 . . . . 0.0 112.288 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 m -155.96 157.34 36.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.5 pt -145.85 157.72 50.44 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.879 1.672 . . . . 0.0 106.637 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.79 147.02 87.06 Favored 'Cis proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.147 1.445 . . . . 0.0 113.329 1.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.7 m -156.72 120.41 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -97.06 116.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 125.354 1.462 . . . . 0.0 107.154 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.2 mtt -99.15 147.84 24.69 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.652 1.115 . . . . 0.0 108.696 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.56 105.45 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -89.47 124.04 34.13 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 4.69 18.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.758 0.823 . . . . 0.0 112.102 -175.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.91 100.46 0.36 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.1 -73.45 1.52 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-N 117.489 0.644 . . . . 0.0 111.874 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -102.12 172.64 6.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.981 0.912 . . . . 0.0 111.594 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -78.6 162.24 26.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.213 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.8 t -120.4 -66.61 1.04 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.675 1.19 . . . . 0.0 108.208 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -126.36 -169.16 1.97 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.27 1.028 . . . . 0.0 109.585 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -156.81 167.7 29.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.573 1.149 . . . . 0.0 108.069 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.88 133.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.1 mt -78.87 142.01 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.64 -157.12 7.51 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.039 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.8 54.62 9.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 109.95 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.42 158.04 74.18 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 125.633 1.573 . . . . 0.0 108.495 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.88 143.21 44.88 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 105.613 -2.495 . . . . 0.0 105.613 167.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.73 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.26 -56.41 8.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -55.22 -46.13 75.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.069 0.948 . . . . 0.0 110.605 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -49.09 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.05 -45.52 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.596 0.759 . . . . 0.0 109.543 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -42.93 87.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.488 1.04 . . . . 0.0 109.119 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.4 m -61.32 -46.77 88.92 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.438 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -48.75 78.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 O-C-N 121.829 -0.545 . . . . 0.0 109.709 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.03 -48.36 76.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -43.68 64.87 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.823 -0.548 . . . . 0.0 109.898 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.5 m-30 -70.88 -39.23 72.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.64 -84.84 0.2 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.886 0.875 . . . . 0.0 110.541 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.111 0 C-N-CA 127.595 2.358 . . . . 0.0 104.739 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 70.52 -70.49 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -168.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.49 142.34 51.9 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 165.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.24 -173.62 36.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.277 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.26 136.83 45.78 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.7 168.2 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 121.916 0.865 . . . . 0.0 109.459 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.75 175.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 106.27 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -47.33 -47.11 25.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.871 0.868 . . . . 0.0 112.156 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.39 -72.2 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.775 0.83 . . . . 0.0 110.714 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -52.57 -33.42 45.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.428 1.091 . . . . 0.0 112.422 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -41.48 -46.43 3.48 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.297 1.439 . . . . 0.0 110.199 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -56.47 -60.85 2.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.613 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -63.64 -31.63 72.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.516 0.726 . . . . 0.0 112.702 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.8 t -95.16 -48.1 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.277 0.631 . . . . 0.0 112.065 -171.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -94.22 -53.13 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.034 1.334 . . . . 0.0 111.713 -175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.02 -58.57 3.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.871 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.23 50.11 1.03 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.278 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 p -90.43 145.75 24.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.769 1.228 . . . . 0.0 112.218 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -93.44 -65.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -79.25 160.77 69.95 Favored Pre-proline 0 C--O 1.232 0.167 0 C-N-CA 124.608 1.163 . . . . 0.0 108.835 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -55.65 162.55 6.38 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.577 1.518 . . . . 0.0 110.692 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.63 144.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.878 1.671 . . . . 0.0 110.128 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 tt -124.91 100.81 6.77 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.427 1.891 . . . . 0.0 106.181 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.19 116.93 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -88.79 116.16 26.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -79.17 108.83 12.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -122.3 -169.15 1.84 Allowed 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 124.184 0.993 . . . . 0.0 111.017 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.02 150.8 2.02 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -57.61 -40.31 81.2 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.026 1.818 . . . . 0.0 111.291 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -67.06 -16.54 64.41 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.836 0.454 . . . . 0.0 111.585 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.1 t -74.69 85.01 2.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.227 -0.921 . . . . 0.0 111.176 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.71 -60.57 1.2 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.317 0.96 . . . . 0.0 113.563 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.48 -50.38 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.022 2.481 . . . . 0.0 112.61 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.06 -45.08 91.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -56.19 -50.29 71.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.556 1.143 . . . . 0.0 110.256 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.08 -37.85 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.437 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 pt -77.37 -25.29 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 120.083 1.31 . . . . 0.0 111.895 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.51 -47.56 4.69 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -62.22 -37.75 60.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.743 2.295 . . . . 0.0 110.484 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.96 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.5 -43.03 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -57.92 -66.14 0.52 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.1 0.409 . . . . 0.0 110.107 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -59.07 -29.52 67.38 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mm -50.8 -34.06 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.486 0.584 . . . . 0.0 109.983 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.4 74.85 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.525 1.057 . . . . 0.0 111.053 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.1 -24.61 76.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.57 -53.55 9.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 117.754 0.777 . . . . 0.0 108.911 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -79.78 58.66 2.88 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.71 -40.97 92.79 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 103.339 -2.837 . . . . 0.0 103.339 164.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.91 110.16 3.22 Favored 'General case' 0 N--CA 1.439 -1.018 1 N-CA-C 98.78 -4.526 . . . . 0.0 98.78 162.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -73.36 125.24 27.4 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 124.822 2.249 . . . . 0.0 115.586 -151.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.5 tp -134.55 120.4 19.61 Favored 'General case' 0 C--N 1.314 -0.962 1 CA-C-N 107.867 -4.242 . . . . 0.0 108.054 164.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.24 94.04 7.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.14 130.34 35.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.834 -0.541 . . . . 0.0 109.565 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.67 174.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.706 0.802 . . . . 0.0 111.934 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -144.08 113.45 6.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.014 1.325 . . . . 0.0 111.283 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.0 tt -98.9 125.62 44.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.849 0.833 . . . . 0.0 110.6 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -71.74 105.24 3.66 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.906 1.283 . . . . 0.0 113.874 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -81.21 45.84 0.88 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.859 -1.151 . . . . 0.0 111.027 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -152.09 -48.94 0.11 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -82.98 -19.04 37.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.737 2.015 . . . . 0.0 110.2 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -137.33 61.4 32.24 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.834 1.254 . . . . 0.0 111.915 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.8 -24.6 8.49 Favored 'Trans proline' 0 N--CA 1.446 -1.304 1 C-N-CA 125.492 4.128 . . . . 0.0 110.317 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -47.62 -68.69 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.765 1.226 . . . . 0.0 110.276 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.79 -43.3 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.094 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.72 70.06 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.249 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.2 m -70.13 -45.95 65.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.583 0.753 . . . . 0.0 109.713 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.18 -45.83 75.81 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.977 0.511 . . . . 0.0 110.749 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -79.43 -30.3 42.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.352 0.261 . . . . 0.0 111.534 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.17 54.39 2.15 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.9 mm -69.75 92.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.859 0.838 . . . . 0.0 108.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -78.04 82.12 4.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t 73.21 -175.81 0.16 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.357 1.863 . . . . 0.0 109.498 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.6 pt -145.38 157.06 53.33 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.22 . . . . 0.0 108.455 -177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.33 138.23 44.0 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 120.62 1.257 . . . . 0.0 111.85 1.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -134.63 98.25 4.01 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -89.53 109.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.2 mmt -97.16 143.57 27.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 64.4 t -114.13 133.51 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.15 161.21 31.6 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.91 77.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.951 0.405 . . . . 0.0 110.163 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.46 1.36 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.632 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.48 -56.52 3.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 123.836 0.732 . . . . 0.0 112.738 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -79.36 155.01 28.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 122.245 1.021 . . . . 0.0 111.893 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.12 130.47 36.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.649 1.979 . . . . 0.0 108.155 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.6 t -89.31 -57.99 2.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.269 1.028 . . . . 0.0 110.109 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.94 166.89 22.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.595 1.158 . . . . 0.0 111.869 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -142.25 126.15 17.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.251 2.22 . . . . 0.0 105.191 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -128.6 103.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -100.52 138.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.183 1.393 . . . . 0.0 109.555 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.81 156.15 21.94 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.953 0.787 . . . . 0.0 112.563 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.66 51.89 0.2 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.11 1.364 . . . . 0.0 113.148 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.91 148.77 69.18 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.81 156.06 64.19 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.356 1.37 . . . . 0.0 111.71 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.78 -46.04 29.99 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.894 1.277 . . . . 0.0 111.007 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.17 -41.89 3.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.776 0.831 . . . . 0.0 111.525 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.268 1.027 . . . . 0.0 109.153 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.47 -52.64 50.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 C-N-CA 124.431 1.092 . . . . 0.0 108.878 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.5 t -53.2 -58.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.783 1.233 . . . . 0.0 109.567 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.39 -50.11 68.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.449 -0.157 . . . . 0.0 110.911 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.2 m -60.4 -55.74 29.94 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.471 0.177 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -41.54 85.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 O-C-N 121.383 -0.823 . . . . 0.0 110.374 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -45.64 90.38 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -53.67 -42.2 67.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.856 -0.527 . . . . 0.0 109.781 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -73.12 -43.06 62.19 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -95.43 -88.52 0.26 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.934 1.294 . . . . 0.0 109.233 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.256 1.406 0 C-N-CA 127.743 2.417 . . . . 0.0 105.345 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 tpp . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -43.34 134.4 3.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.067 0.947 . . . . 0.0 110.579 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.31 157.88 34.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.291 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.85 -168.05 12.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.01 147.02 50.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.54 168.16 21.46 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 CA-C-O 122.038 0.923 . . . . 0.0 111.46 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.32 170.34 16.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.364 2.666 . . . . 0.0 105.93 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -39.93 -50.78 2.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.768 1.627 . . . . 0.0 110.964 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.95 -73.45 0.09 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.243 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 p -52.76 -36.43 57.88 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.274 1.03 . . . . 0.0 112.49 -174.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -40.02 -46.19 2.06 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.928 1.691 . . . . 0.0 110.841 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -49.78 -62.49 1.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.999 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.32 -39.84 71.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.284 0.634 . . . . 0.0 111.879 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.22 -40.01 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.953 -169.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.88 -60.21 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 123.892 0.877 . . . . 0.0 110.706 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -65.07 -68.15 0.38 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.626 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.98 34.98 0.2 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.862 0.865 . . . . 0.0 112.664 -171.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -91.21 143.49 26.6 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.993 0.917 . . . . 0.0 109.5 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.06 -60.91 2.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.4 1.08 . . . . 0.0 108.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.9 m -78.74 155.83 77.97 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -56.39 160.54 10.97 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.203 1.935 . . . . 0.0 114.351 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.23 118.56 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.536 1.134 . . . . 0.0 111.506 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.45 88.01 5.78 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 124.841 1.257 . . . . 0.0 109.593 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.22 133.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 O-C-N 121.157 -0.965 . . . . 0.0 109.259 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.54 121.49 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.924 0.89 . . . . 0.0 108.645 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -79.79 108.67 13.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -123.29 -173.72 2.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 122.275 1.035 . . . . 0.0 110.296 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 152.63 9.78 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.43 -44.97 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-N 120.542 1.229 . . . . 0.0 111.756 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.412 ' CH2' HD11 ' A' ' 74' ' ' ILE . 17.1 p-90 -56.12 -20.7 18.55 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.463 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.7 t -77.46 84.84 3.85 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.585 -0.697 . . . . 0.0 109.412 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.98 -57.94 1.96 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.586 1.089 . . . . 0.0 113.147 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.9 -25.33 69.1 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.089 1.86 . . . . 0.0 113.01 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.9 m -77.2 -50.67 12.43 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -49.14 -50.76 35.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.564 1.546 . . . . 0.0 111.41 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.2 pt -64.81 -39.84 87.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.467 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 pt -76.83 -26.69 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.563 1.074 . . . . 0.0 111.667 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -48.46 4.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.97 -38.03 60.93 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.357 2.038 . . . . 0.0 110.357 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.57 -39.74 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.5 t -52.77 -40.69 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.96 -58.5 4.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.701 0.4 . . . . 0.0 111.054 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.59 -47.59 81.72 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.683 -0.636 . . . . 0.0 111.996 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.97 -38.5 60.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.23 -43.42 98.91 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.421 -0.799 . . . . 0.0 109.301 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.02 -50.49 58.72 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.3 -53.37 44.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.527 0.663 . . . . 0.0 110.222 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -82.08 51.17 1.71 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.126 0.965 . . . . 0.0 112.015 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -41.6 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.935 2.494 . . . . 0.0 111.509 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.19 -54.43 46.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -78.13 -40.54 37.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.37 128.39 37.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 118.204 -1.398 . . . . 0.0 114.387 -152.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -83.11 163.14 21.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.1 t -142.72 145.8 33.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.57 168.42 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.577 -175.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -137.87 112.44 8.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.294 1.038 . . . . 0.0 108.702 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.7 tp -98.2 120.49 38.7 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.2 1.0 . . . . 0.0 109.725 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -73.23 109.99 7.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -67.49 -35.76 79.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.795 1.238 . . . . 0.0 111.086 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.51 -39.69 92.15 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -80.21 -33.52 38.08 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.877 1.671 . . . . 0.0 112.005 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.0 t -120.9 55.56 4.65 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.625 1.57 . . . . 0.0 111.937 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.34 -24.67 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.06 3.173 . . . . 0.0 110.598 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -54.15 -67.54 0.25 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.803 0.841 . . . . 0.0 109.773 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -53.21 -51.1 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 124.2 1.0 . . . . 0.0 109.202 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.47 -48.19 37.93 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.208 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -66.47 -46.65 75.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.018 0.527 . . . . 0.0 110.627 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.55 -45.5 77.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -79.43 -31.17 42.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.589 0.356 . . . . 0.0 111.488 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.59 43.94 3.04 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.655 0.645 . . . . 0.0 111.627 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mm -73.52 90.64 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -77.47 -20.53 54.27 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.3 m -156.18 165.01 37.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.412 HD11 ' CH2' ' A' ' 30' ' ' TRP . 26.7 pt -129.87 153.47 80.93 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.82 165.36 70.35 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.302 1.144 . . . . 0.0 111.954 0.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -156.74 113.55 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.77 115.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.9 mtt -111.56 134.84 52.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.58 115.77 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.79 162.48 15.21 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 0.0 109.619 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.41 151.55 9.75 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.71 1.204 . . . . 0.0 107.899 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.04 45.6 14.74 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.969 1.147 . . . . 0.0 115.969 170.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.06 0.31 60.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.94 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -129.94 159.38 36.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.737 1.769 . . . . 0.0 111.922 -176.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 138.59 31.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.81 1.644 . . . . 0.0 107.989 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.4 t -114.81 -82.25 0.61 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.003 0.921 . . . . 0.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -92.73 163.53 13.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.086 0.554 . . . . 0.0 110.866 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -157.5 122.61 4.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.773 1.229 . . . . 0.0 109.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.93 137.2 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.42 143.6 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 109.743 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.98 165.52 40.19 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 123.37 0.419 . . . . 0.0 112.328 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.63 131.17 45.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.308 0.643 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.3 153.77 41.25 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.8 138.97 27.01 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 104.714 -2.841 . . . . 0.0 104.714 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -56.14 -33.92 65.63 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.389 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.27 -37.3 7.11 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.542 1.064 . . . . 0.0 112.237 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.6 m -70.78 -41.68 71.36 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.499 -0.751 . . . . 0.0 109.302 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.0 mt -61.71 -44.23 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -54.36 -55.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -52.64 -43.5 65.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.966 0.348 . . . . 0.0 110.787 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -59.09 -40.2 84.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.33 -50.74 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.084 -1.01 . . . . 0.0 108.971 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -51.61 -47.48 63.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.047 0.939 . . . . 0.0 112.873 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -25.69 60.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -90.37 -52.69 4.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.44 0.564 . . . . 0.0 109.704 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -112.93 -92.0 0.49 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.4 1.08 . . . . 0.0 109.834 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.207 0 C-N-CA 128.523 2.729 . . . . 0.0 103.862 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tpt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.61 -43.49 84.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.88 135.74 37.94 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 170.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.41 -179.01 51.49 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.43 137.62 54.81 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.89 164.98 32.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 122.299 1.047 . . . . 0.0 111.379 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -144.11 168.74 19.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.853 2.061 . . . . 0.0 105.731 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -39.63 -45.67 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.31 -70.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.432 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -59.57 -33.47 71.48 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.475 1.11 . . . . 0.0 112.336 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -42.17 -46.67 4.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 126.778 2.031 . . . . 0.0 111.265 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -47.45 -48.41 26.65 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.753 1.221 . . . . 0.0 110.651 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -82.33 -63.1 1.45 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.061 0.934 . . . . 0.0 111.268 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.97 -31.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.889 -169.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.21 -59.81 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.004 0.522 . . . . 0.0 111.865 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.38 -71.03 0.26 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.464 0.575 . . . . 0.0 110.041 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.88 48.41 0.83 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.723 0.809 . . . . 0.0 111.212 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 p -90.38 148.37 22.86 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.653 1.581 . . . . 0.0 109.129 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -83.62 -68.03 0.74 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 m -79.49 158.95 73.11 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.274 1.03 . . . . 0.0 108.66 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.12 164.9 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.486 2.124 . . . . 0.0 113.082 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.81 148.95 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.902 2.081 . . . . 0.0 109.207 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -131.68 105.56 7.6 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.19 122.91 52.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.618 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -97.73 117.69 32.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.52 112.13 16.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -126.14 -176.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.202 1.001 . . . . 0.0 110.335 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.89 148.29 3.13 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -53.21 -45.27 42.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.164 . . . . 0.0 112.513 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -67.07 -20.62 65.85 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.776 -0.578 . . . . 0.0 111.898 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.04 85.09 2.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.117 0.871 . . . . 0.0 110.404 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -34.45 -62.96 0.48 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.492 1.52 . . . . 0.0 114.374 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.57 -43.48 50.52 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 119.633 1.716 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.8 m -59.73 -45.37 92.4 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -55.22 -53.64 53.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.787 1.235 . . . . 0.0 110.542 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 pt -69.71 -29.71 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.36 -0.353 . . . . 0.0 111.397 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.1 mt -74.27 -35.32 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.253 0.621 . . . . 0.0 111.471 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.51 -48.03 6.68 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -61.72 -36.71 73.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.483 2.122 . . . . 0.0 109.75 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.77 -45.11 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.75 -43.75 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -66.05 -48.84 69.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.859 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.93 -41.08 99.37 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.829 -1.169 . . . . 0.0 109.65 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.6 mt -56.82 -44.44 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.68 -50.34 68.48 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.41 -45.21 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.93 -46.58 81.04 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -111.91 23.76 13.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -56.16 168.59 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.916 1.286 . . . . 0.0 112.317 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 71.3 -52.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 127.657 2.383 . . . . 0.0 111.199 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -80.19 -50.22 10.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.249 0.547 . . . . 0.0 110.094 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -102.0 106.4 17.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.652 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -78.66 90.04 4.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 49.1 t -78.32 137.9 38.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.53 163.09 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 123.161 0.585 . . . . 0.0 110.12 -175.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -127.57 115.21 18.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.483 1.113 . . . . 0.0 109.614 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tp -91.49 119.06 31.12 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.271 0.628 . . . . 0.0 109.562 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.17 107.1 6.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -67.99 -35.98 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.198 1.399 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.59 -38.82 92.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.701 1.201 . . . . 0.0 109.871 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.5 -25.08 33.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.719 2.008 . . . . 0.0 111.036 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 m -121.46 53.61 3.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 113.93 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.11 -25.82 73.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.061 3.174 . . . . 0.0 109.367 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -50.85 -70.38 0.09 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.896 1.279 . . . . 0.0 109.68 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.8 t -51.41 -50.63 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.059 1.344 . . . . 0.0 109.184 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.82 -47.88 51.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.251 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 m -72.15 -43.35 64.78 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.92 0.888 . . . . 0.0 111.236 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.91 -48.34 70.25 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.286 0.635 . . . . 0.0 110.03 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -79.55 -35.63 39.55 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.21 53.41 9.09 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 pt -57.31 142.11 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.497 1.119 . . . . 0.0 111.775 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -79.91 70.26 6.43 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.0 t 64.52 -160.15 0.29 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -139.51 150.23 62.89 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.78 143.29 73.5 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.985 1.03 . . . . 0.0 113.798 3.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m -140.44 110.04 6.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.82 134.15 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.1 mtt -124.86 128.44 48.67 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.657 1.183 . . . . 0.0 108.881 176.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.77 131.58 45.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -119.94 134.23 55.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 173.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.49 25.48 10.17 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.109 0.964 . . . . 0.0 110.597 -178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.21 123.26 5.22 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.43 -64.99 3.15 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.885 0.842 . . . . 0.0 113.376 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -126.22 172.73 9.82 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.244 1.018 . . . . 0.0 111.93 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -67.46 164.86 17.86 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.179 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -128.7 -57.37 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.815 1.646 . . . . 0.0 108.813 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -140.11 171.29 14.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.565 1.546 . . . . 0.0 109.729 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -160.08 147.83 16.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.5 150.4 33.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.08 144.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.62 162.41 37.85 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.603 0.557 . . . . 0.0 112.565 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.76 131.26 38.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.553 0.741 . . . . 0.0 110.534 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.37 149.5 48.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.05 155.48 33.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.676 2.251 . . . . 0.0 114.003 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -46.03 -52.47 11.82 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.404 1.482 . . . . 0.0 109.771 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.83 -45.85 50.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.281 0.633 . . . . 0.0 110.612 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -49.19 68.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -53.04 -58.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.9 t -52.42 -55.5 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 110.318 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.09 -47.43 78.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.506 0.594 . . . . 0.0 110.967 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.3 m -59.87 -42.27 93.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.96 0.504 . . . . 0.0 110.575 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.19 -57.18 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -45.32 -58.54 3.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.933 1.293 . . . . 0.0 111.342 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -18.59 25.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -80.51 -23.66 39.93 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 120.013 1.279 . . . . 0.0 110.722 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.0 mt -98.86 -43.24 6.82 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.271 1.428 . . . . 0.0 111.863 -177.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 117.297 -1.335 . . . . 0.0 109.853 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -122.19 -44.88 2.26 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.611 0.764 . . . . 0.0 110.839 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.14 122.93 17.79 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.02 166.79 52.12 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.907 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.51 119.65 37.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.56 161.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.734 0.813 . . . . 0.0 109.671 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -138.04 171.7 14.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -39.82 -45.46 1.79 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.001 1.32 . . . . 0.0 111.468 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.68 -77.76 0.06 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.253 0.621 . . . . 0.0 110.974 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.7 p -46.69 -38.65 10.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.133 1.373 . . . . 0.0 112.744 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -39.71 -46.39 1.86 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.522 1.529 . . . . 0.0 110.819 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -48.76 -56.79 7.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.519 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.34 -33.57 49.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.871 -0.518 . . . . 0.0 112.017 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.4 t -92.5 -26.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -169.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.91 -51.25 4.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 124.747 1.219 . . . . 0.0 111.519 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.63 -61.86 1.69 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -77.51 33.22 0.16 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.932 . . . . 0.0 112.1 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 m -91.09 132.65 35.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.42 1.088 . . . . 0.0 111.133 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 p -78.79 -53.29 7.27 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.711 1.604 . . . . 0.0 107.158 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.94 152.56 79.91 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.02 166.61 29.09 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 N-CA-C 108.658 -1.324 . . . . 0.0 108.658 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.488 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -152.48 134.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.423 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 tt -99.06 115.35 28.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.987 1.715 . . . . 0.0 108.864 -176.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.0 t -100.91 114.16 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.72 116.51 24.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -78.64 110.77 14.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 9.0 p-90 -124.17 -172.71 2.6 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.792 0.806 . . . . 0.0 112.111 -172.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.42 151.84 2.55 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 125.239 1.416 . . . . 0.0 107.426 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.55 -42.11 35.5 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.552 2.168 . . . . 0.0 110.044 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.405 ' CH2' HD12 ' A' ' 74' ' ' ILE . 34.6 p-90 -67.35 -17.32 64.7 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.355 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.9 t -80.02 87.52 5.41 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.208 -0.933 . . . . 0.0 110.794 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.49 -61.63 1.49 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.521 1.058 . . . . 0.0 113.712 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.73 -19.94 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.096 1.864 . . . . 0.0 113.21 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.0 m -82.75 -50.79 8.31 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -50.2 -47.4 54.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.567 1.547 . . . . 0.0 110.832 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.21 -18.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.929 -0.558 . . . . 0.0 112.415 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -88.74 -28.32 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.464 1.029 . . . . 0.0 110.052 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.08 -47.31 3.83 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.704 1.602 . . . . 0.0 113.266 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.25 -38.26 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.948 1.766 . . . . 0.0 110.884 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.4 t -69.75 -57.4 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.707 1.203 . . . . 0.0 109.452 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 p -54.02 -42.86 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.96 -56.24 23.45 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.59 -0.693 . . . . 0.0 112.427 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.38 -41.39 89.24 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 122.008 -0.433 . . . . 0.0 110.435 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -55.67 -44.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.34 -53.6 54.09 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -44.65 -44.43 8.38 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.249 0.452 . . . . 0.0 112.422 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.76 -41.84 96.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -121.92 9.76 10.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -39.85 -41.4 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.008 2.123 . . . . 0.0 113.752 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.84 -40.7 2.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.46 1.904 . . . . 0.0 112.991 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -132.47 -54.26 0.95 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.6 tp -83.44 170.83 14.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.488 ' CB ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.36 93.75 2.96 Favored 'General case' 0 N--CA 1.433 -1.323 2 N-CA-C 122.993 4.442 . . . . 0.0 122.993 -164.05 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 11.1 t -151.2 122.2 7.65 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 118.96 -2.338 . . . . 0.0 114.794 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.08 165.68 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.599 1.16 . . . . 0.0 110.202 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 27' ' ' TRP . 7.4 mtmp? -132.73 122.81 25.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.732 1.213 . . . . 0.0 111.576 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -104.82 120.51 41.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.829 0.823 . . . . 0.0 110.21 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -69.45 109.51 4.26 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 124.775 1.23 . . . . 0.0 113.42 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -82.61 47.59 1.2 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 0.0 110.347 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.19 -46.59 0.1 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.43 -23.01 35.04 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.669 1.988 . . . . 0.0 109.705 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.47 53.24 5.65 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 112.542 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.55 -38.78 7.76 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.88 3.72 . . . . 0.0 109.493 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -49.46 -67.31 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.892 1.277 . . . . 0.0 110.528 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.09 -45.53 88.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.93 -39.77 66.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.059 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -72.73 -41.55 65.06 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 124.144 0.978 . . . . 0.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -55.39 -43.23 75.02 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.09 -32.29 44.61 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.89 35.24 6.86 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.12 1.343 . . . . 0.0 111.622 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.5 mt -80.84 62.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.329 1.452 . . . . 0.0 109.37 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -81.59 57.73 3.45 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.551 -0.718 . . . . 0.0 110.355 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 163.3 150.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.963 2.505 . . . . 0.0 107.585 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.405 HD12 ' CH2' ' A' ' 30' ' ' TRP . 13.3 pt -152.85 155.24 32.13 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.12 134.53 28.6 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.362 1.165 . . . . 0.0 112.857 1.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 m -132.8 106.21 7.6 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mt -94.75 130.51 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.138 1.375 . . . . 0.0 107.698 -177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.5 mtt -130.62 152.22 50.22 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.46 141.35 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.22 167.28 20.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 110.623 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.65 152.2 3.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.746 2.018 . . . . 0.0 106.712 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.21 41.25 8.07 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.484 1.038 . . . . 0.0 115.675 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.5 11.49 68.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.103 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -138.38 167.85 21.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.441 1.62 . . . . 0.0 110.421 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.44 160.2 25.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.546 0.738 . . . . 0.0 110.139 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.3 t -115.94 -53.7 2.54 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 125.569 1.548 . . . . 0.0 109.455 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 -177.0 5.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.724 1.21 . . . . 0.0 108.834 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.9 t -158.35 151.8 23.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 0.0 109.48 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.3 mm -135.84 155.88 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 127.549 2.34 . . . . 0.0 105.55 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.1 mt -138.95 145.48 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.01 155.13 20.75 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.46 135.58 45.76 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.65 152.31 68.22 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.63 160.09 47.28 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.007 1.805 . . . . 0.0 112.409 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -43.41 -51.34 6.57 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 126.136 1.774 . . . . 0.0 111.276 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.95 -45.93 60.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.847 0.459 . . . . 0.0 110.948 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 m -66.28 -48.02 71.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.1 mt -55.72 -55.52 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.34 -51.84 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.496 0.718 . . . . 0.0 110.147 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.81 -46.86 81.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.996 0.816 . . . . 0.0 110.445 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.1 m -57.31 -43.32 83.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.294 0.638 . . . . 0.0 109.782 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 t -62.98 -58.91 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.996 0.816 . . . . 0.0 109.213 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -44.16 -51.89 7.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.835 1.254 . . . . 0.0 112.289 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -26.28 30.19 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -80.59 -14.68 57.98 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.379 -0.825 . . . . 0.0 111.328 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.47 -43.5 5.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.237 1.415 . . . . 0.0 110.216 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.184 0 CA-C-O 117.079 -1.439 . . . . 0.0 109.911 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.51 170.13 14.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.21 148.78 35.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.41 111.6 4.1 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 112.2 -0.36 . . . . 0.0 112.2 -177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.65 115.5 19.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.55 165.07 12.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.282 1.039 . . . . 0.0 111.361 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -138.2 170.89 15.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.451 2.3 . . . . 0.0 106.408 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -38.81 -52.86 1.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.219 1.808 . . . . 0.0 111.428 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.69 -73.34 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.567 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -52.28 -38.12 57.44 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.511 1.125 . . . . 0.0 111.769 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -42.91 -45.08 4.84 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.313 1.845 . . . . 0.0 111.356 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -55.55 -51.95 65.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.856 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.11 -50.43 16.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.306 0.574 . . . . 0.0 111.655 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -74.57 -39.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.747 1.219 . . . . 0.0 112.825 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -107.38 -54.67 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 112.763 -170.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -64.53 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.81 49.61 0.78 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 110.432 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -84.13 121.91 28.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.565 1.546 . . . . 0.0 111.373 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.3 p -79.77 -61.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.88 153.88 80.5 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.78 149.86 67.31 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.517 -0.993 . . . . 0.0 109.517 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.455 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -149.96 127.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.38 121.15 30.46 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.29 114.97 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 171.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -99.31 136.83 38.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -87.85 111.9 21.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -117.63 -174.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.66 5.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -56.69 -39.59 90.27 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -70.52 -16.11 62.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.158 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.3 t -73.61 102.3 3.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.216 1.371 . . . . 0.0 111.408 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.8 -62.36 3.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.034 1.302 . . . . 0.0 114.018 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.64 -42.62 35.73 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.137 2.558 . . . . 0.0 111.674 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.7 m -63.14 -50.31 70.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -55.42 -49.76 71.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.134 -0.354 . . . . 0.0 111.098 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.24 -32.9 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.066 -0.969 . . . . 0.0 111.844 -175.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.8 pt -80.51 -28.62 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.646 1.567 . . . . 0.0 111.42 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.54 -49.39 5.13 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.12 -37.34 75.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.983 1.789 . . . . 0.0 110.043 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.56 -44.48 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 108.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.2 t -53.14 -53.28 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.85 -49.3 78.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.769 -0.582 . . . . 0.0 112.184 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.06 -43.63 95.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.968 0.804 . . . . 0.0 109.493 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.1 -41.44 80.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -48.64 76.35 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.27 -44.28 57.77 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -58.52 -53.94 52.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.591 1.195 . . . . 0.0 110.409 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CG ' ' HB3' ' A' ' 52' ' ' LEU . 60.3 m-85 -82.98 53.57 2.47 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.0 -21.59 66.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.861 1.665 . . . . 0.0 108.227 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.16 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 168.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.445 ' CE ' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -161.17 110.41 1.61 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 164.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.429 ' HB3' ' CG ' ' A' ' 48' ' ' TYR . 7.1 tp -151.02 -177.35 5.96 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 116.858 -1.937 . . . . 0.0 112.067 159.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.455 ' CA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.29 66.26 1.73 Allowed 'General case' 0 N--CA 1.419 -1.996 2 N-CA-C 123.845 4.757 . . . . 0.0 123.845 -157.341 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.32 109.75 9.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 117.742 -1.583 . . . . 0.0 113.81 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.43 163.43 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.464 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -153.76 121.54 5.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.005 0.431 . . . . 0.0 110.256 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.13 118.91 29.18 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.821 0.849 . . . . 0.0 110.243 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -72.49 105.64 4.25 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -69.51 -31.72 70.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.797 1.239 . . . . 0.0 111.567 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.1 -39.2 89.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.931 0.893 . . . . 0.0 109.483 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -86.76 -26.08 24.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.734 2.013 . . . . 0.0 111.722 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.6 t -126.21 55.96 14.9 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.571 1.548 . . . . 0.0 112.463 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.62 -31.2 70.42 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.508 2.805 . . . . 0.0 108.056 174.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -40.78 -75.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.485 1.914 . . . . 0.0 111.715 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.88 -48.14 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.849 1.26 . . . . 0.0 110.266 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.64 -41.26 69.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.731 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.0 m -72.27 -42.89 65.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 110.389 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -56.04 -42.18 76.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.677 0.391 . . . . 0.0 110.085 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.41 -36.38 45.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.15 45.64 3.01 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.36 0.981 . . . . 0.0 111.219 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.82 130.07 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -79.09 -38.8 35.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 t -163.62 -173.53 3.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 pt -129.42 156.27 78.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 124.558 1.143 . . . . 0.0 109.267 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.99 157.66 82.64 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.127 1.081 . . . . 0.0 112.621 2.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 m -160.99 142.32 11.81 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-O 122.213 1.006 . . . . 0.0 109.679 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HB ' ' N ' ' A' ' 89' ' ' ILE 0.607 0.8 OUTLIER -75.2 13.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 2 N-CA-C 138.996 10.369 . . . . 0.0 138.996 -160.967 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 65.1 mtt -80.87 128.61 33.86 Favored 'General case' 0 C--N 1.318 -0.801 1 CA-C-N 126.526 4.239 . . . . 0.0 114.708 -162.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.6 137.04 33.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -129.29 160.62 32.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.093 0.957 . . . . 0.0 109.744 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.16 167.81 6.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.576 1.95 . . . . 0.0 105.916 172.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 51.34 34.12 32.99 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.81 9.9 66.73 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 117.88 -1.511 . . . . 0.0 115.409 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -147.81 169.14 20.42 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.469 2.134 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.69 149.4 50.06 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 127.765 2.426 . . . . 0.0 109.993 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.59 -80.17 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.028 0.531 . . . . 0.0 111.58 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.59 175.36 7.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.961 0.8 . . . . 0.0 111.49 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.5 p -143.16 116.01 8.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.433 1.093 . . . . 0.0 111.389 -175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.439 ' N ' ' HB ' ' A' ' 77' ' ' ILE . 23.5 mt -118.88 122.57 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.43 1.492 . . . . 0.0 112.934 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.5 mt -84.25 155.95 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 119.327 -2.108 . . . . 0.0 106.32 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.5 -158.33 7.12 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.35 -16.61 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.62 152.84 80.95 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 120.081 1.31 . . . . 0.0 108.883 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.32 131.73 21.03 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 105.172 -2.665 . . . . 0.0 105.172 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -57.89 -29.12 64.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.21 -38.65 18.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.387 0.994 . . . . 0.0 110.474 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -60.01 -51.92 67.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.609 1.164 . . . . 0.0 109.076 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.72 -49.07 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.352 1.461 . . . . 0.0 110.474 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -52.3 -55.25 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -57.91 -50.14 74.35 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.177 -0.327 . . . . 0.0 110.83 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.2 m -55.61 -41.26 73.21 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.116 0.567 . . . . 0.0 111.567 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.72 -45.24 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.888 0.767 . . . . 0.0 110.513 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -54.55 -35.02 62.8 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.422 0.689 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -44.9 -50.99 10.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.462 0.648 . . . . 0.0 109.465 171.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -81.43 50.18 1.42 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.111 0.964 . . . . 0.0 110.923 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.6 mt -156.16 102.7 2.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.065 1.746 . . . . 0.0 106.64 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.291 0 C-N-CA 128.222 2.609 . . . . 0.0 104.37 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 tpp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -78.9 162.36 26.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.919 0.888 . . . . 0.0 109.265 176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.79 67.48 1.19 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.226 0.61 . . . . 0.0 111.198 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.82 140.73 38.82 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.67 92.36 5.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -81.79 161.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.589 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -160.0 -178.95 7.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -38.27 -56.53 1.21 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.0 1.72 . . . . 0.0 112.888 -170.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.05 -71.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.203 0.601 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 p -49.6 -43.41 46.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.891 1.276 . . . . 0.0 111.695 -175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -39.94 -50.85 2.51 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.266 1.826 . . . . 0.0 112.248 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -49.7 -50.45 43.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.947 0.899 . . . . 0.0 111.405 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -79.61 -56.89 3.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.939 0.895 . . . . 0.0 112.058 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.26 -32.05 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 125.449 1.5 . . . . 0.0 113.073 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.29 -52.38 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.133 0.573 . . . . 0.0 112.432 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -73.6 -73.01 0.23 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.631 0.651 . . . . 0.0 111.293 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -79.62 47.09 0.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.206 0.602 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 m -90.42 151.35 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.566 1.147 . . . . 0.0 109.442 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -78.85 -57.06 3.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -78.42 150.98 77.39 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.52 162.61 39.57 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.491 1.461 . . . . 0.0 109.217 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -150.16 134.39 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.186 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -95.12 99.09 11.13 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 126.229 1.812 . . . . 0.0 108.125 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 p -94.9 125.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -94.32 121.51 35.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.54 108.17 12.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -124.35 -172.88 2.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.787 0.803 . . . . 0.0 110.913 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.48 152.26 3.2 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.25 -40.07 78.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.134 1.889 . . . . 0.0 112.455 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -73.2 -12.17 60.78 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.4 t -73.83 86.65 1.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.084 -1.01 . . . . 0.0 110.84 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -31.74 -66.5 0.17 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.299 1.428 . . . . 0.0 115.284 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -59.46 -45.27 27.19 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.001 1.8 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.5 m -56.4 -46.09 80.32 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -57.02 -50.92 71.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.17 1.388 . . . . 0.0 110.329 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.9 pt -68.36 -36.92 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.408 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.82 -25.47 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 120.178 1.354 . . . . 0.0 111.444 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -38.99 -45.81 3.14 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -64.6 -38.19 33.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.855 2.37 . . . . 0.0 110.241 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -39.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.682 1.593 . . . . 0.0 108.522 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.6 t -58.86 -50.93 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -58.92 -52.07 67.33 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.179 0.592 . . . . 0.0 111.865 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.45 -41.63 94.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.12 0.873 . . . . 0.0 110.469 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.14 -44.03 97.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.62 75.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.59 44.52 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -49.11 -54.38 16.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.421 0.688 . . . . 0.0 111.346 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.66 33.66 3.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -51.8 -45.45 63.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -33.35 -50.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.897 2.879 . . . . 0.0 113.401 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -149.88 -58.89 0.2 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.487 1.115 . . . . 0.0 113.5 -170.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 tp -78.59 179.14 7.28 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -155.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' CB ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.23 92.06 2.7 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 123.196 4.517 . . . . 0.0 123.196 -157.097 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 39.6 t -152.97 120.98 6.14 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 119.949 -1.719 . . . . 0.0 112.584 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.59 171.98 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.711 0.804 . . . . 0.0 110.515 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -143.5 114.3 7.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.5 118.45 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.764 0.711 . . . . 0.0 110.195 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.11 106.49 5.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.9 m -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.667 1.587 . . . . 0.0 111.456 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -34.08 77.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.181 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -87.05 -15.37 38.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 110.972 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -138.53 64.34 37.15 Favored Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 120.239 -1.538 . . . . 0.0 112.687 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.75 -26.91 32.25 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.173 3.249 . . . . 0.0 108.582 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -47.37 -70.51 0.09 Allowed 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 125.535 1.534 . . . . 0.0 110.611 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.22 -49.97 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 125.541 1.536 . . . . 0.0 109.481 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.48 -45.79 69.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.524 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.2 m -68.92 -41.57 77.99 Favored 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 123.739 0.815 . . . . 0.0 111.014 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.03 -42.2 76.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.183 0.593 . . . . 0.0 109.724 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.67 -32.92 47.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.15 36.23 5.78 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.261 0.934 . . . . 0.0 110.797 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -74.45 107.72 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -77.73 -27.34 50.51 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.838 0.455 . . . . 0.0 110.923 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -155.34 159.04 39.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.6 pt -115.02 156.86 44.7 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.59 161.73 81.88 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 120.608 1.253 . . . . 0.0 114.175 3.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.9 m -160.63 124.86 3.6 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.82 106.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.665 1.186 . . . . 0.0 108.327 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.7 mtt -103.85 132.01 50.51 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.737 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.1 t -100.71 110.53 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -92.98 143.86 25.82 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 50.61 1.83 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.45 77.98 1.3 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.79 -61.82 2.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.94 0.781 . . . . 0.0 112.201 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.08 163.07 22.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.962 0.905 . . . . 0.0 111.058 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -89.4 151.24 22.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.94 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -109.17 -57.12 2.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.623 . . . . 0.0 107.765 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -124.36 159.48 30.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.798 1.239 . . . . 0.0 109.367 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.1 m -152.4 93.34 1.78 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -103.82 146.87 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.229 1.412 . . . . 0.0 108.46 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.01 151.45 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.32 -158.48 5.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.52 46.56 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.951 0.9 . . . . 0.0 110.504 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.05 153.18 80.27 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.16 139.22 35.01 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 N-CA-C 105.4 -2.577 . . . . 0.0 105.4 170.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -67.11 -19.67 65.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 118.773 -1.171 . . . . 0.0 109.918 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.23 -49.9 68.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.801 1.182 . . . . 0.0 109.221 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -55.86 -48.11 76.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.518 1.127 . . . . 0.0 109.687 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.67 -49.02 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.018 0.527 . . . . 0.0 109.81 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.88 -56.82 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -51.79 -45.65 63.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.369 0.531 . . . . 0.0 110.793 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.2 m -60.41 -33.07 71.98 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.589 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.6 t -76.75 -47.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 120.408 1.458 . . . . 0.0 109.988 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -49.35 -45.04 45.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.079 0.952 . . . . 0.0 111.063 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -53.86 -27.67 31.41 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -98.82 -12.31 20.96 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.131 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -157.39 87.26 0.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.642 0.656 . . . . 0.0 109.889 -170.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.283 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 tpp . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 71.71 -63.03 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 -166.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.59 128.93 37.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 167.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.25 175.46 54.66 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.83 136.13 54.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.93 164.36 30.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 122.346 1.07 . . . . 0.0 112.775 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.9 170.26 16.04 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 128.033 2.533 . . . . 0.0 104.433 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -39.12 -46.87 1.49 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.281 1.832 . . . . 0.0 112.735 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.13 -66.28 0.43 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.33 1.052 . . . . 0.0 111.723 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -67.21 -41.59 85.51 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.711 1.204 . . . . 0.0 111.641 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -39.52 -47.84 1.94 Allowed 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 127.524 2.33 . . . . 0.0 110.996 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -41.62 -66.67 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.006 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -42.96 65.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 111.364 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.0 t -73.51 -18.39 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.121 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.15 -51.18 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.333 1.053 . . . . 0.0 112.272 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.71 -70.86 0.43 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.121 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.01 40.22 0.4 Allowed 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.973 -1.08 . . . . 0.0 112.22 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 m -91.12 137.87 32.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.734 1.213 . . . . 0.0 110.645 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 p -78.78 -55.62 5.02 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.404 1.482 . . . . 0.0 108.66 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.93 156.38 79.82 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.59 167.17 19.71 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 N-CA-C 108.871 -1.242 . . . . 0.0 108.871 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -136.7 144.77 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 126.595 1.958 . . . . 0.0 109.21 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -124.69 98.37 5.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 106.494 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.31 120.29 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.183 0.901 . . . . 0.0 110.323 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -90.93 117.21 29.35 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.743 0.817 . . . . 0.0 109.143 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.45 108.67 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -127.41 -174.75 3.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 121.717 0.77 . . . . 0.0 111.075 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.62 149.01 4.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.91 -44.05 52.64 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.526 2.151 . . . . 0.0 112.448 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.5 p-90 -68.83 -18.33 64.15 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.146 -0.346 . . . . 0.0 111.823 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 37.9 t -77.89 85.14 4.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -177.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.21 -60.24 1.38 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.649 1.119 . . . . 0.0 114.088 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.12 -17.24 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.84 1.82 . . . . 0.0 112.509 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -81.43 -48.11 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.07 -49.93 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.308 1.443 . . . . 0.0 110.244 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 pt -63.19 -36.52 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.275 -0.869 . . . . 0.0 112.393 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.1 pt -80.04 -25.32 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.741 1.155 . . . . 0.0 111.401 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.87 -48.27 5.55 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 120.071 1.305 . . . . 0.0 114.497 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.72 -39.37 53.71 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.974 2.449 . . . . 0.0 110.026 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -47.07 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.02 -42.56 90.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.06 -56.28 24.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.02 0.528 . . . . 0.0 110.37 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -62.84 -37.84 88.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.917 -1.114 . . . . 0.0 111.108 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.21 -45.79 67.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.1 -51.89 66.26 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -46.18 -42.52 12.64 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 112.199 -0.361 . . . . 0.0 112.199 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -71.61 -54.54 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.675 0.738 . . . . 0.0 112.351 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -92.47 9.03 36.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -45.33 148.94 0.57 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.318 1.447 . . . . 0.0 111.831 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.1 t70 74.61 -50.09 0.67 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.626 1.97 . . . . 0.0 111.569 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -77.56 -29.02 51.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.73 1.212 . . . . 0.0 111.141 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.76 121.42 13.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.136 1.374 . . . . 0.0 108.319 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -79.45 94.12 5.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -79.45 133.34 36.53 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.279 -0.888 . . . . 0.0 108.978 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.84 168.54 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.301 0.572 . . . . 0.0 112.053 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -134.56 111.1 9.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.341 1.456 . . . . 0.0 109.517 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tt -89.56 118.51 29.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.764 0.792 . . . . 0.0 109.966 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -71.93 100.2 2.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 109.208 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 m -85.36 52.82 2.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.753 1.621 . . . . 0.0 110.081 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -148.28 -46.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -79.93 -25.44 40.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.528 2.331 . . . . 0.0 110.062 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 t -132.58 55.47 17.72 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.06 -23.59 29.25 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.994 3.796 . . . . 0.0 109.264 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -44.55 -58.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.784 1.634 . . . . 0.0 109.211 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.32 -53.25 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.027 0.931 . . . . 0.0 109.967 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.51 -40.32 62.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.975 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 m -69.79 -47.73 61.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.058 0.943 . . . . 0.0 110.567 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.55 -44.68 77.0 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.927 . . . . 0.0 110.437 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.01 -31.93 44.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.83 50.19 3.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.16 139.36 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 109.554 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -41.21 29.02 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.967 0.507 . . . . 0.0 111.403 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -167.11 -170.94 1.63 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.6 pt -130.32 152.65 80.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 124.774 1.23 . . . . 0.0 108.384 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.39 157.04 99.45 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.95 1.018 . . . . 0.0 113.478 2.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -160.15 114.43 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.8 mt -97.38 107.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.9 mtt -97.43 142.62 29.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.108 0.867 . . . . 0.0 109.0 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.22 129.56 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -132.92 162.11 32.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.862 0.865 . . . . 0.0 110.663 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.64 152.94 3.95 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.012 1.325 . . . . 0.0 108.151 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.47 44.8 11.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.55 8.17 70.85 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.837 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -138.39 163.05 32.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.597 1.698 . . . . 0.0 111.031 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -90.17 148.29 23.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.5 t -100.07 -60.69 1.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.266 1.027 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.47 -168.5 1.53 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.013 1.725 . . . . 0.0 107.159 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -150.95 172.16 16.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.599 0.76 . . . . 0.0 109.056 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.29 142.04 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.564 1.546 . . . . 0.0 106.835 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.9 mt -79.71 140.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -145.7 4.06 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.48 38.7 28.67 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.793 0.796 . . . . 0.0 111.232 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.22 157.55 60.8 Favored Pre-proline 0 C--N 1.341 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 111.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -70.5 140.07 39.08 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 163.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -58.0 -25.15 60.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.799 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.3 -44.66 34.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.156 0.889 . . . . 0.0 109.918 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -50.49 73.42 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.467 1.107 . . . . 0.0 109.53 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -52.38 50.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.869 0.868 . . . . 0.0 109.783 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.2 t -53.57 -58.88 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.653 0.661 . . . . 0.0 109.806 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -52.32 -53.07 49.02 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.6 m -53.71 -47.6 70.38 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.156 0.285 . . . . 0.0 111.64 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.63 -50.0 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.543 0.737 . . . . 0.0 109.279 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -57.6 -44.88 85.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.86 -51.5 60.81 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.055 0.942 . . . . 0.0 109.337 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -67.87 -45.18 75.29 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.277 -0.265 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.94 71.25 10.94 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 123.164 1.459 . . . . 0.0 109.361 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-N 111.479 -2.601 . . . . 0.0 107.485 179.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -61.95 -44.56 96.51 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.1 125.03 28.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.08 163.23 54.05 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.24 44.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.42 162.37 14.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 122.136 0.97 . . . . 0.0 110.572 -178.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -140.61 168.42 19.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.469 2.308 . . . . 0.0 105.778 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -39.87 -49.29 2.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.444 1.497 . . . . 0.0 110.787 176.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.74 -66.8 0.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.436 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -66.16 -41.38 90.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.436 1.095 . . . . 0.0 112.229 -174.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -38.93 -47.51 1.45 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 128.201 2.6 . . . . 0.0 111.237 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -44.41 -59.66 2.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.537 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.12 -46.04 18.81 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.884 0.849 . . . . 0.0 110.844 -176.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.0 -34.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.031 -168.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.29 -59.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.445 1.098 . . . . 0.0 111.657 -172.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.63 -68.02 0.37 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -175.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -79.61 41.69 0.49 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.556 -0.715 . . . . 0.0 111.762 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -90.18 139.6 30.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -78.52 -54.89 5.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -78.85 157.29 76.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.69 152.68 81.05 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 111.758 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 76.5 t -146.74 124.3 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.357 1.063 . . . . 0.0 113.757 -177.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 tt -107.72 123.77 49.02 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 125.35 1.46 . . . . 0.0 108.341 -178.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.07 133.38 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -96.59 123.37 40.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -78.78 110.94 14.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 175.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -123.15 -173.68 2.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.886 0.851 . . . . 0.0 111.045 -176.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.84 157.9 4.36 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 175.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.33 -38.53 84.16 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.136 1.891 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -73.78 -8.68 56.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.947 0.499 . . . . 0.0 111.422 176.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -80.11 85.44 5.67 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.28 -1.512 . . . . 0.0 109.617 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.58 -61.6 1.81 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.675 1.131 . . . . 0.0 113.151 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -49.34 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.798 2.999 . . . . 0.0 112.04 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -57.6 -50.93 71.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.013 0.925 . . . . 0.0 109.304 -178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.25 -45.87 90.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.186 -0.435 . . . . 0.0 112.152 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 pt -67.34 -38.61 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.23 -178.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.84 -23.35 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.66 1.118 . . . . 0.0 111.939 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.51 4.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -176.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.78 -29.41 23.79 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 122.666 1.988 . . . . 0.0 109.866 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -44.44 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.12 -44.49 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -54.3 41.91 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.36 -40.16 81.48 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.979 -1.076 . . . . 0.0 110.302 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.6 mt -58.21 -45.79 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.04 -44.98 64.5 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.455 0.571 . . . . 0.0 109.546 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 -57.1 10.39 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -50.09 -51.18 44.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.573 0.702 . . . . 0.0 111.288 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -88.26 19.94 3.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -56.4 153.1 10.32 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.075 0.852 . . . . 0.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.3 -52.1 0.7 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.799 2.039 . . . . 0.0 111.485 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -78.57 -51.84 9.34 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.41 -158.32 0.89 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -158.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -76.21 82.12 3.01 Favored 'General case' 0 N--CA 1.441 -0.883 2 N-CA-C 127.687 6.18 . . . . 0.0 127.687 -156.729 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.6 t -148.29 121.7 9.07 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.938 -2.351 . . . . 0.0 114.974 172.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.92 167.35 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.382 1.073 . . . . 0.0 109.88 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -134.18 113.48 12.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.853 1.261 . . . . 0.0 109.758 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 tp -93.36 114.77 27.27 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.043 0.937 . . . . 0.0 110.413 -178.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -72.68 109.78 6.55 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.8 m -70.12 -33.51 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.031 1.333 . . . . 0.0 111.18 -174.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.54 -37.96 89.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.483 1.113 . . . . 0.0 109.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -87.35 -27.01 23.09 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.731 2.012 . . . . 0.0 111.758 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.2 t -121.01 52.8 3.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.275 1.83 . . . . 0.0 111.741 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.46 -38.16 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.642 2.894 . . . . 0.0 108.97 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -38.33 -69.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.657 1.983 . . . . 0.0 110.839 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.93 -54.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.746 1.218 . . . . 0.0 109.957 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.18 -37.46 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.835 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -68.69 -48.09 64.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.414 0.685 . . . . 0.0 109.162 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.62 -42.9 75.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 110.009 177.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.51 -25.62 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.49 13.47 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.723 0.678 . . . . 0.0 111.649 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.5 mt -79.85 90.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -10.74 59.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.621 1.169 . . . . 0.0 112.978 -175.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.9 m -159.38 161.98 35.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.2 pt -132.75 154.92 81.64 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.77 161.88 74.81 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.661 1.272 . . . . 0.0 114.424 4.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -160.85 122.04 2.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 174.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.96 99.14 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.967 0.907 . . . . 0.0 108.62 -172.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.3 mtt -96.83 138.86 33.75 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.586 0.63 . . . . 0.0 110.079 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.19 131.1 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.31 167.57 17.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.743 1.617 . . . . 0.0 111.174 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.17 151.67 3.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.752 2.021 . . . . 0.0 105.955 173.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 47.4 42.3 18.46 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 170.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.1 10.33 68.62 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.691 178.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -141.76 170.75 15.14 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.561 1.68 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.89 162.85 17.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.471 1.109 . . . . 0.0 111.262 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 45.2 t -130.53 -50.9 1.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.384 1.874 . . . . 0.0 110.012 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -138.88 167.38 22.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.468 -177.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.7 m -151.81 89.02 1.43 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 126.234 1.814 . . . . 0.0 106.24 175.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.08 -175.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 106.615 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.43 156.65 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.66 -150.16 2.09 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.9 -43.71 0.57 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.466 1.506 . . . . 0.0 112.166 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.86 151.95 79.73 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.03 149.25 53.87 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.621 1.547 . . . . 0.0 112.543 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -59.19 -37.24 76.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.2 -50.47 38.05 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.722 0.409 . . . . 0.0 110.074 175.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -56.86 -48.41 78.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.615 1.166 . . . . 0.0 110.095 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.1 mt -59.41 -53.01 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.43 -53.56 23.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.22 -42.26 63.43 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.328 0.513 . . . . 0.0 111.143 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.1 m -59.94 -47.72 84.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.58 -38.49 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 122.034 -0.417 . . . . 0.0 112.076 -178.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -45.68 -42.49 11.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.699 1.2 . . . . 0.0 112.304 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -45.84 -39.09 8.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.846 1.258 . . . . 0.0 111.734 176.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -99.3 30.04 3.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.972 2.109 . . . . 0.0 110.556 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 -47.25 0.25 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.645 0.378 . . . . 0.0 111.571 -170.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.394 -1.289 . . . . 0.0 107.678 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 tpt . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -157.44 167.3 30.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -178.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.99 116.8 5.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.613 0.642 . . . . 0.0 111.03 -177.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.19 148.31 36.99 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 174.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.46 100.81 10.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 171.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 m -103.6 161.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.852 0.834 . . . . 0.0 109.432 -176.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -151.34 172.89 15.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.93 2.092 . . . . 0.0 105.494 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.79 -48.41 15.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.073 0.949 . . . . 0.0 112.317 -176.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.22 -72.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 110.77 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -51.7 -36.58 47.26 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.539 1.135 . . . . 0.0 112.491 -174.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -39.8 -49.67 2.35 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 126.28 1.832 . . . . 0.0 110.863 177.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -49.98 -56.92 8.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.552 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -74.02 -45.15 51.61 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.678 -175.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.3 t -74.91 -43.7 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.574 -168.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.5 t -95.9 -64.65 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.22 1.008 . . . . 0.0 111.007 -173.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -64.31 -59.05 4.85 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.36 41.98 0.41 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.162 0.585 . . . . 0.0 111.312 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -89.75 -171.13 3.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 p -128.2 -65.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.799 2.039 . . . . 0.0 106.973 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.1 158.97 74.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.6 159.84 46.15 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.419 1.185 . . . . 0.0 111.347 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.24 123.95 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.178 1.791 . . . . 0.0 109.007 -177.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.84 101.33 12.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.76 137.76 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -110.74 118.08 35.19 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -78.25 112.29 15.08 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -125.31 -174.82 3.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.172 0.987 . . . . 0.0 111.158 -175.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.41 142.73 1.78 Allowed Pre-proline 0 C--O 1.224 -0.287 0 C-N-CA 126.527 1.931 . . . . 0.0 106.165 171.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -37.98 -53.5 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.148 3.232 . . . . 0.0 117.708 179.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.6 p-90 -61.27 -15.96 40.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.449 0.568 . . . . 0.0 112.458 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -73.0 80.91 1.2 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.191 0.596 . . . . 0.0 111.022 -177.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.15 -56.75 1.8 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.642 1.115 . . . . 0.0 112.691 176.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -50.96 -48.64 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.176 2.584 . . . . 0.0 112.585 177.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.6 m -58.61 -47.51 84.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -61.42 -45.66 93.39 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.3 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.05 -25.47 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.331 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.33 -27.99 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.867 1.667 . . . . 0.0 110.391 174.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -38.68 -45.54 2.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.98 -40.24 73.22 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 CA-C-N 122.346 1.874 . . . . 0.0 109.855 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -74.18 -47.67 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.523 1.129 . . . . 0.0 108.668 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -52.01 -36.08 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.422 1.089 . . . . 0.0 108.165 175.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -70.1 -58.63 3.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.797 -0.565 . . . . 0.0 110.709 173.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -49.29 -41.46 38.2 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.347 -0.359 . . . . 0.0 111.757 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -52.76 -42.98 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 118.482 0.583 . . . . 0.0 110.433 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.71 66.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.671 0.669 . . . . 0.0 111.171 178.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.93 -46.01 14.85 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 174.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.06 -65.75 0.88 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.355 1.062 . . . . 0.0 113.104 -176.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -82.91 19.16 1.42 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.498 1.119 . . . . 0.0 112.805 -174.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -39.41 -42.02 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 128.204 2.602 . . . . 0.0 112.057 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -36.17 -46.89 0.54 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 127.719 2.408 . . . . 0.0 111.748 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.96 -55.04 1.3 Allowed 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.687 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.35 113.57 21.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -163.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.89 91.48 8.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.7 t -79.23 142.09 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 120.752 -1.218 . . . . 0.0 109.454 -178.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -156.73 176.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.828 0.74 . . . . 0.0 110.744 -178.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -142.13 137.74 31.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.846 0.858 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.87 122.26 45.77 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.71 1.204 . . . . 0.0 112.824 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.66 105.79 5.92 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 122.071 0.939 . . . . 0.0 109.809 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -59.89 -39.8 86.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.665 1.986 . . . . 0.0 111.94 -173.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.33 -38.27 74.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.67 0.788 . . . . 0.0 110.709 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -80.09 -27.17 39.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.27 1.428 . . . . 0.0 110.995 177.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.4 m -134.57 62.83 56.88 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.813 1.245 . . . . 0.0 111.342 -177.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 -34.33 28.95 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 109.533 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -37.25 -69.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.764 2.026 . . . . 0.0 110.663 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -61.01 -45.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 122.822 0.449 . . . . 0.0 110.753 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -37.11 60.24 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.13 0.172 . . . . 0.0 111.049 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.1 m -74.41 -46.42 40.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.248 1.019 . . . . 0.0 109.859 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.04 -45.45 75.22 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.197 0.599 . . . . 0.0 110.501 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -79.27 -33.33 43.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.905 0.482 . . . . 0.0 110.51 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.57 53.58 2.41 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.9 mm -67.52 130.13 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.15 -42.4 26.26 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.934 -0.479 . . . . 0.0 110.783 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.8 m -166.09 174.95 8.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.799 2.04 . . . . 0.0 106.042 179.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 pt -120.35 150.75 52.4 Favored Pre-proline 0 N--CA 1.455 -0.202 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.33 144.8 81.59 Favored 'Cis proline' 0 N--CA 1.457 -0.654 0 CA-C-N 119.905 1.002 . . . . 0.0 113.355 1.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -143.12 111.67 6.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.05 138.77 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.3 mtt -130.51 128.19 40.68 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 173.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.6 97.2 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -79.34 125.99 30.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -137.29 0.31 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.03 77.82 0.42 Allowed Glycine 0 CA--C 1.531 1.031 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.25 -63.3 4.15 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -79.66 167.84 20.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.47 0.708 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -87.36 149.3 24.58 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.59 -55.19 3.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.351 1.06 . . . . 0.0 109.127 170.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -137.18 163.7 30.24 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.577 1.151 . . . . 0.0 112.808 -176.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.3 t -138.71 128.69 25.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 173.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 mt -140.21 137.27 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -78.64 140.03 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 174.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.11 -137.71 0.72 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.12 -31.1 0.21 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.448 1.499 . . . . 0.0 112.44 -177.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.06 149.5 79.87 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -56.95 144.99 87.43 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 120.988 1.125 . . . . 0.0 110.387 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -55.86 -31.6 62.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.341 0.656 . . . . 0.0 110.189 -178.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -37.87 60.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.021 0.828 . . . . 0.0 111.087 175.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -61.64 -49.55 76.12 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.355 1.062 . . . . 0.0 108.341 178.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.77 -43.23 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.569 1.148 . . . . 0.0 109.817 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.92 -55.03 22.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 124.127 0.971 . . . . 0.0 108.865 177.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -55.07 -48.19 73.84 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.994 -0.441 . . . . 0.0 110.289 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -59.76 -44.67 93.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.637 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.68 -44.75 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 CA-C-N 119.067 0.849 . . . . 0.0 110.636 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -46.65 -47.27 20.23 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.342 1.057 . . . . 0.0 110.731 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -44.48 -39.96 5.21 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.567 1.147 . . . . 0.0 111.818 176.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -101.58 9.55 41.08 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.796 1.238 . . . . 0.0 113.224 -175.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.54 66.11 0.86 Allowed 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -83.77 164.5 19.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.541 0.736 . . . . 0.0 109.316 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.45 74.61 0.16 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.02 157.74 51.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 177.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.55 117.57 33.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -105.58 160.15 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 122.187 0.994 . . . . 0.0 109.87 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -152.1 174.53 13.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.736 2.414 . . . . 0.0 106.774 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -37.72 -58.36 0.9 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 126.549 1.94 . . . . 0.0 112.653 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.26 -67.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -53.67 -45.59 70.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.145 0.978 . . . . 0.0 111.928 -175.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -42.07 -50.42 4.7 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 127.14 2.176 . . . . 0.0 111.447 -178.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -48.52 -48.06 38.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.791 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -81.05 -59.81 2.52 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.367 0.667 . . . . 0.0 111.456 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.31 -31.49 54.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 126.332 1.853 . . . . 0.0 113.116 -172.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.42 -56.51 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.449 0.699 . . . . 0.0 112.009 -173.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.76 -60.0 2.46 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.867 0.758 . . . . 0.0 109.815 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.84 42.32 0.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.9 p -90.16 148.42 22.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.902 -0.499 . . . . 0.0 109.832 -178.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 p -87.57 -62.93 1.39 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.778 1.231 . . . . 0.0 107.964 177.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 151.38 75.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.033 1.333 . . . . 0.0 108.192 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.44 160.49 48.42 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 120.942 1.095 . . . . 0.0 109.585 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -151.14 133.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -172.049 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 tt -92.3 109.46 20.84 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.07 110.14 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -87.15 113.39 22.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -79.11 109.81 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 177.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -130.47 -173.6 3.11 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 121.723 0.773 . . . . 0.0 111.44 -173.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.04 150.73 4.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.72 -40.2 85.73 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.042 1.828 . . . . 0.0 112.422 178.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.403 ' CH2' HD11 ' A' ' 74' ' ' ILE . 41.1 p-90 -70.19 -14.22 62.53 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.904 -0.498 . . . . 0.0 111.789 177.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 84.18 3.54 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.119 -0.988 . . . . 0.0 112.127 -177.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.52 -62.06 1.42 Allowed Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.772 -1.016 . . . . 0.0 114.059 175.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 -23.54 74.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.214 1.942 . . . . 0.0 113.222 -178.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.8 m -77.39 -58.55 3.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -43.45 -52.59 5.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.53 2.332 . . . . 0.0 111.602 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.69 -22.79 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.247 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.88 -27.29 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.488 1.04 . . . . 0.0 110.831 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.71 -44.97 3.9 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 117.023 -1.465 . . . . 0.0 114.005 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.71 -37.25 88.5 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.532 2.155 . . . . 0.0 110.215 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -43.4 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -59.97 -41.95 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -65.05 -48.66 73.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.402 0.681 . . . . 0.0 110.599 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -60.76 -40.44 92.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.354 0.525 . . . . 0.0 109.719 -179.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mt -53.35 -47.29 58.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.88 -52.42 65.2 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.81 -41.72 28.07 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.61 1.1 . . . . 0.0 112.129 178.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.47 -70.27 0.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.335 0.654 . . . . 0.0 110.046 177.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -86.86 48.46 1.65 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.427 1.108 . . . . 0.0 111.28 -174.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -52.02 61.38 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 127.595 2.358 . . . . 0.0 115.011 -168.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -70.08 -72.44 0.2 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.821 0.82 . . . . 0.0 111.834 -177.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -39.47 34.64 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -164.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 tp -105.48 -171.84 1.98 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -155.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 2.7 pptp? -76.34 91.67 3.28 Favored 'General case' 0 N--CA 1.431 -1.389 2 N-CA-C 123.585 4.661 . . . . 0.0 123.585 -160.933 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.4 t -153.82 121.89 6.07 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.492 -1.38 . . . . 0.0 113.2 172.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.59 163.68 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.395 1.478 . . . . 0.0 108.744 173.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 115.08 16.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.514 1.126 . . . . 0.0 110.864 -175.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -92.74 110.22 21.66 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.98 103.83 2.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.231 1.015 . . . . 0.0 108.699 177.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -84.53 54.1 2.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.492 2.317 . . . . 0.0 108.987 -177.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -150.89 -48.67 0.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.23 -26.25 30.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 111.238 172.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.87 53.13 0.94 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.97 2.108 . . . . 0.0 115.042 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.59 -25.75 40.51 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.683 3.589 . . . . 0.0 108.79 174.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -49.14 -70.56 0.09 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.897 1.279 . . . . 0.0 109.951 178.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.6 t -51.56 -49.44 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.232 1.413 . . . . 0.0 108.856 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.89 67.14 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.8 m -69.68 -45.79 67.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.28 0.632 . . . . 0.0 110.335 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.4 -46.05 76.61 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.245 0.618 . . . . 0.0 110.62 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.44 -31.36 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.478 0.311 . . . . 0.0 111.155 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.72 52.46 2.63 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.79 115.61 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -78.4 -33.65 48.63 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.091 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -163.29 -173.39 3.35 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.403 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.3 pt -142.14 149.05 50.71 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.22 139.27 60.45 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 CA-C-N 119.394 0.819 . . . . 0.0 113.304 2.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -130.15 118.89 22.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 102.04 -3.318 . . . . 0.0 102.04 172.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.2 mt -112.49 100.45 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 108.272 -172.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.4 mtt -94.29 138.39 32.34 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.136 0.426 . . . . 0.0 110.287 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.5 104.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.82 147.69 28.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.44 21.57 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.396 1.078 . . . . 0.0 109.618 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.06 127.23 6.04 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.5 -52.06 1.86 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.828 1.68 . . . . 0.0 114.116 178.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -138.48 -179.88 6.06 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.248 1.019 . . . . 0.0 110.649 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 152.71 21.04 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.778 1.231 . . . . 0.0 109.832 176.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -110.82 -71.06 0.78 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.404 1.482 . . . . 0.0 107.883 177.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -96.6 162.91 13.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.693 0.797 . . . . 0.0 109.691 177.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.4 m -153.27 108.58 3.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.347 1.059 . . . . 0.0 108.177 175.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.31 160.65 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -142.98 147.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.67 169.34 45.65 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 121.495 0.497 . . . . 0.0 112.33 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.85 82.71 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.989 0.515 . . . . 0.0 111.122 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.61 151.54 77.29 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.746 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -82.38 149.3 14.88 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.405 2.737 . . . . 0.0 106.76 170.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.01 -42.45 72.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.806 -0.559 . . . . 0.0 112.31 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.54 -51.73 6.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.98 0.912 . . . . 0.0 111.253 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 m -61.5 -50.23 73.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.161 0.584 . . . . 0.0 110.481 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -53.96 -56.37 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.594 0.758 . . . . 0.0 109.016 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -49.88 -64.08 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.741 1.617 . . . . 0.0 108.885 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -51.62 -47.3 63.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.188 0.449 . . . . 0.0 111.824 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -58.35 -45.34 88.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.207 -178.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -44.79 46.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 CA-C-N 119.262 0.937 . . . . 0.0 111.589 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -48.7 -44.33 37.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.244 1.018 . . . . 0.0 110.074 -178.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -44.26 -44.04 7.71 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.125 0.97 . . . . 0.0 111.717 174.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -94.32 -7.0 43.09 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.423 1.489 . . . . 0.0 112.755 -177.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -157.65 85.58 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.009 0.822 . . . . 0.0 110.31 -169.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.3 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 178.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.99 -45.76 73.21 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 171.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.61 135.71 33.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 171.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.16 -173.56 41.76 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.84 139.25 52.25 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.93 167.98 22.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 122.499 1.142 . . . . 0.0 111.514 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -146.71 175.9 10.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.706 2.402 . . . . 0.0 106.419 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -38.54 -58.78 0.99 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.5 1.52 . . . . 0.0 112.793 -176.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.98 -57.45 11.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.623 1.169 . . . . 0.0 111.908 -177.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -65.11 -40.01 93.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.526 0.73 . . . . 0.0 111.658 -173.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -41.02 -47.13 3.03 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.471 1.908 . . . . 0.0 110.866 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -54.96 -62.99 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.656 178.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -63.21 -32.59 74.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.213 1.005 . . . . 0.0 112.314 -176.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.9 t -92.55 -54.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.19 0.596 . . . . 0.0 111.968 -171.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -83.59 -57.35 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.255 1.022 . . . . 0.0 110.854 -175.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.1 mt -70.23 -54.97 10.51 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.06 0.391 . . . . 0.0 111.238 -174.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -79.44 48.7 0.92 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.73 -0.606 . . . . 0.0 110.622 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 p -90.47 158.51 17.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.21 1.404 . . . . 0.0 111.151 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 p -91.26 -72.05 0.6 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.93 1.292 . . . . 0.0 107.569 176.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -79.39 160.63 69.87 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.22 166.15 1.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.114 1.876 . . . . 0.0 111.771 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 t -138.64 145.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 109.944 -176.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -122.33 105.77 10.49 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 m -101.25 150.9 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 118.626 0.648 . . . . 0.0 109.489 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -115.07 119.9 38.01 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.526 0.73 . . . . 0.0 109.321 174.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -80.76 111.31 17.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -128.84 -173.23 2.92 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.47 0.708 . . . . 0.0 111.608 -174.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.63 154.75 12.4 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.532 1.133 . . . . 0.0 108.158 174.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.46 -43.41 40.21 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.367 2.711 . . . . 0.0 112.07 -176.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.6 p-90 -70.9 -13.13 61.91 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.177 0.591 . . . . 0.0 111.262 177.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.23 80.68 3.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.209 -0.932 . . . . 0.0 111.061 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.39 -55.9 4.27 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.907 0.765 . . . . 0.0 112.812 176.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.55 -27.95 78.95 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.55 2.167 . . . . 0.0 112.715 178.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.54 -56.38 4.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -48.71 -48.57 40.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.091 1.357 . . . . 0.0 111.727 -177.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.45 -21.94 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.222 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.4 mm -89.54 -26.58 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 119.461 1.028 . . . . 0.0 110.012 177.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.92 -48.56 5.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.66 -36.88 83.17 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.106 1.871 . . . . 0.0 110.174 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.9 -45.02 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.565 1.146 . . . . 0.0 108.292 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.5 -53.39 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.82 -53.53 57.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.832 0.853 . . . . 0.0 111.943 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.65 -40.48 96.96 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.068 -1.02 . . . . 0.0 110.604 -177.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.5 mt -58.42 -46.7 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.85 68.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.57 -51.44 52.07 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -61.93 -49.22 77.04 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.91 10.43 41.32 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -38.42 -56.94 1.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 126.62 1.968 . . . . 0.0 112.45 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.58 -44.91 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.533 1.933 . . . . 0.0 113.44 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.42 -9.8 19.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.216 1.006 . . . . 0.0 112.458 -176.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -151.08 113.99 4.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -78.65 160.91 27.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 171.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 22.8 t -141.85 142.78 33.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.793 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.06 162.42 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -130.12 111.9 12.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.2 0.6 . . . . 0.0 110.087 -176.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.77 117.21 27.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.572 0.749 . . . . 0.0 109.383 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -74.41 100.94 3.95 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -58.92 -39.71 82.36 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.122 1.769 . . . . 0.0 112.422 -175.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.14 -37.64 75.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.236 1.014 . . . . 0.0 110.343 -173.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -86.34 -28.83 23.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.66 1.584 . . . . 0.0 111.332 177.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -123.43 54.85 7.48 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.464 1.906 . . . . 0.0 110.609 -177.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.71 -40.22 66.42 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.942 3.094 . . . . 0.0 109.006 177.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -29.09 -75.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.404 2.281 . . . . 0.0 111.804 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.7 t -53.37 -49.57 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.049 1.34 . . . . 0.0 109.879 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.92 68.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.949 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -80.3 -42.11 23.65 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.562 1.145 . . . . 0.0 108.957 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.18 -41.39 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -78.64 -30.09 46.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.427 0.691 . . . . 0.0 110.666 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.49 49.32 6.76 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.236 0.922 . . . . 0.0 111.24 176.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -133.28 79.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.661 1.584 . . . . 0.0 109.95 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -31.69 46.67 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.57 145.3 54.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 pt -148.05 154.52 43.12 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.88 140.08 58.76 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 CA-C-N 119.812 0.968 . . . . 0.0 112.273 1.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 m -130.1 107.27 9.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.7 mt -88.78 137.85 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 16.5 mtt -131.59 135.57 47.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.07 141.15 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -127.93 155.45 44.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.949 1.3 . . . . 0.0 108.277 174.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.05 56.42 1.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.884 1.674 . . . . 0.0 107.836 -178.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.49 -153.56 16.93 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 -173.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.2 35.84 1.3 Allowed Glycine 0 CA--C 1.528 0.879 0 O-C-N 121.794 -0.827 . . . . 0.0 114.546 -177.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -151.27 155.26 38.41 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.624 1.569 . . . . 0.0 108.044 177.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -89.84 145.81 24.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.14 1.376 . . . . 0.0 108.323 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.3 t -112.32 -55.85 2.47 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.357 1.063 . . . . 0.0 111.062 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -133.56 170.78 15.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 111.061 -175.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.5 m -156.23 140.62 16.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.115 1.366 . . . . 0.0 108.932 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.4 mm -136.6 153.34 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mt -133.53 144.01 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.97 148.49 24.29 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.028 0.823 . . . . 0.0 112.698 176.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.06 72.76 1.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 110.941 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.4 m -78.91 147.03 69.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -56.66 158.19 17.08 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.901 2.401 . . . . 0.0 114.556 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -46.68 -51.63 15.58 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 125.832 1.653 . . . . 0.0 110.581 177.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.36 -49.42 44.5 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.445 0.698 . . . . 0.0 110.799 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -49.7 73.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.068 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.02 -54.44 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.86 -56.78 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.562 1.145 . . . . 0.0 110.377 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -55.25 -47.47 75.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.3 m -56.92 -44.76 82.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.484 0.714 . . . . 0.0 110.415 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.94 -56.26 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.949 0.795 . . . . 0.0 109.52 176.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -52.51 -45.51 66.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.204 1.002 . . . . 0.0 112.745 -175.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -60.28 -30.75 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.568 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -81.09 -48.04 12.7 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.47 -99.98 0.44 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.755 1.222 . . . . 0.0 109.692 -174.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 tpp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 70.56 -66.51 0.28 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -168.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.41 130.7 43.24 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 167.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.56 175.14 54.35 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.878 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.6 129.5 56.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.67 162.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 122.171 0.986 . . . . 0.0 110.094 -177.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -139.34 175.36 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.572 2.349 . . . . 0.0 106.952 175.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -46.9 -55.26 8.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.0 111.521 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.15 -52.27 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.196 1.398 . . . . 0.0 111.442 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 p -75.94 -37.76 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.579 0.751 . . . . 0.0 112.132 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -41.2 -46.56 3.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.767 2.027 . . . . 0.0 110.644 -177.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.34 -50.12 60.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.417 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -78.03 -52.97 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.62 1.2 . . . . 0.0 110.877 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.81 -35.18 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.205 -169.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.3 -59.71 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.3 mt -66.4 -73.57 0.13 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -174.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -82.93 57.95 4.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.726 0.81 . . . . 0.0 108.924 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 p -87.6 -139.5 0.1 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.098 0.959 . . . . 0.0 109.964 -178.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -160.68 -68.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 m -77.79 158.34 78.21 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 104.959 -2.238 . . . . 0.0 104.959 171.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 165.29 21.9 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 N-CA-C 108.55 -1.365 . . . . 0.0 108.55 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.4 146.01 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 125.419 1.488 . . . . 0.0 108.916 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -126.25 103.76 7.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.09 145.08 10.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -113.36 113.21 24.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -78.59 111.26 14.48 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.61 -173.84 2.78 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.716 0.635 . . . . 0.0 110.719 -178.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.38 141.46 0.92 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.754 1.221 . . . . 0.0 110.499 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.07 110.69 3.0 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.445 2.096 . . . . 0.0 108.919 176.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 137.31 -29.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 131.61 3.964 . . . . 0.0 105.684 -173.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.5 t -68.78 88.53 0.37 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.352 0.596 . . . . 0.0 111.933 -177.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -35.65 -67.3 0.34 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.233 1.873 . . . . 0.0 113.388 177.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.28 -46.54 29.82 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 119.6 1.7 . . . . 0.0 112.268 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.3 m -54.22 -42.44 69.8 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.308 0.503 . . . . 0.0 110.293 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -55.57 -53.34 57.59 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 122.802 0.441 . . . . 0.0 111.065 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 pt -74.1 -27.46 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.878 -178.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.24 -38.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 110.683 177.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.64 -48.33 5.15 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -60.36 -37.6 80.72 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.929 2.419 . . . . 0.0 110.435 178.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.49 -45.52 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.32 -44.55 88.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -58.15 -61.46 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.64 0.776 . . . . 0.0 110.011 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.91 -37.51 82.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.633 0.652 . . . . 0.0 111.309 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.41 -40.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 176.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.29 -43.82 92.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.443 0.565 . . . . 0.0 110.097 175.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.36 -39.86 84.08 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.96 -51.14 42.7 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -99.91 10.11 41.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -46.4 147.49 1.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 112.078 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.18 -46.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.945 2.098 . . . . 0.0 111.91 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.87 -19.48 54.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.959 . . . . 0.0 110.709 -178.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.2 tp -155.3 128.83 8.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 107.338 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tmtp? -90.16 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.0 t -79.55 133.91 36.47 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.534 -0.729 . . . . 0.0 109.517 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.28 169.85 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.427 0.632 . . . . 0.0 111.865 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -133.5 131.28 39.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.983 1.713 . . . . 0.0 110.438 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.47 133.89 55.48 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.098 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -81.52 111.15 17.58 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.107 0.956 . . . . 0.0 111.257 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.6 m -84.22 49.86 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.238 2.215 . . . . 0.0 111.13 -174.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.12 -42.15 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -80.7 -24.1 39.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.748 2.019 . . . . 0.0 108.981 169.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -144.18 62.73 10.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.607 1.563 . . . . 0.0 110.985 178.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.26 -26.67 4.03 Favored 'Trans proline' 0 N--CA 1.445 -1.37 1 C-N-CA 126.397 4.732 . . . . 0.0 109.079 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -38.79 -61.26 0.75 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.938 1.695 . . . . 0.0 109.647 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.9 t -56.79 -52.88 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.765 1.226 . . . . 0.0 110.047 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.16 -35.25 64.57 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.501 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 m -73.65 -46.1 48.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.701 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.52 -43.61 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.528 0.731 . . . . 0.0 109.944 177.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.99 -32.53 45.26 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.66 -0.21 . . . . 0.0 110.721 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.87 51.92 2.54 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 123.75 0.69 . . . . 0.0 111.533 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.9 mt -79.92 112.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 -27.42 43.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.118 0.567 . . . . 0.0 112.142 -177.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -157.72 161.89 38.54 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.76 154.88 81.09 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.3 135.18 38.22 Favored 'Cis proline' 0 N--CA 1.449 -1.098 0 CA-C-N 119.282 0.779 . . . . 0.0 113.074 1.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -121.84 102.48 8.22 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 173.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -79.58 137.2 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 175.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.0 mtt -130.22 148.27 52.03 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.34 128.32 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -116.31 144.91 43.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 12.59 3.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.168 -176.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.35 -154.41 25.12 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.25 20.09 0.59 Allowed Glycine 0 CA--C 1.533 1.165 0 CA-C-N 118.041 0.921 . . . . 0.0 114.866 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -153.9 162.58 41.11 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.587 1.555 . . . . 0.0 108.595 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -78.84 -179.48 6.59 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.77 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.8 t -138.9 -66.08 0.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.403 1.081 . . . . 0.0 108.962 177.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -120.94 170.31 9.63 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.601 1.56 . . . . 0.0 109.784 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 t -156.86 152.25 26.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.758 0.823 . . . . 0.0 108.943 178.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.41 150.15 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.794 1.238 . . . . 0.0 107.788 -177.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.7 mt -79.78 119.85 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 171.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.42 86.27 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.135 -0.814 . . . . 0.0 113.973 -173.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.94 66.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.252 1.021 . . . . 0.0 113.017 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.41 154.68 53.44 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 126.06 1.744 . . . . 0.0 106.958 176.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -58.04 155.13 35.3 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.441 2.094 . . . . 0.0 113.952 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.07 -42.54 63.27 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.339 1.056 . . . . 0.0 109.542 177.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.97 -49.0 66.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.948 0.499 . . . . 0.0 109.985 178.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m -61.14 -47.8 84.56 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.1 mm -54.11 -56.73 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -49.32 -58.55 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 125.183 1.393 . . . . 0.0 109.724 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -54.34 -48.31 71.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.881 0.31 . . . . 0.0 111.218 -178.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.0 m -61.36 -38.99 88.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.945 0.498 . . . . 0.0 110.604 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.4 t -65.67 -55.4 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 119.153 0.888 . . . . 0.0 108.778 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -43.86 -57.58 3.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 111.671 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.84 -26.77 15.6 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -83.26 -21.37 33.34 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.414 -0.804 . . . . 0.0 110.976 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 84.1 mt -95.38 -39.68 9.89 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.709 1.204 . . . . 0.0 111.144 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 116.946 -1.502 . . . . 0.0 109.926 -177.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.76 -39.94 94.46 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.61 148.26 23.45 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.02 162.94 42.07 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.592 1.567 . . . . 0.0 113.601 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.65 122.21 35.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 172.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.3 163.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.492 -176.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -149.25 170.5 18.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.469 1.907 . . . . 0.0 107.242 177.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -77.31 80.53 3.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 125.112 2.387 . . . . 0.0 111.713 -176.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 172.76 -76.83 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 2 CA-C-N 107.644 -4.344 . . . . 0.0 107.415 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.7 p -51.8 -39.34 58.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.616 1.167 . . . . 0.0 110.581 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -43.58 -45.54 6.73 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.584 1.553 . . . . 0.0 111.271 175.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -54.17 -52.16 62.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.289 0.566 . . . . 0.0 110.096 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -70.35 -52.5 22.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 111.052 -177.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.6 -46.23 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.721 1.209 . . . . 0.0 112.804 -172.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.2 -61.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.92 0.888 . . . . 0.0 111.169 -174.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -68.04 -56.81 7.53 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.706 -172.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.59 43.75 0.58 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.267 0.485 . . . . 0.0 111.357 -178.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -90.16 -174.62 4.26 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.76 0.79 . . . . 0.0 109.361 177.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.3 p -120.34 -73.34 0.65 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.58 1.952 . . . . 0.0 106.409 176.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.74 158.83 75.11 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.19 159.27 15.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.563 1.509 . . . . 0.0 112.791 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.72 118.0 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.282 1.433 . . . . 0.0 109.778 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -84.96 104.17 14.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.49 116.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -96.06 109.96 22.28 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -78.8 110.89 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -126.69 -174.36 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.082 0.953 . . . . 0.0 111.119 -174.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.06 149.32 3.31 Favored Pre-proline 0 N--CA 1.456 -0.175 0 C-N-CA 124.979 1.312 . . . . 0.0 108.007 172.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.99 -38.34 93.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.706 2.271 . . . . 0.0 113.888 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -76.35 -12.21 60.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.399 0.545 . . . . 0.0 112.111 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 t -77.91 100.46 6.4 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.865 -176.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.92 -64.8 1.37 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.628 1.585 . . . . 0.0 114.544 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.52 -45.44 37.21 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.596 1.698 . . . . 0.0 110.876 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.79 -50.48 63.49 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.22 0.608 . . . . 0.0 109.612 -178.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -56.24 -48.85 75.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.154 0.582 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.46 -29.28 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.776 -177.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 pt -81.7 -24.54 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 120.608 1.549 . . . . 0.0 110.853 176.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.13 -48.61 4.26 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.47 -41.01 35.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.088 1.858 . . . . 0.0 109.97 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.54 -49.67 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.979 1.312 . . . . 0.0 107.926 178.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.7 -44.13 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -56.59 -33.79 66.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -51.07 -35.79 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.308 0.643 . . . . 0.0 109.504 176.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.17 -38.35 70.79 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.313 0.506 . . . . 0.0 110.919 177.144 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.42 -43.4 45.59 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -55.82 -52.15 65.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -107.58 34.09 3.71 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -58.79 161.84 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.806 0.442 . . . . 0.0 110.172 176.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 t70 74.92 -55.44 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.613 1.965 . . . . 0.0 111.429 178.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -77.87 -31.67 51.52 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 -177.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.47 152.24 49.33 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.761 0.824 . . . . 0.0 109.906 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -106.17 152.08 23.92 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 168.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 54.1 t -132.97 140.41 47.77 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.64 176.4 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 119.033 0.833 . . . . 0.0 109.461 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.72 134.61 26.98 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.442 . . . . 0.0 111.851 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -99.76 119.35 38.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.338 1.855 . . . . 0.0 110.047 -177.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.23 104.06 4.87 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -66.96 -29.64 69.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.684 1.594 . . . . 0.0 111.631 -173.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.2 -42.03 84.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.869 0.842 . . . . 0.0 109.778 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -83.76 -31.63 25.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.281 1.832 . . . . 0.0 111.687 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.1 m -125.85 60.1 31.83 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 -178.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.42 -34.9 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 124.723 3.615 . . . . 0.0 109.779 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -38.46 -72.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.545 1.938 . . . . 0.0 111.626 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.64 -44.78 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 124.026 0.93 . . . . 0.0 110.487 -178.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.15 70.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.538 178.198 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -71.52 -43.8 65.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 109.749 178.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.59 -41.51 77.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.618 0.367 . . . . 0.0 110.437 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -78.19 -33.49 50.06 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.91 47.38 2.1 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.725 0.678 . . . . 0.0 111.827 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.5 mt -78.71 112.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -29.55 47.48 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.12 -0.362 . . . . 0.0 110.908 -177.345 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -160.85 155.01 22.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.58 156.53 38.59 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -66.75 161.23 75.97 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.503 1.215 . . . . 0.0 112.595 2.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -158.37 102.02 1.73 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.4 pt -85.81 133.83 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 174.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.7 mtt -121.25 153.37 37.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.81 117.73 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -112.22 156.39 22.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.144 0.977 . . . . 0.0 109.103 178.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 153.85 8.82 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.363 1.465 . . . . 0.0 107.316 176.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 37.72 9.77 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.005 0.821 . . . . 0.0 114.69 175.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.3 20.51 65.38 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.702 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -141.6 166.03 25.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.332 1.453 . . . . 0.0 109.573 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -90.54 155.22 19.04 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.34 0.656 . . . . 0.0 109.598 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.0 t -108.65 -62.46 1.46 Allowed 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 125.603 1.561 . . . . 0.0 108.941 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.31 179.41 8.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.861 1.265 . . . . 0.0 108.846 177.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 t -155.45 151.4 27.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.631 1.173 . . . . 0.0 109.544 -178.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -146.81 157.25 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.757 1.623 . . . . 0.0 108.208 -179.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -79.6 114.35 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.82 -12.53 21.57 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -174.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.1 63.38 0.33 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.915 . . . . 0.0 111.96 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.97 157.06 58.3 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.434 1.494 . . . . 0.0 107.792 177.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -58.48 155.52 35.79 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.638 2.225 . . . . 0.0 113.729 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.12 -51.81 17.04 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.832 1.653 . . . . 0.0 110.744 178.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -51.88 35.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.598 178.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 m -59.47 -46.51 88.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.776 -0.631 . . . . 0.0 109.874 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.22 -52.02 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.811 0.732 . . . . 0.0 109.366 177.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.3 -57.45 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.055 0.542 . . . . 0.0 109.678 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -53.35 -47.76 69.11 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.984 0.357 . . . . 0.0 110.681 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 m -54.12 -49.29 69.52 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.209 1.003 . . . . 0.0 110.09 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -61.65 -55.18 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.518 -0.739 . . . . 0.0 109.746 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -51.32 -48.41 62.36 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.434 0.693 . . . . 0.0 112.325 -175.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -57.82 -22.29 46.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.782 0.719 . . . . 0.0 112.593 -179.117 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -93.64 9.07 38.41 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.754 0.706 . . . . 0.0 111.404 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.3 mt -129.6 -56.27 1.14 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.222 1.409 . . . . 0.0 109.786 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.049 0 C-N-CA 126.851 2.061 . . . . 0.0 106.682 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -95.66 163.61 13.12 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.541 1.136 . . . . 0.0 109.131 177.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.65 70.55 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.574 1.15 . . . . 0.0 113.126 -177.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.2 151.28 41.84 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.71 104.47 16.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.89 158.73 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.104 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' A' ' 8' ' ' ASP . 4.8 t-20 -143.26 174.93 10.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 177.337 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.425 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 25.7 t0 -39.37 -49.71 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.329 1.452 . . . . 0.0 112.295 -176.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.33 -78.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.129 177.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 p -45.95 -41.33 11.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.256 1.422 . . . . 0.0 112.632 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -39.71 -46.05 1.81 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.162 1.785 . . . . 0.0 111.38 175.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -49.83 -65.85 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.852 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.78 -35.94 82.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.254 0.622 . . . . 0.0 112.196 -176.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.93 -13.09 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.49 -66.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 119.026 0.83 . . . . 0.0 109.475 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.45 -35.12 69.72 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -93.69 -5.19 49.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.99 0.916 . . . . 0.0 111.817 178.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 m -77.26 132.51 38.71 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.712 -1.243 . . . . 0.0 111.909 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.37 -52.9 7.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.809 1.244 . . . . 0.0 109.553 178.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.59 152.8 83.41 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -64.34 154.51 70.96 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 120.925 1.084 . . . . 0.0 113.049 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -147.85 127.27 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 124.626 1.204 . . . . 0.0 113.541 178.609 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.11 95.49 9.46 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.26 113.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -86.9 114.52 23.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -79.0 102.89 8.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 175.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -120.32 -171.5 2.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 110.519 -173.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.67 152.93 3.97 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -56.59 -35.73 97.36 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.847 1.698 . . . . 0.0 112.237 177.056 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 -76.84 -3.92 40.93 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.798 -0.564 . . . . 0.0 111.985 177.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.7 t -82.06 85.37 6.76 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.587 -1.321 . . . . 0.0 112.125 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.1 -57.88 2.46 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.374 0.988 . . . . 0.0 114.055 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.97 -24.04 53.53 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 120.035 1.917 . . . . 0.0 112.311 -178.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.4 m -66.92 -49.49 65.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.022 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -46.93 -45.55 20.76 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.836 0.854 . . . . 0.0 111.481 -178.01 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -77.48 -19.59 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.794 -177.261 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.16 -22.75 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 121.064 1.756 . . . . 0.0 109.752 171.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.37 -43.03 2.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.421 -1.276 . . . . 0.0 114.041 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.39 -40.96 36.28 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.228 1.952 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.5 t -64.21 -47.66 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.2 t -56.88 -54.58 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -176.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -60.7 -49.78 76.13 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.326 0.65 . . . . 0.0 110.894 -179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -53.85 -52.56 60.03 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -54.34 -43.76 63.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.16 -46.27 65.38 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.68 8.43 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 175.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -39.9 -49.49 2.43 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.235 1.414 . . . . 0.0 112.789 -177.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.24 24.65 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -174.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -40.87 -46.62 2.79 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.133 1.773 . . . . 0.0 112.303 -177.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.19 -44.76 1.25 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.068 2.547 . . . . 0.0 113.4 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -140.22 -55.51 0.53 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.148 0.975 . . . . 0.0 112.832 179.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.57 -169.13 1.59 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.72 -1.582 . . . . 0.0 114.322 -155.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 3.4 pttp -75.79 99.88 4.56 Favored 'General case' 0 N--CA 1.432 -1.354 1 N-CA-C 127.605 6.15 . . . . 0.0 127.605 -153.504 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.3 t -160.02 127.8 4.68 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 120.304 -1.498 . . . . 0.0 112.719 168.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.23 167.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.906 0.882 . . . . 0.0 109.081 171.022 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -136.39 109.31 7.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.352 0.661 . . . . 0.0 110.456 -177.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.47 118.29 31.14 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 122.986 0.514 . . . . 0.0 109.877 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -72.46 111.86 8.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -67.97 -33.71 75.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.615 1.166 . . . . 0.0 111.423 -173.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -67.84 -37.4 81.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.529 1.132 . . . . 0.0 109.322 -179.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.88 -27.82 39.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.504 1.521 . . . . 0.0 111.375 177.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 m -119.19 51.03 1.5 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.67 1.588 . . . . 0.0 114.014 -176.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -60.03 -36.25 90.16 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 124.326 3.351 . . . . 0.0 108.419 175.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -44.34 -72.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.405 1.882 . . . . 0.0 109.93 175.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.76 -50.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.593 1.157 . . . . 0.0 109.738 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.28 -40.92 62.39 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.282 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 m -75.84 -41.12 53.36 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.194 0.998 . . . . 0.0 110.731 179.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.26 -45.2 80.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.148 0.579 . . . . 0.0 109.758 178.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -79.11 -35.22 42.59 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.26 50.74 2.93 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.416 1.008 . . . . 0.0 112.53 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.18 -169.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.248 0.619 . . . . 0.0 110.032 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -158.8 -84.81 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.576 0.75 . . . . 0.0 109.096 177.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -57.57 153.84 12.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 110.351 178.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.1 pt -140.84 155.14 69.23 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.03 140.05 45.43 Favored 'Cis proline' 0 N--CA 1.453 -0.903 0 CA-C-N 120.252 1.126 . . . . 0.0 112.879 2.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 m -127.84 104.84 8.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 173.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.0 mt -101.61 102.6 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.661 1.584 . . . . 0.0 108.244 -173.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.6 mtt -102.26 151.62 22.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.76 130.03 67.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 171.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -121.37 148.73 43.97 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 175.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.61 153.88 13.3 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.18 35.98 80.22 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 118.058 -2.02 . . . . 0.0 108.172 -174.199 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.18 -53.2 1.43 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.58 1.562 . . . . 0.0 113.997 -175.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -79.24 165.84 22.8 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -172.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -80.97 152.8 27.81 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 127.137 2.175 . . . . 0.0 110.833 -178.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.8 t -138.46 -80.39 0.33 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -72.09 149.5 44.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.773 0.321 . . . . 0.0 110.343 178.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.12 75.34 1.29 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.28 1.832 . . . . 0.0 106.72 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.0 mm -81.24 154.21 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.2 mt -138.02 147.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -175.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.39 175.1 48.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.608 0.623 . . . . 0.0 111.567 178.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.66 153.2 44.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.54 156.08 45.43 Favored Pre-proline 0 C--O 1.232 0.165 0 C-N-CA 123.484 0.714 . . . . 0.0 109.207 -178.272 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -73.88 143.97 33.92 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 N-CA-C 105.885 -2.39 . . . . 0.0 105.885 166.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -38.46 76.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.239 0.542 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.57 -52.66 28.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 m -58.86 -49.29 78.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.363 0.665 . . . . 0.0 110.065 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -54.21 -53.09 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.9 t -52.15 -56.73 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.533 0.733 . . . . 0.0 109.254 179.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -52.7 -45.87 67.08 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.264 0.554 . . . . 0.0 111.706 178.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.8 m -58.93 -38.95 80.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.156 -177.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -81.63 -36.2 14.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 119.026 0.83 . . . . 0.0 111.334 178.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -55.75 -35.11 65.84 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -46.48 -37.96 8.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.006 0.522 . . . . 0.0 110.704 171.284 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -102.88 14.48 31.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.089 2.156 . . . . 0.0 112.741 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.0 mt -157.59 96.61 1.53 Allowed 'General case' 0 C--N 1.338 0.104 0 C-N-CA 125.174 1.39 . . . . 0.0 108.383 177.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.089 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -69.83 -53.6 17.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 172.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.51 141.86 51.91 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.642 169.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.88 -165.41 31.57 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 176.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.83 141.69 48.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.54 166.08 23.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 122.316 1.055 . . . . 0.0 111.09 -178.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -141.5 169.31 17.84 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -39.33 -46.09 1.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.794 1.638 . . . . 0.0 111.986 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -57.38 -70.55 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.871 177.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.9 p -61.07 -38.2 85.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 112.256 -175.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -39.34 -46.17 1.55 Allowed 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 127.905 2.482 . . . . 0.0 111.107 178.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -42.65 -66.29 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 111.954 175.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -45.05 60.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.933 -174.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.4 t -70.42 -38.26 73.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.001 -171.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -108.69 -69.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.706 -174.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -54.51 -50.78 67.02 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.99 0.359 . . . . 0.0 111.148 -172.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -88.07 17.06 5.3 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.614 -178.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.17 154.21 37.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.12 1.327 . . . . 0.0 111.132 -178.127 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -86.71 -58.63 2.53 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.617 1.567 . . . . 0.0 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.07 161.03 72.33 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.719 1.208 . . . . 0.0 108.01 178.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.41 164.67 8.63 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.659 1.573 . . . . 0.0 109.697 173.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 t -145.88 115.83 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 110.98 -174.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tp -89.06 98.78 11.96 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.32 110.6 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 123.33 0.652 . . . . 0.0 110.549 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -89.11 115.31 26.55 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -80.05 111.39 16.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -131.11 -171.86 2.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.744 0.783 . . . . 0.0 111.035 -173.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.98 150.35 2.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 172.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.4 -42.26 69.31 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.281 1.987 . . . . 0.0 112.177 178.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -66.24 -21.09 66.28 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.077 -0.389 . . . . 0.0 111.757 178.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.0 t -76.26 83.45 3.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.615 -0.678 . . . . 0.0 111.345 -176.166 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.73 -57.18 2.89 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.697 -1.057 . . . . 0.0 113.599 173.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -20.53 67.25 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.977 1.785 . . . . 0.0 112.654 -179.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.2 m -82.06 -59.0 2.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -40.13 -53.0 2.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 127.569 2.347 . . . . 0.0 112.154 -178.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.93 -22.32 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.47 -33.78 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.347 1.059 . . . . 0.0 110.26 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.88 -43.39 3.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 127.311 2.244 . . . . 0.0 115.512 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -67.43 -36.25 20.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.822 1.681 . . . . 0.0 108.86 -179.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -40.2 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 127.166 2.186 . . . . 0.0 107.748 179.032 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.82 -47.77 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.39 -53.19 60.58 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.715 0.406 . . . . 0.0 111.692 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.31 -41.16 96.53 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.16 -0.962 . . . . 0.0 110.813 -179.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.98 -42.8 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.84 -46.84 71.33 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.52 36.83 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 176.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -47.35 -41.75 20.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.546 0.673 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -112.71 31.3 6.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.016 0.926 . . . . 0.0 112.192 -178.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -57.05 154.71 9.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.523 0.678 . . . . 0.0 110.49 -178.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 71.64 -48.45 0.68 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 128.093 2.557 . . . . 0.0 112.028 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -78.37 -13.17 59.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.206 0.457 . . . . 0.0 110.742 179.134 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.62 119.7 6.28 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -80.97 167.73 19.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.6 t -146.9 147.5 30.86 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.93 161.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -125.81 110.61 13.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -89.56 112.43 23.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.38 1.472 . . . . 0.0 109.242 -178.06 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -71.89 107.98 4.93 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.0 m -60.58 -43.18 97.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.147 1.779 . . . . 0.0 111.665 -174.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.21 -33.77 75.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.901 0.881 . . . . 0.0 110.506 -177.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.8 -27.42 36.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.566 1.146 . . . . 0.0 110.425 175.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -122.86 52.81 4.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.914 1.686 . . . . 0.0 113.492 -176.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.23 -31.34 63.97 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.403 3.402 . . . . 0.0 107.985 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -50.43 -60.12 3.32 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.369 1.068 . . . . 0.0 109.457 177.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.59 -55.41 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.8 0.84 . . . . 0.0 109.374 -178.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.43 -45.38 36.19 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.933 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -65.59 -50.23 65.88 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.13 0.572 . . . . 0.0 110.715 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -56.61 -44.06 80.78 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.752 0.421 . . . . 0.0 111.305 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -79.29 -32.22 43.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.607 -0.235 . . . . 0.0 111.579 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.49 60.8 0.98 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.5 mt -129.11 152.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.274 1.43 . . . . 0.0 107.77 -178.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -148.67 -71.08 0.21 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.19 151.11 41.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 pt -146.27 154.77 50.09 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -179.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.74 151.23 74.86 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.656 1.27 . . . . 0.0 113.825 2.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -156.72 100.37 1.92 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 tt -100.7 123.1 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -178.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 mtt -106.02 144.19 33.08 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.413 1.085 . . . . 0.0 110.066 -177.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.9 t -95.87 101.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -95.89 156.36 16.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.178 179.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.31 -154.9 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 171.325 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.56 95.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.301 1.429 . . . . 0.0 114.261 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.02 -76.83 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.919 0.771 . . . . 0.0 113.913 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -79.88 169.71 17.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.097 0.951 . . . . 0.0 113.429 -171.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.59 157.41 17.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.255 171.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 15.9 t -109.36 -60.45 1.77 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.832 1.253 . . . . 0.0 110.113 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -132.86 179.08 6.39 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.602 1.561 . . . . 0.0 109.097 -178.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -160.34 163.78 33.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.979 0.512 . . . . 0.0 110.055 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 mt -137.18 146.53 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.8 mp -135.71 151.1 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.269 1.428 . . . . 0.0 108.52 -174.146 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.99 152.78 10.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.2 67.92 2.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.707 . . . . 0.0 110.77 -179.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.87 144.3 63.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.75 155.65 13.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.593 2.195 . . . . 0.0 113.896 -178.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -49.28 -43.76 43.37 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.064 0.946 . . . . 0.0 111.323 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.32 65.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 110.625 179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -45.91 86.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.05 -54.68 21.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -50.3 -57.45 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 124.442 1.097 . . . . 0.0 110.187 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -54.73 -47.33 73.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.623 0.249 . . . . 0.0 111.044 -178.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.9 m -64.3 -41.31 96.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.517 0.327 . . . . 0.0 110.86 -179.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.2 t -60.2 -50.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -57.43 -50.77 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -48.01 -50.19 28.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.699 0.8 . . . . 0.0 109.976 176.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -75.62 -22.36 56.92 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -153.32 83.88 1.19 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.404 0.682 . . . . 0.0 110.857 -166.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.284 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.61 -169.51 46.04 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.97 141.34 52.01 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.66 165.61 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.884 0.85 . . . . 0.0 110.565 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -146.69 176.84 9.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.819 2.047 . . . . 0.0 105.866 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -39.29 -57.97 1.28 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.849 0.86 . . . . 0.0 112.504 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.67 -58.61 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.822 1.249 . . . . 0.0 112.015 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -67.14 -35.66 80.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.347 0.659 . . . . 0.0 111.645 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -46.12 -47.28 17.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.531 1.533 . . . . 0.0 110.996 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -49.42 -55.28 13.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.107 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.5 -62.02 1.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.933 0.893 . . . . 0.0 111.653 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.83 -27.46 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 125.715 1.606 . . . . 0.0 113.077 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.46 -74.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.567 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.54 -42.31 70.76 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.048 1.295 . . . . 0.0 113.17 -172.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.78 17.07 11.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.727 0.811 . . . . 0.0 111.958 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.9 p -72.99 149.69 43.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.44 1.018 . . . . 0.0 111.892 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.5 p -92.51 -58.77 2.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.43 1.492 . . . . 0.0 108.992 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.67 162.91 63.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.3 1.44 . . . . 0.0 109.058 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.07 164.32 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.518 2.145 . . . . 0.0 112.383 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 t -145.48 144.13 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.66 97.41 5.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.06 119.52 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -94.2 111.67 23.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 57' ' ' LEU . 26.5 m-85 -78.49 109.92 13.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -123.84 -171.42 2.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.826 0.85 . . . . 0.0 111.157 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.7 151.4 2.84 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.64 1.176 . . . . 0.0 108.137 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.51 -33.47 98.04 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.457 2.105 . . . . 0.0 112.759 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -74.47 -14.15 60.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.528 -0.732 . . . . 0.0 111.018 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.45 82.8 8.13 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.123 -0.986 . . . . 0.0 111.304 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.27 -58.03 2.96 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.732 1.158 . . . . 0.0 113.864 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.71 -40.37 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 CA-C-N 119.748 1.774 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -58.53 -52.08 67.15 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -55.95 -48.5 75.66 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.86 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -74.48 -22.26 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.884 0.765 . . . . 0.0 111.741 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.514 HG22 HG23 ' A' ' 41' ' ' VAL . 18.4 mm -81.69 -34.51 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.496 1.043 . . . . 0.0 110.805 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.05 -45.44 4.66 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.207 1.803 . . . . 0.0 115.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -62.52 -40.48 38.29 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.983 1.789 . . . . 0.0 109.821 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.91 -48.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.716 1.207 . . . . 0.0 107.762 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 37' ' ' ILE . 76.2 t -52.09 -51.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.905 0.882 . . . . 0.0 108.823 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.0 -57.78 10.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.08 -43.68 87.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.882 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.26 -49.4 76.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.26 72.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.447 -0.783 . . . . 0.0 111.668 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -48.99 83.24 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -55.19 -47.86 74.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -83.53 59.11 4.92 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.309 1.528 . . . . 0.0 111.379 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 155.35 13.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.925 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 68.51 -55.1 0.53 Allowed 'General case' 0 C--N 1.338 0.099 0 C-N-CA 129.024 2.929 . . . . 0.0 113.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -82.84 -53.16 6.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -81.1 99.28 8.42 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.671 -171.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -79.66 87.38 5.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.24 152.36 32.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.856 -1.152 . . . . 0.0 108.805 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.84 166.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 121.752 -0.592 . . . . 0.0 109.745 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -130.31 121.33 25.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.63 1.172 . . . . 0.0 109.381 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.559 HD23 ' CE2' ' A' ' 26' ' ' PHE . 42.6 tp -108.43 118.9 37.97 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.859 1.264 . . . . 0.0 110.085 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -73.87 112.98 10.5 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 m -69.74 -28.54 65.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.374 1.47 . . . . 0.0 111.498 -173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.6 -40.64 48.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.174 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -83.01 -27.23 30.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.28 2.232 . . . . 0.0 112.162 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.8 m -132.34 62.15 61.49 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.216 1.406 . . . . 0.0 109.718 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.03 -33.65 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 1 C-N-CA 125.509 4.139 . . . . 0.0 109.97 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -30.07 -73.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.332 2.253 . . . . 0.0 111.964 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -35.4 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.328 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.21 76.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -68.2 -47.23 68.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.146 0.978 . . . . 0.0 109.554 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -55.9 -43.34 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.69 -34.81 45.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.018 0.527 . . . . 0.0 111.247 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 56.35 1.07 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.4 mt -122.02 146.36 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.84 1.656 . . . . 0.0 107.638 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -149.35 -64.23 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.26 144.87 56.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 pt -143.54 156.31 60.15 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.11 141.61 57.54 Favored 'Cis proline' 0 N--CA 1.454 -0.812 0 CA-C-N 120.007 1.038 . . . . 0.0 113.528 3.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -133.91 101.25 5.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.11 100.54 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.374 1.47 . . . . 0.0 107.646 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtt -88.25 148.1 24.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.54 139.43 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 C-N-CA 125.659 1.584 . . . . 0.0 107.671 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -129.21 144.59 51.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.411 ' H ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -101.41 -27.03 13.38 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.318 0.386 . . . . 0.0 111.22 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.7 87.95 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 -63.15 2.8 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.554 0.597 . . . . 0.0 112.178 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -79.88 154.6 28.24 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.608 0.763 . . . . 0.0 110.701 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -71.27 158.05 37.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.51 1.124 . . . . 0.0 109.72 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.96 -58.18 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.714 1.206 . . . . 0.0 110.176 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -141.79 177.68 8.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.695 1.198 . . . . 0.0 110.112 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.7 m -156.38 132.74 10.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.282 1.033 . . . . 0.0 109.546 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.3 mt -109.46 144.26 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -130.19 142.58 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 173.61 47.26 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.792 0.71 . . . . 0.0 112.49 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.26 156.1 35.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.797 0.439 . . . . 0.0 109.92 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.66 156.67 38.86 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.028 0.931 . . . . 0.0 109.059 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -82.99 139.35 9.56 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.174 2.582 . . . . 0.0 107.171 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -48.58 -45.27 37.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 0.0 112.672 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -45.66 67.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.985 0.421 . . . . 0.0 110.626 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -65.15 -45.98 82.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.1 mt -56.2 -52.42 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 t -48.86 -58.51 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 124.609 1.163 . . . . 0.0 109.429 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.14 -47.46 83.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.494 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.0 m -56.06 -43.4 77.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.485 1.114 . . . . 0.0 110.11 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.94 -52.04 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 121.387 -0.82 . . . . 0.0 109.095 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -52.63 -47.34 67.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.62 0.768 . . . . 0.0 112.745 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.67 -23.78 65.09 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.944 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 118.809 0.731 . . . . 0.0 109.686 179.002 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.5 167.37 50.14 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.781 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.06 128.21 56.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.68 165.44 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 122.482 1.134 . . . . 0.0 111.604 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -142.89 172.14 13.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.784 2.434 . . . . 0.0 106.023 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -39.26 -49.87 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.99 1.716 . . . . 0.0 112.371 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.57 -74.08 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.227 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 p -50.31 -42.08 52.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.591 1.156 . . . . 0.0 111.826 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -39.93 -42.84 1.41 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.679 1.992 . . . . 0.0 111.15 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -61.88 -58.84 6.39 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 111.76 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -62.09 -32.74 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.323 0.649 . . . . 0.0 111.403 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -93.12 -30.24 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.898 0.879 . . . . 0.0 113.255 -170.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.95 -72.43 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 124.626 1.17 . . . . 0.0 109.828 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.4 mt -46.98 -55.84 7.43 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.981 0.912 . . . . 0.0 111.584 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.49 7.97 8.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 113.175 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -71.29 143.14 50.44 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 120.027 1.285 . . . . 0.0 110.615 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -81.87 -60.5 2.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.652 1.181 . . . . 0.0 108.73 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.04 162.43 64.55 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.186 0.995 . . . . 0.0 109.484 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.02 160.31 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.901 2.4 . . . . 0.0 113.713 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 t -143.06 147.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.174 1.39 . . . . 0.0 108.417 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.36 110.84 13.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.06 139.85 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -111.72 120.46 42.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.21 113.89 17.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -127.27 -172.15 2.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.764 0.793 . . . . 0.0 110.279 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.45 152.52 4.02 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -52.76 -42.87 60.21 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.579 2.186 . . . . 0.0 112.614 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.518 ' CH2' HD11 ' A' ' 74' ' ' ILE . 26.4 p-90 -69.07 -12.81 62.01 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.768 -0.582 . . . . 0.0 112.269 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -77.82 80.78 4.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.797 -1.189 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.93 -56.49 3.78 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.354 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.92 -29.93 88.06 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.945 1.763 . . . . 0.0 112.414 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.26 -48.34 57.27 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -48.32 50.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.657 0.783 . . . . 0.0 111.647 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.25 -20.65 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.877 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.4 pt -90.02 -28.88 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 121.126 1.784 . . . . 0.0 110.264 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.43 -47.37 4.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.36 -39.4 57.16 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.332 2.021 . . . . 0.0 110.216 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.85 -46.34 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.08 -42.18 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.76 -65.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.421 0.688 . . . . 0.0 111.927 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -42.35 78.13 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.275 1.398 . . . . 0.0 111.727 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mt -62.77 -26.23 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.553 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.93 90.82 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.7 1.136 . . . . 0.0 109.016 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -47.49 90.83 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -58.35 -50.66 72.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -97.25 33.19 2.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.387 0.675 . . . . 0.0 112.349 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -60.27 168.83 1.85 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.607 0.718 . . . . 0.0 111.307 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 71.9 -58.55 0.58 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 127.377 2.271 . . . . 0.0 111.743 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.4 -50.15 11.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.866 -174.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.9 105.84 16.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.105 0.562 . . . . 0.0 110.108 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.15 98.96 6.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.0 t -79.32 137.34 37.3 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.559 -0.713 . . . . 0.0 110.47 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.16 163.71 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.524 0.678 . . . . 0.0 112.195 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -133.86 118.53 18.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.406 1.482 . . . . 0.0 109.595 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tp -99.5 124.17 44.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.63 109.05 7.79 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -67.39 -36.82 82.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.008 1.323 . . . . 0.0 111.243 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -66.4 -38.34 87.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.37 1.068 . . . . 0.0 110.106 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.83 -25.43 32.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.162 1.785 . . . . 0.0 111.363 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.2 t -122.6 52.73 4.32 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.461 1.504 . . . . 0.0 112.636 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.29 -25.94 71.79 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.135 3.224 . . . . 0.0 110.45 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -54.62 -63.26 1.21 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.702 0.801 . . . . 0.0 108.911 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.75 -51.23 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.794 0.838 . . . . 0.0 109.061 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.86 -47.99 21.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.228 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -67.37 -48.83 66.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.533 0.733 . . . . 0.0 110.797 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.55 -46.98 73.73 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.539 0.736 . . . . 0.0 111.203 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -79.56 -31.17 41.9 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.162 0.585 . . . . 0.0 111.166 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.84 52.1 3.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mm -73.54 84.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 122.192 0.996 . . . . 0.0 109.345 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -78.42 76.38 4.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m 94.31 166.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.391 2.676 . . . . 0.0 110.383 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.518 HD11 ' CH2' ' A' ' 30' ' ' TRP . 28.9 pt -136.21 153.68 76.75 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.169 0.988 . . . . 0.0 108.544 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.06 145.83 76.44 Favored 'Cis proline' 0 N--CA 1.453 -0.858 0 CA-C-N 120.31 1.146 . . . . 0.0 112.772 1.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 m -139.45 113.17 8.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.58 138.16 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 mtt -129.85 143.89 51.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.5 t -107.76 139.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 126.045 1.738 . . . . 0.0 107.065 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -126.62 134.48 50.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.453 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -100.64 -26.67 13.73 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.69 67.95 0.25 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.35 -56.89 3.71 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.89 157.66 26.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.844 0.857 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -65.76 160.63 22.54 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.87 1.668 . . . . 0.0 111.482 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.0 t -129.61 -66.23 0.81 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.471 1.508 . . . . 0.0 109.541 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -138.27 172.72 12.49 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.818 1.247 . . . . 0.0 110.007 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.6 t -160.47 153.49 21.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.041 0.936 . . . . 0.0 109.819 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.4 mm -134.54 146.24 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.76 142.16 42.54 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 126.379 1.872 . . . . 0.0 108.25 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.92 155.05 16.69 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.316 0.484 . . . . 0.0 111.998 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.95 52.37 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.549 1.14 . . . . 0.0 112.588 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.7 145.69 63.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.44 147.47 68.33 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.24 1.293 . . . . 0.0 111.426 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -58.1 -34.68 70.45 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.59 55.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.247 0.93 . . . . 0.0 110.992 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -49.48 77.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.237 1.015 . . . . 0.0 109.007 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 mm -58.26 -49.68 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.693 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.39 -53.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.45 1.1 . . . . 0.0 109.21 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.09 -48.89 72.94 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.3 m -60.8 -36.74 79.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.233 0.613 . . . . 0.0 111.441 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.81 -53.71 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 121.206 -0.934 . . . . 0.0 108.826 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -53.44 -42.24 66.92 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.412 1.085 . . . . 0.0 110.86 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -49.83 -45.89 50.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.309 0.644 . . . . 0.0 110.404 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.089 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 110.774 -0.084 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.1 -178.47 44.68 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.5 136.86 54.64 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.86 166.7 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.635 1.207 . . . . 0.0 112.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -149.15 172.71 14.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.298 2.639 . . . . 0.0 105.269 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -38.01 -50.12 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.85 2.06 . . . . 0.0 111.687 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.34 -72.22 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 111.572 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -58.64 -33.95 70.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 112.292 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -42.57 -44.64 4.25 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.603 1.961 . . . . 0.0 111.051 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -54.05 -55.61 25.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.504 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.33 -46.11 56.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.344 0.658 . . . . 0.0 111.858 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -85.07 -19.48 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.884 1.274 . . . . 0.0 114.085 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.6 -51.64 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.611 1.096 . . . . 0.0 112.044 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.32 -52.07 25.5 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.938 -0.476 . . . . 0.0 111.543 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -79.12 -9.12 59.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 m -55.73 135.4 51.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.636 1.174 . . . . 0.0 112.852 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 p -79.87 -62.03 1.81 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.805 1.242 . . . . 0.0 109.725 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.93 157.25 76.53 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -54.42 157.62 11.47 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.711 2.274 . . . . 0.0 113.931 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.27 118.45 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.547 1.539 . . . . 0.0 110.676 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.55 91.64 7.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.67 1.188 . . . . 0.0 108.417 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 p -99.27 125.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -99.41 121.31 40.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.57 0.748 . . . . 0.0 109.199 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.425 ' CD2' HD13 ' A' ' 71' ' ' ILE . 6.1 m-85 -79.77 116.51 19.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -133.31 -170.67 2.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.915 0.486 . . . . 0.0 110.662 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.43 151.08 4.35 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -54.58 -40.05 85.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.71 2.273 . . . . 0.0 113.147 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -68.7 -16.62 63.88 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.451 0.568 . . . . 0.0 111.348 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -77.61 79.55 4.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.31 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.57 -57.34 4.53 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.66 -34.55 15.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.423 3.415 . . . . 0.0 114.244 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.01 -54.41 6.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.97 0.891 . . . . 0.0 108.638 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.9 tpt85 -47.42 -49.11 25.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.197 0.999 . . . . 0.0 111.381 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.31 -26.58 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.776 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 pt -87.75 -26.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.194 1.816 . . . . 0.0 110.514 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -46.18 4.05 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.75 -40.98 26.32 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.103 1.868 . . . . 0.0 110.378 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.32 -52.06 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.116 1.366 . . . . 0.0 107.879 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.16 -47.21 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 0.0 108.868 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -68.09 -55.5 12.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -60.59 -32.83 71.92 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.491 0.587 . . . . 0.0 109.483 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.61 -49.27 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.09 -33.87 67.74 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.85 -0.531 . . . . 0.0 110.537 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.05 -56.26 26.32 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.1 -41.45 62.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.078 0.439 . . . . 0.0 110.679 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -98.32 25.97 5.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.272 1.029 . . . . 0.0 113.304 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 169.3 2.0 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.446 0.641 . . . . 0.0 111.97 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 73.82 -53.71 0.69 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.784 2.033 . . . . 0.0 111.28 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -78.44 -54.97 5.6 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.61 114.21 27.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.5 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -78.42 163.33 25.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.8 t -145.56 146.13 31.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.42 168.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.482 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -136.0 107.42 6.88 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.685 1.194 . . . . 0.0 109.611 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -87.57 117.16 26.18 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -73.37 104.15 4.28 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.628 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.7 m -56.37 -46.74 79.9 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.309 1.844 . . . . 0.0 112.023 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.9 -36.7 82.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.26 1.824 . . . . 0.0 110.479 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -84.65 -26.01 28.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.459 1.904 . . . . 0.0 111.116 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -122.01 54.61 5.34 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.855 1.662 . . . . 0.0 111.905 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.6 -24.84 76.85 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 124.098 3.198 . . . . 0.0 111.02 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -51.83 -71.66 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.046 0.938 . . . . 0.0 109.089 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -53.48 -48.34 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.648 1.179 . . . . 0.0 109.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.29 -51.32 46.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.855 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -70.66 -43.99 67.99 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.573 0.749 . . . . 0.0 110.878 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.1 -47.67 68.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.564 0.745 . . . . 0.0 110.303 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -79.35 -31.09 42.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.95 48.08 5.93 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' A' ' 26' ' ' PHE . 2.6 pt -74.38 97.96 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.072 0.939 . . . . 0.0 109.894 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 69.08 4.68 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 109.208 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t 101.6 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 129.48 3.112 . . . . 0.0 109.506 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -143.59 161.01 48.9 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.3 1.84 . . . . 0.0 109.318 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -68.57 157.01 88.94 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 120.697 1.285 . . . . 0.0 113.054 2.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -152.07 102.59 2.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -79.86 131.96 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.7 mtt -125.54 136.79 53.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -96.02 101.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -89.01 148.62 23.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 33.94 1.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.625 0.578 . . . . 0.0 110.728 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 105.57 3.0 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.69 -70.93 0.9 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.524 1.059 . . . . 0.0 113.025 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -101.53 169.84 8.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.055 0.931 . . . . 0.0 112.189 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -84.09 165.09 18.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.334 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.79 -58.88 1.92 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.16 1.384 . . . . 0.0 108.911 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -133.18 176.29 8.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.112 1.365 . . . . 0.0 109.434 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 t -158.76 160.89 36.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.083 0.553 . . . . 0.0 110.706 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.3 mt -138.15 122.92 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.03 139.73 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.988 0.915 . . . . 0.0 109.404 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.0 153.92 14.76 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 121.47 0.483 . . . . 0.0 113.133 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.52 73.69 1.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.991 -0.711 . . . . 0.0 111.307 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.74 148.18 72.26 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.96 157.07 11.25 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.03 2.487 . . . . 0.0 113.948 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -51.94 -45.78 64.48 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.68 0.792 . . . . 0.0 111.646 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.66 64.58 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.277 0.631 . . . . 0.0 110.355 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -48.13 78.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.41 -57.08 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.8 t -48.96 -61.27 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.994 1.318 . . . . 0.0 109.872 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -52.8 -46.49 67.68 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.344 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.8 m -63.18 -44.54 95.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.622 0.369 . . . . 0.0 110.919 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.23 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 121.207 -0.933 . . . . 0.0 108.882 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -55.58 -54.05 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -47.3 -49.79 23.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.45 1.1 . . . . 0.0 110.166 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.613 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.28 -171.94 25.03 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 169.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 141.51 45.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -139.87 173.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 122.801 1.286 . . . . 0.0 110.895 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.98 171.08 18.38 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.323 2.649 . . . . 0.0 104.627 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -39.17 -53.64 1.84 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 112.832 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -52.78 63.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.312 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -73.58 -35.54 65.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.273 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -39.43 -48.16 1.91 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.601 2.36 . . . . 0.0 110.535 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -42.62 -70.44 0.11 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.169 0.988 . . . . 0.0 112.206 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.6 -47.68 80.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.533 1.133 . . . . 0.0 111.602 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.68 -37.18 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.521 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.17 -65.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.056 0.943 . . . . 0.0 110.99 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -62.8 -59.43 4.87 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -172.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.49 41.39 0.47 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.879 -0.513 . . . . 0.0 111.66 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -90.31 168.86 11.58 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -97.18 -71.65 0.67 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.542 1.537 . . . . 0.0 107.904 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.21 157.63 75.39 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.81 159.59 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.0 1.8 . . . . 0.0 114.961 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.18 127.88 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.942 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 23' ' ' LEU . 5.5 tt -103.34 104.82 14.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.031 1.732 . . . . 0.0 107.522 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.02 126.47 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.93 115.88 31.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -79.1 111.74 15.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -128.21 -174.32 3.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 122.111 0.958 . . . . 0.0 110.015 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.7 140.01 2.11 Favored Pre-proline 0 N--CA 1.451 -0.38 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -39.2 -54.47 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.362 2.708 . . . . 0.0 117.393 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -57.79 -20.89 38.73 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.819 0.736 . . . . 0.0 112.549 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 85.91 0.83 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.367 0.667 . . . . 0.0 112.13 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.2 -55.04 4.42 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.322 0.963 . . . . 0.0 113.816 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.01 -36.06 98.31 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.2 1.933 . . . . 0.0 110.959 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -66.44 -49.34 67.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -55.4 -46.31 76.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.456 0.302 . . . . 0.0 111.094 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.88 -30.4 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.128 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 tp -84.69 -35.97 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 120.619 1.554 . . . . 0.0 112.437 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.44 -49.16 4.94 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -60.32 -34.27 93.73 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.835 2.356 . . . . 0.0 110.766 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.84 -47.95 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.366 1.066 . . . . 0.0 108.379 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.58 -51.17 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -57.45 -55.28 36.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.404 . . . . 0.0 110.994 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.37 -50.84 72.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.739 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -51.13 -52.34 18.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.32 73.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.72 -41.21 97.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -66.85 -50.84 61.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -83.71 59.94 5.45 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.456 1.122 . . . . 0.0 109.878 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -46.1 -67.36 0.29 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.965 2.106 . . . . 0.0 111.988 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.92 -57.96 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.097 1.359 . . . . 0.0 114.202 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -78.9 -54.59 5.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.36 117.62 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.85 -163.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -91.34 116.37 28.79 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.754 1.221 . . . . 0.0 110.55 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.3 t -78.47 142.35 37.56 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.329 -0.857 . . . . 0.0 109.665 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.2 164.3 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -137.22 115.82 12.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.073 0.949 . . . . 0.0 109.58 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.45 118.23 34.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.87 0.868 . . . . 0.0 109.508 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -71.81 107.33 4.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.9 m -59.33 -43.06 92.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.092 1.757 . . . . 0.0 111.545 -173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.63 -35.87 82.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.909 0.884 . . . . 0.0 110.316 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.81 -24.71 30.89 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.425 1.49 . . . . 0.0 111.514 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 49.74 2.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.507 1.923 . . . . 0.0 113.23 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.13 -25.56 37.33 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.629 3.552 . . . . 0.0 109.713 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -51.26 -54.72 23.21 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.031 0.932 . . . . 0.0 109.189 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.9 -57.11 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.753 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.39 -45.1 65.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.427 0.691 . . . . 0.0 112.168 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -65.93 -48.74 70.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.996 0.519 . . . . 0.0 109.927 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.91 -38.12 69.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.529 0.332 . . . . 0.0 110.609 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.62 -23.49 45.87 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.14 40.11 11.93 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.203 0.906 . . . . 0.0 111.634 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.03 169.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.494 1.118 . . . . 0.0 109.089 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -154.25 -58.39 0.12 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.893 0.877 . . . . 0.0 109.386 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 147.93 30.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.38 155.54 60.97 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.65 142.32 69.41 Favored 'Cis proline' 0 N--CA 1.453 -0.855 0 CA-C-N 120.134 1.084 . . . . 0.0 112.322 1.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -137.05 102.48 4.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.03 134.71 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 33.5 mtt -128.33 123.52 34.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.5 t -95.88 141.54 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -127.1 158.3 37.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.332 1.453 . . . . 0.0 107.913 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 42.62 1.18 Allowed 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.335 1.022 . . . . 0.0 110.726 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.2 97.17 2.28 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.49 -73.19 0.77 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.428 0.537 . . . . 0.0 112.213 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.84 160.54 26.06 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.315 1.055 . . . . 0.0 111.847 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.95 143.75 28.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.512 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.2 t -88.38 -70.29 0.65 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.283 1.033 . . . . 0.0 108.289 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -150.79 -175.37 5.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.588 1.555 . . . . 0.0 109.256 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -143.73 162.42 36.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.916 1.286 . . . . 0.0 109.719 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.3 mt -139.24 140.78 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.33 138.72 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.78 153.72 25.95 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 121.888 0.716 . . . . 0.0 112.116 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.97 78.01 3.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.246 0.618 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -78.28 152.25 78.76 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.26 153.23 22.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.592 2.194 . . . . 0.0 113.995 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -46.6 -50.25 17.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.278 1.831 . . . . 0.0 110.654 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.2 -47.25 75.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.933 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -62.54 -46.21 89.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.568 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.1 mt -54.68 -55.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 t -52.33 -59.03 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.218 0.607 . . . . 0.0 110.042 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -49.47 -52.14 31.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.436 0.694 . . . . 0.0 110.338 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 45.4 m -61.7 -45.37 94.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.214 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.06 -56.24 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 118.739 0.699 . . . . 0.0 109.583 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -62.72 -43.76 97.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.932 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -51.24 -54.4 26.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.258 0.623 . . . . 0.0 109.552 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.649 -176.095 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.03 157.1 36.07 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.987 1.28 . . . . 0.0 113.285 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.3 114.85 20.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.14 164.54 20.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 122.806 1.289 . . . . 0.0 110.13 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -143.21 174.75 10.43 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.348 1.859 . . . . 0.0 106.691 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -53.41 2.1 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.957 1.303 . . . . 0.0 113.229 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.94 -59.65 2.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.136 0.974 . . . . 0.0 111.46 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -59.11 -34.43 72.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.563 0.745 . . . . 0.0 111.682 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -45.42 -48.29 13.67 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 126.039 1.736 . . . . 0.0 110.541 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -55.15 -53.64 53.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.632 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -53.64 54.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 0.0 112.347 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -75.15 -39.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.875 1.27 . . . . 0.0 113.302 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.61 -66.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.18 0.992 . . . . 0.0 110.903 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.06 -59.2 5.73 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 121.217 0.532 . . . . 0.0 110.877 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -78.87 40.55 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.355 0.662 . . . . 0.0 111.227 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.1 t -90.29 -169.44 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.834 0.854 . . . . 0.0 109.328 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -131.58 -66.14 0.73 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.191 2.196 . . . . 0.0 106.71 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.86 157.0 79.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.02 161.03 7.03 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.391 2.061 . . . . 0.0 112.617 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.28 139.32 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -114.11 117.15 30.44 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.77 115.94 51.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -90.3 111.95 23.33 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.596 ' CD2' HD12 ' A' ' 57' ' ' LEU . 25.8 m-85 -78.76 112.64 16.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -125.36 -173.84 2.92 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.096 0.951 . . . . 0.0 110.265 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.72 152.49 4.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -55.33 -32.02 79.46 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.393 2.062 . . . . 0.0 113.544 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.419 ' CH2' HD11 ' A' ' 74' ' ' ILE . 38.1 p-90 -78.98 -6.42 56.26 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.3 0.955 . . . . 0.0 111.737 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.17 88.22 6.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.827 -1.171 . . . . 0.0 111.192 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.11 -63.52 0.91 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.639 1.114 . . . . 0.0 113.706 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.36 -47.24 23.07 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.959 2.439 . . . . 0.0 112.63 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 77.7 m -54.27 -44.43 71.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.261 0.624 . . . . 0.0 109.854 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -54.76 -50.11 69.22 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -81.94 -19.68 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.594 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 41' ' ' VAL . 41.2 mt -78.78 -38.88 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.842 0.857 . . . . 0.0 109.224 175.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.85 -49.26 5.72 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.893 2.077 . . . . 0.0 115.553 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.83 -37.24 79.4 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.345 2.03 . . . . 0.0 110.109 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.48 -43.65 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 37' ' ' ILE . 29.7 t -55.67 -45.38 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -56.43 -63.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.557 0.743 . . . . 0.0 109.831 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.92 -37.55 76.93 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.684 0.675 . . . . 0.0 112.04 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -52.25 -36.44 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.632 0.773 . . . . 0.0 110.01 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.59 -39.2 76.27 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.333 0.515 . . . . 0.0 110.988 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.14 -50.4 34.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -53.36 -44.5 68.59 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -115.12 37.43 3.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.656 0.782 . . . . 0.0 112.803 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.98 162.2 2.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.906 0.882 . . . . 0.0 111.176 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 72.77 -61.81 0.49 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.314 2.245 . . . . 0.0 111.353 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -78.0 -32.08 51.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -170.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 tp -125.38 102.9 7.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.88 94.86 5.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.43 132.2 37.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 118.589 -0.719 . . . . 0.0 109.317 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.11 176.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.022 0.828 . . . . 0.0 111.793 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -131.13 122.93 27.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.723 2.009 . . . . 0.0 110.943 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.596 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.0 tm? -104.31 120.15 40.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.607 1.563 . . . . 0.0 109.818 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -74.89 107.61 7.09 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 m -66.76 -33.66 76.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.491 1.516 . . . . 0.0 111.427 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.29 -38.92 78.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.58 -27.85 31.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.762 2.025 . . . . 0.0 111.519 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 57' ' ' LEU . 1.5 m -119.84 52.28 2.16 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.579 1.552 . . . . 0.0 112.431 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -65.98 -30.08 48.48 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 125.49 4.127 . . . . 0.0 109.747 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.83 -62.17 2.07 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -55.73 -47.06 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.388 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.3 -47.42 55.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.194 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -65.74 -46.05 80.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.161 0.585 . . . . 0.0 110.515 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -54.45 -45.8 73.18 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.978 0.511 . . . . 0.0 110.638 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -79.48 -30.93 42.26 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.21 43.29 3.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 123.915 0.769 . . . . 0.0 111.22 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.38 88.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -77.29 -23.24 51.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.2 p -157.24 175.08 14.5 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.419 HD11 ' CH2' ' A' ' 30' ' ' TRP . 21.1 pt -146.62 154.4 48.24 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.08 133.94 26.37 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 CA-C-N 120.92 1.364 . . . . 0.0 113.445 1.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -139.98 104.83 4.95 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.571 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.0 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.78 153.27 34.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.74 133.15 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.218 1.007 . . . . 0.0 108.669 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -128.81 141.98 51.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 133.77 18.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.53 41.75 98.85 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -172.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.19 -47.47 2.63 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 124.451 1.024 . . . . 0.0 114.075 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -79.62 157.26 27.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.044 0.938 . . . . 0.0 111.964 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -88.24 156.07 19.41 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 127.296 2.238 . . . . 0.0 112.83 -172.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.83 -80.28 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.665 0.386 . . . . 0.0 111.626 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -74.71 152.84 39.07 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.107 0.48 . . . . 0.0 111.99 -170.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.7 m -132.94 110.88 10.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.969 2.508 . . . . 0.0 106.005 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.47 123.86 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -78.83 146.85 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.93 -137.72 0.69 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 71.53 -46.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.945 1.298 . . . . 0.0 110.687 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.08 148.49 75.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.18 68.75 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.526 1.484 . . . . 0.0 111.696 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -50.62 -37.41 40.22 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.227 1.011 . . . . 0.0 111.27 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.55 -41.73 21.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.508 0.595 . . . . 0.0 111.192 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -47.21 84.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.708 0.803 . . . . 0.0 108.869 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 mt -63.27 -40.29 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.825 1.25 . . . . 0.0 110.072 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.8 t -57.89 -58.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.921 1.288 . . . . 0.0 108.143 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.01 -46.63 68.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.233 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 m -60.39 -51.98 67.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.189 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.77 -44.15 93.18 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.34 -0.85 . . . . 0.0 110.854 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -50.46 -39.73 48.76 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.869 0.868 . . . . 0.0 111.558 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -59.64 -29.25 67.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.294 -0.254 . . . . 0.0 111.399 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 CA--C 1.529 0.156 0 C-N-CA 123.691 0.797 . . . . 0.0 109.995 179.225 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.88 179.68 44.27 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.33 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.67 137.46 54.45 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.428 ' CG1' HG11 ' A' ' 14' ' ' VAL . 5.7 m -130.14 164.02 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 118.972 0.806 . . . . 0.0 111.158 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.02 169.9 17.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 173.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -38.92 -45.26 1.16 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.352 1.861 . . . . 0.0 112.41 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.09 -74.14 0.12 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.028 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -48.81 -38.9 23.48 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.499 1.12 . . . . 0.0 111.564 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -38.95 -47.36 1.44 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.364 2.266 . . . . 0.0 110.591 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -48.3 -64.67 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.96 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.08 -38.55 75.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.126 1.37 . . . . 0.0 111.911 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.775 HG13 HG23 ' A' ' 15' ' ' VAL . 3.7 p -83.0 -47.86 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.293 1.037 . . . . 0.0 113.424 -172.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.775 HG23 HG13 ' A' ' 14' ' ' VAL . 57.3 t -95.85 -57.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.726 0.81 . . . . 0.0 110.886 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.48 -57.0 6.47 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.57 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.39 45.53 0.67 Allowed 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.444 -0.785 . . . . 0.0 111.221 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 p -90.52 164.72 14.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.545 1.138 . . . . 0.0 111.128 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.5 p -104.98 -68.62 0.85 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.623 1.569 . . . . 0.0 107.162 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.0 162.93 62.73 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.034 1.333 . . . . 0.0 108.035 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.613 ' HB2' HD13 ' A' ' 52' ' ' LEU . 53.1 Cg_exo -56.27 167.9 2.33 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.799 1.666 . . . . 0.0 112.294 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -146.28 120.27 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.574 1.549 . . . . 0.0 109.215 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -97.72 102.79 14.64 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -98.21 109.73 24.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.362 0.665 . . . . 0.0 109.801 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -87.77 117.72 26.8 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -79.19 112.6 16.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -126.31 -173.74 2.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.843 0.83 . . . . 0.0 111.008 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.66 156.76 3.43 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.41 -36.42 78.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.315 2.01 . . . . 0.0 109.991 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -76.68 -3.56 38.58 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.708 0.803 . . . . 0.0 111.738 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.4 t -63.69 -60.42 3.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.714 1.143 . . . . 0.0 111.659 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 -86.02 0.52 Allowed Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.069 -1.406 . . . . 0.0 110.761 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.97 -46.13 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.415 2.744 . . . . 0.0 111.843 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.0 m -46.13 -46.53 17.19 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.374 1.47 . . . . 0.0 111.41 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -67.87 -44.08 77.92 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.656 0.783 . . . . 0.0 110.797 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.97 -13.13 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.875 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.59 -38.49 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.062 1.345 . . . . 0.0 108.491 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -37.95 -47.38 2.71 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.905 2.082 . . . . 0.0 114.721 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.13 -39.97 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.828 1.686 . . . . 0.0 109.918 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -74.91 -47.52 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.629 1.972 . . . . 0.0 109.505 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -61.06 -38.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.601 -1.312 . . . . 0.0 109.568 175.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.86 -54.25 24.21 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 119.286 -0.387 . . . . 0.0 110.822 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.08 -41.89 89.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.32 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mm -55.3 -46.49 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.27 -51.09 57.32 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.16 -54.21 13.02 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -61.73 -54.0 48.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.678 0.752 . . . . 0.0 112.916 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -83.21 -8.06 59.53 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -37.31 -58.49 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.501 1.921 . . . . 0.0 113.5 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.21 -39.91 60.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.952 1.301 . . . . 0.0 112.802 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -91.32 -37.47 13.24 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.887 1.275 . . . . 0.0 113.301 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -158.03 145.5 18.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.84 1.256 . . . . 0.0 108.446 -168.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -93.82 154.67 17.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.997 1.719 . . . . 0.0 109.678 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 147.01 49.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.83 167.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.133 0.424 . . . . 0.0 111.021 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -135.54 113.65 11.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.661 1.185 . . . . 0.0 111.545 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 62' ' ' SER . 8.9 tt -94.87 116.53 28.84 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.126 0.971 . . . . 0.0 109.57 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -75.88 111.38 11.19 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -66.53 -29.23 69.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.366 1.466 . . . . 0.0 111.85 -173.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.69 -38.31 54.67 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.915 1.286 . . . . 0.0 109.787 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -80.91 -25.94 37.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.044 1.737 . . . . 0.0 110.782 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' HD21 ' A' ' 57' ' ' LEU . 3.1 m -117.33 51.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.916 2.087 . . . . 0.0 112.232 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -63.78 -31.0 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 125.598 4.198 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -58.4 -64.24 0.99 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.19 -44.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.851 0.357 . . . . 0.0 110.073 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.79 64.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -67.78 -44.46 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.226 0.61 . . . . 0.0 110.628 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.73 -45.85 70.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 110.222 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -79.56 -33.2 42.01 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.79 50.11 2.18 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.85 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.777 0.831 . . . . 0.0 109.351 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' H ' ' CD ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.08 -26.31 43.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.905 0.882 . . . . 0.0 110.812 177.429 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.9 m -160.24 160.17 32.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.833 1.253 . . . . 0.0 107.781 -171.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 pt -143.35 160.7 50.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.956 1.702 . . . . 0.0 107.566 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.7 154.57 79.46 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 CA-C-N 121.426 1.545 . . . . 0.0 113.838 3.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.6 m -151.14 104.04 3.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.8 mt -91.12 118.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.9 mtt -103.86 129.52 51.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.7 t -91.18 115.76 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.47 166.18 12.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.822 1.249 . . . . 0.0 108.626 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.28 -161.0 0.71 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.06 102.86 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.33 1.443 . . . . 0.0 114.656 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.27 -64.35 2.07 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.75 1.167 . . . . 0.0 114.963 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.43 177.74 4.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.479 1.133 . . . . 0.0 113.706 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -87.72 155.92 19.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.041 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.6 t -103.59 -69.15 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.823 1.249 . . . . 0.0 108.994 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.42 177.96 8.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 108.39 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -152.87 149.29 28.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.892 -0.505 . . . . 0.0 109.975 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -121.52 104.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.955 2.102 . . . . 0.0 107.026 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.4 mt -89.49 137.38 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.05 1.34 . . . . 0.0 107.799 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.64 150.0 25.42 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 121.697 0.609 . . . . 0.0 112.284 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.42 64.18 2.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.954 0.901 . . . . 0.0 112.031 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.29 150.66 74.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.21 149.25 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.728 1.619 . . . . 0.0 112.1 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -45.69 66.72 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.95 -43.72 14.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.206 0.602 . . . . 0.0 111.515 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -51.43 67.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.993 0.917 . . . . 0.0 108.931 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.0 -52.19 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 123.829 0.852 . . . . 0.0 109.775 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.28 -57.3 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.267 0.94 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -55.28 -49.28 72.52 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.807 0.336 . . . . 0.0 110.286 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.5 m -57.23 -45.98 83.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.725 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.79 -52.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 120.915 -1.116 . . . . 0.0 109.267 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.02 -38.34 65.03 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.731 1.212 . . . . 0.0 111.721 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -54.7 -33.5 61.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.505 0.322 . . . . 0.0 110.88 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 . . . . . 0 CA--C 1.536 0.427 0 C-N-CA 125.354 1.462 . . . . 0.0 113.145 -174.055 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.38 167.47 54.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.392 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.04 132.16 50.58 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -131.39 173.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 122.074 0.94 . . . . 0.0 110.043 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -155.66 178.28 10.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.309 2.244 . . . . 0.0 105.48 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -45.7 -55.95 5.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.993 0.815 . . . . 0.0 111.699 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.31 -57.79 4.29 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.833 1.653 . . . . 0.0 112.623 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 p -74.06 -47.0 39.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.863 0.865 . . . . 0.0 111.293 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -39.66 -48.7 2.17 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.229 2.212 . . . . 0.0 110.739 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -40.03 -53.83 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.708 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -87.27 -47.83 8.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.366 1.079 . . . . 0.0 110.695 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.28 -32.89 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.217 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -109.95 -64.56 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.02 1.328 . . . . 0.0 111.603 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.23 -71.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.312 0.505 . . . . 0.0 111.14 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.43 53.64 2.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.905 0.882 . . . . 0.0 108.8 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.1 p -90.8 -129.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.024 0.929 . . . . 0.0 109.56 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.1 p -161.54 -78.04 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.05 163.71 58.65 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -50.17 163.13 0.64 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.814 2.343 . . . . 0.0 114.043 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 t -146.45 141.54 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 108.784 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.01 97.53 5.14 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.96 129.85 47.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -102.32 116.67 33.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.21 108.66 12.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -124.49 -175.5 3.28 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 123.716 0.635 . . . . 0.0 110.475 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.53 142.07 1.35 Allowed Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.922 0.889 . . . . 0.0 111.077 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.73 108.72 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.228 1.952 . . . . 0.0 108.468 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 137.85 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 1 C-N-CA 131.756 4.022 . . . . 0.0 105.846 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.7 t -74.93 83.02 2.2 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.54 -58.96 2.84 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.249 0.928 . . . . 0.0 112.25 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -48.54 -34.14 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.967 3.111 . . . . 0.0 113.86 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.41 -46.23 17.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -50.91 -50.24 57.86 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.275 1.43 . . . . 0.0 111.119 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.97 -32.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.422 HG22 HG23 ' A' ' 41' ' ' VAL . 15.5 mm -76.35 -36.86 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.551 1.141 . . . . 0.0 111.95 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.76 -48.49 5.42 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.8 -36.46 61.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.656 2.238 . . . . 0.0 110.179 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.86 -45.23 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 37' ' ' ILE . 46.2 t -54.17 -48.17 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.8 m-20 -59.92 -53.07 62.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.04 -39.69 95.5 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.775 -1.203 . . . . 0.0 110.402 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mt -56.8 -44.4 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 42' ' ' ASP . . . -52.86 -52.82 55.92 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.73 49.06 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -62.99 -43.3 99.16 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -117.08 8.93 13.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -39.65 -46.53 1.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.731 2.012 . . . . 0.0 112.199 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -29.91 -58.81 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.874 2.469 . . . . 0.0 113.508 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -112.29 -31.72 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.343 1.057 . . . . 0.0 112.342 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.46 105.47 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.125 0.57 . . . . 0.0 111.055 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -78.66 91.08 4.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.2 t -79.5 136.44 36.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.997 -1.064 . . . . 0.0 110.328 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.96 173.27 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.522 0.729 . . . . 0.0 111.551 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -139.93 113.07 8.25 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.726 1.21 . . . . 0.0 111.127 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.81 126.84 38.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.738 0.699 . . . . 0.0 110.753 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -77.64 108.97 11.21 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 m -70.87 -33.22 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.754 1.622 . . . . 0.0 111.55 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.4 -40.33 93.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.221 1.01 . . . . 0.0 109.346 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -84.61 -24.16 29.27 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.177 2.191 . . . . 0.0 112.141 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 m -134.97 61.98 50.02 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 120.821 -1.174 . . . . 0.0 111.735 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.06 -23.25 34.18 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 124.962 3.774 . . . . 0.0 109.921 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -42.97 -72.64 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.614 1.565 . . . . 0.0 110.931 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.0 t -52.18 -48.4 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.033 1.333 . . . . 0.0 109.899 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -41.81 66.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.939 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.5 m -74.8 -43.5 54.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.015 . . . . 0.0 110.566 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -54.84 -48.31 73.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.316 0.646 . . . . 0.0 109.938 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -79.44 -33.0 42.84 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.56 56.7 4.12 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.3 pt -67.49 142.28 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.492 0.663 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -79.6 71.7 6.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.6 t 65.33 -157.28 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.616 1.166 . . . . 0.0 109.384 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 153.04 69.96 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.313 1.045 . . . . 0.0 110.103 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.24 145.07 82.33 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 CA-C-N 119.536 0.87 . . . . 0.0 112.515 2.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.1 m -136.08 106.66 6.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.65 105.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.928 1.691 . . . . 0.0 106.54 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.6 mtp -103.62 127.53 51.04 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.46 134.03 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -120.65 136.73 54.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 173.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.426 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -107.43 -101.3 0.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 81' ' ' LYS . . . -71.85 73.15 0.84 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.61 -59.94 3.33 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.328 0.966 . . . . 0.0 112.975 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -86.09 173.27 9.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.36 0.6 . . . . 0.0 112.279 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.21 152.92 10.09 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.948 1.699 . . . . 0.0 113.411 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 t -130.54 -56.87 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.666 1.987 . . . . 0.0 109.058 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.05 166.95 21.54 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.397 1.079 . . . . 0.0 110.632 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 m -152.75 95.5 2.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.817 1.647 . . . . 0.0 106.618 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.33 141.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.3 mt -133.22 142.96 40.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 155.94 32.19 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 71.96 1.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.099 -0.648 . . . . 0.0 111.67 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -79.13 153.66 77.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.43 154.46 53.27 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.343 2.028 . . . . 0.0 114.424 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -45.38 -53.49 8.55 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.364 1.866 . . . . 0.0 109.47 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.49 -55.79 4.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.727 1.211 . . . . 0.0 110.132 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -59.19 -53.39 58.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 110.539 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 80.8 mt -51.87 -58.67 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.88 -60.29 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.976 1.31 . . . . 0.0 109.907 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -49.23 -49.14 44.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.269 0.486 . . . . 0.0 111.163 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.7 m -61.53 -57.72 10.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 p -63.51 -45.06 98.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 118.561 -1.256 . . . . 0.0 111.257 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -50.96 -49.76 59.39 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.765 1.626 . . . . 0.0 110.741 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -51.72 -48.84 63.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.719 175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -173.2 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.436 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.2 168.16 54.73 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.31 131.65 56.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.82 162.83 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 122.167 0.984 . . . . 0.0 110.488 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -142.72 176.59 8.93 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.407 1.883 . . . . 0.0 106.338 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -39.22 -58.84 1.11 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.653 1.181 . . . . 0.0 112.383 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -54.62 -58.09 8.87 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.851 1.661 . . . . 0.0 113.09 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -67.2 -46.38 74.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.3 1.84 . . . . 0.0 110.558 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -40.15 -51.5 2.64 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 126.84 2.056 . . . . 0.0 111.212 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -44.08 -52.5 7.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.664 0.745 . . . . 0.0 110.931 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.66 -58.06 3.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.606 0.717 . . . . 0.0 111.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.33 -43.6 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.565 -169.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.68 -61.54 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.518 1.127 . . . . 0.0 111.348 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -70.68 -63.03 1.17 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.929 0.786 . . . . 0.0 110.508 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -79.92 52.63 1.53 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.619 0.645 . . . . 0.0 111.48 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 p -89.02 155.36 19.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.783 1.633 . . . . 0.0 110.322 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -87.1 -73.77 0.46 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.66 162.01 64.59 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.58 166.88 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.323 2.016 . . . . 0.0 114.18 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.14 149.02 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.362 1.865 . . . . 0.0 110.466 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 tt -126.87 102.03 6.84 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 170.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.0 p -107.08 123.6 62.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.116 1.325 . . . . 0.0 108.789 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -93.59 115.29 27.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CD2' HD12 ' A' ' 57' ' ' LEU . 25.2 m-85 -79.61 104.07 9.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -116.61 -169.91 1.72 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.315 1.046 . . . . 0.0 110.24 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.49 148.73 1.55 Allowed Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 124.595 1.158 . . . . 0.0 107.923 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.03 -37.71 95.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.559 2.173 . . . . 0.0 112.85 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.585 ' CH2' HD11 ' A' ' 74' ' ' ILE . 37.4 p-90 -72.73 -18.7 61.49 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.904 -0.497 . . . . 0.0 111.052 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.69 83.59 6.43 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.057 -1.027 . . . . 0.0 109.715 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.29 -59.53 1.82 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.52 1.057 . . . . 0.0 113.457 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.99 -48.61 20.74 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.694 2.263 . . . . 0.0 111.546 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.4 m -55.74 -50.49 70.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -58.13 -49.93 75.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.332 1.053 . . . . 0.0 111.536 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.73 -22.47 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.722 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.0 mt -82.56 -30.13 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 119.847 1.203 . . . . 0.0 109.435 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.35 -41.69 2.64 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.937 1.695 . . . . 0.0 115.223 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.76 -40.89 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.323 2.015 . . . . 0.0 109.809 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.14 -35.33 34.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 C-N-CA 118.153 -1.419 . . . . 0.0 108.136 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.7 t -52.73 -43.65 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.15 -58.36 8.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.094 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.36 -42.2 77.4 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.558 0.617 . . . . 0.0 111.884 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.98 -36.5 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 122.838 0.455 . . . . 0.0 109.962 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.68 -46.97 80.86 Favored 'General case' 0 C--O 1.223 -0.342 0 O-C-N 121.913 -0.492 . . . . 0.0 110.193 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.9 -42.68 99.63 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.76 -44.06 90.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.55 15.63 8.84 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -39.43 -51.15 2.13 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.132 1.373 . . . . 0.0 113.7 -174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -44.7 -46.65 10.44 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.081 1.752 . . . . 0.0 112.774 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -98.56 -37.76 9.42 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.92 0.888 . . . . 0.0 112.266 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.4 tp -116.16 112.07 21.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.101 -167.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -79.96 93.65 5.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 49.9 t -79.13 134.16 36.72 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.494 -0.754 . . . . 0.0 109.685 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.64 167.9 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.166 0.586 . . . . 0.0 111.758 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -135.27 116.4 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.034 1.334 . . . . 0.0 110.077 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.427 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.3 tm? -98.86 120.83 39.96 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 109.585 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -75.42 103.31 5.5 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.672 0.749 . . . . 0.0 110.265 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -81.96 48.33 1.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.451 1.9 . . . . 0.0 111.27 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -145.5 -47.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.59 -26.43 34.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.86 2.064 . . . . 0.0 109.821 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.4 m -133.05 60.38 49.0 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.006 -1.059 . . . . 0.0 113.813 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.87 -23.78 16.07 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 125.186 3.924 . . . . 0.0 108.716 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -37.38 -69.25 0.12 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.356 1.862 . . . . 0.0 111.099 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -35.68 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.183 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.63 81.24 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 m -72.41 -45.21 60.71 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.095 0.958 . . . . 0.0 109.965 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -54.97 -46.04 75.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.35 0.66 . . . . 0.0 110.386 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.98 -34.76 43.92 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.365 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.23 54.77 1.24 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.516 0.579 . . . . 0.0 111.859 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.6 mt -77.69 121.41 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -79.0 -35.46 42.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.02 0.528 . . . . 0.0 111.537 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.9 m -158.73 168.82 25.84 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.585 HD11 ' CH2' ' A' ' 30' ' ' TRP . 23.1 pt -124.82 154.56 70.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.34 149.69 82.19 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 CA-C-N 120.287 1.138 . . . . 0.0 112.277 2.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -144.04 106.04 4.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.61 116.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.5 mtt -105.76 134.93 48.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -99.47 140.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -127.99 161.1 29.94 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 54.56 0.81 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.521 1.138 . . . . 0.0 110.488 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.18 98.35 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.48 -73.08 1.17 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.103 0.858 . . . . 0.0 112.066 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -94.58 165.21 12.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.825 1.298 . . . . 0.0 113.131 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -77.32 142.35 39.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.265 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 41.7 t -89.08 -65.22 1.04 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.227 1.011 . . . . 0.0 108.643 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -151.28 -174.75 4.92 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.091 1.756 . . . . 0.0 108.166 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.2 t -154.23 166.72 32.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.364 0.666 . . . . 0.0 109.585 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.0 mt -136.02 118.63 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.95 141.0 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 109.027 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.64 163.33 38.3 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.836 0.731 . . . . 0.0 111.569 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.34 142.97 57.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.08 0.552 . . . . 0.0 110.739 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.69 153.54 36.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 124.123 0.969 . . . . 0.0 108.525 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.72 145.29 20.2 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 N-CA-C 105.586 -2.505 . . . . 0.0 105.586 168.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -56.29 -33.41 65.5 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.321 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.88 -42.87 6.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.662 0.785 . . . . 0.0 110.62 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.1 m -75.3 -44.42 45.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.978 0.511 . . . . 0.0 110.018 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.5 mt -54.42 -47.45 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 123.51 0.724 . . . . 0.0 110.08 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -57.15 -55.28 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.439 0.695 . . . . 0.0 109.714 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -56.61 -45.49 81.45 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.889 -0.507 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.3 m -66.34 -43.24 86.65 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.073 0.549 . . . . 0.0 111.752 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.71 -43.62 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 121.024 -1.048 . . . . 0.0 108.878 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.26 -47.75 80.61 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -54.1 -52.0 62.38 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.473 0.709 . . . . 0.0 109.919 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 122.613 0.365 . . . . 0.0 111.791 -178.28 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.06 166.16 44.63 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.32 126.98 55.84 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.52 164.43 30.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 122.271 1.034 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -148.9 179.84 7.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.321 1.848 . . . . 0.0 106.832 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -39.05 -59.05 1.04 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.362 1.465 . . . . 0.0 112.213 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.99 -69.14 0.25 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.546 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -51.59 -39.03 57.18 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.248 1.019 . . . . 0.0 112.11 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -44.74 -48.22 10.79 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.197 1.399 . . . . 0.0 111.045 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -50.29 -51.25 46.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.412 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -74.76 -56.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.428 0.633 . . . . 0.0 111.38 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.7 t -66.86 -23.97 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.078 1.751 . . . . 0.0 113.368 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.51 -75.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.574 0.75 . . . . 0.0 110.524 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.37 -47.06 66.37 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.667 0.667 . . . . 0.0 112.781 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.14 15.03 16.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.423 1.089 . . . . 0.0 112.085 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.34 147.93 27.64 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.034 0.834 . . . . 0.0 111.407 -173.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.2 p -80.01 -61.91 1.84 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.345 1.458 . . . . 0.0 111.753 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.45 160.25 75.57 Favored Pre-proline 0 C--O 1.233 0.185 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.79 159.88 3.27 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.245 1.963 . . . . 0.0 110.403 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.05 149.26 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 123.768 0.827 . . . . 0.0 109.599 -173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.67 98.97 4.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.68 119.29 45.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -95.29 114.04 25.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -79.58 112.37 16.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -128.14 -172.04 2.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.817 0.818 . . . . 0.0 110.526 -174.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.27 151.7 4.71 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 124.516 1.126 . . . . 0.0 108.108 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.62 -31.98 93.26 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.375 2.05 . . . . 0.0 113.266 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.483 ' CH2' HD11 ' A' ' 74' ' ' ILE . 17.5 p-90 -79.47 -7.23 58.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.107 0.867 . . . . 0.0 111.405 176.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.6 t -81.31 83.63 6.83 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.078 -1.013 . . . . 0.0 112.551 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.93 -58.02 2.78 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.551 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.22 -20.19 66.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 CA-C-N 119.634 1.717 . . . . 0.0 113.064 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.8 m -81.15 -49.82 10.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -45.17 -50.21 11.55 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.778 0.831 . . . . 0.0 111.153 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -65.82 -25.75 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.387 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 pt -90.23 -29.05 4.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 CA-C-N 120.689 1.586 . . . . 0.0 110.255 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.02 4.28 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.96 -28.39 24.36 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 122.276 1.849 . . . . 0.0 109.848 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -71.41 -41.42 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -55.94 -46.74 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.38 -54.73 39.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.69 -41.15 94.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.638 1.563 . . . . 0.0 110.669 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.9 mm -60.36 -41.99 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -50.71 67.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.925 0.784 . . . . 0.0 109.302 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.81 -49.7 34.11 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.14 -58.89 4.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -85.38 -0.03 53.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -171.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -39.0 -49.12 1.69 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.549 1.54 . . . . 0.0 113.163 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -46.87 -59.95 2.74 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.859 1.664 . . . . 0.0 112.593 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -83.48 -30.03 27.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.799 1.24 . . . . 0.0 112.579 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.67 110.89 10.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 -168.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.81 95.59 6.07 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.3 t -79.26 140.18 37.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.572 -0.705 . . . . 0.0 109.29 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.82 165.4 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.835 0.854 . . . . 0.0 109.906 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -133.56 116.95 16.52 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.708 1.203 . . . . 0.0 109.268 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 tt -99.1 123.39 43.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.017 0.436 . . . . 0.0 110.385 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.99 108.82 9.14 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.9 m -68.99 -29.82 68.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 124.876 1.27 . . . . 0.0 111.692 -174.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.58 -43.26 66.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.91 0.862 . . . . 0.0 110.177 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -81.19 -27.4 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.299 1.84 . . . . 0.0 111.666 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.2 m -134.0 61.89 54.09 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 121.04 -1.037 . . . . 0.0 110.679 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.14 -35.9 31.31 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.899 3.733 . . . . 0.0 108.861 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -33.55 -69.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.11 2.164 . . . . 0.0 111.058 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.8 t -55.48 -51.45 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.744 1.218 . . . . 0.0 110.057 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.32 -37.03 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.122 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 m -74.6 -45.23 46.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.53 1.132 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.99 -43.28 73.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.421 0.688 . . . . 0.0 109.629 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -78.97 -32.71 45.42 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.385 -0.341 . . . . 0.0 110.952 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.45 51.1 2.42 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 111.675 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.0 mt -84.05 113.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.075 0.95 . . . . 0.0 108.676 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -79.65 -26.86 40.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 113.532 -175.213 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 m -161.08 167.11 26.96 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.483 HD11 ' CH2' ' A' ' 30' ' ' TRP . 18.7 pt -129.53 151.92 78.78 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 146.88 83.0 Favored 'Cis proline' 0 N--CA 1.453 -0.894 0 CA-C-N 119.923 1.008 . . . . 0.0 113.277 1.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.6 m -139.61 114.4 9.4 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.3 mt -104.55 102.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.8 mtt -87.86 131.92 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.44 143.31 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -134.31 158.93 42.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.964 0.906 . . . . 0.0 109.716 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 146.72 28.52 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.554 2.342 . . . . 0.0 104.73 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.92 55.12 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.117 -1.516 . . . . 0.0 111.768 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.1 -52.58 2.95 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 122.258 -0.554 . . . . 0.0 113.525 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -79.67 163.66 24.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.539 1.161 . . . . 0.0 113.409 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -67.67 148.04 51.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.863 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 t -115.11 -63.41 1.46 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.355 1.462 . . . . 0.0 109.125 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -138.3 -177.7 4.96 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 109.771 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -155.22 131.82 10.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.941 0.896 . . . . 0.0 109.455 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.0 mm -104.33 153.28 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.74 142.02 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.154 0.981 . . . . 0.0 108.596 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.31 158.24 20.14 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 121.531 0.517 . . . . 0.0 112.54 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.92 70.18 1.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.53 . . . . 0.0 111.146 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -78.5 153.43 78.8 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.71 147.22 50.91 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.619 1.546 . . . . 0.0 112.208 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -62.05 -39.19 91.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.391 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -48.86 37.12 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -59.56 -51.12 71.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 109.204 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.1 mt -54.96 -58.38 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.039 0.535 . . . . 0.0 109.878 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.2 t -49.67 -55.98 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.886 1.274 . . . . 0.0 110.673 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -48.23 74.25 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -61.38 -41.41 97.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.459 0.303 . . . . 0.0 111.191 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.18 -49.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -57.75 -46.56 84.33 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.509 0.724 . . . . 0.0 110.048 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -51.85 -52.05 52.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.736 0.814 . . . . 0.0 109.482 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.964 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.01 -177.44 39.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.86 136.9 54.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.41 165.49 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.616 0.722 . . . . 0.0 111.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -145.55 172.09 13.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.784 2.034 . . . . 0.0 106.063 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -39.09 -48.12 1.63 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.936 1.694 . . . . 0.0 112.663 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.52 -74.0 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.105 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -52.86 -36.33 58.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.512 1.125 . . . . 0.0 111.951 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -41.06 -46.73 2.99 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 126.258 1.823 . . . . 0.0 111.376 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -49.48 -48.02 48.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.789 1.236 . . . . 0.0 111.086 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -85.12 -57.64 3.01 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.779 0.832 . . . . 0.0 111.157 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.77 -38.58 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.651 1.18 . . . . 0.0 112.163 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -104.91 -59.52 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 112.305 -174.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 mt -66.57 -71.34 0.2 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.162 0.437 . . . . 0.0 110.982 -174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -79.57 52.77 1.46 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.101 0.476 . . . . 0.0 111.483 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 p -90.67 159.29 16.47 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.11 1.764 . . . . 0.0 111.301 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -91.72 -69.87 0.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.243 1.417 . . . . 0.0 107.736 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 m -78.75 154.41 78.32 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.29 163.81 16.47 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.748 0.965 . . . . 0.0 110.194 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.47 113.72 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.667 1.187 . . . . 0.0 111.348 -171.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.32 105.64 13.56 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.85 116.04 45.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 109.762 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -89.44 112.27 23.36 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.555 ' CE2' HD23 ' A' ' 57' ' ' LEU . 18.6 m-85 -78.71 112.93 16.32 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -130.12 -172.52 2.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.575 0.75 . . . . 0.0 110.754 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.5 148.82 3.51 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.967 1.307 . . . . 0.0 107.772 172.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.15 -45.35 41.67 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.702 2.268 . . . . 0.0 112.809 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -64.56 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.031 -0.418 . . . . 0.0 111.96 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.4 t -76.31 84.44 3.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.626 -0.671 . . . . 0.0 110.913 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.53 -54.12 5.77 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.996 0.808 . . . . 0.0 112.883 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -27.78 71.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.365 2.043 . . . . 0.0 112.767 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.4 m -77.15 -53.67 7.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -45.04 -47.2 11.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.981 1.712 . . . . 0.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -71.9 -25.96 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.02 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.6 pt -86.88 -26.43 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 121.267 1.849 . . . . 0.0 110.083 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.14 -45.72 3.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.367 1.467 . . . . 0.0 114.795 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -68.11 -33.17 25.9 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.708 2.272 . . . . 0.0 109.979 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -38.76 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 127.053 2.141 . . . . 0.0 107.901 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.25 -45.69 95.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.92 -52.92 63.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.844 0.457 . . . . 0.0 110.205 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -50.69 -49.85 56.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.434 0.561 . . . . 0.0 109.955 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.91 -38.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.58 -33.73 64.17 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.026 0.376 . . . . 0.0 110.277 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.58 -56.56 7.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.94 -47.53 21.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -106.69 21.95 16.66 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -48.62 -40.4 27.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.958 0.903 . . . . 0.0 111.274 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.48 -68.35 0.19 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.37 1.468 . . . . 0.0 112.4 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -89.94 -14.64 33.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.16 135.04 33.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.683 1.129 . . . . 0.0 113.102 -167.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -79.94 151.63 29.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.1 t -137.34 136.75 38.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.8 166.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 112.069 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -128.3 116.13 19.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.081 1.352 . . . . 0.0 109.542 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 ' CE2' ' A' ' 26' ' ' PHE . 43.8 tp -97.73 115.97 29.02 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.57 0.748 . . . . 0.0 109.983 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -71.1 110.42 5.76 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -64.21 -43.67 94.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 111.4 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.11 -33.68 76.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.584 0.754 . . . . 0.0 110.403 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -82.44 -25.03 33.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 0.0 111.104 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -125.88 54.9 11.44 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 113.034 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.18 -30.83 45.96 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.789 2.993 . . . . 0.0 108.616 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -43.64 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.13 1.772 . . . . 0.0 110.991 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.4 t -50.57 -51.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -39.09 74.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.044 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -70.35 -45.19 66.62 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.014 0.526 . . . . 0.0 109.656 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.58 -42.35 74.65 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.2 -23.97 43.46 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.747 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.85 10.62 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.041 0.829 . . . . 0.0 111.072 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -70.23 128.9 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.88 -45.03 21.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.325 0.65 . . . . 0.0 111.386 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 m -156.48 171.28 20.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.06 154.39 68.1 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.17 149.59 89.81 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 CA-C-N 119.787 0.96 . . . . 0.0 112.118 1.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -135.57 101.18 4.71 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.0 mt -90.61 114.57 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.6 mtm -126.16 150.34 48.35 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.2 t -108.51 139.73 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.5 168.26 12.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.333 1.021 . . . . 0.0 109.994 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 156.78 2.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.979 2.112 . . . . 0.0 106.7 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 37.57 49.96 1.83 Allowed Glycine 0 CA--C 1.535 1.343 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.96 64.55 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.667 -1.074 . . . . 0.0 115.621 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -147.75 172.21 14.45 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.515 1.657 . . . . 0.0 111.099 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -85.76 161.66 19.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.834 1.254 . . . . 0.0 109.412 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 53.1 t -131.16 -63.1 0.86 Allowed 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 126.231 1.813 . . . . 0.0 109.826 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -113.66 162.3 16.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.394 1.078 . . . . 0.0 110.433 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -154.77 131.43 10.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.334 1.454 . . . . 0.0 107.854 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -140.57 113.46 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -99.11 139.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.8 148.26 22.54 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.407 1.004 . . . . 0.0 110.804 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 75.48 1.0 Allowed 'General case' 0 C--N 1.339 0.12 0 O-C-N 122.033 -0.686 . . . . 0.0 110.875 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.9 m -78.73 145.26 66.31 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.33 157.63 39.59 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.972 1.781 . . . . 0.0 113.027 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -42.1 -51.01 4.7 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.372 1.469 . . . . 0.0 110.028 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.08 -44.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 111.861 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -69.17 -48.44 62.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 70.2 mt -54.41 -54.3 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -46.59 -64.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 127.802 2.441 . . . . 0.0 109.271 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -55.6 -49.08 73.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.512 0.196 . . . . 0.0 111.297 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.4 m -56.85 -52.07 66.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.845 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.03 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.918 0.781 . . . . 0.0 110.515 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -52.7 -36.73 57.76 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.368 0.667 . . . . 0.0 112.015 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -46.92 -46.39 21.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.048 0.452 . . . . 0.0 110.49 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 124.146 0.978 . . . . 0.0 111.195 -174.336 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.34 177.69 18.09 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.52 141.77 50.49 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 m -142.07 171.72 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 123.137 1.446 . . . . 0.0 112.674 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.38 169.56 19.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.977 3.311 . . . . 0.0 105.055 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -38.43 -50.39 1.52 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.702 2.401 . . . . 0.0 112.753 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.17 -70.02 0.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.726 0.774 . . . . 0.0 110.577 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -53.25 -38.7 63.23 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.601 1.16 . . . . 0.0 112.415 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -42.97 -46.75 5.55 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.864 2.066 . . . . 0.0 111.5 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -54.26 -55.38 28.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.72 -54.25 17.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.468 0.707 . . . . 0.0 111.516 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.31 -31.17 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.261 1.424 . . . . 0.0 112.79 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.24 -72.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.549 0.739 . . . . 0.0 111.024 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.1 mt -53.79 -41.03 66.81 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -172.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -93.12 13.23 21.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.009 0.924 . . . . 0.0 112.512 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 t -73.71 142.97 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.514 1.052 . . . . 0.0 111.888 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 p -79.64 -61.31 2.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.045 1.338 . . . . 0.0 108.636 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.86 155.14 80.62 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -57.23 161.32 11.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.64 1.56 . . . . 0.0 112.56 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 t -141.1 143.07 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.411 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tt -120.08 102.35 8.47 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.378 1.871 . . . . 0.0 106.689 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t -97.77 127.41 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -103.08 124.87 49.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -79.68 106.69 11.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -118.62 -176.13 3.03 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.872 1.32 . . . . 0.0 111.66 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.79 152.08 6.3 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.49 -42.68 12.11 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.857 1.342 . . . . 0.0 111.665 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -58.25 -18.75 28.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.796 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.8 t -77.97 88.72 4.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.707 1.139 . . . . 0.0 109.773 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.54 -63.07 1.04 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.187 1.375 . . . . 0.0 113.538 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -49.47 -47.29 23.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.39 2.726 . . . . 0.0 112.358 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.5 m -58.75 -53.6 56.58 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -53.25 -54.47 35.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.854 1.262 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -75.79 -27.37 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.652 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.78 -26.87 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.754 1.161 . . . . 0.0 109.796 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.79 -46.2 4.64 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -63.28 -35.68 61.23 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.675 2.25 . . . . 0.0 110.373 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 t -68.69 -44.28 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 t -58.07 -44.37 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.53 -60.81 3.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 122.828 0.451 . . . . 0.0 111.035 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.51 -33.87 71.91 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.435 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mt -56.8 -43.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.17 -47.7 76.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.042 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.28 -60.68 5.53 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 120.191 1.36 . . . . 0.0 110.69 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -48.17 -55.74 9.63 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.616 1.566 . . . . 0.0 110.717 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.39 58.88 4.74 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 123.447 1.594 . . . . 0.0 110.313 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -48.31 138.18 10.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.227 1.811 . . . . 0.0 110.115 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.73 -56.2 0.62 Allowed 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.565 2.346 . . . . 0.0 112.968 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.1 -9.44 58.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -166.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -141.62 108.87 5.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.974 1.261 . . . . 0.0 112.214 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -93.78 111.75 23.49 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.68 138.31 38.23 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.811 -1.18 . . . . 0.0 108.135 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.15 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -133.93 106.53 7.32 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.359 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -89.11 120.03 30.14 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 111.254 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.29 106.75 8.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.3 m -68.87 -31.97 71.3 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.231 1.413 . . . . 0.0 111.453 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.87 -41.5 87.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.438 1.095 . . . . 0.0 109.309 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.51 -28.68 26.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.004 2.122 . . . . 0.0 111.99 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.4 t -127.13 53.21 9.55 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.399 1.48 . . . . 0.0 112.208 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -62.78 -27.14 75.21 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.306 3.337 . . . . 0.0 108.825 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -40.37 -60.05 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.628 1.571 . . . . 0.0 110.263 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.8 -50.78 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.171 0.988 . . . . 0.0 110.167 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.08 64.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.426 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -68.63 -44.91 73.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.898 0.879 . . . . 0.0 110.397 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -56.38 -42.0 77.16 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.644 0.778 . . . . 0.0 110.332 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -78.47 -34.18 47.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.39 45.89 2.46 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.415 1.007 . . . . 0.0 111.588 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.76 -179.16 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 125.938 1.695 . . . . 0.0 108.33 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -158.62 -63.66 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.559 0.744 . . . . 0.0 109.593 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 m -54.94 154.64 5.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 110.223 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 pt -143.2 157.92 59.28 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.175 1.39 . . . . 0.0 107.3 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.27 156.28 84.78 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 120.766 1.309 . . . . 0.0 112.958 2.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -160.46 115.74 2.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -98.65 148.46 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.9 mtt -136.24 133.0 36.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.7 t -99.46 139.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -132.82 144.86 50.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 136.88 15.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 46.14 94.64 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -171.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.01 -59.65 2.66 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.908 0.766 . . . . 0.0 114.006 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -81.44 168.29 18.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -67.73 155.37 39.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.235 1.814 . . . . 0.0 112.96 -173.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.0 t -116.17 -72.38 0.69 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.965 2.106 . . . . 0.0 109.651 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -146.07 172.01 14.04 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.299 1.44 . . . . 0.0 110.246 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.5 m -116.41 146.58 42.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.63 1.972 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.82 -175.43 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.54 153.14 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.36 -153.57 5.83 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 51.48 42.48 29.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.947 0.899 . . . . 0.0 111.828 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.46 153.16 65.39 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.074 1.35 . . . . 0.0 107.477 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.36 160.43 32.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.103 1.868 . . . . 0.0 111.676 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -50.53 -43.57 56.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.807 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.41 -44.71 55.21 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.235 0.614 . . . . 0.0 111.111 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.3 m -65.84 -50.96 62.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -55.41 -52.78 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.392 0.677 . . . . 0.0 109.499 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.42 -58.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.428 1.491 . . . . 0.0 109.595 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -55.31 -47.41 75.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.689 0.677 . . . . 0.0 110.992 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.1 m -60.92 -43.83 98.03 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 119.591 -0.242 . . . . 0.0 111.448 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -72.5 -45.75 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.967 0.803 . . . . 0.0 109.829 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -51.54 -45.56 63.03 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.12 0.968 . . . . 0.0 110.772 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -48.24 -44.32 33.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.964 0.506 . . . . 0.0 110.316 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.176 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.41 -172.64 35.13 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.24 140.58 52.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.88 167.81 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.153 0.978 . . . . 0.0 111.793 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 8' ' ' ASP . 8.1 t-20 -143.5 172.76 12.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.844 2.058 . . . . 0.0 106.389 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.423 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 76.5 m-20 -38.82 -46.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.195 1.798 . . . . 0.0 112.381 -177.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.46 -76.19 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.719 0.408 . . . . 0.0 110.768 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.0 p -46.94 -39.82 13.07 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.271 1.429 . . . . 0.0 112.194 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -39.42 -47.9 1.86 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.526 1.93 . . . . 0.0 111.487 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.774 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -71.23 -45.73 62.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.507 0.67 . . . . 0.0 111.261 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.79 -37.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.031 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -106.33 -73.93 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.883 0.873 . . . . 0.0 110.78 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.9 mt -52.06 -54.53 29.11 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.865 0.466 . . . . 0.0 111.86 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -81.03 11.73 3.86 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -65.6 152.43 44.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.82 1.191 . . . . 0.0 109.614 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 p -79.33 -64.69 1.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.12 155.12 77.41 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.27 165.01 1.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.904 2.403 . . . . 0.0 112.608 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -144.72 143.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.449 1.099 . . . . 0.0 111.588 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -104.52 130.13 52.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.899 1.68 . . . . 0.0 107.67 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.61 111.28 27.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 118.918 0.781 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -89.69 116.28 27.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' CD2' ' CD1' ' A' ' 71' ' ' ILE . 15.9 m-85 -79.75 114.53 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -129.44 -173.48 3.02 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.565 0.698 . . . . 0.0 111.664 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.64 156.59 8.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -59.44 -40.52 66.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.206 1.938 . . . . 0.0 110.658 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.508 ' CH2' HD11 ' A' ' 74' ' ' ILE . 53.1 p-90 -72.24 -10.25 59.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.881 0.472 . . . . 0.0 111.515 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.36 82.29 3.11 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.8 -1.187 . . . . 0.0 110.157 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.2 -61.21 1.01 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.825 1.202 . . . . 0.0 113.529 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.05 -41.3 78.36 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.387 2.058 . . . . 0.0 112.43 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 81.4 m -55.22 -47.66 75.02 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -56.2 -52.32 64.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.729 0.412 . . . . 0.0 111.482 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -73.24 -30.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.91 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.85 -23.08 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.951 0.9 . . . . 0.0 110.361 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.0 -46.54 5.17 Favored Pre-proline 0 CA--C 1.549 0.919 0 O-C-N 119.914 -1.741 . . . . 0.0 115.061 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.92 -37.58 64.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.466 2.111 . . . . 0.0 110.173 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.41 -49.08 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.411 HG12 ' SG ' ' A' ' 54' ' ' CYS . 84.8 t -49.96 -44.76 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.67 -61.92 1.61 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.36 -40.22 81.65 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.532 -0.73 . . . . 0.0 112.256 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.77 -38.42 75.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 54' ' ' CYS . . . -62.21 -52.3 64.34 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -43.58 -53.43 6.06 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.897 0.76 . . . . 0.0 111.572 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -47.95 -35.4 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.24 1.016 . . . . 0.0 112.869 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -120.33 27.03 8.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.447 1.499 . . . . 0.0 112.673 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -39.67 -53.14 2.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.879 1.271 . . . . 0.0 113.799 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.04 -53.22 59.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 122.181 0.991 . . . . 0.0 112.33 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -79.43 -20.29 47.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.822 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 tp -144.8 114.68 7.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.051 0.387 . . . . 0.0 111.988 -170.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.2 168.09 20.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 44.3 t -145.65 141.45 28.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.988 -1.07 . . . . 0.0 110.273 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.21 161.8 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.893 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -127.62 109.38 11.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.452 1.101 . . . . 0.0 109.492 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tp -87.9 121.59 30.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.238 0.542 . . . . 0.0 110.426 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -74.58 105.46 5.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.9 m -65.21 -35.94 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.916 1.686 . . . . 0.0 111.03 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.92 -39.56 94.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.511 1.124 . . . . 0.0 109.539 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.37 -21.7 30.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.804 1.642 . . . . 0.0 110.702 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.1 m -120.96 51.11 2.22 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 114.597 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.53 -27.39 61.78 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.487 2.791 . . . . 0.0 109.68 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -54.28 -75.83 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.849 0.86 . . . . 0.0 109.933 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.63 -44.01 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.036 0.935 . . . . 0.0 110.343 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.63 80.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.76 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.4 p -70.74 -39.58 73.23 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.681 0.392 . . . . 0.0 110.27 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.73 -41.66 77.88 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.106 0.562 . . . . 0.0 109.928 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.29 -31.52 48.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.07 47.19 4.22 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.41 ' CD1' ' CD2' ' A' ' 26' ' ' PHE . 58.6 mt -72.62 114.67 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.438 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.93 -29.74 44.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.305 0.242 . . . . 0.0 111.006 -178.372 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 m -159.84 157.99 30.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.959 0.904 . . . . 0.0 108.619 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.508 HD11 ' CH2' ' A' ' 30' ' ' TRP . 22.0 pt -119.52 150.74 50.51 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.46 77.21 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.126 1.081 . . . . 0.0 114.05 3.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 m -143.06 113.34 7.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.08 119.96 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 mtt -105.22 159.23 16.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.904 0.882 . . . . 0.0 109.247 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 81.8 t -126.5 130.63 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -116.77 147.53 41.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.892 1.677 . . . . 0.0 108.36 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.8 53.1 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.435 0.636 . . . . 0.0 109.582 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.09 85.99 1.74 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.16 -67.32 1.17 Allowed Glycine 0 CA--C 1.527 0.827 0 CA-C-N 117.388 0.594 . . . . 0.0 112.884 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -79.85 163.69 24.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.258 1.023 . . . . 0.0 111.428 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -90.13 150.06 22.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.072 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.1 t -91.23 -51.4 5.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.23 -178.88 6.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 109.519 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -157.67 143.13 17.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.404 1.482 . . . . 0.0 107.816 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.21 153.35 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.119 0.968 . . . . 0.0 109.456 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.0 mt -79.92 141.86 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -138.57 2.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.37 42.34 31.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.806 0.803 . . . . 0.0 111.236 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.88 151.1 67.63 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.95 151.52 64.92 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.86 1.706 . . . . 0.0 112.836 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -45.08 46.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.409 1.484 . . . . 0.0 110.801 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -43.13 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.653 0.781 . . . . 0.0 111.133 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -49.55 74.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.815 . . . . 0.0 109.055 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.66 -52.37 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 123.951 0.9 . . . . 0.0 108.754 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.2 t -53.65 -59.25 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.104 0.962 . . . . 0.0 109.32 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -50.62 -42.36 55.98 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.705 0.402 . . . . 0.0 111.016 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -60.99 -59.49 5.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.8 -45.78 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.91 0.884 . . . . 0.0 111.62 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.47 -39.61 4.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.981 1.713 . . . . 0.0 113.193 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.69 -49.22 78.39 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.286 0.634 . . . . 0.0 110.593 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 N--CA 1.446 -0.641 0 C-N-CA 124.911 1.284 . . . . 0.0 110.257 -172.516 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.15 174.05 54.68 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.46 132.84 56.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.4 164.47 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 122.513 1.149 . . . . 0.0 111.208 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.63 169.31 18.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.998 2.519 . . . . 0.0 105.487 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -40.43 -52.99 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.079 1.352 . . . . 0.0 111.318 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.12 -53.23 56.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.048 . . . . 0.0 112.308 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 p -78.67 -31.4 46.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.344 0.658 . . . . 0.0 112.002 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -42.59 -43.54 3.82 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 127.548 2.339 . . . . 0.0 110.335 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -50.72 -67.68 0.23 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.358 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -42.6 98.91 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.226 1.01 . . . . 0.0 112.352 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.66 -43.9 16.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.971 -168.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.3 t -99.2 -54.03 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.399 1.08 . . . . 0.0 111.307 -174.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -69.17 -57.77 4.94 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.756 0.707 . . . . 0.0 110.283 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.6 51.55 1.28 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.173 0.989 . . . . 0.0 110.112 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 p -90.06 154.69 19.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.766 1.226 . . . . 0.0 112.64 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -100.94 -71.37 0.71 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.023 1.729 . . . . 0.0 107.405 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.7 m -79.19 158.95 73.84 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.56 159.81 12.85 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.565 1.51 . . . . 0.0 109.97 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 t -138.7 119.03 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.064 0.945 . . . . 0.0 110.419 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -94.41 110.35 22.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.375 1.07 . . . . 0.0 108.179 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.76 113.46 40.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -86.24 113.88 22.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.537 ' CD2' HD12 ' A' ' 57' ' ' LEU . 40.3 m-85 -79.3 113.09 17.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.4 p-90 -129.18 -174.71 3.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.79 0.805 . . . . 0.0 111.016 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.77 154.14 5.23 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.888 1.275 . . . . 0.0 108.17 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.98 -42.1 15.32 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.821 2.348 . . . . 0.0 110.45 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.468 ' CH2' HD11 ' A' ' 74' ' ' ILE . 30.8 p-90 -66.39 -17.95 65.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.893 0.477 . . . . 0.0 111.215 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.9 t -75.37 97.59 3.65 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.545 -0.722 . . . . 0.0 110.248 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -32.01 -68.87 0.13 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.908 2.194 . . . . 0.0 115.062 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.13 -44.37 12.58 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.879 1.839 . . . . 0.0 110.8 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.4 m -47.22 -50.37 21.16 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.291 0.636 . . . . 0.0 109.998 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -46.26 -50.4 16.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.045 1.338 . . . . 0.0 111.618 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -90.15 -13.56 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 tp -85.62 -27.86 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.468 1.031 . . . . 0.0 109.561 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.55 -48.3 4.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -62.56 -36.98 61.56 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.56 2.173 . . . . 0.0 110.337 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 t -63.13 -51.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -50.77 -46.05 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.255 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.89 -62.17 1.88 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.617 0.367 . . . . 0.0 111.187 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.19 -30.16 68.0 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.02 0.827 . . . . 0.0 113.161 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -26.15 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 118.048 -1.461 . . . . 0.0 109.387 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.11 73.92 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.042 -1.036 . . . . 0.0 109.757 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.69 -42.36 95.39 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -57.65 -39.37 76.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.058 0.429 . . . . 0.0 109.955 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -78.86 53.76 1.44 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.637 -0.664 . . . . 0.0 112.456 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -62.09 -44.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.8 108.82 3.11 Favored 'General case' 0 N--CA 1.443 -0.812 1 N-CA-C 100.163 -4.014 . . . . 0.0 100.163 162.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -72.67 107.93 5.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.471 -2.15 . . . . 0.0 113.822 -153.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.13 121.98 37.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 108.879 -3.782 . . . . 0.0 105.828 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.89 149.74 32.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.08 138.56 53.71 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.12 165.37 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.006 0.522 . . . . 0.0 109.968 -176.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -132.13 111.9 11.85 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 110.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.537 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.1 tm? -92.86 116.12 28.74 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 124.796 1.238 . . . . 0.0 109.391 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -74.38 109.59 7.99 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -66.25 -33.11 75.02 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 111.289 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.71 -38.44 76.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.745 0.818 . . . . 0.0 110.179 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.96 -29.77 32.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.814 1.646 . . . . 0.0 111.598 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 t -124.27 55.65 10.22 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.571 1.548 . . . . 0.0 111.644 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -65.15 -29.34 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 124.377 3.385 . . . . 0.0 108.593 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -47.3 -69.33 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.6 t -54.5 -56.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.746 0.819 . . . . 0.0 109.928 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.23 -47.59 62.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -63.36 -49.89 72.09 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.816 -0.552 . . . . 0.0 109.849 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.07 -40.23 66.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.502 0.721 . . . . 0.0 110.642 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -78.96 -23.37 44.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.833 1.253 . . . . 0.0 111.814 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.3 28.69 19.27 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.561 1.077 . . . . 0.0 112.182 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -81.45 80.52 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -78.48 -3.19 42.22 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.761 -1.108 . . . . 0.0 112.288 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 m -155.96 157.34 36.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.468 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.5 pt -145.85 157.72 50.44 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.879 1.672 . . . . 0.0 106.637 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.79 147.02 87.06 Favored 'Cis proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.147 1.445 . . . . 0.0 113.329 1.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.7 m -156.72 120.41 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -97.06 116.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 125.354 1.462 . . . . 0.0 107.154 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.2 mtt -99.15 147.84 24.69 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.652 1.115 . . . . 0.0 108.696 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.56 105.45 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -89.47 124.04 34.13 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 4.69 18.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.758 0.823 . . . . 0.0 112.102 -175.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.91 100.46 0.36 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.1 -73.45 1.52 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-N 117.489 0.644 . . . . 0.0 111.874 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -102.12 172.64 6.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.981 0.912 . . . . 0.0 111.594 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -78.6 162.24 26.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.213 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.8 t -120.4 -66.61 1.04 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.675 1.19 . . . . 0.0 108.208 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -126.36 -169.16 1.97 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.27 1.028 . . . . 0.0 109.585 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -156.81 167.7 29.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.573 1.149 . . . . 0.0 108.069 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.88 133.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.1 mt -78.87 142.01 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.64 -157.12 7.51 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.039 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.8 54.62 9.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 109.95 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.42 158.04 74.18 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 125.633 1.573 . . . . 0.0 108.495 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.88 143.21 44.88 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 105.613 -2.495 . . . . 0.0 105.613 167.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.73 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.26 -56.41 8.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -55.22 -46.13 75.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.069 0.948 . . . . 0.0 110.605 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -49.09 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.05 -45.52 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.596 0.759 . . . . 0.0 109.543 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -42.93 87.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.488 1.04 . . . . 0.0 109.119 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.4 m -61.32 -46.77 88.92 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.438 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -48.75 78.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 O-C-N 121.829 -0.545 . . . . 0.0 109.709 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.03 -48.36 76.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -43.68 64.87 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.823 -0.548 . . . . 0.0 109.898 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.5 m-30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.456 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.57 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.24 -173.62 36.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.277 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.26 136.83 45.78 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.7 168.2 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 121.916 0.865 . . . . 0.0 109.459 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.75 175.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 106.27 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -47.33 -47.11 25.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.871 0.868 . . . . 0.0 112.156 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.39 -72.2 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.775 0.83 . . . . 0.0 110.714 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -52.57 -33.42 45.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.428 1.091 . . . . 0.0 112.422 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -41.48 -46.43 3.48 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.297 1.439 . . . . 0.0 110.199 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -56.47 -60.85 2.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.613 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -63.64 -31.63 72.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.516 0.726 . . . . 0.0 112.702 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.8 t -95.16 -48.1 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.277 0.631 . . . . 0.0 112.065 -171.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -94.22 -53.13 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.034 1.334 . . . . 0.0 111.713 -175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.02 -58.57 3.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.871 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.23 50.11 1.03 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.278 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 p -90.43 145.75 24.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.769 1.228 . . . . 0.0 112.218 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -93.44 -65.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -79.25 160.77 69.95 Favored Pre-proline 0 C--O 1.232 0.167 0 C-N-CA 124.608 1.163 . . . . 0.0 108.835 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -55.65 162.55 6.38 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.577 1.518 . . . . 0.0 110.692 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.63 144.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.878 1.671 . . . . 0.0 110.128 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 tt -124.91 100.81 6.77 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.427 1.891 . . . . 0.0 106.181 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.19 116.93 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -88.79 116.16 26.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -79.17 108.83 12.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -122.3 -169.15 1.84 Allowed 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 124.184 0.993 . . . . 0.0 111.017 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.02 150.8 2.02 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -57.61 -40.31 81.2 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.026 1.818 . . . . 0.0 111.291 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 74' ' ' ILE . 36.3 p-90 -67.06 -16.54 64.41 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.836 0.454 . . . . 0.0 111.585 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.1 t -74.69 85.01 2.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.227 -0.921 . . . . 0.0 111.176 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.71 -60.57 1.2 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.317 0.96 . . . . 0.0 113.563 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.48 -50.38 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.022 2.481 . . . . 0.0 112.61 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.06 -45.08 91.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -56.19 -50.29 71.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.556 1.143 . . . . 0.0 110.256 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.08 -37.85 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.437 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 pt -77.37 -25.29 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 120.083 1.31 . . . . 0.0 111.895 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.51 -47.56 4.69 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -62.22 -37.75 60.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.743 2.295 . . . . 0.0 110.484 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.96 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.5 -43.03 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -57.92 -66.14 0.52 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.1 0.409 . . . . 0.0 110.107 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -59.07 -29.52 67.38 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mm -50.8 -34.06 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.486 0.584 . . . . 0.0 109.983 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.4 74.85 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.525 1.057 . . . . 0.0 111.053 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.1 -24.61 76.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.57 -53.55 9.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 117.754 0.777 . . . . 0.0 108.911 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -79.78 58.66 2.88 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.71 -40.97 92.79 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 103.339 -2.837 . . . . 0.0 103.339 164.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.91 110.16 3.22 Favored 'General case' 0 N--CA 1.439 -1.018 1 N-CA-C 98.78 -4.526 . . . . 0.0 98.78 162.287 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -73.36 125.24 27.4 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 124.822 2.249 . . . . 0.0 115.586 -151.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HA ' HD12 ' A' ' 52' ' ' LEU . 16.5 tp -134.55 120.4 19.61 Favored 'General case' 0 C--N 1.314 -0.962 1 CA-C-N 107.867 -4.242 . . . . 0.0 108.054 164.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.24 94.04 7.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.14 130.34 35.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.834 -0.541 . . . . 0.0 109.565 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.67 174.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.706 0.802 . . . . 0.0 111.934 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -144.08 113.45 6.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.014 1.325 . . . . 0.0 111.283 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.0 tt -98.9 125.62 44.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.849 0.833 . . . . 0.0 110.6 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -71.74 105.24 3.66 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.906 1.283 . . . . 0.0 113.874 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -81.21 45.84 0.88 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.859 -1.151 . . . . 0.0 111.027 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -152.09 -48.94 0.11 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -82.98 -19.04 37.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.737 2.015 . . . . 0.0 110.2 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -137.33 61.4 32.24 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.834 1.254 . . . . 0.0 111.915 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.8 -24.6 8.49 Favored 'Trans proline' 0 N--CA 1.446 -1.304 1 C-N-CA 125.492 4.128 . . . . 0.0 110.317 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -47.62 -68.69 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.765 1.226 . . . . 0.0 110.276 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.79 -43.3 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.094 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.72 70.06 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.249 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.2 m -70.13 -45.95 65.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.583 0.753 . . . . 0.0 109.713 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.18 -45.83 75.81 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.977 0.511 . . . . 0.0 110.749 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -79.43 -30.3 42.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.352 0.261 . . . . 0.0 111.534 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.17 54.39 2.15 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.9 mm -69.75 92.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.859 0.838 . . . . 0.0 108.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -78.04 82.12 4.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t 73.21 -175.81 0.16 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.357 1.863 . . . . 0.0 109.498 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 30' ' ' TRP . 24.6 pt -145.38 157.06 53.33 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.22 . . . . 0.0 108.455 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.33 138.23 44.0 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 120.62 1.257 . . . . 0.0 111.85 1.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -134.63 98.25 4.01 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -89.53 109.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.2 mmt -97.16 143.57 27.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 64.4 t -114.13 133.51 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.15 161.21 31.6 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.91 77.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.951 0.405 . . . . 0.0 110.163 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.46 1.36 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.632 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.48 -56.52 3.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 123.836 0.732 . . . . 0.0 112.738 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -79.36 155.01 28.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 122.245 1.021 . . . . 0.0 111.893 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.12 130.47 36.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.649 1.979 . . . . 0.0 108.155 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.6 t -89.31 -57.99 2.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.269 1.028 . . . . 0.0 110.109 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.94 166.89 22.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.595 1.158 . . . . 0.0 111.869 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -142.25 126.15 17.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.251 2.22 . . . . 0.0 105.191 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -128.6 103.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -100.52 138.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.183 1.393 . . . . 0.0 109.555 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.81 156.15 21.94 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.953 0.787 . . . . 0.0 112.563 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.66 51.89 0.2 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.11 1.364 . . . . 0.0 113.148 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.91 148.77 69.18 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.81 156.06 64.19 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.356 1.37 . . . . 0.0 111.71 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.78 -46.04 29.99 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.894 1.277 . . . . 0.0 111.007 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.17 -41.89 3.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.776 0.831 . . . . 0.0 111.525 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.268 1.027 . . . . 0.0 109.153 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.47 -52.64 50.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 C-N-CA 124.431 1.092 . . . . 0.0 108.878 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.5 t -53.2 -58.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.783 1.233 . . . . 0.0 109.567 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.39 -50.11 68.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.449 -0.157 . . . . 0.0 110.911 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.2 m -60.4 -55.74 29.94 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.471 0.177 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -41.54 85.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 O-C-N 121.383 -0.823 . . . . 0.0 110.374 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -45.64 90.38 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -53.67 -42.2 67.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.856 -0.527 . . . . 0.0 109.781 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.744 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.365 0.126 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.85 -168.05 12.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.01 147.02 50.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.54 168.16 21.46 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 CA-C-O 122.038 0.923 . . . . 0.0 111.46 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.32 170.34 16.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.364 2.666 . . . . 0.0 105.93 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -39.93 -50.78 2.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.768 1.627 . . . . 0.0 110.964 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.95 -73.45 0.09 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.243 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 p -52.76 -36.43 57.88 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.274 1.03 . . . . 0.0 112.49 -174.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -40.02 -46.19 2.06 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.928 1.691 . . . . 0.0 110.841 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -49.78 -62.49 1.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.999 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.32 -39.84 71.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.284 0.634 . . . . 0.0 111.879 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.22 -40.01 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.953 -169.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.88 -60.21 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 123.892 0.877 . . . . 0.0 110.706 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -65.07 -68.15 0.38 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.626 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.98 34.98 0.2 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.862 0.865 . . . . 0.0 112.664 -171.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -91.21 143.49 26.6 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.993 0.917 . . . . 0.0 109.5 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.06 -60.91 2.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.4 1.08 . . . . 0.0 108.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.9 m -78.74 155.83 77.97 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -56.39 160.54 10.97 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.203 1.935 . . . . 0.0 114.351 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.23 118.56 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.536 1.134 . . . . 0.0 111.506 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.45 88.01 5.78 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 124.841 1.257 . . . . 0.0 109.593 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.22 133.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 O-C-N 121.157 -0.965 . . . . 0.0 109.259 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.54 121.49 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.924 0.89 . . . . 0.0 108.645 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.445 ' CE2' HD23 ' A' ' 57' ' ' LEU . 53.5 m-85 -79.79 108.67 13.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -123.29 -173.72 2.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 122.275 1.035 . . . . 0.0 110.296 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 152.63 9.78 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.43 -44.97 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-N 120.542 1.229 . . . . 0.0 111.756 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.549 ' CH2' HD11 ' A' ' 74' ' ' ILE . 17.1 p-90 -56.12 -20.7 18.55 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.463 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.7 t -77.46 84.84 3.85 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.585 -0.697 . . . . 0.0 109.412 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.98 -57.94 1.96 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.586 1.089 . . . . 0.0 113.147 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.9 -25.33 69.1 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.089 1.86 . . . . 0.0 113.01 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.9 m -77.2 -50.67 12.43 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -49.14 -50.76 35.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.564 1.546 . . . . 0.0 111.41 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.2 pt -64.81 -39.84 87.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.467 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 pt -76.83 -26.69 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.563 1.074 . . . . 0.0 111.667 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -48.46 4.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.97 -38.03 60.93 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.357 2.038 . . . . 0.0 110.357 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.57 -39.74 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.5 t -52.77 -40.69 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.96 -58.5 4.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.701 0.4 . . . . 0.0 111.054 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.59 -47.59 81.72 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.683 -0.636 . . . . 0.0 111.996 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.97 -38.5 60.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 54' ' ' CYS . . . -61.23 -43.42 98.91 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.421 -0.799 . . . . 0.0 109.301 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.02 -50.49 58.72 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.3 -53.37 44.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.527 0.663 . . . . 0.0 110.222 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -82.08 51.17 1.71 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.126 0.965 . . . . 0.0 112.015 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -41.6 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.935 2.494 . . . . 0.0 111.509 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.19 -54.43 46.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -78.13 -40.54 37.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.37 128.39 37.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 118.204 -1.398 . . . . 0.0 114.387 -152.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -83.11 163.14 21.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.465 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . 54.1 t -142.72 145.8 33.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.57 168.42 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.577 -175.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -137.87 112.44 8.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.294 1.038 . . . . 0.0 108.702 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 26' ' ' PHE . 45.7 tp -98.2 120.49 38.7 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.2 1.0 . . . . 0.0 109.725 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -73.23 109.99 7.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -67.49 -35.76 79.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.795 1.238 . . . . 0.0 111.086 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.51 -39.69 92.15 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -80.21 -33.52 38.08 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.877 1.671 . . . . 0.0 112.005 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.421 ' CB ' HD11 ' A' ' 57' ' ' LEU . 26.0 t -120.9 55.56 4.65 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.625 1.57 . . . . 0.0 111.937 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.34 -24.67 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.06 3.173 . . . . 0.0 110.598 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -54.15 -67.54 0.25 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.803 0.841 . . . . 0.0 109.773 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -53.21 -51.1 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 124.2 1.0 . . . . 0.0 109.202 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.47 -48.19 37.93 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.208 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -66.47 -46.65 75.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.018 0.527 . . . . 0.0 110.627 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.55 -45.5 77.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -79.43 -31.17 42.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.589 0.356 . . . . 0.0 111.488 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.59 43.94 3.04 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.655 0.645 . . . . 0.0 111.627 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mm -73.52 90.64 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -77.47 -20.53 54.27 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.3 m -156.18 165.01 37.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.549 HD11 ' CH2' ' A' ' 30' ' ' TRP . 26.7 pt -129.87 153.47 80.93 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.82 165.36 70.35 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.302 1.144 . . . . 0.0 111.954 0.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -156.74 113.55 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.77 115.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.9 mtt -111.56 134.84 52.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.58 115.77 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.79 162.48 15.21 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 0.0 109.619 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.41 151.55 9.75 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.71 1.204 . . . . 0.0 107.899 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.04 45.6 14.74 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.969 1.147 . . . . 0.0 115.969 170.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.06 0.31 60.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.94 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -129.94 159.38 36.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.737 1.769 . . . . 0.0 111.922 -176.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 138.59 31.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.81 1.644 . . . . 0.0 107.989 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.4 t -114.81 -82.25 0.61 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.003 0.921 . . . . 0.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -92.73 163.53 13.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.086 0.554 . . . . 0.0 110.866 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -157.5 122.61 4.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.773 1.229 . . . . 0.0 109.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.93 137.2 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.42 143.6 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 109.743 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.98 165.52 40.19 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 123.37 0.419 . . . . 0.0 112.328 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.63 131.17 45.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.308 0.643 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.3 153.77 41.25 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.8 138.97 27.01 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 104.714 -2.841 . . . . 0.0 104.714 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -56.14 -33.92 65.63 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.389 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.27 -37.3 7.11 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.542 1.064 . . . . 0.0 112.237 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.6 m -70.78 -41.68 71.36 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.499 -0.751 . . . . 0.0 109.302 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.0 mt -61.71 -44.23 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -54.36 -55.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -52.64 -43.5 65.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.966 0.348 . . . . 0.0 110.787 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -59.09 -40.2 84.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.33 -50.74 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.084 -1.01 . . . . 0.0 108.971 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -51.61 -47.48 63.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.047 0.939 . . . . 0.0 112.873 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -25.69 60.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 N--CA 1.453 -0.322 0 CA-C-N 118.44 0.564 . . . . 0.0 109.704 179.159 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.426 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.41 -179.01 51.49 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.43 137.62 54.81 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.89 164.98 32.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 122.299 1.047 . . . . 0.0 111.379 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -144.11 168.74 19.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.853 2.061 . . . . 0.0 105.731 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -39.63 -45.67 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.31 -70.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.432 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -59.57 -33.47 71.48 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.475 1.11 . . . . 0.0 112.336 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -42.17 -46.67 4.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 126.778 2.031 . . . . 0.0 111.265 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -47.45 -48.41 26.65 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.753 1.221 . . . . 0.0 110.651 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -82.33 -63.1 1.45 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.061 0.934 . . . . 0.0 111.268 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.97 -31.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.889 -169.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.21 -59.81 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.004 0.522 . . . . 0.0 111.865 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.38 -71.03 0.26 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.464 0.575 . . . . 0.0 110.041 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.88 48.41 0.83 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.723 0.809 . . . . 0.0 111.212 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 p -90.38 148.37 22.86 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.653 1.581 . . . . 0.0 109.129 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -83.62 -68.03 0.74 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 m -79.49 158.95 73.11 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.274 1.03 . . . . 0.0 108.66 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.12 164.9 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.486 2.124 . . . . 0.0 113.082 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.81 148.95 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.902 2.081 . . . . 0.0 109.207 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -131.68 105.56 7.6 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.19 122.91 52.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.618 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -97.73 117.69 32.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.52 112.13 16.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -126.14 -176.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.202 1.001 . . . . 0.0 110.335 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.89 148.29 3.13 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -53.21 -45.27 42.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.164 . . . . 0.0 112.513 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -67.07 -20.62 65.85 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.776 -0.578 . . . . 0.0 111.898 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.04 85.09 2.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.117 0.871 . . . . 0.0 110.404 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -34.45 -62.96 0.48 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.492 1.52 . . . . 0.0 114.374 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.57 -43.48 50.52 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 119.633 1.716 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.8 m -59.73 -45.37 92.4 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -55.22 -53.64 53.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.787 1.235 . . . . 0.0 110.542 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 pt -69.71 -29.71 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.36 -0.353 . . . . 0.0 111.397 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.1 mt -74.27 -35.32 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.253 0.621 . . . . 0.0 111.471 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.51 -48.03 6.68 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -61.72 -36.71 73.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.483 2.122 . . . . 0.0 109.75 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.77 -45.11 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.75 -43.75 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -66.05 -48.84 69.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.859 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.93 -41.08 99.37 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.829 -1.169 . . . . 0.0 109.65 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.6 mt -56.82 -44.44 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -54.68 -50.34 68.48 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.41 -45.21 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.93 -46.58 81.04 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -111.91 23.76 13.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -56.16 168.59 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.916 1.286 . . . . 0.0 112.317 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 71.3 -52.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 127.657 2.383 . . . . 0.0 111.199 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -80.19 -50.22 10.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.249 0.547 . . . . 0.0 110.094 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -102.0 106.4 17.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.652 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -78.66 90.04 4.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 49.1 t -78.32 137.9 38.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.53 163.09 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 123.161 0.585 . . . . 0.0 110.12 -175.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -127.57 115.21 18.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.483 1.113 . . . . 0.0 109.614 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tp -91.49 119.06 31.12 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.271 0.628 . . . . 0.0 109.562 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.17 107.1 6.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -67.99 -35.98 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.198 1.399 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.59 -38.82 92.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.701 1.201 . . . . 0.0 109.871 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.5 -25.08 33.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.719 2.008 . . . . 0.0 111.036 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 m -121.46 53.61 3.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 113.93 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.11 -25.82 73.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.061 3.174 . . . . 0.0 109.367 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -50.85 -70.38 0.09 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.896 1.279 . . . . 0.0 109.68 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.8 t -51.41 -50.63 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.059 1.344 . . . . 0.0 109.184 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.82 -47.88 51.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.251 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 m -72.15 -43.35 64.78 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.92 0.888 . . . . 0.0 111.236 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.91 -48.34 70.25 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.286 0.635 . . . . 0.0 110.03 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -79.55 -35.63 39.55 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.21 53.41 9.09 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 pt -57.31 142.11 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.497 1.119 . . . . 0.0 111.775 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -79.91 70.26 6.43 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.0 t 64.52 -160.15 0.29 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -139.51 150.23 62.89 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.78 143.29 73.5 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.985 1.03 . . . . 0.0 113.798 3.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m -140.44 110.04 6.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.82 134.15 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.1 mtt -124.86 128.44 48.67 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.657 1.183 . . . . 0.0 108.881 176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.77 131.58 45.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -119.94 134.23 55.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 173.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.485 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -104.49 25.48 10.17 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.109 0.964 . . . . 0.0 110.597 -178.739 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.21 123.26 5.22 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.43 -64.99 3.15 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.885 0.842 . . . . 0.0 113.376 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -126.22 172.73 9.82 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.244 1.018 . . . . 0.0 111.93 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -67.46 164.86 17.86 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.179 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -128.7 -57.37 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.815 1.646 . . . . 0.0 108.813 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -140.11 171.29 14.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.565 1.546 . . . . 0.0 109.729 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -160.08 147.83 16.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.5 150.4 33.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.08 144.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.62 162.41 37.85 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.603 0.557 . . . . 0.0 112.565 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.76 131.26 38.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.553 0.741 . . . . 0.0 110.534 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.37 149.5 48.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.05 155.48 33.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.676 2.251 . . . . 0.0 114.003 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -46.03 -52.47 11.82 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.404 1.482 . . . . 0.0 109.771 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.83 -45.85 50.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.281 0.633 . . . . 0.0 110.612 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -49.19 68.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -53.04 -58.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.9 t -52.42 -55.5 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 110.318 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.09 -47.43 78.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.506 0.594 . . . . 0.0 110.967 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.3 m -59.87 -42.27 93.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.96 0.504 . . . . 0.0 110.575 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.19 -57.18 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -45.32 -58.54 3.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.933 1.293 . . . . 0.0 111.342 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -18.59 25.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 . . . . . 0 CA--C 1.534 0.356 0 CA-C-N 120.013 1.279 . . . . 0.0 110.722 175.639 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.02 166.79 52.12 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.907 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.51 119.65 37.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.56 161.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.734 0.813 . . . . 0.0 109.671 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -138.04 171.7 14.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -39.82 -45.46 1.79 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.001 1.32 . . . . 0.0 111.468 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.68 -77.76 0.06 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.253 0.621 . . . . 0.0 110.974 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.7 p -46.69 -38.65 10.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.133 1.373 . . . . 0.0 112.744 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -39.71 -46.39 1.86 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.522 1.529 . . . . 0.0 110.819 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -48.76 -56.79 7.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.519 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.34 -33.57 49.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.871 -0.518 . . . . 0.0 112.017 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.4 t -92.5 -26.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -169.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.91 -51.25 4.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 124.747 1.219 . . . . 0.0 111.519 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.63 -61.86 1.69 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -77.51 33.22 0.16 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.932 . . . . 0.0 112.1 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 m -91.09 132.65 35.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.42 1.088 . . . . 0.0 111.133 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 p -78.79 -53.29 7.27 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.711 1.604 . . . . 0.0 107.158 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.94 152.56 79.91 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.02 166.61 29.09 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 N-CA-C 108.658 -1.324 . . . . 0.0 108.658 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.487 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -152.48 134.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.428 HD21 HG23 ' A' ' 77' ' ' ILE . 9.0 tt -99.06 115.35 28.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.987 1.715 . . . . 0.0 108.864 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.0 t -100.91 114.16 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.72 116.51 24.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -78.64 110.77 14.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 9.0 p-90 -124.17 -172.71 2.6 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.792 0.806 . . . . 0.0 112.111 -172.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.42 151.84 2.55 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 125.239 1.416 . . . . 0.0 107.426 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.55 -42.11 35.5 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.552 2.168 . . . . 0.0 110.044 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.477 ' CH2' HD11 ' A' ' 74' ' ' ILE . 34.6 p-90 -67.35 -17.32 64.7 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.355 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.9 t -80.02 87.52 5.41 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.208 -0.933 . . . . 0.0 110.794 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.49 -61.63 1.49 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.521 1.058 . . . . 0.0 113.712 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.73 -19.94 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.096 1.864 . . . . 0.0 113.21 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.0 m -82.75 -50.79 8.31 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -50.2 -47.4 54.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.567 1.547 . . . . 0.0 110.832 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.21 -18.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.929 -0.558 . . . . 0.0 112.415 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -88.74 -28.32 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.464 1.029 . . . . 0.0 110.052 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -39.08 -47.31 3.83 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.704 1.602 . . . . 0.0 113.266 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.25 -38.26 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.948 1.766 . . . . 0.0 110.884 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.4 t -69.75 -57.4 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.707 1.203 . . . . 0.0 109.452 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.519 HG22 ' SG ' ' A' ' 54' ' ' CYS . 3.2 p -54.02 -42.86 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.96 -56.24 23.45 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.59 -0.693 . . . . 0.0 112.427 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.38 -41.39 89.24 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 122.008 -0.433 . . . . 0.0 110.435 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -55.67 -44.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.34 -53.6 54.09 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -44.65 -44.43 8.38 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.249 0.452 . . . . 0.0 112.422 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.76 -41.84 96.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -121.92 9.76 10.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -39.85 -41.4 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.008 2.123 . . . . 0.0 113.752 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.84 -40.7 2.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.46 1.904 . . . . 0.0 112.991 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -132.47 -54.26 0.95 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HG ' ' HG3' ' A' ' 53' ' ' LYS . 12.6 tp -83.44 170.83 14.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' CB ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.36 93.75 2.96 Favored 'General case' 0 N--CA 1.433 -1.323 2 N-CA-C 122.993 4.442 . . . . 0.0 122.993 -164.05 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.519 ' SG ' HG22 ' A' ' 41' ' ' VAL . 11.1 t -151.2 122.2 7.65 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 118.96 -2.338 . . . . 0.0 114.794 174.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.08 165.68 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.599 1.16 . . . . 0.0 110.202 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HB3' ' CD1' ' A' ' 27' ' ' TRP . 7.4 mtmp? -132.73 122.81 25.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.732 1.213 . . . . 0.0 111.576 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -104.82 120.51 41.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.829 0.823 . . . . 0.0 110.21 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -69.45 109.51 4.26 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 124.775 1.23 . . . . 0.0 113.42 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -82.61 47.59 1.2 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 0.0 110.347 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.19 -46.59 0.1 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.43 -23.01 35.04 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.669 1.988 . . . . 0.0 109.705 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.47 53.24 5.65 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 112.542 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.55 -38.78 7.76 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.88 3.72 . . . . 0.0 109.493 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -49.46 -67.31 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.892 1.277 . . . . 0.0 110.528 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.09 -45.53 88.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.93 -39.77 66.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.059 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -72.73 -41.55 65.06 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 124.144 0.978 . . . . 0.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -55.39 -43.23 75.02 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.09 -32.29 44.61 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.89 35.24 6.86 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.12 1.343 . . . . 0.0 111.622 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.5 mt -80.84 62.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.329 1.452 . . . . 0.0 109.37 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -81.59 57.73 3.45 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.551 -0.718 . . . . 0.0 110.355 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 163.3 150.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.963 2.505 . . . . 0.0 107.585 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.477 HD11 ' CH2' ' A' ' 30' ' ' TRP . 13.3 pt -152.85 155.24 32.13 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.12 134.53 28.6 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.362 1.165 . . . . 0.0 112.857 1.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 m -132.8 106.21 7.6 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.428 HG23 HD21 ' A' ' 23' ' ' LEU . 36.1 mt -94.75 130.51 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.138 1.375 . . . . 0.0 107.698 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.5 mtt -130.62 152.22 50.22 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.46 141.35 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.22 167.28 20.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 110.623 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.65 152.2 3.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.746 2.018 . . . . 0.0 106.712 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.21 41.25 8.07 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.484 1.038 . . . . 0.0 115.675 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.5 11.49 68.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.103 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -138.38 167.85 21.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.441 1.62 . . . . 0.0 110.421 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.44 160.2 25.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.546 0.738 . . . . 0.0 110.139 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.3 t -115.94 -53.7 2.54 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 125.569 1.548 . . . . 0.0 109.455 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 -177.0 5.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.724 1.21 . . . . 0.0 108.834 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.9 t -158.35 151.8 23.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 0.0 109.48 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.3 mm -135.84 155.88 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 127.549 2.34 . . . . 0.0 105.55 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.1 mt -138.95 145.48 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.01 155.13 20.75 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.46 135.58 45.76 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.65 152.31 68.22 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.63 160.09 47.28 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.007 1.805 . . . . 0.0 112.409 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -43.41 -51.34 6.57 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 126.136 1.774 . . . . 0.0 111.276 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.95 -45.93 60.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.847 0.459 . . . . 0.0 110.948 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 m -66.28 -48.02 71.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.1 mt -55.72 -55.52 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.34 -51.84 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.496 0.718 . . . . 0.0 110.147 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.81 -46.86 81.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.996 0.816 . . . . 0.0 110.445 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.1 m -57.31 -43.32 83.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.294 0.638 . . . . 0.0 109.782 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 t -62.98 -58.91 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.996 0.816 . . . . 0.0 109.213 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -44.16 -51.89 7.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.835 1.254 . . . . 0.0 112.289 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -26.28 30.19 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 CA--C 1.536 0.404 0 O-C-N 121.379 -0.825 . . . . 0.0 111.328 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.41 111.6 4.1 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 112.2 -0.36 . . . . 0.0 112.2 -177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.65 115.5 19.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.55 165.07 12.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.282 1.039 . . . . 0.0 111.361 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -138.2 170.89 15.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.451 2.3 . . . . 0.0 106.408 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -38.81 -52.86 1.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.219 1.808 . . . . 0.0 111.428 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.69 -73.34 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.567 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -52.28 -38.12 57.44 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.511 1.125 . . . . 0.0 111.769 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -42.91 -45.08 4.84 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.313 1.845 . . . . 0.0 111.356 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -55.55 -51.95 65.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.856 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.11 -50.43 16.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.306 0.574 . . . . 0.0 111.655 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -74.57 -39.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.747 1.219 . . . . 0.0 112.825 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -107.38 -54.67 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 112.763 -170.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -64.53 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.81 49.61 0.78 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 110.432 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -84.13 121.91 28.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.565 1.546 . . . . 0.0 111.373 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.3 p -79.77 -61.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.88 153.88 80.5 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.78 149.86 67.31 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.517 -0.993 . . . . 0.0 109.517 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.484 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -149.96 127.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.38 121.15 30.46 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.29 114.97 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 171.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -99.31 136.83 38.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.498 ' CD2' HD12 ' A' ' 57' ' ' LEU . 5.9 m-85 -87.85 111.9 21.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.418 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 14.3 p-90 -117.63 -174.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.66 5.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -56.69 -39.59 90.27 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -70.52 -16.11 62.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.158 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.3 t -73.61 102.3 3.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.216 1.371 . . . . 0.0 111.408 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.8 -62.36 3.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.034 1.302 . . . . 0.0 114.018 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.64 -42.62 35.73 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.137 2.558 . . . . 0.0 111.674 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.7 m -63.14 -50.31 70.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -55.42 -49.76 71.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.134 -0.354 . . . . 0.0 111.098 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.24 -32.9 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.066 -0.969 . . . . 0.0 111.844 -175.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.8 pt -80.51 -28.62 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.646 1.567 . . . . 0.0 111.42 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.54 -49.39 5.13 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.12 -37.34 75.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.983 1.789 . . . . 0.0 110.043 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.56 -44.48 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 108.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.2 t -53.14 -53.28 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.85 -49.3 78.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.769 -0.582 . . . . 0.0 112.184 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.06 -43.63 95.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.968 0.804 . . . . 0.0 109.493 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.1 -41.44 80.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.34 -48.64 76.35 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.27 -44.28 57.77 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -58.52 -53.94 52.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.591 1.195 . . . . 0.0 110.409 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.483 ' CG ' ' HB3' ' A' ' 52' ' ' LEU . 60.3 m-85 -82.98 53.57 2.47 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.0 -21.59 66.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.861 1.665 . . . . 0.0 108.227 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 5.3 m-20 -62.16 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 168.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.516 ' CE ' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -161.17 110.41 1.61 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 164.613 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.765 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 7.1 tp -151.02 -177.35 5.96 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 116.858 -1.937 . . . . 0.0 112.067 159.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.765 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.29 66.26 1.73 Allowed 'General case' 0 N--CA 1.419 -1.996 2 N-CA-C 123.845 4.757 . . . . 0.0 123.845 -157.341 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -133.32 109.75 9.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 117.742 -1.583 . . . . 0.0 113.81 -177.72 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.43 163.43 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.464 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 36.3 pttt -153.76 121.54 5.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.005 0.431 . . . . 0.0 110.256 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.498 HD12 ' CD2' ' A' ' 26' ' ' PHE . 2.4 tm? -89.13 118.91 29.18 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.821 0.849 . . . . 0.0 110.243 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -72.49 105.64 4.25 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -69.51 -31.72 70.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.797 1.239 . . . . 0.0 111.567 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.1 -39.2 89.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.931 0.893 . . . . 0.0 109.483 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -86.76 -26.08 24.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.734 2.013 . . . . 0.0 111.722 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.405 ' CB ' HD21 ' A' ' 57' ' ' LEU . 14.6 t -126.21 55.96 14.9 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.571 1.548 . . . . 0.0 112.463 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.62 -31.2 70.42 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.508 2.805 . . . . 0.0 108.056 174.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -40.78 -75.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.485 1.914 . . . . 0.0 111.715 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.88 -48.14 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.849 1.26 . . . . 0.0 110.266 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.64 -41.26 69.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.731 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.0 m -72.27 -42.89 65.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 110.389 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -56.04 -42.18 76.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.677 0.391 . . . . 0.0 110.085 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.41 -36.38 45.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.15 45.64 3.01 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.36 0.981 . . . . 0.0 111.219 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.82 130.07 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -79.09 -38.8 35.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 t -163.62 -173.53 3.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 pt -129.42 156.27 78.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 124.558 1.143 . . . . 0.0 109.267 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.99 157.66 82.64 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.127 1.081 . . . . 0.0 112.621 2.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 m -160.99 142.32 11.81 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-O 122.213 1.006 . . . . 0.0 109.679 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.599 ' HB ' ' N ' ' A' ' 89' ' ' ILE 0.607 0.8 OUTLIER -75.2 13.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 2 N-CA-C 138.996 10.369 . . . . 0.0 138.996 -160.967 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 65.1 mtt -80.87 128.61 33.86 Favored 'General case' 0 C--N 1.318 -0.801 1 CA-C-N 126.526 4.239 . . . . 0.0 114.708 -162.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.6 137.04 33.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -129.29 160.62 32.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.093 0.957 . . . . 0.0 109.744 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.16 167.81 6.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.576 1.95 . . . . 0.0 105.916 172.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 51.34 34.12 32.99 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.81 9.9 66.73 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 117.88 -1.511 . . . . 0.0 115.409 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -147.81 169.14 20.42 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.469 2.134 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.69 149.4 50.06 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 127.765 2.426 . . . . 0.0 109.993 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.59 -80.17 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.028 0.531 . . . . 0.0 111.58 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.59 175.36 7.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.961 0.8 . . . . 0.0 111.49 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.5 p -143.16 116.01 8.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.433 1.093 . . . . 0.0 111.389 -175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.599 ' N ' ' HB ' ' A' ' 77' ' ' ILE . 23.5 mt -118.88 122.57 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.43 1.492 . . . . 0.0 112.934 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.5 mt -84.25 155.95 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 119.327 -2.108 . . . . 0.0 106.32 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.5 -158.33 7.12 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.35 -16.61 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.62 152.84 80.95 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 120.081 1.31 . . . . 0.0 108.883 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.32 131.73 21.03 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 105.172 -2.665 . . . . 0.0 105.172 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -57.89 -29.12 64.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.21 -38.65 18.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.387 0.994 . . . . 0.0 110.474 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -60.01 -51.92 67.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.609 1.164 . . . . 0.0 109.076 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.72 -49.07 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.352 1.461 . . . . 0.0 110.474 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -52.3 -55.25 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -57.91 -50.14 74.35 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.177 -0.327 . . . . 0.0 110.83 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.2 m -55.61 -41.26 73.21 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.116 0.567 . . . . 0.0 111.567 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.72 -45.24 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.888 0.767 . . . . 0.0 110.513 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -54.55 -35.02 62.8 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.422 0.689 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -44.9 -50.99 10.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.462 0.648 . . . . 0.0 109.465 171.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 124.111 0.964 . . . . 0.0 110.923 -176.924 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 121.171 0.51 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.82 140.73 38.82 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.67 92.36 5.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -81.79 161.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.589 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -160.0 -178.95 7.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -38.27 -56.53 1.21 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.0 1.72 . . . . 0.0 112.888 -170.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.05 -71.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.203 0.601 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 p -49.6 -43.41 46.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.891 1.276 . . . . 0.0 111.695 -175.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -39.94 -50.85 2.51 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.266 1.826 . . . . 0.0 112.248 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -49.7 -50.45 43.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.947 0.899 . . . . 0.0 111.405 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -79.61 -56.89 3.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.939 0.895 . . . . 0.0 112.058 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.26 -32.05 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 125.449 1.5 . . . . 0.0 113.073 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.29 -52.38 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.133 0.573 . . . . 0.0 112.432 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -73.6 -73.01 0.23 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.631 0.651 . . . . 0.0 111.293 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -79.62 47.09 0.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.206 0.602 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 m -90.42 151.35 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.566 1.147 . . . . 0.0 109.442 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -78.85 -57.06 3.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -78.42 150.98 77.39 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.52 162.61 39.57 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.491 1.461 . . . . 0.0 109.217 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.422 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -150.16 134.39 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.186 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -95.12 99.09 11.13 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 126.229 1.812 . . . . 0.0 108.125 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 p -94.9 125.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -94.32 121.51 35.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.54 108.17 12.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -124.35 -172.88 2.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.787 0.803 . . . . 0.0 110.913 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.48 152.26 3.2 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.25 -40.07 78.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.134 1.889 . . . . 0.0 112.455 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -73.2 -12.17 60.78 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.4 t -73.83 86.65 1.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.084 -1.01 . . . . 0.0 110.84 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -31.74 -66.5 0.17 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.299 1.428 . . . . 0.0 115.284 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -59.46 -45.27 27.19 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.001 1.8 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.5 m -56.4 -46.09 80.32 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -57.02 -50.92 71.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.17 1.388 . . . . 0.0 110.329 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.9 pt -68.36 -36.92 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.408 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.82 -25.47 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 120.178 1.354 . . . . 0.0 111.444 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -38.99 -45.81 3.14 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -64.6 -38.19 33.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.855 2.37 . . . . 0.0 110.241 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -39.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.682 1.593 . . . . 0.0 108.522 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.6 t -58.86 -50.93 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -58.92 -52.07 67.33 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.179 0.592 . . . . 0.0 111.865 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.45 -41.63 94.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.12 0.873 . . . . 0.0 110.469 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.14 -44.03 97.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . . . -57.76 -38.62 75.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.59 44.52 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -49.11 -54.38 16.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.421 0.688 . . . . 0.0 111.346 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.66 33.66 3.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -51.8 -45.45 63.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -33.35 -50.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.897 2.879 . . . . 0.0 113.401 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -149.88 -58.89 0.2 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.487 1.115 . . . . 0.0 113.5 -170.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.663 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 15.8 tp -78.59 179.14 7.28 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -155.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.663 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.23 92.06 2.7 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 123.196 4.517 . . . . 0.0 123.196 -157.097 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.43 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 39.6 t -152.97 120.98 6.14 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 119.949 -1.719 . . . . 0.0 112.584 173.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.59 171.98 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.711 0.804 . . . . 0.0 110.515 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -143.5 114.3 7.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.5 118.45 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.764 0.711 . . . . 0.0 110.195 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.11 106.49 5.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.9 m -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.667 1.587 . . . . 0.0 111.456 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -34.08 77.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.181 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -87.05 -15.37 38.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 110.972 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -138.53 64.34 37.15 Favored Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 120.239 -1.538 . . . . 0.0 112.687 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.75 -26.91 32.25 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.173 3.249 . . . . 0.0 108.582 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -47.37 -70.51 0.09 Allowed 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 125.535 1.534 . . . . 0.0 110.611 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.22 -49.97 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 125.541 1.536 . . . . 0.0 109.481 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.48 -45.79 69.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.524 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.2 m -68.92 -41.57 77.99 Favored 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 123.739 0.815 . . . . 0.0 111.014 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.03 -42.2 76.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.183 0.593 . . . . 0.0 109.724 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.67 -32.92 47.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.15 36.23 5.78 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.261 0.934 . . . . 0.0 110.797 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -74.45 107.72 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -77.73 -27.34 50.51 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.838 0.455 . . . . 0.0 110.923 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -155.34 159.04 39.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.6 pt -115.02 156.86 44.7 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.59 161.73 81.88 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 120.608 1.253 . . . . 0.0 114.175 3.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.9 m -160.63 124.86 3.6 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.82 106.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.665 1.186 . . . . 0.0 108.327 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.7 mtt -103.85 132.01 50.51 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.737 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.1 t -100.71 110.53 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -92.98 143.86 25.82 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 50.61 1.83 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.45 77.98 1.3 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.79 -61.82 2.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.94 0.781 . . . . 0.0 112.201 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.08 163.07 22.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.962 0.905 . . . . 0.0 111.058 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -89.4 151.24 22.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.94 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -109.17 -57.12 2.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.623 . . . . 0.0 107.765 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -124.36 159.48 30.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.798 1.239 . . . . 0.0 109.367 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.1 m -152.4 93.34 1.78 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -103.82 146.87 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.229 1.412 . . . . 0.0 108.46 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 90' ' ' ILE . 3.4 mp -80.01 151.45 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.32 -158.48 5.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.52 46.56 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.951 0.9 . . . . 0.0 110.504 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.05 153.18 80.27 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.16 139.22 35.01 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 N-CA-C 105.4 -2.577 . . . . 0.0 105.4 170.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -67.11 -19.67 65.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 118.773 -1.171 . . . . 0.0 109.918 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.23 -49.9 68.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.801 1.182 . . . . 0.0 109.221 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -55.86 -48.11 76.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.518 1.127 . . . . 0.0 109.687 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.67 -49.02 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.018 0.527 . . . . 0.0 109.81 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.88 -56.82 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -51.79 -45.65 63.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.369 0.531 . . . . 0.0 110.793 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.2 m -60.41 -33.07 71.98 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.589 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.6 t -76.75 -47.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 120.408 1.458 . . . . 0.0 109.988 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -49.35 -45.04 45.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.079 0.952 . . . . 0.0 111.063 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -53.86 -27.67 31.41 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 CA--C 1.531 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.131 177.865 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.25 175.46 54.66 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.83 136.13 54.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.93 164.36 30.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 122.346 1.07 . . . . 0.0 112.775 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.9 170.26 16.04 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 128.033 2.533 . . . . 0.0 104.433 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -39.12 -46.87 1.49 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.281 1.832 . . . . 0.0 112.735 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.13 -66.28 0.43 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.33 1.052 . . . . 0.0 111.723 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -67.21 -41.59 85.51 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.711 1.204 . . . . 0.0 111.641 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -39.52 -47.84 1.94 Allowed 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 127.524 2.33 . . . . 0.0 110.996 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -41.62 -66.67 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.006 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -42.96 65.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 111.364 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.0 t -73.51 -18.39 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.121 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.15 -51.18 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.333 1.053 . . . . 0.0 112.272 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.71 -70.86 0.43 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.121 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.01 40.22 0.4 Allowed 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.973 -1.08 . . . . 0.0 112.22 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 m -91.12 137.87 32.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.734 1.213 . . . . 0.0 110.645 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 p -78.78 -55.62 5.02 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.404 1.482 . . . . 0.0 108.66 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.93 156.38 79.82 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.59 167.17 19.71 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 N-CA-C 108.871 -1.242 . . . . 0.0 108.871 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -136.7 144.77 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 126.595 1.958 . . . . 0.0 109.21 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -124.69 98.37 5.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 106.494 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.31 120.29 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.183 0.901 . . . . 0.0 110.323 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -90.93 117.21 29.35 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.743 0.817 . . . . 0.0 109.143 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.45 108.67 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -127.41 -174.75 3.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 121.717 0.77 . . . . 0.0 111.075 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.62 149.01 4.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.91 -44.05 52.64 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.526 2.151 . . . . 0.0 112.448 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.512 ' CH2' HD11 ' A' ' 74' ' ' ILE . 40.5 p-90 -68.83 -18.33 64.15 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.146 -0.346 . . . . 0.0 111.823 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 37.9 t -77.89 85.14 4.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.21 -60.24 1.38 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.649 1.119 . . . . 0.0 114.088 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.12 -17.24 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.84 1.82 . . . . 0.0 112.509 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -81.43 -48.11 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.07 -49.93 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.308 1.443 . . . . 0.0 110.244 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 pt -63.19 -36.52 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.275 -0.869 . . . . 0.0 112.393 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.1 pt -80.04 -25.32 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.741 1.155 . . . . 0.0 111.401 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.87 -48.27 5.55 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 120.071 1.305 . . . . 0.0 114.497 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.72 -39.37 53.71 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.974 2.449 . . . . 0.0 110.026 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -47.07 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.02 -42.56 90.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.06 -56.28 24.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.02 0.528 . . . . 0.0 110.37 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -62.84 -37.84 88.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.917 -1.114 . . . . 0.0 111.108 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.21 -45.79 67.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.1 -51.89 66.26 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -46.18 -42.52 12.64 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 112.199 -0.361 . . . . 0.0 112.199 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -71.61 -54.54 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.675 0.738 . . . . 0.0 112.351 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -92.47 9.03 36.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -45.33 148.94 0.57 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.318 1.447 . . . . 0.0 111.831 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.1 t70 74.61 -50.09 0.67 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.626 1.97 . . . . 0.0 111.569 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -77.56 -29.02 51.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.73 1.212 . . . . 0.0 111.141 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.76 121.42 13.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.136 1.374 . . . . 0.0 108.319 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -79.45 94.12 5.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -79.45 133.34 36.53 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.279 -0.888 . . . . 0.0 108.978 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.84 168.54 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.301 0.572 . . . . 0.0 112.053 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -134.56 111.1 9.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.341 1.456 . . . . 0.0 109.517 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tt -89.56 118.51 29.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.764 0.792 . . . . 0.0 109.966 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -71.93 100.2 2.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 109.208 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 m -85.36 52.82 2.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.753 1.621 . . . . 0.0 110.081 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -148.28 -46.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -79.93 -25.44 40.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.528 2.331 . . . . 0.0 110.062 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 t -132.58 55.47 17.72 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.06 -23.59 29.25 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.994 3.796 . . . . 0.0 109.264 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -44.55 -58.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.784 1.634 . . . . 0.0 109.211 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.32 -53.25 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.027 0.931 . . . . 0.0 109.967 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.51 -40.32 62.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.975 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 m -69.79 -47.73 61.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.058 0.943 . . . . 0.0 110.567 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.55 -44.68 77.0 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.927 . . . . 0.0 110.437 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.01 -31.93 44.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.83 50.19 3.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.16 139.36 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 109.554 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -41.21 29.02 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.967 0.507 . . . . 0.0 111.403 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -167.11 -170.94 1.63 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.512 HD11 ' CH2' ' A' ' 30' ' ' TRP . 24.6 pt -130.32 152.65 80.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 124.774 1.23 . . . . 0.0 108.384 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.39 157.04 99.45 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.95 1.018 . . . . 0.0 113.478 2.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -160.15 114.43 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.8 mt -97.38 107.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.9 mtt -97.43 142.62 29.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.108 0.867 . . . . 0.0 109.0 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.22 129.56 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -132.92 162.11 32.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.862 0.865 . . . . 0.0 110.663 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.64 152.94 3.95 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.012 1.325 . . . . 0.0 108.151 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.47 44.8 11.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.55 8.17 70.85 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.837 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -138.39 163.05 32.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.597 1.698 . . . . 0.0 111.031 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -90.17 148.29 23.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.5 t -100.07 -60.69 1.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.266 1.027 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.47 -168.5 1.53 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.013 1.725 . . . . 0.0 107.159 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -150.95 172.16 16.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.599 0.76 . . . . 0.0 109.056 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.29 142.04 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.564 1.546 . . . . 0.0 106.835 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.9 mt -79.71 140.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -145.7 4.06 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.48 38.7 28.67 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.793 0.796 . . . . 0.0 111.232 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.22 157.55 60.8 Favored Pre-proline 0 C--N 1.341 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 111.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -70.5 140.07 39.08 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 163.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -58.0 -25.15 60.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.799 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.3 -44.66 34.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.156 0.889 . . . . 0.0 109.918 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -50.49 73.42 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.467 1.107 . . . . 0.0 109.53 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -52.38 50.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.869 0.868 . . . . 0.0 109.783 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.2 t -53.57 -58.88 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.653 0.661 . . . . 0.0 109.806 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -52.32 -53.07 49.02 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.6 m -53.71 -47.6 70.38 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.156 0.285 . . . . 0.0 111.64 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.63 -50.0 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.543 0.737 . . . . 0.0 109.279 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -57.6 -44.88 85.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.86 -51.5 60.81 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.055 0.942 . . . . 0.0 109.337 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 CA--C 1.532 0.285 0 O-C-N 122.277 -0.265 . . . . 0.0 111.613 -178.925 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.08 163.23 54.05 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.24 44.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.42 162.37 14.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 122.136 0.97 . . . . 0.0 110.572 -178.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -140.61 168.42 19.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.469 2.308 . . . . 0.0 105.778 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -39.87 -49.29 2.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.444 1.497 . . . . 0.0 110.787 176.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.74 -66.8 0.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.436 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -66.16 -41.38 90.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.436 1.095 . . . . 0.0 112.229 -174.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -38.93 -47.51 1.45 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 128.201 2.6 . . . . 0.0 111.237 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -44.41 -59.66 2.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.537 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.12 -46.04 18.81 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.884 0.849 . . . . 0.0 110.844 -176.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.0 -34.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.031 -168.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.29 -59.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.445 1.098 . . . . 0.0 111.657 -172.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.63 -68.02 0.37 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -175.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -79.61 41.69 0.49 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.556 -0.715 . . . . 0.0 111.762 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -90.18 139.6 30.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -78.52 -54.89 5.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -78.85 157.29 76.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.69 152.68 81.05 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 111.758 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 76.5 t -146.74 124.3 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.357 1.063 . . . . 0.0 113.757 -177.123 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' N ' ' HB2' ' A' ' 53' ' ' LYS . 4.2 tt -107.72 123.77 49.02 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 125.35 1.46 . . . . 0.0 108.341 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.07 133.38 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -96.59 123.37 40.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CE2' HD23 ' A' ' 57' ' ' LEU . 33.8 m-85 -78.78 110.94 14.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 175.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -123.15 -173.68 2.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.886 0.851 . . . . 0.0 111.045 -176.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.84 157.9 4.36 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 175.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.33 -38.53 84.16 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.136 1.891 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.444 ' CH2' HD11 ' A' ' 74' ' ' ILE . 51.0 p-90 -73.78 -8.68 56.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.947 0.499 . . . . 0.0 111.422 176.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -80.11 85.44 5.67 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.28 -1.512 . . . . 0.0 109.617 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.58 -61.6 1.81 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.675 1.131 . . . . 0.0 113.151 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -49.34 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.798 2.999 . . . . 0.0 112.04 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -57.6 -50.93 71.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.013 0.925 . . . . 0.0 109.304 -178.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.25 -45.87 90.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.186 -0.435 . . . . 0.0 112.152 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 pt -67.34 -38.61 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.23 -178.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.84 -23.35 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.66 1.118 . . . . 0.0 111.939 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.51 4.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -176.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.78 -29.41 23.79 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 122.666 1.988 . . . . 0.0 109.866 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -44.44 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.12 -44.49 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -54.3 41.91 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.36 -40.16 81.48 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.979 -1.076 . . . . 0.0 110.302 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.6 mt -58.21 -45.79 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.04 -44.98 64.5 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.455 0.571 . . . . 0.0 109.546 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 -57.1 10.39 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -50.09 -51.18 44.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.573 0.702 . . . . 0.0 111.288 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -88.26 19.94 3.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -56.4 153.1 10.32 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.075 0.852 . . . . 0.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.3 -52.1 0.7 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.799 2.039 . . . . 0.0 111.485 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -78.57 -51.84 9.34 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.41 -158.32 0.89 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -158.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HB2' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.21 82.12 3.01 Favored 'General case' 0 N--CA 1.441 -0.883 2 N-CA-C 127.687 6.18 . . . . 0.0 127.687 -156.729 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.6 t -148.29 121.7 9.07 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.938 -2.351 . . . . 0.0 114.974 172.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.92 167.35 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.382 1.073 . . . . 0.0 109.88 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -134.18 113.48 12.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.853 1.261 . . . . 0.0 109.758 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' A' ' 26' ' ' PHE . 20.2 tp -93.36 114.77 27.27 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.043 0.937 . . . . 0.0 110.413 -178.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -72.68 109.78 6.55 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.8 m -70.12 -33.51 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.031 1.333 . . . . 0.0 111.18 -174.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.54 -37.96 89.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.483 1.113 . . . . 0.0 109.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -87.35 -27.01 23.09 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.731 2.012 . . . . 0.0 111.758 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.2 t -121.01 52.8 3.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.275 1.83 . . . . 0.0 111.741 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.46 -38.16 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.642 2.894 . . . . 0.0 108.97 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -38.33 -69.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.657 1.983 . . . . 0.0 110.839 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.93 -54.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.746 1.218 . . . . 0.0 109.957 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.18 -37.46 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.835 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -68.69 -48.09 64.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.414 0.685 . . . . 0.0 109.162 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.62 -42.9 75.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 110.009 177.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.51 -25.62 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.49 13.47 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.723 0.678 . . . . 0.0 111.649 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.5 mt -79.85 90.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' CD ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.53 -10.74 59.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.621 1.169 . . . . 0.0 112.978 -175.221 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.9 m -159.38 161.98 35.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.444 HD11 ' CH2' ' A' ' 30' ' ' TRP . 22.2 pt -132.75 154.92 81.64 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.77 161.88 74.81 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.661 1.272 . . . . 0.0 114.424 4.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -160.85 122.04 2.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 174.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.96 99.14 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.967 0.907 . . . . 0.0 108.62 -172.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.3 mtt -96.83 138.86 33.75 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.586 0.63 . . . . 0.0 110.079 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.19 131.1 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.31 167.57 17.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.743 1.617 . . . . 0.0 111.174 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.17 151.67 3.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.752 2.021 . . . . 0.0 105.955 173.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 47.4 42.3 18.46 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 170.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.1 10.33 68.62 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.691 178.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -141.76 170.75 15.14 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.561 1.68 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.89 162.85 17.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.471 1.109 . . . . 0.0 111.262 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 45.2 t -130.53 -50.9 1.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.384 1.874 . . . . 0.0 110.012 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -138.88 167.38 22.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.468 -177.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.7 m -151.81 89.02 1.43 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 126.234 1.814 . . . . 0.0 106.24 175.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.08 -175.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 106.615 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.43 156.65 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.66 -150.16 2.09 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.9 -43.71 0.57 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.466 1.506 . . . . 0.0 112.166 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.86 151.95 79.73 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.03 149.25 53.87 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.621 1.547 . . . . 0.0 112.543 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -59.19 -37.24 76.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.2 -50.47 38.05 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.722 0.409 . . . . 0.0 110.074 175.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -56.86 -48.41 78.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.615 1.166 . . . . 0.0 110.095 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.1 mt -59.41 -53.01 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.43 -53.56 23.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.22 -42.26 63.43 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.328 0.513 . . . . 0.0 111.143 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.1 m -59.94 -47.72 84.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.58 -38.49 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 122.034 -0.417 . . . . 0.0 112.076 -178.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -45.68 -42.49 11.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.699 1.2 . . . . 0.0 112.304 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -45.84 -39.09 8.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.846 1.258 . . . . 0.0 111.734 176.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.452 -0.339 0 C-N-CA 126.972 2.109 . . . . 0.0 110.556 -178.375 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . . . . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 119.837 -0.125 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.19 148.31 36.99 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 174.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.46 100.81 10.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 171.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.421 HG23 ' CB ' ' A' ' 57' ' ' LEU . 12.7 m -103.6 161.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.852 0.834 . . . . 0.0 109.432 -176.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -151.34 172.89 15.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.93 2.092 . . . . 0.0 105.494 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.79 -48.41 15.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.073 0.949 . . . . 0.0 112.317 -176.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.22 -72.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 110.77 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -51.7 -36.58 47.26 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.539 1.135 . . . . 0.0 112.491 -174.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -39.8 -49.67 2.35 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 126.28 1.832 . . . . 0.0 110.863 177.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -49.98 -56.92 8.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.552 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -74.02 -45.15 51.61 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.678 -175.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.3 t -74.91 -43.7 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.574 -168.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.5 t -95.9 -64.65 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.22 1.008 . . . . 0.0 111.007 -173.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -64.31 -59.05 4.85 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.36 41.98 0.41 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.162 0.585 . . . . 0.0 111.312 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -89.75 -171.13 3.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 p -128.2 -65.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.799 2.039 . . . . 0.0 106.973 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.1 158.97 74.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.6 159.84 46.15 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.419 1.185 . . . . 0.0 111.347 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.24 123.95 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.178 1.791 . . . . 0.0 109.007 -177.257 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.84 101.33 12.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.76 137.76 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -110.74 118.08 35.19 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.081 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.499 ' CE2' HD21 ' A' ' 57' ' ' LEU . 34.1 m-85 -78.25 112.29 15.08 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -125.31 -174.82 3.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.172 0.987 . . . . 0.0 111.158 -175.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.41 142.73 1.78 Allowed Pre-proline 0 C--O 1.224 -0.287 0 C-N-CA 126.527 1.931 . . . . 0.0 106.165 171.101 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -37.98 -53.5 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.148 3.232 . . . . 0.0 117.708 179.509 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.6 p-90 -61.27 -15.96 40.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.449 0.568 . . . . 0.0 112.458 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -73.0 80.91 1.2 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.191 0.596 . . . . 0.0 111.022 -177.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.15 -56.75 1.8 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.642 1.115 . . . . 0.0 112.691 176.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -50.96 -48.64 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.176 2.584 . . . . 0.0 112.585 177.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.6 m -58.61 -47.51 84.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -61.42 -45.66 93.39 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.3 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.05 -25.47 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.331 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.33 -27.99 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.867 1.667 . . . . 0.0 110.391 174.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -38.68 -45.54 2.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 178.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.98 -40.24 73.22 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 CA-C-N 122.346 1.874 . . . . 0.0 109.855 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -74.18 -47.67 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.523 1.129 . . . . 0.0 108.668 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' SG ' ' A' ' 54' ' ' CYS . 0.4 OUTLIER -52.01 -36.08 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.422 1.089 . . . . 0.0 108.165 175.728 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 3' ' ' ALA . 16.9 t70 -70.1 -58.63 3.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.797 -0.565 . . . . 0.0 110.709 173.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -49.29 -41.46 38.2 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.347 -0.359 . . . . 0.0 111.757 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -52.76 -42.98 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 118.482 0.583 . . . . 0.0 110.433 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.71 66.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.671 0.669 . . . . 0.0 111.171 178.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.93 -46.01 14.85 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 174.109 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.06 -65.75 0.88 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.355 1.062 . . . . 0.0 113.104 -176.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -82.91 19.16 1.42 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.498 1.119 . . . . 0.0 112.805 -174.356 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -39.41 -42.02 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 128.204 2.602 . . . . 0.0 112.057 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -36.17 -46.89 0.54 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 127.719 2.408 . . . . 0.0 111.748 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.96 -55.04 1.3 Allowed 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.687 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.35 113.57 21.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -163.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.89 91.48 8.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.076 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 41' ' ' VAL . 7.7 t -79.23 142.09 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 120.752 -1.218 . . . . 0.0 109.454 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -156.73 176.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.828 0.74 . . . . 0.0 110.744 -178.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -142.13 137.74 31.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.846 0.858 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.499 HD21 ' CE2' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -114.87 122.26 45.77 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.71 1.204 . . . . 0.0 112.824 -179.268 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.66 105.79 5.92 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 122.071 0.939 . . . . 0.0 109.809 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -59.89 -39.8 86.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.665 1.986 . . . . 0.0 111.94 -173.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.33 -38.27 74.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.67 0.788 . . . . 0.0 110.709 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -80.09 -27.17 39.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.27 1.428 . . . . 0.0 110.995 177.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.4 m -134.57 62.83 56.88 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.813 1.245 . . . . 0.0 111.342 -177.06 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 -34.33 28.95 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 109.533 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -37.25 -69.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.764 2.026 . . . . 0.0 110.663 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -61.01 -45.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 122.822 0.449 . . . . 0.0 110.753 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -37.11 60.24 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.13 0.172 . . . . 0.0 111.049 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.1 m -74.41 -46.42 40.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.248 1.019 . . . . 0.0 109.859 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.04 -45.45 75.22 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.197 0.599 . . . . 0.0 110.501 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -79.27 -33.33 43.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.905 0.482 . . . . 0.0 110.51 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.57 53.58 2.41 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.195 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.9 mm -67.52 130.13 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.15 -42.4 26.26 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.934 -0.479 . . . . 0.0 110.783 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.8 m -166.09 174.95 8.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.799 2.04 . . . . 0.0 106.042 179.362 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 pt -120.35 150.75 52.4 Favored Pre-proline 0 N--CA 1.455 -0.202 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.072 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.33 144.8 81.59 Favored 'Cis proline' 0 N--CA 1.457 -0.654 0 CA-C-N 119.905 1.002 . . . . 0.0 113.355 1.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -143.12 111.67 6.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.05 138.77 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.3 mtt -130.51 128.19 40.68 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 173.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.6 97.2 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -79.34 125.99 30.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.09 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -137.29 0.31 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.03 77.82 0.42 Allowed Glycine 0 CA--C 1.531 1.031 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.088 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.25 -63.3 4.15 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -79.66 167.84 20.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.47 0.708 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -87.36 149.3 24.58 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.59 -55.19 3.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.351 1.06 . . . . 0.0 109.127 170.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -137.18 163.7 30.24 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.577 1.151 . . . . 0.0 112.808 -176.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.3 t -138.71 128.69 25.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 173.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 mt -140.21 137.27 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -78.64 140.03 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 174.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.11 -137.71 0.72 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.12 -31.1 0.21 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.448 1.499 . . . . 0.0 112.44 -177.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.06 149.5 79.87 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -56.95 144.99 87.43 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 120.988 1.125 . . . . 0.0 110.387 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -55.86 -31.6 62.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.341 0.656 . . . . 0.0 110.189 -178.174 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -37.87 60.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.021 0.828 . . . . 0.0 111.087 175.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -61.64 -49.55 76.12 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.355 1.062 . . . . 0.0 108.341 178.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.77 -43.23 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.569 1.148 . . . . 0.0 109.817 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.92 -55.03 22.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 124.127 0.971 . . . . 0.0 108.865 177.813 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -55.07 -48.19 73.84 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.994 -0.441 . . . . 0.0 110.289 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -59.76 -44.67 93.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.637 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.68 -44.75 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 CA-C-N 119.067 0.849 . . . . 0.0 110.636 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -46.65 -47.27 20.23 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.342 1.057 . . . . 0.0 110.731 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -44.48 -39.96 5.21 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.567 1.147 . . . . 0.0 111.818 176.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 CA--C 1.533 0.31 0 C-N-CA 124.796 1.238 . . . . 0.0 113.224 -175.538 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.02 157.74 51.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 177.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.55 117.57 33.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -105.58 160.15 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 122.187 0.994 . . . . 0.0 109.87 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -152.1 174.53 13.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.736 2.414 . . . . 0.0 106.774 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -37.72 -58.36 0.9 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 126.549 1.94 . . . . 0.0 112.653 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.26 -67.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -53.67 -45.59 70.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.145 0.978 . . . . 0.0 111.928 -175.426 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -42.07 -50.42 4.7 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 127.14 2.176 . . . . 0.0 111.447 -178.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -48.52 -48.06 38.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.791 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -81.05 -59.81 2.52 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.367 0.667 . . . . 0.0 111.456 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.31 -31.49 54.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 126.332 1.853 . . . . 0.0 113.116 -172.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.42 -56.51 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.449 0.699 . . . . 0.0 112.009 -173.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.76 -60.0 2.46 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.867 0.758 . . . . 0.0 109.815 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.84 42.32 0.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.9 p -90.16 148.42 22.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.902 -0.499 . . . . 0.0 109.832 -178.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 p -87.57 -62.93 1.39 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.778 1.231 . . . . 0.0 107.964 177.04 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 151.38 75.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.033 1.333 . . . . 0.0 108.192 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.44 160.49 48.42 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 120.942 1.095 . . . . 0.0 109.585 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.435 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -151.14 133.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -172.049 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.551 HD21 HG23 ' A' ' 77' ' ' ILE . 8.3 tt -92.3 109.46 20.84 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.07 110.14 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -87.15 113.39 22.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -79.11 109.81 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 177.241 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -130.47 -173.6 3.11 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 121.723 0.773 . . . . 0.0 111.44 -173.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.04 150.73 4.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.336 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.72 -40.2 85.73 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.042 1.828 . . . . 0.0 112.422 178.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.604 ' CH2' HD11 ' A' ' 74' ' ' ILE . 41.1 p-90 -70.19 -14.22 62.53 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.904 -0.498 . . . . 0.0 111.789 177.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 84.18 3.54 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.119 -0.988 . . . . 0.0 112.127 -177.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.52 -62.06 1.42 Allowed Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.772 -1.016 . . . . 0.0 114.059 175.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 -23.54 74.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.214 1.942 . . . . 0.0 113.222 -178.338 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.8 m -77.39 -58.55 3.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -43.45 -52.59 5.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.53 2.332 . . . . 0.0 111.602 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.69 -22.79 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.247 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.88 -27.29 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.488 1.04 . . . . 0.0 110.831 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.71 -44.97 3.9 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 117.023 -1.465 . . . . 0.0 114.005 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.71 -37.25 88.5 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.532 2.155 . . . . 0.0 110.215 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -43.4 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -59.97 -41.95 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 67.9 m-20 -65.05 -48.66 73.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.402 0.681 . . . . 0.0 110.599 178.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -60.76 -40.44 92.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.354 0.525 . . . . 0.0 109.719 -179.064 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mt -53.35 -47.29 58.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.519 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . . . -56.88 -52.42 65.2 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.81 -41.72 28.07 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.61 1.1 . . . . 0.0 112.129 178.283 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.47 -70.27 0.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.335 0.654 . . . . 0.0 110.046 177.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -86.86 48.46 1.65 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.427 1.108 . . . . 0.0 111.28 -174.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -52.02 61.38 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 127.595 2.358 . . . . 0.0 115.011 -168.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -70.08 -72.44 0.2 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.821 0.82 . . . . 0.0 111.834 -177.524 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -39.47 34.64 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -164.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 8.7 tp -105.48 -171.84 1.98 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -155.092 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.559 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.7 pptp? -76.34 91.67 3.28 Favored 'General case' 0 N--CA 1.431 -1.389 2 N-CA-C 123.585 4.661 . . . . 0.0 123.585 -160.933 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 52.4 t -153.82 121.89 6.07 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.492 -1.38 . . . . 0.0 113.2 172.012 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.59 163.68 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.395 1.478 . . . . 0.0 108.744 173.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 115.08 16.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.514 1.126 . . . . 0.0 110.864 -175.729 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -92.74 110.22 21.66 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.98 103.83 2.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.231 1.015 . . . . 0.0 108.699 177.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -84.53 54.1 2.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.492 2.317 . . . . 0.0 108.987 -177.223 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -150.89 -48.67 0.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.23 -26.25 30.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 111.238 172.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.87 53.13 0.94 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.97 2.108 . . . . 0.0 115.042 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.59 -25.75 40.51 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.683 3.589 . . . . 0.0 108.79 174.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -49.14 -70.56 0.09 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.897 1.279 . . . . 0.0 109.951 178.091 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.6 t -51.56 -49.44 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.232 1.413 . . . . 0.0 108.856 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.89 67.14 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.8 m -69.68 -45.79 67.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.28 0.632 . . . . 0.0 110.335 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.4 -46.05 76.61 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.245 0.618 . . . . 0.0 110.62 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.44 -31.36 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.478 0.311 . . . . 0.0 111.155 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.72 52.46 2.63 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.79 115.61 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -78.4 -33.65 48.63 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.091 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -163.29 -173.39 3.35 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.604 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.3 pt -142.14 149.05 50.71 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.22 139.27 60.45 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 CA-C-N 119.394 0.819 . . . . 0.0 113.304 2.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -130.15 118.89 22.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 102.04 -3.318 . . . . 0.0 102.04 172.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.551 HG23 HD21 ' A' ' 23' ' ' LEU . 45.2 mt -112.49 100.45 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 108.272 -172.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.4 mtt -94.29 138.39 32.34 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.136 0.426 . . . . 0.0 110.287 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.5 104.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.82 147.69 28.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.44 21.57 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.396 1.078 . . . . 0.0 109.618 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.06 127.23 6.04 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.067 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.5 -52.06 1.86 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.828 1.68 . . . . 0.0 114.116 178.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -138.48 -179.88 6.06 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.248 1.019 . . . . 0.0 110.649 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 152.71 21.04 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.778 1.231 . . . . 0.0 109.832 176.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -110.82 -71.06 0.78 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.404 1.482 . . . . 0.0 107.883 177.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -96.6 162.91 13.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.693 0.797 . . . . 0.0 109.691 177.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.4 m -153.27 108.58 3.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.347 1.059 . . . . 0.0 108.177 175.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.31 160.65 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -142.98 147.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.67 169.34 45.65 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 121.495 0.497 . . . . 0.0 112.33 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.85 82.71 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.989 0.515 . . . . 0.0 111.122 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.61 151.54 77.29 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.746 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -82.38 149.3 14.88 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.405 2.737 . . . . 0.0 106.76 170.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.01 -42.45 72.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.806 -0.559 . . . . 0.0 112.31 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.54 -51.73 6.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.98 0.912 . . . . 0.0 111.253 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 m -61.5 -50.23 73.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.161 0.584 . . . . 0.0 110.481 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -53.96 -56.37 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.594 0.758 . . . . 0.0 109.016 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -49.88 -64.08 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.741 1.617 . . . . 0.0 108.885 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -51.62 -47.3 63.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.188 0.449 . . . . 0.0 111.824 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -58.35 -45.34 88.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.207 -178.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -44.79 46.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 CA-C-N 119.262 0.937 . . . . 0.0 111.589 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -48.7 -44.33 37.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.244 1.018 . . . . 0.0 110.074 -178.319 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -44.26 -44.04 7.71 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.125 0.97 . . . . 0.0 111.717 174.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 CA--C 1.531 0.217 0 C-N-CA 125.423 1.489 . . . . 0.0 112.755 -177.955 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.16 -173.56 41.76 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.84 139.25 52.25 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.93 167.98 22.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 122.499 1.142 . . . . 0.0 111.514 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -146.71 175.9 10.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.706 2.402 . . . . 0.0 106.419 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -38.54 -58.78 0.99 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.5 1.52 . . . . 0.0 112.793 -176.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.98 -57.45 11.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.623 1.169 . . . . 0.0 111.908 -177.171 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -65.11 -40.01 93.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.526 0.73 . . . . 0.0 111.658 -173.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -41.02 -47.13 3.03 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.471 1.908 . . . . 0.0 110.866 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -54.96 -62.99 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.656 178.55 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -63.21 -32.59 74.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.213 1.005 . . . . 0.0 112.314 -176.114 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.9 t -92.55 -54.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.19 0.596 . . . . 0.0 111.968 -171.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -83.59 -57.35 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.255 1.022 . . . . 0.0 110.854 -175.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.1 mt -70.23 -54.97 10.51 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.06 0.391 . . . . 0.0 111.238 -174.079 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -79.44 48.7 0.92 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.73 -0.606 . . . . 0.0 110.622 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 p -90.47 158.51 17.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.21 1.404 . . . . 0.0 111.151 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 p -91.26 -72.05 0.6 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.93 1.292 . . . . 0.0 107.569 176.259 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -79.39 160.63 69.87 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.22 166.15 1.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.114 1.876 . . . . 0.0 111.771 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 t -138.64 145.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 109.944 -176.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -122.33 105.77 10.49 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 m -101.25 150.9 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 118.626 0.648 . . . . 0.0 109.489 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -115.07 119.9 38.01 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.526 0.73 . . . . 0.0 109.321 174.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.472 ' CD2' HD12 ' A' ' 57' ' ' LEU . 23.1 m-85 -80.76 111.31 17.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -128.84 -173.23 2.92 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.47 0.708 . . . . 0.0 111.608 -174.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.63 154.75 12.4 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.532 1.133 . . . . 0.0 108.158 174.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.46 -43.41 40.21 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.367 2.711 . . . . 0.0 112.07 -176.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.428 ' CH2' HD11 ' A' ' 74' ' ' ILE . 55.6 p-90 -70.9 -13.13 61.91 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.177 0.591 . . . . 0.0 111.262 177.094 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.23 80.68 3.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.209 -0.932 . . . . 0.0 111.061 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.39 -55.9 4.27 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.907 0.765 . . . . 0.0 112.812 176.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.55 -27.95 78.95 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.55 2.167 . . . . 0.0 112.715 178.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.54 -56.38 4.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -48.71 -48.57 40.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.091 1.357 . . . . 0.0 111.727 -177.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.45 -21.94 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.222 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.4 mm -89.54 -26.58 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 119.461 1.028 . . . . 0.0 110.012 177.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.92 -48.56 5.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.66 -36.88 83.17 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.106 1.871 . . . . 0.0 110.174 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.9 -45.02 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.565 1.146 . . . . 0.0 108.292 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.5 -53.39 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.024 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.82 -53.53 57.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.832 0.853 . . . . 0.0 111.943 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.65 -40.48 96.96 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.068 -1.02 . . . . 0.0 110.604 -177.27 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.5 mt -58.42 -46.7 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.85 68.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.57 -51.44 52.07 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -61.93 -49.22 77.04 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.91 10.43 41.32 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -38.42 -56.94 1.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 126.62 1.968 . . . . 0.0 112.45 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.58 -44.91 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.533 1.933 . . . . 0.0 113.44 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.42 -9.8 19.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.216 1.006 . . . . 0.0 112.458 -176.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -151.08 113.99 4.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -78.65 160.91 27.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 171.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 22.8 t -141.85 142.78 33.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.793 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.06 162.42 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.05 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -130.12 111.9 12.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.2 0.6 . . . . 0.0 110.087 -176.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.472 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.2 tm? -88.77 117.21 27.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.572 0.749 . . . . 0.0 109.383 -178.025 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -74.41 100.94 3.95 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -58.92 -39.71 82.36 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.122 1.769 . . . . 0.0 112.422 -175.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.14 -37.64 75.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.236 1.014 . . . . 0.0 110.343 -173.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -86.34 -28.83 23.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.66 1.584 . . . . 0.0 111.332 177.537 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -123.43 54.85 7.48 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.464 1.906 . . . . 0.0 110.609 -177.594 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.71 -40.22 66.42 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.942 3.094 . . . . 0.0 109.006 177.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -29.09 -75.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.404 2.281 . . . . 0.0 111.804 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.7 t -53.37 -49.57 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.049 1.34 . . . . 0.0 109.879 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.92 68.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.949 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -80.3 -42.11 23.65 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.562 1.145 . . . . 0.0 108.957 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.18 -41.39 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -78.64 -30.09 46.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.427 0.691 . . . . 0.0 110.666 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.49 49.32 6.76 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.236 0.922 . . . . 0.0 111.24 176.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -133.28 79.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.661 1.584 . . . . 0.0 109.95 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -31.69 46.67 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.57 145.3 54.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.428 HD11 ' CH2' ' A' ' 30' ' ' TRP . 13.4 pt -148.05 154.52 43.12 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.88 140.08 58.76 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 CA-C-N 119.812 0.968 . . . . 0.0 112.273 1.054 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 m -130.1 107.27 9.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.372 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.7 mt -88.78 137.85 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 16.5 mtt -131.59 135.57 47.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.07 141.15 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -127.93 155.45 44.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.949 1.3 . . . . 0.0 108.277 174.484 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.05 56.42 1.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.884 1.674 . . . . 0.0 107.836 -178.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.49 -153.56 16.93 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 -173.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.2 35.84 1.3 Allowed Glycine 0 CA--C 1.528 0.879 0 O-C-N 121.794 -0.827 . . . . 0.0 114.546 -177.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -151.27 155.26 38.41 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.624 1.569 . . . . 0.0 108.044 177.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -89.84 145.81 24.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.14 1.376 . . . . 0.0 108.323 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.3 t -112.32 -55.85 2.47 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.357 1.063 . . . . 0.0 111.062 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -133.56 170.78 15.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 111.061 -175.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.5 m -156.23 140.62 16.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.115 1.366 . . . . 0.0 108.932 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.4 mm -136.6 153.34 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.163 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mt -133.53 144.01 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.97 148.49 24.29 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.028 0.823 . . . . 0.0 112.698 176.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.06 72.76 1.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 110.941 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.4 m -78.91 147.03 69.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -56.66 158.19 17.08 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.901 2.401 . . . . 0.0 114.556 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -46.68 -51.63 15.58 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 125.832 1.653 . . . . 0.0 110.581 177.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.36 -49.42 44.5 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.445 0.698 . . . . 0.0 110.799 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -49.7 73.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.068 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.02 -54.44 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.86 -56.78 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.562 1.145 . . . . 0.0 110.377 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -55.25 -47.47 75.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.3 m -56.92 -44.76 82.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.484 0.714 . . . . 0.0 110.415 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.94 -56.26 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.949 0.795 . . . . 0.0 109.52 176.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -52.51 -45.51 66.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.204 1.002 . . . . 0.0 112.745 -175.587 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -60.28 -30.75 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.568 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.445 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.56 175.14 54.35 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.878 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.6 129.5 56.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.67 162.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 122.171 0.986 . . . . 0.0 110.094 -177.464 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -139.34 175.36 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.572 2.349 . . . . 0.0 106.952 175.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -46.9 -55.26 8.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.0 111.521 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.15 -52.27 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.196 1.398 . . . . 0.0 111.442 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 p -75.94 -37.76 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.579 0.751 . . . . 0.0 112.132 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -41.2 -46.56 3.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.767 2.027 . . . . 0.0 110.644 -177.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.34 -50.12 60.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.417 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -78.03 -52.97 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.62 1.2 . . . . 0.0 110.877 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.81 -35.18 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.205 -169.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.3 -59.71 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.3 mt -66.4 -73.57 0.13 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -174.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -82.93 57.95 4.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.726 0.81 . . . . 0.0 108.924 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 p -87.6 -139.5 0.1 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.098 0.959 . . . . 0.0 109.964 -178.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -160.68 -68.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 m -77.79 158.34 78.21 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 104.959 -2.238 . . . . 0.0 104.959 171.049 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 165.29 21.9 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 N-CA-C 108.55 -1.365 . . . . 0.0 108.55 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.4 146.01 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 125.419 1.488 . . . . 0.0 108.916 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -126.25 103.76 7.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.09 145.08 10.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -113.36 113.21 24.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 57' ' ' LEU . 52.7 m-85 -78.59 111.26 14.48 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.442 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.61 -173.84 2.78 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.716 0.635 . . . . 0.0 110.719 -178.009 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.38 141.46 0.92 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.754 1.221 . . . . 0.0 110.499 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.07 110.69 3.0 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.445 2.096 . . . . 0.0 108.919 176.09 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 137.31 -29.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 131.61 3.964 . . . . 0.0 105.684 -173.299 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.5 t -68.78 88.53 0.37 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.352 0.596 . . . . 0.0 111.933 -177.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -35.65 -67.3 0.34 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.233 1.873 . . . . 0.0 113.388 177.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.28 -46.54 29.82 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 119.6 1.7 . . . . 0.0 112.268 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.3 m -54.22 -42.44 69.8 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.308 0.503 . . . . 0.0 110.293 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -55.57 -53.34 57.59 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 122.802 0.441 . . . . 0.0 111.065 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 pt -74.1 -27.46 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.878 -178.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.24 -38.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 110.683 177.154 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.64 -48.33 5.15 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -60.36 -37.6 80.72 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.929 2.419 . . . . 0.0 110.435 178.227 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.49 -45.52 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.32 -44.55 88.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -58.15 -61.46 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.64 0.776 . . . . 0.0 110.011 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.91 -37.51 82.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.633 0.652 . . . . 0.0 111.309 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.41 -40.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 176.028 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -59.29 -43.82 92.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.443 0.565 . . . . 0.0 110.097 175.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.36 -39.86 84.08 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.96 -51.14 42.7 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -99.91 10.11 41.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -46.4 147.49 1.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 112.078 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.18 -46.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.945 2.098 . . . . 0.0 111.91 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.87 -19.48 54.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.959 . . . . 0.0 110.709 -178.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.2 tp -155.3 128.83 8.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 107.338 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tmtp? -90.16 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 54.0 t -79.55 133.91 36.47 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.534 -0.729 . . . . 0.0 109.517 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.28 169.85 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.427 0.632 . . . . 0.0 111.865 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -133.5 131.28 39.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.983 1.713 . . . . 0.0 110.438 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -119.47 133.89 55.48 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.098 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -81.52 111.15 17.58 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.107 0.956 . . . . 0.0 111.257 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.6 m -84.22 49.86 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.238 2.215 . . . . 0.0 111.13 -174.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.12 -42.15 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -80.7 -24.1 39.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.748 2.019 . . . . 0.0 108.981 169.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -144.18 62.73 10.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.607 1.563 . . . . 0.0 110.985 178.134 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.26 -26.67 4.03 Favored 'Trans proline' 0 N--CA 1.445 -1.37 1 C-N-CA 126.397 4.732 . . . . 0.0 109.079 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -38.79 -61.26 0.75 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.938 1.695 . . . . 0.0 109.647 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.9 t -56.79 -52.88 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.765 1.226 . . . . 0.0 110.047 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.16 -35.25 64.57 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.501 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 m -73.65 -46.1 48.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.701 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.52 -43.61 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.528 0.731 . . . . 0.0 109.944 177.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.99 -32.53 45.26 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.66 -0.21 . . . . 0.0 110.721 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.87 51.92 2.54 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 123.75 0.69 . . . . 0.0 111.533 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.9 mt -79.92 112.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.46 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.07 -27.42 43.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.118 0.567 . . . . 0.0 112.142 -177.62 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -157.72 161.89 38.54 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.299 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.76 154.88 81.09 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.3 135.18 38.22 Favored 'Cis proline' 0 N--CA 1.449 -1.098 0 CA-C-N 119.282 0.779 . . . . 0.0 113.074 1.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -121.84 102.48 8.22 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 173.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -79.58 137.2 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 175.586 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.0 mtt -130.22 148.27 52.03 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.34 128.32 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -116.31 144.91 43.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.407 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 12.59 3.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.168 -176.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.35 -154.41 25.12 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.25 20.09 0.59 Allowed Glycine 0 CA--C 1.533 1.165 0 CA-C-N 118.041 0.921 . . . . 0.0 114.866 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -153.9 162.58 41.11 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.587 1.555 . . . . 0.0 108.595 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -78.84 -179.48 6.59 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.77 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.8 t -138.9 -66.08 0.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.403 1.081 . . . . 0.0 108.962 177.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -120.94 170.31 9.63 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.601 1.56 . . . . 0.0 109.784 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 t -156.86 152.25 26.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.758 0.823 . . . . 0.0 108.943 178.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.41 150.15 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.794 1.238 . . . . 0.0 107.788 -177.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.7 mt -79.78 119.85 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 171.069 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.42 86.27 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.135 -0.814 . . . . 0.0 113.973 -173.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.94 66.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.252 1.021 . . . . 0.0 113.017 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.41 154.68 53.44 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 126.06 1.744 . . . . 0.0 106.958 176.26 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -58.04 155.13 35.3 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.441 2.094 . . . . 0.0 113.952 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.07 -42.54 63.27 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.339 1.056 . . . . 0.0 109.542 177.265 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.97 -49.0 66.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.948 0.499 . . . . 0.0 109.985 178.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m -61.14 -47.8 84.56 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.1 mm -54.11 -56.73 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -49.32 -58.55 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 125.183 1.393 . . . . 0.0 109.724 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -54.34 -48.31 71.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.881 0.31 . . . . 0.0 111.218 -178.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.0 m -61.36 -38.99 88.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.945 0.498 . . . . 0.0 110.604 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.4 t -65.67 -55.4 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 119.153 0.888 . . . . 0.0 108.778 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -43.86 -57.58 3.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 111.671 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.84 -26.77 15.6 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 CA--C 1.533 0.31 0 O-C-N 121.414 -0.804 . . . . 0.0 110.976 -179.601 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.435 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.02 162.94 42.07 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.592 1.567 . . . . 0.0 113.601 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.65 122.21 35.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 172.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.3 163.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.492 -176.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -149.25 170.5 18.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.469 1.907 . . . . 0.0 107.242 177.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -77.31 80.53 3.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 125.112 2.387 . . . . 0.0 111.713 -176.875 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 172.76 -76.83 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 2 CA-C-N 107.644 -4.344 . . . . 0.0 107.415 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.7 p -51.8 -39.34 58.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.616 1.167 . . . . 0.0 110.581 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -43.58 -45.54 6.73 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.584 1.553 . . . . 0.0 111.271 175.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -54.17 -52.16 62.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.289 0.566 . . . . 0.0 110.096 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -70.35 -52.5 22.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 111.052 -177.525 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.6 -46.23 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.721 1.209 . . . . 0.0 112.804 -172.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.2 -61.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.92 0.888 . . . . 0.0 111.169 -174.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -68.04 -56.81 7.53 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.706 -172.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.59 43.75 0.58 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.267 0.485 . . . . 0.0 111.357 -178.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -90.16 -174.62 4.26 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.76 0.79 . . . . 0.0 109.361 177.328 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.3 p -120.34 -73.34 0.65 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.58 1.952 . . . . 0.0 106.409 176.168 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.74 158.83 75.11 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.19 159.27 15.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.563 1.509 . . . . 0.0 112.791 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.72 118.0 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.282 1.433 . . . . 0.0 109.778 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -84.96 104.17 14.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.49 116.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -96.06 109.96 22.28 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.505 ' CD2' HD12 ' A' ' 57' ' ' LEU . 31.9 m-85 -78.8 110.89 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.245 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -126.69 -174.36 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.082 0.953 . . . . 0.0 111.119 -174.517 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.06 149.32 3.31 Favored Pre-proline 0 N--CA 1.456 -0.175 0 C-N-CA 124.979 1.312 . . . . 0.0 108.007 172.373 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.99 -38.34 93.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.706 2.271 . . . . 0.0 113.888 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -76.35 -12.21 60.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.399 0.545 . . . . 0.0 112.111 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 t -77.91 100.46 6.4 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.865 -176.264 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.92 -64.8 1.37 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.628 1.585 . . . . 0.0 114.544 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.52 -45.44 37.21 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.596 1.698 . . . . 0.0 110.876 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.79 -50.48 63.49 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.22 0.608 . . . . 0.0 109.612 -178.517 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -56.24 -48.85 75.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.154 0.582 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.46 -29.28 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.776 -177.066 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 pt -81.7 -24.54 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 120.608 1.549 . . . . 0.0 110.853 176.542 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.13 -48.61 4.26 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.07 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.47 -41.01 35.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.088 1.858 . . . . 0.0 109.97 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.54 -49.67 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.979 1.312 . . . . 0.0 107.926 178.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.7 -44.13 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -56.59 -33.79 66.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.209 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -51.07 -35.79 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.308 0.643 . . . . 0.0 109.504 176.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.17 -38.35 70.79 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.313 0.506 . . . . 0.0 110.919 177.144 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.42 -43.4 45.59 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -55.82 -52.15 65.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -107.58 34.09 3.71 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.41 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -58.79 161.84 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.806 0.442 . . . . 0.0 110.172 176.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 t70 74.92 -55.44 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.613 1.965 . . . . 0.0 111.429 178.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -77.87 -31.67 51.52 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 -177.318 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.47 152.24 49.33 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.761 0.824 . . . . 0.0 109.906 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -106.17 152.08 23.92 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 168.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 54.1 t -132.97 140.41 47.77 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.435 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.64 176.4 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 119.033 0.833 . . . . 0.0 109.461 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.72 134.61 26.98 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.442 . . . . 0.0 111.851 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.2 tm? -99.76 119.35 38.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.338 1.855 . . . . 0.0 110.047 -177.606 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.23 104.06 4.87 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -66.96 -29.64 69.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.684 1.594 . . . . 0.0 111.631 -173.785 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.2 -42.03 84.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.869 0.842 . . . . 0.0 109.778 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -83.76 -31.63 25.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.281 1.832 . . . . 0.0 111.687 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.1 m -125.85 60.1 31.83 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 -178.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.42 -34.9 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 124.723 3.615 . . . . 0.0 109.779 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -38.46 -72.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.545 1.938 . . . . 0.0 111.626 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.64 -44.78 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 124.026 0.93 . . . . 0.0 110.487 -178.403 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.15 70.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.538 178.198 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -71.52 -43.8 65.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 109.749 178.75 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.59 -41.51 77.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.618 0.367 . . . . 0.0 110.437 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -78.19 -33.49 50.06 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.91 47.38 2.1 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.725 0.678 . . . . 0.0 111.827 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.5 mt -78.71 112.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.45 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.37 -29.55 47.48 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.12 -0.362 . . . . 0.0 110.908 -177.345 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -160.85 155.01 22.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.58 156.53 38.59 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.666 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -66.75 161.23 75.97 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.503 1.215 . . . . 0.0 112.595 2.514 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -158.37 102.02 1.73 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.4 pt -85.81 133.83 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 174.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.7 mtt -121.25 153.37 37.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.81 117.73 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -112.22 156.39 22.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.144 0.977 . . . . 0.0 109.103 178.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 153.85 8.82 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.363 1.465 . . . . 0.0 107.316 176.598 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 37.72 9.77 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.005 0.821 . . . . 0.0 114.69 175.73 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.3 20.51 65.38 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.702 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -141.6 166.03 25.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.332 1.453 . . . . 0.0 109.573 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -90.54 155.22 19.04 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.34 0.656 . . . . 0.0 109.598 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.0 t -108.65 -62.46 1.46 Allowed 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 125.603 1.561 . . . . 0.0 108.941 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.31 179.41 8.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.861 1.265 . . . . 0.0 108.846 177.263 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 t -155.45 151.4 27.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.631 1.173 . . . . 0.0 109.544 -178.68 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -146.81 157.25 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.757 1.623 . . . . 0.0 108.208 -179.086 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -79.6 114.35 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.82 -12.53 21.57 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -174.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.1 63.38 0.33 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.915 . . . . 0.0 111.96 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.97 157.06 58.3 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.434 1.494 . . . . 0.0 107.792 177.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -58.48 155.52 35.79 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.638 2.225 . . . . 0.0 113.729 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.12 -51.81 17.04 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.832 1.653 . . . . 0.0 110.744 178.066 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -51.88 35.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.598 178.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 m -59.47 -46.51 88.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.776 -0.631 . . . . 0.0 109.874 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.22 -52.02 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.811 0.732 . . . . 0.0 109.366 177.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.3 -57.45 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.055 0.542 . . . . 0.0 109.678 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -53.35 -47.76 69.11 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.984 0.357 . . . . 0.0 110.681 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 m -54.12 -49.29 69.52 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.209 1.003 . . . . 0.0 110.09 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -61.65 -55.18 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.518 -0.739 . . . . 0.0 109.746 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -51.32 -48.41 62.36 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.434 0.693 . . . . 0.0 112.325 -175.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -57.82 -22.29 46.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.782 0.719 . . . . 0.0 112.593 -179.117 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 118.754 0.706 . . . . 0.0 111.404 179.4 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.2 151.28 41.84 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.221 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.71 104.47 16.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.307 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.89 158.73 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.104 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -143.26 174.93 10.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 177.337 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -39.37 -49.71 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.329 1.452 . . . . 0.0 112.295 -176.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.33 -78.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.129 177.515 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 p -45.95 -41.33 11.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.256 1.422 . . . . 0.0 112.632 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -39.71 -46.05 1.81 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.162 1.785 . . . . 0.0 111.38 175.869 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -49.83 -65.85 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.852 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.78 -35.94 82.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.254 0.622 . . . . 0.0 112.196 -176.483 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.93 -13.09 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.49 -66.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 119.026 0.83 . . . . 0.0 109.475 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.45 -35.12 69.72 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -93.69 -5.19 49.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.99 0.916 . . . . 0.0 111.817 178.594 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 m -77.26 132.51 38.71 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.712 -1.243 . . . . 0.0 111.909 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.37 -52.9 7.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.809 1.244 . . . . 0.0 109.553 178.324 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.59 152.8 83.41 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -64.34 154.51 70.96 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 120.925 1.084 . . . . 0.0 113.049 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.461 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -147.85 127.27 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 124.626 1.204 . . . . 0.0 113.541 178.609 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.11 95.49 9.46 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.26 113.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -86.9 114.52 23.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -79.0 102.89 8.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 175.25 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -120.32 -171.5 2.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 110.519 -173.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.67 152.93 3.97 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -56.59 -35.73 97.36 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.847 1.698 . . . . 0.0 112.237 177.056 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CH2' HD11 ' A' ' 74' ' ' ILE . 24.6 p-90 -76.84 -3.92 40.93 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.798 -0.564 . . . . 0.0 111.985 177.392 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.7 t -82.06 85.37 6.76 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.587 -1.321 . . . . 0.0 112.125 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.1 -57.88 2.46 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.374 0.988 . . . . 0.0 114.055 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.97 -24.04 53.53 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 120.035 1.917 . . . . 0.0 112.311 -178.062 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.4 m -66.92 -49.49 65.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.022 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -46.93 -45.55 20.76 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.836 0.854 . . . . 0.0 111.481 -178.01 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -77.48 -19.59 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.794 -177.261 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.16 -22.75 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 121.064 1.756 . . . . 0.0 109.752 171.848 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.37 -43.03 2.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.421 -1.276 . . . . 0.0 114.041 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.39 -40.96 36.28 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.228 1.952 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.5 t -64.21 -47.66 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.2 t -56.88 -54.58 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -176.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 68.9 m-20 -60.7 -49.78 76.13 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.326 0.65 . . . . 0.0 110.894 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -53.85 -52.56 60.03 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -54.34 -43.76 63.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 42' ' ' ASP . . . -52.16 -46.27 65.38 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.324 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.68 8.43 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 175.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -39.9 -49.49 2.43 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.235 1.414 . . . . 0.0 112.789 -177.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.24 24.65 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -174.473 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -40.87 -46.62 2.79 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.133 1.773 . . . . 0.0 112.303 -177.595 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.19 -44.76 1.25 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.068 2.547 . . . . 0.0 113.4 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -140.22 -55.51 0.53 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.148 0.975 . . . . 0.0 112.832 179.051 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.697 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 46.3 tp -78.57 -169.13 1.59 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.72 -1.582 . . . . 0.0 114.322 -155.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.697 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 3.4 pttp -75.79 99.88 4.56 Favored 'General case' 0 N--CA 1.432 -1.354 1 N-CA-C 127.605 6.15 . . . . 0.0 127.605 -153.504 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 52.3 t -160.02 127.8 4.68 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 120.304 -1.498 . . . . 0.0 112.719 168.558 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.23 167.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.906 0.882 . . . . 0.0 109.081 171.022 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -136.39 109.31 7.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.352 0.661 . . . . 0.0 110.456 -177.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.47 118.29 31.14 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 122.986 0.514 . . . . 0.0 109.877 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -72.46 111.86 8.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -67.97 -33.71 75.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.615 1.166 . . . . 0.0 111.423 -173.356 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -67.84 -37.4 81.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.529 1.132 . . . . 0.0 109.322 -179.655 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.88 -27.82 39.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.504 1.521 . . . . 0.0 111.375 177.004 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 m -119.19 51.03 1.5 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.67 1.588 . . . . 0.0 114.014 -176.64 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -60.03 -36.25 90.16 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 124.326 3.351 . . . . 0.0 108.419 175.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -44.34 -72.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.405 1.882 . . . . 0.0 109.93 175.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.76 -50.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.593 1.157 . . . . 0.0 109.738 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.28 -40.92 62.39 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.282 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 m -75.84 -41.12 53.36 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.194 0.998 . . . . 0.0 110.731 179.315 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.26 -45.2 80.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.148 0.579 . . . . 0.0 109.758 178.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -79.11 -35.22 42.59 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.6 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.26 50.74 2.93 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.416 1.008 . . . . 0.0 112.53 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.18 -169.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.248 0.619 . . . . 0.0 110.032 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -158.8 -84.81 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.576 0.75 . . . . 0.0 109.096 177.866 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -57.57 153.84 12.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 110.351 178.829 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.525 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.1 pt -140.84 155.14 69.23 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.914 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.03 140.05 45.43 Favored 'Cis proline' 0 N--CA 1.453 -0.903 0 CA-C-N 120.252 1.126 . . . . 0.0 112.879 2.431 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 m -127.84 104.84 8.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 173.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.0 mt -101.61 102.6 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.661 1.584 . . . . 0.0 108.244 -173.06 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.6 mtt -102.26 151.62 22.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -112.76 130.03 67.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 171.835 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -121.37 148.73 43.97 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 175.411 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.61 153.88 13.3 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.731 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.18 35.98 80.22 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 118.058 -2.02 . . . . 0.0 108.172 -174.199 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.18 -53.2 1.43 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.58 1.562 . . . . 0.0 113.997 -175.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -79.24 165.84 22.8 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -172.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -80.97 152.8 27.81 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 127.137 2.175 . . . . 0.0 110.833 -178.246 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.8 t -138.46 -80.39 0.33 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.401 ' H ' HG12 ' A' ' 79' ' ' VAL . 30.5 mm-40 -72.09 149.5 44.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.773 0.321 . . . . 0.0 110.343 178.225 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.12 75.34 1.29 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.28 1.832 . . . . 0.0 106.72 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.0 mm -81.24 154.21 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.2 mt -138.02 147.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -175.357 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.39 175.1 48.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.608 0.623 . . . . 0.0 111.567 178.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.66 153.2 44.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.54 156.08 45.43 Favored Pre-proline 0 C--O 1.232 0.165 0 C-N-CA 123.484 0.714 . . . . 0.0 109.207 -178.272 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -73.88 143.97 33.92 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 N-CA-C 105.885 -2.39 . . . . 0.0 105.885 166.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -38.46 76.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.239 0.542 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.57 -52.66 28.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 m -58.86 -49.29 78.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.363 0.665 . . . . 0.0 110.065 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -54.21 -53.09 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.006 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.9 t -52.15 -56.73 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.533 0.733 . . . . 0.0 109.254 179.324 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -52.7 -45.87 67.08 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.264 0.554 . . . . 0.0 111.706 178.788 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.8 m -58.93 -38.95 80.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.156 -177.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -81.63 -36.2 14.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 119.026 0.83 . . . . 0.0 111.334 178.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -55.75 -35.11 65.84 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -46.48 -37.96 8.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.006 0.522 . . . . 0.0 110.704 171.284 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 127.089 2.156 . . . . 0.0 112.741 -179.169 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.706 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.88 -165.41 31.57 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 176.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.83 141.69 48.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.54 166.08 23.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 122.316 1.055 . . . . 0.0 111.09 -178.52 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.5 169.31 17.84 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.163 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -39.33 -46.09 1.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.794 1.638 . . . . 0.0 111.986 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -57.38 -70.55 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.871 177.644 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.9 p -61.07 -38.2 85.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 112.256 -175.164 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -39.34 -46.17 1.55 Allowed 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 127.905 2.482 . . . . 0.0 111.107 178.802 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -42.65 -66.29 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 111.954 175.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -45.05 60.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.933 -174.624 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.4 t -70.42 -38.26 73.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.001 -171.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -108.69 -69.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.706 -174.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -54.51 -50.78 67.02 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.99 0.359 . . . . 0.0 111.148 -172.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -88.07 17.06 5.3 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.614 -178.49 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.17 154.21 37.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.12 1.327 . . . . 0.0 111.132 -178.127 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -86.71 -58.63 2.53 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.617 1.567 . . . . 0.0 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.07 161.03 72.33 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.719 1.208 . . . . 0.0 108.01 178.429 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.41 164.67 8.63 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.659 1.573 . . . . 0.0 109.697 173.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 t -145.88 115.83 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 110.98 -174.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tp -89.06 98.78 11.96 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.437 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.32 110.6 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 123.33 0.652 . . . . 0.0 110.549 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -89.11 115.31 26.55 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 57' ' ' LEU . 7.9 m-85 -80.05 111.39 16.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.788 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -131.11 -171.86 2.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.744 0.783 . . . . 0.0 111.035 -173.371 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.98 150.35 2.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 172.802 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.4 -42.26 69.31 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.281 1.987 . . . . 0.0 112.177 178.373 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -66.24 -21.09 66.28 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.077 -0.389 . . . . 0.0 111.757 178.505 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.0 t -76.26 83.45 3.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.615 -0.678 . . . . 0.0 111.345 -176.166 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.73 -57.18 2.89 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.697 -1.057 . . . . 0.0 113.599 173.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -20.53 67.25 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.977 1.785 . . . . 0.0 112.654 -179.658 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.2 m -82.06 -59.0 2.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.413 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -40.13 -53.0 2.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 127.569 2.347 . . . . 0.0 112.154 -178.219 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.93 -22.32 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.47 -33.78 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.347 1.059 . . . . 0.0 110.26 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.88 -43.39 3.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 127.311 2.244 . . . . 0.0 115.512 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -67.43 -36.25 20.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.822 1.681 . . . . 0.0 108.86 -179.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -40.2 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 127.166 2.186 . . . . 0.0 107.748 179.032 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.82 -47.77 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.424 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.39 -53.19 60.58 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.715 0.406 . . . . 0.0 111.692 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.31 -41.16 96.53 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.16 -0.962 . . . . 0.0 110.813 -179.206 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.98 -42.8 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.782 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' A' ' 54' ' ' CYS . . . -53.84 -46.84 71.33 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.52 36.83 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 176.527 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -47.35 -41.75 20.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.546 0.673 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -112.71 31.3 6.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.016 0.926 . . . . 0.0 112.192 -178.282 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -57.05 154.71 9.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.523 0.678 . . . . 0.0 110.49 -178.046 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 71.64 -48.45 0.68 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 128.093 2.557 . . . . 0.0 112.028 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -78.37 -13.17 59.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.206 0.457 . . . . 0.0 110.742 179.134 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.62 119.7 6.28 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -80.97 167.73 19.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.409 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . 45.6 t -146.9 147.5 30.86 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.93 161.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.82 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -125.81 110.61 13.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.435 HD12 ' CD2' ' A' ' 26' ' ' PHE . 2.9 tm? -89.56 112.43 23.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.38 1.472 . . . . 0.0 109.242 -178.06 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -71.89 107.98 4.93 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.0 m -60.58 -43.18 97.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.147 1.779 . . . . 0.0 111.665 -174.153 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.21 -33.77 75.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.901 0.881 . . . . 0.0 110.506 -177.341 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.8 -27.42 36.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.566 1.146 . . . . 0.0 110.425 175.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' HD11 ' A' ' 57' ' ' LEU . 1.4 m -122.86 52.81 4.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.914 1.686 . . . . 0.0 113.492 -176.33 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.23 -31.34 63.97 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.403 3.402 . . . . 0.0 107.985 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -50.43 -60.12 3.32 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.369 1.068 . . . . 0.0 109.457 177.246 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.59 -55.41 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.8 0.84 . . . . 0.0 109.374 -178.757 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.43 -45.38 36.19 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.933 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -65.59 -50.23 65.88 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.13 0.572 . . . . 0.0 110.715 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -56.61 -44.06 80.78 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.752 0.421 . . . . 0.0 111.305 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -79.29 -32.22 43.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.607 -0.235 . . . . 0.0 111.579 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.49 60.8 0.98 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.692 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.5 mt -129.11 152.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.274 1.43 . . . . 0.0 107.77 -178.112 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -148.67 -71.08 0.21 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.19 151.11 41.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 pt -146.27 154.77 50.09 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -179.097 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.74 151.23 74.86 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.656 1.27 . . . . 0.0 113.825 2.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -156.72 100.37 1.92 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 tt -100.7 123.1 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -178.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 mtt -106.02 144.19 33.08 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.413 1.085 . . . . 0.0 110.066 -177.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.9 t -95.87 101.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -95.89 156.36 16.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.178 179.048 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.31 -154.9 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 171.325 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.56 95.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.301 1.429 . . . . 0.0 114.261 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.02 -76.83 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.919 0.771 . . . . 0.0 113.913 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -79.88 169.71 17.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.097 0.951 . . . . 0.0 113.429 -171.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.59 157.41 17.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.255 171.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 15.9 t -109.36 -60.45 1.77 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.832 1.253 . . . . 0.0 110.113 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -132.86 179.08 6.39 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.602 1.561 . . . . 0.0 109.097 -178.729 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -160.34 163.78 33.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.979 0.512 . . . . 0.0 110.055 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 mt -137.18 146.53 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.272 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.8 mp -135.71 151.1 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.269 1.428 . . . . 0.0 108.52 -174.146 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.99 152.78 10.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.2 67.92 2.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.707 . . . . 0.0 110.77 -179.306 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.87 144.3 63.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.706 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.75 155.65 13.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.593 2.195 . . . . 0.0 113.896 -178.056 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -49.28 -43.76 43.37 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.064 0.946 . . . . 0.0 111.323 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.32 65.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 110.625 179.273 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -45.91 86.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.374 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.05 -54.68 21.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -50.3 -57.45 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 124.442 1.097 . . . . 0.0 110.187 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -54.73 -47.33 73.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.623 0.249 . . . . 0.0 111.044 -178.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.9 m -64.3 -41.31 96.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.517 0.327 . . . . 0.0 110.86 -179.212 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.2 t -60.2 -50.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -57.43 -50.77 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.289 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -48.01 -50.19 28.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.699 0.8 . . . . 0.0 109.976 176.6 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.528 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 118.048 -0.977 . . . . 0.0 108.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -45.03 136.88 4.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.842 0.857 . . . . 0.0 112.49 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.44 123.14 20.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.871 1.268 . . . . 0.0 113.764 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.61 -169.51 46.04 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.97 141.34 52.01 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.66 165.61 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.884 0.85 . . . . 0.0 110.565 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -146.69 176.84 9.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.819 2.047 . . . . 0.0 105.866 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -39.29 -57.97 1.28 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.849 0.86 . . . . 0.0 112.504 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.67 -58.61 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.822 1.249 . . . . 0.0 112.015 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -67.14 -35.66 80.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.347 0.659 . . . . 0.0 111.645 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -46.12 -47.28 17.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.531 1.533 . . . . 0.0 110.996 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -49.42 -55.28 13.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.107 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.5 -62.02 1.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.933 0.893 . . . . 0.0 111.653 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.83 -27.46 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 125.715 1.606 . . . . 0.0 113.077 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.46 -74.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.567 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.54 -42.31 70.76 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.048 1.295 . . . . 0.0 113.17 -172.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.78 17.07 11.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.727 0.811 . . . . 0.0 111.958 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.9 p -72.99 149.69 43.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.44 1.018 . . . . 0.0 111.892 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.5 p -92.51 -58.77 2.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.43 1.492 . . . . 0.0 108.992 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.67 162.91 63.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.3 1.44 . . . . 0.0 109.058 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.07 164.32 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.518 2.145 . . . . 0.0 112.383 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 t -145.48 144.13 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.66 97.41 5.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.06 119.52 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -94.2 111.67 23.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 57' ' ' LEU . 26.5 m-85 -78.49 109.92 13.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -123.84 -171.42 2.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.826 0.85 . . . . 0.0 111.157 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.7 151.4 2.84 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.64 1.176 . . . . 0.0 108.137 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.51 -33.47 98.04 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.457 2.105 . . . . 0.0 112.759 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -74.47 -14.15 60.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.528 -0.732 . . . . 0.0 111.018 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.45 82.8 8.13 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.123 -0.986 . . . . 0.0 111.304 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.27 -58.03 2.96 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.732 1.158 . . . . 0.0 113.864 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.71 -40.37 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 CA-C-N 119.748 1.774 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -58.53 -52.08 67.15 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -55.95 -48.5 75.66 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.86 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -74.48 -22.26 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.884 0.765 . . . . 0.0 111.741 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.514 HG22 HG23 ' A' ' 41' ' ' VAL . 18.4 mm -81.69 -34.51 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.496 1.043 . . . . 0.0 110.805 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.05 -45.44 4.66 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.207 1.803 . . . . 0.0 115.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -62.52 -40.48 38.29 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.983 1.789 . . . . 0.0 109.821 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.91 -48.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.716 1.207 . . . . 0.0 107.762 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 37' ' ' ILE . 76.2 t -52.09 -51.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.905 0.882 . . . . 0.0 108.823 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.0 -57.78 10.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.08 -43.68 87.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.882 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.26 -49.4 76.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.26 72.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.447 -0.783 . . . . 0.0 111.668 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -48.99 83.24 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -55.19 -47.86 74.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -83.53 59.11 4.92 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.309 1.528 . . . . 0.0 111.379 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 155.35 13.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.925 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 68.51 -55.1 0.53 Allowed 'General case' 0 C--N 1.338 0.099 0 C-N-CA 129.024 2.929 . . . . 0.0 113.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -82.84 -53.16 6.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -81.1 99.28 8.42 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.671 -171.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -79.66 87.38 5.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.24 152.36 32.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.856 -1.152 . . . . 0.0 108.805 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.84 166.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 121.752 -0.592 . . . . 0.0 109.745 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -130.31 121.33 25.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.63 1.172 . . . . 0.0 109.381 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.559 HD23 ' CE2' ' A' ' 26' ' ' PHE . 42.6 tp -108.43 118.9 37.97 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.859 1.264 . . . . 0.0 110.085 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -73.87 112.98 10.5 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 m -69.74 -28.54 65.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.374 1.47 . . . . 0.0 111.498 -173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.6 -40.64 48.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.174 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -83.01 -27.23 30.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.28 2.232 . . . . 0.0 112.162 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.8 m -132.34 62.15 61.49 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.216 1.406 . . . . 0.0 109.718 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.03 -33.65 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 1 C-N-CA 125.509 4.139 . . . . 0.0 109.97 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -30.07 -73.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.332 2.253 . . . . 0.0 111.964 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -35.4 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.328 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.21 76.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -68.2 -47.23 68.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.146 0.978 . . . . 0.0 109.554 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -55.9 -43.34 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.69 -34.81 45.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.018 0.527 . . . . 0.0 111.247 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 56.35 1.07 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.4 mt -122.02 146.36 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.84 1.656 . . . . 0.0 107.638 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -149.35 -64.23 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.26 144.87 56.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 pt -143.54 156.31 60.15 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.11 141.61 57.54 Favored 'Cis proline' 0 N--CA 1.454 -0.812 0 CA-C-N 120.007 1.038 . . . . 0.0 113.528 3.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -133.91 101.25 5.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.11 100.54 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.374 1.47 . . . . 0.0 107.646 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtt -88.25 148.1 24.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.54 139.43 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 C-N-CA 125.659 1.584 . . . . 0.0 107.671 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -129.21 144.59 51.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.411 ' H ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -101.41 -27.03 13.38 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.318 0.386 . . . . 0.0 111.22 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.7 87.95 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 -63.15 2.8 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.554 0.597 . . . . 0.0 112.178 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -79.88 154.6 28.24 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.608 0.763 . . . . 0.0 110.701 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -71.27 158.05 37.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.51 1.124 . . . . 0.0 109.72 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.96 -58.18 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.714 1.206 . . . . 0.0 110.176 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -141.79 177.68 8.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.695 1.198 . . . . 0.0 110.112 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.7 m -156.38 132.74 10.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.282 1.033 . . . . 0.0 109.546 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.3 mt -109.46 144.26 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -130.19 142.58 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 173.61 47.26 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.792 0.71 . . . . 0.0 112.49 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.26 156.1 35.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.797 0.439 . . . . 0.0 109.92 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.66 156.67 38.86 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.028 0.931 . . . . 0.0 109.059 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -82.99 139.35 9.56 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.174 2.582 . . . . 0.0 107.171 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -48.58 -45.27 37.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 0.0 112.672 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -45.66 67.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.985 0.421 . . . . 0.0 110.626 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -65.15 -45.98 82.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.1 mt -56.2 -52.42 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 t -48.86 -58.51 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 124.609 1.163 . . . . 0.0 109.429 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.14 -47.46 83.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.494 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.0 m -56.06 -43.4 77.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.485 1.114 . . . . 0.0 110.11 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.94 -52.04 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 121.387 -0.82 . . . . 0.0 109.095 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -52.63 -47.34 67.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.62 0.768 . . . . 0.0 112.745 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.67 -23.78 65.09 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.944 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -90.11 -44.8 9.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.809 0.731 . . . . 0.0 109.686 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.5 mp -92.09 -97.09 0.13 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.083 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.17 -45.83 75.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 171.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.92 135.92 38.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 170.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.5 167.37 50.14 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.781 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.06 128.21 56.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.68 165.44 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 122.482 1.134 . . . . 0.0 111.604 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -142.89 172.14 13.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.784 2.434 . . . . 0.0 106.023 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -39.26 -49.87 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.99 1.716 . . . . 0.0 112.371 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.57 -74.08 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.227 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 p -50.31 -42.08 52.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.591 1.156 . . . . 0.0 111.826 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -39.93 -42.84 1.41 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.679 1.992 . . . . 0.0 111.15 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -61.88 -58.84 6.39 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 111.76 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -62.09 -32.74 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.323 0.649 . . . . 0.0 111.403 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -93.12 -30.24 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.898 0.879 . . . . 0.0 113.255 -170.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.95 -72.43 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 124.626 1.17 . . . . 0.0 109.828 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.4 mt -46.98 -55.84 7.43 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.981 0.912 . . . . 0.0 111.584 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.49 7.97 8.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 113.175 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -71.29 143.14 50.44 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 120.027 1.285 . . . . 0.0 110.615 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -81.87 -60.5 2.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.652 1.181 . . . . 0.0 108.73 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.04 162.43 64.55 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.186 0.995 . . . . 0.0 109.484 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.02 160.31 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.901 2.4 . . . . 0.0 113.713 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 t -143.06 147.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.174 1.39 . . . . 0.0 108.417 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.36 110.84 13.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.06 139.85 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -111.72 120.46 42.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.21 113.89 17.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -127.27 -172.15 2.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.764 0.793 . . . . 0.0 110.279 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.45 152.52 4.02 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -52.76 -42.87 60.21 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.579 2.186 . . . . 0.0 112.614 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.518 ' CH2' HD11 ' A' ' 74' ' ' ILE . 26.4 p-90 -69.07 -12.81 62.01 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.768 -0.582 . . . . 0.0 112.269 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -77.82 80.78 4.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.797 -1.189 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.93 -56.49 3.78 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.354 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.92 -29.93 88.06 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.945 1.763 . . . . 0.0 112.414 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.26 -48.34 57.27 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -48.32 50.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.657 0.783 . . . . 0.0 111.647 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.25 -20.65 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.877 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.4 pt -90.02 -28.88 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 121.126 1.784 . . . . 0.0 110.264 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.43 -47.37 4.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.36 -39.4 57.16 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.332 2.021 . . . . 0.0 110.216 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.85 -46.34 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.08 -42.18 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.76 -65.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.421 0.688 . . . . 0.0 111.927 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -42.35 78.13 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.275 1.398 . . . . 0.0 111.727 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mt -62.77 -26.23 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.553 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.93 90.82 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.7 1.136 . . . . 0.0 109.016 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -47.49 90.83 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -58.35 -50.66 72.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -97.25 33.19 2.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.387 0.675 . . . . 0.0 112.349 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -60.27 168.83 1.85 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.607 0.718 . . . . 0.0 111.307 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 71.9 -58.55 0.58 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 127.377 2.271 . . . . 0.0 111.743 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.4 -50.15 11.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.866 -174.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.9 105.84 16.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.105 0.562 . . . . 0.0 110.108 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.15 98.96 6.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.0 t -79.32 137.34 37.3 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.559 -0.713 . . . . 0.0 110.47 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.16 163.71 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.524 0.678 . . . . 0.0 112.195 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -133.86 118.53 18.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.406 1.482 . . . . 0.0 109.595 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tp -99.5 124.17 44.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.63 109.05 7.79 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -67.39 -36.82 82.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.008 1.323 . . . . 0.0 111.243 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -66.4 -38.34 87.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.37 1.068 . . . . 0.0 110.106 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.83 -25.43 32.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.162 1.785 . . . . 0.0 111.363 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.2 t -122.6 52.73 4.32 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.461 1.504 . . . . 0.0 112.636 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.29 -25.94 71.79 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.135 3.224 . . . . 0.0 110.45 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -54.62 -63.26 1.21 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.702 0.801 . . . . 0.0 108.911 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.75 -51.23 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.794 0.838 . . . . 0.0 109.061 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.86 -47.99 21.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.228 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -67.37 -48.83 66.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.533 0.733 . . . . 0.0 110.797 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.55 -46.98 73.73 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.539 0.736 . . . . 0.0 111.203 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -79.56 -31.17 41.9 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.162 0.585 . . . . 0.0 111.166 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.84 52.1 3.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mm -73.54 84.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 122.192 0.996 . . . . 0.0 109.345 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -78.42 76.38 4.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m 94.31 166.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.391 2.676 . . . . 0.0 110.383 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.518 HD11 ' CH2' ' A' ' 30' ' ' TRP . 28.9 pt -136.21 153.68 76.75 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.169 0.988 . . . . 0.0 108.544 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.06 145.83 76.44 Favored 'Cis proline' 0 N--CA 1.453 -0.858 0 CA-C-N 120.31 1.146 . . . . 0.0 112.772 1.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 m -139.45 113.17 8.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.58 138.16 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 mtt -129.85 143.89 51.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.5 t -107.76 139.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 126.045 1.738 . . . . 0.0 107.065 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -126.62 134.48 50.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.453 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -100.64 -26.67 13.73 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.69 67.95 0.25 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.35 -56.89 3.71 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.89 157.66 26.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.844 0.857 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -65.76 160.63 22.54 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.87 1.668 . . . . 0.0 111.482 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.0 t -129.61 -66.23 0.81 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.471 1.508 . . . . 0.0 109.541 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -138.27 172.72 12.49 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.818 1.247 . . . . 0.0 110.007 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.6 t -160.47 153.49 21.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.041 0.936 . . . . 0.0 109.819 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.4 mm -134.54 146.24 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.76 142.16 42.54 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 126.379 1.872 . . . . 0.0 108.25 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.92 155.05 16.69 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.316 0.484 . . . . 0.0 111.998 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.95 52.37 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.549 1.14 . . . . 0.0 112.588 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.7 145.69 63.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.44 147.47 68.33 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.24 1.293 . . . . 0.0 111.426 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -58.1 -34.68 70.45 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.59 55.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.247 0.93 . . . . 0.0 110.992 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -49.48 77.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.237 1.015 . . . . 0.0 109.007 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 mm -58.26 -49.68 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.693 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.39 -53.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.45 1.1 . . . . 0.0 109.21 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.09 -48.89 72.94 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.3 m -60.8 -36.74 79.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.233 0.613 . . . . 0.0 111.441 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.81 -53.71 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 121.206 -0.934 . . . . 0.0 108.826 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -53.44 -42.24 66.92 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.412 1.085 . . . . 0.0 110.86 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -49.83 -45.89 50.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.309 0.644 . . . . 0.0 110.404 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -77.18 -57.72 3.68 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.04 66.54 8.7 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.917 0.887 . . . . 0.0 108.975 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.185 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.623 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 117.818 -1.086 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -64.77 -40.51 95.39 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 119.533 1.06 . . . . 0.0 110.538 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.84 92.07 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.797 0.839 . . . . 0.0 110.774 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.1 -178.47 44.68 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.5 136.86 54.64 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.86 166.7 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.635 1.207 . . . . 0.0 112.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -149.15 172.71 14.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.298 2.639 . . . . 0.0 105.269 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -38.01 -50.12 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.85 2.06 . . . . 0.0 111.687 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.34 -72.22 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 111.572 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -58.64 -33.95 70.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 112.292 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -42.57 -44.64 4.25 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.603 1.961 . . . . 0.0 111.051 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -54.05 -55.61 25.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.504 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.33 -46.11 56.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.344 0.658 . . . . 0.0 111.858 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -85.07 -19.48 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.884 1.274 . . . . 0.0 114.085 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.6 -51.64 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.611 1.096 . . . . 0.0 112.044 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.32 -52.07 25.5 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.938 -0.476 . . . . 0.0 111.543 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -79.12 -9.12 59.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 m -55.73 135.4 51.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.636 1.174 . . . . 0.0 112.852 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 p -79.87 -62.03 1.81 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.805 1.242 . . . . 0.0 109.725 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.93 157.25 76.53 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -54.42 157.62 11.47 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.711 2.274 . . . . 0.0 113.931 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.27 118.45 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.547 1.539 . . . . 0.0 110.676 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.55 91.64 7.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.67 1.188 . . . . 0.0 108.417 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 p -99.27 125.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -99.41 121.31 40.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.57 0.748 . . . . 0.0 109.199 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.425 ' CD2' HD13 ' A' ' 71' ' ' ILE . 6.1 m-85 -79.77 116.51 19.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -133.31 -170.67 2.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.915 0.486 . . . . 0.0 110.662 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.43 151.08 4.35 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -54.58 -40.05 85.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.71 2.273 . . . . 0.0 113.147 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -68.7 -16.62 63.88 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.451 0.568 . . . . 0.0 111.348 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -77.61 79.55 4.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.31 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.57 -57.34 4.53 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.66 -34.55 15.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.423 3.415 . . . . 0.0 114.244 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.01 -54.41 6.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.97 0.891 . . . . 0.0 108.638 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.9 tpt85 -47.42 -49.11 25.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.197 0.999 . . . . 0.0 111.381 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.31 -26.58 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.776 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 pt -87.75 -26.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.194 1.816 . . . . 0.0 110.514 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -46.18 4.05 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.75 -40.98 26.32 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.103 1.868 . . . . 0.0 110.378 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.32 -52.06 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.116 1.366 . . . . 0.0 107.879 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.16 -47.21 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 0.0 108.868 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -68.09 -55.5 12.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -60.59 -32.83 71.92 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.491 0.587 . . . . 0.0 109.483 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.61 -49.27 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.09 -33.87 67.74 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.85 -0.531 . . . . 0.0 110.537 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.05 -56.26 26.32 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.1 -41.45 62.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.078 0.439 . . . . 0.0 110.679 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -98.32 25.97 5.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.272 1.029 . . . . 0.0 113.304 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 169.3 2.0 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.446 0.641 . . . . 0.0 111.97 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 73.82 -53.71 0.69 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.784 2.033 . . . . 0.0 111.28 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -78.44 -54.97 5.6 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.61 114.21 27.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.5 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -78.42 163.33 25.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.8 t -145.56 146.13 31.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.42 168.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.482 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -136.0 107.42 6.88 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.685 1.194 . . . . 0.0 109.611 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -87.57 117.16 26.18 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -73.37 104.15 4.28 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.628 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.7 m -56.37 -46.74 79.9 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.309 1.844 . . . . 0.0 112.023 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.9 -36.7 82.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.26 1.824 . . . . 0.0 110.479 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -84.65 -26.01 28.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.459 1.904 . . . . 0.0 111.116 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -122.01 54.61 5.34 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.855 1.662 . . . . 0.0 111.905 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.6 -24.84 76.85 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 124.098 3.198 . . . . 0.0 111.02 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -51.83 -71.66 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.046 0.938 . . . . 0.0 109.089 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -53.48 -48.34 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.648 1.179 . . . . 0.0 109.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.29 -51.32 46.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.855 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -70.66 -43.99 67.99 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.573 0.749 . . . . 0.0 110.878 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.1 -47.67 68.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.564 0.745 . . . . 0.0 110.303 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -79.35 -31.09 42.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.95 48.08 5.93 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' A' ' 26' ' ' PHE . 2.6 pt -74.38 97.96 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.072 0.939 . . . . 0.0 109.894 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 69.08 4.68 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 109.208 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t 101.6 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 129.48 3.112 . . . . 0.0 109.506 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -143.59 161.01 48.9 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.3 1.84 . . . . 0.0 109.318 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -68.57 157.01 88.94 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 120.697 1.285 . . . . 0.0 113.054 2.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -152.07 102.59 2.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -79.86 131.96 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.7 mtt -125.54 136.79 53.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -96.02 101.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -89.01 148.62 23.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 33.94 1.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.625 0.578 . . . . 0.0 110.728 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 105.57 3.0 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.69 -70.93 0.9 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.524 1.059 . . . . 0.0 113.025 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -101.53 169.84 8.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.055 0.931 . . . . 0.0 112.189 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -84.09 165.09 18.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.334 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.79 -58.88 1.92 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.16 1.384 . . . . 0.0 108.911 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -133.18 176.29 8.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.112 1.365 . . . . 0.0 109.434 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 t -158.76 160.89 36.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.083 0.553 . . . . 0.0 110.706 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.3 mt -138.15 122.92 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.03 139.73 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.988 0.915 . . . . 0.0 109.404 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.0 153.92 14.76 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 121.47 0.483 . . . . 0.0 113.133 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.52 73.69 1.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.991 -0.711 . . . . 0.0 111.307 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.74 148.18 72.26 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.96 157.07 11.25 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.03 2.487 . . . . 0.0 113.948 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -51.94 -45.78 64.48 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.68 0.792 . . . . 0.0 111.646 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.66 64.58 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.277 0.631 . . . . 0.0 110.355 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -48.13 78.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.41 -57.08 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.8 t -48.96 -61.27 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.994 1.318 . . . . 0.0 109.872 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -52.8 -46.49 67.68 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.344 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.8 m -63.18 -44.54 95.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.622 0.369 . . . . 0.0 110.919 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.23 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 121.207 -0.933 . . . . 0.0 108.882 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -55.58 -54.05 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -47.3 -49.79 23.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.45 1.1 . . . . 0.0 110.166 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -73.31 -30.94 63.72 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.4 mt -154.8 103.42 2.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.92 1.288 . . . . 0.0 109.639 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.283 0 C-N-CA 129.158 2.983 . . . . 0.0 104.128 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pm0 -52.52 156.3 1.87 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.957 0.903 . . . . 0.0 112.345 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.45 128.43 35.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.493 1.517 . . . . 0.0 114.543 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.28 -171.94 25.03 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 169.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 141.51 45.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -139.87 173.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 122.801 1.286 . . . . 0.0 110.895 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.98 171.08 18.38 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.323 2.649 . . . . 0.0 104.627 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -39.17 -53.64 1.84 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 112.832 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -52.78 63.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.312 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -73.58 -35.54 65.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.273 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -39.43 -48.16 1.91 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.601 2.36 . . . . 0.0 110.535 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -42.62 -70.44 0.11 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.169 0.988 . . . . 0.0 112.206 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.6 -47.68 80.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.533 1.133 . . . . 0.0 111.602 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.68 -37.18 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.521 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.17 -65.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.056 0.943 . . . . 0.0 110.99 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -62.8 -59.43 4.87 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -172.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.49 41.39 0.47 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.879 -0.513 . . . . 0.0 111.66 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -90.31 168.86 11.58 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -97.18 -71.65 0.67 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.542 1.537 . . . . 0.0 107.904 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.21 157.63 75.39 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.81 159.59 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.0 1.8 . . . . 0.0 114.961 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.18 127.88 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.942 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 23' ' ' LEU . 5.5 tt -103.34 104.82 14.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.031 1.732 . . . . 0.0 107.522 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.02 126.47 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.93 115.88 31.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -79.1 111.74 15.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -128.21 -174.32 3.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 122.111 0.958 . . . . 0.0 110.015 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.7 140.01 2.11 Favored Pre-proline 0 N--CA 1.451 -0.38 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -39.2 -54.47 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.362 2.708 . . . . 0.0 117.393 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -57.79 -20.89 38.73 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.819 0.736 . . . . 0.0 112.549 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 85.91 0.83 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.367 0.667 . . . . 0.0 112.13 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.2 -55.04 4.42 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.322 0.963 . . . . 0.0 113.816 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.01 -36.06 98.31 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.2 1.933 . . . . 0.0 110.959 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -66.44 -49.34 67.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -55.4 -46.31 76.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.456 0.302 . . . . 0.0 111.094 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.88 -30.4 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.128 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 tp -84.69 -35.97 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 120.619 1.554 . . . . 0.0 112.437 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.44 -49.16 4.94 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -60.32 -34.27 93.73 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.835 2.356 . . . . 0.0 110.766 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.84 -47.95 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.366 1.066 . . . . 0.0 108.379 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.58 -51.17 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -57.45 -55.28 36.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.404 . . . . 0.0 110.994 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.37 -50.84 72.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.739 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -51.13 -52.34 18.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.32 73.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.72 -41.21 97.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -66.85 -50.84 61.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -83.71 59.94 5.45 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.456 1.122 . . . . 0.0 109.878 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -46.1 -67.36 0.29 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.965 2.106 . . . . 0.0 111.988 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.92 -57.96 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.097 1.359 . . . . 0.0 114.202 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -78.9 -54.59 5.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.36 117.62 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.85 -163.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -91.34 116.37 28.79 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.754 1.221 . . . . 0.0 110.55 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.3 t -78.47 142.35 37.56 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.329 -0.857 . . . . 0.0 109.665 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.2 164.3 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -137.22 115.82 12.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.073 0.949 . . . . 0.0 109.58 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.45 118.23 34.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.87 0.868 . . . . 0.0 109.508 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -71.81 107.33 4.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.9 m -59.33 -43.06 92.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.092 1.757 . . . . 0.0 111.545 -173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.63 -35.87 82.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.909 0.884 . . . . 0.0 110.316 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.81 -24.71 30.89 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.425 1.49 . . . . 0.0 111.514 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 49.74 2.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.507 1.923 . . . . 0.0 113.23 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.13 -25.56 37.33 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.629 3.552 . . . . 0.0 109.713 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -51.26 -54.72 23.21 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.031 0.932 . . . . 0.0 109.189 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.9 -57.11 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.753 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.39 -45.1 65.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.427 0.691 . . . . 0.0 112.168 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -65.93 -48.74 70.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.996 0.519 . . . . 0.0 109.927 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.91 -38.12 69.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.529 0.332 . . . . 0.0 110.609 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.62 -23.49 45.87 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.14 40.11 11.93 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.203 0.906 . . . . 0.0 111.634 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.03 169.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.494 1.118 . . . . 0.0 109.089 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -154.25 -58.39 0.12 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.893 0.877 . . . . 0.0 109.386 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 147.93 30.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.38 155.54 60.97 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.65 142.32 69.41 Favored 'Cis proline' 0 N--CA 1.453 -0.855 0 CA-C-N 120.134 1.084 . . . . 0.0 112.322 1.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -137.05 102.48 4.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.03 134.71 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 33.5 mtt -128.33 123.52 34.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.5 t -95.88 141.54 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -127.1 158.3 37.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.332 1.453 . . . . 0.0 107.913 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 42.62 1.18 Allowed 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.335 1.022 . . . . 0.0 110.726 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.2 97.17 2.28 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.49 -73.19 0.77 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.428 0.537 . . . . 0.0 112.213 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.84 160.54 26.06 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.315 1.055 . . . . 0.0 111.847 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.95 143.75 28.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.512 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.2 t -88.38 -70.29 0.65 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.283 1.033 . . . . 0.0 108.289 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -150.79 -175.37 5.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.588 1.555 . . . . 0.0 109.256 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -143.73 162.42 36.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.916 1.286 . . . . 0.0 109.719 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.3 mt -139.24 140.78 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.33 138.72 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.78 153.72 25.95 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 121.888 0.716 . . . . 0.0 112.116 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.97 78.01 3.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.246 0.618 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -78.28 152.25 78.76 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.26 153.23 22.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.592 2.194 . . . . 0.0 113.995 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -46.6 -50.25 17.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.278 1.831 . . . . 0.0 110.654 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.2 -47.25 75.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.933 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -62.54 -46.21 89.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.568 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.1 mt -54.68 -55.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 t -52.33 -59.03 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.218 0.607 . . . . 0.0 110.042 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -49.47 -52.14 31.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.436 0.694 . . . . 0.0 110.338 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 45.4 m -61.7 -45.37 94.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.214 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.06 -56.24 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 118.739 0.699 . . . . 0.0 109.583 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -62.72 -43.76 97.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.932 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -51.24 -54.4 26.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.258 0.623 . . . . 0.0 109.552 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -64.57 -43.91 92.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.649 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.3 mt -118.11 -95.44 0.48 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.045 0.938 . . . . 0.0 110.251 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.077 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 72.08 -67.26 0.27 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.87 140.47 56.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.03 157.1 36.07 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.987 1.28 . . . . 0.0 113.285 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.3 114.85 20.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.14 164.54 20.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 122.806 1.289 . . . . 0.0 110.13 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -143.21 174.75 10.43 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.348 1.859 . . . . 0.0 106.691 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -53.41 2.1 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.957 1.303 . . . . 0.0 113.229 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.94 -59.65 2.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.136 0.974 . . . . 0.0 111.46 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -59.11 -34.43 72.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.563 0.745 . . . . 0.0 111.682 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -45.42 -48.29 13.67 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 126.039 1.736 . . . . 0.0 110.541 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -55.15 -53.64 53.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.632 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -53.64 54.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 0.0 112.347 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -75.15 -39.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.875 1.27 . . . . 0.0 113.302 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.61 -66.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.18 0.992 . . . . 0.0 110.903 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.06 -59.2 5.73 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 121.217 0.532 . . . . 0.0 110.877 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -78.87 40.55 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.355 0.662 . . . . 0.0 111.227 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.1 t -90.29 -169.44 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.834 0.854 . . . . 0.0 109.328 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -131.58 -66.14 0.73 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.191 2.196 . . . . 0.0 106.71 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.86 157.0 79.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.02 161.03 7.03 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.391 2.061 . . . . 0.0 112.617 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.28 139.32 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -114.11 117.15 30.44 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.77 115.94 51.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -90.3 111.95 23.33 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.596 ' CD2' HD12 ' A' ' 57' ' ' LEU . 25.8 m-85 -78.76 112.64 16.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -125.36 -173.84 2.92 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.096 0.951 . . . . 0.0 110.265 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.72 152.49 4.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -55.33 -32.02 79.46 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.393 2.062 . . . . 0.0 113.544 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.419 ' CH2' HD11 ' A' ' 74' ' ' ILE . 38.1 p-90 -78.98 -6.42 56.26 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.3 0.955 . . . . 0.0 111.737 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.17 88.22 6.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.827 -1.171 . . . . 0.0 111.192 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.11 -63.52 0.91 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.639 1.114 . . . . 0.0 113.706 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.36 -47.24 23.07 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.959 2.439 . . . . 0.0 112.63 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 77.7 m -54.27 -44.43 71.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.261 0.624 . . . . 0.0 109.854 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -54.76 -50.11 69.22 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -81.94 -19.68 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.594 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 41' ' ' VAL . 41.2 mt -78.78 -38.88 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.842 0.857 . . . . 0.0 109.224 175.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.85 -49.26 5.72 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.893 2.077 . . . . 0.0 115.553 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.83 -37.24 79.4 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.345 2.03 . . . . 0.0 110.109 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.48 -43.65 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 37' ' ' ILE . 29.7 t -55.67 -45.38 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -56.43 -63.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.557 0.743 . . . . 0.0 109.831 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.92 -37.55 76.93 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.684 0.675 . . . . 0.0 112.04 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -52.25 -36.44 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.632 0.773 . . . . 0.0 110.01 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.59 -39.2 76.27 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.333 0.515 . . . . 0.0 110.988 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.14 -50.4 34.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -53.36 -44.5 68.59 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -115.12 37.43 3.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.656 0.782 . . . . 0.0 112.803 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.98 162.2 2.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.906 0.882 . . . . 0.0 111.176 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 72.77 -61.81 0.49 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.314 2.245 . . . . 0.0 111.353 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -78.0 -32.08 51.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -170.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 tp -125.38 102.9 7.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.88 94.86 5.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.43 132.2 37.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 118.589 -0.719 . . . . 0.0 109.317 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.11 176.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.022 0.828 . . . . 0.0 111.793 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -131.13 122.93 27.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.723 2.009 . . . . 0.0 110.943 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.596 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.0 tm? -104.31 120.15 40.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.607 1.563 . . . . 0.0 109.818 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -74.89 107.61 7.09 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 m -66.76 -33.66 76.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.491 1.516 . . . . 0.0 111.427 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.29 -38.92 78.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.58 -27.85 31.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.762 2.025 . . . . 0.0 111.519 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 57' ' ' LEU . 1.5 m -119.84 52.28 2.16 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.579 1.552 . . . . 0.0 112.431 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -65.98 -30.08 48.48 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 125.49 4.127 . . . . 0.0 109.747 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.83 -62.17 2.07 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -55.73 -47.06 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.388 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.3 -47.42 55.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.194 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -65.74 -46.05 80.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.161 0.585 . . . . 0.0 110.515 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -54.45 -45.8 73.18 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.978 0.511 . . . . 0.0 110.638 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -79.48 -30.93 42.26 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.21 43.29 3.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 123.915 0.769 . . . . 0.0 111.22 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.38 88.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -77.29 -23.24 51.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.2 p -157.24 175.08 14.5 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.419 HD11 ' CH2' ' A' ' 30' ' ' TRP . 21.1 pt -146.62 154.4 48.24 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.08 133.94 26.37 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 CA-C-N 120.92 1.364 . . . . 0.0 113.445 1.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -139.98 104.83 4.95 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.571 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.0 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.78 153.27 34.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.74 133.15 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.218 1.007 . . . . 0.0 108.669 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -128.81 141.98 51.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 133.77 18.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.53 41.75 98.85 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -172.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.19 -47.47 2.63 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 124.451 1.024 . . . . 0.0 114.075 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -79.62 157.26 27.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.044 0.938 . . . . 0.0 111.964 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -88.24 156.07 19.41 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 127.296 2.238 . . . . 0.0 112.83 -172.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.83 -80.28 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.665 0.386 . . . . 0.0 111.626 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -74.71 152.84 39.07 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.107 0.48 . . . . 0.0 111.99 -170.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.7 m -132.94 110.88 10.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.969 2.508 . . . . 0.0 106.005 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.47 123.86 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -78.83 146.85 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.93 -137.72 0.69 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 71.53 -46.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.945 1.298 . . . . 0.0 110.687 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.08 148.49 75.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.18 68.75 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.526 1.484 . . . . 0.0 111.696 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -50.62 -37.41 40.22 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.227 1.011 . . . . 0.0 111.27 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.55 -41.73 21.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.508 0.595 . . . . 0.0 111.192 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -47.21 84.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.708 0.803 . . . . 0.0 108.869 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 mt -63.27 -40.29 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.825 1.25 . . . . 0.0 110.072 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.8 t -57.89 -58.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.921 1.288 . . . . 0.0 108.143 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.01 -46.63 68.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.233 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 m -60.39 -51.98 67.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.189 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.77 -44.15 93.18 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.34 -0.85 . . . . 0.0 110.854 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -50.46 -39.73 48.76 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.869 0.868 . . . . 0.0 111.558 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -59.64 -29.25 67.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.294 -0.254 . . . . 0.0 111.399 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -91.35 -43.89 9.49 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.691 0.797 . . . . 0.0 109.995 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.44 -107.1 0.15 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.736 0.815 . . . . 0.0 108.856 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.359 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.09 -51.52 45.48 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.74 131.71 41.05 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 167.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.88 179.68 44.27 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.33 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.67 137.46 54.45 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' CG1' HG11 ' A' ' 14' ' ' VAL . 5.7 m -130.14 164.02 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 118.972 0.806 . . . . 0.0 111.158 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.02 169.9 17.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 173.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -38.92 -45.26 1.16 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.352 1.861 . . . . 0.0 112.41 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.09 -74.14 0.12 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.028 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -48.81 -38.9 23.48 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.499 1.12 . . . . 0.0 111.564 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -38.95 -47.36 1.44 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.364 2.266 . . . . 0.0 110.591 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -48.3 -64.67 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.96 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.08 -38.55 75.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.126 1.37 . . . . 0.0 111.911 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.775 HG13 HG23 ' A' ' 15' ' ' VAL . 3.7 p -83.0 -47.86 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.293 1.037 . . . . 0.0 113.424 -172.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.775 HG23 HG13 ' A' ' 14' ' ' VAL . 57.3 t -95.85 -57.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.726 0.81 . . . . 0.0 110.886 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.48 -57.0 6.47 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.57 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.39 45.53 0.67 Allowed 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.444 -0.785 . . . . 0.0 111.221 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 p -90.52 164.72 14.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.545 1.138 . . . . 0.0 111.128 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.5 p -104.98 -68.62 0.85 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.623 1.569 . . . . 0.0 107.162 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.0 162.93 62.73 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.034 1.333 . . . . 0.0 108.035 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.613 ' HB2' HD13 ' A' ' 52' ' ' LEU . 53.1 Cg_exo -56.27 167.9 2.33 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.799 1.666 . . . . 0.0 112.294 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -146.28 120.27 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.574 1.549 . . . . 0.0 109.215 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -97.72 102.79 14.64 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -98.21 109.73 24.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.362 0.665 . . . . 0.0 109.801 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -87.77 117.72 26.8 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -79.19 112.6 16.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -126.31 -173.74 2.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.843 0.83 . . . . 0.0 111.008 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.66 156.76 3.43 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.41 -36.42 78.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.315 2.01 . . . . 0.0 109.991 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -76.68 -3.56 38.58 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.708 0.803 . . . . 0.0 111.738 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.4 t -63.69 -60.42 3.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.714 1.143 . . . . 0.0 111.659 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 -86.02 0.52 Allowed Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.069 -1.406 . . . . 0.0 110.761 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.97 -46.13 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.415 2.744 . . . . 0.0 111.843 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.0 m -46.13 -46.53 17.19 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.374 1.47 . . . . 0.0 111.41 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -67.87 -44.08 77.92 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.656 0.783 . . . . 0.0 110.797 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.97 -13.13 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.875 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.59 -38.49 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.062 1.345 . . . . 0.0 108.491 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -37.95 -47.38 2.71 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.905 2.082 . . . . 0.0 114.721 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.13 -39.97 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.828 1.686 . . . . 0.0 109.918 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -74.91 -47.52 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.629 1.972 . . . . 0.0 109.505 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -61.06 -38.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.601 -1.312 . . . . 0.0 109.568 175.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.86 -54.25 24.21 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 119.286 -0.387 . . . . 0.0 110.822 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.08 -41.89 89.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.32 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mm -55.3 -46.49 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.27 -51.09 57.32 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.16 -54.21 13.02 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -61.73 -54.0 48.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.678 0.752 . . . . 0.0 112.916 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -83.21 -8.06 59.53 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -37.31 -58.49 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.501 1.921 . . . . 0.0 113.5 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.21 -39.91 60.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.952 1.301 . . . . 0.0 112.802 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -91.32 -37.47 13.24 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.887 1.275 . . . . 0.0 113.301 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -158.03 145.5 18.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.84 1.256 . . . . 0.0 108.446 -168.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -93.82 154.67 17.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.997 1.719 . . . . 0.0 109.678 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 147.01 49.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.83 167.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.133 0.424 . . . . 0.0 111.021 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -135.54 113.65 11.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.661 1.185 . . . . 0.0 111.545 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 62' ' ' SER . 8.9 tt -94.87 116.53 28.84 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.126 0.971 . . . . 0.0 109.57 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -75.88 111.38 11.19 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -66.53 -29.23 69.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.366 1.466 . . . . 0.0 111.85 -173.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.69 -38.31 54.67 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.915 1.286 . . . . 0.0 109.787 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -80.91 -25.94 37.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.044 1.737 . . . . 0.0 110.782 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' HD21 ' A' ' 57' ' ' LEU . 3.1 m -117.33 51.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.916 2.087 . . . . 0.0 112.232 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -63.78 -31.0 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 125.598 4.198 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -58.4 -64.24 0.99 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.19 -44.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.851 0.357 . . . . 0.0 110.073 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.79 64.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -67.78 -44.46 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.226 0.61 . . . . 0.0 110.628 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.73 -45.85 70.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 110.222 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -79.56 -33.2 42.01 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.79 50.11 2.18 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.85 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.777 0.831 . . . . 0.0 109.351 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' H ' ' CD ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.08 -26.31 43.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.905 0.882 . . . . 0.0 110.812 177.429 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.9 m -160.24 160.17 32.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.833 1.253 . . . . 0.0 107.781 -171.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 pt -143.35 160.7 50.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.956 1.702 . . . . 0.0 107.566 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.7 154.57 79.46 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 CA-C-N 121.426 1.545 . . . . 0.0 113.838 3.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.6 m -151.14 104.04 3.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.8 mt -91.12 118.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.9 mtt -103.86 129.52 51.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.7 t -91.18 115.76 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.47 166.18 12.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.822 1.249 . . . . 0.0 108.626 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.28 -161.0 0.71 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.06 102.86 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.33 1.443 . . . . 0.0 114.656 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.27 -64.35 2.07 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.75 1.167 . . . . 0.0 114.963 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.43 177.74 4.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.479 1.133 . . . . 0.0 113.706 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -87.72 155.92 19.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.041 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.6 t -103.59 -69.15 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.823 1.249 . . . . 0.0 108.994 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.42 177.96 8.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 108.39 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -152.87 149.29 28.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.892 -0.505 . . . . 0.0 109.975 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -121.52 104.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.955 2.102 . . . . 0.0 107.026 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.4 mt -89.49 137.38 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.05 1.34 . . . . 0.0 107.799 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.64 150.0 25.42 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 121.697 0.609 . . . . 0.0 112.284 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.42 64.18 2.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.954 0.901 . . . . 0.0 112.031 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.29 150.66 74.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.21 149.25 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.728 1.619 . . . . 0.0 112.1 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -45.69 66.72 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.95 -43.72 14.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.206 0.602 . . . . 0.0 111.515 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -51.43 67.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.993 0.917 . . . . 0.0 108.931 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.0 -52.19 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 123.829 0.852 . . . . 0.0 109.775 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.28 -57.3 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.267 0.94 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -55.28 -49.28 72.52 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.807 0.336 . . . . 0.0 110.286 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.5 m -57.23 -45.98 83.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.725 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.79 -52.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 120.915 -1.116 . . . . 0.0 109.267 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.02 -38.34 65.03 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.731 1.212 . . . . 0.0 111.721 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -54.7 -33.5 61.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.505 0.322 . . . . 0.0 110.88 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -105.46 -77.0 0.59 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.354 1.462 . . . . 0.0 113.145 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 mt 67.62 -58.91 0.42 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 129.752 3.221 . . . . 0.0 111.423 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.551 1.54 . . . . 0.0 108.583 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.71 -48.72 53.16 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 170.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.53 138.6 40.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.38 167.47 54.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.392 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.04 132.16 50.58 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -131.39 173.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 122.074 0.94 . . . . 0.0 110.043 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -155.66 178.28 10.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.309 2.244 . . . . 0.0 105.48 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -45.7 -55.95 5.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.993 0.815 . . . . 0.0 111.699 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.31 -57.79 4.29 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.833 1.653 . . . . 0.0 112.623 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 p -74.06 -47.0 39.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.863 0.865 . . . . 0.0 111.293 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -39.66 -48.7 2.17 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.229 2.212 . . . . 0.0 110.739 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -40.03 -53.83 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.708 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -87.27 -47.83 8.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.366 1.079 . . . . 0.0 110.695 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.28 -32.89 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.217 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -109.95 -64.56 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.02 1.328 . . . . 0.0 111.603 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.23 -71.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.312 0.505 . . . . 0.0 111.14 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.43 53.64 2.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.905 0.882 . . . . 0.0 108.8 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.1 p -90.8 -129.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.024 0.929 . . . . 0.0 109.56 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.1 p -161.54 -78.04 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.05 163.71 58.65 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -50.17 163.13 0.64 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.814 2.343 . . . . 0.0 114.043 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 t -146.45 141.54 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 108.784 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.01 97.53 5.14 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.96 129.85 47.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -102.32 116.67 33.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.21 108.66 12.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -124.49 -175.5 3.28 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 123.716 0.635 . . . . 0.0 110.475 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.53 142.07 1.35 Allowed Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.922 0.889 . . . . 0.0 111.077 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.73 108.72 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.228 1.952 . . . . 0.0 108.468 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 137.85 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 1 C-N-CA 131.756 4.022 . . . . 0.0 105.846 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.7 t -74.93 83.02 2.2 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.54 -58.96 2.84 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.249 0.928 . . . . 0.0 112.25 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -48.54 -34.14 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.967 3.111 . . . . 0.0 113.86 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.41 -46.23 17.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -50.91 -50.24 57.86 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.275 1.43 . . . . 0.0 111.119 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.97 -32.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.422 HG22 HG23 ' A' ' 41' ' ' VAL . 15.5 mm -76.35 -36.86 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.551 1.141 . . . . 0.0 111.95 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.76 -48.49 5.42 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.8 -36.46 61.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.656 2.238 . . . . 0.0 110.179 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.86 -45.23 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 37' ' ' ILE . 46.2 t -54.17 -48.17 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.8 m-20 -59.92 -53.07 62.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.04 -39.69 95.5 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.775 -1.203 . . . . 0.0 110.402 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mt -56.8 -44.4 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 42' ' ' ASP . . . -52.86 -52.82 55.92 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.73 49.06 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -62.99 -43.3 99.16 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -117.08 8.93 13.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -39.65 -46.53 1.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.731 2.012 . . . . 0.0 112.199 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -29.91 -58.81 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.874 2.469 . . . . 0.0 113.508 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -112.29 -31.72 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.343 1.057 . . . . 0.0 112.342 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.46 105.47 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.125 0.57 . . . . 0.0 111.055 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -78.66 91.08 4.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.2 t -79.5 136.44 36.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.997 -1.064 . . . . 0.0 110.328 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.96 173.27 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.522 0.729 . . . . 0.0 111.551 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -139.93 113.07 8.25 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.726 1.21 . . . . 0.0 111.127 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.81 126.84 38.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.738 0.699 . . . . 0.0 110.753 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -77.64 108.97 11.21 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 m -70.87 -33.22 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.754 1.622 . . . . 0.0 111.55 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.4 -40.33 93.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.221 1.01 . . . . 0.0 109.346 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -84.61 -24.16 29.27 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.177 2.191 . . . . 0.0 112.141 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 m -134.97 61.98 50.02 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 120.821 -1.174 . . . . 0.0 111.735 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.06 -23.25 34.18 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 124.962 3.774 . . . . 0.0 109.921 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -42.97 -72.64 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.614 1.565 . . . . 0.0 110.931 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.0 t -52.18 -48.4 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.033 1.333 . . . . 0.0 109.899 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -41.81 66.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.939 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.5 m -74.8 -43.5 54.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.015 . . . . 0.0 110.566 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -54.84 -48.31 73.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.316 0.646 . . . . 0.0 109.938 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -79.44 -33.0 42.84 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.56 56.7 4.12 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.3 pt -67.49 142.28 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.492 0.663 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -79.6 71.7 6.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.6 t 65.33 -157.28 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.616 1.166 . . . . 0.0 109.384 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 153.04 69.96 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.313 1.045 . . . . 0.0 110.103 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.24 145.07 82.33 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 CA-C-N 119.536 0.87 . . . . 0.0 112.515 2.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.1 m -136.08 106.66 6.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.65 105.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.928 1.691 . . . . 0.0 106.54 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.6 mtp -103.62 127.53 51.04 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.46 134.03 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -120.65 136.73 54.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 173.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.426 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -107.43 -101.3 0.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 81' ' ' LYS . . . -71.85 73.15 0.84 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.61 -59.94 3.33 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.328 0.966 . . . . 0.0 112.975 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -86.09 173.27 9.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.36 0.6 . . . . 0.0 112.279 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.21 152.92 10.09 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.948 1.699 . . . . 0.0 113.411 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 t -130.54 -56.87 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.666 1.987 . . . . 0.0 109.058 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.05 166.95 21.54 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.397 1.079 . . . . 0.0 110.632 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 m -152.75 95.5 2.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.817 1.647 . . . . 0.0 106.618 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.33 141.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.3 mt -133.22 142.96 40.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 155.94 32.19 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 71.96 1.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.099 -0.648 . . . . 0.0 111.67 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -79.13 153.66 77.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.43 154.46 53.27 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.343 2.028 . . . . 0.0 114.424 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -45.38 -53.49 8.55 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.364 1.866 . . . . 0.0 109.47 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.49 -55.79 4.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.727 1.211 . . . . 0.0 110.132 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -59.19 -53.39 58.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 110.539 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 80.8 mt -51.87 -58.67 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.88 -60.29 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.976 1.31 . . . . 0.0 109.907 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -49.23 -49.14 44.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.269 0.486 . . . . 0.0 111.163 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.7 m -61.53 -57.72 10.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 p -63.51 -45.06 98.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 118.561 -1.256 . . . . 0.0 111.257 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -50.96 -49.76 59.39 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.765 1.626 . . . . 0.0 110.741 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -51.72 -48.84 63.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.719 175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -78.09 -76.15 0.2 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -173.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.573 HD12 ' H ' ' A' ' 107' ' ' ASN . 0.4 OUTLIER 11.95 -52.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 1 C-N-CA 133.622 4.769 . . . . 0.0 118.457 -169.343 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.573 ' H ' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.257 0 C-N-CA 127.448 2.299 . . . . 0.0 110.552 -173.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.43 -41.8 98.99 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.51 144.64 27.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.2 168.16 54.73 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.31 131.65 56.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.82 162.83 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 122.167 0.984 . . . . 0.0 110.488 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -142.72 176.59 8.93 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.407 1.883 . . . . 0.0 106.338 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -39.22 -58.84 1.11 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.653 1.181 . . . . 0.0 112.383 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -54.62 -58.09 8.87 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.851 1.661 . . . . 0.0 113.09 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -67.2 -46.38 74.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.3 1.84 . . . . 0.0 110.558 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -40.15 -51.5 2.64 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 126.84 2.056 . . . . 0.0 111.212 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -44.08 -52.5 7.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.664 0.745 . . . . 0.0 110.931 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.66 -58.06 3.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.606 0.717 . . . . 0.0 111.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.33 -43.6 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.565 -169.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.68 -61.54 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.518 1.127 . . . . 0.0 111.348 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -70.68 -63.03 1.17 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.929 0.786 . . . . 0.0 110.508 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -79.92 52.63 1.53 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.619 0.645 . . . . 0.0 111.48 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 p -89.02 155.36 19.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.783 1.633 . . . . 0.0 110.322 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -87.1 -73.77 0.46 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.66 162.01 64.59 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.58 166.88 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.323 2.016 . . . . 0.0 114.18 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.14 149.02 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.362 1.865 . . . . 0.0 110.466 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 tt -126.87 102.03 6.84 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 170.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.0 p -107.08 123.6 62.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.116 1.325 . . . . 0.0 108.789 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -93.59 115.29 27.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CD2' HD12 ' A' ' 57' ' ' LEU . 25.2 m-85 -79.61 104.07 9.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -116.61 -169.91 1.72 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.315 1.046 . . . . 0.0 110.24 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.49 148.73 1.55 Allowed Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 124.595 1.158 . . . . 0.0 107.923 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.03 -37.71 95.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.559 2.173 . . . . 0.0 112.85 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.585 ' CH2' HD11 ' A' ' 74' ' ' ILE . 37.4 p-90 -72.73 -18.7 61.49 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.904 -0.497 . . . . 0.0 111.052 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.69 83.59 6.43 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.057 -1.027 . . . . 0.0 109.715 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.29 -59.53 1.82 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.52 1.057 . . . . 0.0 113.457 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.99 -48.61 20.74 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.694 2.263 . . . . 0.0 111.546 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.4 m -55.74 -50.49 70.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -58.13 -49.93 75.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.332 1.053 . . . . 0.0 111.536 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.73 -22.47 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.722 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.0 mt -82.56 -30.13 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 119.847 1.203 . . . . 0.0 109.435 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.35 -41.69 2.64 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.937 1.695 . . . . 0.0 115.223 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.76 -40.89 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.323 2.015 . . . . 0.0 109.809 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.14 -35.33 34.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 C-N-CA 118.153 -1.419 . . . . 0.0 108.136 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.7 t -52.73 -43.65 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.15 -58.36 8.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.094 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.36 -42.2 77.4 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.558 0.617 . . . . 0.0 111.884 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.98 -36.5 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 122.838 0.455 . . . . 0.0 109.962 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.68 -46.97 80.86 Favored 'General case' 0 C--O 1.223 -0.342 0 O-C-N 121.913 -0.492 . . . . 0.0 110.193 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.9 -42.68 99.63 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.76 -44.06 90.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.55 15.63 8.84 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -39.43 -51.15 2.13 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.132 1.373 . . . . 0.0 113.7 -174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -44.7 -46.65 10.44 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.081 1.752 . . . . 0.0 112.774 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -98.56 -37.76 9.42 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.92 0.888 . . . . 0.0 112.266 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.4 tp -116.16 112.07 21.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.101 -167.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -79.96 93.65 5.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 49.9 t -79.13 134.16 36.72 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.494 -0.754 . . . . 0.0 109.685 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.64 167.9 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.166 0.586 . . . . 0.0 111.758 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -135.27 116.4 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.034 1.334 . . . . 0.0 110.077 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.427 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.3 tm? -98.86 120.83 39.96 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 109.585 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -75.42 103.31 5.5 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.672 0.749 . . . . 0.0 110.265 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -81.96 48.33 1.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.451 1.9 . . . . 0.0 111.27 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -145.5 -47.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.59 -26.43 34.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.86 2.064 . . . . 0.0 109.821 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.4 m -133.05 60.38 49.0 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.006 -1.059 . . . . 0.0 113.813 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.87 -23.78 16.07 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 125.186 3.924 . . . . 0.0 108.716 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -37.38 -69.25 0.12 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.356 1.862 . . . . 0.0 111.099 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -35.68 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.183 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.63 81.24 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 m -72.41 -45.21 60.71 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.095 0.958 . . . . 0.0 109.965 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -54.97 -46.04 75.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.35 0.66 . . . . 0.0 110.386 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.98 -34.76 43.92 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.365 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.23 54.77 1.24 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.516 0.579 . . . . 0.0 111.859 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.6 mt -77.69 121.41 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -79.0 -35.46 42.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.02 0.528 . . . . 0.0 111.537 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.9 m -158.73 168.82 25.84 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.585 HD11 ' CH2' ' A' ' 30' ' ' TRP . 23.1 pt -124.82 154.56 70.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.34 149.69 82.19 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 CA-C-N 120.287 1.138 . . . . 0.0 112.277 2.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -144.04 106.04 4.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.61 116.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.5 mtt -105.76 134.93 48.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -99.47 140.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -127.99 161.1 29.94 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 54.56 0.81 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.521 1.138 . . . . 0.0 110.488 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.18 98.35 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.48 -73.08 1.17 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.103 0.858 . . . . 0.0 112.066 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -94.58 165.21 12.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.825 1.298 . . . . 0.0 113.131 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -77.32 142.35 39.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.265 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 41.7 t -89.08 -65.22 1.04 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.227 1.011 . . . . 0.0 108.643 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -151.28 -174.75 4.92 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.091 1.756 . . . . 0.0 108.166 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.2 t -154.23 166.72 32.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.364 0.666 . . . . 0.0 109.585 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.0 mt -136.02 118.63 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.95 141.0 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 109.027 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.64 163.33 38.3 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.836 0.731 . . . . 0.0 111.569 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.34 142.97 57.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.08 0.552 . . . . 0.0 110.739 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.69 153.54 36.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 124.123 0.969 . . . . 0.0 108.525 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.72 145.29 20.2 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 N-CA-C 105.586 -2.505 . . . . 0.0 105.586 168.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -56.29 -33.41 65.5 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.321 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.88 -42.87 6.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.662 0.785 . . . . 0.0 110.62 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.1 m -75.3 -44.42 45.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.978 0.511 . . . . 0.0 110.018 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.5 mt -54.42 -47.45 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 123.51 0.724 . . . . 0.0 110.08 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -57.15 -55.28 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.439 0.695 . . . . 0.0 109.714 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -56.61 -45.49 81.45 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.889 -0.507 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.3 m -66.34 -43.24 86.65 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.073 0.549 . . . . 0.0 111.752 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.71 -43.62 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 121.024 -1.048 . . . . 0.0 108.878 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.26 -47.75 80.61 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -54.1 -52.0 62.38 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.473 0.709 . . . . 0.0 109.919 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -63.06 -41.79 99.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.613 0.365 . . . . 0.0 111.791 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.7 -99.68 0.32 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.875 1.27 . . . . 0.0 109.299 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.354 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 tpp . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.09 -44.48 76.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.09 135.46 41.19 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 169.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.06 166.16 44.63 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.32 126.98 55.84 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.52 164.43 30.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 122.271 1.034 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -148.9 179.84 7.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.321 1.848 . . . . 0.0 106.832 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -39.05 -59.05 1.04 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.362 1.465 . . . . 0.0 112.213 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.99 -69.14 0.25 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.546 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -51.59 -39.03 57.18 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.248 1.019 . . . . 0.0 112.11 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -44.74 -48.22 10.79 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.197 1.399 . . . . 0.0 111.045 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -50.29 -51.25 46.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.412 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -74.76 -56.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.428 0.633 . . . . 0.0 111.38 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.7 t -66.86 -23.97 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.078 1.751 . . . . 0.0 113.368 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.51 -75.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.574 0.75 . . . . 0.0 110.524 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.37 -47.06 66.37 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.667 0.667 . . . . 0.0 112.781 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.14 15.03 16.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.423 1.089 . . . . 0.0 112.085 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.34 147.93 27.64 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.034 0.834 . . . . 0.0 111.407 -173.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.2 p -80.01 -61.91 1.84 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.345 1.458 . . . . 0.0 111.753 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.45 160.25 75.57 Favored Pre-proline 0 C--O 1.233 0.185 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.79 159.88 3.27 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.245 1.963 . . . . 0.0 110.403 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.05 149.26 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 123.768 0.827 . . . . 0.0 109.599 -173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.67 98.97 4.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.68 119.29 45.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -95.29 114.04 25.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -79.58 112.37 16.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -128.14 -172.04 2.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.817 0.818 . . . . 0.0 110.526 -174.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.27 151.7 4.71 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 124.516 1.126 . . . . 0.0 108.108 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.62 -31.98 93.26 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.375 2.05 . . . . 0.0 113.266 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.483 ' CH2' HD11 ' A' ' 74' ' ' ILE . 17.5 p-90 -79.47 -7.23 58.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.107 0.867 . . . . 0.0 111.405 176.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.6 t -81.31 83.63 6.83 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.078 -1.013 . . . . 0.0 112.551 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.93 -58.02 2.78 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.551 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.22 -20.19 66.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 CA-C-N 119.634 1.717 . . . . 0.0 113.064 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.8 m -81.15 -49.82 10.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -45.17 -50.21 11.55 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.778 0.831 . . . . 0.0 111.153 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -65.82 -25.75 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.387 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 pt -90.23 -29.05 4.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 CA-C-N 120.689 1.586 . . . . 0.0 110.255 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.02 4.28 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.96 -28.39 24.36 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 122.276 1.849 . . . . 0.0 109.848 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -71.41 -41.42 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -55.94 -46.74 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.38 -54.73 39.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.69 -41.15 94.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.638 1.563 . . . . 0.0 110.669 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.9 mm -60.36 -41.99 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -50.71 67.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.925 0.784 . . . . 0.0 109.302 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.81 -49.7 34.11 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.14 -58.89 4.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -85.38 -0.03 53.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -171.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -39.0 -49.12 1.69 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.549 1.54 . . . . 0.0 113.163 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -46.87 -59.95 2.74 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.859 1.664 . . . . 0.0 112.593 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -83.48 -30.03 27.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.799 1.24 . . . . 0.0 112.579 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.67 110.89 10.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 -168.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.81 95.59 6.07 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.3 t -79.26 140.18 37.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.572 -0.705 . . . . 0.0 109.29 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.82 165.4 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.835 0.854 . . . . 0.0 109.906 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -133.56 116.95 16.52 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.708 1.203 . . . . 0.0 109.268 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 tt -99.1 123.39 43.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.017 0.436 . . . . 0.0 110.385 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.99 108.82 9.14 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.9 m -68.99 -29.82 68.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 124.876 1.27 . . . . 0.0 111.692 -174.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.58 -43.26 66.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.91 0.862 . . . . 0.0 110.177 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -81.19 -27.4 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.299 1.84 . . . . 0.0 111.666 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.2 m -134.0 61.89 54.09 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 121.04 -1.037 . . . . 0.0 110.679 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.14 -35.9 31.31 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.899 3.733 . . . . 0.0 108.861 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -33.55 -69.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.11 2.164 . . . . 0.0 111.058 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.8 t -55.48 -51.45 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.744 1.218 . . . . 0.0 110.057 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.32 -37.03 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.122 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 m -74.6 -45.23 46.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.53 1.132 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.99 -43.28 73.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.421 0.688 . . . . 0.0 109.629 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -78.97 -32.71 45.42 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.385 -0.341 . . . . 0.0 110.952 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.45 51.1 2.42 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 111.675 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.0 mt -84.05 113.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.075 0.95 . . . . 0.0 108.676 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -79.65 -26.86 40.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 113.532 -175.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 m -161.08 167.11 26.96 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.483 HD11 ' CH2' ' A' ' 30' ' ' TRP . 18.7 pt -129.53 151.92 78.78 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 146.88 83.0 Favored 'Cis proline' 0 N--CA 1.453 -0.894 0 CA-C-N 119.923 1.008 . . . . 0.0 113.277 1.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.6 m -139.61 114.4 9.4 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.3 mt -104.55 102.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.8 mtt -87.86 131.92 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.44 143.31 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -134.31 158.93 42.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.964 0.906 . . . . 0.0 109.716 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 146.72 28.52 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.554 2.342 . . . . 0.0 104.73 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.92 55.12 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.117 -1.516 . . . . 0.0 111.768 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.1 -52.58 2.95 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 122.258 -0.554 . . . . 0.0 113.525 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -79.67 163.66 24.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.539 1.161 . . . . 0.0 113.409 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -67.67 148.04 51.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.863 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 t -115.11 -63.41 1.46 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.355 1.462 . . . . 0.0 109.125 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -138.3 -177.7 4.96 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 109.771 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -155.22 131.82 10.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.941 0.896 . . . . 0.0 109.455 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.0 mm -104.33 153.28 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.74 142.02 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.154 0.981 . . . . 0.0 108.596 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.31 158.24 20.14 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 121.531 0.517 . . . . 0.0 112.54 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.92 70.18 1.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.53 . . . . 0.0 111.146 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -78.5 153.43 78.8 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.71 147.22 50.91 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.619 1.546 . . . . 0.0 112.208 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -62.05 -39.19 91.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.391 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -48.86 37.12 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -59.56 -51.12 71.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 109.204 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.1 mt -54.96 -58.38 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.039 0.535 . . . . 0.0 109.878 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.2 t -49.67 -55.98 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.886 1.274 . . . . 0.0 110.673 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -48.23 74.25 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -61.38 -41.41 97.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.459 0.303 . . . . 0.0 111.191 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.18 -49.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -57.75 -46.56 84.33 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.509 0.724 . . . . 0.0 110.048 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -51.85 -52.05 52.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.736 0.814 . . . . 0.0 109.482 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -65.82 -45.4 82.44 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.1 mt -108.16 -98.99 0.37 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.037 1.335 . . . . 0.0 109.894 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.338 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.29 -41.13 98.24 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.05 129.35 34.43 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 168.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.01 -177.44 39.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.86 136.9 54.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.41 165.49 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.616 0.722 . . . . 0.0 111.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -145.55 172.09 13.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.784 2.034 . . . . 0.0 106.063 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -39.09 -48.12 1.63 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.936 1.694 . . . . 0.0 112.663 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.52 -74.0 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.105 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -52.86 -36.33 58.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.512 1.125 . . . . 0.0 111.951 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -41.06 -46.73 2.99 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 126.258 1.823 . . . . 0.0 111.376 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -49.48 -48.02 48.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.789 1.236 . . . . 0.0 111.086 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -85.12 -57.64 3.01 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.779 0.832 . . . . 0.0 111.157 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.77 -38.58 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.651 1.18 . . . . 0.0 112.163 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -104.91 -59.52 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 112.305 -174.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 mt -66.57 -71.34 0.2 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.162 0.437 . . . . 0.0 110.982 -174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -79.57 52.77 1.46 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.101 0.476 . . . . 0.0 111.483 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 p -90.67 159.29 16.47 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.11 1.764 . . . . 0.0 111.301 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -91.72 -69.87 0.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.243 1.417 . . . . 0.0 107.736 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 m -78.75 154.41 78.32 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.29 163.81 16.47 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.748 0.965 . . . . 0.0 110.194 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.47 113.72 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.667 1.187 . . . . 0.0 111.348 -171.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.32 105.64 13.56 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.85 116.04 45.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 109.762 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -89.44 112.27 23.36 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.555 ' CE2' HD23 ' A' ' 57' ' ' LEU . 18.6 m-85 -78.71 112.93 16.32 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -130.12 -172.52 2.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.575 0.75 . . . . 0.0 110.754 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.5 148.82 3.51 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.967 1.307 . . . . 0.0 107.772 172.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.15 -45.35 41.67 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.702 2.268 . . . . 0.0 112.809 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -64.56 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.031 -0.418 . . . . 0.0 111.96 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.4 t -76.31 84.44 3.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.626 -0.671 . . . . 0.0 110.913 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.53 -54.12 5.77 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.996 0.808 . . . . 0.0 112.883 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -27.78 71.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.365 2.043 . . . . 0.0 112.767 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.4 m -77.15 -53.67 7.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -45.04 -47.2 11.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.981 1.712 . . . . 0.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -71.9 -25.96 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.02 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.6 pt -86.88 -26.43 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 121.267 1.849 . . . . 0.0 110.083 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.14 -45.72 3.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.367 1.467 . . . . 0.0 114.795 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -68.11 -33.17 25.9 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.708 2.272 . . . . 0.0 109.979 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -38.76 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 127.053 2.141 . . . . 0.0 107.901 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.25 -45.69 95.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.92 -52.92 63.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.844 0.457 . . . . 0.0 110.205 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -50.69 -49.85 56.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.434 0.561 . . . . 0.0 109.955 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.91 -38.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.58 -33.73 64.17 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.026 0.376 . . . . 0.0 110.277 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.58 -56.56 7.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.94 -47.53 21.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -106.69 21.95 16.66 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -48.62 -40.4 27.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.958 0.903 . . . . 0.0 111.274 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.48 -68.35 0.19 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.37 1.468 . . . . 0.0 112.4 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -89.94 -14.64 33.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.16 135.04 33.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.683 1.129 . . . . 0.0 113.102 -167.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -79.94 151.63 29.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.1 t -137.34 136.75 38.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.8 166.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 112.069 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -128.3 116.13 19.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.081 1.352 . . . . 0.0 109.542 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 ' CE2' ' A' ' 26' ' ' PHE . 43.8 tp -97.73 115.97 29.02 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.57 0.748 . . . . 0.0 109.983 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -71.1 110.42 5.76 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -64.21 -43.67 94.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 111.4 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.11 -33.68 76.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.584 0.754 . . . . 0.0 110.403 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -82.44 -25.03 33.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 0.0 111.104 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -125.88 54.9 11.44 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 113.034 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.18 -30.83 45.96 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.789 2.993 . . . . 0.0 108.616 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -43.64 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.13 1.772 . . . . 0.0 110.991 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.4 t -50.57 -51.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -39.09 74.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.044 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -70.35 -45.19 66.62 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.014 0.526 . . . . 0.0 109.656 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.58 -42.35 74.65 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.2 -23.97 43.46 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.747 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.85 10.62 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.041 0.829 . . . . 0.0 111.072 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -70.23 128.9 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.88 -45.03 21.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.325 0.65 . . . . 0.0 111.386 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 m -156.48 171.28 20.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.06 154.39 68.1 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.17 149.59 89.81 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 CA-C-N 119.787 0.96 . . . . 0.0 112.118 1.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -135.57 101.18 4.71 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.0 mt -90.61 114.57 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.6 mtm -126.16 150.34 48.35 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.2 t -108.51 139.73 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.5 168.26 12.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.333 1.021 . . . . 0.0 109.994 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 156.78 2.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.979 2.112 . . . . 0.0 106.7 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 37.57 49.96 1.83 Allowed Glycine 0 CA--C 1.535 1.343 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.96 64.55 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.667 -1.074 . . . . 0.0 115.621 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -147.75 172.21 14.45 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.515 1.657 . . . . 0.0 111.099 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -85.76 161.66 19.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.834 1.254 . . . . 0.0 109.412 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 53.1 t -131.16 -63.1 0.86 Allowed 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 126.231 1.813 . . . . 0.0 109.826 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -113.66 162.3 16.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.394 1.078 . . . . 0.0 110.433 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -154.77 131.43 10.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.334 1.454 . . . . 0.0 107.854 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -140.57 113.46 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -99.11 139.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.8 148.26 22.54 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.407 1.004 . . . . 0.0 110.804 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 75.48 1.0 Allowed 'General case' 0 C--N 1.339 0.12 0 O-C-N 122.033 -0.686 . . . . 0.0 110.875 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.9 m -78.73 145.26 66.31 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.33 157.63 39.59 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.972 1.781 . . . . 0.0 113.027 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -42.1 -51.01 4.7 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.372 1.469 . . . . 0.0 110.028 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.08 -44.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 111.861 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -69.17 -48.44 62.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 70.2 mt -54.41 -54.3 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -46.59 -64.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 127.802 2.441 . . . . 0.0 109.271 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -55.6 -49.08 73.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.512 0.196 . . . . 0.0 111.297 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.4 m -56.85 -52.07 66.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.845 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.03 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.918 0.781 . . . . 0.0 110.515 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -52.7 -36.73 57.76 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.368 0.667 . . . . 0.0 112.015 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -46.92 -46.39 21.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.048 0.452 . . . . 0.0 110.49 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -87.95 -42.65 12.33 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.146 0.978 . . . . 0.0 111.195 -174.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 mp -129.26 83.42 2.14 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.554 1.142 . . . . 0.0 109.41 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 117.433 -1.27 . . . . 0.0 109.975 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 118.915 -0.564 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -163.22 178.35 8.28 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.82 143.32 31.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.155 0.982 . . . . 0.0 112.359 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.34 177.69 18.09 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.52 141.77 50.49 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 m -142.07 171.72 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 123.137 1.446 . . . . 0.0 112.674 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.38 169.56 19.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.977 3.311 . . . . 0.0 105.055 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -38.43 -50.39 1.52 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.702 2.401 . . . . 0.0 112.753 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.17 -70.02 0.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.726 0.774 . . . . 0.0 110.577 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -53.25 -38.7 63.23 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.601 1.16 . . . . 0.0 112.415 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -42.97 -46.75 5.55 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.864 2.066 . . . . 0.0 111.5 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -54.26 -55.38 28.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.72 -54.25 17.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.468 0.707 . . . . 0.0 111.516 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.31 -31.17 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.261 1.424 . . . . 0.0 112.79 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.24 -72.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.549 0.739 . . . . 0.0 111.024 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.1 mt -53.79 -41.03 66.81 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -172.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -93.12 13.23 21.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.009 0.924 . . . . 0.0 112.512 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 t -73.71 142.97 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.514 1.052 . . . . 0.0 111.888 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 p -79.64 -61.31 2.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.045 1.338 . . . . 0.0 108.636 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.86 155.14 80.62 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -57.23 161.32 11.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.64 1.56 . . . . 0.0 112.56 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 t -141.1 143.07 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.411 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tt -120.08 102.35 8.47 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.378 1.871 . . . . 0.0 106.689 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t -97.77 127.41 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -103.08 124.87 49.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -79.68 106.69 11.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -118.62 -176.13 3.03 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.872 1.32 . . . . 0.0 111.66 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.79 152.08 6.3 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.49 -42.68 12.11 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.857 1.342 . . . . 0.0 111.665 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -58.25 -18.75 28.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.796 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.8 t -77.97 88.72 4.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.707 1.139 . . . . 0.0 109.773 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.54 -63.07 1.04 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.187 1.375 . . . . 0.0 113.538 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -49.47 -47.29 23.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.39 2.726 . . . . 0.0 112.358 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.5 m -58.75 -53.6 56.58 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -53.25 -54.47 35.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.854 1.262 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -75.79 -27.37 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.652 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.78 -26.87 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.754 1.161 . . . . 0.0 109.796 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.79 -46.2 4.64 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -63.28 -35.68 61.23 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.675 2.25 . . . . 0.0 110.373 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 t -68.69 -44.28 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 t -58.07 -44.37 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.53 -60.81 3.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 122.828 0.451 . . . . 0.0 111.035 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.51 -33.87 71.91 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.435 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mt -56.8 -43.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.17 -47.7 76.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.042 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.28 -60.68 5.53 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 120.191 1.36 . . . . 0.0 110.69 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -48.17 -55.74 9.63 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.616 1.566 . . . . 0.0 110.717 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.39 58.88 4.74 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 123.447 1.594 . . . . 0.0 110.313 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -48.31 138.18 10.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.227 1.811 . . . . 0.0 110.115 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.73 -56.2 0.62 Allowed 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.565 2.346 . . . . 0.0 112.968 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.1 -9.44 58.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -166.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -141.62 108.87 5.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.974 1.261 . . . . 0.0 112.214 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -93.78 111.75 23.49 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.68 138.31 38.23 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.811 -1.18 . . . . 0.0 108.135 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.15 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -133.93 106.53 7.32 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.359 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -89.11 120.03 30.14 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 111.254 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.29 106.75 8.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.3 m -68.87 -31.97 71.3 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.231 1.413 . . . . 0.0 111.453 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.87 -41.5 87.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.438 1.095 . . . . 0.0 109.309 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.51 -28.68 26.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.004 2.122 . . . . 0.0 111.99 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.4 t -127.13 53.21 9.55 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.399 1.48 . . . . 0.0 112.208 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -62.78 -27.14 75.21 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.306 3.337 . . . . 0.0 108.825 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -40.37 -60.05 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.628 1.571 . . . . 0.0 110.263 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.8 -50.78 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.171 0.988 . . . . 0.0 110.167 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.08 64.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.426 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -68.63 -44.91 73.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.898 0.879 . . . . 0.0 110.397 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -56.38 -42.0 77.16 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.644 0.778 . . . . 0.0 110.332 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -78.47 -34.18 47.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.39 45.89 2.46 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.415 1.007 . . . . 0.0 111.588 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.76 -179.16 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 125.938 1.695 . . . . 0.0 108.33 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -158.62 -63.66 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.559 0.744 . . . . 0.0 109.593 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 m -54.94 154.64 5.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 110.223 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 pt -143.2 157.92 59.28 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.175 1.39 . . . . 0.0 107.3 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.27 156.28 84.78 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 120.766 1.309 . . . . 0.0 112.958 2.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -160.46 115.74 2.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -98.65 148.46 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.9 mtt -136.24 133.0 36.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.7 t -99.46 139.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -132.82 144.86 50.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 136.88 15.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 46.14 94.64 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -171.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.01 -59.65 2.66 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.908 0.766 . . . . 0.0 114.006 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -81.44 168.29 18.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -67.73 155.37 39.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.235 1.814 . . . . 0.0 112.96 -173.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.0 t -116.17 -72.38 0.69 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.965 2.106 . . . . 0.0 109.651 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -146.07 172.01 14.04 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.299 1.44 . . . . 0.0 110.246 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.5 m -116.41 146.58 42.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.63 1.972 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.82 -175.43 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.54 153.14 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.36 -153.57 5.83 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 51.48 42.48 29.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.947 0.899 . . . . 0.0 111.828 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.46 153.16 65.39 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.074 1.35 . . . . 0.0 107.477 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.36 160.43 32.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.103 1.868 . . . . 0.0 111.676 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -50.53 -43.57 56.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.807 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.41 -44.71 55.21 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.235 0.614 . . . . 0.0 111.111 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.3 m -65.84 -50.96 62.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -55.41 -52.78 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.392 0.677 . . . . 0.0 109.499 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.42 -58.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.428 1.491 . . . . 0.0 109.595 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -55.31 -47.41 75.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.689 0.677 . . . . 0.0 110.992 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.1 m -60.92 -43.83 98.03 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 119.591 -0.242 . . . . 0.0 111.448 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -72.5 -45.75 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.967 0.803 . . . . 0.0 109.829 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -51.54 -45.56 63.03 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.12 0.968 . . . . 0.0 110.772 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -48.24 -44.32 33.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.964 0.506 . . . . 0.0 110.316 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -78.88 -41.63 29.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.4 -104.02 0.1 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.132 0.973 . . . . 0.0 109.02 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.364 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -113.54 -34.62 5.5 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.841 0.856 . . . . 0.0 111.352 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.75 95.67 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.547 0.739 . . . . 0.0 111.545 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.41 -172.64 35.13 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.24 140.58 52.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.88 167.81 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.153 0.978 . . . . 0.0 111.793 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 8' ' ' ASP . 8.1 t-20 -143.5 172.76 12.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.844 2.058 . . . . 0.0 106.389 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.423 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 76.5 m-20 -38.82 -46.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.195 1.798 . . . . 0.0 112.381 -177.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.46 -76.19 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.719 0.408 . . . . 0.0 110.768 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.0 p -46.94 -39.82 13.07 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.271 1.429 . . . . 0.0 112.194 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -39.42 -47.9 1.86 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.526 1.93 . . . . 0.0 111.487 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.774 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -71.23 -45.73 62.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.507 0.67 . . . . 0.0 111.261 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.79 -37.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.031 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -106.33 -73.93 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.883 0.873 . . . . 0.0 110.78 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.9 mt -52.06 -54.53 29.11 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.865 0.466 . . . . 0.0 111.86 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -81.03 11.73 3.86 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -65.6 152.43 44.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.82 1.191 . . . . 0.0 109.614 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 p -79.33 -64.69 1.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.12 155.12 77.41 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.27 165.01 1.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.904 2.403 . . . . 0.0 112.608 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -144.72 143.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.449 1.099 . . . . 0.0 111.588 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -104.52 130.13 52.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.899 1.68 . . . . 0.0 107.67 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.61 111.28 27.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 118.918 0.781 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -89.69 116.28 27.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' CD2' ' CD1' ' A' ' 71' ' ' ILE . 15.9 m-85 -79.75 114.53 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -129.44 -173.48 3.02 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.565 0.698 . . . . 0.0 111.664 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.64 156.59 8.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -59.44 -40.52 66.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.206 1.938 . . . . 0.0 110.658 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.508 ' CH2' HD11 ' A' ' 74' ' ' ILE . 53.1 p-90 -72.24 -10.25 59.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.881 0.472 . . . . 0.0 111.515 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.36 82.29 3.11 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.8 -1.187 . . . . 0.0 110.157 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.2 -61.21 1.01 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.825 1.202 . . . . 0.0 113.529 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.05 -41.3 78.36 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.387 2.058 . . . . 0.0 112.43 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 81.4 m -55.22 -47.66 75.02 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -56.2 -52.32 64.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.729 0.412 . . . . 0.0 111.482 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -73.24 -30.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.91 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.85 -23.08 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.951 0.9 . . . . 0.0 110.361 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.0 -46.54 5.17 Favored Pre-proline 0 CA--C 1.549 0.919 0 O-C-N 119.914 -1.741 . . . . 0.0 115.061 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.92 -37.58 64.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.466 2.111 . . . . 0.0 110.173 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.41 -49.08 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.411 HG12 ' SG ' ' A' ' 54' ' ' CYS . 84.8 t -49.96 -44.76 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.67 -61.92 1.61 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.36 -40.22 81.65 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.532 -0.73 . . . . 0.0 112.256 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.77 -38.42 75.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 54' ' ' CYS . . . -62.21 -52.3 64.34 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -43.58 -53.43 6.06 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.897 0.76 . . . . 0.0 111.572 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -47.95 -35.4 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.24 1.016 . . . . 0.0 112.869 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -120.33 27.03 8.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.447 1.499 . . . . 0.0 112.673 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -39.67 -53.14 2.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.879 1.271 . . . . 0.0 113.799 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.04 -53.22 59.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 122.181 0.991 . . . . 0.0 112.33 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -79.43 -20.29 47.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.822 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 tp -144.8 114.68 7.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.051 0.387 . . . . 0.0 111.988 -170.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.2 168.09 20.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 44.3 t -145.65 141.45 28.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.988 -1.07 . . . . 0.0 110.273 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.21 161.8 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.893 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -127.62 109.38 11.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.452 1.101 . . . . 0.0 109.492 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tp -87.9 121.59 30.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.238 0.542 . . . . 0.0 110.426 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -74.58 105.46 5.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.9 m -65.21 -35.94 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.916 1.686 . . . . 0.0 111.03 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.92 -39.56 94.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.511 1.124 . . . . 0.0 109.539 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.37 -21.7 30.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.804 1.642 . . . . 0.0 110.702 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.1 m -120.96 51.11 2.22 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 114.597 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.53 -27.39 61.78 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.487 2.791 . . . . 0.0 109.68 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -54.28 -75.83 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.849 0.86 . . . . 0.0 109.933 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.63 -44.01 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.036 0.935 . . . . 0.0 110.343 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.63 80.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.76 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.4 p -70.74 -39.58 73.23 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.681 0.392 . . . . 0.0 110.27 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.73 -41.66 77.88 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.106 0.562 . . . . 0.0 109.928 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.29 -31.52 48.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.07 47.19 4.22 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.41 ' CD1' ' CD2' ' A' ' 26' ' ' PHE . 58.6 mt -72.62 114.67 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.438 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.93 -29.74 44.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.305 0.242 . . . . 0.0 111.006 -178.372 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 m -159.84 157.99 30.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.959 0.904 . . . . 0.0 108.619 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.508 HD11 ' CH2' ' A' ' 30' ' ' TRP . 22.0 pt -119.52 150.74 50.51 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.46 77.21 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.126 1.081 . . . . 0.0 114.05 3.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 m -143.06 113.34 7.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.08 119.96 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 mtt -105.22 159.23 16.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.904 0.882 . . . . 0.0 109.247 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 81.8 t -126.5 130.63 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -116.77 147.53 41.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.892 1.677 . . . . 0.0 108.36 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.8 53.1 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.435 0.636 . . . . 0.0 109.582 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.09 85.99 1.74 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.16 -67.32 1.17 Allowed Glycine 0 CA--C 1.527 0.827 0 CA-C-N 117.388 0.594 . . . . 0.0 112.884 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -79.85 163.69 24.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.258 1.023 . . . . 0.0 111.428 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -90.13 150.06 22.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.072 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.1 t -91.23 -51.4 5.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.23 -178.88 6.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 109.519 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -157.67 143.13 17.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.404 1.482 . . . . 0.0 107.816 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.21 153.35 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.119 0.968 . . . . 0.0 109.456 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.0 mt -79.92 141.86 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -138.57 2.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.37 42.34 31.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.806 0.803 . . . . 0.0 111.236 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.88 151.1 67.63 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.95 151.52 64.92 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.86 1.706 . . . . 0.0 112.836 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -45.08 46.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.409 1.484 . . . . 0.0 110.801 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -43.13 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.653 0.781 . . . . 0.0 111.133 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -49.55 74.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.815 . . . . 0.0 109.055 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.66 -52.37 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 123.951 0.9 . . . . 0.0 108.754 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.2 t -53.65 -59.25 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.104 0.962 . . . . 0.0 109.32 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -50.62 -42.36 55.98 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.705 0.402 . . . . 0.0 111.016 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -60.99 -59.49 5.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.8 -45.78 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.91 0.884 . . . . 0.0 111.62 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.47 -39.61 4.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.981 1.713 . . . . 0.0 113.193 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.69 -49.22 78.39 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.286 0.634 . . . . 0.0 110.593 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -80.33 -62.66 1.61 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.911 1.284 . . . . 0.0 110.257 -172.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.18 63.02 7.79 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.549 -1.691 . . . . 0.0 108.869 179.927 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 119.32 -0.371 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.17 -48.49 65.16 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.46 140.1 30.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 169.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.15 174.05 54.68 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.46 132.84 56.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.4 164.47 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 122.513 1.149 . . . . 0.0 111.208 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.63 169.31 18.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.998 2.519 . . . . 0.0 105.487 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -40.43 -52.99 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.079 1.352 . . . . 0.0 111.318 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.12 -53.23 56.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.048 . . . . 0.0 112.308 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 p -78.67 -31.4 46.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.344 0.658 . . . . 0.0 112.002 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -42.59 -43.54 3.82 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 127.548 2.339 . . . . 0.0 110.335 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -50.72 -67.68 0.23 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.358 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -42.6 98.91 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.226 1.01 . . . . 0.0 112.352 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.66 -43.9 16.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.971 -168.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.3 t -99.2 -54.03 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.399 1.08 . . . . 0.0 111.307 -174.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -69.17 -57.77 4.94 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.756 0.707 . . . . 0.0 110.283 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.6 51.55 1.28 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.173 0.989 . . . . 0.0 110.112 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 p -90.06 154.69 19.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.766 1.226 . . . . 0.0 112.64 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -100.94 -71.37 0.71 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.023 1.729 . . . . 0.0 107.405 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.7 m -79.19 158.95 73.84 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.56 159.81 12.85 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.565 1.51 . . . . 0.0 109.97 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 t -138.7 119.03 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.064 0.945 . . . . 0.0 110.419 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -94.41 110.35 22.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.375 1.07 . . . . 0.0 108.179 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.76 113.46 40.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -86.24 113.88 22.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.537 ' CD2' HD12 ' A' ' 57' ' ' LEU . 40.3 m-85 -79.3 113.09 17.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.4 p-90 -129.18 -174.71 3.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.79 0.805 . . . . 0.0 111.016 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.77 154.14 5.23 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.888 1.275 . . . . 0.0 108.17 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.98 -42.1 15.32 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.821 2.348 . . . . 0.0 110.45 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.468 ' CH2' HD11 ' A' ' 74' ' ' ILE . 30.8 p-90 -66.39 -17.95 65.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.893 0.477 . . . . 0.0 111.215 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.9 t -75.37 97.59 3.65 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.545 -0.722 . . . . 0.0 110.248 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -32.01 -68.87 0.13 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.908 2.194 . . . . 0.0 115.062 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.13 -44.37 12.58 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.879 1.839 . . . . 0.0 110.8 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.4 m -47.22 -50.37 21.16 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.291 0.636 . . . . 0.0 109.998 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -46.26 -50.4 16.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.045 1.338 . . . . 0.0 111.618 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -90.15 -13.56 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 tp -85.62 -27.86 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.468 1.031 . . . . 0.0 109.561 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.55 -48.3 4.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -62.56 -36.98 61.56 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.56 2.173 . . . . 0.0 110.337 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 t -63.13 -51.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -50.77 -46.05 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.255 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.89 -62.17 1.88 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.617 0.367 . . . . 0.0 111.187 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.19 -30.16 68.0 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.02 0.827 . . . . 0.0 113.161 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -26.15 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 118.048 -1.461 . . . . 0.0 109.387 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.11 73.92 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.042 -1.036 . . . . 0.0 109.757 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.69 -42.36 95.39 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -57.65 -39.37 76.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.058 0.429 . . . . 0.0 109.955 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -78.86 53.76 1.44 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.637 -0.664 . . . . 0.0 112.456 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -62.09 -44.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.8 108.82 3.11 Favored 'General case' 0 N--CA 1.443 -0.812 1 N-CA-C 100.163 -4.014 . . . . 0.0 100.163 162.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -72.67 107.93 5.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.471 -2.15 . . . . 0.0 113.822 -153.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.13 121.98 37.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 108.879 -3.782 . . . . 0.0 105.828 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.89 149.74 32.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.08 138.56 53.71 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.12 165.37 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.006 0.522 . . . . 0.0 109.968 -176.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -132.13 111.9 11.85 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 110.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.537 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.1 tm? -92.86 116.12 28.74 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 124.796 1.238 . . . . 0.0 109.391 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -74.38 109.59 7.99 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -66.25 -33.11 75.02 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 111.289 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.71 -38.44 76.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.745 0.818 . . . . 0.0 110.179 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.96 -29.77 32.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.814 1.646 . . . . 0.0 111.598 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 t -124.27 55.65 10.22 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.571 1.548 . . . . 0.0 111.644 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -65.15 -29.34 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 124.377 3.385 . . . . 0.0 108.593 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -47.3 -69.33 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.6 t -54.5 -56.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.746 0.819 . . . . 0.0 109.928 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.23 -47.59 62.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -63.36 -49.89 72.09 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.816 -0.552 . . . . 0.0 109.849 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.07 -40.23 66.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.502 0.721 . . . . 0.0 110.642 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -78.96 -23.37 44.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.833 1.253 . . . . 0.0 111.814 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.3 28.69 19.27 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.561 1.077 . . . . 0.0 112.182 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -81.45 80.52 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -78.48 -3.19 42.22 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.761 -1.108 . . . . 0.0 112.288 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 m -155.96 157.34 36.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.468 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.5 pt -145.85 157.72 50.44 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.879 1.672 . . . . 0.0 106.637 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.79 147.02 87.06 Favored 'Cis proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.147 1.445 . . . . 0.0 113.329 1.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.7 m -156.72 120.41 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -97.06 116.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 125.354 1.462 . . . . 0.0 107.154 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.2 mtt -99.15 147.84 24.69 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.652 1.115 . . . . 0.0 108.696 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.56 105.45 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -89.47 124.04 34.13 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 4.69 18.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.758 0.823 . . . . 0.0 112.102 -175.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.91 100.46 0.36 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.1 -73.45 1.52 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-N 117.489 0.644 . . . . 0.0 111.874 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -102.12 172.64 6.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.981 0.912 . . . . 0.0 111.594 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -78.6 162.24 26.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.213 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.8 t -120.4 -66.61 1.04 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.675 1.19 . . . . 0.0 108.208 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -126.36 -169.16 1.97 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.27 1.028 . . . . 0.0 109.585 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -156.81 167.7 29.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.573 1.149 . . . . 0.0 108.069 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.88 133.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.1 mt -78.87 142.01 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.64 -157.12 7.51 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.039 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.8 54.62 9.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 109.95 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.42 158.04 74.18 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 125.633 1.573 . . . . 0.0 108.495 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.88 143.21 44.88 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 105.613 -2.495 . . . . 0.0 105.613 167.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.73 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.26 -56.41 8.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -55.22 -46.13 75.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.069 0.948 . . . . 0.0 110.605 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -49.09 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.05 -45.52 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.596 0.759 . . . . 0.0 109.543 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -42.93 87.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.488 1.04 . . . . 0.0 109.119 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.4 m -61.32 -46.77 88.92 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.438 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -48.75 78.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 O-C-N 121.829 -0.545 . . . . 0.0 109.709 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.03 -48.36 76.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -43.68 64.87 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.823 -0.548 . . . . 0.0 109.898 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.5 m-30 -70.88 -39.23 72.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.64 -84.84 0.2 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.886 0.875 . . . . 0.0 110.541 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.111 0 C-N-CA 127.595 2.358 . . . . 0.0 104.739 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 70.52 -70.49 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -168.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.49 142.34 51.9 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 165.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.24 -173.62 36.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.277 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.26 136.83 45.78 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.7 168.2 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 121.916 0.865 . . . . 0.0 109.459 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.75 175.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 106.27 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -47.33 -47.11 25.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.871 0.868 . . . . 0.0 112.156 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.39 -72.2 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.775 0.83 . . . . 0.0 110.714 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -52.57 -33.42 45.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.428 1.091 . . . . 0.0 112.422 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -41.48 -46.43 3.48 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.297 1.439 . . . . 0.0 110.199 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -56.47 -60.85 2.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.613 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -63.64 -31.63 72.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.516 0.726 . . . . 0.0 112.702 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.8 t -95.16 -48.1 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.277 0.631 . . . . 0.0 112.065 -171.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -94.22 -53.13 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.034 1.334 . . . . 0.0 111.713 -175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.02 -58.57 3.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.871 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.23 50.11 1.03 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.278 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 p -90.43 145.75 24.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.769 1.228 . . . . 0.0 112.218 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -93.44 -65.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -79.25 160.77 69.95 Favored Pre-proline 0 C--O 1.232 0.167 0 C-N-CA 124.608 1.163 . . . . 0.0 108.835 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -55.65 162.55 6.38 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.577 1.518 . . . . 0.0 110.692 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.63 144.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.878 1.671 . . . . 0.0 110.128 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 tt -124.91 100.81 6.77 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.427 1.891 . . . . 0.0 106.181 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.19 116.93 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -88.79 116.16 26.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -79.17 108.83 12.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -122.3 -169.15 1.84 Allowed 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 124.184 0.993 . . . . 0.0 111.017 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.02 150.8 2.02 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -57.61 -40.31 81.2 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.026 1.818 . . . . 0.0 111.291 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 74' ' ' ILE . 36.3 p-90 -67.06 -16.54 64.41 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.836 0.454 . . . . 0.0 111.585 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.1 t -74.69 85.01 2.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.227 -0.921 . . . . 0.0 111.176 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.71 -60.57 1.2 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.317 0.96 . . . . 0.0 113.563 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.48 -50.38 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.022 2.481 . . . . 0.0 112.61 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.06 -45.08 91.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -56.19 -50.29 71.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.556 1.143 . . . . 0.0 110.256 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.08 -37.85 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.437 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 pt -77.37 -25.29 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 120.083 1.31 . . . . 0.0 111.895 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.51 -47.56 4.69 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -62.22 -37.75 60.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.743 2.295 . . . . 0.0 110.484 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.96 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.5 -43.03 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -57.92 -66.14 0.52 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.1 0.409 . . . . 0.0 110.107 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -59.07 -29.52 67.38 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mm -50.8 -34.06 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.486 0.584 . . . . 0.0 109.983 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.4 74.85 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.525 1.057 . . . . 0.0 111.053 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.1 -24.61 76.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.57 -53.55 9.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 117.754 0.777 . . . . 0.0 108.911 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -79.78 58.66 2.88 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.71 -40.97 92.79 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 103.339 -2.837 . . . . 0.0 103.339 164.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.91 110.16 3.22 Favored 'General case' 0 N--CA 1.439 -1.018 1 N-CA-C 98.78 -4.526 . . . . 0.0 98.78 162.287 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -73.36 125.24 27.4 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 124.822 2.249 . . . . 0.0 115.586 -151.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HA ' HD12 ' A' ' 52' ' ' LEU . 16.5 tp -134.55 120.4 19.61 Favored 'General case' 0 C--N 1.314 -0.962 1 CA-C-N 107.867 -4.242 . . . . 0.0 108.054 164.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.24 94.04 7.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.14 130.34 35.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.834 -0.541 . . . . 0.0 109.565 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.67 174.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.706 0.802 . . . . 0.0 111.934 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -144.08 113.45 6.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.014 1.325 . . . . 0.0 111.283 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.0 tt -98.9 125.62 44.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.849 0.833 . . . . 0.0 110.6 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -71.74 105.24 3.66 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.906 1.283 . . . . 0.0 113.874 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -81.21 45.84 0.88 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.859 -1.151 . . . . 0.0 111.027 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -152.09 -48.94 0.11 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -82.98 -19.04 37.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.737 2.015 . . . . 0.0 110.2 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -137.33 61.4 32.24 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.834 1.254 . . . . 0.0 111.915 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.8 -24.6 8.49 Favored 'Trans proline' 0 N--CA 1.446 -1.304 1 C-N-CA 125.492 4.128 . . . . 0.0 110.317 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -47.62 -68.69 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.765 1.226 . . . . 0.0 110.276 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.79 -43.3 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.094 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.72 70.06 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.249 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.2 m -70.13 -45.95 65.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.583 0.753 . . . . 0.0 109.713 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.18 -45.83 75.81 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.977 0.511 . . . . 0.0 110.749 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -79.43 -30.3 42.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.352 0.261 . . . . 0.0 111.534 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.17 54.39 2.15 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.9 mm -69.75 92.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.859 0.838 . . . . 0.0 108.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -78.04 82.12 4.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t 73.21 -175.81 0.16 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.357 1.863 . . . . 0.0 109.498 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 30' ' ' TRP . 24.6 pt -145.38 157.06 53.33 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.22 . . . . 0.0 108.455 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.33 138.23 44.0 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 120.62 1.257 . . . . 0.0 111.85 1.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -134.63 98.25 4.01 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -89.53 109.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.2 mmt -97.16 143.57 27.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 64.4 t -114.13 133.51 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.15 161.21 31.6 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.91 77.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.951 0.405 . . . . 0.0 110.163 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.46 1.36 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.632 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.48 -56.52 3.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 123.836 0.732 . . . . 0.0 112.738 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -79.36 155.01 28.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 122.245 1.021 . . . . 0.0 111.893 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.12 130.47 36.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.649 1.979 . . . . 0.0 108.155 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.6 t -89.31 -57.99 2.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.269 1.028 . . . . 0.0 110.109 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.94 166.89 22.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.595 1.158 . . . . 0.0 111.869 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -142.25 126.15 17.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.251 2.22 . . . . 0.0 105.191 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -128.6 103.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -100.52 138.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.183 1.393 . . . . 0.0 109.555 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.81 156.15 21.94 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.953 0.787 . . . . 0.0 112.563 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.66 51.89 0.2 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.11 1.364 . . . . 0.0 113.148 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.91 148.77 69.18 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.81 156.06 64.19 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.356 1.37 . . . . 0.0 111.71 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.78 -46.04 29.99 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.894 1.277 . . . . 0.0 111.007 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.17 -41.89 3.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.776 0.831 . . . . 0.0 111.525 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.268 1.027 . . . . 0.0 109.153 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.47 -52.64 50.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 C-N-CA 124.431 1.092 . . . . 0.0 108.878 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.5 t -53.2 -58.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.783 1.233 . . . . 0.0 109.567 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.39 -50.11 68.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.449 -0.157 . . . . 0.0 110.911 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.2 m -60.4 -55.74 29.94 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.471 0.177 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -41.54 85.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 O-C-N 121.383 -0.823 . . . . 0.0 110.374 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -45.64 90.38 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -53.67 -42.2 67.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.856 -0.527 . . . . 0.0 109.781 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -73.12 -43.06 62.19 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -95.43 -88.52 0.26 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.934 1.294 . . . . 0.0 109.233 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.256 1.406 0 C-N-CA 127.743 2.417 . . . . 0.0 105.345 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 41.5 tpp . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -43.34 134.4 3.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.067 0.947 . . . . 0.0 110.579 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.31 157.88 34.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.291 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.85 -168.05 12.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.01 147.02 50.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.54 168.16 21.46 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 CA-C-O 122.038 0.923 . . . . 0.0 111.46 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.32 170.34 16.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.364 2.666 . . . . 0.0 105.93 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -39.93 -50.78 2.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.768 1.627 . . . . 0.0 110.964 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.95 -73.45 0.09 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.243 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 p -52.76 -36.43 57.88 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.274 1.03 . . . . 0.0 112.49 -174.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -40.02 -46.19 2.06 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.928 1.691 . . . . 0.0 110.841 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -49.78 -62.49 1.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.999 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.32 -39.84 71.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.284 0.634 . . . . 0.0 111.879 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.22 -40.01 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.953 -169.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.88 -60.21 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 123.892 0.877 . . . . 0.0 110.706 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -65.07 -68.15 0.38 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.626 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.98 34.98 0.2 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.862 0.865 . . . . 0.0 112.664 -171.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -91.21 143.49 26.6 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.993 0.917 . . . . 0.0 109.5 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.06 -60.91 2.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.4 1.08 . . . . 0.0 108.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.9 m -78.74 155.83 77.97 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -56.39 160.54 10.97 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.203 1.935 . . . . 0.0 114.351 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.23 118.56 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.536 1.134 . . . . 0.0 111.506 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.45 88.01 5.78 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 124.841 1.257 . . . . 0.0 109.593 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.22 133.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 O-C-N 121.157 -0.965 . . . . 0.0 109.259 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.54 121.49 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.924 0.89 . . . . 0.0 108.645 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.445 ' CE2' HD23 ' A' ' 57' ' ' LEU . 53.5 m-85 -79.79 108.67 13.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -123.29 -173.72 2.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 122.275 1.035 . . . . 0.0 110.296 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 152.63 9.78 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.43 -44.97 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-N 120.542 1.229 . . . . 0.0 111.756 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.549 ' CH2' HD11 ' A' ' 74' ' ' ILE . 17.1 p-90 -56.12 -20.7 18.55 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.463 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.7 t -77.46 84.84 3.85 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.585 -0.697 . . . . 0.0 109.412 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.98 -57.94 1.96 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.586 1.089 . . . . 0.0 113.147 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.9 -25.33 69.1 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.089 1.86 . . . . 0.0 113.01 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.9 m -77.2 -50.67 12.43 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -49.14 -50.76 35.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.564 1.546 . . . . 0.0 111.41 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.2 pt -64.81 -39.84 87.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.467 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 pt -76.83 -26.69 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.563 1.074 . . . . 0.0 111.667 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -48.46 4.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.97 -38.03 60.93 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.357 2.038 . . . . 0.0 110.357 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.57 -39.74 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.5 t -52.77 -40.69 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.96 -58.5 4.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.701 0.4 . . . . 0.0 111.054 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.59 -47.59 81.72 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.683 -0.636 . . . . 0.0 111.996 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.97 -38.5 60.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 54' ' ' CYS . . . -61.23 -43.42 98.91 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.421 -0.799 . . . . 0.0 109.301 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.02 -50.49 58.72 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.3 -53.37 44.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.527 0.663 . . . . 0.0 110.222 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -82.08 51.17 1.71 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.126 0.965 . . . . 0.0 112.015 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -41.6 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.935 2.494 . . . . 0.0 111.509 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.19 -54.43 46.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -78.13 -40.54 37.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.37 128.39 37.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 118.204 -1.398 . . . . 0.0 114.387 -152.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -83.11 163.14 21.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.465 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . 54.1 t -142.72 145.8 33.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.57 168.42 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.577 -175.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -137.87 112.44 8.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.294 1.038 . . . . 0.0 108.702 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 26' ' ' PHE . 45.7 tp -98.2 120.49 38.7 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.2 1.0 . . . . 0.0 109.725 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -73.23 109.99 7.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -67.49 -35.76 79.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.795 1.238 . . . . 0.0 111.086 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.51 -39.69 92.15 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -80.21 -33.52 38.08 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.877 1.671 . . . . 0.0 112.005 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.421 ' CB ' HD11 ' A' ' 57' ' ' LEU . 26.0 t -120.9 55.56 4.65 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.625 1.57 . . . . 0.0 111.937 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.34 -24.67 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.06 3.173 . . . . 0.0 110.598 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -54.15 -67.54 0.25 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.803 0.841 . . . . 0.0 109.773 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -53.21 -51.1 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 124.2 1.0 . . . . 0.0 109.202 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.47 -48.19 37.93 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.208 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -66.47 -46.65 75.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.018 0.527 . . . . 0.0 110.627 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.55 -45.5 77.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -79.43 -31.17 42.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.589 0.356 . . . . 0.0 111.488 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.59 43.94 3.04 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.655 0.645 . . . . 0.0 111.627 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mm -73.52 90.64 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -77.47 -20.53 54.27 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.3 m -156.18 165.01 37.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.549 HD11 ' CH2' ' A' ' 30' ' ' TRP . 26.7 pt -129.87 153.47 80.93 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.82 165.36 70.35 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.302 1.144 . . . . 0.0 111.954 0.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -156.74 113.55 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.77 115.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.9 mtt -111.56 134.84 52.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.58 115.77 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.79 162.48 15.21 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 0.0 109.619 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.41 151.55 9.75 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.71 1.204 . . . . 0.0 107.899 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.04 45.6 14.74 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.969 1.147 . . . . 0.0 115.969 170.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.06 0.31 60.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.94 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -129.94 159.38 36.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.737 1.769 . . . . 0.0 111.922 -176.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 138.59 31.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.81 1.644 . . . . 0.0 107.989 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.4 t -114.81 -82.25 0.61 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.003 0.921 . . . . 0.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -92.73 163.53 13.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.086 0.554 . . . . 0.0 110.866 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -157.5 122.61 4.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.773 1.229 . . . . 0.0 109.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.93 137.2 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.42 143.6 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 109.743 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.98 165.52 40.19 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 123.37 0.419 . . . . 0.0 112.328 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.63 131.17 45.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.308 0.643 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.3 153.77 41.25 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.8 138.97 27.01 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 104.714 -2.841 . . . . 0.0 104.714 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -56.14 -33.92 65.63 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.389 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.27 -37.3 7.11 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.542 1.064 . . . . 0.0 112.237 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.6 m -70.78 -41.68 71.36 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.499 -0.751 . . . . 0.0 109.302 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.0 mt -61.71 -44.23 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -54.36 -55.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -52.64 -43.5 65.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.966 0.348 . . . . 0.0 110.787 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -59.09 -40.2 84.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.33 -50.74 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.084 -1.01 . . . . 0.0 108.971 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -51.61 -47.48 63.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.047 0.939 . . . . 0.0 112.873 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -25.69 60.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -90.37 -52.69 4.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.44 0.564 . . . . 0.0 109.704 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -112.93 -92.0 0.49 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.4 1.08 . . . . 0.0 109.834 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.207 0 C-N-CA 128.523 2.729 . . . . 0.0 103.862 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tpt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.61 -43.49 84.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.88 135.74 37.94 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 170.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.41 -179.01 51.49 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.43 137.62 54.81 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.89 164.98 32.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 122.299 1.047 . . . . 0.0 111.379 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -144.11 168.74 19.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.853 2.061 . . . . 0.0 105.731 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -39.63 -45.67 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.31 -70.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.432 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -59.57 -33.47 71.48 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.475 1.11 . . . . 0.0 112.336 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -42.17 -46.67 4.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 126.778 2.031 . . . . 0.0 111.265 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -47.45 -48.41 26.65 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.753 1.221 . . . . 0.0 110.651 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -82.33 -63.1 1.45 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.061 0.934 . . . . 0.0 111.268 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.97 -31.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.889 -169.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.21 -59.81 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.004 0.522 . . . . 0.0 111.865 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.38 -71.03 0.26 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.464 0.575 . . . . 0.0 110.041 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.88 48.41 0.83 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.723 0.809 . . . . 0.0 111.212 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 p -90.38 148.37 22.86 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.653 1.581 . . . . 0.0 109.129 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -83.62 -68.03 0.74 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 m -79.49 158.95 73.11 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.274 1.03 . . . . 0.0 108.66 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.12 164.9 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.486 2.124 . . . . 0.0 113.082 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.81 148.95 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.902 2.081 . . . . 0.0 109.207 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -131.68 105.56 7.6 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.19 122.91 52.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.618 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -97.73 117.69 32.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.52 112.13 16.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -126.14 -176.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.202 1.001 . . . . 0.0 110.335 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.89 148.29 3.13 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -53.21 -45.27 42.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.164 . . . . 0.0 112.513 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -67.07 -20.62 65.85 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.776 -0.578 . . . . 0.0 111.898 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.04 85.09 2.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.117 0.871 . . . . 0.0 110.404 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -34.45 -62.96 0.48 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.492 1.52 . . . . 0.0 114.374 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.57 -43.48 50.52 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 119.633 1.716 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.8 m -59.73 -45.37 92.4 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -55.22 -53.64 53.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.787 1.235 . . . . 0.0 110.542 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 pt -69.71 -29.71 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.36 -0.353 . . . . 0.0 111.397 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.1 mt -74.27 -35.32 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.253 0.621 . . . . 0.0 111.471 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.51 -48.03 6.68 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -61.72 -36.71 73.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.483 2.122 . . . . 0.0 109.75 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.77 -45.11 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.75 -43.75 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -66.05 -48.84 69.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.859 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.93 -41.08 99.37 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.829 -1.169 . . . . 0.0 109.65 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.6 mt -56.82 -44.44 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -54.68 -50.34 68.48 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.41 -45.21 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.93 -46.58 81.04 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -111.91 23.76 13.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -56.16 168.59 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.916 1.286 . . . . 0.0 112.317 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 71.3 -52.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 127.657 2.383 . . . . 0.0 111.199 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -80.19 -50.22 10.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.249 0.547 . . . . 0.0 110.094 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -102.0 106.4 17.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.652 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -78.66 90.04 4.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 49.1 t -78.32 137.9 38.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.53 163.09 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 123.161 0.585 . . . . 0.0 110.12 -175.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -127.57 115.21 18.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.483 1.113 . . . . 0.0 109.614 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tp -91.49 119.06 31.12 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.271 0.628 . . . . 0.0 109.562 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.17 107.1 6.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -67.99 -35.98 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.198 1.399 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.59 -38.82 92.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.701 1.201 . . . . 0.0 109.871 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.5 -25.08 33.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.719 2.008 . . . . 0.0 111.036 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 m -121.46 53.61 3.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 113.93 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.11 -25.82 73.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.061 3.174 . . . . 0.0 109.367 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -50.85 -70.38 0.09 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.896 1.279 . . . . 0.0 109.68 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.8 t -51.41 -50.63 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.059 1.344 . . . . 0.0 109.184 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.82 -47.88 51.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.251 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 m -72.15 -43.35 64.78 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.92 0.888 . . . . 0.0 111.236 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.91 -48.34 70.25 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.286 0.635 . . . . 0.0 110.03 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -79.55 -35.63 39.55 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.21 53.41 9.09 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 pt -57.31 142.11 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.497 1.119 . . . . 0.0 111.775 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -79.91 70.26 6.43 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.0 t 64.52 -160.15 0.29 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -139.51 150.23 62.89 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.78 143.29 73.5 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.985 1.03 . . . . 0.0 113.798 3.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m -140.44 110.04 6.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.82 134.15 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.1 mtt -124.86 128.44 48.67 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.657 1.183 . . . . 0.0 108.881 176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.77 131.58 45.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -119.94 134.23 55.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 173.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.485 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -104.49 25.48 10.17 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.109 0.964 . . . . 0.0 110.597 -178.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.21 123.26 5.22 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.43 -64.99 3.15 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.885 0.842 . . . . 0.0 113.376 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -126.22 172.73 9.82 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.244 1.018 . . . . 0.0 111.93 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -67.46 164.86 17.86 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.179 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -128.7 -57.37 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.815 1.646 . . . . 0.0 108.813 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -140.11 171.29 14.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.565 1.546 . . . . 0.0 109.729 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -160.08 147.83 16.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.5 150.4 33.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.08 144.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.62 162.41 37.85 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.603 0.557 . . . . 0.0 112.565 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.76 131.26 38.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.553 0.741 . . . . 0.0 110.534 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.37 149.5 48.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.05 155.48 33.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.676 2.251 . . . . 0.0 114.003 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -46.03 -52.47 11.82 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.404 1.482 . . . . 0.0 109.771 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.83 -45.85 50.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.281 0.633 . . . . 0.0 110.612 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -49.19 68.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -53.04 -58.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.9 t -52.42 -55.5 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 110.318 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.09 -47.43 78.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.506 0.594 . . . . 0.0 110.967 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.3 m -59.87 -42.27 93.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.96 0.504 . . . . 0.0 110.575 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.19 -57.18 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -45.32 -58.54 3.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.933 1.293 . . . . 0.0 111.342 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -18.59 25.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -80.51 -23.66 39.93 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 120.013 1.279 . . . . 0.0 110.722 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.0 mt -98.86 -43.24 6.82 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.271 1.428 . . . . 0.0 111.863 -177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 117.297 -1.335 . . . . 0.0 109.853 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -122.19 -44.88 2.26 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.611 0.764 . . . . 0.0 110.839 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.14 122.93 17.79 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.02 166.79 52.12 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.907 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.51 119.65 37.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.56 161.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.734 0.813 . . . . 0.0 109.671 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -138.04 171.7 14.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -39.82 -45.46 1.79 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.001 1.32 . . . . 0.0 111.468 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.68 -77.76 0.06 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.253 0.621 . . . . 0.0 110.974 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.7 p -46.69 -38.65 10.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.133 1.373 . . . . 0.0 112.744 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -39.71 -46.39 1.86 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.522 1.529 . . . . 0.0 110.819 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -48.76 -56.79 7.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.519 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.34 -33.57 49.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.871 -0.518 . . . . 0.0 112.017 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.4 t -92.5 -26.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -169.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.91 -51.25 4.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 124.747 1.219 . . . . 0.0 111.519 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.63 -61.86 1.69 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -77.51 33.22 0.16 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.932 . . . . 0.0 112.1 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 m -91.09 132.65 35.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.42 1.088 . . . . 0.0 111.133 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 p -78.79 -53.29 7.27 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.711 1.604 . . . . 0.0 107.158 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.94 152.56 79.91 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.02 166.61 29.09 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 N-CA-C 108.658 -1.324 . . . . 0.0 108.658 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.487 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -152.48 134.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.428 HD21 HG23 ' A' ' 77' ' ' ILE . 9.0 tt -99.06 115.35 28.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.987 1.715 . . . . 0.0 108.864 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.0 t -100.91 114.16 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.72 116.51 24.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -78.64 110.77 14.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 9.0 p-90 -124.17 -172.71 2.6 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.792 0.806 . . . . 0.0 112.111 -172.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.42 151.84 2.55 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 125.239 1.416 . . . . 0.0 107.426 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.55 -42.11 35.5 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.552 2.168 . . . . 0.0 110.044 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.477 ' CH2' HD11 ' A' ' 74' ' ' ILE . 34.6 p-90 -67.35 -17.32 64.7 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.355 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.9 t -80.02 87.52 5.41 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.208 -0.933 . . . . 0.0 110.794 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.49 -61.63 1.49 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.521 1.058 . . . . 0.0 113.712 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.73 -19.94 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.096 1.864 . . . . 0.0 113.21 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.0 m -82.75 -50.79 8.31 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -50.2 -47.4 54.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.567 1.547 . . . . 0.0 110.832 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.21 -18.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.929 -0.558 . . . . 0.0 112.415 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -88.74 -28.32 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.464 1.029 . . . . 0.0 110.052 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -39.08 -47.31 3.83 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.704 1.602 . . . . 0.0 113.266 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.25 -38.26 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.948 1.766 . . . . 0.0 110.884 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.4 t -69.75 -57.4 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.707 1.203 . . . . 0.0 109.452 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.519 HG22 ' SG ' ' A' ' 54' ' ' CYS . 3.2 p -54.02 -42.86 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.96 -56.24 23.45 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.59 -0.693 . . . . 0.0 112.427 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.38 -41.39 89.24 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 122.008 -0.433 . . . . 0.0 110.435 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -55.67 -44.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.34 -53.6 54.09 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -44.65 -44.43 8.38 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.249 0.452 . . . . 0.0 112.422 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.76 -41.84 96.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -121.92 9.76 10.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -39.85 -41.4 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.008 2.123 . . . . 0.0 113.752 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.84 -40.7 2.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.46 1.904 . . . . 0.0 112.991 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -132.47 -54.26 0.95 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HG ' ' HG3' ' A' ' 53' ' ' LYS . 12.6 tp -83.44 170.83 14.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' CB ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.36 93.75 2.96 Favored 'General case' 0 N--CA 1.433 -1.323 2 N-CA-C 122.993 4.442 . . . . 0.0 122.993 -164.05 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.519 ' SG ' HG22 ' A' ' 41' ' ' VAL . 11.1 t -151.2 122.2 7.65 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 118.96 -2.338 . . . . 0.0 114.794 174.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.08 165.68 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.599 1.16 . . . . 0.0 110.202 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HB3' ' CD1' ' A' ' 27' ' ' TRP . 7.4 mtmp? -132.73 122.81 25.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.732 1.213 . . . . 0.0 111.576 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -104.82 120.51 41.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.829 0.823 . . . . 0.0 110.21 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -69.45 109.51 4.26 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 124.775 1.23 . . . . 0.0 113.42 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -82.61 47.59 1.2 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 0.0 110.347 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.19 -46.59 0.1 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.43 -23.01 35.04 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.669 1.988 . . . . 0.0 109.705 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.47 53.24 5.65 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 112.542 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.55 -38.78 7.76 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.88 3.72 . . . . 0.0 109.493 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -49.46 -67.31 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.892 1.277 . . . . 0.0 110.528 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.09 -45.53 88.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.93 -39.77 66.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.059 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -72.73 -41.55 65.06 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 124.144 0.978 . . . . 0.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -55.39 -43.23 75.02 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.09 -32.29 44.61 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.89 35.24 6.86 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.12 1.343 . . . . 0.0 111.622 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.5 mt -80.84 62.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.329 1.452 . . . . 0.0 109.37 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -81.59 57.73 3.45 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.551 -0.718 . . . . 0.0 110.355 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 163.3 150.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.963 2.505 . . . . 0.0 107.585 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.477 HD11 ' CH2' ' A' ' 30' ' ' TRP . 13.3 pt -152.85 155.24 32.13 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.12 134.53 28.6 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.362 1.165 . . . . 0.0 112.857 1.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 m -132.8 106.21 7.6 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.428 HG23 HD21 ' A' ' 23' ' ' LEU . 36.1 mt -94.75 130.51 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.138 1.375 . . . . 0.0 107.698 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.5 mtt -130.62 152.22 50.22 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.46 141.35 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.22 167.28 20.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 110.623 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.65 152.2 3.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.746 2.018 . . . . 0.0 106.712 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.21 41.25 8.07 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.484 1.038 . . . . 0.0 115.675 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.5 11.49 68.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.103 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -138.38 167.85 21.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.441 1.62 . . . . 0.0 110.421 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.44 160.2 25.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.546 0.738 . . . . 0.0 110.139 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.3 t -115.94 -53.7 2.54 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 125.569 1.548 . . . . 0.0 109.455 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 -177.0 5.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.724 1.21 . . . . 0.0 108.834 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.9 t -158.35 151.8 23.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 0.0 109.48 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.3 mm -135.84 155.88 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 127.549 2.34 . . . . 0.0 105.55 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.1 mt -138.95 145.48 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.01 155.13 20.75 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.46 135.58 45.76 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.65 152.31 68.22 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.63 160.09 47.28 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.007 1.805 . . . . 0.0 112.409 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -43.41 -51.34 6.57 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 126.136 1.774 . . . . 0.0 111.276 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.95 -45.93 60.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.847 0.459 . . . . 0.0 110.948 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 m -66.28 -48.02 71.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.1 mt -55.72 -55.52 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.34 -51.84 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.496 0.718 . . . . 0.0 110.147 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.81 -46.86 81.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.996 0.816 . . . . 0.0 110.445 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.1 m -57.31 -43.32 83.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.294 0.638 . . . . 0.0 109.782 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 t -62.98 -58.91 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.996 0.816 . . . . 0.0 109.213 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -44.16 -51.89 7.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.835 1.254 . . . . 0.0 112.289 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -26.28 30.19 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -80.59 -14.68 57.98 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.379 -0.825 . . . . 0.0 111.328 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.47 -43.5 5.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.237 1.415 . . . . 0.0 110.216 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.184 0 CA-C-O 117.079 -1.439 . . . . 0.0 109.911 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.51 170.13 14.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.21 148.78 35.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.41 111.6 4.1 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 112.2 -0.36 . . . . 0.0 112.2 -177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.65 115.5 19.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.55 165.07 12.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.282 1.039 . . . . 0.0 111.361 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -138.2 170.89 15.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.451 2.3 . . . . 0.0 106.408 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -38.81 -52.86 1.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.219 1.808 . . . . 0.0 111.428 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.69 -73.34 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.567 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -52.28 -38.12 57.44 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.511 1.125 . . . . 0.0 111.769 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -42.91 -45.08 4.84 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.313 1.845 . . . . 0.0 111.356 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -55.55 -51.95 65.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.856 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.11 -50.43 16.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.306 0.574 . . . . 0.0 111.655 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -74.57 -39.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.747 1.219 . . . . 0.0 112.825 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -107.38 -54.67 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 112.763 -170.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -64.53 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.81 49.61 0.78 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 110.432 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -84.13 121.91 28.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.565 1.546 . . . . 0.0 111.373 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.3 p -79.77 -61.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.88 153.88 80.5 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.78 149.86 67.31 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.517 -0.993 . . . . 0.0 109.517 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.484 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -149.96 127.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.38 121.15 30.46 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.29 114.97 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 171.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -99.31 136.83 38.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.498 ' CD2' HD12 ' A' ' 57' ' ' LEU . 5.9 m-85 -87.85 111.9 21.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.418 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 14.3 p-90 -117.63 -174.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.66 5.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -56.69 -39.59 90.27 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -70.52 -16.11 62.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.158 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.3 t -73.61 102.3 3.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.216 1.371 . . . . 0.0 111.408 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.8 -62.36 3.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.034 1.302 . . . . 0.0 114.018 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.64 -42.62 35.73 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.137 2.558 . . . . 0.0 111.674 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.7 m -63.14 -50.31 70.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -55.42 -49.76 71.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.134 -0.354 . . . . 0.0 111.098 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.24 -32.9 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.066 -0.969 . . . . 0.0 111.844 -175.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.8 pt -80.51 -28.62 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.646 1.567 . . . . 0.0 111.42 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.54 -49.39 5.13 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.12 -37.34 75.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.983 1.789 . . . . 0.0 110.043 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.56 -44.48 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 108.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.2 t -53.14 -53.28 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.85 -49.3 78.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.769 -0.582 . . . . 0.0 112.184 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.06 -43.63 95.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.968 0.804 . . . . 0.0 109.493 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.1 -41.44 80.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.34 -48.64 76.35 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.27 -44.28 57.77 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -58.52 -53.94 52.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.591 1.195 . . . . 0.0 110.409 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.483 ' CG ' ' HB3' ' A' ' 52' ' ' LEU . 60.3 m-85 -82.98 53.57 2.47 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.0 -21.59 66.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.861 1.665 . . . . 0.0 108.227 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 5.3 m-20 -62.16 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 168.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.516 ' CE ' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -161.17 110.41 1.61 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 164.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.765 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 7.1 tp -151.02 -177.35 5.96 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 116.858 -1.937 . . . . 0.0 112.067 159.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.765 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.29 66.26 1.73 Allowed 'General case' 0 N--CA 1.419 -1.996 2 N-CA-C 123.845 4.757 . . . . 0.0 123.845 -157.341 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -133.32 109.75 9.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 117.742 -1.583 . . . . 0.0 113.81 -177.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.43 163.43 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.464 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 36.3 pttt -153.76 121.54 5.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.005 0.431 . . . . 0.0 110.256 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD12 ' CD2' ' A' ' 26' ' ' PHE . 2.4 tm? -89.13 118.91 29.18 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.821 0.849 . . . . 0.0 110.243 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -72.49 105.64 4.25 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -69.51 -31.72 70.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.797 1.239 . . . . 0.0 111.567 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.1 -39.2 89.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.931 0.893 . . . . 0.0 109.483 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -86.76 -26.08 24.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.734 2.013 . . . . 0.0 111.722 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.405 ' CB ' HD21 ' A' ' 57' ' ' LEU . 14.6 t -126.21 55.96 14.9 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.571 1.548 . . . . 0.0 112.463 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.62 -31.2 70.42 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.508 2.805 . . . . 0.0 108.056 174.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -40.78 -75.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.485 1.914 . . . . 0.0 111.715 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.88 -48.14 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.849 1.26 . . . . 0.0 110.266 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.64 -41.26 69.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.731 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.0 m -72.27 -42.89 65.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 110.389 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -56.04 -42.18 76.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.677 0.391 . . . . 0.0 110.085 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.41 -36.38 45.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.15 45.64 3.01 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.36 0.981 . . . . 0.0 111.219 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.82 130.07 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -79.09 -38.8 35.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 t -163.62 -173.53 3.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 pt -129.42 156.27 78.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 124.558 1.143 . . . . 0.0 109.267 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.99 157.66 82.64 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.127 1.081 . . . . 0.0 112.621 2.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 m -160.99 142.32 11.81 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-O 122.213 1.006 . . . . 0.0 109.679 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.599 ' HB ' ' N ' ' A' ' 89' ' ' ILE 0.607 0.8 OUTLIER -75.2 13.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 2 N-CA-C 138.996 10.369 . . . . 0.0 138.996 -160.967 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 65.1 mtt -80.87 128.61 33.86 Favored 'General case' 0 C--N 1.318 -0.801 1 CA-C-N 126.526 4.239 . . . . 0.0 114.708 -162.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.6 137.04 33.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -129.29 160.62 32.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.093 0.957 . . . . 0.0 109.744 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.16 167.81 6.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.576 1.95 . . . . 0.0 105.916 172.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 51.34 34.12 32.99 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.81 9.9 66.73 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 117.88 -1.511 . . . . 0.0 115.409 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -147.81 169.14 20.42 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.469 2.134 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.69 149.4 50.06 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 127.765 2.426 . . . . 0.0 109.993 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.59 -80.17 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.028 0.531 . . . . 0.0 111.58 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.59 175.36 7.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.961 0.8 . . . . 0.0 111.49 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.5 p -143.16 116.01 8.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.433 1.093 . . . . 0.0 111.389 -175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.599 ' N ' ' HB ' ' A' ' 77' ' ' ILE . 23.5 mt -118.88 122.57 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.43 1.492 . . . . 0.0 112.934 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.5 mt -84.25 155.95 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 119.327 -2.108 . . . . 0.0 106.32 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.5 -158.33 7.12 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.35 -16.61 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.62 152.84 80.95 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 120.081 1.31 . . . . 0.0 108.883 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.32 131.73 21.03 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 105.172 -2.665 . . . . 0.0 105.172 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -57.89 -29.12 64.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.21 -38.65 18.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.387 0.994 . . . . 0.0 110.474 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -60.01 -51.92 67.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.609 1.164 . . . . 0.0 109.076 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.72 -49.07 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.352 1.461 . . . . 0.0 110.474 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -52.3 -55.25 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -57.91 -50.14 74.35 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.177 -0.327 . . . . 0.0 110.83 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.2 m -55.61 -41.26 73.21 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.116 0.567 . . . . 0.0 111.567 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.72 -45.24 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.888 0.767 . . . . 0.0 110.513 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -54.55 -35.02 62.8 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.422 0.689 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -44.9 -50.99 10.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.462 0.648 . . . . 0.0 109.465 171.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -81.43 50.18 1.42 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.111 0.964 . . . . 0.0 110.923 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 106' ' ' LEU . 10.6 mt -156.16 102.7 2.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.065 1.746 . . . . 0.0 106.64 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.291 0 C-N-CA 128.222 2.609 . . . . 0.0 104.37 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 tpp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -78.9 162.36 26.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.919 0.888 . . . . 0.0 109.265 176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.79 67.48 1.19 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.226 0.61 . . . . 0.0 111.198 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.82 140.73 38.82 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.67 92.36 5.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -81.79 161.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.589 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -160.0 -178.95 7.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -38.27 -56.53 1.21 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.0 1.72 . . . . 0.0 112.888 -170.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.05 -71.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.203 0.601 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 p -49.6 -43.41 46.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.891 1.276 . . . . 0.0 111.695 -175.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -39.94 -50.85 2.51 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.266 1.826 . . . . 0.0 112.248 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -49.7 -50.45 43.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.947 0.899 . . . . 0.0 111.405 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -79.61 -56.89 3.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.939 0.895 . . . . 0.0 112.058 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.26 -32.05 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 125.449 1.5 . . . . 0.0 113.073 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.29 -52.38 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.133 0.573 . . . . 0.0 112.432 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -73.6 -73.01 0.23 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.631 0.651 . . . . 0.0 111.293 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -79.62 47.09 0.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.206 0.602 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 m -90.42 151.35 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.566 1.147 . . . . 0.0 109.442 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -78.85 -57.06 3.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -78.42 150.98 77.39 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.52 162.61 39.57 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.491 1.461 . . . . 0.0 109.217 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.422 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -150.16 134.39 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.186 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -95.12 99.09 11.13 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 126.229 1.812 . . . . 0.0 108.125 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 p -94.9 125.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -94.32 121.51 35.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.54 108.17 12.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -124.35 -172.88 2.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.787 0.803 . . . . 0.0 110.913 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.48 152.26 3.2 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.25 -40.07 78.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.134 1.889 . . . . 0.0 112.455 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -73.2 -12.17 60.78 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.4 t -73.83 86.65 1.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.084 -1.01 . . . . 0.0 110.84 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -31.74 -66.5 0.17 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.299 1.428 . . . . 0.0 115.284 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -59.46 -45.27 27.19 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.001 1.8 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.5 m -56.4 -46.09 80.32 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -57.02 -50.92 71.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.17 1.388 . . . . 0.0 110.329 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.9 pt -68.36 -36.92 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.408 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.82 -25.47 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 120.178 1.354 . . . . 0.0 111.444 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -38.99 -45.81 3.14 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -64.6 -38.19 33.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.855 2.37 . . . . 0.0 110.241 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -39.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.682 1.593 . . . . 0.0 108.522 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.6 t -58.86 -50.93 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -58.92 -52.07 67.33 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.179 0.592 . . . . 0.0 111.865 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.45 -41.63 94.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.12 0.873 . . . . 0.0 110.469 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.14 -44.03 97.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . . . -57.76 -38.62 75.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.59 44.52 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -49.11 -54.38 16.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.421 0.688 . . . . 0.0 111.346 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.66 33.66 3.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -51.8 -45.45 63.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -33.35 -50.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.897 2.879 . . . . 0.0 113.401 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -149.88 -58.89 0.2 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.487 1.115 . . . . 0.0 113.5 -170.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.663 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 15.8 tp -78.59 179.14 7.28 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -155.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.663 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.23 92.06 2.7 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 123.196 4.517 . . . . 0.0 123.196 -157.097 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.43 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 39.6 t -152.97 120.98 6.14 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 119.949 -1.719 . . . . 0.0 112.584 173.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.59 171.98 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.711 0.804 . . . . 0.0 110.515 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -143.5 114.3 7.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.5 118.45 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.764 0.711 . . . . 0.0 110.195 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.11 106.49 5.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.9 m -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.667 1.587 . . . . 0.0 111.456 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -34.08 77.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.181 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -87.05 -15.37 38.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 110.972 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -138.53 64.34 37.15 Favored Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 120.239 -1.538 . . . . 0.0 112.687 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.75 -26.91 32.25 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.173 3.249 . . . . 0.0 108.582 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -47.37 -70.51 0.09 Allowed 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 125.535 1.534 . . . . 0.0 110.611 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.22 -49.97 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 125.541 1.536 . . . . 0.0 109.481 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.48 -45.79 69.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.524 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.2 m -68.92 -41.57 77.99 Favored 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 123.739 0.815 . . . . 0.0 111.014 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.03 -42.2 76.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.183 0.593 . . . . 0.0 109.724 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.67 -32.92 47.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.15 36.23 5.78 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.261 0.934 . . . . 0.0 110.797 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -74.45 107.72 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -77.73 -27.34 50.51 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.838 0.455 . . . . 0.0 110.923 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -155.34 159.04 39.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.6 pt -115.02 156.86 44.7 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.59 161.73 81.88 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 120.608 1.253 . . . . 0.0 114.175 3.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.9 m -160.63 124.86 3.6 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.82 106.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.665 1.186 . . . . 0.0 108.327 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.7 mtt -103.85 132.01 50.51 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.737 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.1 t -100.71 110.53 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -92.98 143.86 25.82 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 50.61 1.83 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.45 77.98 1.3 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.79 -61.82 2.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.94 0.781 . . . . 0.0 112.201 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.08 163.07 22.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.962 0.905 . . . . 0.0 111.058 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -89.4 151.24 22.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.94 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -109.17 -57.12 2.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.623 . . . . 0.0 107.765 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -124.36 159.48 30.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.798 1.239 . . . . 0.0 109.367 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.1 m -152.4 93.34 1.78 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -103.82 146.87 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.229 1.412 . . . . 0.0 108.46 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 90' ' ' ILE . 3.4 mp -80.01 151.45 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.32 -158.48 5.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.52 46.56 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.951 0.9 . . . . 0.0 110.504 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.05 153.18 80.27 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.16 139.22 35.01 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 N-CA-C 105.4 -2.577 . . . . 0.0 105.4 170.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -67.11 -19.67 65.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 118.773 -1.171 . . . . 0.0 109.918 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.23 -49.9 68.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.801 1.182 . . . . 0.0 109.221 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -55.86 -48.11 76.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.518 1.127 . . . . 0.0 109.687 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.67 -49.02 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.018 0.527 . . . . 0.0 109.81 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.88 -56.82 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -51.79 -45.65 63.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.369 0.531 . . . . 0.0 110.793 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.2 m -60.41 -33.07 71.98 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.589 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.6 t -76.75 -47.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 120.408 1.458 . . . . 0.0 109.988 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -49.35 -45.04 45.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.079 0.952 . . . . 0.0 111.063 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -53.86 -27.67 31.41 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -98.82 -12.31 20.96 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.131 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -157.39 87.26 0.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.642 0.656 . . . . 0.0 109.889 -170.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.283 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 tpp . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 71.71 -63.03 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 -166.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.59 128.93 37.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 167.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.25 175.46 54.66 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.83 136.13 54.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.93 164.36 30.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 122.346 1.07 . . . . 0.0 112.775 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.9 170.26 16.04 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 128.033 2.533 . . . . 0.0 104.433 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -39.12 -46.87 1.49 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.281 1.832 . . . . 0.0 112.735 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.13 -66.28 0.43 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.33 1.052 . . . . 0.0 111.723 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -67.21 -41.59 85.51 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.711 1.204 . . . . 0.0 111.641 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -39.52 -47.84 1.94 Allowed 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 127.524 2.33 . . . . 0.0 110.996 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -41.62 -66.67 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.006 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -42.96 65.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 111.364 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.0 t -73.51 -18.39 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.121 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.15 -51.18 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.333 1.053 . . . . 0.0 112.272 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.71 -70.86 0.43 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.121 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.01 40.22 0.4 Allowed 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.973 -1.08 . . . . 0.0 112.22 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 m -91.12 137.87 32.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.734 1.213 . . . . 0.0 110.645 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 p -78.78 -55.62 5.02 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.404 1.482 . . . . 0.0 108.66 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.93 156.38 79.82 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.59 167.17 19.71 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 N-CA-C 108.871 -1.242 . . . . 0.0 108.871 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -136.7 144.77 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 126.595 1.958 . . . . 0.0 109.21 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -124.69 98.37 5.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 106.494 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.31 120.29 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.183 0.901 . . . . 0.0 110.323 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -90.93 117.21 29.35 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.743 0.817 . . . . 0.0 109.143 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.45 108.67 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -127.41 -174.75 3.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 121.717 0.77 . . . . 0.0 111.075 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.62 149.01 4.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.91 -44.05 52.64 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.526 2.151 . . . . 0.0 112.448 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.512 ' CH2' HD11 ' A' ' 74' ' ' ILE . 40.5 p-90 -68.83 -18.33 64.15 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.146 -0.346 . . . . 0.0 111.823 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 37.9 t -77.89 85.14 4.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.21 -60.24 1.38 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.649 1.119 . . . . 0.0 114.088 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.12 -17.24 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.84 1.82 . . . . 0.0 112.509 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -81.43 -48.11 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.07 -49.93 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.308 1.443 . . . . 0.0 110.244 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 pt -63.19 -36.52 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.275 -0.869 . . . . 0.0 112.393 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.1 pt -80.04 -25.32 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.741 1.155 . . . . 0.0 111.401 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.87 -48.27 5.55 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 120.071 1.305 . . . . 0.0 114.497 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.72 -39.37 53.71 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.974 2.449 . . . . 0.0 110.026 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -47.07 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.02 -42.56 90.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.06 -56.28 24.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.02 0.528 . . . . 0.0 110.37 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -62.84 -37.84 88.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.917 -1.114 . . . . 0.0 111.108 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.21 -45.79 67.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.1 -51.89 66.26 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -46.18 -42.52 12.64 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 112.199 -0.361 . . . . 0.0 112.199 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -71.61 -54.54 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.675 0.738 . . . . 0.0 112.351 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -92.47 9.03 36.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -45.33 148.94 0.57 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.318 1.447 . . . . 0.0 111.831 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.1 t70 74.61 -50.09 0.67 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.626 1.97 . . . . 0.0 111.569 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -77.56 -29.02 51.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.73 1.212 . . . . 0.0 111.141 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.76 121.42 13.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.136 1.374 . . . . 0.0 108.319 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -79.45 94.12 5.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -79.45 133.34 36.53 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.279 -0.888 . . . . 0.0 108.978 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.84 168.54 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.301 0.572 . . . . 0.0 112.053 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -134.56 111.1 9.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.341 1.456 . . . . 0.0 109.517 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tt -89.56 118.51 29.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.764 0.792 . . . . 0.0 109.966 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -71.93 100.2 2.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 109.208 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 m -85.36 52.82 2.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.753 1.621 . . . . 0.0 110.081 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -148.28 -46.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -79.93 -25.44 40.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.528 2.331 . . . . 0.0 110.062 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 t -132.58 55.47 17.72 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.06 -23.59 29.25 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.994 3.796 . . . . 0.0 109.264 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -44.55 -58.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.784 1.634 . . . . 0.0 109.211 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.32 -53.25 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.027 0.931 . . . . 0.0 109.967 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.51 -40.32 62.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.975 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 m -69.79 -47.73 61.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.058 0.943 . . . . 0.0 110.567 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.55 -44.68 77.0 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.927 . . . . 0.0 110.437 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.01 -31.93 44.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.83 50.19 3.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.16 139.36 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 109.554 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -41.21 29.02 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.967 0.507 . . . . 0.0 111.403 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -167.11 -170.94 1.63 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.512 HD11 ' CH2' ' A' ' 30' ' ' TRP . 24.6 pt -130.32 152.65 80.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 124.774 1.23 . . . . 0.0 108.384 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.39 157.04 99.45 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.95 1.018 . . . . 0.0 113.478 2.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -160.15 114.43 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.8 mt -97.38 107.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.9 mtt -97.43 142.62 29.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.108 0.867 . . . . 0.0 109.0 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.22 129.56 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -132.92 162.11 32.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.862 0.865 . . . . 0.0 110.663 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.64 152.94 3.95 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.012 1.325 . . . . 0.0 108.151 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.47 44.8 11.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.55 8.17 70.85 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.837 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -138.39 163.05 32.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.597 1.698 . . . . 0.0 111.031 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -90.17 148.29 23.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.5 t -100.07 -60.69 1.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.266 1.027 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.47 -168.5 1.53 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.013 1.725 . . . . 0.0 107.159 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -150.95 172.16 16.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.599 0.76 . . . . 0.0 109.056 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.29 142.04 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.564 1.546 . . . . 0.0 106.835 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.9 mt -79.71 140.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -145.7 4.06 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.48 38.7 28.67 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.793 0.796 . . . . 0.0 111.232 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.22 157.55 60.8 Favored Pre-proline 0 C--N 1.341 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 111.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -70.5 140.07 39.08 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 163.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -58.0 -25.15 60.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.799 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.3 -44.66 34.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.156 0.889 . . . . 0.0 109.918 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -50.49 73.42 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.467 1.107 . . . . 0.0 109.53 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -52.38 50.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.869 0.868 . . . . 0.0 109.783 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.2 t -53.57 -58.88 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.653 0.661 . . . . 0.0 109.806 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -52.32 -53.07 49.02 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.6 m -53.71 -47.6 70.38 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.156 0.285 . . . . 0.0 111.64 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.63 -50.0 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.543 0.737 . . . . 0.0 109.279 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -57.6 -44.88 85.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.86 -51.5 60.81 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.055 0.942 . . . . 0.0 109.337 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -67.87 -45.18 75.29 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.277 -0.265 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.94 71.25 10.94 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 123.164 1.459 . . . . 0.0 109.361 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-N 111.479 -2.601 . . . . 0.0 107.485 179.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -61.95 -44.56 96.51 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.1 125.03 28.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.08 163.23 54.05 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.24 44.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.42 162.37 14.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 122.136 0.97 . . . . 0.0 110.572 -178.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -140.61 168.42 19.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.469 2.308 . . . . 0.0 105.778 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -39.87 -49.29 2.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.444 1.497 . . . . 0.0 110.787 176.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.74 -66.8 0.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.436 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -66.16 -41.38 90.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.436 1.095 . . . . 0.0 112.229 -174.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -38.93 -47.51 1.45 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 128.201 2.6 . . . . 0.0 111.237 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -44.41 -59.66 2.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.537 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.12 -46.04 18.81 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.884 0.849 . . . . 0.0 110.844 -176.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.0 -34.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.031 -168.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.29 -59.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.445 1.098 . . . . 0.0 111.657 -172.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.63 -68.02 0.37 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -175.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -79.61 41.69 0.49 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.556 -0.715 . . . . 0.0 111.762 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -90.18 139.6 30.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -78.52 -54.89 5.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -78.85 157.29 76.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.69 152.68 81.05 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 111.758 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 76.5 t -146.74 124.3 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.357 1.063 . . . . 0.0 113.757 -177.123 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' N ' ' HB2' ' A' ' 53' ' ' LYS . 4.2 tt -107.72 123.77 49.02 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 125.35 1.46 . . . . 0.0 108.341 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.07 133.38 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -96.59 123.37 40.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CE2' HD23 ' A' ' 57' ' ' LEU . 33.8 m-85 -78.78 110.94 14.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 175.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -123.15 -173.68 2.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.886 0.851 . . . . 0.0 111.045 -176.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.84 157.9 4.36 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 175.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.33 -38.53 84.16 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.136 1.891 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.444 ' CH2' HD11 ' A' ' 74' ' ' ILE . 51.0 p-90 -73.78 -8.68 56.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.947 0.499 . . . . 0.0 111.422 176.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -80.11 85.44 5.67 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.28 -1.512 . . . . 0.0 109.617 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.58 -61.6 1.81 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.675 1.131 . . . . 0.0 113.151 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -49.34 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.798 2.999 . . . . 0.0 112.04 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -57.6 -50.93 71.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.013 0.925 . . . . 0.0 109.304 -178.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.25 -45.87 90.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.186 -0.435 . . . . 0.0 112.152 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 pt -67.34 -38.61 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.23 -178.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.84 -23.35 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.66 1.118 . . . . 0.0 111.939 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.51 4.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -176.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.78 -29.41 23.79 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 122.666 1.988 . . . . 0.0 109.866 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -44.44 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.12 -44.49 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -54.3 41.91 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.36 -40.16 81.48 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.979 -1.076 . . . . 0.0 110.302 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.6 mt -58.21 -45.79 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.04 -44.98 64.5 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.455 0.571 . . . . 0.0 109.546 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 -57.1 10.39 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -50.09 -51.18 44.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.573 0.702 . . . . 0.0 111.288 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -88.26 19.94 3.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -56.4 153.1 10.32 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.075 0.852 . . . . 0.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.3 -52.1 0.7 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.799 2.039 . . . . 0.0 111.485 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -78.57 -51.84 9.34 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.41 -158.32 0.89 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -158.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HB2' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.21 82.12 3.01 Favored 'General case' 0 N--CA 1.441 -0.883 2 N-CA-C 127.687 6.18 . . . . 0.0 127.687 -156.729 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.6 t -148.29 121.7 9.07 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.938 -2.351 . . . . 0.0 114.974 172.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.92 167.35 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.382 1.073 . . . . 0.0 109.88 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -134.18 113.48 12.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.853 1.261 . . . . 0.0 109.758 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' A' ' 26' ' ' PHE . 20.2 tp -93.36 114.77 27.27 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.043 0.937 . . . . 0.0 110.413 -178.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -72.68 109.78 6.55 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.8 m -70.12 -33.51 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.031 1.333 . . . . 0.0 111.18 -174.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.54 -37.96 89.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.483 1.113 . . . . 0.0 109.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -87.35 -27.01 23.09 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.731 2.012 . . . . 0.0 111.758 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.2 t -121.01 52.8 3.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.275 1.83 . . . . 0.0 111.741 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.46 -38.16 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.642 2.894 . . . . 0.0 108.97 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -38.33 -69.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.657 1.983 . . . . 0.0 110.839 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.93 -54.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.746 1.218 . . . . 0.0 109.957 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.18 -37.46 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.835 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -68.69 -48.09 64.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.414 0.685 . . . . 0.0 109.162 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.62 -42.9 75.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 110.009 177.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.51 -25.62 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.49 13.47 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.723 0.678 . . . . 0.0 111.649 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.5 mt -79.85 90.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' CD ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.53 -10.74 59.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.621 1.169 . . . . 0.0 112.978 -175.221 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.9 m -159.38 161.98 35.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.444 HD11 ' CH2' ' A' ' 30' ' ' TRP . 22.2 pt -132.75 154.92 81.64 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.77 161.88 74.81 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.661 1.272 . . . . 0.0 114.424 4.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -160.85 122.04 2.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 174.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.96 99.14 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.967 0.907 . . . . 0.0 108.62 -172.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.3 mtt -96.83 138.86 33.75 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.586 0.63 . . . . 0.0 110.079 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.19 131.1 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.31 167.57 17.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.743 1.617 . . . . 0.0 111.174 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.17 151.67 3.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.752 2.021 . . . . 0.0 105.955 173.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 47.4 42.3 18.46 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 170.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.1 10.33 68.62 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.691 178.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -141.76 170.75 15.14 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.561 1.68 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.89 162.85 17.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.471 1.109 . . . . 0.0 111.262 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 45.2 t -130.53 -50.9 1.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.384 1.874 . . . . 0.0 110.012 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -138.88 167.38 22.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.468 -177.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.7 m -151.81 89.02 1.43 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 126.234 1.814 . . . . 0.0 106.24 175.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.08 -175.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 106.615 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.43 156.65 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.66 -150.16 2.09 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.9 -43.71 0.57 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.466 1.506 . . . . 0.0 112.166 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.86 151.95 79.73 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.03 149.25 53.87 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.621 1.547 . . . . 0.0 112.543 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -59.19 -37.24 76.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.2 -50.47 38.05 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.722 0.409 . . . . 0.0 110.074 175.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -56.86 -48.41 78.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.615 1.166 . . . . 0.0 110.095 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.1 mt -59.41 -53.01 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.43 -53.56 23.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.22 -42.26 63.43 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.328 0.513 . . . . 0.0 111.143 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.1 m -59.94 -47.72 84.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.58 -38.49 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 122.034 -0.417 . . . . 0.0 112.076 -178.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -45.68 -42.49 11.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.699 1.2 . . . . 0.0 112.304 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -45.84 -39.09 8.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.846 1.258 . . . . 0.0 111.734 176.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -99.3 30.04 3.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.972 2.109 . . . . 0.0 110.556 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 -47.25 0.25 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.645 0.378 . . . . 0.0 111.571 -170.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.394 -1.289 . . . . 0.0 107.678 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 tpt . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -157.44 167.3 30.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -178.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . . . -62.99 116.8 5.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.613 0.642 . . . . 0.0 111.03 -177.238 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.19 148.31 36.99 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 174.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.46 100.81 10.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 171.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.421 HG23 ' CB ' ' A' ' 57' ' ' LEU . 12.7 m -103.6 161.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.852 0.834 . . . . 0.0 109.432 -176.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -151.34 172.89 15.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.93 2.092 . . . . 0.0 105.494 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.79 -48.41 15.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.073 0.949 . . . . 0.0 112.317 -176.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.22 -72.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 110.77 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -51.7 -36.58 47.26 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.539 1.135 . . . . 0.0 112.491 -174.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -39.8 -49.67 2.35 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 126.28 1.832 . . . . 0.0 110.863 177.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -49.98 -56.92 8.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.552 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -74.02 -45.15 51.61 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.678 -175.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.3 t -74.91 -43.7 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.574 -168.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.5 t -95.9 -64.65 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.22 1.008 . . . . 0.0 111.007 -173.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -64.31 -59.05 4.85 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.36 41.98 0.41 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.162 0.585 . . . . 0.0 111.312 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -89.75 -171.13 3.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 p -128.2 -65.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.799 2.039 . . . . 0.0 106.973 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.1 158.97 74.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.6 159.84 46.15 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.419 1.185 . . . . 0.0 111.347 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.24 123.95 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.178 1.791 . . . . 0.0 109.007 -177.257 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.84 101.33 12.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.76 137.76 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -110.74 118.08 35.19 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.081 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.499 ' CE2' HD21 ' A' ' 57' ' ' LEU . 34.1 m-85 -78.25 112.29 15.08 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -125.31 -174.82 3.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.172 0.987 . . . . 0.0 111.158 -175.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.41 142.73 1.78 Allowed Pre-proline 0 C--O 1.224 -0.287 0 C-N-CA 126.527 1.931 . . . . 0.0 106.165 171.101 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -37.98 -53.5 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.148 3.232 . . . . 0.0 117.708 179.509 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.6 p-90 -61.27 -15.96 40.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.449 0.568 . . . . 0.0 112.458 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -73.0 80.91 1.2 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.191 0.596 . . . . 0.0 111.022 -177.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.15 -56.75 1.8 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.642 1.115 . . . . 0.0 112.691 176.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -50.96 -48.64 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.176 2.584 . . . . 0.0 112.585 177.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.6 m -58.61 -47.51 84.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -61.42 -45.66 93.39 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.3 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.05 -25.47 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.331 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.33 -27.99 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.867 1.667 . . . . 0.0 110.391 174.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -38.68 -45.54 2.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 178.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.98 -40.24 73.22 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 CA-C-N 122.346 1.874 . . . . 0.0 109.855 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -74.18 -47.67 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.523 1.129 . . . . 0.0 108.668 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' SG ' ' A' ' 54' ' ' CYS . 0.4 OUTLIER -52.01 -36.08 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.422 1.089 . . . . 0.0 108.165 175.728 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 3' ' ' ALA . 16.9 t70 -70.1 -58.63 3.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.797 -0.565 . . . . 0.0 110.709 173.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -49.29 -41.46 38.2 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.347 -0.359 . . . . 0.0 111.757 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -52.76 -42.98 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 118.482 0.583 . . . . 0.0 110.433 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.71 66.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.671 0.669 . . . . 0.0 111.171 178.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.93 -46.01 14.85 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 174.109 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.06 -65.75 0.88 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.355 1.062 . . . . 0.0 113.104 -176.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -82.91 19.16 1.42 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.498 1.119 . . . . 0.0 112.805 -174.356 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -39.41 -42.02 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 128.204 2.602 . . . . 0.0 112.057 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -36.17 -46.89 0.54 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 127.719 2.408 . . . . 0.0 111.748 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.96 -55.04 1.3 Allowed 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.687 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.35 113.57 21.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -163.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.89 91.48 8.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.076 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 41' ' ' VAL . 7.7 t -79.23 142.09 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 120.752 -1.218 . . . . 0.0 109.454 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -156.73 176.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.828 0.74 . . . . 0.0 110.744 -178.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -142.13 137.74 31.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.846 0.858 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.499 HD21 ' CE2' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -114.87 122.26 45.77 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.71 1.204 . . . . 0.0 112.824 -179.268 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.66 105.79 5.92 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 122.071 0.939 . . . . 0.0 109.809 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -59.89 -39.8 86.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.665 1.986 . . . . 0.0 111.94 -173.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.33 -38.27 74.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.67 0.788 . . . . 0.0 110.709 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -80.09 -27.17 39.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.27 1.428 . . . . 0.0 110.995 177.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.4 m -134.57 62.83 56.88 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.813 1.245 . . . . 0.0 111.342 -177.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 -34.33 28.95 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 109.533 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -37.25 -69.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.764 2.026 . . . . 0.0 110.663 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -61.01 -45.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 122.822 0.449 . . . . 0.0 110.753 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -37.11 60.24 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.13 0.172 . . . . 0.0 111.049 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.1 m -74.41 -46.42 40.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.248 1.019 . . . . 0.0 109.859 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.04 -45.45 75.22 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.197 0.599 . . . . 0.0 110.501 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -79.27 -33.33 43.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.905 0.482 . . . . 0.0 110.51 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.57 53.58 2.41 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.195 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.9 mm -67.52 130.13 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.15 -42.4 26.26 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.934 -0.479 . . . . 0.0 110.783 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.8 m -166.09 174.95 8.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.799 2.04 . . . . 0.0 106.042 179.362 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 pt -120.35 150.75 52.4 Favored Pre-proline 0 N--CA 1.455 -0.202 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.072 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.33 144.8 81.59 Favored 'Cis proline' 0 N--CA 1.457 -0.654 0 CA-C-N 119.905 1.002 . . . . 0.0 113.355 1.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -143.12 111.67 6.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.05 138.77 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.3 mtt -130.51 128.19 40.68 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 173.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.6 97.2 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -79.34 125.99 30.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.09 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -137.29 0.31 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.03 77.82 0.42 Allowed Glycine 0 CA--C 1.531 1.031 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.25 -63.3 4.15 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -79.66 167.84 20.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.47 0.708 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -87.36 149.3 24.58 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.59 -55.19 3.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.351 1.06 . . . . 0.0 109.127 170.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -137.18 163.7 30.24 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.577 1.151 . . . . 0.0 112.808 -176.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.3 t -138.71 128.69 25.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 173.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 mt -140.21 137.27 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -78.64 140.03 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 174.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.11 -137.71 0.72 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.12 -31.1 0.21 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.448 1.499 . . . . 0.0 112.44 -177.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.06 149.5 79.87 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -56.95 144.99 87.43 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 120.988 1.125 . . . . 0.0 110.387 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -55.86 -31.6 62.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.341 0.656 . . . . 0.0 110.189 -178.174 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -37.87 60.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.021 0.828 . . . . 0.0 111.087 175.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -61.64 -49.55 76.12 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.355 1.062 . . . . 0.0 108.341 178.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.77 -43.23 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.569 1.148 . . . . 0.0 109.817 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.92 -55.03 22.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 124.127 0.971 . . . . 0.0 108.865 177.813 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -55.07 -48.19 73.84 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.994 -0.441 . . . . 0.0 110.289 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -59.76 -44.67 93.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.637 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.68 -44.75 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 CA-C-N 119.067 0.849 . . . . 0.0 110.636 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -46.65 -47.27 20.23 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.342 1.057 . . . . 0.0 110.731 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -44.48 -39.96 5.21 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.567 1.147 . . . . 0.0 111.818 176.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -101.58 9.55 41.08 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.796 1.238 . . . . 0.0 113.224 -175.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.54 66.11 0.86 Allowed 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 9.7 pt-20 -83.77 164.5 19.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.541 0.736 . . . . 0.0 109.316 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.45 74.61 0.16 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.02 157.74 51.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 177.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.55 117.57 33.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -105.58 160.15 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 122.187 0.994 . . . . 0.0 109.87 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -152.1 174.53 13.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.736 2.414 . . . . 0.0 106.774 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -37.72 -58.36 0.9 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 126.549 1.94 . . . . 0.0 112.653 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.26 -67.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -53.67 -45.59 70.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.145 0.978 . . . . 0.0 111.928 -175.426 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -42.07 -50.42 4.7 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 127.14 2.176 . . . . 0.0 111.447 -178.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -48.52 -48.06 38.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.791 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -81.05 -59.81 2.52 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.367 0.667 . . . . 0.0 111.456 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.31 -31.49 54.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 126.332 1.853 . . . . 0.0 113.116 -172.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.42 -56.51 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.449 0.699 . . . . 0.0 112.009 -173.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.76 -60.0 2.46 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.867 0.758 . . . . 0.0 109.815 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.84 42.32 0.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.9 p -90.16 148.42 22.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.902 -0.499 . . . . 0.0 109.832 -178.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 p -87.57 -62.93 1.39 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.778 1.231 . . . . 0.0 107.964 177.04 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 151.38 75.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.033 1.333 . . . . 0.0 108.192 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.44 160.49 48.42 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 120.942 1.095 . . . . 0.0 109.585 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.435 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -151.14 133.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -172.049 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.551 HD21 HG23 ' A' ' 77' ' ' ILE . 8.3 tt -92.3 109.46 20.84 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.07 110.14 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -87.15 113.39 22.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -79.11 109.81 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 177.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -130.47 -173.6 3.11 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 121.723 0.773 . . . . 0.0 111.44 -173.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.04 150.73 4.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.336 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.72 -40.2 85.73 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.042 1.828 . . . . 0.0 112.422 178.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.604 ' CH2' HD11 ' A' ' 74' ' ' ILE . 41.1 p-90 -70.19 -14.22 62.53 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.904 -0.498 . . . . 0.0 111.789 177.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 84.18 3.54 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.119 -0.988 . . . . 0.0 112.127 -177.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.52 -62.06 1.42 Allowed Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.772 -1.016 . . . . 0.0 114.059 175.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 -23.54 74.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.214 1.942 . . . . 0.0 113.222 -178.338 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.8 m -77.39 -58.55 3.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -43.45 -52.59 5.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.53 2.332 . . . . 0.0 111.602 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.69 -22.79 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.247 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.88 -27.29 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.488 1.04 . . . . 0.0 110.831 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.71 -44.97 3.9 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 117.023 -1.465 . . . . 0.0 114.005 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.71 -37.25 88.5 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.532 2.155 . . . . 0.0 110.215 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -43.4 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -59.97 -41.95 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 67.9 m-20 -65.05 -48.66 73.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.402 0.681 . . . . 0.0 110.599 178.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -60.76 -40.44 92.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.354 0.525 . . . . 0.0 109.719 -179.064 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mt -53.35 -47.29 58.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.519 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . . . -56.88 -52.42 65.2 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.81 -41.72 28.07 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.61 1.1 . . . . 0.0 112.129 178.283 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.47 -70.27 0.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.335 0.654 . . . . 0.0 110.046 177.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -86.86 48.46 1.65 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.427 1.108 . . . . 0.0 111.28 -174.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -52.02 61.38 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 127.595 2.358 . . . . 0.0 115.011 -168.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -70.08 -72.44 0.2 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.821 0.82 . . . . 0.0 111.834 -177.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -39.47 34.64 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -164.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 8.7 tp -105.48 -171.84 1.98 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -155.092 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.559 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.7 pptp? -76.34 91.67 3.28 Favored 'General case' 0 N--CA 1.431 -1.389 2 N-CA-C 123.585 4.661 . . . . 0.0 123.585 -160.933 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 52.4 t -153.82 121.89 6.07 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.492 -1.38 . . . . 0.0 113.2 172.012 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.59 163.68 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.395 1.478 . . . . 0.0 108.744 173.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 115.08 16.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.514 1.126 . . . . 0.0 110.864 -175.729 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -92.74 110.22 21.66 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.98 103.83 2.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.231 1.015 . . . . 0.0 108.699 177.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -84.53 54.1 2.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.492 2.317 . . . . 0.0 108.987 -177.223 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -150.89 -48.67 0.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.23 -26.25 30.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 111.238 172.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.87 53.13 0.94 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.97 2.108 . . . . 0.0 115.042 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.59 -25.75 40.51 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.683 3.589 . . . . 0.0 108.79 174.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -49.14 -70.56 0.09 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.897 1.279 . . . . 0.0 109.951 178.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.6 t -51.56 -49.44 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.232 1.413 . . . . 0.0 108.856 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.89 67.14 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.8 m -69.68 -45.79 67.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.28 0.632 . . . . 0.0 110.335 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.4 -46.05 76.61 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.245 0.618 . . . . 0.0 110.62 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.44 -31.36 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.478 0.311 . . . . 0.0 111.155 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.72 52.46 2.63 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.79 115.61 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -78.4 -33.65 48.63 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.091 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -163.29 -173.39 3.35 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.604 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.3 pt -142.14 149.05 50.71 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.22 139.27 60.45 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 CA-C-N 119.394 0.819 . . . . 0.0 113.304 2.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -130.15 118.89 22.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 102.04 -3.318 . . . . 0.0 102.04 172.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.551 HG23 HD21 ' A' ' 23' ' ' LEU . 45.2 mt -112.49 100.45 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 108.272 -172.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.4 mtt -94.29 138.39 32.34 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.136 0.426 . . . . 0.0 110.287 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.5 104.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.82 147.69 28.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.44 21.57 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.396 1.078 . . . . 0.0 109.618 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.06 127.23 6.04 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.067 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.5 -52.06 1.86 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.828 1.68 . . . . 0.0 114.116 178.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -138.48 -179.88 6.06 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.248 1.019 . . . . 0.0 110.649 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 152.71 21.04 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.778 1.231 . . . . 0.0 109.832 176.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -110.82 -71.06 0.78 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.404 1.482 . . . . 0.0 107.883 177.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -96.6 162.91 13.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.693 0.797 . . . . 0.0 109.691 177.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.4 m -153.27 108.58 3.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.347 1.059 . . . . 0.0 108.177 175.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.31 160.65 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -142.98 147.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.67 169.34 45.65 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 121.495 0.497 . . . . 0.0 112.33 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.85 82.71 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.989 0.515 . . . . 0.0 111.122 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.61 151.54 77.29 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.746 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -82.38 149.3 14.88 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.405 2.737 . . . . 0.0 106.76 170.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.01 -42.45 72.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.806 -0.559 . . . . 0.0 112.31 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.54 -51.73 6.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.98 0.912 . . . . 0.0 111.253 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 m -61.5 -50.23 73.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.161 0.584 . . . . 0.0 110.481 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -53.96 -56.37 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.594 0.758 . . . . 0.0 109.016 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -49.88 -64.08 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.741 1.617 . . . . 0.0 108.885 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -51.62 -47.3 63.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.188 0.449 . . . . 0.0 111.824 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -58.35 -45.34 88.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.207 -178.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -44.79 46.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 CA-C-N 119.262 0.937 . . . . 0.0 111.589 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -48.7 -44.33 37.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.244 1.018 . . . . 0.0 110.074 -178.319 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -44.26 -44.04 7.71 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.125 0.97 . . . . 0.0 111.717 174.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -94.32 -7.0 43.09 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.423 1.489 . . . . 0.0 112.755 -177.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -157.65 85.58 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.009 0.822 . . . . 0.0 110.31 -169.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.3 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 178.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.99 -45.76 73.21 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 171.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.61 135.71 33.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 171.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.16 -173.56 41.76 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.84 139.25 52.25 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.93 167.98 22.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 122.499 1.142 . . . . 0.0 111.514 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -146.71 175.9 10.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.706 2.402 . . . . 0.0 106.419 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -38.54 -58.78 0.99 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.5 1.52 . . . . 0.0 112.793 -176.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.98 -57.45 11.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.623 1.169 . . . . 0.0 111.908 -177.171 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -65.11 -40.01 93.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.526 0.73 . . . . 0.0 111.658 -173.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -41.02 -47.13 3.03 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.471 1.908 . . . . 0.0 110.866 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -54.96 -62.99 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.656 178.55 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -63.21 -32.59 74.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.213 1.005 . . . . 0.0 112.314 -176.114 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.9 t -92.55 -54.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.19 0.596 . . . . 0.0 111.968 -171.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -83.59 -57.35 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.255 1.022 . . . . 0.0 110.854 -175.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.1 mt -70.23 -54.97 10.51 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.06 0.391 . . . . 0.0 111.238 -174.079 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -79.44 48.7 0.92 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.73 -0.606 . . . . 0.0 110.622 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 p -90.47 158.51 17.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.21 1.404 . . . . 0.0 111.151 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 p -91.26 -72.05 0.6 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.93 1.292 . . . . 0.0 107.569 176.259 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -79.39 160.63 69.87 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.22 166.15 1.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.114 1.876 . . . . 0.0 111.771 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 t -138.64 145.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 109.944 -176.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -122.33 105.77 10.49 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 m -101.25 150.9 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 118.626 0.648 . . . . 0.0 109.489 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -115.07 119.9 38.01 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.526 0.73 . . . . 0.0 109.321 174.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.472 ' CD2' HD12 ' A' ' 57' ' ' LEU . 23.1 m-85 -80.76 111.31 17.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -128.84 -173.23 2.92 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.47 0.708 . . . . 0.0 111.608 -174.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.63 154.75 12.4 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.532 1.133 . . . . 0.0 108.158 174.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.46 -43.41 40.21 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.367 2.711 . . . . 0.0 112.07 -176.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.428 ' CH2' HD11 ' A' ' 74' ' ' ILE . 55.6 p-90 -70.9 -13.13 61.91 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.177 0.591 . . . . 0.0 111.262 177.094 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.23 80.68 3.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.209 -0.932 . . . . 0.0 111.061 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.39 -55.9 4.27 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.907 0.765 . . . . 0.0 112.812 176.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.55 -27.95 78.95 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.55 2.167 . . . . 0.0 112.715 178.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.54 -56.38 4.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -48.71 -48.57 40.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.091 1.357 . . . . 0.0 111.727 -177.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.45 -21.94 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.222 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.4 mm -89.54 -26.58 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 119.461 1.028 . . . . 0.0 110.012 177.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.92 -48.56 5.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.66 -36.88 83.17 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.106 1.871 . . . . 0.0 110.174 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.9 -45.02 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.565 1.146 . . . . 0.0 108.292 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.5 -53.39 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.024 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.82 -53.53 57.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.832 0.853 . . . . 0.0 111.943 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.65 -40.48 96.96 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.068 -1.02 . . . . 0.0 110.604 -177.27 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.5 mt -58.42 -46.7 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.85 68.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.57 -51.44 52.07 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -61.93 -49.22 77.04 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.91 10.43 41.32 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -38.42 -56.94 1.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 126.62 1.968 . . . . 0.0 112.45 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.58 -44.91 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.533 1.933 . . . . 0.0 113.44 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.42 -9.8 19.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.216 1.006 . . . . 0.0 112.458 -176.014 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -151.08 113.99 4.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -78.65 160.91 27.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 171.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 22.8 t -141.85 142.78 33.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.793 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.06 162.42 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.05 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -130.12 111.9 12.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.2 0.6 . . . . 0.0 110.087 -176.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.472 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.2 tm? -88.77 117.21 27.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.572 0.749 . . . . 0.0 109.383 -178.025 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -74.41 100.94 3.95 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -58.92 -39.71 82.36 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.122 1.769 . . . . 0.0 112.422 -175.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.14 -37.64 75.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.236 1.014 . . . . 0.0 110.343 -173.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -86.34 -28.83 23.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.66 1.584 . . . . 0.0 111.332 177.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -123.43 54.85 7.48 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.464 1.906 . . . . 0.0 110.609 -177.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.71 -40.22 66.42 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.942 3.094 . . . . 0.0 109.006 177.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -29.09 -75.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.404 2.281 . . . . 0.0 111.804 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.7 t -53.37 -49.57 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.049 1.34 . . . . 0.0 109.879 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.92 68.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.949 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -80.3 -42.11 23.65 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.562 1.145 . . . . 0.0 108.957 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.18 -41.39 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -78.64 -30.09 46.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.427 0.691 . . . . 0.0 110.666 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.49 49.32 6.76 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.236 0.922 . . . . 0.0 111.24 176.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -133.28 79.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.661 1.584 . . . . 0.0 109.95 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -31.69 46.67 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.57 145.3 54.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.428 HD11 ' CH2' ' A' ' 30' ' ' TRP . 13.4 pt -148.05 154.52 43.12 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.88 140.08 58.76 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 CA-C-N 119.812 0.968 . . . . 0.0 112.273 1.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 m -130.1 107.27 9.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.372 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.7 mt -88.78 137.85 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 16.5 mtt -131.59 135.57 47.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.07 141.15 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -127.93 155.45 44.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.949 1.3 . . . . 0.0 108.277 174.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.05 56.42 1.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.884 1.674 . . . . 0.0 107.836 -178.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.49 -153.56 16.93 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 -173.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.2 35.84 1.3 Allowed Glycine 0 CA--C 1.528 0.879 0 O-C-N 121.794 -0.827 . . . . 0.0 114.546 -177.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -151.27 155.26 38.41 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.624 1.569 . . . . 0.0 108.044 177.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -89.84 145.81 24.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.14 1.376 . . . . 0.0 108.323 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.3 t -112.32 -55.85 2.47 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.357 1.063 . . . . 0.0 111.062 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -133.56 170.78 15.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 111.061 -175.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.5 m -156.23 140.62 16.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.115 1.366 . . . . 0.0 108.932 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.4 mm -136.6 153.34 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mt -133.53 144.01 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.97 148.49 24.29 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.028 0.823 . . . . 0.0 112.698 176.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.06 72.76 1.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 110.941 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.4 m -78.91 147.03 69.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -56.66 158.19 17.08 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.901 2.401 . . . . 0.0 114.556 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -46.68 -51.63 15.58 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 125.832 1.653 . . . . 0.0 110.581 177.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.36 -49.42 44.5 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.445 0.698 . . . . 0.0 110.799 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -49.7 73.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.068 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.02 -54.44 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.86 -56.78 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.562 1.145 . . . . 0.0 110.377 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -55.25 -47.47 75.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.3 m -56.92 -44.76 82.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.484 0.714 . . . . 0.0 110.415 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.94 -56.26 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.949 0.795 . . . . 0.0 109.52 176.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -52.51 -45.51 66.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.204 1.002 . . . . 0.0 112.745 -175.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -60.28 -30.75 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.568 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -81.09 -48.04 12.7 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.47 -99.98 0.44 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.755 1.222 . . . . 0.0 109.692 -174.556 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 tpp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 70.56 -66.51 0.28 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -168.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.41 130.7 43.24 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 167.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.56 175.14 54.35 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.878 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.6 129.5 56.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.67 162.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 122.171 0.986 . . . . 0.0 110.094 -177.464 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -139.34 175.36 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.572 2.349 . . . . 0.0 106.952 175.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -46.9 -55.26 8.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.0 111.521 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.15 -52.27 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.196 1.398 . . . . 0.0 111.442 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 p -75.94 -37.76 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.579 0.751 . . . . 0.0 112.132 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -41.2 -46.56 3.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.767 2.027 . . . . 0.0 110.644 -177.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.34 -50.12 60.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.417 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -78.03 -52.97 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.62 1.2 . . . . 0.0 110.877 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.81 -35.18 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.205 -169.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.3 -59.71 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.3 mt -66.4 -73.57 0.13 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -174.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -82.93 57.95 4.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.726 0.81 . . . . 0.0 108.924 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 p -87.6 -139.5 0.1 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.098 0.959 . . . . 0.0 109.964 -178.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -160.68 -68.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 m -77.79 158.34 78.21 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 104.959 -2.238 . . . . 0.0 104.959 171.049 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 165.29 21.9 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 N-CA-C 108.55 -1.365 . . . . 0.0 108.55 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.4 146.01 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 125.419 1.488 . . . . 0.0 108.916 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -126.25 103.76 7.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.09 145.08 10.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -113.36 113.21 24.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 57' ' ' LEU . 52.7 m-85 -78.59 111.26 14.48 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.442 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.61 -173.84 2.78 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.716 0.635 . . . . 0.0 110.719 -178.009 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.38 141.46 0.92 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.754 1.221 . . . . 0.0 110.499 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.07 110.69 3.0 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.445 2.096 . . . . 0.0 108.919 176.09 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 137.31 -29.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 131.61 3.964 . . . . 0.0 105.684 -173.299 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.5 t -68.78 88.53 0.37 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.352 0.596 . . . . 0.0 111.933 -177.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -35.65 -67.3 0.34 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.233 1.873 . . . . 0.0 113.388 177.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.28 -46.54 29.82 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 119.6 1.7 . . . . 0.0 112.268 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.3 m -54.22 -42.44 69.8 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.308 0.503 . . . . 0.0 110.293 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -55.57 -53.34 57.59 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 122.802 0.441 . . . . 0.0 111.065 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 pt -74.1 -27.46 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.878 -178.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.24 -38.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 110.683 177.154 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.64 -48.33 5.15 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -60.36 -37.6 80.72 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.929 2.419 . . . . 0.0 110.435 178.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.49 -45.52 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.32 -44.55 88.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -58.15 -61.46 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.64 0.776 . . . . 0.0 110.011 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.91 -37.51 82.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.633 0.652 . . . . 0.0 111.309 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.41 -40.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 176.028 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -59.29 -43.82 92.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.443 0.565 . . . . 0.0 110.097 175.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.36 -39.86 84.08 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.96 -51.14 42.7 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -99.91 10.11 41.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -46.4 147.49 1.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 112.078 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.18 -46.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.945 2.098 . . . . 0.0 111.91 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.87 -19.48 54.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.959 . . . . 0.0 110.709 -178.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.2 tp -155.3 128.83 8.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 107.338 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tmtp? -90.16 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 54.0 t -79.55 133.91 36.47 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.534 -0.729 . . . . 0.0 109.517 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.28 169.85 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.427 0.632 . . . . 0.0 111.865 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -133.5 131.28 39.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.983 1.713 . . . . 0.0 110.438 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -119.47 133.89 55.48 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.098 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -81.52 111.15 17.58 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.107 0.956 . . . . 0.0 111.257 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.6 m -84.22 49.86 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.238 2.215 . . . . 0.0 111.13 -174.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.12 -42.15 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -80.7 -24.1 39.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.748 2.019 . . . . 0.0 108.981 169.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -144.18 62.73 10.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.607 1.563 . . . . 0.0 110.985 178.134 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.26 -26.67 4.03 Favored 'Trans proline' 0 N--CA 1.445 -1.37 1 C-N-CA 126.397 4.732 . . . . 0.0 109.079 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -38.79 -61.26 0.75 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.938 1.695 . . . . 0.0 109.647 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.9 t -56.79 -52.88 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.765 1.226 . . . . 0.0 110.047 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.16 -35.25 64.57 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.501 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 m -73.65 -46.1 48.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.701 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.52 -43.61 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.528 0.731 . . . . 0.0 109.944 177.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.99 -32.53 45.26 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.66 -0.21 . . . . 0.0 110.721 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.87 51.92 2.54 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 123.75 0.69 . . . . 0.0 111.533 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.9 mt -79.92 112.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.46 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.07 -27.42 43.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.118 0.567 . . . . 0.0 112.142 -177.62 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -157.72 161.89 38.54 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.299 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.76 154.88 81.09 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.3 135.18 38.22 Favored 'Cis proline' 0 N--CA 1.449 -1.098 0 CA-C-N 119.282 0.779 . . . . 0.0 113.074 1.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -121.84 102.48 8.22 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 173.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -79.58 137.2 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 175.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.0 mtt -130.22 148.27 52.03 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.34 128.32 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -116.31 144.91 43.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.407 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 12.59 3.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.168 -176.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.35 -154.41 25.12 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.25 20.09 0.59 Allowed Glycine 0 CA--C 1.533 1.165 0 CA-C-N 118.041 0.921 . . . . 0.0 114.866 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -153.9 162.58 41.11 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.587 1.555 . . . . 0.0 108.595 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -78.84 -179.48 6.59 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.77 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.8 t -138.9 -66.08 0.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.403 1.081 . . . . 0.0 108.962 177.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -120.94 170.31 9.63 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.601 1.56 . . . . 0.0 109.784 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 t -156.86 152.25 26.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.758 0.823 . . . . 0.0 108.943 178.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.41 150.15 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.794 1.238 . . . . 0.0 107.788 -177.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.7 mt -79.78 119.85 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 171.069 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.42 86.27 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.135 -0.814 . . . . 0.0 113.973 -173.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.94 66.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.252 1.021 . . . . 0.0 113.017 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.41 154.68 53.44 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 126.06 1.744 . . . . 0.0 106.958 176.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -58.04 155.13 35.3 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.441 2.094 . . . . 0.0 113.952 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.07 -42.54 63.27 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.339 1.056 . . . . 0.0 109.542 177.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.97 -49.0 66.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.948 0.499 . . . . 0.0 109.985 178.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m -61.14 -47.8 84.56 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.1 mm -54.11 -56.73 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -49.32 -58.55 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 125.183 1.393 . . . . 0.0 109.724 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -54.34 -48.31 71.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.881 0.31 . . . . 0.0 111.218 -178.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.0 m -61.36 -38.99 88.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.945 0.498 . . . . 0.0 110.604 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.4 t -65.67 -55.4 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 119.153 0.888 . . . . 0.0 108.778 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -43.86 -57.58 3.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 111.671 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.84 -26.77 15.6 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -83.26 -21.37 33.34 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.414 -0.804 . . . . 0.0 110.976 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 84.1 mt -95.38 -39.68 9.89 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.709 1.204 . . . . 0.0 111.144 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 116.946 -1.502 . . . . 0.0 109.926 -177.45 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.76 -39.94 94.46 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.61 148.26 23.45 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.02 162.94 42.07 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.592 1.567 . . . . 0.0 113.601 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.65 122.21 35.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 172.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.3 163.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.492 -176.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -149.25 170.5 18.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.469 1.907 . . . . 0.0 107.242 177.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -77.31 80.53 3.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 125.112 2.387 . . . . 0.0 111.713 -176.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 172.76 -76.83 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 2 CA-C-N 107.644 -4.344 . . . . 0.0 107.415 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.7 p -51.8 -39.34 58.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.616 1.167 . . . . 0.0 110.581 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -43.58 -45.54 6.73 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.584 1.553 . . . . 0.0 111.271 175.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -54.17 -52.16 62.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.289 0.566 . . . . 0.0 110.096 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -70.35 -52.5 22.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 111.052 -177.525 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.6 -46.23 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.721 1.209 . . . . 0.0 112.804 -172.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.2 -61.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.92 0.888 . . . . 0.0 111.169 -174.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -68.04 -56.81 7.53 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.706 -172.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.59 43.75 0.58 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.267 0.485 . . . . 0.0 111.357 -178.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -90.16 -174.62 4.26 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.76 0.79 . . . . 0.0 109.361 177.328 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.3 p -120.34 -73.34 0.65 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.58 1.952 . . . . 0.0 106.409 176.168 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.74 158.83 75.11 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.19 159.27 15.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.563 1.509 . . . . 0.0 112.791 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.72 118.0 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.282 1.433 . . . . 0.0 109.778 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -84.96 104.17 14.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.49 116.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -96.06 109.96 22.28 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.505 ' CD2' HD12 ' A' ' 57' ' ' LEU . 31.9 m-85 -78.8 110.89 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.245 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -126.69 -174.36 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.082 0.953 . . . . 0.0 111.119 -174.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.06 149.32 3.31 Favored Pre-proline 0 N--CA 1.456 -0.175 0 C-N-CA 124.979 1.312 . . . . 0.0 108.007 172.373 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.99 -38.34 93.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.706 2.271 . . . . 0.0 113.888 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -76.35 -12.21 60.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.399 0.545 . . . . 0.0 112.111 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 t -77.91 100.46 6.4 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.865 -176.264 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.92 -64.8 1.37 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.628 1.585 . . . . 0.0 114.544 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.52 -45.44 37.21 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.596 1.698 . . . . 0.0 110.876 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.79 -50.48 63.49 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.22 0.608 . . . . 0.0 109.612 -178.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -56.24 -48.85 75.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.154 0.582 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.46 -29.28 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.776 -177.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 pt -81.7 -24.54 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 120.608 1.549 . . . . 0.0 110.853 176.542 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.13 -48.61 4.26 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.07 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.47 -41.01 35.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.088 1.858 . . . . 0.0 109.97 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.54 -49.67 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.979 1.312 . . . . 0.0 107.926 178.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.7 -44.13 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -56.59 -33.79 66.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.209 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -51.07 -35.79 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.308 0.643 . . . . 0.0 109.504 176.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.17 -38.35 70.79 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.313 0.506 . . . . 0.0 110.919 177.144 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.42 -43.4 45.59 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -55.82 -52.15 65.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -107.58 34.09 3.71 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.41 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -58.79 161.84 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.806 0.442 . . . . 0.0 110.172 176.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 t70 74.92 -55.44 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.613 1.965 . . . . 0.0 111.429 178.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -77.87 -31.67 51.52 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 -177.318 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.47 152.24 49.33 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.761 0.824 . . . . 0.0 109.906 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -106.17 152.08 23.92 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 168.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 54.1 t -132.97 140.41 47.77 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.435 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.64 176.4 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 119.033 0.833 . . . . 0.0 109.461 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.72 134.61 26.98 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.442 . . . . 0.0 111.851 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.2 tm? -99.76 119.35 38.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.338 1.855 . . . . 0.0 110.047 -177.606 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.23 104.06 4.87 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -66.96 -29.64 69.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.684 1.594 . . . . 0.0 111.631 -173.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.2 -42.03 84.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.869 0.842 . . . . 0.0 109.778 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -83.76 -31.63 25.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.281 1.832 . . . . 0.0 111.687 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.1 m -125.85 60.1 31.83 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 -178.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.42 -34.9 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 124.723 3.615 . . . . 0.0 109.779 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -38.46 -72.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.545 1.938 . . . . 0.0 111.626 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.64 -44.78 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 124.026 0.93 . . . . 0.0 110.487 -178.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.15 70.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.538 178.198 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -71.52 -43.8 65.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 109.749 178.75 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.59 -41.51 77.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.618 0.367 . . . . 0.0 110.437 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -78.19 -33.49 50.06 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.91 47.38 2.1 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.725 0.678 . . . . 0.0 111.827 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.5 mt -78.71 112.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.45 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.37 -29.55 47.48 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.12 -0.362 . . . . 0.0 110.908 -177.345 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -160.85 155.01 22.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.58 156.53 38.59 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -66.75 161.23 75.97 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.503 1.215 . . . . 0.0 112.595 2.514 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -158.37 102.02 1.73 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.4 pt -85.81 133.83 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 174.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.7 mtt -121.25 153.37 37.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.81 117.73 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -112.22 156.39 22.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.144 0.977 . . . . 0.0 109.103 178.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 153.85 8.82 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.363 1.465 . . . . 0.0 107.316 176.598 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 37.72 9.77 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.005 0.821 . . . . 0.0 114.69 175.73 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.3 20.51 65.38 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.702 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -141.6 166.03 25.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.332 1.453 . . . . 0.0 109.573 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -90.54 155.22 19.04 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.34 0.656 . . . . 0.0 109.598 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.0 t -108.65 -62.46 1.46 Allowed 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 125.603 1.561 . . . . 0.0 108.941 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.31 179.41 8.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.861 1.265 . . . . 0.0 108.846 177.263 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 t -155.45 151.4 27.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.631 1.173 . . . . 0.0 109.544 -178.68 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -146.81 157.25 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.757 1.623 . . . . 0.0 108.208 -179.086 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -79.6 114.35 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.82 -12.53 21.57 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -174.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.1 63.38 0.33 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.915 . . . . 0.0 111.96 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.97 157.06 58.3 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.434 1.494 . . . . 0.0 107.792 177.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -58.48 155.52 35.79 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.638 2.225 . . . . 0.0 113.729 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.12 -51.81 17.04 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.832 1.653 . . . . 0.0 110.744 178.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -51.88 35.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.598 178.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 m -59.47 -46.51 88.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.776 -0.631 . . . . 0.0 109.874 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.22 -52.02 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.811 0.732 . . . . 0.0 109.366 177.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.3 -57.45 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.055 0.542 . . . . 0.0 109.678 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -53.35 -47.76 69.11 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.984 0.357 . . . . 0.0 110.681 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 m -54.12 -49.29 69.52 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.209 1.003 . . . . 0.0 110.09 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -61.65 -55.18 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.518 -0.739 . . . . 0.0 109.746 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -51.32 -48.41 62.36 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.434 0.693 . . . . 0.0 112.325 -175.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -57.82 -22.29 46.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.782 0.719 . . . . 0.0 112.593 -179.117 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -93.64 9.07 38.41 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.754 0.706 . . . . 0.0 111.404 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.3 mt -129.6 -56.27 1.14 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.222 1.409 . . . . 0.0 109.786 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.049 0 C-N-CA 126.851 2.061 . . . . 0.0 106.682 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 10.1 pt-20 -95.66 163.61 13.12 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.541 1.136 . . . . 0.0 109.131 177.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.65 70.55 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.574 1.15 . . . . 0.0 113.126 -177.701 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.2 151.28 41.84 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.221 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.71 104.47 16.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.307 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.89 158.73 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.104 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -143.26 174.93 10.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 177.337 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -39.37 -49.71 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.329 1.452 . . . . 0.0 112.295 -176.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.33 -78.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.129 177.515 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 p -45.95 -41.33 11.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.256 1.422 . . . . 0.0 112.632 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -39.71 -46.05 1.81 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.162 1.785 . . . . 0.0 111.38 175.869 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -49.83 -65.85 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.852 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.78 -35.94 82.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.254 0.622 . . . . 0.0 112.196 -176.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.93 -13.09 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.49 -66.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 119.026 0.83 . . . . 0.0 109.475 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.45 -35.12 69.72 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -93.69 -5.19 49.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.99 0.916 . . . . 0.0 111.817 178.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 m -77.26 132.51 38.71 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.712 -1.243 . . . . 0.0 111.909 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.37 -52.9 7.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.809 1.244 . . . . 0.0 109.553 178.324 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.59 152.8 83.41 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -64.34 154.51 70.96 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 120.925 1.084 . . . . 0.0 113.049 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.461 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -147.85 127.27 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 124.626 1.204 . . . . 0.0 113.541 178.609 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.11 95.49 9.46 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.26 113.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -86.9 114.52 23.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -79.0 102.89 8.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 175.25 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -120.32 -171.5 2.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 110.519 -173.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.67 152.93 3.97 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -56.59 -35.73 97.36 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.847 1.698 . . . . 0.0 112.237 177.056 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CH2' HD11 ' A' ' 74' ' ' ILE . 24.6 p-90 -76.84 -3.92 40.93 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.798 -0.564 . . . . 0.0 111.985 177.392 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.7 t -82.06 85.37 6.76 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.587 -1.321 . . . . 0.0 112.125 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.1 -57.88 2.46 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.374 0.988 . . . . 0.0 114.055 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.97 -24.04 53.53 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 120.035 1.917 . . . . 0.0 112.311 -178.062 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.4 m -66.92 -49.49 65.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.022 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -46.93 -45.55 20.76 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.836 0.854 . . . . 0.0 111.481 -178.01 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -77.48 -19.59 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.794 -177.261 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.16 -22.75 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 121.064 1.756 . . . . 0.0 109.752 171.848 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.37 -43.03 2.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.421 -1.276 . . . . 0.0 114.041 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.39 -40.96 36.28 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.228 1.952 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.5 t -64.21 -47.66 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.2 t -56.88 -54.58 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -176.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 68.9 m-20 -60.7 -49.78 76.13 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.326 0.65 . . . . 0.0 110.894 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -53.85 -52.56 60.03 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -54.34 -43.76 63.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 2' ' ' GLU . . . -52.16 -46.27 65.38 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.324 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.68 8.43 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 175.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -39.9 -49.49 2.43 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.235 1.414 . . . . 0.0 112.789 -177.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.24 24.65 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -174.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -40.87 -46.62 2.79 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.133 1.773 . . . . 0.0 112.303 -177.595 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.19 -44.76 1.25 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.068 2.547 . . . . 0.0 113.4 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -140.22 -55.51 0.53 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.148 0.975 . . . . 0.0 112.832 179.051 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.697 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 46.3 tp -78.57 -169.13 1.59 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.72 -1.582 . . . . 0.0 114.322 -155.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.697 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 3.4 pttp -75.79 99.88 4.56 Favored 'General case' 0 N--CA 1.432 -1.354 1 N-CA-C 127.605 6.15 . . . . 0.0 127.605 -153.504 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 52.3 t -160.02 127.8 4.68 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 120.304 -1.498 . . . . 0.0 112.719 168.558 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.23 167.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.906 0.882 . . . . 0.0 109.081 171.022 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -136.39 109.31 7.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.352 0.661 . . . . 0.0 110.456 -177.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.47 118.29 31.14 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 122.986 0.514 . . . . 0.0 109.877 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -72.46 111.86 8.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -67.97 -33.71 75.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.615 1.166 . . . . 0.0 111.423 -173.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -67.84 -37.4 81.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.529 1.132 . . . . 0.0 109.322 -179.655 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.88 -27.82 39.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.504 1.521 . . . . 0.0 111.375 177.004 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 m -119.19 51.03 1.5 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.67 1.588 . . . . 0.0 114.014 -176.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -60.03 -36.25 90.16 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 124.326 3.351 . . . . 0.0 108.419 175.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -44.34 -72.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.405 1.882 . . . . 0.0 109.93 175.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.76 -50.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.593 1.157 . . . . 0.0 109.738 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.28 -40.92 62.39 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.282 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 m -75.84 -41.12 53.36 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.194 0.998 . . . . 0.0 110.731 179.315 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.26 -45.2 80.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.148 0.579 . . . . 0.0 109.758 178.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -79.11 -35.22 42.59 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.6 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.26 50.74 2.93 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.416 1.008 . . . . 0.0 112.53 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.18 -169.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.248 0.619 . . . . 0.0 110.032 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -158.8 -84.81 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.576 0.75 . . . . 0.0 109.096 177.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -57.57 153.84 12.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 110.351 178.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.525 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.1 pt -140.84 155.14 69.23 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.03 140.05 45.43 Favored 'Cis proline' 0 N--CA 1.453 -0.903 0 CA-C-N 120.252 1.126 . . . . 0.0 112.879 2.431 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 m -127.84 104.84 8.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 173.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.0 mt -101.61 102.6 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.661 1.584 . . . . 0.0 108.244 -173.06 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.6 mtt -102.26 151.62 22.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -112.76 130.03 67.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 171.835 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -121.37 148.73 43.97 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 175.411 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.61 153.88 13.3 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.731 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.18 35.98 80.22 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 118.058 -2.02 . . . . 0.0 108.172 -174.199 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.18 -53.2 1.43 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.58 1.562 . . . . 0.0 113.997 -175.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -79.24 165.84 22.8 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -172.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -80.97 152.8 27.81 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 127.137 2.175 . . . . 0.0 110.833 -178.246 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.8 t -138.46 -80.39 0.33 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.401 ' H ' HG12 ' A' ' 79' ' ' VAL . 30.5 mm-40 -72.09 149.5 44.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.773 0.321 . . . . 0.0 110.343 178.225 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.12 75.34 1.29 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.28 1.832 . . . . 0.0 106.72 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.0 mm -81.24 154.21 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.2 mt -138.02 147.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -175.357 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.39 175.1 48.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.608 0.623 . . . . 0.0 111.567 178.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.66 153.2 44.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.54 156.08 45.43 Favored Pre-proline 0 C--O 1.232 0.165 0 C-N-CA 123.484 0.714 . . . . 0.0 109.207 -178.272 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -73.88 143.97 33.92 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 N-CA-C 105.885 -2.39 . . . . 0.0 105.885 166.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -38.46 76.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.239 0.542 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.57 -52.66 28.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 m -58.86 -49.29 78.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.363 0.665 . . . . 0.0 110.065 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -54.21 -53.09 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.006 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.9 t -52.15 -56.73 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.533 0.733 . . . . 0.0 109.254 179.324 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -52.7 -45.87 67.08 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.264 0.554 . . . . 0.0 111.706 178.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.8 m -58.93 -38.95 80.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.156 -177.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -81.63 -36.2 14.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 119.026 0.83 . . . . 0.0 111.334 178.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -55.75 -35.11 65.84 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -46.48 -37.96 8.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.006 0.522 . . . . 0.0 110.704 171.284 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -102.88 14.48 31.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.089 2.156 . . . . 0.0 112.741 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.0 mt -157.59 96.61 1.53 Allowed 'General case' 0 C--N 1.338 0.104 0 C-N-CA 125.174 1.39 . . . . 0.0 108.383 177.222 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.089 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -69.83 -53.6 17.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 172.413 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.51 141.86 51.91 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.642 169.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.88 -165.41 31.57 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 176.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.83 141.69 48.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.54 166.08 23.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 122.316 1.055 . . . . 0.0 111.09 -178.52 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -141.5 169.31 17.84 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.163 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -39.33 -46.09 1.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.794 1.638 . . . . 0.0 111.986 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -57.38 -70.55 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.871 177.644 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.9 p -61.07 -38.2 85.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 112.256 -175.164 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -39.34 -46.17 1.55 Allowed 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 127.905 2.482 . . . . 0.0 111.107 178.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -42.65 -66.29 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 111.954 175.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -45.05 60.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.933 -174.624 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.4 t -70.42 -38.26 73.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.001 -171.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -108.69 -69.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.706 -174.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -54.51 -50.78 67.02 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.99 0.359 . . . . 0.0 111.148 -172.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -88.07 17.06 5.3 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.614 -178.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.17 154.21 37.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.12 1.327 . . . . 0.0 111.132 -178.127 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -86.71 -58.63 2.53 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.617 1.567 . . . . 0.0 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.07 161.03 72.33 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.719 1.208 . . . . 0.0 108.01 178.429 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.41 164.67 8.63 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.659 1.573 . . . . 0.0 109.697 173.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 t -145.88 115.83 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 110.98 -174.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tp -89.06 98.78 11.96 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.437 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.32 110.6 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 123.33 0.652 . . . . 0.0 110.549 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -89.11 115.31 26.55 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 57' ' ' LEU . 7.9 m-85 -80.05 111.39 16.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.788 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -131.11 -171.86 2.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.744 0.783 . . . . 0.0 111.035 -173.371 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.98 150.35 2.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 172.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.4 -42.26 69.31 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.281 1.987 . . . . 0.0 112.177 178.373 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -66.24 -21.09 66.28 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.077 -0.389 . . . . 0.0 111.757 178.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.0 t -76.26 83.45 3.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.615 -0.678 . . . . 0.0 111.345 -176.166 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.73 -57.18 2.89 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.697 -1.057 . . . . 0.0 113.599 173.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -20.53 67.25 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.977 1.785 . . . . 0.0 112.654 -179.658 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.2 m -82.06 -59.0 2.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.413 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -40.13 -53.0 2.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 127.569 2.347 . . . . 0.0 112.154 -178.219 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.93 -22.32 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.47 -33.78 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.347 1.059 . . . . 0.0 110.26 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.88 -43.39 3.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 127.311 2.244 . . . . 0.0 115.512 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -67.43 -36.25 20.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.822 1.681 . . . . 0.0 108.86 -179.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -40.2 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 127.166 2.186 . . . . 0.0 107.748 179.032 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.82 -47.77 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.39 -53.19 60.58 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.715 0.406 . . . . 0.0 111.692 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.31 -41.16 96.53 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.16 -0.962 . . . . 0.0 110.813 -179.206 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.98 -42.8 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.782 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' A' ' 54' ' ' CYS . . . -53.84 -46.84 71.33 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.52 36.83 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 176.527 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -47.35 -41.75 20.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.546 0.673 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -112.71 31.3 6.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.016 0.926 . . . . 0.0 112.192 -178.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -57.05 154.71 9.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.523 0.678 . . . . 0.0 110.49 -178.046 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 71.64 -48.45 0.68 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 128.093 2.557 . . . . 0.0 112.028 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -78.37 -13.17 59.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.206 0.457 . . . . 0.0 110.742 179.134 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.62 119.7 6.28 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -80.97 167.73 19.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.409 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . 45.6 t -146.9 147.5 30.86 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.93 161.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.82 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -125.81 110.61 13.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.435 HD12 ' CD2' ' A' ' 26' ' ' PHE . 2.9 tm? -89.56 112.43 23.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.38 1.472 . . . . 0.0 109.242 -178.06 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -71.89 107.98 4.93 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.0 m -60.58 -43.18 97.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.147 1.779 . . . . 0.0 111.665 -174.153 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.21 -33.77 75.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.901 0.881 . . . . 0.0 110.506 -177.341 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.8 -27.42 36.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.566 1.146 . . . . 0.0 110.425 175.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' HD11 ' A' ' 57' ' ' LEU . 1.4 m -122.86 52.81 4.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.914 1.686 . . . . 0.0 113.492 -176.33 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.23 -31.34 63.97 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.403 3.402 . . . . 0.0 107.985 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -50.43 -60.12 3.32 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.369 1.068 . . . . 0.0 109.457 177.246 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.59 -55.41 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.8 0.84 . . . . 0.0 109.374 -178.757 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.43 -45.38 36.19 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.933 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -65.59 -50.23 65.88 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.13 0.572 . . . . 0.0 110.715 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -56.61 -44.06 80.78 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.752 0.421 . . . . 0.0 111.305 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -79.29 -32.22 43.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.607 -0.235 . . . . 0.0 111.579 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.49 60.8 0.98 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.692 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.5 mt -129.11 152.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.274 1.43 . . . . 0.0 107.77 -178.112 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -148.67 -71.08 0.21 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.19 151.11 41.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 pt -146.27 154.77 50.09 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -179.097 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.74 151.23 74.86 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.656 1.27 . . . . 0.0 113.825 2.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -156.72 100.37 1.92 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 tt -100.7 123.1 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -178.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 mtt -106.02 144.19 33.08 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.413 1.085 . . . . 0.0 110.066 -177.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.9 t -95.87 101.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -95.89 156.36 16.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.178 179.048 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.31 -154.9 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 171.325 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.56 95.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.301 1.429 . . . . 0.0 114.261 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.02 -76.83 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.919 0.771 . . . . 0.0 113.913 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -79.88 169.71 17.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.097 0.951 . . . . 0.0 113.429 -171.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.59 157.41 17.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.255 171.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 15.9 t -109.36 -60.45 1.77 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.832 1.253 . . . . 0.0 110.113 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -132.86 179.08 6.39 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.602 1.561 . . . . 0.0 109.097 -178.729 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -160.34 163.78 33.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.979 0.512 . . . . 0.0 110.055 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 mt -137.18 146.53 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.272 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.8 mp -135.71 151.1 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.269 1.428 . . . . 0.0 108.52 -174.146 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.99 152.78 10.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.2 67.92 2.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.707 . . . . 0.0 110.77 -179.306 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.87 144.3 63.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.75 155.65 13.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.593 2.195 . . . . 0.0 113.896 -178.056 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -49.28 -43.76 43.37 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.064 0.946 . . . . 0.0 111.323 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.32 65.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 110.625 179.273 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -45.91 86.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.374 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.05 -54.68 21.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -50.3 -57.45 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 124.442 1.097 . . . . 0.0 110.187 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -54.73 -47.33 73.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.623 0.249 . . . . 0.0 111.044 -178.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.9 m -64.3 -41.31 96.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.517 0.327 . . . . 0.0 110.86 -179.212 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.2 t -60.2 -50.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -57.43 -50.77 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.289 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -48.01 -50.19 28.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.699 0.8 . . . . 0.0 109.976 176.6 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -75.62 -22.36 56.92 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -153.32 83.88 1.19 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.404 0.682 . . . . 0.0 110.857 -166.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.284 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.61 -169.51 46.04 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.97 141.34 52.01 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.66 165.61 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.884 0.85 . . . . 0.0 110.565 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -146.69 176.84 9.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.819 2.047 . . . . 0.0 105.866 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -39.29 -57.97 1.28 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.849 0.86 . . . . 0.0 112.504 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.67 -58.61 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.822 1.249 . . . . 0.0 112.015 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -67.14 -35.66 80.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.347 0.659 . . . . 0.0 111.645 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -46.12 -47.28 17.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.531 1.533 . . . . 0.0 110.996 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -49.42 -55.28 13.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.107 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.5 -62.02 1.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.933 0.893 . . . . 0.0 111.653 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.83 -27.46 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 125.715 1.606 . . . . 0.0 113.077 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.46 -74.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.567 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.54 -42.31 70.76 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.048 1.295 . . . . 0.0 113.17 -172.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.78 17.07 11.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.727 0.811 . . . . 0.0 111.958 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.9 p -72.99 149.69 43.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.44 1.018 . . . . 0.0 111.892 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.5 p -92.51 -58.77 2.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.43 1.492 . . . . 0.0 108.992 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.67 162.91 63.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.3 1.44 . . . . 0.0 109.058 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.07 164.32 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.518 2.145 . . . . 0.0 112.383 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 t -145.48 144.13 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.66 97.41 5.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.06 119.52 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -94.2 111.67 23.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 57' ' ' LEU . 26.5 m-85 -78.49 109.92 13.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -123.84 -171.42 2.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.826 0.85 . . . . 0.0 111.157 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.7 151.4 2.84 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.64 1.176 . . . . 0.0 108.137 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.51 -33.47 98.04 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.457 2.105 . . . . 0.0 112.759 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -74.47 -14.15 60.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.528 -0.732 . . . . 0.0 111.018 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.45 82.8 8.13 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.123 -0.986 . . . . 0.0 111.304 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.27 -58.03 2.96 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.732 1.158 . . . . 0.0 113.864 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.71 -40.37 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 CA-C-N 119.748 1.774 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -58.53 -52.08 67.15 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -55.95 -48.5 75.66 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.86 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -74.48 -22.26 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.884 0.765 . . . . 0.0 111.741 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.514 HG22 HG23 ' A' ' 41' ' ' VAL . 18.4 mm -81.69 -34.51 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.496 1.043 . . . . 0.0 110.805 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.05 -45.44 4.66 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.207 1.803 . . . . 0.0 115.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -62.52 -40.48 38.29 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.983 1.789 . . . . 0.0 109.821 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.91 -48.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.716 1.207 . . . . 0.0 107.762 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 37' ' ' ILE . 76.2 t -52.09 -51.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.905 0.882 . . . . 0.0 108.823 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.0 -57.78 10.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.08 -43.68 87.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.882 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.26 -49.4 76.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.26 72.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.447 -0.783 . . . . 0.0 111.668 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -48.99 83.24 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -55.19 -47.86 74.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -83.53 59.11 4.92 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.309 1.528 . . . . 0.0 111.379 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 155.35 13.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.925 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 68.51 -55.1 0.53 Allowed 'General case' 0 C--N 1.338 0.099 0 C-N-CA 129.024 2.929 . . . . 0.0 113.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -82.84 -53.16 6.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -81.1 99.28 8.42 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.671 -171.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -79.66 87.38 5.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.24 152.36 32.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.856 -1.152 . . . . 0.0 108.805 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.84 166.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 121.752 -0.592 . . . . 0.0 109.745 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -130.31 121.33 25.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.63 1.172 . . . . 0.0 109.381 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.559 HD23 ' CE2' ' A' ' 26' ' ' PHE . 42.6 tp -108.43 118.9 37.97 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.859 1.264 . . . . 0.0 110.085 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -73.87 112.98 10.5 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 m -69.74 -28.54 65.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.374 1.47 . . . . 0.0 111.498 -173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.6 -40.64 48.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.174 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -83.01 -27.23 30.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.28 2.232 . . . . 0.0 112.162 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.8 m -132.34 62.15 61.49 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.216 1.406 . . . . 0.0 109.718 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.03 -33.65 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 1 C-N-CA 125.509 4.139 . . . . 0.0 109.97 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -30.07 -73.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.332 2.253 . . . . 0.0 111.964 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -35.4 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.328 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.21 76.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -68.2 -47.23 68.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.146 0.978 . . . . 0.0 109.554 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -55.9 -43.34 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.69 -34.81 45.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.018 0.527 . . . . 0.0 111.247 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 56.35 1.07 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.4 mt -122.02 146.36 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.84 1.656 . . . . 0.0 107.638 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -149.35 -64.23 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.26 144.87 56.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 pt -143.54 156.31 60.15 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.11 141.61 57.54 Favored 'Cis proline' 0 N--CA 1.454 -0.812 0 CA-C-N 120.007 1.038 . . . . 0.0 113.528 3.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -133.91 101.25 5.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.11 100.54 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.374 1.47 . . . . 0.0 107.646 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtt -88.25 148.1 24.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.54 139.43 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 C-N-CA 125.659 1.584 . . . . 0.0 107.671 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -129.21 144.59 51.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.411 ' H ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -101.41 -27.03 13.38 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.318 0.386 . . . . 0.0 111.22 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.7 87.95 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 -63.15 2.8 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.554 0.597 . . . . 0.0 112.178 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -79.88 154.6 28.24 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.608 0.763 . . . . 0.0 110.701 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -71.27 158.05 37.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.51 1.124 . . . . 0.0 109.72 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.96 -58.18 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.714 1.206 . . . . 0.0 110.176 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -141.79 177.68 8.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.695 1.198 . . . . 0.0 110.112 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.7 m -156.38 132.74 10.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.282 1.033 . . . . 0.0 109.546 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.3 mt -109.46 144.26 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -130.19 142.58 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 173.61 47.26 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.792 0.71 . . . . 0.0 112.49 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.26 156.1 35.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.797 0.439 . . . . 0.0 109.92 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.66 156.67 38.86 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.028 0.931 . . . . 0.0 109.059 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -82.99 139.35 9.56 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.174 2.582 . . . . 0.0 107.171 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -48.58 -45.27 37.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 0.0 112.672 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -45.66 67.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.985 0.421 . . . . 0.0 110.626 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -65.15 -45.98 82.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.1 mt -56.2 -52.42 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 t -48.86 -58.51 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 124.609 1.163 . . . . 0.0 109.429 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.14 -47.46 83.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.494 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.0 m -56.06 -43.4 77.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.485 1.114 . . . . 0.0 110.11 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.94 -52.04 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 121.387 -0.82 . . . . 0.0 109.095 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -52.63 -47.34 67.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.62 0.768 . . . . 0.0 112.745 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.67 -23.78 65.09 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.944 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 . . . . . 0 CA--C 1.534 0.348 0 CA-C-N 118.809 0.731 . . . . 0.0 109.686 179.002 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.5 167.37 50.14 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.781 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.06 128.21 56.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.68 165.44 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 122.482 1.134 . . . . 0.0 111.604 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -142.89 172.14 13.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.784 2.434 . . . . 0.0 106.023 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -39.26 -49.87 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.99 1.716 . . . . 0.0 112.371 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.57 -74.08 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.227 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 p -50.31 -42.08 52.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.591 1.156 . . . . 0.0 111.826 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -39.93 -42.84 1.41 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.679 1.992 . . . . 0.0 111.15 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -61.88 -58.84 6.39 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 111.76 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -62.09 -32.74 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.323 0.649 . . . . 0.0 111.403 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -93.12 -30.24 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.898 0.879 . . . . 0.0 113.255 -170.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.95 -72.43 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 124.626 1.17 . . . . 0.0 109.828 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.4 mt -46.98 -55.84 7.43 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.981 0.912 . . . . 0.0 111.584 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.49 7.97 8.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 113.175 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -71.29 143.14 50.44 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 120.027 1.285 . . . . 0.0 110.615 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -81.87 -60.5 2.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.652 1.181 . . . . 0.0 108.73 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.04 162.43 64.55 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.186 0.995 . . . . 0.0 109.484 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.02 160.31 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.901 2.4 . . . . 0.0 113.713 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 t -143.06 147.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.174 1.39 . . . . 0.0 108.417 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.36 110.84 13.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.06 139.85 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -111.72 120.46 42.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.21 113.89 17.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -127.27 -172.15 2.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.764 0.793 . . . . 0.0 110.279 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.45 152.52 4.02 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -52.76 -42.87 60.21 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.579 2.186 . . . . 0.0 112.614 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.518 ' CH2' HD11 ' A' ' 74' ' ' ILE . 26.4 p-90 -69.07 -12.81 62.01 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.768 -0.582 . . . . 0.0 112.269 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -77.82 80.78 4.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.797 -1.189 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.93 -56.49 3.78 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.354 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.92 -29.93 88.06 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.945 1.763 . . . . 0.0 112.414 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.26 -48.34 57.27 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -48.32 50.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.657 0.783 . . . . 0.0 111.647 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.25 -20.65 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.877 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.4 pt -90.02 -28.88 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 121.126 1.784 . . . . 0.0 110.264 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.43 -47.37 4.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.36 -39.4 57.16 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.332 2.021 . . . . 0.0 110.216 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.85 -46.34 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.08 -42.18 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.76 -65.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.421 0.688 . . . . 0.0 111.927 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -42.35 78.13 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.275 1.398 . . . . 0.0 111.727 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mt -62.77 -26.23 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.553 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.93 90.82 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.7 1.136 . . . . 0.0 109.016 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -47.49 90.83 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -58.35 -50.66 72.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -97.25 33.19 2.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.387 0.675 . . . . 0.0 112.349 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -60.27 168.83 1.85 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.607 0.718 . . . . 0.0 111.307 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 71.9 -58.55 0.58 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 127.377 2.271 . . . . 0.0 111.743 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.4 -50.15 11.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.866 -174.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.9 105.84 16.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.105 0.562 . . . . 0.0 110.108 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.15 98.96 6.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.0 t -79.32 137.34 37.3 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.559 -0.713 . . . . 0.0 110.47 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.16 163.71 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.524 0.678 . . . . 0.0 112.195 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -133.86 118.53 18.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.406 1.482 . . . . 0.0 109.595 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tp -99.5 124.17 44.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.63 109.05 7.79 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -67.39 -36.82 82.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.008 1.323 . . . . 0.0 111.243 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -66.4 -38.34 87.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.37 1.068 . . . . 0.0 110.106 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.83 -25.43 32.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.162 1.785 . . . . 0.0 111.363 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.2 t -122.6 52.73 4.32 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.461 1.504 . . . . 0.0 112.636 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.29 -25.94 71.79 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.135 3.224 . . . . 0.0 110.45 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -54.62 -63.26 1.21 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.702 0.801 . . . . 0.0 108.911 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.75 -51.23 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.794 0.838 . . . . 0.0 109.061 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.86 -47.99 21.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.228 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -67.37 -48.83 66.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.533 0.733 . . . . 0.0 110.797 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.55 -46.98 73.73 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.539 0.736 . . . . 0.0 111.203 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -79.56 -31.17 41.9 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.162 0.585 . . . . 0.0 111.166 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.84 52.1 3.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mm -73.54 84.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 122.192 0.996 . . . . 0.0 109.345 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -78.42 76.38 4.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m 94.31 166.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.391 2.676 . . . . 0.0 110.383 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.518 HD11 ' CH2' ' A' ' 30' ' ' TRP . 28.9 pt -136.21 153.68 76.75 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.169 0.988 . . . . 0.0 108.544 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.06 145.83 76.44 Favored 'Cis proline' 0 N--CA 1.453 -0.858 0 CA-C-N 120.31 1.146 . . . . 0.0 112.772 1.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 m -139.45 113.17 8.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.58 138.16 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 mtt -129.85 143.89 51.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.5 t -107.76 139.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 126.045 1.738 . . . . 0.0 107.065 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -126.62 134.48 50.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.453 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -100.64 -26.67 13.73 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.69 67.95 0.25 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.35 -56.89 3.71 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.89 157.66 26.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.844 0.857 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -65.76 160.63 22.54 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.87 1.668 . . . . 0.0 111.482 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.0 t -129.61 -66.23 0.81 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.471 1.508 . . . . 0.0 109.541 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -138.27 172.72 12.49 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.818 1.247 . . . . 0.0 110.007 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.6 t -160.47 153.49 21.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.041 0.936 . . . . 0.0 109.819 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.4 mm -134.54 146.24 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.76 142.16 42.54 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 126.379 1.872 . . . . 0.0 108.25 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.92 155.05 16.69 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.316 0.484 . . . . 0.0 111.998 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.95 52.37 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.549 1.14 . . . . 0.0 112.588 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.7 145.69 63.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.44 147.47 68.33 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.24 1.293 . . . . 0.0 111.426 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -58.1 -34.68 70.45 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.59 55.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.247 0.93 . . . . 0.0 110.992 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -49.48 77.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.237 1.015 . . . . 0.0 109.007 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 mm -58.26 -49.68 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.693 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.39 -53.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.45 1.1 . . . . 0.0 109.21 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.09 -48.89 72.94 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.3 m -60.8 -36.74 79.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.233 0.613 . . . . 0.0 111.441 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.81 -53.71 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 121.206 -0.934 . . . . 0.0 108.826 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -53.44 -42.24 66.92 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.412 1.085 . . . . 0.0 110.86 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -49.83 -45.89 50.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.309 0.644 . . . . 0.0 110.404 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.089 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 110.774 -0.084 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.1 -178.47 44.68 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.5 136.86 54.64 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.86 166.7 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.635 1.207 . . . . 0.0 112.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -149.15 172.71 14.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.298 2.639 . . . . 0.0 105.269 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -38.01 -50.12 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.85 2.06 . . . . 0.0 111.687 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.34 -72.22 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 111.572 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -58.64 -33.95 70.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 112.292 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -42.57 -44.64 4.25 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.603 1.961 . . . . 0.0 111.051 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -54.05 -55.61 25.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.504 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.33 -46.11 56.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.344 0.658 . . . . 0.0 111.858 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -85.07 -19.48 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.884 1.274 . . . . 0.0 114.085 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.6 -51.64 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.611 1.096 . . . . 0.0 112.044 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.32 -52.07 25.5 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.938 -0.476 . . . . 0.0 111.543 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -79.12 -9.12 59.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 m -55.73 135.4 51.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.636 1.174 . . . . 0.0 112.852 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 p -79.87 -62.03 1.81 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.805 1.242 . . . . 0.0 109.725 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.93 157.25 76.53 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -54.42 157.62 11.47 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.711 2.274 . . . . 0.0 113.931 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.27 118.45 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.547 1.539 . . . . 0.0 110.676 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.55 91.64 7.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.67 1.188 . . . . 0.0 108.417 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 p -99.27 125.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -99.41 121.31 40.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.57 0.748 . . . . 0.0 109.199 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.425 ' CD2' HD13 ' A' ' 71' ' ' ILE . 6.1 m-85 -79.77 116.51 19.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -133.31 -170.67 2.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.915 0.486 . . . . 0.0 110.662 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.43 151.08 4.35 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -54.58 -40.05 85.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.71 2.273 . . . . 0.0 113.147 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -68.7 -16.62 63.88 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.451 0.568 . . . . 0.0 111.348 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -77.61 79.55 4.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.31 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.57 -57.34 4.53 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.66 -34.55 15.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.423 3.415 . . . . 0.0 114.244 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.01 -54.41 6.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.97 0.891 . . . . 0.0 108.638 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.9 tpt85 -47.42 -49.11 25.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.197 0.999 . . . . 0.0 111.381 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.31 -26.58 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.776 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 pt -87.75 -26.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.194 1.816 . . . . 0.0 110.514 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -46.18 4.05 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.75 -40.98 26.32 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.103 1.868 . . . . 0.0 110.378 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.32 -52.06 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.116 1.366 . . . . 0.0 107.879 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.16 -47.21 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 0.0 108.868 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -68.09 -55.5 12.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -60.59 -32.83 71.92 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.491 0.587 . . . . 0.0 109.483 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.61 -49.27 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.09 -33.87 67.74 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.85 -0.531 . . . . 0.0 110.537 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.05 -56.26 26.32 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.1 -41.45 62.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.078 0.439 . . . . 0.0 110.679 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -98.32 25.97 5.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.272 1.029 . . . . 0.0 113.304 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 169.3 2.0 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.446 0.641 . . . . 0.0 111.97 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 73.82 -53.71 0.69 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.784 2.033 . . . . 0.0 111.28 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -78.44 -54.97 5.6 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.61 114.21 27.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.5 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -78.42 163.33 25.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.8 t -145.56 146.13 31.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.42 168.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.482 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -136.0 107.42 6.88 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.685 1.194 . . . . 0.0 109.611 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -87.57 117.16 26.18 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -73.37 104.15 4.28 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.628 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.7 m -56.37 -46.74 79.9 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.309 1.844 . . . . 0.0 112.023 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.9 -36.7 82.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.26 1.824 . . . . 0.0 110.479 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -84.65 -26.01 28.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.459 1.904 . . . . 0.0 111.116 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -122.01 54.61 5.34 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.855 1.662 . . . . 0.0 111.905 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.6 -24.84 76.85 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 124.098 3.198 . . . . 0.0 111.02 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -51.83 -71.66 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.046 0.938 . . . . 0.0 109.089 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -53.48 -48.34 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.648 1.179 . . . . 0.0 109.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.29 -51.32 46.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.855 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -70.66 -43.99 67.99 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.573 0.749 . . . . 0.0 110.878 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.1 -47.67 68.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.564 0.745 . . . . 0.0 110.303 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -79.35 -31.09 42.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.95 48.08 5.93 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' A' ' 26' ' ' PHE . 2.6 pt -74.38 97.96 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.072 0.939 . . . . 0.0 109.894 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 69.08 4.68 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 109.208 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t 101.6 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 129.48 3.112 . . . . 0.0 109.506 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -143.59 161.01 48.9 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.3 1.84 . . . . 0.0 109.318 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -68.57 157.01 88.94 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 120.697 1.285 . . . . 0.0 113.054 2.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -152.07 102.59 2.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -79.86 131.96 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.7 mtt -125.54 136.79 53.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -96.02 101.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -89.01 148.62 23.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 33.94 1.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.625 0.578 . . . . 0.0 110.728 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 105.57 3.0 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.69 -70.93 0.9 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.524 1.059 . . . . 0.0 113.025 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -101.53 169.84 8.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.055 0.931 . . . . 0.0 112.189 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -84.09 165.09 18.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.334 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.79 -58.88 1.92 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.16 1.384 . . . . 0.0 108.911 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -133.18 176.29 8.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.112 1.365 . . . . 0.0 109.434 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 t -158.76 160.89 36.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.083 0.553 . . . . 0.0 110.706 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.3 mt -138.15 122.92 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.03 139.73 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.988 0.915 . . . . 0.0 109.404 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.0 153.92 14.76 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 121.47 0.483 . . . . 0.0 113.133 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.52 73.69 1.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.991 -0.711 . . . . 0.0 111.307 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.74 148.18 72.26 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.96 157.07 11.25 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.03 2.487 . . . . 0.0 113.948 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -51.94 -45.78 64.48 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.68 0.792 . . . . 0.0 111.646 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.66 64.58 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.277 0.631 . . . . 0.0 110.355 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -48.13 78.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.41 -57.08 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.8 t -48.96 -61.27 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.994 1.318 . . . . 0.0 109.872 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -52.8 -46.49 67.68 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.344 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.8 m -63.18 -44.54 95.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.622 0.369 . . . . 0.0 110.919 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.23 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 121.207 -0.933 . . . . 0.0 108.882 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -55.58 -54.05 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -47.3 -49.79 23.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.45 1.1 . . . . 0.0 110.166 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.613 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.28 -171.94 25.03 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 169.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 141.51 45.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -139.87 173.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 122.801 1.286 . . . . 0.0 110.895 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.98 171.08 18.38 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.323 2.649 . . . . 0.0 104.627 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -39.17 -53.64 1.84 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 112.832 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -52.78 63.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.312 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -73.58 -35.54 65.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.273 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -39.43 -48.16 1.91 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.601 2.36 . . . . 0.0 110.535 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -42.62 -70.44 0.11 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.169 0.988 . . . . 0.0 112.206 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.6 -47.68 80.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.533 1.133 . . . . 0.0 111.602 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.68 -37.18 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.521 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.17 -65.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.056 0.943 . . . . 0.0 110.99 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -62.8 -59.43 4.87 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -172.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.49 41.39 0.47 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.879 -0.513 . . . . 0.0 111.66 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -90.31 168.86 11.58 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -97.18 -71.65 0.67 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.542 1.537 . . . . 0.0 107.904 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.21 157.63 75.39 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.81 159.59 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.0 1.8 . . . . 0.0 114.961 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.18 127.88 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.942 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 23' ' ' LEU . 5.5 tt -103.34 104.82 14.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.031 1.732 . . . . 0.0 107.522 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.02 126.47 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.93 115.88 31.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -79.1 111.74 15.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -128.21 -174.32 3.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 122.111 0.958 . . . . 0.0 110.015 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.7 140.01 2.11 Favored Pre-proline 0 N--CA 1.451 -0.38 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -39.2 -54.47 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.362 2.708 . . . . 0.0 117.393 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -57.79 -20.89 38.73 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.819 0.736 . . . . 0.0 112.549 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 85.91 0.83 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.367 0.667 . . . . 0.0 112.13 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.2 -55.04 4.42 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.322 0.963 . . . . 0.0 113.816 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.01 -36.06 98.31 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.2 1.933 . . . . 0.0 110.959 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -66.44 -49.34 67.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -55.4 -46.31 76.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.456 0.302 . . . . 0.0 111.094 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.88 -30.4 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.128 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 tp -84.69 -35.97 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 120.619 1.554 . . . . 0.0 112.437 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.44 -49.16 4.94 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -60.32 -34.27 93.73 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.835 2.356 . . . . 0.0 110.766 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.84 -47.95 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.366 1.066 . . . . 0.0 108.379 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.58 -51.17 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -57.45 -55.28 36.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.404 . . . . 0.0 110.994 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.37 -50.84 72.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.739 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -51.13 -52.34 18.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.32 73.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.72 -41.21 97.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -66.85 -50.84 61.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -83.71 59.94 5.45 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.456 1.122 . . . . 0.0 109.878 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -46.1 -67.36 0.29 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.965 2.106 . . . . 0.0 111.988 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.92 -57.96 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.097 1.359 . . . . 0.0 114.202 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -78.9 -54.59 5.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.36 117.62 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.85 -163.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -91.34 116.37 28.79 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.754 1.221 . . . . 0.0 110.55 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.3 t -78.47 142.35 37.56 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.329 -0.857 . . . . 0.0 109.665 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.2 164.3 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -137.22 115.82 12.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.073 0.949 . . . . 0.0 109.58 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.45 118.23 34.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.87 0.868 . . . . 0.0 109.508 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -71.81 107.33 4.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.9 m -59.33 -43.06 92.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.092 1.757 . . . . 0.0 111.545 -173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.63 -35.87 82.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.909 0.884 . . . . 0.0 110.316 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.81 -24.71 30.89 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.425 1.49 . . . . 0.0 111.514 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 49.74 2.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.507 1.923 . . . . 0.0 113.23 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.13 -25.56 37.33 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.629 3.552 . . . . 0.0 109.713 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -51.26 -54.72 23.21 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.031 0.932 . . . . 0.0 109.189 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.9 -57.11 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.753 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.39 -45.1 65.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.427 0.691 . . . . 0.0 112.168 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -65.93 -48.74 70.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.996 0.519 . . . . 0.0 109.927 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.91 -38.12 69.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.529 0.332 . . . . 0.0 110.609 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.62 -23.49 45.87 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.14 40.11 11.93 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.203 0.906 . . . . 0.0 111.634 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.03 169.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.494 1.118 . . . . 0.0 109.089 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -154.25 -58.39 0.12 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.893 0.877 . . . . 0.0 109.386 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 147.93 30.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.38 155.54 60.97 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.65 142.32 69.41 Favored 'Cis proline' 0 N--CA 1.453 -0.855 0 CA-C-N 120.134 1.084 . . . . 0.0 112.322 1.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -137.05 102.48 4.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.03 134.71 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 33.5 mtt -128.33 123.52 34.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.5 t -95.88 141.54 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -127.1 158.3 37.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.332 1.453 . . . . 0.0 107.913 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 42.62 1.18 Allowed 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.335 1.022 . . . . 0.0 110.726 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.2 97.17 2.28 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.49 -73.19 0.77 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.428 0.537 . . . . 0.0 112.213 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.84 160.54 26.06 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.315 1.055 . . . . 0.0 111.847 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.95 143.75 28.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.512 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.2 t -88.38 -70.29 0.65 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.283 1.033 . . . . 0.0 108.289 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -150.79 -175.37 5.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.588 1.555 . . . . 0.0 109.256 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -143.73 162.42 36.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.916 1.286 . . . . 0.0 109.719 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.3 mt -139.24 140.78 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.33 138.72 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.78 153.72 25.95 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 121.888 0.716 . . . . 0.0 112.116 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.97 78.01 3.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.246 0.618 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -78.28 152.25 78.76 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.26 153.23 22.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.592 2.194 . . . . 0.0 113.995 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -46.6 -50.25 17.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.278 1.831 . . . . 0.0 110.654 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.2 -47.25 75.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.933 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -62.54 -46.21 89.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.568 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.1 mt -54.68 -55.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 t -52.33 -59.03 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.218 0.607 . . . . 0.0 110.042 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -49.47 -52.14 31.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.436 0.694 . . . . 0.0 110.338 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 45.4 m -61.7 -45.37 94.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.214 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.06 -56.24 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 118.739 0.699 . . . . 0.0 109.583 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -62.72 -43.76 97.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.932 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -51.24 -54.4 26.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.258 0.623 . . . . 0.0 109.552 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.649 -176.095 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.03 157.1 36.07 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.987 1.28 . . . . 0.0 113.285 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.3 114.85 20.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.14 164.54 20.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 122.806 1.289 . . . . 0.0 110.13 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -143.21 174.75 10.43 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.348 1.859 . . . . 0.0 106.691 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -53.41 2.1 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.957 1.303 . . . . 0.0 113.229 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.94 -59.65 2.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.136 0.974 . . . . 0.0 111.46 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -59.11 -34.43 72.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.563 0.745 . . . . 0.0 111.682 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -45.42 -48.29 13.67 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 126.039 1.736 . . . . 0.0 110.541 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -55.15 -53.64 53.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.632 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -53.64 54.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 0.0 112.347 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -75.15 -39.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.875 1.27 . . . . 0.0 113.302 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.61 -66.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.18 0.992 . . . . 0.0 110.903 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.06 -59.2 5.73 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 121.217 0.532 . . . . 0.0 110.877 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -78.87 40.55 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.355 0.662 . . . . 0.0 111.227 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.1 t -90.29 -169.44 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.834 0.854 . . . . 0.0 109.328 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -131.58 -66.14 0.73 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.191 2.196 . . . . 0.0 106.71 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.86 157.0 79.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.02 161.03 7.03 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.391 2.061 . . . . 0.0 112.617 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.28 139.32 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -114.11 117.15 30.44 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.77 115.94 51.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -90.3 111.95 23.33 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.596 ' CD2' HD12 ' A' ' 57' ' ' LEU . 25.8 m-85 -78.76 112.64 16.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -125.36 -173.84 2.92 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.096 0.951 . . . . 0.0 110.265 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.72 152.49 4.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -55.33 -32.02 79.46 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.393 2.062 . . . . 0.0 113.544 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.419 ' CH2' HD11 ' A' ' 74' ' ' ILE . 38.1 p-90 -78.98 -6.42 56.26 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.3 0.955 . . . . 0.0 111.737 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.17 88.22 6.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.827 -1.171 . . . . 0.0 111.192 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.11 -63.52 0.91 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.639 1.114 . . . . 0.0 113.706 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.36 -47.24 23.07 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.959 2.439 . . . . 0.0 112.63 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 77.7 m -54.27 -44.43 71.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.261 0.624 . . . . 0.0 109.854 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -54.76 -50.11 69.22 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -81.94 -19.68 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.594 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 41' ' ' VAL . 41.2 mt -78.78 -38.88 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.842 0.857 . . . . 0.0 109.224 175.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.85 -49.26 5.72 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.893 2.077 . . . . 0.0 115.553 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.83 -37.24 79.4 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.345 2.03 . . . . 0.0 110.109 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.48 -43.65 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 37' ' ' ILE . 29.7 t -55.67 -45.38 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -56.43 -63.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.557 0.743 . . . . 0.0 109.831 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.92 -37.55 76.93 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.684 0.675 . . . . 0.0 112.04 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -52.25 -36.44 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.632 0.773 . . . . 0.0 110.01 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.59 -39.2 76.27 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.333 0.515 . . . . 0.0 110.988 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.14 -50.4 34.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -53.36 -44.5 68.59 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -115.12 37.43 3.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.656 0.782 . . . . 0.0 112.803 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.98 162.2 2.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.906 0.882 . . . . 0.0 111.176 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 72.77 -61.81 0.49 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.314 2.245 . . . . 0.0 111.353 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -78.0 -32.08 51.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -170.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 tp -125.38 102.9 7.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.88 94.86 5.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.43 132.2 37.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 118.589 -0.719 . . . . 0.0 109.317 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.11 176.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.022 0.828 . . . . 0.0 111.793 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -131.13 122.93 27.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.723 2.009 . . . . 0.0 110.943 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.596 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.0 tm? -104.31 120.15 40.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.607 1.563 . . . . 0.0 109.818 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -74.89 107.61 7.09 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 m -66.76 -33.66 76.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.491 1.516 . . . . 0.0 111.427 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.29 -38.92 78.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.58 -27.85 31.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.762 2.025 . . . . 0.0 111.519 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 57' ' ' LEU . 1.5 m -119.84 52.28 2.16 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.579 1.552 . . . . 0.0 112.431 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -65.98 -30.08 48.48 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 125.49 4.127 . . . . 0.0 109.747 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.83 -62.17 2.07 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -55.73 -47.06 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.388 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.3 -47.42 55.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.194 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -65.74 -46.05 80.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.161 0.585 . . . . 0.0 110.515 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -54.45 -45.8 73.18 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.978 0.511 . . . . 0.0 110.638 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -79.48 -30.93 42.26 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.21 43.29 3.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 123.915 0.769 . . . . 0.0 111.22 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.38 88.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -77.29 -23.24 51.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.2 p -157.24 175.08 14.5 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.419 HD11 ' CH2' ' A' ' 30' ' ' TRP . 21.1 pt -146.62 154.4 48.24 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.08 133.94 26.37 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 CA-C-N 120.92 1.364 . . . . 0.0 113.445 1.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -139.98 104.83 4.95 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.571 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.0 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.78 153.27 34.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.74 133.15 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.218 1.007 . . . . 0.0 108.669 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -128.81 141.98 51.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 133.77 18.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.53 41.75 98.85 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -172.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.19 -47.47 2.63 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 124.451 1.024 . . . . 0.0 114.075 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -79.62 157.26 27.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.044 0.938 . . . . 0.0 111.964 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -88.24 156.07 19.41 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 127.296 2.238 . . . . 0.0 112.83 -172.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.83 -80.28 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.665 0.386 . . . . 0.0 111.626 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -74.71 152.84 39.07 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.107 0.48 . . . . 0.0 111.99 -170.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.7 m -132.94 110.88 10.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.969 2.508 . . . . 0.0 106.005 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.47 123.86 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -78.83 146.85 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.93 -137.72 0.69 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 71.53 -46.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.945 1.298 . . . . 0.0 110.687 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.08 148.49 75.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.18 68.75 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.526 1.484 . . . . 0.0 111.696 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -50.62 -37.41 40.22 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.227 1.011 . . . . 0.0 111.27 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.55 -41.73 21.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.508 0.595 . . . . 0.0 111.192 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -47.21 84.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.708 0.803 . . . . 0.0 108.869 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 mt -63.27 -40.29 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.825 1.25 . . . . 0.0 110.072 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.8 t -57.89 -58.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.921 1.288 . . . . 0.0 108.143 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.01 -46.63 68.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.233 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 m -60.39 -51.98 67.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.189 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.77 -44.15 93.18 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.34 -0.85 . . . . 0.0 110.854 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -50.46 -39.73 48.76 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.869 0.868 . . . . 0.0 111.558 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -59.64 -29.25 67.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.294 -0.254 . . . . 0.0 111.399 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 CA--C 1.529 0.156 0 C-N-CA 123.691 0.797 . . . . 0.0 109.995 179.225 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.88 179.68 44.27 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.33 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.67 137.46 54.45 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.428 ' CG1' HG11 ' A' ' 14' ' ' VAL . 5.7 m -130.14 164.02 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 118.972 0.806 . . . . 0.0 111.158 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.02 169.9 17.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 173.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -38.92 -45.26 1.16 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.352 1.861 . . . . 0.0 112.41 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.09 -74.14 0.12 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.028 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -48.81 -38.9 23.48 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.499 1.12 . . . . 0.0 111.564 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -38.95 -47.36 1.44 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.364 2.266 . . . . 0.0 110.591 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -48.3 -64.67 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.96 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.08 -38.55 75.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.126 1.37 . . . . 0.0 111.911 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.775 HG13 HG23 ' A' ' 15' ' ' VAL . 3.7 p -83.0 -47.86 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.293 1.037 . . . . 0.0 113.424 -172.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.775 HG23 HG13 ' A' ' 14' ' ' VAL . 57.3 t -95.85 -57.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.726 0.81 . . . . 0.0 110.886 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.48 -57.0 6.47 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.57 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.39 45.53 0.67 Allowed 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.444 -0.785 . . . . 0.0 111.221 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 p -90.52 164.72 14.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.545 1.138 . . . . 0.0 111.128 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.5 p -104.98 -68.62 0.85 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.623 1.569 . . . . 0.0 107.162 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.0 162.93 62.73 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.034 1.333 . . . . 0.0 108.035 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.613 ' HB2' HD13 ' A' ' 52' ' ' LEU . 53.1 Cg_exo -56.27 167.9 2.33 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.799 1.666 . . . . 0.0 112.294 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -146.28 120.27 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.574 1.549 . . . . 0.0 109.215 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -97.72 102.79 14.64 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -98.21 109.73 24.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.362 0.665 . . . . 0.0 109.801 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -87.77 117.72 26.8 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -79.19 112.6 16.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -126.31 -173.74 2.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.843 0.83 . . . . 0.0 111.008 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.66 156.76 3.43 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.41 -36.42 78.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.315 2.01 . . . . 0.0 109.991 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -76.68 -3.56 38.58 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.708 0.803 . . . . 0.0 111.738 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.4 t -63.69 -60.42 3.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.714 1.143 . . . . 0.0 111.659 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 -86.02 0.52 Allowed Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.069 -1.406 . . . . 0.0 110.761 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.97 -46.13 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.415 2.744 . . . . 0.0 111.843 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.0 m -46.13 -46.53 17.19 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.374 1.47 . . . . 0.0 111.41 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -67.87 -44.08 77.92 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.656 0.783 . . . . 0.0 110.797 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.97 -13.13 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.875 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.59 -38.49 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.062 1.345 . . . . 0.0 108.491 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -37.95 -47.38 2.71 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.905 2.082 . . . . 0.0 114.721 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.13 -39.97 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.828 1.686 . . . . 0.0 109.918 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -74.91 -47.52 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.629 1.972 . . . . 0.0 109.505 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -61.06 -38.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.601 -1.312 . . . . 0.0 109.568 175.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.86 -54.25 24.21 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 119.286 -0.387 . . . . 0.0 110.822 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.08 -41.89 89.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.32 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mm -55.3 -46.49 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.27 -51.09 57.32 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.16 -54.21 13.02 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -61.73 -54.0 48.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.678 0.752 . . . . 0.0 112.916 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -83.21 -8.06 59.53 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -37.31 -58.49 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.501 1.921 . . . . 0.0 113.5 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.21 -39.91 60.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.952 1.301 . . . . 0.0 112.802 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -91.32 -37.47 13.24 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.887 1.275 . . . . 0.0 113.301 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -158.03 145.5 18.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.84 1.256 . . . . 0.0 108.446 -168.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -93.82 154.67 17.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.997 1.719 . . . . 0.0 109.678 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 147.01 49.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.83 167.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.133 0.424 . . . . 0.0 111.021 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -135.54 113.65 11.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.661 1.185 . . . . 0.0 111.545 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 62' ' ' SER . 8.9 tt -94.87 116.53 28.84 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.126 0.971 . . . . 0.0 109.57 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -75.88 111.38 11.19 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -66.53 -29.23 69.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.366 1.466 . . . . 0.0 111.85 -173.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.69 -38.31 54.67 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.915 1.286 . . . . 0.0 109.787 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -80.91 -25.94 37.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.044 1.737 . . . . 0.0 110.782 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' HD21 ' A' ' 57' ' ' LEU . 3.1 m -117.33 51.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.916 2.087 . . . . 0.0 112.232 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -63.78 -31.0 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 125.598 4.198 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -58.4 -64.24 0.99 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.19 -44.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.851 0.357 . . . . 0.0 110.073 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.79 64.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -67.78 -44.46 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.226 0.61 . . . . 0.0 110.628 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.73 -45.85 70.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 110.222 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -79.56 -33.2 42.01 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.79 50.11 2.18 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.85 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.777 0.831 . . . . 0.0 109.351 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' H ' ' CD ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.08 -26.31 43.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.905 0.882 . . . . 0.0 110.812 177.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.9 m -160.24 160.17 32.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.833 1.253 . . . . 0.0 107.781 -171.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 pt -143.35 160.7 50.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.956 1.702 . . . . 0.0 107.566 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.7 154.57 79.46 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 CA-C-N 121.426 1.545 . . . . 0.0 113.838 3.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.6 m -151.14 104.04 3.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.8 mt -91.12 118.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.9 mtt -103.86 129.52 51.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.7 t -91.18 115.76 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.47 166.18 12.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.822 1.249 . . . . 0.0 108.626 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.28 -161.0 0.71 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.06 102.86 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.33 1.443 . . . . 0.0 114.656 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.27 -64.35 2.07 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.75 1.167 . . . . 0.0 114.963 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.43 177.74 4.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.479 1.133 . . . . 0.0 113.706 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -87.72 155.92 19.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.041 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.6 t -103.59 -69.15 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.823 1.249 . . . . 0.0 108.994 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.42 177.96 8.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 108.39 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -152.87 149.29 28.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.892 -0.505 . . . . 0.0 109.975 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -121.52 104.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.955 2.102 . . . . 0.0 107.026 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.4 mt -89.49 137.38 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.05 1.34 . . . . 0.0 107.799 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.64 150.0 25.42 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 121.697 0.609 . . . . 0.0 112.284 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.42 64.18 2.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.954 0.901 . . . . 0.0 112.031 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.29 150.66 74.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.21 149.25 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.728 1.619 . . . . 0.0 112.1 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -45.69 66.72 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.95 -43.72 14.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.206 0.602 . . . . 0.0 111.515 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -51.43 67.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.993 0.917 . . . . 0.0 108.931 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.0 -52.19 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 123.829 0.852 . . . . 0.0 109.775 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.28 -57.3 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.267 0.94 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -55.28 -49.28 72.52 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.807 0.336 . . . . 0.0 110.286 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.5 m -57.23 -45.98 83.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.725 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.79 -52.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 120.915 -1.116 . . . . 0.0 109.267 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.02 -38.34 65.03 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.731 1.212 . . . . 0.0 111.721 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -54.7 -33.5 61.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.505 0.322 . . . . 0.0 110.88 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 . . . . . 0 CA--C 1.536 0.427 0 C-N-CA 125.354 1.462 . . . . 0.0 113.145 -174.055 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.38 167.47 54.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.392 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.04 132.16 50.58 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -131.39 173.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 122.074 0.94 . . . . 0.0 110.043 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -155.66 178.28 10.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.309 2.244 . . . . 0.0 105.48 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -45.7 -55.95 5.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.993 0.815 . . . . 0.0 111.699 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.31 -57.79 4.29 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.833 1.653 . . . . 0.0 112.623 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 p -74.06 -47.0 39.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.863 0.865 . . . . 0.0 111.293 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -39.66 -48.7 2.17 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.229 2.212 . . . . 0.0 110.739 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -40.03 -53.83 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.708 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -87.27 -47.83 8.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.366 1.079 . . . . 0.0 110.695 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.28 -32.89 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.217 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -109.95 -64.56 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.02 1.328 . . . . 0.0 111.603 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.23 -71.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.312 0.505 . . . . 0.0 111.14 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.43 53.64 2.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.905 0.882 . . . . 0.0 108.8 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.1 p -90.8 -129.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.024 0.929 . . . . 0.0 109.56 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.1 p -161.54 -78.04 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.05 163.71 58.65 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -50.17 163.13 0.64 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.814 2.343 . . . . 0.0 114.043 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 t -146.45 141.54 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 108.784 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.01 97.53 5.14 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.96 129.85 47.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -102.32 116.67 33.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.21 108.66 12.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -124.49 -175.5 3.28 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 123.716 0.635 . . . . 0.0 110.475 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.53 142.07 1.35 Allowed Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.922 0.889 . . . . 0.0 111.077 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.73 108.72 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.228 1.952 . . . . 0.0 108.468 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 137.85 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 1 C-N-CA 131.756 4.022 . . . . 0.0 105.846 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.7 t -74.93 83.02 2.2 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.54 -58.96 2.84 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.249 0.928 . . . . 0.0 112.25 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -48.54 -34.14 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.967 3.111 . . . . 0.0 113.86 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.41 -46.23 17.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -50.91 -50.24 57.86 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.275 1.43 . . . . 0.0 111.119 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.97 -32.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.422 HG22 HG23 ' A' ' 41' ' ' VAL . 15.5 mm -76.35 -36.86 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.551 1.141 . . . . 0.0 111.95 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.76 -48.49 5.42 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.8 -36.46 61.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.656 2.238 . . . . 0.0 110.179 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.86 -45.23 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 37' ' ' ILE . 46.2 t -54.17 -48.17 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.8 m-20 -59.92 -53.07 62.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.04 -39.69 95.5 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.775 -1.203 . . . . 0.0 110.402 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mt -56.8 -44.4 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 42' ' ' ASP . . . -52.86 -52.82 55.92 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.73 49.06 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -62.99 -43.3 99.16 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -117.08 8.93 13.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -39.65 -46.53 1.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.731 2.012 . . . . 0.0 112.199 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -29.91 -58.81 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.874 2.469 . . . . 0.0 113.508 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -112.29 -31.72 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.343 1.057 . . . . 0.0 112.342 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.46 105.47 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.125 0.57 . . . . 0.0 111.055 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -78.66 91.08 4.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.2 t -79.5 136.44 36.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.997 -1.064 . . . . 0.0 110.328 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.96 173.27 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.522 0.729 . . . . 0.0 111.551 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -139.93 113.07 8.25 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.726 1.21 . . . . 0.0 111.127 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.81 126.84 38.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.738 0.699 . . . . 0.0 110.753 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -77.64 108.97 11.21 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 m -70.87 -33.22 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.754 1.622 . . . . 0.0 111.55 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.4 -40.33 93.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.221 1.01 . . . . 0.0 109.346 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -84.61 -24.16 29.27 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.177 2.191 . . . . 0.0 112.141 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 m -134.97 61.98 50.02 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 120.821 -1.174 . . . . 0.0 111.735 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.06 -23.25 34.18 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 124.962 3.774 . . . . 0.0 109.921 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -42.97 -72.64 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.614 1.565 . . . . 0.0 110.931 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.0 t -52.18 -48.4 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.033 1.333 . . . . 0.0 109.899 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -41.81 66.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.939 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.5 m -74.8 -43.5 54.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.015 . . . . 0.0 110.566 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -54.84 -48.31 73.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.316 0.646 . . . . 0.0 109.938 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -79.44 -33.0 42.84 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.56 56.7 4.12 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.3 pt -67.49 142.28 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.492 0.663 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -79.6 71.7 6.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.6 t 65.33 -157.28 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.616 1.166 . . . . 0.0 109.384 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 153.04 69.96 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.313 1.045 . . . . 0.0 110.103 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.24 145.07 82.33 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 CA-C-N 119.536 0.87 . . . . 0.0 112.515 2.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.1 m -136.08 106.66 6.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.65 105.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.928 1.691 . . . . 0.0 106.54 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.6 mtp -103.62 127.53 51.04 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.46 134.03 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -120.65 136.73 54.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 173.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.426 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -107.43 -101.3 0.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 81' ' ' LYS . . . -71.85 73.15 0.84 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.61 -59.94 3.33 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.328 0.966 . . . . 0.0 112.975 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -86.09 173.27 9.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.36 0.6 . . . . 0.0 112.279 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.21 152.92 10.09 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.948 1.699 . . . . 0.0 113.411 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 t -130.54 -56.87 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.666 1.987 . . . . 0.0 109.058 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.05 166.95 21.54 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.397 1.079 . . . . 0.0 110.632 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 m -152.75 95.5 2.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.817 1.647 . . . . 0.0 106.618 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.33 141.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.3 mt -133.22 142.96 40.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 155.94 32.19 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 71.96 1.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.099 -0.648 . . . . 0.0 111.67 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -79.13 153.66 77.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.43 154.46 53.27 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.343 2.028 . . . . 0.0 114.424 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -45.38 -53.49 8.55 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.364 1.866 . . . . 0.0 109.47 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.49 -55.79 4.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.727 1.211 . . . . 0.0 110.132 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -59.19 -53.39 58.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 110.539 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 80.8 mt -51.87 -58.67 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.88 -60.29 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.976 1.31 . . . . 0.0 109.907 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -49.23 -49.14 44.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.269 0.486 . . . . 0.0 111.163 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.7 m -61.53 -57.72 10.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 p -63.51 -45.06 98.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 118.561 -1.256 . . . . 0.0 111.257 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -50.96 -49.76 59.39 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.765 1.626 . . . . 0.0 110.741 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -51.72 -48.84 63.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.719 175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -173.2 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.436 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.2 168.16 54.73 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.31 131.65 56.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.82 162.83 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 122.167 0.984 . . . . 0.0 110.488 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -142.72 176.59 8.93 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.407 1.883 . . . . 0.0 106.338 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -39.22 -58.84 1.11 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.653 1.181 . . . . 0.0 112.383 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -54.62 -58.09 8.87 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.851 1.661 . . . . 0.0 113.09 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -67.2 -46.38 74.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.3 1.84 . . . . 0.0 110.558 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -40.15 -51.5 2.64 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 126.84 2.056 . . . . 0.0 111.212 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -44.08 -52.5 7.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.664 0.745 . . . . 0.0 110.931 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.66 -58.06 3.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.606 0.717 . . . . 0.0 111.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.33 -43.6 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.565 -169.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.68 -61.54 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.518 1.127 . . . . 0.0 111.348 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -70.68 -63.03 1.17 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.929 0.786 . . . . 0.0 110.508 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -79.92 52.63 1.53 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.619 0.645 . . . . 0.0 111.48 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 p -89.02 155.36 19.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.783 1.633 . . . . 0.0 110.322 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -87.1 -73.77 0.46 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.66 162.01 64.59 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.58 166.88 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.323 2.016 . . . . 0.0 114.18 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.14 149.02 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.362 1.865 . . . . 0.0 110.466 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 tt -126.87 102.03 6.84 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 170.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.0 p -107.08 123.6 62.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.116 1.325 . . . . 0.0 108.789 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -93.59 115.29 27.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CD2' HD12 ' A' ' 57' ' ' LEU . 25.2 m-85 -79.61 104.07 9.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -116.61 -169.91 1.72 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.315 1.046 . . . . 0.0 110.24 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.49 148.73 1.55 Allowed Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 124.595 1.158 . . . . 0.0 107.923 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.03 -37.71 95.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.559 2.173 . . . . 0.0 112.85 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.585 ' CH2' HD11 ' A' ' 74' ' ' ILE . 37.4 p-90 -72.73 -18.7 61.49 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.904 -0.497 . . . . 0.0 111.052 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.69 83.59 6.43 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.057 -1.027 . . . . 0.0 109.715 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.29 -59.53 1.82 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.52 1.057 . . . . 0.0 113.457 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.99 -48.61 20.74 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.694 2.263 . . . . 0.0 111.546 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.4 m -55.74 -50.49 70.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -58.13 -49.93 75.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.332 1.053 . . . . 0.0 111.536 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.73 -22.47 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.722 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.0 mt -82.56 -30.13 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 119.847 1.203 . . . . 0.0 109.435 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.35 -41.69 2.64 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.937 1.695 . . . . 0.0 115.223 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.76 -40.89 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.323 2.015 . . . . 0.0 109.809 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.14 -35.33 34.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 C-N-CA 118.153 -1.419 . . . . 0.0 108.136 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.7 t -52.73 -43.65 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.15 -58.36 8.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.094 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.36 -42.2 77.4 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.558 0.617 . . . . 0.0 111.884 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.98 -36.5 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 122.838 0.455 . . . . 0.0 109.962 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.68 -46.97 80.86 Favored 'General case' 0 C--O 1.223 -0.342 0 O-C-N 121.913 -0.492 . . . . 0.0 110.193 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.9 -42.68 99.63 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.76 -44.06 90.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.55 15.63 8.84 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -39.43 -51.15 2.13 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.132 1.373 . . . . 0.0 113.7 -174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -44.7 -46.65 10.44 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.081 1.752 . . . . 0.0 112.774 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -98.56 -37.76 9.42 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.92 0.888 . . . . 0.0 112.266 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.4 tp -116.16 112.07 21.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.101 -167.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -79.96 93.65 5.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 49.9 t -79.13 134.16 36.72 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.494 -0.754 . . . . 0.0 109.685 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.64 167.9 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.166 0.586 . . . . 0.0 111.758 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -135.27 116.4 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.034 1.334 . . . . 0.0 110.077 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.427 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.3 tm? -98.86 120.83 39.96 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 109.585 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -75.42 103.31 5.5 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.672 0.749 . . . . 0.0 110.265 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -81.96 48.33 1.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.451 1.9 . . . . 0.0 111.27 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -145.5 -47.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.59 -26.43 34.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.86 2.064 . . . . 0.0 109.821 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.4 m -133.05 60.38 49.0 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.006 -1.059 . . . . 0.0 113.813 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.87 -23.78 16.07 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 125.186 3.924 . . . . 0.0 108.716 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -37.38 -69.25 0.12 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.356 1.862 . . . . 0.0 111.099 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -35.68 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.183 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.63 81.24 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 m -72.41 -45.21 60.71 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.095 0.958 . . . . 0.0 109.965 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -54.97 -46.04 75.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.35 0.66 . . . . 0.0 110.386 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.98 -34.76 43.92 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.365 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.23 54.77 1.24 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.516 0.579 . . . . 0.0 111.859 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.6 mt -77.69 121.41 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -79.0 -35.46 42.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.02 0.528 . . . . 0.0 111.537 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.9 m -158.73 168.82 25.84 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.585 HD11 ' CH2' ' A' ' 30' ' ' TRP . 23.1 pt -124.82 154.56 70.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.34 149.69 82.19 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 CA-C-N 120.287 1.138 . . . . 0.0 112.277 2.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -144.04 106.04 4.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.61 116.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.5 mtt -105.76 134.93 48.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -99.47 140.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -127.99 161.1 29.94 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 54.56 0.81 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.521 1.138 . . . . 0.0 110.488 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.18 98.35 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.48 -73.08 1.17 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.103 0.858 . . . . 0.0 112.066 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -94.58 165.21 12.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.825 1.298 . . . . 0.0 113.131 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -77.32 142.35 39.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.265 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 41.7 t -89.08 -65.22 1.04 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.227 1.011 . . . . 0.0 108.643 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -151.28 -174.75 4.92 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.091 1.756 . . . . 0.0 108.166 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.2 t -154.23 166.72 32.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.364 0.666 . . . . 0.0 109.585 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.0 mt -136.02 118.63 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.95 141.0 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 109.027 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.64 163.33 38.3 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.836 0.731 . . . . 0.0 111.569 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.34 142.97 57.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.08 0.552 . . . . 0.0 110.739 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.69 153.54 36.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 124.123 0.969 . . . . 0.0 108.525 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.72 145.29 20.2 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 N-CA-C 105.586 -2.505 . . . . 0.0 105.586 168.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -56.29 -33.41 65.5 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.321 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.88 -42.87 6.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.662 0.785 . . . . 0.0 110.62 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.1 m -75.3 -44.42 45.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.978 0.511 . . . . 0.0 110.018 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.5 mt -54.42 -47.45 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 123.51 0.724 . . . . 0.0 110.08 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -57.15 -55.28 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.439 0.695 . . . . 0.0 109.714 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -56.61 -45.49 81.45 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.889 -0.507 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.3 m -66.34 -43.24 86.65 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.073 0.549 . . . . 0.0 111.752 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.71 -43.62 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 121.024 -1.048 . . . . 0.0 108.878 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.26 -47.75 80.61 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -54.1 -52.0 62.38 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.473 0.709 . . . . 0.0 109.919 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 122.613 0.365 . . . . 0.0 111.791 -178.28 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.06 166.16 44.63 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.32 126.98 55.84 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.52 164.43 30.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 122.271 1.034 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -148.9 179.84 7.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.321 1.848 . . . . 0.0 106.832 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -39.05 -59.05 1.04 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.362 1.465 . . . . 0.0 112.213 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.99 -69.14 0.25 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.546 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -51.59 -39.03 57.18 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.248 1.019 . . . . 0.0 112.11 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -44.74 -48.22 10.79 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.197 1.399 . . . . 0.0 111.045 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -50.29 -51.25 46.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.412 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -74.76 -56.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.428 0.633 . . . . 0.0 111.38 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.7 t -66.86 -23.97 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.078 1.751 . . . . 0.0 113.368 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.51 -75.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.574 0.75 . . . . 0.0 110.524 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.37 -47.06 66.37 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.667 0.667 . . . . 0.0 112.781 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.14 15.03 16.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.423 1.089 . . . . 0.0 112.085 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.34 147.93 27.64 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.034 0.834 . . . . 0.0 111.407 -173.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.2 p -80.01 -61.91 1.84 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.345 1.458 . . . . 0.0 111.753 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.45 160.25 75.57 Favored Pre-proline 0 C--O 1.233 0.185 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.79 159.88 3.27 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.245 1.963 . . . . 0.0 110.403 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.05 149.26 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 123.768 0.827 . . . . 0.0 109.599 -173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.67 98.97 4.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.68 119.29 45.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -95.29 114.04 25.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -79.58 112.37 16.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -128.14 -172.04 2.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.817 0.818 . . . . 0.0 110.526 -174.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.27 151.7 4.71 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 124.516 1.126 . . . . 0.0 108.108 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.62 -31.98 93.26 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.375 2.05 . . . . 0.0 113.266 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.483 ' CH2' HD11 ' A' ' 74' ' ' ILE . 17.5 p-90 -79.47 -7.23 58.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.107 0.867 . . . . 0.0 111.405 176.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.6 t -81.31 83.63 6.83 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.078 -1.013 . . . . 0.0 112.551 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.93 -58.02 2.78 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.551 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.22 -20.19 66.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 CA-C-N 119.634 1.717 . . . . 0.0 113.064 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.8 m -81.15 -49.82 10.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -45.17 -50.21 11.55 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.778 0.831 . . . . 0.0 111.153 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -65.82 -25.75 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.387 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 pt -90.23 -29.05 4.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 CA-C-N 120.689 1.586 . . . . 0.0 110.255 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.02 4.28 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.96 -28.39 24.36 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 122.276 1.849 . . . . 0.0 109.848 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -71.41 -41.42 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -55.94 -46.74 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.38 -54.73 39.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.69 -41.15 94.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.638 1.563 . . . . 0.0 110.669 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.9 mm -60.36 -41.99 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -50.71 67.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.925 0.784 . . . . 0.0 109.302 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.81 -49.7 34.11 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.14 -58.89 4.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -85.38 -0.03 53.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -171.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -39.0 -49.12 1.69 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.549 1.54 . . . . 0.0 113.163 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -46.87 -59.95 2.74 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.859 1.664 . . . . 0.0 112.593 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -83.48 -30.03 27.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.799 1.24 . . . . 0.0 112.579 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.67 110.89 10.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 -168.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.81 95.59 6.07 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.3 t -79.26 140.18 37.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.572 -0.705 . . . . 0.0 109.29 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.82 165.4 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.835 0.854 . . . . 0.0 109.906 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -133.56 116.95 16.52 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.708 1.203 . . . . 0.0 109.268 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 tt -99.1 123.39 43.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.017 0.436 . . . . 0.0 110.385 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.99 108.82 9.14 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.9 m -68.99 -29.82 68.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 124.876 1.27 . . . . 0.0 111.692 -174.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.58 -43.26 66.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.91 0.862 . . . . 0.0 110.177 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -81.19 -27.4 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.299 1.84 . . . . 0.0 111.666 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.2 m -134.0 61.89 54.09 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 121.04 -1.037 . . . . 0.0 110.679 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.14 -35.9 31.31 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.899 3.733 . . . . 0.0 108.861 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -33.55 -69.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.11 2.164 . . . . 0.0 111.058 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.8 t -55.48 -51.45 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.744 1.218 . . . . 0.0 110.057 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.32 -37.03 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.122 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 m -74.6 -45.23 46.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.53 1.132 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.99 -43.28 73.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.421 0.688 . . . . 0.0 109.629 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -78.97 -32.71 45.42 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.385 -0.341 . . . . 0.0 110.952 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.45 51.1 2.42 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 111.675 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.0 mt -84.05 113.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.075 0.95 . . . . 0.0 108.676 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -79.65 -26.86 40.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 113.532 -175.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 m -161.08 167.11 26.96 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.483 HD11 ' CH2' ' A' ' 30' ' ' TRP . 18.7 pt -129.53 151.92 78.78 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 146.88 83.0 Favored 'Cis proline' 0 N--CA 1.453 -0.894 0 CA-C-N 119.923 1.008 . . . . 0.0 113.277 1.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.6 m -139.61 114.4 9.4 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.3 mt -104.55 102.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.8 mtt -87.86 131.92 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.44 143.31 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -134.31 158.93 42.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.964 0.906 . . . . 0.0 109.716 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 146.72 28.52 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.554 2.342 . . . . 0.0 104.73 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.92 55.12 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.117 -1.516 . . . . 0.0 111.768 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.1 -52.58 2.95 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 122.258 -0.554 . . . . 0.0 113.525 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -79.67 163.66 24.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.539 1.161 . . . . 0.0 113.409 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -67.67 148.04 51.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.863 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 t -115.11 -63.41 1.46 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.355 1.462 . . . . 0.0 109.125 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -138.3 -177.7 4.96 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 109.771 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -155.22 131.82 10.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.941 0.896 . . . . 0.0 109.455 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.0 mm -104.33 153.28 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.74 142.02 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.154 0.981 . . . . 0.0 108.596 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.31 158.24 20.14 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 121.531 0.517 . . . . 0.0 112.54 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.92 70.18 1.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.53 . . . . 0.0 111.146 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -78.5 153.43 78.8 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.71 147.22 50.91 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.619 1.546 . . . . 0.0 112.208 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -62.05 -39.19 91.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.391 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -48.86 37.12 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -59.56 -51.12 71.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 109.204 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.1 mt -54.96 -58.38 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.039 0.535 . . . . 0.0 109.878 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.2 t -49.67 -55.98 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.886 1.274 . . . . 0.0 110.673 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -48.23 74.25 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -61.38 -41.41 97.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.459 0.303 . . . . 0.0 111.191 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.18 -49.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -57.75 -46.56 84.33 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.509 0.724 . . . . 0.0 110.048 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -51.85 -52.05 52.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.736 0.814 . . . . 0.0 109.482 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.01 -177.44 39.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.86 136.9 54.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.41 165.49 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.616 0.722 . . . . 0.0 111.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -145.55 172.09 13.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.784 2.034 . . . . 0.0 106.063 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -39.09 -48.12 1.63 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.936 1.694 . . . . 0.0 112.663 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.52 -74.0 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.105 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -52.86 -36.33 58.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.512 1.125 . . . . 0.0 111.951 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -41.06 -46.73 2.99 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 126.258 1.823 . . . . 0.0 111.376 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -49.48 -48.02 48.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.789 1.236 . . . . 0.0 111.086 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -85.12 -57.64 3.01 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.779 0.832 . . . . 0.0 111.157 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.77 -38.58 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.651 1.18 . . . . 0.0 112.163 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -104.91 -59.52 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 112.305 -174.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 mt -66.57 -71.34 0.2 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.162 0.437 . . . . 0.0 110.982 -174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -79.57 52.77 1.46 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.101 0.476 . . . . 0.0 111.483 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 p -90.67 159.29 16.47 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.11 1.764 . . . . 0.0 111.301 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -91.72 -69.87 0.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.243 1.417 . . . . 0.0 107.736 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 m -78.75 154.41 78.32 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.29 163.81 16.47 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.748 0.965 . . . . 0.0 110.194 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.47 113.72 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.667 1.187 . . . . 0.0 111.348 -171.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.32 105.64 13.56 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.85 116.04 45.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 109.762 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -89.44 112.27 23.36 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.555 ' CE2' HD23 ' A' ' 57' ' ' LEU . 18.6 m-85 -78.71 112.93 16.32 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -130.12 -172.52 2.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.575 0.75 . . . . 0.0 110.754 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.5 148.82 3.51 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.967 1.307 . . . . 0.0 107.772 172.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.15 -45.35 41.67 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.702 2.268 . . . . 0.0 112.809 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -64.56 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.031 -0.418 . . . . 0.0 111.96 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.4 t -76.31 84.44 3.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.626 -0.671 . . . . 0.0 110.913 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.53 -54.12 5.77 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.996 0.808 . . . . 0.0 112.883 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -27.78 71.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.365 2.043 . . . . 0.0 112.767 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.4 m -77.15 -53.67 7.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -45.04 -47.2 11.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.981 1.712 . . . . 0.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -71.9 -25.96 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.02 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.6 pt -86.88 -26.43 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 121.267 1.849 . . . . 0.0 110.083 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.14 -45.72 3.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.367 1.467 . . . . 0.0 114.795 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -68.11 -33.17 25.9 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.708 2.272 . . . . 0.0 109.979 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -38.76 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 127.053 2.141 . . . . 0.0 107.901 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.25 -45.69 95.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.92 -52.92 63.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.844 0.457 . . . . 0.0 110.205 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -50.69 -49.85 56.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.434 0.561 . . . . 0.0 109.955 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.91 -38.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.58 -33.73 64.17 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.026 0.376 . . . . 0.0 110.277 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.58 -56.56 7.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.94 -47.53 21.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -106.69 21.95 16.66 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -48.62 -40.4 27.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.958 0.903 . . . . 0.0 111.274 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.48 -68.35 0.19 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.37 1.468 . . . . 0.0 112.4 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -89.94 -14.64 33.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.16 135.04 33.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.683 1.129 . . . . 0.0 113.102 -167.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -79.94 151.63 29.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.1 t -137.34 136.75 38.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.8 166.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 112.069 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -128.3 116.13 19.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.081 1.352 . . . . 0.0 109.542 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 ' CE2' ' A' ' 26' ' ' PHE . 43.8 tp -97.73 115.97 29.02 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.57 0.748 . . . . 0.0 109.983 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -71.1 110.42 5.76 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -64.21 -43.67 94.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 111.4 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.11 -33.68 76.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.584 0.754 . . . . 0.0 110.403 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -82.44 -25.03 33.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 0.0 111.104 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -125.88 54.9 11.44 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 113.034 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.18 -30.83 45.96 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.789 2.993 . . . . 0.0 108.616 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -43.64 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.13 1.772 . . . . 0.0 110.991 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.4 t -50.57 -51.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -39.09 74.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.044 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -70.35 -45.19 66.62 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.014 0.526 . . . . 0.0 109.656 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.58 -42.35 74.65 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.2 -23.97 43.46 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.747 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.85 10.62 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.041 0.829 . . . . 0.0 111.072 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -70.23 128.9 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.88 -45.03 21.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.325 0.65 . . . . 0.0 111.386 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 m -156.48 171.28 20.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.06 154.39 68.1 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.17 149.59 89.81 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 CA-C-N 119.787 0.96 . . . . 0.0 112.118 1.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -135.57 101.18 4.71 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.0 mt -90.61 114.57 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.6 mtm -126.16 150.34 48.35 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.2 t -108.51 139.73 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.5 168.26 12.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.333 1.021 . . . . 0.0 109.994 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 156.78 2.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.979 2.112 . . . . 0.0 106.7 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 37.57 49.96 1.83 Allowed Glycine 0 CA--C 1.535 1.343 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.96 64.55 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.667 -1.074 . . . . 0.0 115.621 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -147.75 172.21 14.45 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.515 1.657 . . . . 0.0 111.099 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -85.76 161.66 19.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.834 1.254 . . . . 0.0 109.412 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 53.1 t -131.16 -63.1 0.86 Allowed 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 126.231 1.813 . . . . 0.0 109.826 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -113.66 162.3 16.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.394 1.078 . . . . 0.0 110.433 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -154.77 131.43 10.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.334 1.454 . . . . 0.0 107.854 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -140.57 113.46 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -99.11 139.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.8 148.26 22.54 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.407 1.004 . . . . 0.0 110.804 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 75.48 1.0 Allowed 'General case' 0 C--N 1.339 0.12 0 O-C-N 122.033 -0.686 . . . . 0.0 110.875 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.9 m -78.73 145.26 66.31 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.33 157.63 39.59 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.972 1.781 . . . . 0.0 113.027 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -42.1 -51.01 4.7 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.372 1.469 . . . . 0.0 110.028 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.08 -44.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 111.861 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -69.17 -48.44 62.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 70.2 mt -54.41 -54.3 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -46.59 -64.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 127.802 2.441 . . . . 0.0 109.271 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -55.6 -49.08 73.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.512 0.196 . . . . 0.0 111.297 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.4 m -56.85 -52.07 66.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.845 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.03 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.918 0.781 . . . . 0.0 110.515 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -52.7 -36.73 57.76 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.368 0.667 . . . . 0.0 112.015 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -46.92 -46.39 21.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.048 0.452 . . . . 0.0 110.49 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 124.146 0.978 . . . . 0.0 111.195 -174.336 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.34 177.69 18.09 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.52 141.77 50.49 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 m -142.07 171.72 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 123.137 1.446 . . . . 0.0 112.674 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.38 169.56 19.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.977 3.311 . . . . 0.0 105.055 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -38.43 -50.39 1.52 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.702 2.401 . . . . 0.0 112.753 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.17 -70.02 0.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.726 0.774 . . . . 0.0 110.577 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -53.25 -38.7 63.23 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.601 1.16 . . . . 0.0 112.415 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -42.97 -46.75 5.55 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.864 2.066 . . . . 0.0 111.5 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -54.26 -55.38 28.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.72 -54.25 17.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.468 0.707 . . . . 0.0 111.516 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.31 -31.17 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.261 1.424 . . . . 0.0 112.79 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.24 -72.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.549 0.739 . . . . 0.0 111.024 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.1 mt -53.79 -41.03 66.81 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -172.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -93.12 13.23 21.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.009 0.924 . . . . 0.0 112.512 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 t -73.71 142.97 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.514 1.052 . . . . 0.0 111.888 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 p -79.64 -61.31 2.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.045 1.338 . . . . 0.0 108.636 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.86 155.14 80.62 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -57.23 161.32 11.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.64 1.56 . . . . 0.0 112.56 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 t -141.1 143.07 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.411 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tt -120.08 102.35 8.47 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.378 1.871 . . . . 0.0 106.689 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t -97.77 127.41 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -103.08 124.87 49.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -79.68 106.69 11.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -118.62 -176.13 3.03 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.872 1.32 . . . . 0.0 111.66 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.79 152.08 6.3 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.49 -42.68 12.11 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.857 1.342 . . . . 0.0 111.665 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -58.25 -18.75 28.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.796 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.8 t -77.97 88.72 4.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.707 1.139 . . . . 0.0 109.773 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.54 -63.07 1.04 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.187 1.375 . . . . 0.0 113.538 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -49.47 -47.29 23.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.39 2.726 . . . . 0.0 112.358 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.5 m -58.75 -53.6 56.58 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -53.25 -54.47 35.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.854 1.262 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -75.79 -27.37 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.652 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.78 -26.87 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.754 1.161 . . . . 0.0 109.796 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.79 -46.2 4.64 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -63.28 -35.68 61.23 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.675 2.25 . . . . 0.0 110.373 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 t -68.69 -44.28 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 t -58.07 -44.37 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.53 -60.81 3.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 122.828 0.451 . . . . 0.0 111.035 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.51 -33.87 71.91 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.435 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mt -56.8 -43.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.17 -47.7 76.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.042 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.28 -60.68 5.53 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 120.191 1.36 . . . . 0.0 110.69 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -48.17 -55.74 9.63 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.616 1.566 . . . . 0.0 110.717 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.39 58.88 4.74 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 123.447 1.594 . . . . 0.0 110.313 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -48.31 138.18 10.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.227 1.811 . . . . 0.0 110.115 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.73 -56.2 0.62 Allowed 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.565 2.346 . . . . 0.0 112.968 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.1 -9.44 58.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -166.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -141.62 108.87 5.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.974 1.261 . . . . 0.0 112.214 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -93.78 111.75 23.49 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.68 138.31 38.23 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.811 -1.18 . . . . 0.0 108.135 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.15 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -133.93 106.53 7.32 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.359 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -89.11 120.03 30.14 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 111.254 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.29 106.75 8.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.3 m -68.87 -31.97 71.3 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.231 1.413 . . . . 0.0 111.453 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.87 -41.5 87.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.438 1.095 . . . . 0.0 109.309 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.51 -28.68 26.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.004 2.122 . . . . 0.0 111.99 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.4 t -127.13 53.21 9.55 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.399 1.48 . . . . 0.0 112.208 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -62.78 -27.14 75.21 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.306 3.337 . . . . 0.0 108.825 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -40.37 -60.05 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.628 1.571 . . . . 0.0 110.263 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.8 -50.78 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.171 0.988 . . . . 0.0 110.167 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.08 64.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.426 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -68.63 -44.91 73.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.898 0.879 . . . . 0.0 110.397 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -56.38 -42.0 77.16 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.644 0.778 . . . . 0.0 110.332 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -78.47 -34.18 47.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.39 45.89 2.46 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.415 1.007 . . . . 0.0 111.588 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.76 -179.16 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 125.938 1.695 . . . . 0.0 108.33 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -158.62 -63.66 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.559 0.744 . . . . 0.0 109.593 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 m -54.94 154.64 5.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 110.223 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 pt -143.2 157.92 59.28 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.175 1.39 . . . . 0.0 107.3 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.27 156.28 84.78 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 120.766 1.309 . . . . 0.0 112.958 2.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -160.46 115.74 2.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -98.65 148.46 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.9 mtt -136.24 133.0 36.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.7 t -99.46 139.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -132.82 144.86 50.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 136.88 15.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 46.14 94.64 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -171.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.01 -59.65 2.66 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.908 0.766 . . . . 0.0 114.006 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -81.44 168.29 18.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -67.73 155.37 39.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.235 1.814 . . . . 0.0 112.96 -173.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.0 t -116.17 -72.38 0.69 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.965 2.106 . . . . 0.0 109.651 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -146.07 172.01 14.04 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.299 1.44 . . . . 0.0 110.246 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.5 m -116.41 146.58 42.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.63 1.972 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.82 -175.43 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.54 153.14 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.36 -153.57 5.83 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 51.48 42.48 29.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.947 0.899 . . . . 0.0 111.828 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.46 153.16 65.39 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.074 1.35 . . . . 0.0 107.477 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.36 160.43 32.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.103 1.868 . . . . 0.0 111.676 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -50.53 -43.57 56.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.807 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.41 -44.71 55.21 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.235 0.614 . . . . 0.0 111.111 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.3 m -65.84 -50.96 62.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -55.41 -52.78 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.392 0.677 . . . . 0.0 109.499 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.42 -58.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.428 1.491 . . . . 0.0 109.595 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -55.31 -47.41 75.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.689 0.677 . . . . 0.0 110.992 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.1 m -60.92 -43.83 98.03 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 119.591 -0.242 . . . . 0.0 111.448 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -72.5 -45.75 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.967 0.803 . . . . 0.0 109.829 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -51.54 -45.56 63.03 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.12 0.968 . . . . 0.0 110.772 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -48.24 -44.32 33.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.964 0.506 . . . . 0.0 110.316 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.176 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.41 -172.64 35.13 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.24 140.58 52.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.88 167.81 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.153 0.978 . . . . 0.0 111.793 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 8' ' ' ASP . 8.1 t-20 -143.5 172.76 12.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.844 2.058 . . . . 0.0 106.389 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.423 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 76.5 m-20 -38.82 -46.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.195 1.798 . . . . 0.0 112.381 -177.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.46 -76.19 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.719 0.408 . . . . 0.0 110.768 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.0 p -46.94 -39.82 13.07 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.271 1.429 . . . . 0.0 112.194 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -39.42 -47.9 1.86 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.526 1.93 . . . . 0.0 111.487 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.774 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -71.23 -45.73 62.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.507 0.67 . . . . 0.0 111.261 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.79 -37.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.031 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -106.33 -73.93 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.883 0.873 . . . . 0.0 110.78 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.9 mt -52.06 -54.53 29.11 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.865 0.466 . . . . 0.0 111.86 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -81.03 11.73 3.86 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -65.6 152.43 44.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.82 1.191 . . . . 0.0 109.614 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 p -79.33 -64.69 1.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.12 155.12 77.41 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.27 165.01 1.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.904 2.403 . . . . 0.0 112.608 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -144.72 143.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.449 1.099 . . . . 0.0 111.588 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -104.52 130.13 52.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.899 1.68 . . . . 0.0 107.67 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.61 111.28 27.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 118.918 0.781 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -89.69 116.28 27.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' CD2' ' CD1' ' A' ' 71' ' ' ILE . 15.9 m-85 -79.75 114.53 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -129.44 -173.48 3.02 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.565 0.698 . . . . 0.0 111.664 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.64 156.59 8.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -59.44 -40.52 66.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.206 1.938 . . . . 0.0 110.658 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.508 ' CH2' HD11 ' A' ' 74' ' ' ILE . 53.1 p-90 -72.24 -10.25 59.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.881 0.472 . . . . 0.0 111.515 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.36 82.29 3.11 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.8 -1.187 . . . . 0.0 110.157 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.2 -61.21 1.01 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.825 1.202 . . . . 0.0 113.529 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.05 -41.3 78.36 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.387 2.058 . . . . 0.0 112.43 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 81.4 m -55.22 -47.66 75.02 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -56.2 -52.32 64.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.729 0.412 . . . . 0.0 111.482 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -73.24 -30.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.91 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.85 -23.08 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.951 0.9 . . . . 0.0 110.361 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.0 -46.54 5.17 Favored Pre-proline 0 CA--C 1.549 0.919 0 O-C-N 119.914 -1.741 . . . . 0.0 115.061 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.92 -37.58 64.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.466 2.111 . . . . 0.0 110.173 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.41 -49.08 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.411 HG12 ' SG ' ' A' ' 54' ' ' CYS . 84.8 t -49.96 -44.76 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.67 -61.92 1.61 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.36 -40.22 81.65 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.532 -0.73 . . . . 0.0 112.256 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.77 -38.42 75.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 54' ' ' CYS . . . -62.21 -52.3 64.34 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -43.58 -53.43 6.06 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.897 0.76 . . . . 0.0 111.572 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -47.95 -35.4 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.24 1.016 . . . . 0.0 112.869 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -120.33 27.03 8.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.447 1.499 . . . . 0.0 112.673 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -39.67 -53.14 2.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.879 1.271 . . . . 0.0 113.799 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.04 -53.22 59.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 122.181 0.991 . . . . 0.0 112.33 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -79.43 -20.29 47.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.822 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 tp -144.8 114.68 7.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.051 0.387 . . . . 0.0 111.988 -170.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.2 168.09 20.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 44.3 t -145.65 141.45 28.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.988 -1.07 . . . . 0.0 110.273 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.21 161.8 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.893 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -127.62 109.38 11.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.452 1.101 . . . . 0.0 109.492 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tp -87.9 121.59 30.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.238 0.542 . . . . 0.0 110.426 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -74.58 105.46 5.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.9 m -65.21 -35.94 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.916 1.686 . . . . 0.0 111.03 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.92 -39.56 94.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.511 1.124 . . . . 0.0 109.539 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.37 -21.7 30.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.804 1.642 . . . . 0.0 110.702 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.1 m -120.96 51.11 2.22 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 114.597 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.53 -27.39 61.78 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.487 2.791 . . . . 0.0 109.68 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -54.28 -75.83 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.849 0.86 . . . . 0.0 109.933 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.63 -44.01 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.036 0.935 . . . . 0.0 110.343 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.63 80.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.76 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.4 p -70.74 -39.58 73.23 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.681 0.392 . . . . 0.0 110.27 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.73 -41.66 77.88 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.106 0.562 . . . . 0.0 109.928 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.29 -31.52 48.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.07 47.19 4.22 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.41 ' CD1' ' CD2' ' A' ' 26' ' ' PHE . 58.6 mt -72.62 114.67 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.438 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.93 -29.74 44.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.305 0.242 . . . . 0.0 111.006 -178.372 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 m -159.84 157.99 30.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.959 0.904 . . . . 0.0 108.619 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.508 HD11 ' CH2' ' A' ' 30' ' ' TRP . 22.0 pt -119.52 150.74 50.51 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.46 77.21 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.126 1.081 . . . . 0.0 114.05 3.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 m -143.06 113.34 7.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.08 119.96 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 mtt -105.22 159.23 16.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.904 0.882 . . . . 0.0 109.247 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 81.8 t -126.5 130.63 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -116.77 147.53 41.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.892 1.677 . . . . 0.0 108.36 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.8 53.1 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.435 0.636 . . . . 0.0 109.582 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.09 85.99 1.74 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.16 -67.32 1.17 Allowed Glycine 0 CA--C 1.527 0.827 0 CA-C-N 117.388 0.594 . . . . 0.0 112.884 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -79.85 163.69 24.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.258 1.023 . . . . 0.0 111.428 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -90.13 150.06 22.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.072 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.1 t -91.23 -51.4 5.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.23 -178.88 6.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 109.519 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -157.67 143.13 17.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.404 1.482 . . . . 0.0 107.816 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.21 153.35 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.119 0.968 . . . . 0.0 109.456 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.0 mt -79.92 141.86 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -138.57 2.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.37 42.34 31.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.806 0.803 . . . . 0.0 111.236 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.88 151.1 67.63 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.95 151.52 64.92 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.86 1.706 . . . . 0.0 112.836 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -45.08 46.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.409 1.484 . . . . 0.0 110.801 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -43.13 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.653 0.781 . . . . 0.0 111.133 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -49.55 74.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.815 . . . . 0.0 109.055 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.66 -52.37 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 123.951 0.9 . . . . 0.0 108.754 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.2 t -53.65 -59.25 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.104 0.962 . . . . 0.0 109.32 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -50.62 -42.36 55.98 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.705 0.402 . . . . 0.0 111.016 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -60.99 -59.49 5.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.8 -45.78 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.91 0.884 . . . . 0.0 111.62 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.47 -39.61 4.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.981 1.713 . . . . 0.0 113.193 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.69 -49.22 78.39 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.286 0.634 . . . . 0.0 110.593 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 N--CA 1.446 -0.641 0 C-N-CA 124.911 1.284 . . . . 0.0 110.257 -172.516 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.15 174.05 54.68 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.46 132.84 56.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.4 164.47 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 122.513 1.149 . . . . 0.0 111.208 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.63 169.31 18.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.998 2.519 . . . . 0.0 105.487 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -40.43 -52.99 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.079 1.352 . . . . 0.0 111.318 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.12 -53.23 56.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.048 . . . . 0.0 112.308 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 p -78.67 -31.4 46.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.344 0.658 . . . . 0.0 112.002 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -42.59 -43.54 3.82 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 127.548 2.339 . . . . 0.0 110.335 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -50.72 -67.68 0.23 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.358 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -42.6 98.91 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.226 1.01 . . . . 0.0 112.352 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.66 -43.9 16.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.971 -168.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.3 t -99.2 -54.03 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.399 1.08 . . . . 0.0 111.307 -174.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -69.17 -57.77 4.94 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.756 0.707 . . . . 0.0 110.283 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.6 51.55 1.28 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.173 0.989 . . . . 0.0 110.112 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 p -90.06 154.69 19.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.766 1.226 . . . . 0.0 112.64 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -100.94 -71.37 0.71 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.023 1.729 . . . . 0.0 107.405 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.7 m -79.19 158.95 73.84 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.56 159.81 12.85 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.565 1.51 . . . . 0.0 109.97 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 t -138.7 119.03 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.064 0.945 . . . . 0.0 110.419 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -94.41 110.35 22.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.375 1.07 . . . . 0.0 108.179 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.76 113.46 40.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -86.24 113.88 22.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.537 ' CD2' HD12 ' A' ' 57' ' ' LEU . 40.3 m-85 -79.3 113.09 17.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.4 p-90 -129.18 -174.71 3.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.79 0.805 . . . . 0.0 111.016 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.77 154.14 5.23 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.888 1.275 . . . . 0.0 108.17 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.98 -42.1 15.32 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.821 2.348 . . . . 0.0 110.45 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.468 ' CH2' HD11 ' A' ' 74' ' ' ILE . 30.8 p-90 -66.39 -17.95 65.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.893 0.477 . . . . 0.0 111.215 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.9 t -75.37 97.59 3.65 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.545 -0.722 . . . . 0.0 110.248 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -32.01 -68.87 0.13 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.908 2.194 . . . . 0.0 115.062 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.13 -44.37 12.58 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.879 1.839 . . . . 0.0 110.8 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.4 m -47.22 -50.37 21.16 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.291 0.636 . . . . 0.0 109.998 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -46.26 -50.4 16.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.045 1.338 . . . . 0.0 111.618 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -90.15 -13.56 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 tp -85.62 -27.86 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.468 1.031 . . . . 0.0 109.561 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.55 -48.3 4.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -62.56 -36.98 61.56 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.56 2.173 . . . . 0.0 110.337 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 t -63.13 -51.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -50.77 -46.05 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.255 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.89 -62.17 1.88 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.617 0.367 . . . . 0.0 111.187 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.19 -30.16 68.0 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.02 0.827 . . . . 0.0 113.161 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -26.15 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 118.048 -1.461 . . . . 0.0 109.387 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.11 73.92 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.042 -1.036 . . . . 0.0 109.757 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.69 -42.36 95.39 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -57.65 -39.37 76.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.058 0.429 . . . . 0.0 109.955 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -78.86 53.76 1.44 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.637 -0.664 . . . . 0.0 112.456 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -62.09 -44.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.8 108.82 3.11 Favored 'General case' 0 N--CA 1.443 -0.812 1 N-CA-C 100.163 -4.014 . . . . 0.0 100.163 162.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -72.67 107.93 5.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.471 -2.15 . . . . 0.0 113.822 -153.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.13 121.98 37.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 108.879 -3.782 . . . . 0.0 105.828 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.89 149.74 32.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.08 138.56 53.71 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.12 165.37 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.006 0.522 . . . . 0.0 109.968 -176.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -132.13 111.9 11.85 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 110.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.537 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.1 tm? -92.86 116.12 28.74 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 124.796 1.238 . . . . 0.0 109.391 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -74.38 109.59 7.99 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -66.25 -33.11 75.02 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 111.289 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.71 -38.44 76.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.745 0.818 . . . . 0.0 110.179 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.96 -29.77 32.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.814 1.646 . . . . 0.0 111.598 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 t -124.27 55.65 10.22 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.571 1.548 . . . . 0.0 111.644 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -65.15 -29.34 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 124.377 3.385 . . . . 0.0 108.593 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -47.3 -69.33 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.6 t -54.5 -56.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.746 0.819 . . . . 0.0 109.928 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.23 -47.59 62.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -63.36 -49.89 72.09 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.816 -0.552 . . . . 0.0 109.849 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.07 -40.23 66.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.502 0.721 . . . . 0.0 110.642 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -78.96 -23.37 44.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.833 1.253 . . . . 0.0 111.814 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.3 28.69 19.27 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.561 1.077 . . . . 0.0 112.182 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -81.45 80.52 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -78.48 -3.19 42.22 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.761 -1.108 . . . . 0.0 112.288 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 m -155.96 157.34 36.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.468 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.5 pt -145.85 157.72 50.44 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.879 1.672 . . . . 0.0 106.637 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.79 147.02 87.06 Favored 'Cis proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.147 1.445 . . . . 0.0 113.329 1.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.7 m -156.72 120.41 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -97.06 116.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 125.354 1.462 . . . . 0.0 107.154 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.2 mtt -99.15 147.84 24.69 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.652 1.115 . . . . 0.0 108.696 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.56 105.45 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -89.47 124.04 34.13 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 4.69 18.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.758 0.823 . . . . 0.0 112.102 -175.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.91 100.46 0.36 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.1 -73.45 1.52 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-N 117.489 0.644 . . . . 0.0 111.874 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -102.12 172.64 6.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.981 0.912 . . . . 0.0 111.594 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -78.6 162.24 26.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.213 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.8 t -120.4 -66.61 1.04 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.675 1.19 . . . . 0.0 108.208 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -126.36 -169.16 1.97 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.27 1.028 . . . . 0.0 109.585 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -156.81 167.7 29.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.573 1.149 . . . . 0.0 108.069 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.88 133.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.1 mt -78.87 142.01 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.64 -157.12 7.51 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.039 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.8 54.62 9.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 109.95 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.42 158.04 74.18 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 125.633 1.573 . . . . 0.0 108.495 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.88 143.21 44.88 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 105.613 -2.495 . . . . 0.0 105.613 167.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.73 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.26 -56.41 8.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -55.22 -46.13 75.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.069 0.948 . . . . 0.0 110.605 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -49.09 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.05 -45.52 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.596 0.759 . . . . 0.0 109.543 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -42.93 87.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.488 1.04 . . . . 0.0 109.119 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.4 m -61.32 -46.77 88.92 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.438 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -48.75 78.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 O-C-N 121.829 -0.545 . . . . 0.0 109.709 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.03 -48.36 76.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -43.68 64.87 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.823 -0.548 . . . . 0.0 109.898 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.5 m-30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.456 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.57 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.24 -173.62 36.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.277 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.26 136.83 45.78 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.7 168.2 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 121.916 0.865 . . . . 0.0 109.459 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.75 175.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 106.27 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -47.33 -47.11 25.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.871 0.868 . . . . 0.0 112.156 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.39 -72.2 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.775 0.83 . . . . 0.0 110.714 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -52.57 -33.42 45.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.428 1.091 . . . . 0.0 112.422 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -41.48 -46.43 3.48 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.297 1.439 . . . . 0.0 110.199 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -56.47 -60.85 2.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.613 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -63.64 -31.63 72.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.516 0.726 . . . . 0.0 112.702 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.8 t -95.16 -48.1 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.277 0.631 . . . . 0.0 112.065 -171.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -94.22 -53.13 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.034 1.334 . . . . 0.0 111.713 -175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.02 -58.57 3.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.871 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.23 50.11 1.03 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.278 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 p -90.43 145.75 24.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.769 1.228 . . . . 0.0 112.218 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -93.44 -65.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -79.25 160.77 69.95 Favored Pre-proline 0 C--O 1.232 0.167 0 C-N-CA 124.608 1.163 . . . . 0.0 108.835 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -55.65 162.55 6.38 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.577 1.518 . . . . 0.0 110.692 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.63 144.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.878 1.671 . . . . 0.0 110.128 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 tt -124.91 100.81 6.77 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.427 1.891 . . . . 0.0 106.181 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.19 116.93 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -88.79 116.16 26.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -79.17 108.83 12.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -122.3 -169.15 1.84 Allowed 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 124.184 0.993 . . . . 0.0 111.017 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.02 150.8 2.02 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -57.61 -40.31 81.2 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.026 1.818 . . . . 0.0 111.291 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 74' ' ' ILE . 36.3 p-90 -67.06 -16.54 64.41 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.836 0.454 . . . . 0.0 111.585 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.1 t -74.69 85.01 2.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.227 -0.921 . . . . 0.0 111.176 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.71 -60.57 1.2 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.317 0.96 . . . . 0.0 113.563 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.48 -50.38 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.022 2.481 . . . . 0.0 112.61 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.06 -45.08 91.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -56.19 -50.29 71.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.556 1.143 . . . . 0.0 110.256 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.08 -37.85 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.437 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 pt -77.37 -25.29 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 120.083 1.31 . . . . 0.0 111.895 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.51 -47.56 4.69 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -62.22 -37.75 60.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.743 2.295 . . . . 0.0 110.484 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.96 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.5 -43.03 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -57.92 -66.14 0.52 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.1 0.409 . . . . 0.0 110.107 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -59.07 -29.52 67.38 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mm -50.8 -34.06 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.486 0.584 . . . . 0.0 109.983 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.4 74.85 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.525 1.057 . . . . 0.0 111.053 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.1 -24.61 76.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.57 -53.55 9.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 117.754 0.777 . . . . 0.0 108.911 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -79.78 58.66 2.88 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.71 -40.97 92.79 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 103.339 -2.837 . . . . 0.0 103.339 164.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.91 110.16 3.22 Favored 'General case' 0 N--CA 1.439 -1.018 1 N-CA-C 98.78 -4.526 . . . . 0.0 98.78 162.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -73.36 125.24 27.4 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 124.822 2.249 . . . . 0.0 115.586 -151.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HA ' HD12 ' A' ' 52' ' ' LEU . 16.5 tp -134.55 120.4 19.61 Favored 'General case' 0 C--N 1.314 -0.962 1 CA-C-N 107.867 -4.242 . . . . 0.0 108.054 164.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.24 94.04 7.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.14 130.34 35.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.834 -0.541 . . . . 0.0 109.565 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.67 174.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.706 0.802 . . . . 0.0 111.934 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -144.08 113.45 6.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.014 1.325 . . . . 0.0 111.283 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.0 tt -98.9 125.62 44.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.849 0.833 . . . . 0.0 110.6 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -71.74 105.24 3.66 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.906 1.283 . . . . 0.0 113.874 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -81.21 45.84 0.88 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.859 -1.151 . . . . 0.0 111.027 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -152.09 -48.94 0.11 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -82.98 -19.04 37.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.737 2.015 . . . . 0.0 110.2 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -137.33 61.4 32.24 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.834 1.254 . . . . 0.0 111.915 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.8 -24.6 8.49 Favored 'Trans proline' 0 N--CA 1.446 -1.304 1 C-N-CA 125.492 4.128 . . . . 0.0 110.317 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -47.62 -68.69 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.765 1.226 . . . . 0.0 110.276 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.79 -43.3 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.094 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.72 70.06 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.249 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.2 m -70.13 -45.95 65.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.583 0.753 . . . . 0.0 109.713 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.18 -45.83 75.81 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.977 0.511 . . . . 0.0 110.749 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -79.43 -30.3 42.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.352 0.261 . . . . 0.0 111.534 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.17 54.39 2.15 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.9 mm -69.75 92.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.859 0.838 . . . . 0.0 108.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -78.04 82.12 4.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t 73.21 -175.81 0.16 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.357 1.863 . . . . 0.0 109.498 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 30' ' ' TRP . 24.6 pt -145.38 157.06 53.33 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.22 . . . . 0.0 108.455 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.33 138.23 44.0 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 120.62 1.257 . . . . 0.0 111.85 1.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -134.63 98.25 4.01 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -89.53 109.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.2 mmt -97.16 143.57 27.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 64.4 t -114.13 133.51 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.15 161.21 31.6 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.91 77.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.951 0.405 . . . . 0.0 110.163 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.46 1.36 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.632 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.48 -56.52 3.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 123.836 0.732 . . . . 0.0 112.738 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -79.36 155.01 28.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 122.245 1.021 . . . . 0.0 111.893 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.12 130.47 36.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.649 1.979 . . . . 0.0 108.155 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.6 t -89.31 -57.99 2.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.269 1.028 . . . . 0.0 110.109 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.94 166.89 22.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.595 1.158 . . . . 0.0 111.869 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -142.25 126.15 17.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.251 2.22 . . . . 0.0 105.191 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -128.6 103.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -100.52 138.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.183 1.393 . . . . 0.0 109.555 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.81 156.15 21.94 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.953 0.787 . . . . 0.0 112.563 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.66 51.89 0.2 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.11 1.364 . . . . 0.0 113.148 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.91 148.77 69.18 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.81 156.06 64.19 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.356 1.37 . . . . 0.0 111.71 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.78 -46.04 29.99 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.894 1.277 . . . . 0.0 111.007 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.17 -41.89 3.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.776 0.831 . . . . 0.0 111.525 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.268 1.027 . . . . 0.0 109.153 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.47 -52.64 50.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 C-N-CA 124.431 1.092 . . . . 0.0 108.878 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.5 t -53.2 -58.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.783 1.233 . . . . 0.0 109.567 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.39 -50.11 68.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.449 -0.157 . . . . 0.0 110.911 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.2 m -60.4 -55.74 29.94 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.471 0.177 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -41.54 85.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 O-C-N 121.383 -0.823 . . . . 0.0 110.374 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -45.64 90.38 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -53.67 -42.2 67.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.856 -0.527 . . . . 0.0 109.781 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.744 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.365 0.126 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.85 -168.05 12.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.01 147.02 50.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.54 168.16 21.46 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 CA-C-O 122.038 0.923 . . . . 0.0 111.46 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.32 170.34 16.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.364 2.666 . . . . 0.0 105.93 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -39.93 -50.78 2.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.768 1.627 . . . . 0.0 110.964 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.95 -73.45 0.09 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.243 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 p -52.76 -36.43 57.88 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.274 1.03 . . . . 0.0 112.49 -174.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -40.02 -46.19 2.06 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.928 1.691 . . . . 0.0 110.841 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -49.78 -62.49 1.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.999 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.32 -39.84 71.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.284 0.634 . . . . 0.0 111.879 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.22 -40.01 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.953 -169.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.88 -60.21 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 123.892 0.877 . . . . 0.0 110.706 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -65.07 -68.15 0.38 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.626 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.98 34.98 0.2 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.862 0.865 . . . . 0.0 112.664 -171.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -91.21 143.49 26.6 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.993 0.917 . . . . 0.0 109.5 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.06 -60.91 2.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.4 1.08 . . . . 0.0 108.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.9 m -78.74 155.83 77.97 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -56.39 160.54 10.97 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.203 1.935 . . . . 0.0 114.351 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.23 118.56 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.536 1.134 . . . . 0.0 111.506 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.45 88.01 5.78 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 124.841 1.257 . . . . 0.0 109.593 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.22 133.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 O-C-N 121.157 -0.965 . . . . 0.0 109.259 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.54 121.49 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.924 0.89 . . . . 0.0 108.645 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.445 ' CE2' HD23 ' A' ' 57' ' ' LEU . 53.5 m-85 -79.79 108.67 13.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -123.29 -173.72 2.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 122.275 1.035 . . . . 0.0 110.296 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 152.63 9.78 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.43 -44.97 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-N 120.542 1.229 . . . . 0.0 111.756 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.549 ' CH2' HD11 ' A' ' 74' ' ' ILE . 17.1 p-90 -56.12 -20.7 18.55 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.463 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.7 t -77.46 84.84 3.85 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.585 -0.697 . . . . 0.0 109.412 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.98 -57.94 1.96 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.586 1.089 . . . . 0.0 113.147 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.9 -25.33 69.1 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.089 1.86 . . . . 0.0 113.01 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.9 m -77.2 -50.67 12.43 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -49.14 -50.76 35.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.564 1.546 . . . . 0.0 111.41 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.2 pt -64.81 -39.84 87.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.467 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 pt -76.83 -26.69 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.563 1.074 . . . . 0.0 111.667 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -48.46 4.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.97 -38.03 60.93 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.357 2.038 . . . . 0.0 110.357 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.57 -39.74 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.5 t -52.77 -40.69 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.96 -58.5 4.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.701 0.4 . . . . 0.0 111.054 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.59 -47.59 81.72 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.683 -0.636 . . . . 0.0 111.996 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.97 -38.5 60.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 54' ' ' CYS . . . -61.23 -43.42 98.91 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.421 -0.799 . . . . 0.0 109.301 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.02 -50.49 58.72 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.3 -53.37 44.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.527 0.663 . . . . 0.0 110.222 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -82.08 51.17 1.71 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.126 0.965 . . . . 0.0 112.015 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -41.6 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.935 2.494 . . . . 0.0 111.509 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.19 -54.43 46.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -78.13 -40.54 37.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.37 128.39 37.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 118.204 -1.398 . . . . 0.0 114.387 -152.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -83.11 163.14 21.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.465 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . 54.1 t -142.72 145.8 33.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.57 168.42 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.577 -175.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -137.87 112.44 8.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.294 1.038 . . . . 0.0 108.702 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 26' ' ' PHE . 45.7 tp -98.2 120.49 38.7 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.2 1.0 . . . . 0.0 109.725 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -73.23 109.99 7.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -67.49 -35.76 79.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.795 1.238 . . . . 0.0 111.086 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.51 -39.69 92.15 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -80.21 -33.52 38.08 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.877 1.671 . . . . 0.0 112.005 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.421 ' CB ' HD11 ' A' ' 57' ' ' LEU . 26.0 t -120.9 55.56 4.65 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.625 1.57 . . . . 0.0 111.937 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.34 -24.67 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.06 3.173 . . . . 0.0 110.598 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -54.15 -67.54 0.25 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.803 0.841 . . . . 0.0 109.773 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -53.21 -51.1 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 124.2 1.0 . . . . 0.0 109.202 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.47 -48.19 37.93 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.208 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -66.47 -46.65 75.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.018 0.527 . . . . 0.0 110.627 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.55 -45.5 77.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -79.43 -31.17 42.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.589 0.356 . . . . 0.0 111.488 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.59 43.94 3.04 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.655 0.645 . . . . 0.0 111.627 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mm -73.52 90.64 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -77.47 -20.53 54.27 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.3 m -156.18 165.01 37.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.549 HD11 ' CH2' ' A' ' 30' ' ' TRP . 26.7 pt -129.87 153.47 80.93 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.82 165.36 70.35 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.302 1.144 . . . . 0.0 111.954 0.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -156.74 113.55 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.77 115.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.9 mtt -111.56 134.84 52.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.58 115.77 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.79 162.48 15.21 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 0.0 109.619 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.41 151.55 9.75 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.71 1.204 . . . . 0.0 107.899 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.04 45.6 14.74 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.969 1.147 . . . . 0.0 115.969 170.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.06 0.31 60.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.94 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -129.94 159.38 36.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.737 1.769 . . . . 0.0 111.922 -176.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 138.59 31.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.81 1.644 . . . . 0.0 107.989 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.4 t -114.81 -82.25 0.61 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.003 0.921 . . . . 0.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -92.73 163.53 13.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.086 0.554 . . . . 0.0 110.866 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -157.5 122.61 4.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.773 1.229 . . . . 0.0 109.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.93 137.2 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.42 143.6 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 109.743 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.98 165.52 40.19 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 123.37 0.419 . . . . 0.0 112.328 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.63 131.17 45.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.308 0.643 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.3 153.77 41.25 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.8 138.97 27.01 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 104.714 -2.841 . . . . 0.0 104.714 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -56.14 -33.92 65.63 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.389 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.27 -37.3 7.11 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.542 1.064 . . . . 0.0 112.237 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.6 m -70.78 -41.68 71.36 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.499 -0.751 . . . . 0.0 109.302 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.0 mt -61.71 -44.23 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -54.36 -55.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -52.64 -43.5 65.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.966 0.348 . . . . 0.0 110.787 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -59.09 -40.2 84.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.33 -50.74 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.084 -1.01 . . . . 0.0 108.971 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -51.61 -47.48 63.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.047 0.939 . . . . 0.0 112.873 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -25.69 60.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 N--CA 1.453 -0.322 0 CA-C-N 118.44 0.564 . . . . 0.0 109.704 179.159 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.426 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.41 -179.01 51.49 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.43 137.62 54.81 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.89 164.98 32.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 122.299 1.047 . . . . 0.0 111.379 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -144.11 168.74 19.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.853 2.061 . . . . 0.0 105.731 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -39.63 -45.67 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.31 -70.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.432 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -59.57 -33.47 71.48 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.475 1.11 . . . . 0.0 112.336 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -42.17 -46.67 4.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 126.778 2.031 . . . . 0.0 111.265 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -47.45 -48.41 26.65 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.753 1.221 . . . . 0.0 110.651 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -82.33 -63.1 1.45 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.061 0.934 . . . . 0.0 111.268 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.97 -31.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.889 -169.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.21 -59.81 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.004 0.522 . . . . 0.0 111.865 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.38 -71.03 0.26 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.464 0.575 . . . . 0.0 110.041 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.88 48.41 0.83 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.723 0.809 . . . . 0.0 111.212 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 p -90.38 148.37 22.86 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.653 1.581 . . . . 0.0 109.129 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -83.62 -68.03 0.74 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 m -79.49 158.95 73.11 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.274 1.03 . . . . 0.0 108.66 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.12 164.9 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.486 2.124 . . . . 0.0 113.082 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.81 148.95 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.902 2.081 . . . . 0.0 109.207 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -131.68 105.56 7.6 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.19 122.91 52.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.618 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -97.73 117.69 32.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.52 112.13 16.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -126.14 -176.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.202 1.001 . . . . 0.0 110.335 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.89 148.29 3.13 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -53.21 -45.27 42.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.164 . . . . 0.0 112.513 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -67.07 -20.62 65.85 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.776 -0.578 . . . . 0.0 111.898 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.04 85.09 2.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.117 0.871 . . . . 0.0 110.404 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -34.45 -62.96 0.48 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.492 1.52 . . . . 0.0 114.374 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.57 -43.48 50.52 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 119.633 1.716 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.8 m -59.73 -45.37 92.4 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -55.22 -53.64 53.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.787 1.235 . . . . 0.0 110.542 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 pt -69.71 -29.71 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.36 -0.353 . . . . 0.0 111.397 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.1 mt -74.27 -35.32 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.253 0.621 . . . . 0.0 111.471 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.51 -48.03 6.68 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -61.72 -36.71 73.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.483 2.122 . . . . 0.0 109.75 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.77 -45.11 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.75 -43.75 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -66.05 -48.84 69.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.859 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.93 -41.08 99.37 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.829 -1.169 . . . . 0.0 109.65 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.6 mt -56.82 -44.44 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -54.68 -50.34 68.48 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.41 -45.21 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.93 -46.58 81.04 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -111.91 23.76 13.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -56.16 168.59 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.916 1.286 . . . . 0.0 112.317 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 71.3 -52.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 127.657 2.383 . . . . 0.0 111.199 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -80.19 -50.22 10.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.249 0.547 . . . . 0.0 110.094 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -102.0 106.4 17.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.652 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -78.66 90.04 4.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 49.1 t -78.32 137.9 38.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.53 163.09 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 123.161 0.585 . . . . 0.0 110.12 -175.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -127.57 115.21 18.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.483 1.113 . . . . 0.0 109.614 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tp -91.49 119.06 31.12 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.271 0.628 . . . . 0.0 109.562 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.17 107.1 6.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -67.99 -35.98 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.198 1.399 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.59 -38.82 92.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.701 1.201 . . . . 0.0 109.871 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.5 -25.08 33.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.719 2.008 . . . . 0.0 111.036 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 m -121.46 53.61 3.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 113.93 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.11 -25.82 73.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.061 3.174 . . . . 0.0 109.367 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -50.85 -70.38 0.09 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.896 1.279 . . . . 0.0 109.68 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.8 t -51.41 -50.63 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.059 1.344 . . . . 0.0 109.184 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.82 -47.88 51.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.251 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 m -72.15 -43.35 64.78 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.92 0.888 . . . . 0.0 111.236 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.91 -48.34 70.25 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.286 0.635 . . . . 0.0 110.03 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -79.55 -35.63 39.55 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.21 53.41 9.09 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 pt -57.31 142.11 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.497 1.119 . . . . 0.0 111.775 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -79.91 70.26 6.43 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.0 t 64.52 -160.15 0.29 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -139.51 150.23 62.89 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.78 143.29 73.5 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.985 1.03 . . . . 0.0 113.798 3.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m -140.44 110.04 6.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.82 134.15 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.1 mtt -124.86 128.44 48.67 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.657 1.183 . . . . 0.0 108.881 176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.77 131.58 45.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -119.94 134.23 55.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 173.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.485 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -104.49 25.48 10.17 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.109 0.964 . . . . 0.0 110.597 -178.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.21 123.26 5.22 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.43 -64.99 3.15 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.885 0.842 . . . . 0.0 113.376 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -126.22 172.73 9.82 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.244 1.018 . . . . 0.0 111.93 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -67.46 164.86 17.86 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.179 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -128.7 -57.37 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.815 1.646 . . . . 0.0 108.813 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -140.11 171.29 14.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.565 1.546 . . . . 0.0 109.729 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -160.08 147.83 16.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.5 150.4 33.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.08 144.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.62 162.41 37.85 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.603 0.557 . . . . 0.0 112.565 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.76 131.26 38.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.553 0.741 . . . . 0.0 110.534 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.37 149.5 48.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.05 155.48 33.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.676 2.251 . . . . 0.0 114.003 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -46.03 -52.47 11.82 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.404 1.482 . . . . 0.0 109.771 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.83 -45.85 50.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.281 0.633 . . . . 0.0 110.612 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -49.19 68.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -53.04 -58.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.9 t -52.42 -55.5 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 110.318 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.09 -47.43 78.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.506 0.594 . . . . 0.0 110.967 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.3 m -59.87 -42.27 93.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.96 0.504 . . . . 0.0 110.575 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.19 -57.18 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -45.32 -58.54 3.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.933 1.293 . . . . 0.0 111.342 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -18.59 25.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 . . . . . 0 CA--C 1.534 0.356 0 CA-C-N 120.013 1.279 . . . . 0.0 110.722 175.639 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.02 166.79 52.12 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.907 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.51 119.65 37.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.56 161.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.734 0.813 . . . . 0.0 109.671 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -138.04 171.7 14.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -39.82 -45.46 1.79 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.001 1.32 . . . . 0.0 111.468 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.68 -77.76 0.06 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.253 0.621 . . . . 0.0 110.974 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.7 p -46.69 -38.65 10.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.133 1.373 . . . . 0.0 112.744 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -39.71 -46.39 1.86 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.522 1.529 . . . . 0.0 110.819 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -48.76 -56.79 7.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.519 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.34 -33.57 49.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.871 -0.518 . . . . 0.0 112.017 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.4 t -92.5 -26.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -169.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.91 -51.25 4.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 124.747 1.219 . . . . 0.0 111.519 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.63 -61.86 1.69 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -77.51 33.22 0.16 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.932 . . . . 0.0 112.1 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 m -91.09 132.65 35.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.42 1.088 . . . . 0.0 111.133 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 p -78.79 -53.29 7.27 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.711 1.604 . . . . 0.0 107.158 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.94 152.56 79.91 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.02 166.61 29.09 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 N-CA-C 108.658 -1.324 . . . . 0.0 108.658 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.487 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -152.48 134.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.428 HD21 HG23 ' A' ' 77' ' ' ILE . 9.0 tt -99.06 115.35 28.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.987 1.715 . . . . 0.0 108.864 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.0 t -100.91 114.16 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.72 116.51 24.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -78.64 110.77 14.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 9.0 p-90 -124.17 -172.71 2.6 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.792 0.806 . . . . 0.0 112.111 -172.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.42 151.84 2.55 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 125.239 1.416 . . . . 0.0 107.426 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.55 -42.11 35.5 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.552 2.168 . . . . 0.0 110.044 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.477 ' CH2' HD11 ' A' ' 74' ' ' ILE . 34.6 p-90 -67.35 -17.32 64.7 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.355 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.9 t -80.02 87.52 5.41 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.208 -0.933 . . . . 0.0 110.794 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.49 -61.63 1.49 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.521 1.058 . . . . 0.0 113.712 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.73 -19.94 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.096 1.864 . . . . 0.0 113.21 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.0 m -82.75 -50.79 8.31 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -50.2 -47.4 54.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.567 1.547 . . . . 0.0 110.832 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.21 -18.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.929 -0.558 . . . . 0.0 112.415 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -88.74 -28.32 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.464 1.029 . . . . 0.0 110.052 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -39.08 -47.31 3.83 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.704 1.602 . . . . 0.0 113.266 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.25 -38.26 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.948 1.766 . . . . 0.0 110.884 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.4 t -69.75 -57.4 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.707 1.203 . . . . 0.0 109.452 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.519 HG22 ' SG ' ' A' ' 54' ' ' CYS . 3.2 p -54.02 -42.86 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.96 -56.24 23.45 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.59 -0.693 . . . . 0.0 112.427 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.38 -41.39 89.24 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 122.008 -0.433 . . . . 0.0 110.435 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -55.67 -44.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.34 -53.6 54.09 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -44.65 -44.43 8.38 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.249 0.452 . . . . 0.0 112.422 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.76 -41.84 96.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -121.92 9.76 10.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -39.85 -41.4 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.008 2.123 . . . . 0.0 113.752 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.84 -40.7 2.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.46 1.904 . . . . 0.0 112.991 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -132.47 -54.26 0.95 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HG ' ' HG3' ' A' ' 53' ' ' LYS . 12.6 tp -83.44 170.83 14.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' CB ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.36 93.75 2.96 Favored 'General case' 0 N--CA 1.433 -1.323 2 N-CA-C 122.993 4.442 . . . . 0.0 122.993 -164.05 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.519 ' SG ' HG22 ' A' ' 41' ' ' VAL . 11.1 t -151.2 122.2 7.65 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 118.96 -2.338 . . . . 0.0 114.794 174.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.08 165.68 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.599 1.16 . . . . 0.0 110.202 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HB3' ' CD1' ' A' ' 27' ' ' TRP . 7.4 mtmp? -132.73 122.81 25.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.732 1.213 . . . . 0.0 111.576 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -104.82 120.51 41.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.829 0.823 . . . . 0.0 110.21 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -69.45 109.51 4.26 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 124.775 1.23 . . . . 0.0 113.42 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -82.61 47.59 1.2 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 0.0 110.347 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.19 -46.59 0.1 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.43 -23.01 35.04 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.669 1.988 . . . . 0.0 109.705 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.47 53.24 5.65 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 112.542 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.55 -38.78 7.76 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.88 3.72 . . . . 0.0 109.493 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -49.46 -67.31 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.892 1.277 . . . . 0.0 110.528 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.09 -45.53 88.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.93 -39.77 66.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.059 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -72.73 -41.55 65.06 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 124.144 0.978 . . . . 0.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -55.39 -43.23 75.02 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.09 -32.29 44.61 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.89 35.24 6.86 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.12 1.343 . . . . 0.0 111.622 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.5 mt -80.84 62.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.329 1.452 . . . . 0.0 109.37 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -81.59 57.73 3.45 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.551 -0.718 . . . . 0.0 110.355 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 163.3 150.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.963 2.505 . . . . 0.0 107.585 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.477 HD11 ' CH2' ' A' ' 30' ' ' TRP . 13.3 pt -152.85 155.24 32.13 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.12 134.53 28.6 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.362 1.165 . . . . 0.0 112.857 1.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 m -132.8 106.21 7.6 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.428 HG23 HD21 ' A' ' 23' ' ' LEU . 36.1 mt -94.75 130.51 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.138 1.375 . . . . 0.0 107.698 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.5 mtt -130.62 152.22 50.22 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.46 141.35 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.22 167.28 20.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 110.623 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.65 152.2 3.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.746 2.018 . . . . 0.0 106.712 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.21 41.25 8.07 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.484 1.038 . . . . 0.0 115.675 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.5 11.49 68.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.103 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -138.38 167.85 21.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.441 1.62 . . . . 0.0 110.421 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.44 160.2 25.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.546 0.738 . . . . 0.0 110.139 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.3 t -115.94 -53.7 2.54 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 125.569 1.548 . . . . 0.0 109.455 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 -177.0 5.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.724 1.21 . . . . 0.0 108.834 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.9 t -158.35 151.8 23.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 0.0 109.48 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.3 mm -135.84 155.88 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 127.549 2.34 . . . . 0.0 105.55 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.1 mt -138.95 145.48 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.01 155.13 20.75 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.46 135.58 45.76 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.65 152.31 68.22 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.63 160.09 47.28 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.007 1.805 . . . . 0.0 112.409 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -43.41 -51.34 6.57 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 126.136 1.774 . . . . 0.0 111.276 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.95 -45.93 60.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.847 0.459 . . . . 0.0 110.948 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 m -66.28 -48.02 71.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.1 mt -55.72 -55.52 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.34 -51.84 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.496 0.718 . . . . 0.0 110.147 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.81 -46.86 81.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.996 0.816 . . . . 0.0 110.445 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.1 m -57.31 -43.32 83.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.294 0.638 . . . . 0.0 109.782 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 t -62.98 -58.91 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.996 0.816 . . . . 0.0 109.213 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -44.16 -51.89 7.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.835 1.254 . . . . 0.0 112.289 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -26.28 30.19 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 CA--C 1.536 0.404 0 O-C-N 121.379 -0.825 . . . . 0.0 111.328 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.41 111.6 4.1 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 112.2 -0.36 . . . . 0.0 112.2 -177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.65 115.5 19.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.55 165.07 12.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.282 1.039 . . . . 0.0 111.361 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -138.2 170.89 15.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.451 2.3 . . . . 0.0 106.408 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -38.81 -52.86 1.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.219 1.808 . . . . 0.0 111.428 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.69 -73.34 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.567 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -52.28 -38.12 57.44 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.511 1.125 . . . . 0.0 111.769 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -42.91 -45.08 4.84 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.313 1.845 . . . . 0.0 111.356 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -55.55 -51.95 65.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.856 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.11 -50.43 16.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.306 0.574 . . . . 0.0 111.655 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -74.57 -39.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.747 1.219 . . . . 0.0 112.825 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -107.38 -54.67 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 112.763 -170.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -64.53 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.81 49.61 0.78 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 110.432 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -84.13 121.91 28.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.565 1.546 . . . . 0.0 111.373 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.3 p -79.77 -61.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.88 153.88 80.5 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.78 149.86 67.31 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.517 -0.993 . . . . 0.0 109.517 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.484 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -149.96 127.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.38 121.15 30.46 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.29 114.97 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 171.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -99.31 136.83 38.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.498 ' CD2' HD12 ' A' ' 57' ' ' LEU . 5.9 m-85 -87.85 111.9 21.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.418 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 14.3 p-90 -117.63 -174.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.66 5.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -56.69 -39.59 90.27 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -70.52 -16.11 62.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.158 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.3 t -73.61 102.3 3.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.216 1.371 . . . . 0.0 111.408 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.8 -62.36 3.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.034 1.302 . . . . 0.0 114.018 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.64 -42.62 35.73 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.137 2.558 . . . . 0.0 111.674 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.7 m -63.14 -50.31 70.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -55.42 -49.76 71.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.134 -0.354 . . . . 0.0 111.098 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.24 -32.9 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.066 -0.969 . . . . 0.0 111.844 -175.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.8 pt -80.51 -28.62 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.646 1.567 . . . . 0.0 111.42 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.54 -49.39 5.13 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.12 -37.34 75.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.983 1.789 . . . . 0.0 110.043 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.56 -44.48 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 108.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.2 t -53.14 -53.28 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.85 -49.3 78.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.769 -0.582 . . . . 0.0 112.184 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.06 -43.63 95.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.968 0.804 . . . . 0.0 109.493 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.1 -41.44 80.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.34 -48.64 76.35 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.27 -44.28 57.77 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -58.52 -53.94 52.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.591 1.195 . . . . 0.0 110.409 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.483 ' CG ' ' HB3' ' A' ' 52' ' ' LEU . 60.3 m-85 -82.98 53.57 2.47 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.0 -21.59 66.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.861 1.665 . . . . 0.0 108.227 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 5.3 m-20 -62.16 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 168.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.516 ' CE ' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -161.17 110.41 1.61 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 164.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.765 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 7.1 tp -151.02 -177.35 5.96 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 116.858 -1.937 . . . . 0.0 112.067 159.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.765 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.29 66.26 1.73 Allowed 'General case' 0 N--CA 1.419 -1.996 2 N-CA-C 123.845 4.757 . . . . 0.0 123.845 -157.341 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -133.32 109.75 9.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 117.742 -1.583 . . . . 0.0 113.81 -177.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.43 163.43 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.464 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 36.3 pttt -153.76 121.54 5.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.005 0.431 . . . . 0.0 110.256 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.498 HD12 ' CD2' ' A' ' 26' ' ' PHE . 2.4 tm? -89.13 118.91 29.18 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.821 0.849 . . . . 0.0 110.243 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -72.49 105.64 4.25 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -69.51 -31.72 70.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.797 1.239 . . . . 0.0 111.567 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.1 -39.2 89.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.931 0.893 . . . . 0.0 109.483 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -86.76 -26.08 24.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.734 2.013 . . . . 0.0 111.722 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.405 ' CB ' HD21 ' A' ' 57' ' ' LEU . 14.6 t -126.21 55.96 14.9 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.571 1.548 . . . . 0.0 112.463 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.62 -31.2 70.42 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.508 2.805 . . . . 0.0 108.056 174.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -40.78 -75.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.485 1.914 . . . . 0.0 111.715 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.88 -48.14 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.849 1.26 . . . . 0.0 110.266 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.64 -41.26 69.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.731 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.0 m -72.27 -42.89 65.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 110.389 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -56.04 -42.18 76.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.677 0.391 . . . . 0.0 110.085 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.41 -36.38 45.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.15 45.64 3.01 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.36 0.981 . . . . 0.0 111.219 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.82 130.07 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -79.09 -38.8 35.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 t -163.62 -173.53 3.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 pt -129.42 156.27 78.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 124.558 1.143 . . . . 0.0 109.267 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.99 157.66 82.64 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.127 1.081 . . . . 0.0 112.621 2.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 m -160.99 142.32 11.81 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-O 122.213 1.006 . . . . 0.0 109.679 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.599 ' HB ' ' N ' ' A' ' 89' ' ' ILE 0.607 0.8 OUTLIER -75.2 13.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 2 N-CA-C 138.996 10.369 . . . . 0.0 138.996 -160.967 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 65.1 mtt -80.87 128.61 33.86 Favored 'General case' 0 C--N 1.318 -0.801 1 CA-C-N 126.526 4.239 . . . . 0.0 114.708 -162.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.6 137.04 33.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -129.29 160.62 32.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.093 0.957 . . . . 0.0 109.744 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.16 167.81 6.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.576 1.95 . . . . 0.0 105.916 172.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 51.34 34.12 32.99 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.81 9.9 66.73 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 117.88 -1.511 . . . . 0.0 115.409 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -147.81 169.14 20.42 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.469 2.134 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.69 149.4 50.06 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 127.765 2.426 . . . . 0.0 109.993 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.59 -80.17 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.028 0.531 . . . . 0.0 111.58 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.59 175.36 7.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.961 0.8 . . . . 0.0 111.49 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.5 p -143.16 116.01 8.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.433 1.093 . . . . 0.0 111.389 -175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.599 ' N ' ' HB ' ' A' ' 77' ' ' ILE . 23.5 mt -118.88 122.57 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.43 1.492 . . . . 0.0 112.934 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.5 mt -84.25 155.95 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 119.327 -2.108 . . . . 0.0 106.32 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.5 -158.33 7.12 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.35 -16.61 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.62 152.84 80.95 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 120.081 1.31 . . . . 0.0 108.883 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.32 131.73 21.03 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 105.172 -2.665 . . . . 0.0 105.172 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -57.89 -29.12 64.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.21 -38.65 18.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.387 0.994 . . . . 0.0 110.474 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -60.01 -51.92 67.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.609 1.164 . . . . 0.0 109.076 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.72 -49.07 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.352 1.461 . . . . 0.0 110.474 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -52.3 -55.25 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -57.91 -50.14 74.35 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.177 -0.327 . . . . 0.0 110.83 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.2 m -55.61 -41.26 73.21 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.116 0.567 . . . . 0.0 111.567 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.72 -45.24 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.888 0.767 . . . . 0.0 110.513 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -54.55 -35.02 62.8 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.422 0.689 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -44.9 -50.99 10.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.462 0.648 . . . . 0.0 109.465 171.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 124.111 0.964 . . . . 0.0 110.923 -176.924 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 121.171 0.51 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.82 140.73 38.82 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.67 92.36 5.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -81.79 161.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.589 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -160.0 -178.95 7.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -38.27 -56.53 1.21 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.0 1.72 . . . . 0.0 112.888 -170.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.05 -71.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.203 0.601 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 p -49.6 -43.41 46.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.891 1.276 . . . . 0.0 111.695 -175.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -39.94 -50.85 2.51 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.266 1.826 . . . . 0.0 112.248 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -49.7 -50.45 43.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.947 0.899 . . . . 0.0 111.405 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -79.61 -56.89 3.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.939 0.895 . . . . 0.0 112.058 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.26 -32.05 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 125.449 1.5 . . . . 0.0 113.073 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.29 -52.38 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.133 0.573 . . . . 0.0 112.432 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -73.6 -73.01 0.23 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.631 0.651 . . . . 0.0 111.293 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -79.62 47.09 0.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.206 0.602 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 m -90.42 151.35 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.566 1.147 . . . . 0.0 109.442 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -78.85 -57.06 3.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -78.42 150.98 77.39 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.52 162.61 39.57 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.491 1.461 . . . . 0.0 109.217 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.422 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -150.16 134.39 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -95.12 99.09 11.13 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 126.229 1.812 . . . . 0.0 108.125 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 p -94.9 125.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -94.32 121.51 35.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.54 108.17 12.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -124.35 -172.88 2.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.787 0.803 . . . . 0.0 110.913 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.48 152.26 3.2 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.25 -40.07 78.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.134 1.889 . . . . 0.0 112.455 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -73.2 -12.17 60.78 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.4 t -73.83 86.65 1.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.084 -1.01 . . . . 0.0 110.84 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -31.74 -66.5 0.17 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.299 1.428 . . . . 0.0 115.284 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -59.46 -45.27 27.19 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.001 1.8 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.5 m -56.4 -46.09 80.32 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -57.02 -50.92 71.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.17 1.388 . . . . 0.0 110.329 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.9 pt -68.36 -36.92 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.408 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.82 -25.47 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 120.178 1.354 . . . . 0.0 111.444 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -38.99 -45.81 3.14 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -64.6 -38.19 33.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.855 2.37 . . . . 0.0 110.241 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -39.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.682 1.593 . . . . 0.0 108.522 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.6 t -58.86 -50.93 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -58.92 -52.07 67.33 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.179 0.592 . . . . 0.0 111.865 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.45 -41.63 94.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.12 0.873 . . . . 0.0 110.469 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.14 -44.03 97.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . . . -57.76 -38.62 75.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.59 44.52 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -49.11 -54.38 16.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.421 0.688 . . . . 0.0 111.346 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.66 33.66 3.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -51.8 -45.45 63.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -33.35 -50.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.897 2.879 . . . . 0.0 113.401 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -149.88 -58.89 0.2 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.487 1.115 . . . . 0.0 113.5 -170.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.663 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 15.8 tp -78.59 179.14 7.28 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -155.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.663 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.23 92.06 2.7 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 123.196 4.517 . . . . 0.0 123.196 -157.097 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.43 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 39.6 t -152.97 120.98 6.14 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 119.949 -1.719 . . . . 0.0 112.584 173.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.59 171.98 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.711 0.804 . . . . 0.0 110.515 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -143.5 114.3 7.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.5 118.45 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.764 0.711 . . . . 0.0 110.195 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.11 106.49 5.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.9 m -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.667 1.587 . . . . 0.0 111.456 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -34.08 77.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.181 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -87.05 -15.37 38.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 110.972 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -138.53 64.34 37.15 Favored Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 120.239 -1.538 . . . . 0.0 112.687 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.75 -26.91 32.25 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.173 3.249 . . . . 0.0 108.582 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -47.37 -70.51 0.09 Allowed 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 125.535 1.534 . . . . 0.0 110.611 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.22 -49.97 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 125.541 1.536 . . . . 0.0 109.481 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.48 -45.79 69.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.524 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.2 m -68.92 -41.57 77.99 Favored 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 123.739 0.815 . . . . 0.0 111.014 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.03 -42.2 76.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.183 0.593 . . . . 0.0 109.724 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.67 -32.92 47.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.15 36.23 5.78 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.261 0.934 . . . . 0.0 110.797 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -74.45 107.72 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -77.73 -27.34 50.51 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.838 0.455 . . . . 0.0 110.923 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -155.34 159.04 39.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.6 pt -115.02 156.86 44.7 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.59 161.73 81.88 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 120.608 1.253 . . . . 0.0 114.175 3.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.9 m -160.63 124.86 3.6 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.82 106.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.665 1.186 . . . . 0.0 108.327 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.7 mtt -103.85 132.01 50.51 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.737 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.1 t -100.71 110.53 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -92.98 143.86 25.82 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 50.61 1.83 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.45 77.98 1.3 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.79 -61.82 2.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.94 0.781 . . . . 0.0 112.201 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.08 163.07 22.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.962 0.905 . . . . 0.0 111.058 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -89.4 151.24 22.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.94 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -109.17 -57.12 2.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.623 . . . . 0.0 107.765 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -124.36 159.48 30.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.798 1.239 . . . . 0.0 109.367 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.1 m -152.4 93.34 1.78 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -103.82 146.87 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.229 1.412 . . . . 0.0 108.46 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 90' ' ' ILE . 3.4 mp -80.01 151.45 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.32 -158.48 5.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.52 46.56 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.951 0.9 . . . . 0.0 110.504 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.05 153.18 80.27 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.16 139.22 35.01 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 N-CA-C 105.4 -2.577 . . . . 0.0 105.4 170.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -67.11 -19.67 65.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 118.773 -1.171 . . . . 0.0 109.918 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.23 -49.9 68.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.801 1.182 . . . . 0.0 109.221 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -55.86 -48.11 76.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.518 1.127 . . . . 0.0 109.687 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.67 -49.02 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.018 0.527 . . . . 0.0 109.81 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.88 -56.82 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -51.79 -45.65 63.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.369 0.531 . . . . 0.0 110.793 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.2 m -60.41 -33.07 71.98 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.589 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.6 t -76.75 -47.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 120.408 1.458 . . . . 0.0 109.988 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -49.35 -45.04 45.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.079 0.952 . . . . 0.0 111.063 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -53.86 -27.67 31.41 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 CA--C 1.531 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.131 177.865 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.25 175.46 54.66 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.83 136.13 54.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.93 164.36 30.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 122.346 1.07 . . . . 0.0 112.775 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.9 170.26 16.04 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 128.033 2.533 . . . . 0.0 104.433 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -39.12 -46.87 1.49 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.281 1.832 . . . . 0.0 112.735 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.13 -66.28 0.43 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.33 1.052 . . . . 0.0 111.723 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -67.21 -41.59 85.51 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.711 1.204 . . . . 0.0 111.641 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -39.52 -47.84 1.94 Allowed 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 127.524 2.33 . . . . 0.0 110.996 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -41.62 -66.67 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.006 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -42.96 65.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 111.364 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.0 t -73.51 -18.39 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.121 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.15 -51.18 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.333 1.053 . . . . 0.0 112.272 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.71 -70.86 0.43 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.121 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.01 40.22 0.4 Allowed 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.973 -1.08 . . . . 0.0 112.22 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 m -91.12 137.87 32.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.734 1.213 . . . . 0.0 110.645 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 p -78.78 -55.62 5.02 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.404 1.482 . . . . 0.0 108.66 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.93 156.38 79.82 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.59 167.17 19.71 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 N-CA-C 108.871 -1.242 . . . . 0.0 108.871 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -136.7 144.77 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 126.595 1.958 . . . . 0.0 109.21 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -124.69 98.37 5.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 106.494 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.31 120.29 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.183 0.901 . . . . 0.0 110.323 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -90.93 117.21 29.35 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.743 0.817 . . . . 0.0 109.143 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.45 108.67 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -127.41 -174.75 3.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 121.717 0.77 . . . . 0.0 111.075 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.62 149.01 4.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.91 -44.05 52.64 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.526 2.151 . . . . 0.0 112.448 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.512 ' CH2' HD11 ' A' ' 74' ' ' ILE . 40.5 p-90 -68.83 -18.33 64.15 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.146 -0.346 . . . . 0.0 111.823 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 37.9 t -77.89 85.14 4.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.21 -60.24 1.38 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.649 1.119 . . . . 0.0 114.088 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.12 -17.24 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.84 1.82 . . . . 0.0 112.509 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -81.43 -48.11 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.07 -49.93 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.308 1.443 . . . . 0.0 110.244 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 pt -63.19 -36.52 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.275 -0.869 . . . . 0.0 112.393 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.1 pt -80.04 -25.32 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.741 1.155 . . . . 0.0 111.401 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.87 -48.27 5.55 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 120.071 1.305 . . . . 0.0 114.497 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.72 -39.37 53.71 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.974 2.449 . . . . 0.0 110.026 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -47.07 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.02 -42.56 90.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.06 -56.28 24.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.02 0.528 . . . . 0.0 110.37 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -62.84 -37.84 88.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.917 -1.114 . . . . 0.0 111.108 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.21 -45.79 67.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.1 -51.89 66.26 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -46.18 -42.52 12.64 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 112.199 -0.361 . . . . 0.0 112.199 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -71.61 -54.54 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.675 0.738 . . . . 0.0 112.351 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -92.47 9.03 36.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -45.33 148.94 0.57 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.318 1.447 . . . . 0.0 111.831 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.1 t70 74.61 -50.09 0.67 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.626 1.97 . . . . 0.0 111.569 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -77.56 -29.02 51.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.73 1.212 . . . . 0.0 111.141 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.76 121.42 13.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.136 1.374 . . . . 0.0 108.319 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -79.45 94.12 5.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -79.45 133.34 36.53 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.279 -0.888 . . . . 0.0 108.978 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.84 168.54 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.301 0.572 . . . . 0.0 112.053 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -134.56 111.1 9.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.341 1.456 . . . . 0.0 109.517 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tt -89.56 118.51 29.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.764 0.792 . . . . 0.0 109.966 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -71.93 100.2 2.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 109.208 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 m -85.36 52.82 2.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.753 1.621 . . . . 0.0 110.081 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -148.28 -46.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -79.93 -25.44 40.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.528 2.331 . . . . 0.0 110.062 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 t -132.58 55.47 17.72 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.06 -23.59 29.25 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.994 3.796 . . . . 0.0 109.264 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -44.55 -58.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.784 1.634 . . . . 0.0 109.211 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.32 -53.25 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.027 0.931 . . . . 0.0 109.967 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.51 -40.32 62.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.975 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 m -69.79 -47.73 61.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.058 0.943 . . . . 0.0 110.567 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.55 -44.68 77.0 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.927 . . . . 0.0 110.437 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.01 -31.93 44.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.83 50.19 3.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.16 139.36 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 109.554 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -41.21 29.02 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.967 0.507 . . . . 0.0 111.403 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -167.11 -170.94 1.63 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.512 HD11 ' CH2' ' A' ' 30' ' ' TRP . 24.6 pt -130.32 152.65 80.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 124.774 1.23 . . . . 0.0 108.384 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.39 157.04 99.45 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.95 1.018 . . . . 0.0 113.478 2.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -160.15 114.43 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.8 mt -97.38 107.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.9 mtt -97.43 142.62 29.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.108 0.867 . . . . 0.0 109.0 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.22 129.56 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -132.92 162.11 32.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.862 0.865 . . . . 0.0 110.663 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.64 152.94 3.95 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.012 1.325 . . . . 0.0 108.151 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.47 44.8 11.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.55 8.17 70.85 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.837 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -138.39 163.05 32.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.597 1.698 . . . . 0.0 111.031 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -90.17 148.29 23.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.5 t -100.07 -60.69 1.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.266 1.027 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.47 -168.5 1.53 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.013 1.725 . . . . 0.0 107.159 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -150.95 172.16 16.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.599 0.76 . . . . 0.0 109.056 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.29 142.04 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.564 1.546 . . . . 0.0 106.835 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.9 mt -79.71 140.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -145.7 4.06 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.48 38.7 28.67 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.793 0.796 . . . . 0.0 111.232 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.22 157.55 60.8 Favored Pre-proline 0 C--N 1.341 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 111.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -70.5 140.07 39.08 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 163.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -58.0 -25.15 60.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.799 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.3 -44.66 34.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.156 0.889 . . . . 0.0 109.918 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -50.49 73.42 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.467 1.107 . . . . 0.0 109.53 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -52.38 50.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.869 0.868 . . . . 0.0 109.783 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.2 t -53.57 -58.88 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.653 0.661 . . . . 0.0 109.806 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -52.32 -53.07 49.02 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.6 m -53.71 -47.6 70.38 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.156 0.285 . . . . 0.0 111.64 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.63 -50.0 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.543 0.737 . . . . 0.0 109.279 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -57.6 -44.88 85.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.86 -51.5 60.81 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.055 0.942 . . . . 0.0 109.337 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 CA--C 1.532 0.285 0 O-C-N 122.277 -0.265 . . . . 0.0 111.613 -178.925 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.08 163.23 54.05 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.24 44.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.42 162.37 14.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 122.136 0.97 . . . . 0.0 110.572 -178.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -140.61 168.42 19.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.469 2.308 . . . . 0.0 105.778 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -39.87 -49.29 2.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.444 1.497 . . . . 0.0 110.787 176.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.74 -66.8 0.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.436 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -66.16 -41.38 90.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.436 1.095 . . . . 0.0 112.229 -174.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -38.93 -47.51 1.45 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 128.201 2.6 . . . . 0.0 111.237 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -44.41 -59.66 2.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.537 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.12 -46.04 18.81 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.884 0.849 . . . . 0.0 110.844 -176.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.0 -34.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.031 -168.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.29 -59.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.445 1.098 . . . . 0.0 111.657 -172.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.63 -68.02 0.37 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -175.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -79.61 41.69 0.49 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.556 -0.715 . . . . 0.0 111.762 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -90.18 139.6 30.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -78.52 -54.89 5.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -78.85 157.29 76.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.69 152.68 81.05 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 111.758 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 76.5 t -146.74 124.3 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.357 1.063 . . . . 0.0 113.757 -177.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' N ' ' HB2' ' A' ' 53' ' ' LYS . 4.2 tt -107.72 123.77 49.02 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 125.35 1.46 . . . . 0.0 108.341 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.07 133.38 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -96.59 123.37 40.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CE2' HD23 ' A' ' 57' ' ' LEU . 33.8 m-85 -78.78 110.94 14.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 175.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -123.15 -173.68 2.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.886 0.851 . . . . 0.0 111.045 -176.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.84 157.9 4.36 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 175.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.33 -38.53 84.16 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.136 1.891 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.444 ' CH2' HD11 ' A' ' 74' ' ' ILE . 51.0 p-90 -73.78 -8.68 56.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.947 0.499 . . . . 0.0 111.422 176.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -80.11 85.44 5.67 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.28 -1.512 . . . . 0.0 109.617 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.58 -61.6 1.81 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.675 1.131 . . . . 0.0 113.151 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -49.34 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.798 2.999 . . . . 0.0 112.04 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -57.6 -50.93 71.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.013 0.925 . . . . 0.0 109.304 -178.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.25 -45.87 90.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.186 -0.435 . . . . 0.0 112.152 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 pt -67.34 -38.61 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.23 -178.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.84 -23.35 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.66 1.118 . . . . 0.0 111.939 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.51 4.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -176.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.78 -29.41 23.79 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 122.666 1.988 . . . . 0.0 109.866 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -44.44 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.12 -44.49 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -54.3 41.91 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.36 -40.16 81.48 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.979 -1.076 . . . . 0.0 110.302 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.6 mt -58.21 -45.79 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.04 -44.98 64.5 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.455 0.571 . . . . 0.0 109.546 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 -57.1 10.39 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -50.09 -51.18 44.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.573 0.702 . . . . 0.0 111.288 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -88.26 19.94 3.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -56.4 153.1 10.32 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.075 0.852 . . . . 0.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.3 -52.1 0.7 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.799 2.039 . . . . 0.0 111.485 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -78.57 -51.84 9.34 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.41 -158.32 0.89 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -158.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HB2' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.21 82.12 3.01 Favored 'General case' 0 N--CA 1.441 -0.883 2 N-CA-C 127.687 6.18 . . . . 0.0 127.687 -156.729 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.6 t -148.29 121.7 9.07 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.938 -2.351 . . . . 0.0 114.974 172.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.92 167.35 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.382 1.073 . . . . 0.0 109.88 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -134.18 113.48 12.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.853 1.261 . . . . 0.0 109.758 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' A' ' 26' ' ' PHE . 20.2 tp -93.36 114.77 27.27 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.043 0.937 . . . . 0.0 110.413 -178.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -72.68 109.78 6.55 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.8 m -70.12 -33.51 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.031 1.333 . . . . 0.0 111.18 -174.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.54 -37.96 89.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.483 1.113 . . . . 0.0 109.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -87.35 -27.01 23.09 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.731 2.012 . . . . 0.0 111.758 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.2 t -121.01 52.8 3.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.275 1.83 . . . . 0.0 111.741 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.46 -38.16 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.642 2.894 . . . . 0.0 108.97 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -38.33 -69.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.657 1.983 . . . . 0.0 110.839 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.93 -54.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.746 1.218 . . . . 0.0 109.957 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.18 -37.46 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.835 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -68.69 -48.09 64.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.414 0.685 . . . . 0.0 109.162 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.62 -42.9 75.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 110.009 177.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.51 -25.62 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.49 13.47 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.723 0.678 . . . . 0.0 111.649 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.5 mt -79.85 90.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' CD ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.53 -10.74 59.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.621 1.169 . . . . 0.0 112.978 -175.221 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.9 m -159.38 161.98 35.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.444 HD11 ' CH2' ' A' ' 30' ' ' TRP . 22.2 pt -132.75 154.92 81.64 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.77 161.88 74.81 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.661 1.272 . . . . 0.0 114.424 4.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -160.85 122.04 2.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 174.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.96 99.14 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.967 0.907 . . . . 0.0 108.62 -172.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.3 mtt -96.83 138.86 33.75 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.586 0.63 . . . . 0.0 110.079 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.19 131.1 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.31 167.57 17.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.743 1.617 . . . . 0.0 111.174 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.17 151.67 3.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.752 2.021 . . . . 0.0 105.955 173.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 47.4 42.3 18.46 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 170.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.1 10.33 68.62 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.691 178.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -141.76 170.75 15.14 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.561 1.68 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.89 162.85 17.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.471 1.109 . . . . 0.0 111.262 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 45.2 t -130.53 -50.9 1.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.384 1.874 . . . . 0.0 110.012 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -138.88 167.38 22.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.468 -177.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.7 m -151.81 89.02 1.43 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 126.234 1.814 . . . . 0.0 106.24 175.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.08 -175.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 106.615 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.43 156.65 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.66 -150.16 2.09 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.9 -43.71 0.57 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.466 1.506 . . . . 0.0 112.166 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.86 151.95 79.73 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.03 149.25 53.87 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.621 1.547 . . . . 0.0 112.543 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -59.19 -37.24 76.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.2 -50.47 38.05 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.722 0.409 . . . . 0.0 110.074 175.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -56.86 -48.41 78.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.615 1.166 . . . . 0.0 110.095 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.1 mt -59.41 -53.01 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.43 -53.56 23.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.22 -42.26 63.43 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.328 0.513 . . . . 0.0 111.143 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.1 m -59.94 -47.72 84.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.58 -38.49 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 122.034 -0.417 . . . . 0.0 112.076 -178.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -45.68 -42.49 11.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.699 1.2 . . . . 0.0 112.304 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -45.84 -39.09 8.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.846 1.258 . . . . 0.0 111.734 176.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.452 -0.339 0 C-N-CA 126.972 2.109 . . . . 0.0 110.556 -178.375 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . . . . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 119.837 -0.125 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.19 148.31 36.99 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 174.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.46 100.81 10.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 171.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.421 HG23 ' CB ' ' A' ' 57' ' ' LEU . 12.7 m -103.6 161.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.852 0.834 . . . . 0.0 109.432 -176.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -151.34 172.89 15.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.93 2.092 . . . . 0.0 105.494 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.79 -48.41 15.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.073 0.949 . . . . 0.0 112.317 -176.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.22 -72.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 110.77 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -51.7 -36.58 47.26 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.539 1.135 . . . . 0.0 112.491 -174.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -39.8 -49.67 2.35 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 126.28 1.832 . . . . 0.0 110.863 177.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -49.98 -56.92 8.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.552 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -74.02 -45.15 51.61 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.678 -175.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.3 t -74.91 -43.7 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.574 -168.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.5 t -95.9 -64.65 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.22 1.008 . . . . 0.0 111.007 -173.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -64.31 -59.05 4.85 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.36 41.98 0.41 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.162 0.585 . . . . 0.0 111.312 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -89.75 -171.13 3.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 p -128.2 -65.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.799 2.039 . . . . 0.0 106.973 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.1 158.97 74.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.6 159.84 46.15 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.419 1.185 . . . . 0.0 111.347 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.24 123.95 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.178 1.791 . . . . 0.0 109.007 -177.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.84 101.33 12.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.76 137.76 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -110.74 118.08 35.19 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.499 ' CE2' HD21 ' A' ' 57' ' ' LEU . 34.1 m-85 -78.25 112.29 15.08 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -125.31 -174.82 3.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.172 0.987 . . . . 0.0 111.158 -175.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.41 142.73 1.78 Allowed Pre-proline 0 C--O 1.224 -0.287 0 C-N-CA 126.527 1.931 . . . . 0.0 106.165 171.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -37.98 -53.5 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.148 3.232 . . . . 0.0 117.708 179.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.6 p-90 -61.27 -15.96 40.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.449 0.568 . . . . 0.0 112.458 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -73.0 80.91 1.2 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.191 0.596 . . . . 0.0 111.022 -177.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.15 -56.75 1.8 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.642 1.115 . . . . 0.0 112.691 176.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -50.96 -48.64 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.176 2.584 . . . . 0.0 112.585 177.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.6 m -58.61 -47.51 84.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -61.42 -45.66 93.39 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.3 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.05 -25.47 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.331 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.33 -27.99 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.867 1.667 . . . . 0.0 110.391 174.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -38.68 -45.54 2.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 178.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.98 -40.24 73.22 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 CA-C-N 122.346 1.874 . . . . 0.0 109.855 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -74.18 -47.67 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.523 1.129 . . . . 0.0 108.668 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' SG ' ' A' ' 54' ' ' CYS . 0.4 OUTLIER -52.01 -36.08 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.422 1.089 . . . . 0.0 108.165 175.728 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 3' ' ' ALA . 16.9 t70 -70.1 -58.63 3.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.797 -0.565 . . . . 0.0 110.709 173.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -49.29 -41.46 38.2 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.347 -0.359 . . . . 0.0 111.757 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -52.76 -42.98 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 118.482 0.583 . . . . 0.0 110.433 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.71 66.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.671 0.669 . . . . 0.0 111.171 178.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.93 -46.01 14.85 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 174.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.06 -65.75 0.88 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.355 1.062 . . . . 0.0 113.104 -176.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -82.91 19.16 1.42 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.498 1.119 . . . . 0.0 112.805 -174.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -39.41 -42.02 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 128.204 2.602 . . . . 0.0 112.057 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -36.17 -46.89 0.54 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 127.719 2.408 . . . . 0.0 111.748 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.96 -55.04 1.3 Allowed 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.687 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.35 113.57 21.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -163.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.89 91.48 8.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 41' ' ' VAL . 7.7 t -79.23 142.09 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 120.752 -1.218 . . . . 0.0 109.454 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -156.73 176.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.828 0.74 . . . . 0.0 110.744 -178.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -142.13 137.74 31.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.846 0.858 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.499 HD21 ' CE2' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -114.87 122.26 45.77 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.71 1.204 . . . . 0.0 112.824 -179.268 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.66 105.79 5.92 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 122.071 0.939 . . . . 0.0 109.809 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -59.89 -39.8 86.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.665 1.986 . . . . 0.0 111.94 -173.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.33 -38.27 74.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.67 0.788 . . . . 0.0 110.709 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -80.09 -27.17 39.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.27 1.428 . . . . 0.0 110.995 177.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.4 m -134.57 62.83 56.88 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.813 1.245 . . . . 0.0 111.342 -177.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 -34.33 28.95 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 109.533 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -37.25 -69.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.764 2.026 . . . . 0.0 110.663 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -61.01 -45.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 122.822 0.449 . . . . 0.0 110.753 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -37.11 60.24 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.13 0.172 . . . . 0.0 111.049 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.1 m -74.41 -46.42 40.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.248 1.019 . . . . 0.0 109.859 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.04 -45.45 75.22 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.197 0.599 . . . . 0.0 110.501 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -79.27 -33.33 43.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.905 0.482 . . . . 0.0 110.51 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.57 53.58 2.41 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.9 mm -67.52 130.13 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.15 -42.4 26.26 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.934 -0.479 . . . . 0.0 110.783 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.8 m -166.09 174.95 8.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.799 2.04 . . . . 0.0 106.042 179.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 pt -120.35 150.75 52.4 Favored Pre-proline 0 N--CA 1.455 -0.202 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.33 144.8 81.59 Favored 'Cis proline' 0 N--CA 1.457 -0.654 0 CA-C-N 119.905 1.002 . . . . 0.0 113.355 1.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -143.12 111.67 6.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.05 138.77 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.3 mtt -130.51 128.19 40.68 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 173.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.6 97.2 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -79.34 125.99 30.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.09 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -137.29 0.31 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.03 77.82 0.42 Allowed Glycine 0 CA--C 1.531 1.031 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.25 -63.3 4.15 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -79.66 167.84 20.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.47 0.708 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -87.36 149.3 24.58 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.59 -55.19 3.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.351 1.06 . . . . 0.0 109.127 170.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -137.18 163.7 30.24 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.577 1.151 . . . . 0.0 112.808 -176.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.3 t -138.71 128.69 25.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 173.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 mt -140.21 137.27 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -78.64 140.03 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 174.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.11 -137.71 0.72 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.12 -31.1 0.21 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.448 1.499 . . . . 0.0 112.44 -177.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.06 149.5 79.87 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -56.95 144.99 87.43 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 120.988 1.125 . . . . 0.0 110.387 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -55.86 -31.6 62.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.341 0.656 . . . . 0.0 110.189 -178.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -37.87 60.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.021 0.828 . . . . 0.0 111.087 175.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -61.64 -49.55 76.12 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.355 1.062 . . . . 0.0 108.341 178.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.77 -43.23 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.569 1.148 . . . . 0.0 109.817 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.92 -55.03 22.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 124.127 0.971 . . . . 0.0 108.865 177.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -55.07 -48.19 73.84 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.994 -0.441 . . . . 0.0 110.289 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -59.76 -44.67 93.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.637 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.68 -44.75 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 CA-C-N 119.067 0.849 . . . . 0.0 110.636 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -46.65 -47.27 20.23 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.342 1.057 . . . . 0.0 110.731 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -44.48 -39.96 5.21 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.567 1.147 . . . . 0.0 111.818 176.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 CA--C 1.533 0.31 0 C-N-CA 124.796 1.238 . . . . 0.0 113.224 -175.538 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.02 157.74 51.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 177.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.55 117.57 33.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -105.58 160.15 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 122.187 0.994 . . . . 0.0 109.87 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -152.1 174.53 13.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.736 2.414 . . . . 0.0 106.774 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -37.72 -58.36 0.9 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 126.549 1.94 . . . . 0.0 112.653 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.26 -67.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -53.67 -45.59 70.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.145 0.978 . . . . 0.0 111.928 -175.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -42.07 -50.42 4.7 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 127.14 2.176 . . . . 0.0 111.447 -178.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -48.52 -48.06 38.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.791 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -81.05 -59.81 2.52 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.367 0.667 . . . . 0.0 111.456 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.31 -31.49 54.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 126.332 1.853 . . . . 0.0 113.116 -172.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.42 -56.51 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.449 0.699 . . . . 0.0 112.009 -173.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.76 -60.0 2.46 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.867 0.758 . . . . 0.0 109.815 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.84 42.32 0.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.9 p -90.16 148.42 22.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.902 -0.499 . . . . 0.0 109.832 -178.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 p -87.57 -62.93 1.39 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.778 1.231 . . . . 0.0 107.964 177.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 151.38 75.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.033 1.333 . . . . 0.0 108.192 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.44 160.49 48.42 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 120.942 1.095 . . . . 0.0 109.585 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.435 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -151.14 133.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -172.049 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.551 HD21 HG23 ' A' ' 77' ' ' ILE . 8.3 tt -92.3 109.46 20.84 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.07 110.14 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -87.15 113.39 22.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -79.11 109.81 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 177.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -130.47 -173.6 3.11 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 121.723 0.773 . . . . 0.0 111.44 -173.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.04 150.73 4.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.72 -40.2 85.73 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.042 1.828 . . . . 0.0 112.422 178.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.604 ' CH2' HD11 ' A' ' 74' ' ' ILE . 41.1 p-90 -70.19 -14.22 62.53 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.904 -0.498 . . . . 0.0 111.789 177.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 84.18 3.54 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.119 -0.988 . . . . 0.0 112.127 -177.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.52 -62.06 1.42 Allowed Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.772 -1.016 . . . . 0.0 114.059 175.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 -23.54 74.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.214 1.942 . . . . 0.0 113.222 -178.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.8 m -77.39 -58.55 3.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -43.45 -52.59 5.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.53 2.332 . . . . 0.0 111.602 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.69 -22.79 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.247 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.88 -27.29 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.488 1.04 . . . . 0.0 110.831 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.71 -44.97 3.9 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 117.023 -1.465 . . . . 0.0 114.005 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.71 -37.25 88.5 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.532 2.155 . . . . 0.0 110.215 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -43.4 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -59.97 -41.95 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 67.9 m-20 -65.05 -48.66 73.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.402 0.681 . . . . 0.0 110.599 178.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -60.76 -40.44 92.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.354 0.525 . . . . 0.0 109.719 -179.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mt -53.35 -47.29 58.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.519 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . . . -56.88 -52.42 65.2 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.81 -41.72 28.07 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.61 1.1 . . . . 0.0 112.129 178.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.47 -70.27 0.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.335 0.654 . . . . 0.0 110.046 177.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -86.86 48.46 1.65 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.427 1.108 . . . . 0.0 111.28 -174.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -52.02 61.38 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 127.595 2.358 . . . . 0.0 115.011 -168.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -70.08 -72.44 0.2 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.821 0.82 . . . . 0.0 111.834 -177.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -39.47 34.64 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -164.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 8.7 tp -105.48 -171.84 1.98 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -155.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.559 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.7 pptp? -76.34 91.67 3.28 Favored 'General case' 0 N--CA 1.431 -1.389 2 N-CA-C 123.585 4.661 . . . . 0.0 123.585 -160.933 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 52.4 t -153.82 121.89 6.07 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.492 -1.38 . . . . 0.0 113.2 172.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.59 163.68 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.395 1.478 . . . . 0.0 108.744 173.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 115.08 16.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.514 1.126 . . . . 0.0 110.864 -175.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -92.74 110.22 21.66 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.98 103.83 2.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.231 1.015 . . . . 0.0 108.699 177.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -84.53 54.1 2.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.492 2.317 . . . . 0.0 108.987 -177.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -150.89 -48.67 0.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.23 -26.25 30.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 111.238 172.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.87 53.13 0.94 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.97 2.108 . . . . 0.0 115.042 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.59 -25.75 40.51 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.683 3.589 . . . . 0.0 108.79 174.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -49.14 -70.56 0.09 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.897 1.279 . . . . 0.0 109.951 178.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.6 t -51.56 -49.44 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.232 1.413 . . . . 0.0 108.856 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.89 67.14 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.8 m -69.68 -45.79 67.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.28 0.632 . . . . 0.0 110.335 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.4 -46.05 76.61 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.245 0.618 . . . . 0.0 110.62 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.44 -31.36 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.478 0.311 . . . . 0.0 111.155 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.72 52.46 2.63 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.79 115.61 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -78.4 -33.65 48.63 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.091 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -163.29 -173.39 3.35 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.604 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.3 pt -142.14 149.05 50.71 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.22 139.27 60.45 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 CA-C-N 119.394 0.819 . . . . 0.0 113.304 2.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -130.15 118.89 22.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 102.04 -3.318 . . . . 0.0 102.04 172.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.551 HG23 HD21 ' A' ' 23' ' ' LEU . 45.2 mt -112.49 100.45 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 108.272 -172.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.4 mtt -94.29 138.39 32.34 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.136 0.426 . . . . 0.0 110.287 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.5 104.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.82 147.69 28.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.44 21.57 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.396 1.078 . . . . 0.0 109.618 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.06 127.23 6.04 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.5 -52.06 1.86 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.828 1.68 . . . . 0.0 114.116 178.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -138.48 -179.88 6.06 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.248 1.019 . . . . 0.0 110.649 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 152.71 21.04 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.778 1.231 . . . . 0.0 109.832 176.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -110.82 -71.06 0.78 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.404 1.482 . . . . 0.0 107.883 177.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -96.6 162.91 13.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.693 0.797 . . . . 0.0 109.691 177.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.4 m -153.27 108.58 3.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.347 1.059 . . . . 0.0 108.177 175.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.31 160.65 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -142.98 147.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.67 169.34 45.65 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 121.495 0.497 . . . . 0.0 112.33 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.85 82.71 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.989 0.515 . . . . 0.0 111.122 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.61 151.54 77.29 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.746 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -82.38 149.3 14.88 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.405 2.737 . . . . 0.0 106.76 170.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.01 -42.45 72.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.806 -0.559 . . . . 0.0 112.31 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.54 -51.73 6.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.98 0.912 . . . . 0.0 111.253 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 m -61.5 -50.23 73.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.161 0.584 . . . . 0.0 110.481 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -53.96 -56.37 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.594 0.758 . . . . 0.0 109.016 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -49.88 -64.08 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.741 1.617 . . . . 0.0 108.885 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -51.62 -47.3 63.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.188 0.449 . . . . 0.0 111.824 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -58.35 -45.34 88.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.207 -178.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -44.79 46.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 CA-C-N 119.262 0.937 . . . . 0.0 111.589 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -48.7 -44.33 37.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.244 1.018 . . . . 0.0 110.074 -178.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -44.26 -44.04 7.71 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.125 0.97 . . . . 0.0 111.717 174.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 CA--C 1.531 0.217 0 C-N-CA 125.423 1.489 . . . . 0.0 112.755 -177.955 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.16 -173.56 41.76 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.84 139.25 52.25 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.93 167.98 22.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 122.499 1.142 . . . . 0.0 111.514 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -146.71 175.9 10.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.706 2.402 . . . . 0.0 106.419 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -38.54 -58.78 0.99 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.5 1.52 . . . . 0.0 112.793 -176.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.98 -57.45 11.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.623 1.169 . . . . 0.0 111.908 -177.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -65.11 -40.01 93.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.526 0.73 . . . . 0.0 111.658 -173.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -41.02 -47.13 3.03 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.471 1.908 . . . . 0.0 110.866 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -54.96 -62.99 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.656 178.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -63.21 -32.59 74.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.213 1.005 . . . . 0.0 112.314 -176.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.9 t -92.55 -54.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.19 0.596 . . . . 0.0 111.968 -171.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -83.59 -57.35 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.255 1.022 . . . . 0.0 110.854 -175.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.1 mt -70.23 -54.97 10.51 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.06 0.391 . . . . 0.0 111.238 -174.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -79.44 48.7 0.92 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.73 -0.606 . . . . 0.0 110.622 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 p -90.47 158.51 17.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.21 1.404 . . . . 0.0 111.151 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 p -91.26 -72.05 0.6 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.93 1.292 . . . . 0.0 107.569 176.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -79.39 160.63 69.87 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.22 166.15 1.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.114 1.876 . . . . 0.0 111.771 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 t -138.64 145.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 109.944 -176.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -122.33 105.77 10.49 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 m -101.25 150.9 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 118.626 0.648 . . . . 0.0 109.489 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -115.07 119.9 38.01 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.526 0.73 . . . . 0.0 109.321 174.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.472 ' CD2' HD12 ' A' ' 57' ' ' LEU . 23.1 m-85 -80.76 111.31 17.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -128.84 -173.23 2.92 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.47 0.708 . . . . 0.0 111.608 -174.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.63 154.75 12.4 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.532 1.133 . . . . 0.0 108.158 174.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.46 -43.41 40.21 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.367 2.711 . . . . 0.0 112.07 -176.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.428 ' CH2' HD11 ' A' ' 74' ' ' ILE . 55.6 p-90 -70.9 -13.13 61.91 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.177 0.591 . . . . 0.0 111.262 177.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.23 80.68 3.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.209 -0.932 . . . . 0.0 111.061 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.39 -55.9 4.27 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.907 0.765 . . . . 0.0 112.812 176.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.55 -27.95 78.95 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.55 2.167 . . . . 0.0 112.715 178.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.54 -56.38 4.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -48.71 -48.57 40.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.091 1.357 . . . . 0.0 111.727 -177.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.45 -21.94 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.222 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.4 mm -89.54 -26.58 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 119.461 1.028 . . . . 0.0 110.012 177.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.92 -48.56 5.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.66 -36.88 83.17 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.106 1.871 . . . . 0.0 110.174 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.9 -45.02 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.565 1.146 . . . . 0.0 108.292 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.5 -53.39 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.82 -53.53 57.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.832 0.853 . . . . 0.0 111.943 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.65 -40.48 96.96 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.068 -1.02 . . . . 0.0 110.604 -177.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.5 mt -58.42 -46.7 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.85 68.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.57 -51.44 52.07 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -61.93 -49.22 77.04 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.91 10.43 41.32 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -38.42 -56.94 1.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 126.62 1.968 . . . . 0.0 112.45 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.58 -44.91 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.533 1.933 . . . . 0.0 113.44 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.42 -9.8 19.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.216 1.006 . . . . 0.0 112.458 -176.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -151.08 113.99 4.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -78.65 160.91 27.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 171.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 22.8 t -141.85 142.78 33.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.793 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.06 162.42 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -130.12 111.9 12.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.2 0.6 . . . . 0.0 110.087 -176.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.472 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.2 tm? -88.77 117.21 27.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.572 0.749 . . . . 0.0 109.383 -178.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -74.41 100.94 3.95 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -58.92 -39.71 82.36 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.122 1.769 . . . . 0.0 112.422 -175.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.14 -37.64 75.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.236 1.014 . . . . 0.0 110.343 -173.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -86.34 -28.83 23.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.66 1.584 . . . . 0.0 111.332 177.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -123.43 54.85 7.48 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.464 1.906 . . . . 0.0 110.609 -177.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.71 -40.22 66.42 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.942 3.094 . . . . 0.0 109.006 177.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -29.09 -75.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.404 2.281 . . . . 0.0 111.804 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.7 t -53.37 -49.57 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.049 1.34 . . . . 0.0 109.879 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.92 68.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.949 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -80.3 -42.11 23.65 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.562 1.145 . . . . 0.0 108.957 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.18 -41.39 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -78.64 -30.09 46.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.427 0.691 . . . . 0.0 110.666 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.49 49.32 6.76 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.236 0.922 . . . . 0.0 111.24 176.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -133.28 79.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.661 1.584 . . . . 0.0 109.95 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -31.69 46.67 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.57 145.3 54.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.428 HD11 ' CH2' ' A' ' 30' ' ' TRP . 13.4 pt -148.05 154.52 43.12 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.88 140.08 58.76 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 CA-C-N 119.812 0.968 . . . . 0.0 112.273 1.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 m -130.1 107.27 9.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.7 mt -88.78 137.85 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 16.5 mtt -131.59 135.57 47.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.07 141.15 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -127.93 155.45 44.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.949 1.3 . . . . 0.0 108.277 174.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.05 56.42 1.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.884 1.674 . . . . 0.0 107.836 -178.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.49 -153.56 16.93 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 -173.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.2 35.84 1.3 Allowed Glycine 0 CA--C 1.528 0.879 0 O-C-N 121.794 -0.827 . . . . 0.0 114.546 -177.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -151.27 155.26 38.41 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.624 1.569 . . . . 0.0 108.044 177.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -89.84 145.81 24.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.14 1.376 . . . . 0.0 108.323 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.3 t -112.32 -55.85 2.47 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.357 1.063 . . . . 0.0 111.062 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -133.56 170.78 15.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 111.061 -175.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.5 m -156.23 140.62 16.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.115 1.366 . . . . 0.0 108.932 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.4 mm -136.6 153.34 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mt -133.53 144.01 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.97 148.49 24.29 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.028 0.823 . . . . 0.0 112.698 176.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.06 72.76 1.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 110.941 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.4 m -78.91 147.03 69.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -56.66 158.19 17.08 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.901 2.401 . . . . 0.0 114.556 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -46.68 -51.63 15.58 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 125.832 1.653 . . . . 0.0 110.581 177.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.36 -49.42 44.5 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.445 0.698 . . . . 0.0 110.799 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -49.7 73.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.068 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.02 -54.44 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.86 -56.78 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.562 1.145 . . . . 0.0 110.377 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -55.25 -47.47 75.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.3 m -56.92 -44.76 82.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.484 0.714 . . . . 0.0 110.415 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.94 -56.26 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.949 0.795 . . . . 0.0 109.52 176.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -52.51 -45.51 66.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.204 1.002 . . . . 0.0 112.745 -175.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -60.28 -30.75 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.568 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.445 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.56 175.14 54.35 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.878 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.6 129.5 56.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.67 162.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 122.171 0.986 . . . . 0.0 110.094 -177.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -139.34 175.36 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.572 2.349 . . . . 0.0 106.952 175.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -46.9 -55.26 8.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.0 111.521 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.15 -52.27 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.196 1.398 . . . . 0.0 111.442 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 p -75.94 -37.76 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.579 0.751 . . . . 0.0 112.132 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -41.2 -46.56 3.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.767 2.027 . . . . 0.0 110.644 -177.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.34 -50.12 60.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.417 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -78.03 -52.97 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.62 1.2 . . . . 0.0 110.877 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.81 -35.18 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.205 -169.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.3 -59.71 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.3 mt -66.4 -73.57 0.13 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -174.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -82.93 57.95 4.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.726 0.81 . . . . 0.0 108.924 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 p -87.6 -139.5 0.1 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.098 0.959 . . . . 0.0 109.964 -178.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -160.68 -68.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 m -77.79 158.34 78.21 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 104.959 -2.238 . . . . 0.0 104.959 171.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 165.29 21.9 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 N-CA-C 108.55 -1.365 . . . . 0.0 108.55 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.4 146.01 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 125.419 1.488 . . . . 0.0 108.916 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -126.25 103.76 7.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.09 145.08 10.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -113.36 113.21 24.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 57' ' ' LEU . 52.7 m-85 -78.59 111.26 14.48 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.61 -173.84 2.78 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.716 0.635 . . . . 0.0 110.719 -178.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.38 141.46 0.92 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.754 1.221 . . . . 0.0 110.499 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.07 110.69 3.0 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.445 2.096 . . . . 0.0 108.919 176.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 137.31 -29.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 131.61 3.964 . . . . 0.0 105.684 -173.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.5 t -68.78 88.53 0.37 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.352 0.596 . . . . 0.0 111.933 -177.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -35.65 -67.3 0.34 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.233 1.873 . . . . 0.0 113.388 177.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.28 -46.54 29.82 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 119.6 1.7 . . . . 0.0 112.268 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.3 m -54.22 -42.44 69.8 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.308 0.503 . . . . 0.0 110.293 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -55.57 -53.34 57.59 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 122.802 0.441 . . . . 0.0 111.065 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 pt -74.1 -27.46 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.878 -178.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.24 -38.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 110.683 177.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.64 -48.33 5.15 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -60.36 -37.6 80.72 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.929 2.419 . . . . 0.0 110.435 178.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.49 -45.52 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.32 -44.55 88.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -58.15 -61.46 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.64 0.776 . . . . 0.0 110.011 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.91 -37.51 82.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.633 0.652 . . . . 0.0 111.309 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.41 -40.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 176.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -59.29 -43.82 92.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.443 0.565 . . . . 0.0 110.097 175.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.36 -39.86 84.08 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.96 -51.14 42.7 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -99.91 10.11 41.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -46.4 147.49 1.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 112.078 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.18 -46.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.945 2.098 . . . . 0.0 111.91 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.87 -19.48 54.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.959 . . . . 0.0 110.709 -178.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.2 tp -155.3 128.83 8.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 107.338 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tmtp? -90.16 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 54.0 t -79.55 133.91 36.47 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.534 -0.729 . . . . 0.0 109.517 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.28 169.85 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.427 0.632 . . . . 0.0 111.865 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -133.5 131.28 39.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.983 1.713 . . . . 0.0 110.438 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -119.47 133.89 55.48 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.098 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -81.52 111.15 17.58 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.107 0.956 . . . . 0.0 111.257 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.6 m -84.22 49.86 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.238 2.215 . . . . 0.0 111.13 -174.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.12 -42.15 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -80.7 -24.1 39.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.748 2.019 . . . . 0.0 108.981 169.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -144.18 62.73 10.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.607 1.563 . . . . 0.0 110.985 178.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.26 -26.67 4.03 Favored 'Trans proline' 0 N--CA 1.445 -1.37 1 C-N-CA 126.397 4.732 . . . . 0.0 109.079 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -38.79 -61.26 0.75 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.938 1.695 . . . . 0.0 109.647 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.9 t -56.79 -52.88 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.765 1.226 . . . . 0.0 110.047 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.16 -35.25 64.57 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.501 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 m -73.65 -46.1 48.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.701 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.52 -43.61 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.528 0.731 . . . . 0.0 109.944 177.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.99 -32.53 45.26 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.66 -0.21 . . . . 0.0 110.721 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.87 51.92 2.54 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 123.75 0.69 . . . . 0.0 111.533 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.9 mt -79.92 112.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.46 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.07 -27.42 43.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.118 0.567 . . . . 0.0 112.142 -177.62 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -157.72 161.89 38.54 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.76 154.88 81.09 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.3 135.18 38.22 Favored 'Cis proline' 0 N--CA 1.449 -1.098 0 CA-C-N 119.282 0.779 . . . . 0.0 113.074 1.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -121.84 102.48 8.22 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 173.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -79.58 137.2 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 175.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.0 mtt -130.22 148.27 52.03 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.34 128.32 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -116.31 144.91 43.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 12.59 3.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.168 -176.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.35 -154.41 25.12 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.25 20.09 0.59 Allowed Glycine 0 CA--C 1.533 1.165 0 CA-C-N 118.041 0.921 . . . . 0.0 114.866 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -153.9 162.58 41.11 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.587 1.555 . . . . 0.0 108.595 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -78.84 -179.48 6.59 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.77 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.8 t -138.9 -66.08 0.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.403 1.081 . . . . 0.0 108.962 177.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -120.94 170.31 9.63 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.601 1.56 . . . . 0.0 109.784 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 t -156.86 152.25 26.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.758 0.823 . . . . 0.0 108.943 178.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.41 150.15 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.794 1.238 . . . . 0.0 107.788 -177.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.7 mt -79.78 119.85 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 171.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.42 86.27 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.135 -0.814 . . . . 0.0 113.973 -173.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.94 66.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.252 1.021 . . . . 0.0 113.017 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.41 154.68 53.44 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 126.06 1.744 . . . . 0.0 106.958 176.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -58.04 155.13 35.3 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.441 2.094 . . . . 0.0 113.952 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.07 -42.54 63.27 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.339 1.056 . . . . 0.0 109.542 177.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.97 -49.0 66.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.948 0.499 . . . . 0.0 109.985 178.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m -61.14 -47.8 84.56 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.1 mm -54.11 -56.73 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -49.32 -58.55 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 125.183 1.393 . . . . 0.0 109.724 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -54.34 -48.31 71.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.881 0.31 . . . . 0.0 111.218 -178.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.0 m -61.36 -38.99 88.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.945 0.498 . . . . 0.0 110.604 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.4 t -65.67 -55.4 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 119.153 0.888 . . . . 0.0 108.778 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -43.86 -57.58 3.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 111.671 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.84 -26.77 15.6 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 CA--C 1.533 0.31 0 O-C-N 121.414 -0.804 . . . . 0.0 110.976 -179.601 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.435 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.02 162.94 42.07 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.592 1.567 . . . . 0.0 113.601 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.65 122.21 35.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 172.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.3 163.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.492 -176.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -149.25 170.5 18.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.469 1.907 . . . . 0.0 107.242 177.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -77.31 80.53 3.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 125.112 2.387 . . . . 0.0 111.713 -176.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 172.76 -76.83 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 2 CA-C-N 107.644 -4.344 . . . . 0.0 107.415 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.7 p -51.8 -39.34 58.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.616 1.167 . . . . 0.0 110.581 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -43.58 -45.54 6.73 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.584 1.553 . . . . 0.0 111.271 175.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -54.17 -52.16 62.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.289 0.566 . . . . 0.0 110.096 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -70.35 -52.5 22.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 111.052 -177.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.6 -46.23 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.721 1.209 . . . . 0.0 112.804 -172.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.2 -61.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.92 0.888 . . . . 0.0 111.169 -174.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -68.04 -56.81 7.53 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.706 -172.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.59 43.75 0.58 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.267 0.485 . . . . 0.0 111.357 -178.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -90.16 -174.62 4.26 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.76 0.79 . . . . 0.0 109.361 177.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.3 p -120.34 -73.34 0.65 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.58 1.952 . . . . 0.0 106.409 176.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.74 158.83 75.11 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.19 159.27 15.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.563 1.509 . . . . 0.0 112.791 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.72 118.0 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.282 1.433 . . . . 0.0 109.778 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -84.96 104.17 14.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.49 116.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -96.06 109.96 22.28 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.505 ' CD2' HD12 ' A' ' 57' ' ' LEU . 31.9 m-85 -78.8 110.89 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -126.69 -174.36 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.082 0.953 . . . . 0.0 111.119 -174.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.06 149.32 3.31 Favored Pre-proline 0 N--CA 1.456 -0.175 0 C-N-CA 124.979 1.312 . . . . 0.0 108.007 172.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.99 -38.34 93.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.706 2.271 . . . . 0.0 113.888 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -76.35 -12.21 60.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.399 0.545 . . . . 0.0 112.111 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 t -77.91 100.46 6.4 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.865 -176.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.92 -64.8 1.37 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.628 1.585 . . . . 0.0 114.544 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.52 -45.44 37.21 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.596 1.698 . . . . 0.0 110.876 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.79 -50.48 63.49 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.22 0.608 . . . . 0.0 109.612 -178.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -56.24 -48.85 75.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.154 0.582 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.46 -29.28 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.776 -177.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 pt -81.7 -24.54 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 120.608 1.549 . . . . 0.0 110.853 176.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.13 -48.61 4.26 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.47 -41.01 35.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.088 1.858 . . . . 0.0 109.97 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.54 -49.67 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.979 1.312 . . . . 0.0 107.926 178.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.7 -44.13 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -56.59 -33.79 66.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -51.07 -35.79 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.308 0.643 . . . . 0.0 109.504 176.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.17 -38.35 70.79 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.313 0.506 . . . . 0.0 110.919 177.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.42 -43.4 45.59 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -55.82 -52.15 65.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -107.58 34.09 3.71 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -58.79 161.84 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.806 0.442 . . . . 0.0 110.172 176.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 t70 74.92 -55.44 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.613 1.965 . . . . 0.0 111.429 178.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -77.87 -31.67 51.52 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 -177.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.47 152.24 49.33 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.761 0.824 . . . . 0.0 109.906 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -106.17 152.08 23.92 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 168.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 54.1 t -132.97 140.41 47.77 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.64 176.4 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 119.033 0.833 . . . . 0.0 109.461 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.72 134.61 26.98 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.442 . . . . 0.0 111.851 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.2 tm? -99.76 119.35 38.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.338 1.855 . . . . 0.0 110.047 -177.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.23 104.06 4.87 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -66.96 -29.64 69.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.684 1.594 . . . . 0.0 111.631 -173.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.2 -42.03 84.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.869 0.842 . . . . 0.0 109.778 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -83.76 -31.63 25.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.281 1.832 . . . . 0.0 111.687 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.1 m -125.85 60.1 31.83 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 -178.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.42 -34.9 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 124.723 3.615 . . . . 0.0 109.779 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -38.46 -72.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.545 1.938 . . . . 0.0 111.626 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.64 -44.78 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 124.026 0.93 . . . . 0.0 110.487 -178.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.15 70.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.538 178.198 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -71.52 -43.8 65.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 109.749 178.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.59 -41.51 77.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.618 0.367 . . . . 0.0 110.437 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -78.19 -33.49 50.06 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.91 47.38 2.1 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.725 0.678 . . . . 0.0 111.827 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.5 mt -78.71 112.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.45 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.37 -29.55 47.48 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.12 -0.362 . . . . 0.0 110.908 -177.345 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -160.85 155.01 22.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.58 156.53 38.59 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -66.75 161.23 75.97 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.503 1.215 . . . . 0.0 112.595 2.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -158.37 102.02 1.73 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.4 pt -85.81 133.83 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 174.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.7 mtt -121.25 153.37 37.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.81 117.73 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -112.22 156.39 22.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.144 0.977 . . . . 0.0 109.103 178.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 153.85 8.82 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.363 1.465 . . . . 0.0 107.316 176.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 37.72 9.77 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.005 0.821 . . . . 0.0 114.69 175.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.3 20.51 65.38 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.702 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -141.6 166.03 25.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.332 1.453 . . . . 0.0 109.573 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -90.54 155.22 19.04 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.34 0.656 . . . . 0.0 109.598 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.0 t -108.65 -62.46 1.46 Allowed 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 125.603 1.561 . . . . 0.0 108.941 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.31 179.41 8.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.861 1.265 . . . . 0.0 108.846 177.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 t -155.45 151.4 27.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.631 1.173 . . . . 0.0 109.544 -178.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -146.81 157.25 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.757 1.623 . . . . 0.0 108.208 -179.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -79.6 114.35 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.82 -12.53 21.57 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -174.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.1 63.38 0.33 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.915 . . . . 0.0 111.96 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.97 157.06 58.3 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.434 1.494 . . . . 0.0 107.792 177.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -58.48 155.52 35.79 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.638 2.225 . . . . 0.0 113.729 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.12 -51.81 17.04 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.832 1.653 . . . . 0.0 110.744 178.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -51.88 35.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.598 178.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 m -59.47 -46.51 88.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.776 -0.631 . . . . 0.0 109.874 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.22 -52.02 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.811 0.732 . . . . 0.0 109.366 177.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.3 -57.45 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.055 0.542 . . . . 0.0 109.678 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -53.35 -47.76 69.11 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.984 0.357 . . . . 0.0 110.681 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 m -54.12 -49.29 69.52 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.209 1.003 . . . . 0.0 110.09 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -61.65 -55.18 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.518 -0.739 . . . . 0.0 109.746 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -51.32 -48.41 62.36 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.434 0.693 . . . . 0.0 112.325 -175.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -57.82 -22.29 46.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.782 0.719 . . . . 0.0 112.593 -179.117 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 118.754 0.706 . . . . 0.0 111.404 179.4 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.2 151.28 41.84 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.71 104.47 16.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.89 158.73 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.104 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -143.26 174.93 10.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 177.337 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -39.37 -49.71 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.329 1.452 . . . . 0.0 112.295 -176.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.33 -78.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.129 177.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 p -45.95 -41.33 11.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.256 1.422 . . . . 0.0 112.632 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -39.71 -46.05 1.81 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.162 1.785 . . . . 0.0 111.38 175.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -49.83 -65.85 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.852 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.78 -35.94 82.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.254 0.622 . . . . 0.0 112.196 -176.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.93 -13.09 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.49 -66.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 119.026 0.83 . . . . 0.0 109.475 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.45 -35.12 69.72 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -93.69 -5.19 49.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.99 0.916 . . . . 0.0 111.817 178.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 m -77.26 132.51 38.71 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.712 -1.243 . . . . 0.0 111.909 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.37 -52.9 7.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.809 1.244 . . . . 0.0 109.553 178.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.59 152.8 83.41 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -64.34 154.51 70.96 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 120.925 1.084 . . . . 0.0 113.049 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.461 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -147.85 127.27 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 124.626 1.204 . . . . 0.0 113.541 178.609 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.11 95.49 9.46 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.26 113.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -86.9 114.52 23.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -79.0 102.89 8.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 175.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -120.32 -171.5 2.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 110.519 -173.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.67 152.93 3.97 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -56.59 -35.73 97.36 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.847 1.698 . . . . 0.0 112.237 177.056 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CH2' HD11 ' A' ' 74' ' ' ILE . 24.6 p-90 -76.84 -3.92 40.93 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.798 -0.564 . . . . 0.0 111.985 177.392 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.7 t -82.06 85.37 6.76 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.587 -1.321 . . . . 0.0 112.125 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.1 -57.88 2.46 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.374 0.988 . . . . 0.0 114.055 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.97 -24.04 53.53 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 120.035 1.917 . . . . 0.0 112.311 -178.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.4 m -66.92 -49.49 65.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.022 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -46.93 -45.55 20.76 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.836 0.854 . . . . 0.0 111.481 -178.01 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -77.48 -19.59 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.794 -177.261 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.16 -22.75 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 121.064 1.756 . . . . 0.0 109.752 171.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.37 -43.03 2.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.421 -1.276 . . . . 0.0 114.041 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.39 -40.96 36.28 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.228 1.952 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.5 t -64.21 -47.66 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.2 t -56.88 -54.58 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -176.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 68.9 m-20 -60.7 -49.78 76.13 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.326 0.65 . . . . 0.0 110.894 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -53.85 -52.56 60.03 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -54.34 -43.76 63.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 42' ' ' ASP . . . -52.16 -46.27 65.38 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.68 8.43 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 175.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -39.9 -49.49 2.43 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.235 1.414 . . . . 0.0 112.789 -177.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.24 24.65 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -174.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -40.87 -46.62 2.79 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.133 1.773 . . . . 0.0 112.303 -177.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.19 -44.76 1.25 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.068 2.547 . . . . 0.0 113.4 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -140.22 -55.51 0.53 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.148 0.975 . . . . 0.0 112.832 179.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.697 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 46.3 tp -78.57 -169.13 1.59 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.72 -1.582 . . . . 0.0 114.322 -155.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.697 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 3.4 pttp -75.79 99.88 4.56 Favored 'General case' 0 N--CA 1.432 -1.354 1 N-CA-C 127.605 6.15 . . . . 0.0 127.605 -153.504 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 52.3 t -160.02 127.8 4.68 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 120.304 -1.498 . . . . 0.0 112.719 168.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.23 167.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.906 0.882 . . . . 0.0 109.081 171.022 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -136.39 109.31 7.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.352 0.661 . . . . 0.0 110.456 -177.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.47 118.29 31.14 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 122.986 0.514 . . . . 0.0 109.877 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -72.46 111.86 8.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -67.97 -33.71 75.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.615 1.166 . . . . 0.0 111.423 -173.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -67.84 -37.4 81.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.529 1.132 . . . . 0.0 109.322 -179.655 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.88 -27.82 39.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.504 1.521 . . . . 0.0 111.375 177.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 m -119.19 51.03 1.5 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.67 1.588 . . . . 0.0 114.014 -176.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -60.03 -36.25 90.16 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 124.326 3.351 . . . . 0.0 108.419 175.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -44.34 -72.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.405 1.882 . . . . 0.0 109.93 175.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.76 -50.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.593 1.157 . . . . 0.0 109.738 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.28 -40.92 62.39 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.282 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 m -75.84 -41.12 53.36 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.194 0.998 . . . . 0.0 110.731 179.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.26 -45.2 80.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.148 0.579 . . . . 0.0 109.758 178.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -79.11 -35.22 42.59 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.26 50.74 2.93 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.416 1.008 . . . . 0.0 112.53 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.18 -169.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.248 0.619 . . . . 0.0 110.032 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -158.8 -84.81 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.576 0.75 . . . . 0.0 109.096 177.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -57.57 153.84 12.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 110.351 178.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.525 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.1 pt -140.84 155.14 69.23 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.03 140.05 45.43 Favored 'Cis proline' 0 N--CA 1.453 -0.903 0 CA-C-N 120.252 1.126 . . . . 0.0 112.879 2.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 m -127.84 104.84 8.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 173.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.0 mt -101.61 102.6 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.661 1.584 . . . . 0.0 108.244 -173.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.6 mtt -102.26 151.62 22.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -112.76 130.03 67.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 171.835 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -121.37 148.73 43.97 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 175.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.61 153.88 13.3 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.18 35.98 80.22 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 118.058 -2.02 . . . . 0.0 108.172 -174.199 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.18 -53.2 1.43 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.58 1.562 . . . . 0.0 113.997 -175.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -79.24 165.84 22.8 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -172.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -80.97 152.8 27.81 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 127.137 2.175 . . . . 0.0 110.833 -178.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.8 t -138.46 -80.39 0.33 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.401 ' H ' HG12 ' A' ' 79' ' ' VAL . 30.5 mm-40 -72.09 149.5 44.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.773 0.321 . . . . 0.0 110.343 178.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.12 75.34 1.29 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.28 1.832 . . . . 0.0 106.72 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.0 mm -81.24 154.21 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.2 mt -138.02 147.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -175.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.39 175.1 48.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.608 0.623 . . . . 0.0 111.567 178.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.66 153.2 44.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.54 156.08 45.43 Favored Pre-proline 0 C--O 1.232 0.165 0 C-N-CA 123.484 0.714 . . . . 0.0 109.207 -178.272 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -73.88 143.97 33.92 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 N-CA-C 105.885 -2.39 . . . . 0.0 105.885 166.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -38.46 76.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.239 0.542 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.57 -52.66 28.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 m -58.86 -49.29 78.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.363 0.665 . . . . 0.0 110.065 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -54.21 -53.09 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.006 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.9 t -52.15 -56.73 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.533 0.733 . . . . 0.0 109.254 179.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -52.7 -45.87 67.08 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.264 0.554 . . . . 0.0 111.706 178.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.8 m -58.93 -38.95 80.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.156 -177.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -81.63 -36.2 14.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 119.026 0.83 . . . . 0.0 111.334 178.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -55.75 -35.11 65.84 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -46.48 -37.96 8.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.006 0.522 . . . . 0.0 110.704 171.284 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 127.089 2.156 . . . . 0.0 112.741 -179.169 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.706 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.88 -165.41 31.57 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 176.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.83 141.69 48.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.54 166.08 23.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 122.316 1.055 . . . . 0.0 111.09 -178.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -141.5 169.31 17.84 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -39.33 -46.09 1.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.794 1.638 . . . . 0.0 111.986 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -57.38 -70.55 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.871 177.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.9 p -61.07 -38.2 85.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 112.256 -175.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -39.34 -46.17 1.55 Allowed 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 127.905 2.482 . . . . 0.0 111.107 178.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -42.65 -66.29 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 111.954 175.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -45.05 60.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.933 -174.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.4 t -70.42 -38.26 73.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.001 -171.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -108.69 -69.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.706 -174.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -54.51 -50.78 67.02 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.99 0.359 . . . . 0.0 111.148 -172.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -88.07 17.06 5.3 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.614 -178.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.17 154.21 37.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.12 1.327 . . . . 0.0 111.132 -178.127 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -86.71 -58.63 2.53 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.617 1.567 . . . . 0.0 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.07 161.03 72.33 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.719 1.208 . . . . 0.0 108.01 178.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.41 164.67 8.63 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.659 1.573 . . . . 0.0 109.697 173.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 t -145.88 115.83 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 110.98 -174.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tp -89.06 98.78 11.96 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.32 110.6 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 123.33 0.652 . . . . 0.0 110.549 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -89.11 115.31 26.55 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 57' ' ' LEU . 7.9 m-85 -80.05 111.39 16.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -131.11 -171.86 2.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.744 0.783 . . . . 0.0 111.035 -173.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.98 150.35 2.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 172.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.4 -42.26 69.31 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.281 1.987 . . . . 0.0 112.177 178.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -66.24 -21.09 66.28 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.077 -0.389 . . . . 0.0 111.757 178.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.0 t -76.26 83.45 3.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.615 -0.678 . . . . 0.0 111.345 -176.166 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.73 -57.18 2.89 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.697 -1.057 . . . . 0.0 113.599 173.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -20.53 67.25 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.977 1.785 . . . . 0.0 112.654 -179.658 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.2 m -82.06 -59.0 2.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -40.13 -53.0 2.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 127.569 2.347 . . . . 0.0 112.154 -178.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.93 -22.32 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.47 -33.78 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.347 1.059 . . . . 0.0 110.26 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.88 -43.39 3.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 127.311 2.244 . . . . 0.0 115.512 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -67.43 -36.25 20.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.822 1.681 . . . . 0.0 108.86 -179.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -40.2 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 127.166 2.186 . . . . 0.0 107.748 179.032 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.82 -47.77 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.39 -53.19 60.58 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.715 0.406 . . . . 0.0 111.692 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.31 -41.16 96.53 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.16 -0.962 . . . . 0.0 110.813 -179.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.98 -42.8 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' A' ' 54' ' ' CYS . . . -53.84 -46.84 71.33 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.52 36.83 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 176.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -47.35 -41.75 20.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.546 0.673 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -112.71 31.3 6.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.016 0.926 . . . . 0.0 112.192 -178.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -57.05 154.71 9.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.523 0.678 . . . . 0.0 110.49 -178.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 71.64 -48.45 0.68 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 128.093 2.557 . . . . 0.0 112.028 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -78.37 -13.17 59.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.206 0.457 . . . . 0.0 110.742 179.134 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.62 119.7 6.28 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -80.97 167.73 19.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.409 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . 45.6 t -146.9 147.5 30.86 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.93 161.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -125.81 110.61 13.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.435 HD12 ' CD2' ' A' ' 26' ' ' PHE . 2.9 tm? -89.56 112.43 23.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.38 1.472 . . . . 0.0 109.242 -178.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -71.89 107.98 4.93 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.0 m -60.58 -43.18 97.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.147 1.779 . . . . 0.0 111.665 -174.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.21 -33.77 75.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.901 0.881 . . . . 0.0 110.506 -177.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.8 -27.42 36.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.566 1.146 . . . . 0.0 110.425 175.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' HD11 ' A' ' 57' ' ' LEU . 1.4 m -122.86 52.81 4.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.914 1.686 . . . . 0.0 113.492 -176.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.23 -31.34 63.97 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.403 3.402 . . . . 0.0 107.985 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -50.43 -60.12 3.32 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.369 1.068 . . . . 0.0 109.457 177.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.59 -55.41 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.8 0.84 . . . . 0.0 109.374 -178.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.43 -45.38 36.19 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.933 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -65.59 -50.23 65.88 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.13 0.572 . . . . 0.0 110.715 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -56.61 -44.06 80.78 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.752 0.421 . . . . 0.0 111.305 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -79.29 -32.22 43.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.607 -0.235 . . . . 0.0 111.579 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.49 60.8 0.98 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.5 mt -129.11 152.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.274 1.43 . . . . 0.0 107.77 -178.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -148.67 -71.08 0.21 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.19 151.11 41.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 pt -146.27 154.77 50.09 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -179.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.74 151.23 74.86 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.656 1.27 . . . . 0.0 113.825 2.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -156.72 100.37 1.92 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 tt -100.7 123.1 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -178.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 mtt -106.02 144.19 33.08 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.413 1.085 . . . . 0.0 110.066 -177.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.9 t -95.87 101.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -95.89 156.36 16.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.178 179.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.31 -154.9 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 171.325 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.56 95.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.301 1.429 . . . . 0.0 114.261 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.02 -76.83 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.919 0.771 . . . . 0.0 113.913 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -79.88 169.71 17.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.097 0.951 . . . . 0.0 113.429 -171.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.59 157.41 17.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.255 171.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 15.9 t -109.36 -60.45 1.77 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.832 1.253 . . . . 0.0 110.113 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -132.86 179.08 6.39 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.602 1.561 . . . . 0.0 109.097 -178.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -160.34 163.78 33.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.979 0.512 . . . . 0.0 110.055 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 mt -137.18 146.53 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.8 mp -135.71 151.1 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.269 1.428 . . . . 0.0 108.52 -174.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.99 152.78 10.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.2 67.92 2.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.707 . . . . 0.0 110.77 -179.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.87 144.3 63.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.75 155.65 13.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.593 2.195 . . . . 0.0 113.896 -178.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -49.28 -43.76 43.37 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.064 0.946 . . . . 0.0 111.323 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.32 65.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 110.625 179.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -45.91 86.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.05 -54.68 21.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -50.3 -57.45 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 124.442 1.097 . . . . 0.0 110.187 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -54.73 -47.33 73.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.623 0.249 . . . . 0.0 111.044 -178.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.9 m -64.3 -41.31 96.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.517 0.327 . . . . 0.0 110.86 -179.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.2 t -60.2 -50.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -57.43 -50.77 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -48.01 -50.19 28.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.699 0.8 . . . . 0.0 109.976 176.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.528 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 118.048 -0.977 . . . . 0.0 108.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -45.03 136.88 4.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.842 0.857 . . . . 0.0 112.49 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.44 123.14 20.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.871 1.268 . . . . 0.0 113.764 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.61 -169.51 46.04 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.97 141.34 52.01 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.66 165.61 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 CA-C-O 121.884 0.85 . . . . 0.0 110.565 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -146.69 176.84 9.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.819 2.047 . . . . 0.0 105.866 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -39.29 -57.97 1.28 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.849 0.86 . . . . 0.0 112.504 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.67 -58.61 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.822 1.249 . . . . 0.0 112.015 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -67.14 -35.66 80.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.347 0.659 . . . . 0.0 111.645 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -46.12 -47.28 17.43 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.531 1.533 . . . . 0.0 110.996 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -49.42 -55.28 13.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.107 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.5 -62.02 1.68 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.933 0.893 . . . . 0.0 111.653 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.83 -27.46 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 125.715 1.606 . . . . 0.0 113.077 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -115.46 -74.82 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.567 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.54 -42.31 70.76 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.048 1.295 . . . . 0.0 113.17 -172.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.78 17.07 11.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.727 0.811 . . . . 0.0 111.958 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.9 p -72.99 149.69 43.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.44 1.018 . . . . 0.0 111.892 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.5 p -92.51 -58.77 2.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.43 1.492 . . . . 0.0 108.992 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.67 162.91 63.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 125.3 1.44 . . . . 0.0 109.058 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -55.07 164.32 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.518 2.145 . . . . 0.0 112.383 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 t -145.48 144.13 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -126.66 97.41 5.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.9 t -95.06 119.52 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -94.2 111.67 23.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 57' ' ' LEU . 26.5 m-85 -78.49 109.92 13.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -123.84 -171.42 2.32 Favored 'General case' 0 N--CA 1.458 -0.05 0 C-N-CA 123.826 0.85 . . . . 0.0 111.157 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.7 151.4 2.84 Favored Pre-proline 0 N--CA 1.455 -0.198 0 C-N-CA 124.64 1.176 . . . . 0.0 108.137 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.51 -33.47 98.04 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.457 2.105 . . . . 0.0 112.759 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -74.47 -14.15 60.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.528 -0.732 . . . . 0.0 111.018 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -83.45 82.8 8.13 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.123 -0.986 . . . . 0.0 111.304 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.27 -58.03 2.96 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.732 1.158 . . . . 0.0 113.864 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -57.71 -40.37 80.01 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 CA-C-N 119.748 1.774 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -58.53 -52.08 67.15 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -55.95 -48.5 75.66 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.86 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -74.48 -22.26 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 118.884 0.765 . . . . 0.0 111.741 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.514 HG22 HG23 ' A' ' 41' ' ' VAL . 18.4 mm -81.69 -34.51 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 119.496 1.043 . . . . 0.0 110.805 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.05 -45.44 4.66 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.207 1.803 . . . . 0.0 115.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -62.52 -40.48 38.29 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.983 1.789 . . . . 0.0 109.821 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.91 -48.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.716 1.207 . . . . 0.0 107.762 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 37' ' ' ILE . 76.2 t -52.09 -51.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 123.905 0.882 . . . . 0.0 108.823 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.0 -57.78 10.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.08 -43.68 87.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.882 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mt -56.26 -49.4 76.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.26 72.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 121.447 -0.783 . . . . 0.0 111.668 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -48.99 83.24 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -55.19 -47.86 74.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -83.53 59.11 4.92 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.309 1.528 . . . . 0.0 111.379 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.81 155.35 13.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.925 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 68.51 -55.1 0.53 Allowed 'General case' 0 C--N 1.338 0.099 0 C-N-CA 129.024 2.929 . . . . 0.0 113.589 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -82.84 -53.16 6.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -81.1 99.28 8.42 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.671 -171.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -79.66 87.38 5.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 41.9 t -78.24 152.36 32.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.856 -1.152 . . . . 0.0 108.805 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.84 166.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 121.752 -0.592 . . . . 0.0 109.745 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -130.31 121.33 25.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.63 1.172 . . . . 0.0 109.381 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.559 HD23 ' CE2' ' A' ' 26' ' ' PHE . 42.6 tp -108.43 118.9 37.97 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.859 1.264 . . . . 0.0 110.085 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -73.87 112.98 10.5 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.0 m -69.74 -28.54 65.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.374 1.47 . . . . 0.0 111.498 -173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -76.6 -40.64 48.88 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 122.013 0.911 . . . . 0.0 110.174 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -83.01 -27.23 30.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.28 2.232 . . . . 0.0 112.162 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.8 m -132.34 62.15 61.49 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.216 1.406 . . . . 0.0 109.718 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -68.03 -33.65 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 1 C-N-CA 125.509 4.139 . . . . 0.0 109.97 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -30.07 -73.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.332 2.253 . . . . 0.0 111.964 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -35.4 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.328 -175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.21 76.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.5 m -68.2 -47.23 68.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.146 0.978 . . . . 0.0 109.554 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -55.9 -43.34 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.173 0.589 . . . . 0.0 111.062 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.69 -34.81 45.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.018 0.527 . . . . 0.0 111.247 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.17 56.35 1.07 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.4 mt -122.02 146.36 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.84 1.656 . . . . 0.0 107.638 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -149.35 -64.23 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.26 144.87 56.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 pt -143.54 156.31 60.15 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.11 141.61 57.54 Favored 'Cis proline' 0 N--CA 1.454 -0.812 0 CA-C-N 120.007 1.038 . . . . 0.0 113.528 3.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -133.91 101.25 5.0 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.742 -3.058 . . . . 0.0 102.742 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.6 mt -97.11 100.54 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.374 1.47 . . . . 0.0 107.646 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 6.7 mtt -88.25 148.1 24.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.54 139.43 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 C-N-CA 125.659 1.584 . . . . 0.0 107.671 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -129.21 144.59 51.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.411 ' H ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -101.41 -27.03 13.38 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.318 0.386 . . . . 0.0 111.22 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.7 87.95 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 -63.15 2.8 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 123.554 0.597 . . . . 0.0 112.178 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -79.88 154.6 28.24 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.608 0.763 . . . . 0.0 110.701 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -71.27 158.05 37.05 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.51 1.124 . . . . 0.0 109.72 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.96 -58.18 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.714 1.206 . . . . 0.0 110.176 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -141.79 177.68 8.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.695 1.198 . . . . 0.0 110.112 -174.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.7 m -156.38 132.74 10.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.282 1.033 . . . . 0.0 109.546 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.3 mt -109.46 144.26 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mt -130.19 142.58 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 173.61 47.26 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.792 0.71 . . . . 0.0 112.49 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.26 156.1 35.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.797 0.439 . . . . 0.0 109.92 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.66 156.67 38.86 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.028 0.931 . . . . 0.0 109.059 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -82.99 139.35 9.56 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.174 2.582 . . . . 0.0 107.171 170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -48.58 -45.27 37.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 0.0 112.672 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -45.66 67.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.985 0.421 . . . . 0.0 110.626 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -65.15 -45.98 82.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.1 mt -56.2 -52.42 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 t -48.86 -58.51 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 124.609 1.163 . . . . 0.0 109.429 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.14 -47.46 83.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.494 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.0 m -56.06 -43.4 77.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.485 1.114 . . . . 0.0 110.11 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.94 -52.04 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 121.387 -0.82 . . . . 0.0 109.095 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -52.63 -47.34 67.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.62 0.768 . . . . 0.0 112.745 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.67 -23.78 65.09 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.944 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -90.11 -44.8 9.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.809 0.731 . . . . 0.0 109.686 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.5 mp -92.09 -97.09 0.13 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.083 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.17 -45.83 75.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 171.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.92 135.92 38.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 170.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.5 167.37 50.14 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.781 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.06 128.21 56.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -129.68 165.44 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 122.482 1.134 . . . . 0.0 111.604 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -142.89 172.14 13.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.784 2.434 . . . . 0.0 106.023 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -39.26 -49.87 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.99 1.716 . . . . 0.0 112.371 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.57 -74.08 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.227 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 p -50.31 -42.08 52.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.591 1.156 . . . . 0.0 111.826 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -39.93 -42.84 1.41 Allowed 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.679 1.992 . . . . 0.0 111.15 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -61.88 -58.84 6.39 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.669 -0.644 . . . . 0.0 111.76 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -62.09 -32.74 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.323 0.649 . . . . 0.0 111.403 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -93.12 -30.24 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.898 0.879 . . . . 0.0 113.255 -170.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.95 -72.43 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.103 0 C-N-CA 124.626 1.17 . . . . 0.0 109.828 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.4 mt -46.98 -55.84 7.43 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.981 0.912 . . . . 0.0 111.584 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.49 7.97 8.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.714 1.206 . . . . 0.0 113.175 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -71.29 143.14 50.44 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 120.027 1.285 . . . . 0.0 110.615 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -81.87 -60.5 2.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.652 1.181 . . . . 0.0 108.73 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.04 162.43 64.55 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.186 0.995 . . . . 0.0 109.484 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.02 160.31 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.901 2.4 . . . . 0.0 113.713 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.0 t -143.06 147.64 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.174 1.39 . . . . 0.0 108.417 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 tt -127.36 110.84 13.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.06 139.85 28.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -111.72 120.46 42.08 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.21 113.89 17.7 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -127.27 -172.15 2.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.764 0.793 . . . . 0.0 110.279 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.45 152.52 4.02 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -52.76 -42.87 60.21 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.579 2.186 . . . . 0.0 112.614 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.518 ' CH2' HD11 ' A' ' 74' ' ' ILE . 26.4 p-90 -69.07 -12.81 62.01 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.768 -0.582 . . . . 0.0 112.269 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -77.82 80.78 4.26 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.797 -1.189 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.93 -56.49 3.78 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.354 173.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.92 -29.93 88.06 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.945 1.763 . . . . 0.0 112.414 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.26 -48.34 57.27 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -48.32 50.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.657 0.783 . . . . 0.0 111.647 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.25 -20.65 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.877 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.4 pt -90.02 -28.88 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 121.126 1.784 . . . . 0.0 110.264 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.43 -47.37 4.5 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.36 -39.4 57.16 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.332 2.021 . . . . 0.0 110.216 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.85 -46.34 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.08 -42.18 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.76 -65.26 0.7 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.421 0.688 . . . . 0.0 111.927 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -42.35 78.13 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 120.275 1.398 . . . . 0.0 111.727 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.8 mt -62.77 -26.23 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.553 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.93 90.82 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.7 1.136 . . . . 0.0 109.016 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -47.49 90.83 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -58.35 -50.66 72.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -97.25 33.19 2.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.387 0.675 . . . . 0.0 112.349 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -60.27 168.83 1.85 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.607 0.718 . . . . 0.0 111.307 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 71.9 -58.55 0.58 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 127.377 2.271 . . . . 0.0 111.743 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.4 -50.15 11.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.866 -174.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.9 105.84 16.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.105 0.562 . . . . 0.0 110.108 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.15 98.96 6.76 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.0 t -79.32 137.34 37.3 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.559 -0.713 . . . . 0.0 110.47 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.16 163.71 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.524 0.678 . . . . 0.0 112.195 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -133.86 118.53 18.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.406 1.482 . . . . 0.0 109.595 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tp -99.5 124.17 44.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.511 0.724 . . . . 0.0 110.69 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.63 109.05 7.79 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -67.39 -36.82 82.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.008 1.323 . . . . 0.0 111.243 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -66.4 -38.34 87.26 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.37 1.068 . . . . 0.0 110.106 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -82.83 -25.43 32.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.162 1.785 . . . . 0.0 111.363 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.2 t -122.6 52.73 4.32 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.461 1.504 . . . . 0.0 112.636 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.29 -25.94 71.79 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 124.135 3.224 . . . . 0.0 110.45 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -54.62 -63.26 1.21 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.702 0.801 . . . . 0.0 108.911 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.75 -51.23 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.794 0.838 . . . . 0.0 109.061 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.86 -47.99 21.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.228 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -67.37 -48.83 66.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.533 0.733 . . . . 0.0 110.797 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -54.55 -46.98 73.73 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.539 0.736 . . . . 0.0 111.203 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -79.56 -31.17 41.9 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.162 0.585 . . . . 0.0 111.166 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.84 52.1 3.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mm -73.54 84.03 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 122.192 0.996 . . . . 0.0 109.345 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -78.42 76.38 4.93 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 m 94.31 166.19 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.391 2.676 . . . . 0.0 110.383 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.518 HD11 ' CH2' ' A' ' 30' ' ' TRP . 28.9 pt -136.21 153.68 76.75 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.169 0.988 . . . . 0.0 108.544 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.06 145.83 76.44 Favored 'Cis proline' 0 N--CA 1.453 -0.858 0 CA-C-N 120.31 1.146 . . . . 0.0 112.772 1.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 m -139.45 113.17 8.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.58 138.16 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.7 mtt -129.85 143.89 51.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.5 t -107.76 139.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 126.045 1.738 . . . . 0.0 107.065 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -126.62 134.48 50.76 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 173.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.453 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -100.64 -26.67 13.73 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -176.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.69 67.95 0.25 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.35 -56.89 3.71 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.89 157.66 26.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.844 0.857 . . . . 0.0 110.559 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -65.76 160.63 22.54 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.87 1.668 . . . . 0.0 111.482 -175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.0 t -129.61 -66.23 0.81 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.471 1.508 . . . . 0.0 109.541 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -138.27 172.72 12.49 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.818 1.247 . . . . 0.0 110.007 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.6 t -160.47 153.49 21.52 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.041 0.936 . . . . 0.0 109.819 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.4 mm -134.54 146.24 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.76 142.16 42.54 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 126.379 1.872 . . . . 0.0 108.25 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.92 155.05 16.69 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.316 0.484 . . . . 0.0 111.998 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.95 52.37 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.549 1.14 . . . . 0.0 112.588 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.7 145.69 63.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -56.44 147.47 68.33 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.24 1.293 . . . . 0.0 111.426 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -58.1 -34.68 70.45 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.59 55.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.247 0.93 . . . . 0.0 110.992 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -49.48 77.28 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.237 1.015 . . . . 0.0 109.007 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.0 mm -58.26 -49.68 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.693 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.39 -53.08 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.45 1.1 . . . . 0.0 109.21 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.09 -48.89 72.94 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.3 m -60.8 -36.74 79.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.233 0.613 . . . . 0.0 111.441 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.81 -53.71 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 O-C-N 121.206 -0.934 . . . . 0.0 108.826 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -53.44 -42.24 66.92 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 124.412 1.085 . . . . 0.0 110.86 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -49.83 -45.89 50.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.309 0.644 . . . . 0.0 110.404 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -77.18 -57.72 3.68 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.04 66.54 8.7 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.917 0.887 . . . . 0.0 108.975 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.185 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.623 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 117.818 -1.086 . . . . 0.0 108.578 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -64.77 -40.51 95.39 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 119.533 1.06 . . . . 0.0 110.538 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.84 92.07 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.797 0.839 . . . . 0.0 110.774 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.1 -178.47 44.68 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.5 136.86 54.64 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.86 166.7 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 122.635 1.207 . . . . 0.0 112.064 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -149.15 172.71 14.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.298 2.639 . . . . 0.0 105.269 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -38.01 -50.12 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.85 2.06 . . . . 0.0 111.687 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.34 -72.22 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 111.572 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -58.64 -33.95 70.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.711 1.204 . . . . 0.0 112.292 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -42.57 -44.64 4.25 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.603 1.961 . . . . 0.0 111.051 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -54.05 -55.61 25.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.504 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -72.33 -46.11 56.98 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.344 0.658 . . . . 0.0 111.858 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -85.07 -19.48 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.884 1.274 . . . . 0.0 114.085 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.6 -51.64 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 119.611 1.096 . . . . 0.0 112.044 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -70.32 -52.07 25.5 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.938 -0.476 . . . . 0.0 111.543 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -79.12 -9.12 59.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 m -55.73 135.4 51.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.636 1.174 . . . . 0.0 112.852 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 p -79.87 -62.03 1.81 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.805 1.242 . . . . 0.0 109.725 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.93 157.25 76.53 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -54.42 157.62 11.47 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.711 2.274 . . . . 0.0 113.931 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -140.27 118.45 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.547 1.539 . . . . 0.0 110.676 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.55 91.64 7.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.67 1.188 . . . . 0.0 108.417 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 p -99.27 125.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -99.41 121.31 40.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.57 0.748 . . . . 0.0 109.199 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.425 ' CD2' HD13 ' A' ' 71' ' ' ILE . 6.1 m-85 -79.77 116.51 19.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -133.31 -170.67 2.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.915 0.486 . . . . 0.0 110.662 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.43 151.08 4.35 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -54.58 -40.05 85.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.71 2.273 . . . . 0.0 113.147 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -68.7 -16.62 63.88 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.451 0.568 . . . . 0.0 111.348 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -77.61 79.55 4.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.985 -1.072 . . . . 0.0 111.31 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.57 -57.34 4.53 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -46.66 -34.55 15.55 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.423 3.415 . . . . 0.0 114.244 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.01 -54.41 6.32 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.97 0.891 . . . . 0.0 108.638 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.9 tpt85 -47.42 -49.11 25.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.197 0.999 . . . . 0.0 111.381 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.31 -26.58 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.776 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.1 pt -87.75 -26.47 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.194 1.816 . . . . 0.0 110.514 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -46.18 4.05 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.75 -40.98 26.32 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.103 1.868 . . . . 0.0 110.378 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.9 t -62.32 -52.06 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.116 1.366 . . . . 0.0 107.879 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.16 -47.21 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.832 1.253 . . . . 0.0 108.868 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -68.09 -55.5 12.24 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -60.59 -32.83 71.92 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.491 0.587 . . . . 0.0 109.483 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.61 -49.27 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.09 -33.87 67.74 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.85 -0.531 . . . . 0.0 110.537 176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.05 -56.26 26.32 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.1 -41.45 62.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.078 0.439 . . . . 0.0 110.679 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -98.32 25.97 5.81 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.272 1.029 . . . . 0.0 113.304 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 169.3 2.0 Allowed 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.446 0.641 . . . . 0.0 111.97 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 73.82 -53.71 0.69 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.784 2.033 . . . . 0.0 111.28 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -78.44 -54.97 5.6 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 tp -100.61 114.21 27.7 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.5 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -78.42 163.33 25.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 45.8 t -145.56 146.13 31.28 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.42 168.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.482 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -136.0 107.42 6.88 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.685 1.194 . . . . 0.0 109.611 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -87.57 117.16 26.18 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -73.37 104.15 4.28 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.628 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.7 m -56.37 -46.74 79.9 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.309 1.844 . . . . 0.0 112.023 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.9 -36.7 82.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.26 1.824 . . . . 0.0 110.479 -172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -84.65 -26.01 28.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.459 1.904 . . . . 0.0 111.116 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.9 t -122.01 54.61 5.34 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.855 1.662 . . . . 0.0 111.905 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.6 -24.84 76.85 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 124.098 3.198 . . . . 0.0 111.02 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -51.83 -71.66 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.046 0.938 . . . . 0.0 109.089 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -53.48 -48.34 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.648 1.179 . . . . 0.0 109.885 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.29 -51.32 46.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.855 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -70.66 -43.99 67.99 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.573 0.749 . . . . 0.0 110.878 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -53.1 -47.67 68.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.564 0.745 . . . . 0.0 110.303 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -79.35 -31.09 42.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.95 48.08 5.93 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' A' ' 26' ' ' PHE . 2.6 pt -74.38 97.96 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.072 0.939 . . . . 0.0 109.894 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 69.08 4.68 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.653 1.181 . . . . 0.0 109.208 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t 101.6 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 129.48 3.112 . . . . 0.0 109.506 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -143.59 161.01 48.9 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.3 1.84 . . . . 0.0 109.318 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -68.57 157.01 88.94 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 120.697 1.285 . . . . 0.0 113.054 2.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.0 m -152.07 102.59 2.81 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.8 mt -79.86 131.96 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 42.7 mtt -125.54 136.79 53.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -96.02 101.47 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -89.01 148.62 23.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 33.94 1.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.625 0.578 . . . . 0.0 110.728 -177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.31 105.57 3.0 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.69 -70.93 0.9 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.524 1.059 . . . . 0.0 113.025 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -101.53 169.84 8.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 122.055 0.931 . . . . 0.0 112.189 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -84.09 165.09 18.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.334 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.9 t -118.79 -58.88 1.92 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.16 1.384 . . . . 0.0 108.911 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -133.18 176.29 8.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.112 1.365 . . . . 0.0 109.434 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 t -158.76 160.89 36.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.083 0.553 . . . . 0.0 110.706 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.3 mt -138.15 122.92 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.8 mt -108.03 139.73 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.988 0.915 . . . . 0.0 109.404 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.0 153.92 14.76 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 121.47 0.483 . . . . 0.0 113.133 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.52 73.69 1.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.991 -0.711 . . . . 0.0 111.307 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.2 m -78.74 148.18 72.26 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.96 157.07 11.25 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.03 2.487 . . . . 0.0 113.948 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -51.94 -45.78 64.48 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 123.68 0.792 . . . . 0.0 111.646 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.93 -47.66 64.58 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.277 0.631 . . . . 0.0 110.355 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -48.13 78.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.7 mt -53.41 -57.08 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.8 t -48.96 -61.27 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.994 1.318 . . . . 0.0 109.872 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -52.8 -46.49 67.68 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.344 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.8 m -63.18 -44.54 95.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.622 0.369 . . . . 0.0 110.919 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.23 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 121.207 -0.933 . . . . 0.0 108.882 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -55.58 -54.05 48.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -47.3 -49.79 23.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.45 1.1 . . . . 0.0 110.166 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -73.31 -30.94 63.72 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.4 mt -154.8 103.42 2.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.92 1.288 . . . . 0.0 109.639 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.283 0 C-N-CA 129.158 2.983 . . . . 0.0 104.128 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pm0 -52.52 156.3 1.87 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.957 0.903 . . . . 0.0 112.345 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.45 128.43 35.77 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.493 1.517 . . . . 0.0 114.543 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.28 -171.94 25.03 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 169.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.56 141.51 45.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 m -139.87 173.56 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 122.801 1.286 . . . . 0.0 110.895 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.98 171.08 18.38 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.323 2.649 . . . . 0.0 104.627 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -39.17 -53.64 1.84 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 112.832 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -52.78 63.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.312 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -73.58 -35.54 65.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.273 -175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -39.43 -48.16 1.91 Allowed 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 127.601 2.36 . . . . 0.0 110.535 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -42.62 -70.44 0.11 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.169 0.988 . . . . 0.0 112.206 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.6 -47.68 80.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.533 1.133 . . . . 0.0 111.602 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -73.68 -37.18 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.521 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -104.17 -65.5 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.056 0.943 . . . . 0.0 110.99 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -62.8 -59.43 4.87 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -172.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.49 41.39 0.47 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.879 -0.513 . . . . 0.0 111.66 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.4 t -90.31 168.86 11.58 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -97.18 -71.65 0.67 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.542 1.537 . . . . 0.0 107.904 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.21 157.63 75.39 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.81 159.59 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.0 1.8 . . . . 0.0 114.961 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -141.18 127.88 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.942 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.429 ' C ' HD23 ' A' ' 23' ' ' LEU . 5.5 tt -103.34 104.82 14.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 126.031 1.732 . . . . 0.0 107.522 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.02 126.47 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.93 115.88 31.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -79.1 111.74 15.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -128.21 -174.32 3.19 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 122.111 0.958 . . . . 0.0 110.015 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.7 140.01 2.11 Favored Pre-proline 0 N--CA 1.451 -0.38 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 171.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -39.2 -54.47 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.362 2.708 . . . . 0.0 117.393 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -57.79 -20.89 38.73 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.819 0.736 . . . . 0.0 112.549 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -71.39 85.91 0.83 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.367 0.667 . . . . 0.0 112.13 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.2 -55.04 4.42 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.322 0.963 . . . . 0.0 113.816 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.01 -36.06 98.31 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.2 1.933 . . . . 0.0 110.959 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -66.44 -49.34 67.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -55.4 -46.31 76.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.456 0.302 . . . . 0.0 111.094 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.88 -30.4 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 117.846 -1.073 . . . . 0.0 112.128 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 tp -84.69 -35.97 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 120.619 1.554 . . . . 0.0 112.437 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.44 -49.16 4.94 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -60.32 -34.27 93.73 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.835 2.356 . . . . 0.0 110.766 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.0 t -69.84 -47.95 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.366 1.066 . . . . 0.0 108.379 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.58 -51.17 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -57.45 -55.28 36.89 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.404 . . . . 0.0 110.994 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.37 -50.84 72.42 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.739 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.3 mt -51.13 -52.34 18.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.13 -32.32 73.67 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.72 -41.21 97.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -66.85 -50.84 61.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -83.71 59.94 5.45 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.456 1.122 . . . . 0.0 109.878 -176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -46.1 -67.36 0.29 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.965 2.106 . . . . 0.0 111.988 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -50.92 -57.96 7.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.097 1.359 . . . . 0.0 114.202 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -78.9 -54.59 5.89 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.4 tp -122.36 117.62 26.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.001 -1.08 . . . . 0.0 113.85 -163.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -91.34 116.37 28.79 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.754 1.221 . . . . 0.0 110.55 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.3 t -78.47 142.35 37.56 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.329 -0.857 . . . . 0.0 109.665 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.2 164.3 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -137.22 115.82 12.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.073 0.949 . . . . 0.0 109.58 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.45 118.23 34.67 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.87 0.868 . . . . 0.0 109.508 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -71.81 107.33 4.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.9 m -59.33 -43.06 92.78 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.092 1.757 . . . . 0.0 111.545 -173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.63 -35.87 82.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.909 0.884 . . . . 0.0 110.316 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.81 -24.71 30.89 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.425 1.49 . . . . 0.0 111.514 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 49.74 2.73 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.507 1.923 . . . . 0.0 113.23 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -68.13 -25.56 37.33 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.629 3.552 . . . . 0.0 109.713 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -51.26 -54.72 23.21 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.031 0.932 . . . . 0.0 109.189 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -60.9 -57.11 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.753 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.39 -45.1 65.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.427 0.691 . . . . 0.0 112.168 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 61.0 p -65.93 -48.74 70.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.996 0.519 . . . . 0.0 109.927 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.91 -38.12 69.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.529 0.332 . . . . 0.0 110.609 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -78.62 -23.49 45.87 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.14 40.11 11.93 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.203 0.906 . . . . 0.0 111.634 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 pt -124.03 169.47 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.494 1.118 . . . . 0.0 109.089 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -154.25 -58.39 0.12 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.893 0.877 . . . . 0.0 109.386 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.62 147.93 30.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 pt -143.38 155.54 60.97 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.65 142.32 69.41 Favored 'Cis proline' 0 N--CA 1.453 -0.855 0 CA-C-N 120.134 1.084 . . . . 0.0 112.322 1.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -137.05 102.48 4.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.03 134.71 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 33.5 mtt -128.33 123.52 34.17 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.5 t -95.88 141.54 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -127.1 158.3 37.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.332 1.453 . . . . 0.0 107.913 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 42.62 1.18 Allowed 'General case' 0 C--N 1.333 -0.126 0 O-C-N 124.335 1.022 . . . . 0.0 110.726 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.2 97.17 2.28 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.49 -73.19 0.77 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.428 0.537 . . . . 0.0 112.213 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -79.84 160.54 26.06 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 122.315 1.055 . . . . 0.0 111.847 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -84.95 143.75 28.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.512 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.2 t -88.38 -70.29 0.65 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.283 1.033 . . . . 0.0 108.289 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -150.79 -175.37 5.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.588 1.555 . . . . 0.0 109.256 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -143.73 162.42 36.03 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.916 1.286 . . . . 0.0 109.719 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.3 mt -139.24 140.78 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.7 mt -122.33 138.72 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.78 153.72 25.95 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 121.888 0.716 . . . . 0.0 112.116 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.97 78.01 3.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.246 0.618 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.3 m -78.28 152.25 78.76 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.26 153.23 22.55 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.592 2.194 . . . . 0.0 113.995 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -46.6 -50.25 17.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.278 1.831 . . . . 0.0 110.654 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.2 -47.25 75.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.933 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -62.54 -46.21 89.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.568 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 64.1 mt -54.68 -55.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 t -52.33 -59.03 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.218 0.607 . . . . 0.0 110.042 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -49.47 -52.14 31.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.436 0.694 . . . . 0.0 110.338 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 45.4 m -61.7 -45.37 94.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.214 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.06 -56.24 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 118.739 0.699 . . . . 0.0 109.583 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -62.72 -43.76 97.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.932 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -51.24 -54.4 26.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.258 0.623 . . . . 0.0 109.552 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -64.57 -43.91 92.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.649 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.3 mt -118.11 -95.44 0.48 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.045 0.938 . . . . 0.0 110.251 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.077 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 72.08 -67.26 0.27 Allowed 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.87 140.47 56.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.03 157.1 36.07 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.987 1.28 . . . . 0.0 113.285 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.3 114.85 20.76 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.14 164.54 20.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 122.806 1.289 . . . . 0.0 110.13 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -143.21 174.75 10.43 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.348 1.859 . . . . 0.0 106.691 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -53.41 2.1 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.957 1.303 . . . . 0.0 113.229 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.94 -59.65 2.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.136 0.974 . . . . 0.0 111.46 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -59.11 -34.43 72.02 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.563 0.745 . . . . 0.0 111.682 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -45.42 -48.29 13.67 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 126.039 1.736 . . . . 0.0 110.541 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -55.15 -53.64 53.34 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.632 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -53.64 54.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 0.0 112.347 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.5 t -75.15 -39.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 124.875 1.27 . . . . 0.0 113.302 -170.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.61 -66.26 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.18 0.992 . . . . 0.0 110.903 -175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.0 mt -61.06 -59.2 5.73 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 121.217 0.532 . . . . 0.0 110.877 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -78.87 40.55 0.4 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.355 0.662 . . . . 0.0 111.227 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.1 t -90.29 -169.44 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.834 0.854 . . . . 0.0 109.328 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 p -131.58 -66.14 0.73 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.191 2.196 . . . . 0.0 106.71 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.86 157.0 79.71 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.02 161.03 7.03 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.391 2.061 . . . . 0.0 112.617 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 t -140.28 139.32 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 125.207 1.403 . . . . 0.0 109.339 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -114.11 117.15 30.44 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.77 115.94 51.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -90.3 111.95 23.33 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.596 ' CD2' HD12 ' A' ' 57' ' ' LEU . 25.8 m-85 -78.76 112.64 16.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -125.36 -173.84 2.92 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 122.096 0.951 . . . . 0.0 110.265 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.72 152.49 4.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -55.33 -32.02 79.46 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.393 2.062 . . . . 0.0 113.544 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.419 ' CH2' HD11 ' A' ' 74' ' ' ILE . 38.1 p-90 -78.98 -6.42 56.26 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.3 0.955 . . . . 0.0 111.737 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.17 88.22 6.03 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.827 -1.171 . . . . 0.0 111.192 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.11 -63.52 0.91 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.639 1.114 . . . . 0.0 113.706 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.36 -47.24 23.07 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.959 2.439 . . . . 0.0 112.63 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 77.7 m -54.27 -44.43 71.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.261 0.624 . . . . 0.0 109.854 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -54.76 -50.11 69.22 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 111.651 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 pp -81.94 -19.68 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.594 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 41' ' ' VAL . 41.2 mt -78.78 -38.88 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.842 0.857 . . . . 0.0 109.224 175.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.85 -49.26 5.72 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 126.893 2.077 . . . . 0.0 115.553 -176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.83 -37.24 79.4 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.345 2.03 . . . . 0.0 110.109 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.48 -43.65 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 37' ' ' ILE . 29.7 t -55.67 -45.38 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -56.43 -63.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.557 0.743 . . . . 0.0 109.831 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -58.92 -37.55 76.93 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.684 0.675 . . . . 0.0 112.04 -176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -52.25 -36.44 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.632 0.773 . . . . 0.0 110.01 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.59 -39.2 76.27 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 118.333 0.515 . . . . 0.0 110.988 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.14 -50.4 34.05 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -53.36 -44.5 68.59 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -115.12 37.43 3.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.656 0.782 . . . . 0.0 112.803 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.98 162.2 2.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.906 0.882 . . . . 0.0 111.176 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 t70 72.77 -61.81 0.49 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.314 2.245 . . . . 0.0 111.353 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -78.0 -32.08 51.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -170.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 tp -125.38 102.9 7.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.88 94.86 5.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.43 132.2 37.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 118.589 -0.719 . . . . 0.0 109.317 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.11 176.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 119.022 0.828 . . . . 0.0 111.793 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -131.13 122.93 27.52 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.723 2.009 . . . . 0.0 110.943 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.596 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.0 tm? -104.31 120.15 40.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.607 1.563 . . . . 0.0 109.818 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -74.89 107.61 7.09 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.8 m -66.76 -33.66 76.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.491 1.516 . . . . 0.0 111.427 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -69.29 -38.92 78.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.269 1.428 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.58 -27.85 31.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.762 2.025 . . . . 0.0 111.519 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.529 ' HB2' HD11 ' A' ' 57' ' ' LEU . 1.5 m -119.84 52.28 2.16 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.579 1.552 . . . . 0.0 112.431 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -65.98 -30.08 48.48 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 125.49 4.127 . . . . 0.0 109.747 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.83 -62.17 2.07 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.5 t -55.73 -47.06 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.388 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.3 -47.42 55.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.194 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -65.74 -46.05 80.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.161 0.585 . . . . 0.0 110.515 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -54.45 -45.8 73.18 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.978 0.511 . . . . 0.0 110.638 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -79.48 -30.93 42.26 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.21 43.29 3.28 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 123.915 0.769 . . . . 0.0 111.22 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.38 88.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -77.29 -23.24 51.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.566 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.2 p -157.24 175.08 14.5 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.419 HD11 ' CH2' ' A' ' 30' ' ' TRP . 21.1 pt -146.62 154.4 48.24 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.08 133.94 26.37 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 CA-C-N 120.92 1.364 . . . . 0.0 113.445 1.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.4 m -139.98 104.83 4.95 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.571 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.0 134.36 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.8 mmt -118.78 153.27 34.72 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.3 t -119.74 133.15 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.218 1.007 . . . . 0.0 108.669 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -128.81 141.98 51.13 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 133.77 18.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.53 41.75 98.85 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -172.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.19 -47.47 2.63 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 124.451 1.024 . . . . 0.0 114.075 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -79.62 157.26 27.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.044 0.938 . . . . 0.0 111.964 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -88.24 156.07 19.41 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 127.296 2.238 . . . . 0.0 112.83 -172.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m -148.83 -80.28 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.665 0.386 . . . . 0.0 111.626 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -74.71 152.84 39.07 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.107 0.48 . . . . 0.0 111.99 -170.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.7 m -132.94 110.88 10.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.969 2.508 . . . . 0.0 106.005 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 63.5 mt -121.47 123.86 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.2 mt -78.83 146.85 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.93 -137.72 0.69 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 71.53 -46.57 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.945 1.298 . . . . 0.0 110.687 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.08 148.49 75.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.18 68.75 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.526 1.484 . . . . 0.0 111.696 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -50.62 -37.41 40.22 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.227 1.011 . . . . 0.0 111.27 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.55 -41.73 21.99 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.508 0.595 . . . . 0.0 111.192 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -47.21 84.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.708 0.803 . . . . 0.0 108.869 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 mt -63.27 -40.29 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.825 1.25 . . . . 0.0 110.072 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.8 t -57.89 -58.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.921 1.288 . . . . 0.0 108.143 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.01 -46.63 68.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.233 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.5 m -60.39 -51.98 67.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.189 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.77 -44.15 93.18 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.34 -0.85 . . . . 0.0 110.854 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -50.46 -39.73 48.76 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.869 0.868 . . . . 0.0 111.558 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -59.64 -29.25 67.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.294 -0.254 . . . . 0.0 111.399 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -91.35 -43.89 9.49 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.691 0.797 . . . . 0.0 109.995 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.44 -107.1 0.15 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.736 0.815 . . . . 0.0 108.856 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.359 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.09 -51.52 45.48 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.74 131.71 41.05 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 167.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.88 179.68 44.27 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.33 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.67 137.46 54.45 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' CG1' HG11 ' A' ' 14' ' ' VAL . 5.7 m -130.14 164.02 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 118.972 0.806 . . . . 0.0 111.158 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.02 169.9 17.73 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 173.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -38.92 -45.26 1.16 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.352 1.861 . . . . 0.0 112.41 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -66.09 -74.14 0.12 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.028 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -48.81 -38.9 23.48 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.499 1.12 . . . . 0.0 111.564 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -38.95 -47.36 1.44 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.364 2.266 . . . . 0.0 110.591 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -48.3 -64.67 0.73 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.96 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.08 -38.55 75.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.126 1.37 . . . . 0.0 111.911 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.775 HG13 HG23 ' A' ' 15' ' ' VAL . 3.7 p -83.0 -47.86 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 124.293 1.037 . . . . 0.0 113.424 -172.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.775 HG23 HG13 ' A' ' 14' ' ' VAL . 57.3 t -95.85 -57.6 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.726 0.81 . . . . 0.0 110.886 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.1 mt -68.48 -57.0 6.47 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.57 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -79.39 45.53 0.67 Allowed 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.444 -0.785 . . . . 0.0 111.221 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.3 p -90.52 164.72 14.13 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.545 1.138 . . . . 0.0 111.128 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.5 p -104.98 -68.62 0.85 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.623 1.569 . . . . 0.0 107.162 175.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.0 162.93 62.73 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.034 1.333 . . . . 0.0 108.035 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.613 ' HB2' HD13 ' A' ' 52' ' ' LEU . 53.1 Cg_exo -56.27 167.9 2.33 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.799 1.666 . . . . 0.0 112.294 177.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.8 t -146.28 120.27 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.574 1.549 . . . . 0.0 109.215 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -97.72 102.79 14.64 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.0 t -98.21 109.73 24.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.362 0.665 . . . . 0.0 109.801 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -87.77 117.72 26.8 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -79.19 112.6 16.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -126.31 -173.74 2.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.843 0.83 . . . . 0.0 111.008 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.66 156.76 3.43 Favored Pre-proline 0 N--CA 1.452 -0.332 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -61.41 -36.42 78.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.315 2.01 . . . . 0.0 109.991 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -76.68 -3.56 38.58 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.708 0.803 . . . . 0.0 111.738 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.4 t -63.69 -60.42 3.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.714 1.143 . . . . 0.0 111.659 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 -86.02 0.52 Allowed Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.069 -1.406 . . . . 0.0 110.761 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.97 -46.13 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.415 2.744 . . . . 0.0 111.843 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.0 m -46.13 -46.53 17.19 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.374 1.47 . . . . 0.0 111.41 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -67.87 -44.08 77.92 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.656 0.783 . . . . 0.0 110.797 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.97 -13.13 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.875 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.59 -38.49 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.062 1.345 . . . . 0.0 108.491 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -37.95 -47.38 2.71 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 126.905 2.082 . . . . 0.0 114.721 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.13 -39.97 36.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.828 1.686 . . . . 0.0 109.918 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -74.91 -47.52 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.629 1.972 . . . . 0.0 109.505 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -61.06 -38.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 120.601 -1.312 . . . . 0.0 109.568 175.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -66.86 -54.25 24.21 Favored 'General case' 0 CA--C 1.527 0.059 0 CA-C-O 119.286 -0.387 . . . . 0.0 110.822 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.08 -41.89 89.11 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.32 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.4 mm -55.3 -46.49 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.27 -51.09 57.32 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.16 -54.21 13.02 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -61.73 -54.0 48.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.678 0.752 . . . . 0.0 112.916 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -83.21 -8.06 59.53 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -37.31 -58.49 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.501 1.921 . . . . 0.0 113.5 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.21 -39.91 60.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.952 1.301 . . . . 0.0 112.802 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -91.32 -37.47 13.24 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.887 1.275 . . . . 0.0 113.301 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -158.03 145.5 18.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.84 1.256 . . . . 0.0 108.446 -168.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -93.82 154.67 17.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.997 1.719 . . . . 0.0 109.678 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 147.01 49.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.83 167.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.133 0.424 . . . . 0.0 111.021 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -135.54 113.65 11.3 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.661 1.185 . . . . 0.0 111.545 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 62' ' ' SER . 8.9 tt -94.87 116.53 28.84 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.126 0.971 . . . . 0.0 109.57 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -75.88 111.38 11.19 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.9 m -66.53 -29.23 69.27 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.366 1.466 . . . . 0.0 111.85 -173.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.69 -38.31 54.67 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.915 1.286 . . . . 0.0 109.787 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -80.91 -25.94 37.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.044 1.737 . . . . 0.0 110.782 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' HD21 ' A' ' 57' ' ' LEU . 3.1 m -117.33 51.29 1.07 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.916 2.087 . . . . 0.0 112.232 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -63.78 -31.0 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 125.598 4.198 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -58.4 -64.24 0.99 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -57.19 -44.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.851 0.357 . . . . 0.0 110.073 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.82 -46.79 64.43 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.095 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -67.78 -44.46 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.226 0.61 . . . . 0.0 110.628 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.73 -45.85 70.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 110.222 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -79.56 -33.2 42.01 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.79 50.11 2.18 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.85 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.777 0.831 . . . . 0.0 109.351 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' H ' ' CD ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.08 -26.31 43.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.905 0.882 . . . . 0.0 110.812 177.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.9 m -160.24 160.17 32.35 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.833 1.253 . . . . 0.0 107.781 -171.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 pt -143.35 160.7 50.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 125.956 1.702 . . . . 0.0 107.566 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.7 154.57 79.46 Favored 'Cis proline' 0 N--CA 1.455 -0.774 0 CA-C-N 121.426 1.545 . . . . 0.0 113.838 3.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.6 m -151.14 104.04 3.09 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.8 mt -91.12 118.71 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.9 mtt -103.86 129.52 51.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.7 t -91.18 115.76 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.47 166.18 12.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.822 1.249 . . . . 0.0 108.626 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.28 -161.0 0.71 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.06 102.86 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.33 1.443 . . . . 0.0 114.656 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.27 -64.35 2.07 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.75 1.167 . . . . 0.0 114.963 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.43 177.74 4.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.479 1.133 . . . . 0.0 113.706 -171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -87.72 155.92 19.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.041 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.6 t -103.59 -69.15 0.81 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.823 1.249 . . . . 0.0 108.994 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.42 177.96 8.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.057 1.743 . . . . 0.0 108.39 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -152.87 149.29 28.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.892 -0.505 . . . . 0.0 109.975 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.2 mt -121.52 104.83 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.955 2.102 . . . . 0.0 107.026 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.4 mt -89.49 137.38 21.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.05 1.34 . . . . 0.0 107.799 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.64 150.0 25.42 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 121.697 0.609 . . . . 0.0 112.284 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.42 64.18 2.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.954 0.901 . . . . 0.0 112.031 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.29 150.66 74.35 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.21 149.25 65.1 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.728 1.619 . . . . 0.0 112.1 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -45.69 66.72 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.95 -43.72 14.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.206 0.602 . . . . 0.0 111.515 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -51.43 67.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.993 0.917 . . . . 0.0 108.931 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.6 mt -56.0 -52.19 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 C-N-CA 123.829 0.852 . . . . 0.0 109.775 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.28 -57.3 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.267 0.94 . . . . 0.0 110.275 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -55.28 -49.28 72.52 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.807 0.336 . . . . 0.0 110.286 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.5 m -57.23 -45.98 83.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.725 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.79 -52.43 60.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 O-C-N 120.915 -1.116 . . . . 0.0 109.267 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.02 -38.34 65.03 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.731 1.212 . . . . 0.0 111.721 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -54.7 -33.5 61.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.505 0.322 . . . . 0.0 110.88 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -105.46 -77.0 0.59 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.354 1.462 . . . . 0.0 113.145 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 mt 67.62 -58.91 0.42 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 129.752 3.221 . . . . 0.0 111.423 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.551 1.54 . . . . 0.0 108.583 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.71 -48.72 53.16 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 170.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.53 138.6 40.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.38 167.47 54.67 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.392 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.04 132.16 50.58 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -131.39 173.54 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 122.074 0.94 . . . . 0.0 110.043 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -155.66 178.28 10.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.309 2.244 . . . . 0.0 105.48 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -45.7 -55.95 5.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.993 0.815 . . . . 0.0 111.699 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -46.31 -57.79 4.29 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 125.833 1.653 . . . . 0.0 112.623 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 p -74.06 -47.0 39.63 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.863 0.865 . . . . 0.0 111.293 -176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -39.66 -48.7 2.17 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.229 2.212 . . . . 0.0 110.739 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -40.03 -53.83 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.708 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -87.27 -47.83 8.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 122.366 1.079 . . . . 0.0 110.695 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -62.28 -32.89 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 113.999 -1.455 . . . . 0.0 111.217 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 t -109.95 -64.56 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.02 1.328 . . . . 0.0 111.603 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.23 -71.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.312 0.505 . . . . 0.0 111.14 -173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.43 53.64 2.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.905 0.882 . . . . 0.0 108.8 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.1 p -90.8 -129.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.024 0.929 . . . . 0.0 109.56 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.1 p -161.54 -78.04 0.05 OUTLIER 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.05 163.71 58.65 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -50.17 163.13 0.64 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.814 2.343 . . . . 0.0 114.043 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.6 t -146.45 141.54 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.85 1.66 . . . . 0.0 108.784 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.01 97.53 5.14 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.96 129.85 47.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -102.32 116.67 33.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.21 108.66 12.88 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -124.49 -175.5 3.28 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 123.716 0.635 . . . . 0.0 110.475 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.53 142.07 1.35 Allowed Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 123.922 0.889 . . . . 0.0 111.077 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.73 108.72 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.228 1.952 . . . . 0.0 108.468 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 137.85 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 1 C-N-CA 131.756 4.022 . . . . 0.0 105.846 -173.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.7 t -74.93 83.02 2.2 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.54 -58.96 2.84 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.249 0.928 . . . . 0.0 112.25 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -48.54 -34.14 25.5 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.967 3.111 . . . . 0.0 113.86 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -79.41 -46.23 17.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -50.91 -50.24 57.86 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.275 1.43 . . . . 0.0 111.119 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.97 -32.81 59.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.207 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.422 HG22 HG23 ' A' ' 41' ' ' VAL . 15.5 mm -76.35 -36.86 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.551 1.141 . . . . 0.0 111.95 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.76 -48.49 5.42 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.8 -36.46 61.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.656 2.238 . . . . 0.0 110.179 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -65.86 -45.23 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 37' ' ' ILE . 46.2 t -54.17 -48.17 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 18.8 m-20 -59.92 -53.07 62.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.04 -39.69 95.5 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.775 -1.203 . . . . 0.0 110.402 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mt -56.8 -44.4 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 42' ' ' ASP . . . -52.86 -52.82 55.92 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.73 49.06 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -62.99 -43.3 99.16 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -117.08 8.93 13.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -39.65 -46.53 1.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.731 2.012 . . . . 0.0 112.199 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -29.91 -58.81 0.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.874 2.469 . . . . 0.0 113.508 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -112.29 -31.72 6.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.343 1.057 . . . . 0.0 112.342 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.46 105.47 17.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.125 0.57 . . . . 0.0 111.055 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -78.66 91.08 4.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.2 t -79.5 136.44 36.9 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 120.997 -1.064 . . . . 0.0 110.328 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.96 173.27 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.522 0.729 . . . . 0.0 111.551 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -139.93 113.07 8.25 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.726 1.21 . . . . 0.0 111.127 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.81 126.84 38.08 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.738 0.699 . . . . 0.0 110.753 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -77.64 108.97 11.21 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 173.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 m -70.87 -33.22 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.754 1.622 . . . . 0.0 111.55 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.4 -40.33 93.3 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.221 1.01 . . . . 0.0 109.346 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -84.61 -24.16 29.27 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.177 2.191 . . . . 0.0 112.141 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 m -134.97 61.98 50.02 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 120.821 -1.174 . . . . 0.0 111.735 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.06 -23.25 34.18 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 124.962 3.774 . . . . 0.0 109.921 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -42.97 -72.64 0.06 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.614 1.565 . . . . 0.0 110.931 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.0 t -52.18 -48.4 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 125.033 1.333 . . . . 0.0 109.899 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -41.81 66.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.939 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.5 m -74.8 -43.5 54.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.015 . . . . 0.0 110.566 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -54.84 -48.31 73.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.316 0.646 . . . . 0.0 109.938 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -79.44 -33.0 42.84 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.56 56.7 4.12 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.3 pt -67.49 142.28 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.492 0.663 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -79.6 71.7 6.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.6 t 65.33 -157.28 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.616 1.166 . . . . 0.0 109.384 -176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.6 153.04 69.96 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.313 1.045 . . . . 0.0 110.103 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.24 145.07 82.33 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 CA-C-N 119.536 0.87 . . . . 0.0 112.515 2.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.1 m -136.08 106.66 6.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 97.3 mt -96.65 105.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.928 1.691 . . . . 0.0 106.54 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 94.6 mtp -103.62 127.53 51.04 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.46 134.03 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -120.65 136.73 54.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 173.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.426 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -107.43 -101.3 0.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 81' ' ' LYS . . . -71.85 73.15 0.84 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.61 -59.94 3.33 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.328 0.966 . . . . 0.0 112.975 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -86.09 173.27 9.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.36 0.6 . . . . 0.0 112.279 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.21 152.92 10.09 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.948 1.699 . . . . 0.0 113.411 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 34.8 t -130.54 -56.87 1.07 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.666 1.987 . . . . 0.0 109.058 176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -134.05 166.95 21.54 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.397 1.079 . . . . 0.0 110.632 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 m -152.75 95.5 2.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.817 1.647 . . . . 0.0 106.618 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.33 141.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.3 mt -133.22 142.96 40.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 155.94 32.19 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 71.96 1.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.099 -0.648 . . . . 0.0 111.67 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -79.13 153.66 77.2 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.43 154.46 53.27 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.343 2.028 . . . . 0.0 114.424 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -45.38 -53.49 8.55 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 126.364 1.866 . . . . 0.0 109.47 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.49 -55.79 4.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.727 1.211 . . . . 0.0 110.132 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 m -59.19 -53.39 58.79 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.91 0.884 . . . . 0.0 110.539 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 80.8 mt -51.87 -58.67 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.88 -60.29 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.976 1.31 . . . . 0.0 109.907 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -49.23 -49.14 44.49 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 118.269 0.486 . . . . 0.0 111.163 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.7 m -61.53 -57.72 10.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 p -63.51 -45.06 98.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 118.561 -1.256 . . . . 0.0 111.257 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -50.96 -49.76 59.39 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.765 1.626 . . . . 0.0 110.741 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.1 ttmm -51.72 -48.84 63.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.719 175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -78.09 -76.15 0.2 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -173.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.573 HD12 ' H ' ' A' ' 107' ' ' ASN . 0.4 OUTLIER 11.95 -52.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 1 C-N-CA 133.622 4.769 . . . . 0.0 118.457 -169.343 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.573 ' H ' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.257 0 C-N-CA 127.448 2.299 . . . . 0.0 110.552 -173.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.43 -41.8 98.99 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.51 144.64 27.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.2 168.16 54.73 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.31 131.65 56.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.82 162.83 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 122.167 0.984 . . . . 0.0 110.488 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -142.72 176.59 8.93 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.407 1.883 . . . . 0.0 106.338 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -39.22 -58.84 1.11 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.653 1.181 . . . . 0.0 112.383 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -54.62 -58.09 8.87 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.851 1.661 . . . . 0.0 113.09 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -67.2 -46.38 74.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.3 1.84 . . . . 0.0 110.558 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -40.15 -51.5 2.64 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 126.84 2.056 . . . . 0.0 111.212 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -44.08 -52.5 7.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.664 0.745 . . . . 0.0 110.931 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -76.66 -58.06 3.5 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.606 0.717 . . . . 0.0 111.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.33 -43.6 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.565 -169.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.68 -61.54 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.518 1.127 . . . . 0.0 111.348 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.8 mt -70.68 -63.03 1.17 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 118.929 0.786 . . . . 0.0 110.508 -173.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -79.92 52.63 1.53 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.619 0.645 . . . . 0.0 111.48 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 p -89.02 155.36 19.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.783 1.633 . . . . 0.0 110.322 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.0 p -87.1 -73.77 0.46 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -79.66 162.01 64.59 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.58 166.88 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.323 2.016 . . . . 0.0 114.18 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.14 149.02 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.362 1.865 . . . . 0.0 110.466 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.2 tt -126.87 102.03 6.84 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 170.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.0 p -107.08 123.6 62.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 120.116 1.325 . . . . 0.0 108.789 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -93.59 115.29 27.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CD2' HD12 ' A' ' 57' ' ' LEU . 25.2 m-85 -79.61 104.07 9.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -116.61 -169.91 1.72 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.315 1.046 . . . . 0.0 110.24 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.49 148.73 1.55 Allowed Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 124.595 1.158 . . . . 0.0 107.923 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.03 -37.71 95.81 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.559 2.173 . . . . 0.0 112.85 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.585 ' CH2' HD11 ' A' ' 74' ' ' ILE . 37.4 p-90 -72.73 -18.7 61.49 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.904 -0.497 . . . . 0.0 111.052 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.5 t -80.69 83.59 6.43 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.057 -1.027 . . . . 0.0 109.715 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.29 -59.53 1.82 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.52 1.057 . . . . 0.0 113.457 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -53.99 -48.61 20.74 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.694 2.263 . . . . 0.0 111.546 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.4 m -55.74 -50.49 70.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -58.13 -49.93 75.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.332 1.053 . . . . 0.0 111.536 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.73 -22.47 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.722 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.0 mt -82.56 -30.13 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 119.847 1.203 . . . . 0.0 109.435 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.35 -41.69 2.64 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.937 1.695 . . . . 0.0 115.223 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.76 -40.89 42.06 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.323 2.015 . . . . 0.0 109.809 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.14 -35.33 34.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 C-N-CA 118.153 -1.419 . . . . 0.0 108.136 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.7 t -52.73 -43.65 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.15 -58.36 8.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.094 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -56.36 -42.2 77.4 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.558 0.617 . . . . 0.0 111.884 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.98 -36.5 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 122.838 0.455 . . . . 0.0 109.962 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.68 -46.97 80.86 Favored 'General case' 0 C--O 1.223 -0.342 0 O-C-N 121.913 -0.492 . . . . 0.0 110.193 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.9 -42.68 99.63 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -58.76 -44.06 90.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -124.55 15.63 8.84 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -39.43 -51.15 2.13 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.132 1.373 . . . . 0.0 113.7 -174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -44.7 -46.65 10.44 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.081 1.752 . . . . 0.0 112.774 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -98.56 -37.76 9.42 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.92 0.888 . . . . 0.0 112.266 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 16.4 tp -116.16 112.07 21.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.101 -167.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -79.96 93.65 5.74 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 49.9 t -79.13 134.16 36.72 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.494 -0.754 . . . . 0.0 109.685 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.64 167.9 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.166 0.586 . . . . 0.0 111.758 -175.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -135.27 116.4 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.034 1.334 . . . . 0.0 110.077 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.427 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.3 tm? -98.86 120.83 39.96 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 109.585 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -75.42 103.31 5.5 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.672 0.749 . . . . 0.0 110.265 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -81.96 48.33 1.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.451 1.9 . . . . 0.0 111.27 -176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -145.5 -47.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -81.59 -26.43 34.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.86 2.064 . . . . 0.0 109.821 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.4 m -133.05 60.38 49.0 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.006 -1.059 . . . . 0.0 113.813 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.87 -23.78 16.07 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 125.186 3.924 . . . . 0.0 108.716 175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -37.38 -69.25 0.12 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.356 1.862 . . . . 0.0 111.099 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -35.68 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.183 -175.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.63 81.24 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.9 m -72.41 -45.21 60.71 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.095 0.958 . . . . 0.0 109.965 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -54.97 -46.04 75.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.35 0.66 . . . . 0.0 110.386 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.98 -34.76 43.92 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 119.595 -0.241 . . . . 0.0 110.365 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.23 54.77 1.24 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.516 0.579 . . . . 0.0 111.859 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.6 mt -77.69 121.41 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -79.0 -35.46 42.78 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.02 0.528 . . . . 0.0 111.537 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.9 m -158.73 168.82 25.84 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.585 HD11 ' CH2' ' A' ' 30' ' ' TRP . 23.1 pt -124.82 154.56 70.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.34 149.69 82.19 Favored 'Cis proline' 0 N--CA 1.453 -0.882 0 CA-C-N 120.287 1.138 . . . . 0.0 112.277 2.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.0 m -144.04 106.04 4.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.61 116.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.5 mtt -105.76 134.93 48.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.6 t -99.47 140.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -127.99 161.1 29.94 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 54.56 0.81 Allowed 'General case' 0 CA--C 1.53 0.194 0 O-C-N 124.521 1.138 . . . . 0.0 110.488 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.18 98.35 1.6 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.48 -73.08 1.17 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.103 0.858 . . . . 0.0 112.066 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -94.58 165.21 12.64 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 122.825 1.298 . . . . 0.0 113.131 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -77.32 142.35 39.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.265 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 41.7 t -89.08 -65.22 1.04 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.227 1.011 . . . . 0.0 108.643 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -151.28 -174.75 4.92 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.091 1.756 . . . . 0.0 108.166 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.2 t -154.23 166.72 32.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.364 0.666 . . . . 0.0 109.585 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.0 mt -136.02 118.63 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.6 mt -106.95 141.0 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.367 1.067 . . . . 0.0 109.027 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.64 163.33 38.3 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.836 0.731 . . . . 0.0 111.569 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.34 142.97 57.51 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.08 0.552 . . . . 0.0 110.739 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.69 153.54 36.6 Favored Pre-proline 0 N--CA 1.455 -0.179 0 C-N-CA 124.123 0.969 . . . . 0.0 108.525 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.72 145.29 20.2 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 N-CA-C 105.586 -2.505 . . . . 0.0 105.586 168.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -56.29 -33.41 65.5 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.321 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.88 -42.87 6.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.662 0.785 . . . . 0.0 110.62 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.1 m -75.3 -44.42 45.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.978 0.511 . . . . 0.0 110.018 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.5 mt -54.42 -47.45 70.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 123.51 0.724 . . . . 0.0 110.08 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -57.15 -55.28 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.439 0.695 . . . . 0.0 109.714 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -56.61 -45.49 81.45 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.889 -0.507 . . . . 0.0 110.682 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.3 m -66.34 -43.24 86.65 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.073 0.549 . . . . 0.0 111.752 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.71 -43.62 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 O-C-N 121.024 -1.048 . . . . 0.0 108.878 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.26 -47.75 80.61 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -54.1 -52.0 62.38 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.473 0.709 . . . . 0.0 109.919 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -63.06 -41.79 99.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.613 0.365 . . . . 0.0 111.791 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.7 -99.68 0.32 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.875 1.27 . . . . 0.0 109.299 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.354 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 tpp . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.09 -44.48 76.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.09 135.46 41.19 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 169.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.06 166.16 44.63 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.32 126.98 55.84 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -128.52 164.43 30.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 122.271 1.034 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -148.9 179.84 7.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.321 1.848 . . . . 0.0 106.832 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -39.05 -59.05 1.04 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.362 1.465 . . . . 0.0 112.213 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.99 -69.14 0.25 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.546 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -51.59 -39.03 57.18 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.248 1.019 . . . . 0.0 112.11 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -44.74 -48.22 10.79 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.197 1.399 . . . . 0.0 111.045 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -50.29 -51.25 46.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.412 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -74.76 -56.94 4.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.428 0.633 . . . . 0.0 111.38 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.7 t -66.86 -23.97 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.078 1.751 . . . . 0.0 113.368 -173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.51 -75.1 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.574 0.75 . . . . 0.0 110.524 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.37 -47.06 66.37 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.667 0.667 . . . . 0.0 112.781 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -93.14 15.03 16.22 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.423 1.089 . . . . 0.0 112.085 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.34 147.93 27.64 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.034 0.834 . . . . 0.0 111.407 -173.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.2 p -80.01 -61.91 1.84 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.345 1.458 . . . . 0.0 111.753 -176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.45 160.25 75.57 Favored Pre-proline 0 C--O 1.233 0.185 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.79 159.88 3.27 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.245 1.963 . . . . 0.0 110.403 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.05 149.26 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 123.768 0.827 . . . . 0.0 109.599 -173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.67 98.97 4.98 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.68 119.29 45.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -95.29 114.04 25.78 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -79.58 112.37 16.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -128.14 -172.04 2.59 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.817 0.818 . . . . 0.0 110.526 -174.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.27 151.7 4.71 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 124.516 1.126 . . . . 0.0 108.108 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -57.62 -31.98 93.26 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.375 2.05 . . . . 0.0 113.266 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.483 ' CH2' HD11 ' A' ' 74' ' ' ILE . 17.5 p-90 -79.47 -7.23 58.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.107 0.867 . . . . 0.0 111.405 176.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.6 t -81.31 83.63 6.83 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.078 -1.013 . . . . 0.0 112.551 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.93 -58.02 2.78 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.551 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.22 -20.19 66.97 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 CA-C-N 119.634 1.717 . . . . 0.0 113.064 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.8 m -81.15 -49.82 10.36 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -45.17 -50.21 11.55 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.778 0.831 . . . . 0.0 111.153 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -65.82 -25.75 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 117.894 -1.05 . . . . 0.0 112.387 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 pt -90.23 -29.05 4.93 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 CA-C-N 120.689 1.586 . . . . 0.0 110.255 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.02 4.28 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.96 -28.39 24.36 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 122.276 1.849 . . . . 0.0 109.848 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -71.41 -41.42 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.0 t -55.94 -46.74 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.38 -54.73 39.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.69 -41.15 94.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.638 1.563 . . . . 0.0 110.669 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.9 mm -60.36 -41.99 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.55 -50.71 67.29 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.925 0.784 . . . . 0.0 109.302 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.81 -49.7 34.11 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.14 -58.89 4.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -85.38 -0.03 53.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -171.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -39.0 -49.12 1.69 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.549 1.54 . . . . 0.0 113.163 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -46.87 -59.95 2.74 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.859 1.664 . . . . 0.0 112.593 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -83.48 -30.03 27.52 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.799 1.24 . . . . 0.0 112.579 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 tp -133.67 110.89 10.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.343 1.057 . . . . 0.0 111.099 -168.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -79.81 95.59 6.07 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 48.3 t -79.26 140.18 37.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.572 -0.705 . . . . 0.0 109.29 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.82 165.4 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 123.835 0.854 . . . . 0.0 109.906 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt -133.56 116.95 16.52 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.708 1.203 . . . . 0.0 109.268 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 tt -99.1 123.39 43.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.017 0.436 . . . . 0.0 110.385 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.99 108.82 9.14 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.9 m -68.99 -29.82 68.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 124.876 1.27 . . . . 0.0 111.692 -174.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.58 -43.26 66.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.91 0.862 . . . . 0.0 110.177 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -81.19 -27.4 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.299 1.84 . . . . 0.0 111.666 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.2 m -134.0 61.89 54.09 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 121.04 -1.037 . . . . 0.0 110.679 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.14 -35.9 31.31 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.899 3.733 . . . . 0.0 108.861 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -33.55 -69.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.11 2.164 . . . . 0.0 111.058 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.8 t -55.48 -51.45 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.744 1.218 . . . . 0.0 110.057 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.32 -37.03 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.122 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 m -74.6 -45.23 46.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.53 1.132 . . . . 0.0 109.899 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.99 -43.28 73.42 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.421 0.688 . . . . 0.0 109.629 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -78.97 -32.71 45.42 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.385 -0.341 . . . . 0.0 110.952 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.45 51.1 2.42 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 111.675 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.0 mt -84.05 113.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.075 0.95 . . . . 0.0 108.676 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -79.65 -26.86 40.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.032 1.333 . . . . 0.0 113.532 -175.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.1 m -161.08 167.11 26.96 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.483 HD11 ' CH2' ' A' ' 30' ' ' TRP . 18.7 pt -129.53 151.92 78.78 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 146.88 83.0 Favored 'Cis proline' 0 N--CA 1.453 -0.894 0 CA-C-N 119.923 1.008 . . . . 0.0 113.277 1.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.6 m -139.61 114.4 9.4 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.3 mt -104.55 102.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 10.8 mtt -87.86 131.92 34.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.2 t -101.44 143.31 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -134.31 158.93 42.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.964 0.906 . . . . 0.0 109.716 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 146.72 28.52 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.554 2.342 . . . . 0.0 104.73 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 52.67 39.92 55.12 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.117 -1.516 . . . . 0.0 111.768 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.1 -52.58 2.95 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 122.258 -0.554 . . . . 0.0 113.525 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -79.67 163.66 24.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.539 1.161 . . . . 0.0 113.409 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -67.67 148.04 51.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.863 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 t -115.11 -63.41 1.46 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.355 1.462 . . . . 0.0 109.125 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -138.3 -177.7 4.96 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.642 1.577 . . . . 0.0 109.771 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.2 m -155.22 131.82 10.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.941 0.896 . . . . 0.0 109.455 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.0 mm -104.33 153.28 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.74 142.02 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 124.154 0.981 . . . . 0.0 108.596 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.31 158.24 20.14 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 121.531 0.517 . . . . 0.0 112.54 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.92 70.18 1.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.53 . . . . 0.0 111.146 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -78.5 153.43 78.8 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.71 147.22 50.91 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.619 1.546 . . . . 0.0 112.208 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -62.05 -39.19 91.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.391 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.44 -48.86 37.12 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 m -59.56 -51.12 71.21 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.775 0.83 . . . . 0.0 109.204 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.1 mt -54.96 -58.38 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.039 0.535 . . . . 0.0 109.878 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.2 t -49.67 -55.98 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 124.886 1.274 . . . . 0.0 110.673 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -48.23 74.25 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -61.38 -41.41 97.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.459 0.303 . . . . 0.0 111.191 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.18 -49.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 121.253 -0.904 . . . . 0.0 109.26 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -57.75 -46.56 84.33 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.509 0.724 . . . . 0.0 110.048 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -51.85 -52.05 52.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.736 0.814 . . . . 0.0 109.482 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -65.82 -45.4 82.44 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 80.1 mt -108.16 -98.99 0.37 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.037 1.335 . . . . 0.0 109.894 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.338 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.29 -41.13 98.24 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.05 129.35 34.43 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 168.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.01 -177.44 39.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.86 136.9 54.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.41 165.49 31.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.616 0.722 . . . . 0.0 111.188 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -145.55 172.09 13.74 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.784 2.034 . . . . 0.0 106.063 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -39.09 -48.12 1.63 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.936 1.694 . . . . 0.0 112.663 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.52 -74.0 0.08 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.105 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -52.86 -36.33 58.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.512 1.125 . . . . 0.0 111.951 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -41.06 -46.73 2.99 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 126.258 1.823 . . . . 0.0 111.376 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -49.48 -48.02 48.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.789 1.236 . . . . 0.0 111.086 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -85.12 -57.64 3.01 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.779 0.832 . . . . 0.0 111.157 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.77 -38.58 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 124.651 1.18 . . . . 0.0 112.163 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -104.91 -59.52 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 112.305 -174.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.2 mt -66.57 -71.34 0.2 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.162 0.437 . . . . 0.0 110.982 -174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -79.57 52.77 1.46 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.101 0.476 . . . . 0.0 111.483 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 p -90.67 159.29 16.47 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.11 1.764 . . . . 0.0 111.301 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -91.72 -69.87 0.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.243 1.417 . . . . 0.0 107.736 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.1 m -78.75 154.41 78.32 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -61.29 163.81 16.47 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.748 0.965 . . . . 0.0 110.194 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.47 113.72 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.667 1.187 . . . . 0.0 111.348 -171.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.32 105.64 13.56 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.85 116.04 45.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 109.762 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -89.44 112.27 23.36 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.555 ' CE2' HD23 ' A' ' 57' ' ' LEU . 18.6 m-85 -78.71 112.93 16.32 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -130.12 -172.52 2.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.575 0.75 . . . . 0.0 110.754 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.5 148.82 3.51 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.967 1.307 . . . . 0.0 107.772 172.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.15 -45.35 41.67 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.702 2.268 . . . . 0.0 112.809 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -64.56 -22.75 67.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.031 -0.418 . . . . 0.0 111.96 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 38.4 t -76.31 84.44 3.09 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.626 -0.671 . . . . 0.0 110.913 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.53 -54.12 5.77 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 123.996 0.808 . . . . 0.0 112.883 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -27.78 71.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.365 2.043 . . . . 0.0 112.767 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.4 m -77.15 -53.67 7.47 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -45.04 -47.2 11.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.981 1.712 . . . . 0.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -71.9 -25.96 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 117.625 -1.179 . . . . 0.0 113.02 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.6 pt -86.88 -26.43 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 121.267 1.849 . . . . 0.0 110.083 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.14 -45.72 3.35 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.367 1.467 . . . . 0.0 114.795 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -68.11 -33.17 25.9 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.708 2.272 . . . . 0.0 109.979 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -38.76 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 127.053 2.141 . . . . 0.0 107.901 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.25 -45.69 95.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.92 -52.92 63.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.844 0.457 . . . . 0.0 110.205 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -50.69 -49.85 56.4 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.434 0.561 . . . . 0.0 109.955 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.91 -38.96 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.58 -33.73 64.17 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.026 0.376 . . . . 0.0 110.277 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.58 -56.56 7.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -46.94 -47.53 21.7 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -106.69 21.95 16.66 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -48.62 -40.4 27.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.958 0.903 . . . . 0.0 111.274 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.48 -68.35 0.19 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.37 1.468 . . . . 0.0 112.4 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -89.94 -14.64 33.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.16 135.04 33.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.683 1.129 . . . . 0.0 113.102 -167.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -79.94 151.63 29.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 52.1 t -137.34 136.75 38.23 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.8 166.92 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.186 0.517 . . . . 0.0 112.069 -172.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -128.3 116.13 19.35 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.081 1.352 . . . . 0.0 109.542 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 ' CE2' ' A' ' 26' ' ' PHE . 43.8 tp -97.73 115.97 29.02 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.57 0.748 . . . . 0.0 109.983 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -71.1 110.42 5.76 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.9 m -64.21 -43.67 94.31 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 111.4 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -65.11 -33.68 76.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.584 0.754 . . . . 0.0 110.403 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -82.44 -25.03 33.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.899 1.28 . . . . 0.0 111.104 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -125.88 54.9 11.44 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 125.492 1.517 . . . . 0.0 113.034 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.18 -30.83 45.96 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.789 2.993 . . . . 0.0 108.616 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -43.64 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.13 1.772 . . . . 0.0 110.991 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.4 t -50.57 -51.34 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.76 1.224 . . . . 0.0 110.035 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -39.09 74.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.044 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -70.35 -45.19 66.62 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.014 0.526 . . . . 0.0 109.656 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.58 -42.35 74.65 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -79.2 -23.97 43.46 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.747 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.72 46.85 10.62 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.041 0.829 . . . . 0.0 111.072 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -70.23 128.9 34.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.88 -45.03 21.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.325 0.65 . . . . 0.0 111.386 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 m -156.48 171.28 20.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.06 154.39 68.1 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.17 149.59 89.81 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 CA-C-N 119.787 0.96 . . . . 0.0 112.118 1.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 m -135.57 101.18 4.71 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.0 mt -90.61 114.57 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.6 mtm -126.16 150.34 48.35 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.2 t -108.51 139.73 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -123.5 168.26 12.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.333 1.021 . . . . 0.0 109.994 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 156.78 2.98 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.979 2.112 . . . . 0.0 106.7 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 37.57 49.96 1.83 Allowed Glycine 0 CA--C 1.535 1.343 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.96 64.55 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 118.667 -1.074 . . . . 0.0 115.621 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -147.75 172.21 14.45 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.515 1.657 . . . . 0.0 111.099 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -85.76 161.66 19.06 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.834 1.254 . . . . 0.0 109.412 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 53.1 t -131.16 -63.1 0.86 Allowed 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 126.231 1.813 . . . . 0.0 109.826 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -113.66 162.3 16.41 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.394 1.078 . . . . 0.0 110.433 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -154.77 131.43 10.66 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.334 1.454 . . . . 0.0 107.854 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -140.57 113.46 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -99.11 139.31 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.8 148.26 22.54 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.407 1.004 . . . . 0.0 110.804 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 75.48 1.0 Allowed 'General case' 0 C--N 1.339 0.12 0 O-C-N 122.033 -0.686 . . . . 0.0 110.875 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.9 m -78.73 145.26 66.31 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.33 157.63 39.59 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.972 1.781 . . . . 0.0 113.027 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -42.1 -51.01 4.7 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.372 1.469 . . . . 0.0 110.028 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.08 -44.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.967 0.907 . . . . 0.0 111.861 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -69.17 -48.44 62.21 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 70.2 mt -54.41 -54.3 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -46.59 -64.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 127.802 2.441 . . . . 0.0 109.271 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -55.6 -49.08 73.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.512 0.196 . . . . 0.0 111.297 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.4 m -56.85 -52.07 66.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.845 -177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -42.03 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.918 0.781 . . . . 0.0 110.515 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -52.7 -36.73 57.76 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.368 0.667 . . . . 0.0 112.015 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -46.92 -46.39 21.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.048 0.452 . . . . 0.0 110.49 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -87.95 -42.65 12.33 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.146 0.978 . . . . 0.0 111.195 -174.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 mp -129.26 83.42 2.14 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.554 1.142 . . . . 0.0 109.41 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 117.433 -1.27 . . . . 0.0 109.975 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tpt . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 118.915 -0.564 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -163.22 178.35 8.28 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.82 143.32 31.11 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.155 0.982 . . . . 0.0 112.359 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.34 177.69 18.09 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.52 141.77 50.49 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.2 m -142.07 171.72 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 123.137 1.446 . . . . 0.0 112.674 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.38 169.56 19.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.977 3.311 . . . . 0.0 105.055 175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -38.43 -50.39 1.52 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.702 2.401 . . . . 0.0 112.753 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.17 -70.02 0.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.726 0.774 . . . . 0.0 110.577 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -53.25 -38.7 63.23 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.601 1.16 . . . . 0.0 112.415 -177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -42.97 -46.75 5.55 Favored 'General case' 0 CA--C 1.522 -0.113 0 C-N-CA 126.864 2.066 . . . . 0.0 111.5 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -54.26 -55.38 28.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -68.72 -54.25 17.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.468 0.707 . . . . 0.0 111.516 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.31 -31.17 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.261 1.424 . . . . 0.0 112.79 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -114.24 -72.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.549 0.739 . . . . 0.0 111.024 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.1 mt -53.79 -41.03 66.81 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -172.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -93.12 13.23 21.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.009 0.924 . . . . 0.0 112.512 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.8 t -73.71 142.97 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.514 1.052 . . . . 0.0 111.888 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.8 p -79.64 -61.31 2.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.045 1.338 . . . . 0.0 108.636 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.86 155.14 80.62 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -57.23 161.32 11.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.64 1.56 . . . . 0.0 112.56 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 t -141.1 143.07 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.411 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tt -120.08 102.35 8.47 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.378 1.871 . . . . 0.0 106.689 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.1 t -97.77 127.41 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -103.08 124.87 49.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -79.68 106.69 11.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -118.62 -176.13 3.03 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 122.872 1.32 . . . . 0.0 111.66 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.79 152.08 6.3 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.49 -42.68 12.11 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 CA-C-N 120.857 1.342 . . . . 0.0 111.665 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -58.25 -18.75 28.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.796 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.8 t -77.97 88.72 4.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.707 1.139 . . . . 0.0 109.773 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.54 -63.07 1.04 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.187 1.375 . . . . 0.0 113.538 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -49.47 -47.29 23.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.39 2.726 . . . . 0.0 112.358 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.5 m -58.75 -53.6 56.58 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -53.25 -54.47 35.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.854 1.262 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -75.79 -27.37 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.594 -0.717 . . . . 0.0 112.652 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 mm -83.78 -26.87 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.754 1.161 . . . . 0.0 109.796 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.79 -46.2 4.64 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -63.28 -35.68 61.23 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.675 2.25 . . . . 0.0 110.373 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 t -68.69 -44.28 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 t -58.07 -44.37 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.53 -60.81 3.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 122.828 0.451 . . . . 0.0 111.035 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -59.51 -33.87 71.91 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.435 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mt -56.8 -43.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.17 -47.7 76.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.134 -1.027 . . . . 0.0 110.042 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.28 -60.68 5.53 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 120.191 1.36 . . . . 0.0 110.69 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -48.17 -55.74 9.63 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.616 1.566 . . . . 0.0 110.717 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -83.39 58.88 4.74 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 123.447 1.594 . . . . 0.0 110.313 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -48.31 138.18 10.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.227 1.811 . . . . 0.0 110.115 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.5 t70 70.73 -56.2 0.62 Allowed 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 127.565 2.346 . . . . 0.0 112.968 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -77.1 -9.44 58.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -166.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -141.62 108.87 5.51 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 119.974 1.261 . . . . 0.0 112.214 -176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -93.78 111.75 23.49 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.68 138.31 38.23 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.811 -1.18 . . . . 0.0 108.135 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.15 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.717 0.77 . . . . 0.0 110.227 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -133.93 106.53 7.32 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.359 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -89.11 120.03 30.14 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 111.254 178.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.29 106.75 8.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.3 m -68.87 -31.97 71.3 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.231 1.413 . . . . 0.0 111.453 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.87 -41.5 87.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.438 1.095 . . . . 0.0 109.309 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -84.51 -28.68 26.54 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.004 2.122 . . . . 0.0 111.99 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.4 t -127.13 53.21 9.55 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 125.399 1.48 . . . . 0.0 112.208 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -62.78 -27.14 75.21 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 124.306 3.337 . . . . 0.0 108.825 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -40.37 -60.05 1.18 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.628 1.571 . . . . 0.0 110.263 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.8 -50.78 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.171 0.988 . . . . 0.0 110.167 -177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.08 64.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.426 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -68.63 -44.91 73.21 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.898 0.879 . . . . 0.0 110.397 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -56.38 -42.0 77.16 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.644 0.778 . . . . 0.0 110.332 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -78.47 -34.18 47.81 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.39 45.89 2.46 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.415 1.007 . . . . 0.0 111.588 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.76 -179.16 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 125.938 1.695 . . . . 0.0 108.33 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -158.62 -63.66 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.559 0.744 . . . . 0.0 109.593 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.7 m -54.94 154.64 5.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.909 0.385 . . . . 0.0 110.223 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 pt -143.2 157.92 59.28 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.175 1.39 . . . . 0.0 107.3 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.27 156.28 84.78 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 120.766 1.309 . . . . 0.0 112.958 2.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -160.46 115.74 2.27 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.6 mt -98.65 148.46 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 57.9 mtt -136.24 133.0 36.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.7 t -99.46 139.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -132.82 144.86 50.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.72 136.88 15.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 46.14 94.64 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -171.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.01 -59.65 2.66 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 123.908 0.766 . . . . 0.0 114.006 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -81.44 168.29 18.47 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -67.73 155.37 39.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.235 1.814 . . . . 0.0 112.96 -173.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.0 t -116.17 -72.38 0.69 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.965 2.106 . . . . 0.0 109.651 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -146.07 172.01 14.04 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.299 1.44 . . . . 0.0 110.246 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.5 m -116.41 146.58 42.4 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.63 1.972 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.82 -175.43 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.54 153.14 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.36 -153.57 5.83 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 51.48 42.48 29.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.947 0.899 . . . . 0.0 111.828 -177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.46 153.16 65.39 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 125.074 1.35 . . . . 0.0 107.477 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.36 160.43 32.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.103 1.868 . . . . 0.0 111.676 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -50.53 -43.57 56.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.807 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.41 -44.71 55.21 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.235 0.614 . . . . 0.0 111.111 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.3 m -65.84 -50.96 62.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.1 mt -55.41 -52.78 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.392 0.677 . . . . 0.0 109.499 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.42 -58.14 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.428 1.491 . . . . 0.0 109.595 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -55.31 -47.41 75.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.689 0.677 . . . . 0.0 110.992 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 42.1 m -60.92 -43.83 98.03 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 119.591 -0.242 . . . . 0.0 111.448 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -72.5 -45.75 58.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.967 0.803 . . . . 0.0 109.829 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -51.54 -45.56 63.03 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.12 0.968 . . . . 0.0 110.772 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -48.24 -44.32 33.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.964 0.506 . . . . 0.0 110.316 176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -78.88 -41.63 29.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.616 -0.142 . . . . 0.0 110.616 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.4 -104.02 0.1 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.132 0.973 . . . . 0.0 109.02 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.364 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -113.54 -34.62 5.5 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.841 0.856 . . . . 0.0 111.352 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.75 95.67 0.25 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.547 0.739 . . . . 0.0 111.545 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.41 -172.64 35.13 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.24 140.58 52.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.88 167.81 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.153 0.978 . . . . 0.0 111.793 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 8' ' ' ASP . 8.1 t-20 -143.5 172.76 12.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.844 2.058 . . . . 0.0 106.389 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.423 ' H ' ' ND2' ' A' ' 7' ' ' ASN . 76.5 m-20 -38.82 -46.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.195 1.798 . . . . 0.0 112.381 -177.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.46 -76.19 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.719 0.408 . . . . 0.0 110.768 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.0 p -46.94 -39.82 13.07 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.271 1.429 . . . . 0.0 112.194 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -39.42 -47.9 1.86 Allowed 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.526 1.93 . . . . 0.0 111.487 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.774 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -71.23 -45.73 62.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.507 0.67 . . . . 0.0 111.261 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.79 -37.01 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.031 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -106.33 -73.93 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 123.883 0.873 . . . . 0.0 110.78 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.9 mt -52.06 -54.53 29.11 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.865 0.466 . . . . 0.0 111.86 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -81.03 11.73 3.86 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -65.6 152.43 44.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.82 1.191 . . . . 0.0 109.614 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 p -79.33 -64.69 1.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.12 155.12 77.41 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.27 165.01 1.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.904 2.403 . . . . 0.0 112.608 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.6 t -144.72 143.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.449 1.099 . . . . 0.0 111.588 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -104.52 130.13 52.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.899 1.68 . . . . 0.0 107.67 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -124.61 111.28 27.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 118.918 0.781 . . . . 0.0 109.529 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -89.69 116.28 27.69 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' CD2' ' CD1' ' A' ' 71' ' ' ILE . 15.9 m-85 -79.75 114.53 18.75 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -129.44 -173.48 3.02 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.565 0.698 . . . . 0.0 111.664 -175.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -167.64 156.59 8.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -59.44 -40.52 66.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.206 1.938 . . . . 0.0 110.658 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.508 ' CH2' HD11 ' A' ' 74' ' ' ILE . 53.1 p-90 -72.24 -10.25 59.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 122.881 0.472 . . . . 0.0 111.515 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.36 82.29 3.11 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.8 -1.187 . . . . 0.0 110.157 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.2 -61.21 1.01 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.825 1.202 . . . . 0.0 113.529 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.05 -41.3 78.36 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.387 2.058 . . . . 0.0 112.43 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 81.4 m -55.22 -47.66 75.02 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -56.2 -52.32 64.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.729 0.412 . . . . 0.0 111.482 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -73.24 -30.23 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.91 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 97.1 mt -77.85 -23.08 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.951 0.9 . . . . 0.0 110.361 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.0 -46.54 5.17 Favored Pre-proline 0 CA--C 1.549 0.919 0 O-C-N 119.914 -1.741 . . . . 0.0 115.061 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.92 -37.58 64.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.466 2.111 . . . . 0.0 110.173 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.41 -49.08 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.411 HG12 ' SG ' ' A' ' 54' ' ' CYS . 84.8 t -49.96 -44.76 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.67 -61.92 1.61 Allowed 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.36 -40.22 81.65 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.532 -0.73 . . . . 0.0 112.256 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.77 -38.42 75.95 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 54' ' ' CYS . . . -62.21 -52.3 64.34 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -43.58 -53.43 6.06 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.897 0.76 . . . . 0.0 111.572 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -47.95 -35.4 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.24 1.016 . . . . 0.0 112.869 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -120.33 27.03 8.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.447 1.499 . . . . 0.0 112.673 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -39.67 -53.14 2.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.879 1.271 . . . . 0.0 113.799 -173.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.04 -53.22 59.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 122.181 0.991 . . . . 0.0 112.33 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -79.43 -20.29 47.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.822 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.0 tp -144.8 114.68 7.33 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.051 0.387 . . . . 0.0 111.988 -170.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.2 168.09 20.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 44.3 t -145.65 141.45 28.14 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.988 -1.07 . . . . 0.0 110.273 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.21 161.8 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.893 -174.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -127.62 109.38 11.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.452 1.101 . . . . 0.0 109.492 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tp -87.9 121.59 30.5 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.238 0.542 . . . . 0.0 110.426 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -74.58 105.46 5.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.9 m -65.21 -35.94 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.916 1.686 . . . . 0.0 111.03 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.92 -39.56 94.93 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.511 1.124 . . . . 0.0 109.539 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -84.37 -21.7 30.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.804 1.642 . . . . 0.0 110.702 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.1 m -120.96 51.11 2.22 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.346 1.458 . . . . 0.0 114.597 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.53 -27.39 61.78 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.487 2.791 . . . . 0.0 109.68 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -54.28 -75.83 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.849 0.86 . . . . 0.0 109.933 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.4 t -52.63 -44.01 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 124.036 0.935 . . . . 0.0 110.343 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.63 80.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.76 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.4 p -70.74 -39.58 73.23 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.681 0.392 . . . . 0.0 110.27 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.73 -41.66 77.88 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.106 0.562 . . . . 0.0 109.928 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.29 -31.52 48.98 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.07 47.19 4.22 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.41 ' CD1' ' CD2' ' A' ' 26' ' ' PHE . 58.6 mt -72.62 114.67 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.438 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.93 -29.74 44.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.305 0.242 . . . . 0.0 111.006 -178.372 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 m -159.84 157.99 30.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.959 0.904 . . . . 0.0 108.619 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.508 HD11 ' CH2' ' A' ' 30' ' ' TRP . 22.0 pt -119.52 150.74 50.51 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.46 77.21 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.126 1.081 . . . . 0.0 114.05 3.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 m -143.06 113.34 7.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.08 119.96 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 mtt -105.22 159.23 16.03 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.904 0.882 . . . . 0.0 109.247 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 81.8 t -126.5 130.63 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -116.77 147.53 41.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.892 1.677 . . . . 0.0 108.36 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.8 53.1 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.435 0.636 . . . . 0.0 109.582 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.09 85.99 1.74 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.16 -67.32 1.17 Allowed Glycine 0 CA--C 1.527 0.827 0 CA-C-N 117.388 0.594 . . . . 0.0 112.884 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -79.85 163.69 24.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.258 1.023 . . . . 0.0 111.428 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -90.13 150.06 22.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.072 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.1 t -91.23 -51.4 5.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.23 -178.88 6.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 109.519 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.9 m -157.67 143.13 17.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.404 1.482 . . . . 0.0 107.816 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.21 153.35 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.119 0.968 . . . . 0.0 109.456 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.0 mt -79.92 141.86 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -138.57 2.03 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.37 42.34 31.01 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.806 0.803 . . . . 0.0 111.236 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.88 151.1 67.63 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.95 151.52 64.92 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.86 1.706 . . . . 0.0 112.836 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.47 -45.08 46.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.409 1.484 . . . . 0.0 110.801 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -43.13 47.61 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.653 0.781 . . . . 0.0 111.133 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -49.55 74.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.736 0.815 . . . . 0.0 109.055 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.66 -52.37 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 123.951 0.9 . . . . 0.0 108.754 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.2 t -53.65 -59.25 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.104 0.962 . . . . 0.0 109.32 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -50.62 -42.36 55.98 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.705 0.402 . . . . 0.0 111.016 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -60.99 -59.49 5.29 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.8 -45.78 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.91 0.884 . . . . 0.0 111.62 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -44.47 -39.61 4.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.981 1.713 . . . . 0.0 113.193 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.69 -49.22 78.39 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.286 0.634 . . . . 0.0 110.593 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -80.33 -62.66 1.61 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.911 1.284 . . . . 0.0 110.257 -172.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.18 63.02 7.79 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.549 -1.691 . . . . 0.0 108.869 179.927 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 119.32 -0.371 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.17 -48.49 65.16 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.46 140.1 30.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 169.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.15 174.05 54.68 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.46 132.84 56.23 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.4 164.47 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-O 122.513 1.149 . . . . 0.0 111.208 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.63 169.31 18.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.998 2.519 . . . . 0.0 105.487 177.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -40.43 -52.99 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.079 1.352 . . . . 0.0 111.318 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.12 -53.23 56.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.319 1.048 . . . . 0.0 112.308 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.0 p -78.67 -31.4 46.71 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.344 0.658 . . . . 0.0 112.002 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -42.59 -43.54 3.82 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 127.548 2.339 . . . . 0.0 110.335 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -50.72 -67.68 0.23 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.358 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -42.6 98.91 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.226 1.01 . . . . 0.0 112.352 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.66 -43.9 16.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.971 -168.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.3 t -99.2 -54.03 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.399 1.08 . . . . 0.0 111.307 -174.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -69.17 -57.77 4.94 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.756 0.707 . . . . 0.0 110.283 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.6 51.55 1.28 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.173 0.989 . . . . 0.0 110.112 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 p -90.06 154.69 19.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.766 1.226 . . . . 0.0 112.64 -175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -100.94 -71.37 0.71 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.023 1.729 . . . . 0.0 107.405 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.7 m -79.19 158.95 73.84 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.56 159.81 12.85 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.565 1.51 . . . . 0.0 109.97 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 t -138.7 119.03 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.064 0.945 . . . . 0.0 110.419 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mp -94.41 110.35 22.14 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.375 1.07 . . . . 0.0 108.179 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.76 113.46 40.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -86.24 113.88 22.61 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.537 ' CD2' HD12 ' A' ' 57' ' ' LEU . 40.3 m-85 -79.3 113.09 17.15 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.4 p-90 -129.18 -174.71 3.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.79 0.805 . . . . 0.0 111.016 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.77 154.14 5.23 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.888 1.275 . . . . 0.0 108.17 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -64.98 -42.1 15.32 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.821 2.348 . . . . 0.0 110.45 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.468 ' CH2' HD11 ' A' ' 74' ' ' ILE . 30.8 p-90 -66.39 -17.95 65.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.893 0.477 . . . . 0.0 111.215 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 10.9 t -75.37 97.59 3.65 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.545 -0.722 . . . . 0.0 110.248 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -32.01 -68.87 0.13 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.908 2.194 . . . . 0.0 115.062 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.13 -44.37 12.58 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 CA-C-N 119.879 1.839 . . . . 0.0 110.8 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 65.4 m -47.22 -50.37 21.16 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.291 0.636 . . . . 0.0 109.998 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -46.26 -50.4 16.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.045 1.338 . . . . 0.0 111.618 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -90.15 -13.56 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 tp -85.62 -27.86 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.468 1.031 . . . . 0.0 109.561 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.55 -48.3 4.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -62.56 -36.98 61.56 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.56 2.173 . . . . 0.0 110.337 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 t -63.13 -51.87 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -50.77 -46.05 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 123.683 0.793 . . . . 0.0 109.255 177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.89 -62.17 1.88 Allowed 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.617 0.367 . . . . 0.0 111.187 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.19 -30.16 68.0 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.02 0.827 . . . . 0.0 113.161 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -26.15 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 118.048 -1.461 . . . . 0.0 109.387 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -40.11 73.92 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.042 -1.036 . . . . 0.0 109.757 174.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.69 -42.36 95.39 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -57.65 -39.37 76.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.058 0.429 . . . . 0.0 109.955 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -78.86 53.76 1.44 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.637 -0.664 . . . . 0.0 112.456 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -62.09 -44.97 95.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.8 108.82 3.11 Favored 'General case' 0 N--CA 1.443 -0.812 1 N-CA-C 100.163 -4.014 . . . . 0.0 100.163 162.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -72.67 107.93 5.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.471 -2.15 . . . . 0.0 113.822 -153.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.13 121.98 37.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 108.879 -3.782 . . . . 0.0 105.828 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -78.89 149.74 32.36 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.5 t -126.08 138.56 53.71 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.12 165.37 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.006 0.522 . . . . 0.0 109.968 -176.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.6 mtmt -132.13 111.9 11.85 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 110.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.537 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.1 tm? -92.86 116.12 28.74 Favored 'General case' 0 C--O 1.23 0.072 0 C-N-CA 124.796 1.238 . . . . 0.0 109.391 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -74.38 109.59 7.99 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -66.25 -33.11 75.02 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.791 1.236 . . . . 0.0 111.289 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -69.71 -38.44 76.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.745 0.818 . . . . 0.0 110.179 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -81.96 -29.77 32.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.814 1.646 . . . . 0.0 111.598 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 t -124.27 55.65 10.22 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.571 1.548 . . . . 0.0 111.644 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -65.15 -29.34 56.03 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 124.377 3.385 . . . . 0.0 108.593 176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -47.3 -69.33 0.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.603 1.161 . . . . 0.0 109.624 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.6 t -54.5 -56.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.746 0.819 . . . . 0.0 109.928 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.23 -47.59 62.3 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 78.8 p -63.36 -49.89 72.09 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.816 -0.552 . . . . 0.0 109.849 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.07 -40.23 66.99 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.502 0.721 . . . . 0.0 110.642 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -78.96 -23.37 44.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.833 1.253 . . . . 0.0 111.814 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.3 28.69 19.27 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.561 1.077 . . . . 0.0 112.182 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -81.45 80.52 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.8 ptt85 -78.48 -3.19 42.22 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.761 -1.108 . . . . 0.0 112.288 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 m -155.96 157.34 36.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.468 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.5 pt -145.85 157.72 50.44 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 125.879 1.672 . . . . 0.0 106.637 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.79 147.02 87.06 Favored 'Cis proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.147 1.445 . . . . 0.0 113.329 1.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.7 m -156.72 120.41 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mt -97.06 116.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 125.354 1.462 . . . . 0.0 107.154 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.2 mtt -99.15 147.84 24.69 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 119.652 1.115 . . . . 0.0 108.696 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.56 105.45 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -89.47 124.04 34.13 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 173.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 4.69 18.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.758 0.823 . . . . 0.0 112.102 -175.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.91 100.46 0.36 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.1 -73.45 1.52 Allowed Glycine 0 CA--C 1.525 0.667 0 CA-C-N 117.489 0.644 . . . . 0.0 111.874 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -102.12 172.64 6.79 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.981 0.912 . . . . 0.0 111.594 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -78.6 162.24 26.41 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.213 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 49.8 t -120.4 -66.61 1.04 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.675 1.19 . . . . 0.0 108.208 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -126.36 -169.16 1.97 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.27 1.028 . . . . 0.0 109.585 177.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -156.81 167.7 29.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.573 1.149 . . . . 0.0 108.069 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.88 133.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.1 mt -78.87 142.01 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.64 -157.12 7.51 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.039 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.8 54.62 9.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.786 0.834 . . . . 0.0 109.95 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.42 158.04 74.18 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 125.633 1.573 . . . . 0.0 108.495 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.88 143.21 44.88 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 105.613 -2.495 . . . . 0.0 105.613 167.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.73 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.26 -56.41 8.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.4 m -55.22 -46.13 75.95 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.069 0.948 . . . . 0.0 110.605 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.3 mt -56.67 -49.09 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.05 -45.52 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.596 0.759 . . . . 0.0 109.543 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -42.93 87.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.488 1.04 . . . . 0.0 109.119 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.4 m -61.32 -46.77 88.92 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.438 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.8 t -56.01 -48.75 78.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 O-C-N 121.829 -0.545 . . . . 0.0 109.709 176.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.03 -48.36 76.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -43.68 64.87 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.823 -0.548 . . . . 0.0 109.898 177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.5 m-30 -70.88 -39.23 72.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.64 -84.84 0.2 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.886 0.875 . . . . 0.0 110.541 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.111 0 C-N-CA 127.595 2.358 . . . . 0.0 104.739 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 70.52 -70.49 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -168.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.49 142.34 51.9 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 165.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.24 -173.62 36.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.277 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.26 136.83 45.78 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.7 168.2 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-O 121.916 0.865 . . . . 0.0 109.459 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -140.75 175.06 9.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.083 1.753 . . . . 0.0 106.27 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -47.33 -47.11 25.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.871 0.868 . . . . 0.0 112.156 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.39 -72.2 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.775 0.83 . . . . 0.0 110.714 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -52.57 -33.42 45.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.428 1.091 . . . . 0.0 112.422 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -41.48 -46.43 3.48 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.297 1.439 . . . . 0.0 110.199 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -56.47 -60.85 2.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.613 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -63.64 -31.63 72.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.516 0.726 . . . . 0.0 112.702 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.8 t -95.16 -48.1 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.277 0.631 . . . . 0.0 112.065 -171.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -94.22 -53.13 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 125.034 1.334 . . . . 0.0 111.713 -175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.02 -58.57 3.92 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.871 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -79.23 50.11 1.03 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.544 1.138 . . . . 0.0 110.278 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.6 p -90.43 145.75 24.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 124.769 1.228 . . . . 0.0 112.218 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -93.44 -65.77 0.97 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -79.25 160.77 69.95 Favored Pre-proline 0 C--O 1.232 0.167 0 C-N-CA 124.608 1.163 . . . . 0.0 108.835 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -55.65 162.55 6.38 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.577 1.518 . . . . 0.0 110.692 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -138.63 144.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.878 1.671 . . . . 0.0 110.128 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 tt -124.91 100.81 6.77 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 126.427 1.891 . . . . 0.0 106.181 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.19 116.93 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -88.79 116.16 26.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -79.17 108.83 12.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -122.3 -169.15 1.84 Allowed 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 124.184 0.993 . . . . 0.0 111.017 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.02 150.8 2.02 Favored Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -57.61 -40.31 81.2 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.026 1.818 . . . . 0.0 111.291 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 74' ' ' ILE . 36.3 p-90 -67.06 -16.54 64.41 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.836 0.454 . . . . 0.0 111.585 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.1 t -74.69 85.01 2.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.227 -0.921 . . . . 0.0 111.176 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -37.71 -60.57 1.2 Allowed Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.317 0.96 . . . . 0.0 113.563 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.48 -50.38 13.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.022 2.481 . . . . 0.0 112.61 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.06 -45.08 91.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -56.19 -50.29 71.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.556 1.143 . . . . 0.0 110.256 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.08 -37.85 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.437 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 pt -77.37 -25.29 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 120.083 1.31 . . . . 0.0 111.895 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.51 -47.56 4.69 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -62.22 -37.75 60.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.743 2.295 . . . . 0.0 110.484 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.96 -47.71 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.5 -43.03 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -57.92 -66.14 0.52 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.1 0.409 . . . . 0.0 110.107 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -59.07 -29.52 67.38 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -175.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 mm -50.8 -34.06 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 118.486 0.584 . . . . 0.0 109.983 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.4 74.85 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.525 1.057 . . . . 0.0 111.053 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.1 -24.61 76.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.57 -53.55 9.19 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 117.754 0.777 . . . . 0.0 108.911 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -79.78 58.66 2.88 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -65.71 -40.97 92.79 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 103.339 -2.837 . . . . 0.0 103.339 164.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.91 110.16 3.22 Favored 'General case' 0 N--CA 1.439 -1.018 1 N-CA-C 98.78 -4.526 . . . . 0.0 98.78 162.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -73.36 125.24 27.4 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 124.822 2.249 . . . . 0.0 115.586 -151.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HA ' HD12 ' A' ' 52' ' ' LEU . 16.5 tp -134.55 120.4 19.61 Favored 'General case' 0 C--N 1.314 -0.962 1 CA-C-N 107.867 -4.242 . . . . 0.0 108.054 164.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.24 94.04 7.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.14 130.34 35.39 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.834 -0.541 . . . . 0.0 109.565 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.67 174.56 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.706 0.802 . . . . 0.0 111.934 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -144.08 113.45 6.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.014 1.325 . . . . 0.0 111.283 -174.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.0 tt -98.9 125.62 44.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.849 0.833 . . . . 0.0 110.6 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -71.74 105.24 3.66 Favored 'General case' 0 N--CA 1.436 -1.139 0 C-N-CA 124.906 1.283 . . . . 0.0 113.874 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -81.21 45.84 0.88 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.859 -1.151 . . . . 0.0 111.027 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -152.09 -48.94 0.11 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -82.98 -19.04 37.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.737 2.015 . . . . 0.0 110.2 173.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.5 m -137.33 61.4 32.24 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.834 1.254 . . . . 0.0 111.915 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.8 -24.6 8.49 Favored 'Trans proline' 0 N--CA 1.446 -1.304 1 C-N-CA 125.492 4.128 . . . . 0.0 110.317 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -47.62 -68.69 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.765 1.226 . . . . 0.0 110.276 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.79 -43.3 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.094 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.72 70.06 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.249 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.2 m -70.13 -45.95 65.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.583 0.753 . . . . 0.0 109.713 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -55.18 -45.83 75.81 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.977 0.511 . . . . 0.0 110.749 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -79.43 -30.3 42.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.352 0.261 . . . . 0.0 111.534 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.17 54.39 2.15 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.9 mm -69.75 92.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.859 0.838 . . . . 0.0 108.962 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -78.04 82.12 4.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t 73.21 -175.81 0.16 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 126.357 1.863 . . . . 0.0 109.498 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 30' ' ' TRP . 24.6 pt -145.38 157.06 53.33 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.749 1.22 . . . . 0.0 108.455 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.33 138.23 44.0 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 120.62 1.257 . . . . 0.0 111.85 1.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.9 m -134.63 98.25 4.01 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -89.53 109.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.2 mmt -97.16 143.57 27.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 64.4 t -114.13 133.51 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.15 161.21 31.6 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.91 77.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.951 0.405 . . . . 0.0 110.163 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.46 1.36 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.632 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.48 -56.52 3.34 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 123.836 0.732 . . . . 0.0 112.738 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -79.36 155.01 28.61 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 122.245 1.021 . . . . 0.0 111.893 -174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.12 130.47 36.28 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.649 1.979 . . . . 0.0 108.155 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 39.6 t -89.31 -57.99 2.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.269 1.028 . . . . 0.0 110.109 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.94 166.89 22.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.595 1.158 . . . . 0.0 111.869 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -142.25 126.15 17.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.251 2.22 . . . . 0.0 105.191 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.8 mt -128.6 103.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -100.52 138.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.183 1.393 . . . . 0.0 109.555 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.81 156.15 21.94 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.953 0.787 . . . . 0.0 112.563 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.66 51.89 0.2 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.11 1.364 . . . . 0.0 113.148 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.4 m -79.91 148.77 69.18 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.81 156.06 64.19 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.356 1.37 . . . . 0.0 111.71 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.78 -46.04 29.99 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.894 1.277 . . . . 0.0 111.007 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.17 -41.89 3.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.776 0.831 . . . . 0.0 111.525 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.268 1.027 . . . . 0.0 109.153 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.47 -52.64 50.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 C-N-CA 124.431 1.092 . . . . 0.0 108.878 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.5 t -53.2 -58.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.783 1.233 . . . . 0.0 109.567 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -54.39 -50.11 68.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.449 -0.157 . . . . 0.0 110.911 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.2 m -60.4 -55.74 29.94 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.471 0.177 . . . . 0.0 110.99 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -41.54 85.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 O-C-N 121.383 -0.823 . . . . 0.0 110.374 -176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.32 -45.64 90.38 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -53.67 -42.2 67.66 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.856 -0.527 . . . . 0.0 109.781 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -73.12 -43.06 62.19 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -95.43 -88.52 0.26 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.934 1.294 . . . . 0.0 109.233 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.256 1.406 0 C-N-CA 127.743 2.417 . . . . 0.0 105.345 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' HB1' ' A' ' 45' ' ' ALA . 41.5 tpp . . . . . 0 N--CA 1.467 0.41 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -43.34 134.4 3.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.067 0.947 . . . . 0.0 110.579 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.31 157.88 34.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.291 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.85 -168.05 12.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.01 147.02 50.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.54 168.16 21.46 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 CA-C-O 122.038 0.923 . . . . 0.0 111.46 -177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.32 170.34 16.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.364 2.666 . . . . 0.0 105.93 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -39.93 -50.78 2.5 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.768 1.627 . . . . 0.0 110.964 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.95 -73.45 0.09 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.243 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.9 p -52.76 -36.43 57.88 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.274 1.03 . . . . 0.0 112.49 -174.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -40.02 -46.19 2.06 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.928 1.691 . . . . 0.0 110.841 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -49.78 -62.49 1.53 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.999 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -71.32 -39.84 71.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.284 0.634 . . . . 0.0 111.879 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.22 -40.01 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.953 -169.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.4 t -100.88 -60.21 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 C-N-CA 123.892 0.877 . . . . 0.0 110.706 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -65.07 -68.15 0.38 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.876 0.37 . . . . 0.0 110.626 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -77.98 34.98 0.2 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.862 0.865 . . . . 0.0 112.664 -171.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -91.21 143.49 26.6 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.993 0.917 . . . . 0.0 109.5 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.06 -60.91 2.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.4 1.08 . . . . 0.0 108.197 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.9 m -78.74 155.83 77.97 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -56.39 160.54 10.97 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.203 1.935 . . . . 0.0 114.351 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.23 118.56 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.536 1.134 . . . . 0.0 111.506 -175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tt -93.45 88.01 5.78 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 124.841 1.257 . . . . 0.0 109.593 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.22 133.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 O-C-N 121.157 -0.965 . . . . 0.0 109.259 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.54 121.49 44.75 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.924 0.89 . . . . 0.0 108.645 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.445 ' CE2' HD23 ' A' ' 57' ' ' LEU . 53.5 m-85 -79.79 108.67 13.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -123.29 -173.72 2.79 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 122.275 1.035 . . . . 0.0 110.296 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.18 152.63 9.78 Favored Pre-proline 0 N--CA 1.449 -0.493 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.43 -44.97 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-N 120.542 1.229 . . . . 0.0 111.756 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.549 ' CH2' HD11 ' A' ' 74' ' ' ILE . 17.1 p-90 -56.12 -20.7 18.55 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.463 174.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.7 t -77.46 84.84 3.85 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 121.585 -0.697 . . . . 0.0 109.412 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.98 -57.94 1.96 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.586 1.089 . . . . 0.0 113.147 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.9 -25.33 69.1 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.089 1.86 . . . . 0.0 113.01 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.9 m -77.2 -50.67 12.43 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -49.14 -50.76 35.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.564 1.546 . . . . 0.0 111.41 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.2 pt -64.81 -39.84 87.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.467 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 pt -76.83 -26.69 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.563 1.074 . . . . 0.0 111.667 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.45 -48.46 4.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.97 -38.03 60.93 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.357 2.038 . . . . 0.0 110.357 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.57 -39.74 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.5 t -52.77 -40.69 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -67.96 -58.5 4.43 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.701 0.4 . . . . 0.0 111.054 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.59 -47.59 81.72 Favored 'General case' 0 C--N 1.34 0.18 0 O-C-N 121.683 -0.636 . . . . 0.0 111.996 -172.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mm -56.97 -38.5 60.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 54' ' ' CYS . . . -61.23 -43.42 98.91 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.421 -0.799 . . . . 0.0 109.301 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.02 -50.49 58.72 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.3 -53.37 44.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.527 0.663 . . . . 0.0 110.222 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -82.08 51.17 1.71 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.126 0.965 . . . . 0.0 112.015 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -41.6 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 127.935 2.494 . . . . 0.0 111.509 -176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -57.19 -54.43 46.92 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -170.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -78.13 -40.54 37.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 -166.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.37 128.39 37.52 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 118.204 -1.398 . . . . 0.0 114.387 -152.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -83.11 163.14 21.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.465 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . 54.1 t -142.72 145.8 33.71 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.57 168.42 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.577 -175.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -137.87 112.44 8.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.294 1.038 . . . . 0.0 108.702 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 26' ' ' PHE . 45.7 tp -98.2 120.49 38.7 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.2 1.0 . . . . 0.0 109.725 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -73.23 109.99 7.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -67.49 -35.76 79.79 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.795 1.238 . . . . 0.0 111.086 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.51 -39.69 92.15 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.159 0.984 . . . . 0.0 109.779 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -80.21 -33.52 38.08 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.877 1.671 . . . . 0.0 112.005 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.421 ' CB ' HD11 ' A' ' 57' ' ' LEU . 26.0 t -120.9 55.56 4.65 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.625 1.57 . . . . 0.0 111.937 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.34 -24.67 64.49 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 124.06 3.173 . . . . 0.0 110.598 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -54.15 -67.54 0.25 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.803 0.841 . . . . 0.0 109.773 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -53.21 -51.1 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 124.2 1.0 . . . . 0.0 109.202 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.47 -48.19 37.93 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.208 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -66.47 -46.65 75.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.018 0.527 . . . . 0.0 110.627 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.55 -45.5 77.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.036 0.534 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -79.43 -31.17 42.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.589 0.356 . . . . 0.0 111.488 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.59 43.94 3.04 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.655 0.645 . . . . 0.0 111.627 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mm -73.52 90.64 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -77.47 -20.53 54.27 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.334 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.3 m -156.18 165.01 37.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.549 HD11 ' CH2' ' A' ' 30' ' ' TRP . 26.7 pt -129.87 153.47 80.93 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.82 165.36 70.35 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.302 1.144 . . . . 0.0 111.954 0.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -156.74 113.55 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.77 115.29 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.9 mtt -111.56 134.84 52.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.58 115.77 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.79 162.48 15.21 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.71 1.204 . . . . 0.0 109.619 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.41 151.55 9.75 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.71 1.204 . . . . 0.0 107.899 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.04 45.6 14.74 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 115.969 1.147 . . . . 0.0 115.969 170.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.06 0.31 60.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.17 -1.35 . . . . 0.0 114.94 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -129.94 159.38 36.83 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.737 1.769 . . . . 0.0 111.922 -176.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.51 138.59 31.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.81 1.644 . . . . 0.0 107.989 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.4 t -114.81 -82.25 0.61 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.003 0.921 . . . . 0.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -92.73 163.53 13.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.086 0.554 . . . . 0.0 110.866 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -157.5 122.61 4.49 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.773 1.229 . . . . 0.0 109.862 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.93 137.2 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.42 143.6 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 109.743 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.98 165.52 40.19 Favored Glycine 0 C--N 1.338 0.647 0 O-C-N 123.37 0.419 . . . . 0.0 112.328 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.63 131.17 45.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.308 0.643 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.3 153.77 41.25 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.8 138.97 27.01 Favored 'Trans proline' 0 N--CA 1.44 -1.673 0 N-CA-C 104.714 -2.841 . . . . 0.0 104.714 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -56.14 -33.92 65.63 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.389 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.27 -37.3 7.11 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.542 1.064 . . . . 0.0 112.237 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.6 m -70.78 -41.68 71.36 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.499 -0.751 . . . . 0.0 109.302 177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 82.0 mt -61.71 -44.23 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -54.36 -55.49 14.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -52.64 -43.5 65.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.966 0.348 . . . . 0.0 110.787 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.2 m -59.09 -40.2 84.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.33 -50.74 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.084 -1.01 . . . . 0.0 108.971 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -51.61 -47.48 63.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.047 0.939 . . . . 0.0 112.873 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -25.69 60.43 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -90.37 -52.69 4.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.44 0.564 . . . . 0.0 109.704 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -112.93 -92.0 0.49 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.4 1.08 . . . . 0.0 109.834 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.207 0 C-N-CA 128.523 2.729 . . . . 0.0 103.862 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tpt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.61 -43.49 84.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.88 135.74 37.94 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 170.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.41 -179.01 51.49 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.43 137.62 54.81 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.89 164.98 32.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 122.299 1.047 . . . . 0.0 111.379 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -144.11 168.74 19.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.853 2.061 . . . . 0.0 105.731 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -39.63 -45.67 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -57.31 -70.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.432 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -59.57 -33.47 71.48 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.475 1.11 . . . . 0.0 112.336 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -42.17 -46.67 4.45 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 126.778 2.031 . . . . 0.0 111.265 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -47.45 -48.41 26.65 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.753 1.221 . . . . 0.0 110.651 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -82.33 -63.1 1.45 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.061 0.934 . . . . 0.0 111.268 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.97 -31.58 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.889 -169.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.21 -59.81 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.004 0.522 . . . . 0.0 111.865 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.38 -71.03 0.26 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.464 0.575 . . . . 0.0 110.041 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.88 48.41 0.83 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.723 0.809 . . . . 0.0 111.212 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 p -90.38 148.37 22.86 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.653 1.581 . . . . 0.0 109.129 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 p -83.62 -68.03 0.74 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 m -79.49 158.95 73.11 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.274 1.03 . . . . 0.0 108.66 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -53.12 164.9 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.486 2.124 . . . . 0.0 113.082 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.0 t -141.81 148.95 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.902 2.081 . . . . 0.0 109.207 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 tt -131.68 105.56 7.6 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.19 122.91 52.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.618 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -97.73 117.69 32.59 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -79.52 112.13 16.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -126.14 -176.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.202 1.001 . . . . 0.0 110.335 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.89 148.29 3.13 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 173.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -53.21 -45.27 42.31 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.164 . . . . 0.0 112.513 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.0 p-90 -67.07 -20.62 65.85 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.776 -0.578 . . . . 0.0 111.898 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.04 85.09 2.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 119.117 0.871 . . . . 0.0 110.404 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -34.45 -62.96 0.48 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.492 1.52 . . . . 0.0 114.374 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.57 -43.48 50.52 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 119.633 1.716 . . . . 0.0 111.311 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.8 m -59.73 -45.37 92.4 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -55.22 -53.64 53.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.787 1.235 . . . . 0.0 110.542 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 pt -69.71 -29.71 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.36 -0.353 . . . . 0.0 111.397 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.1 mt -74.27 -35.32 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.253 0.621 . . . . 0.0 111.471 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -40.51 -48.03 6.68 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -61.72 -36.71 73.02 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.483 2.122 . . . . 0.0 109.75 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.1 t -66.77 -45.11 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.4 t -53.75 -43.75 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -66.05 -48.84 69.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.859 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.93 -41.08 99.37 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 120.829 -1.169 . . . . 0.0 109.65 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.6 mt -56.82 -44.44 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -54.68 -50.34 68.48 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.41 -45.21 45.63 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.93 -46.58 81.04 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -111.91 23.76 13.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -56.16 168.59 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.916 1.286 . . . . 0.0 112.317 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 71.3 -52.62 0.69 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 127.657 2.383 . . . . 0.0 111.199 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -80.19 -50.22 10.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.249 0.547 . . . . 0.0 110.094 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -102.0 106.4 17.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.652 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -78.66 90.04 4.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 49.1 t -78.32 137.9 38.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.53 163.09 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 123.161 0.585 . . . . 0.0 110.12 -175.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -127.57 115.21 18.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.483 1.113 . . . . 0.0 109.614 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tp -91.49 119.06 31.12 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.271 0.628 . . . . 0.0 109.562 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.17 107.1 6.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.5 m -67.99 -35.98 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.198 1.399 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -63.59 -38.82 92.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.701 1.201 . . . . 0.0 109.871 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -82.5 -25.08 33.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.719 2.008 . . . . 0.0 111.036 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.6 m -121.46 53.61 3.94 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 113.93 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.11 -25.82 73.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.061 3.174 . . . . 0.0 109.367 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -50.85 -70.38 0.09 Allowed 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.896 1.279 . . . . 0.0 109.68 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.8 t -51.41 -50.63 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.059 1.344 . . . . 0.0 109.184 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.82 -47.88 51.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.251 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 m -72.15 -43.35 64.78 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.92 0.888 . . . . 0.0 111.236 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.91 -48.34 70.25 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.286 0.635 . . . . 0.0 110.03 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -79.55 -35.63 39.55 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.21 53.41 9.09 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 pt -57.31 142.11 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.497 1.119 . . . . 0.0 111.775 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -79.91 70.26 6.43 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.0 t 64.52 -160.15 0.29 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -139.51 150.23 62.89 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.78 143.29 73.5 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.985 1.03 . . . . 0.0 113.798 3.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.5 m -140.44 110.04 6.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.82 134.15 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.1 mtt -124.86 128.44 48.67 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.657 1.183 . . . . 0.0 108.881 176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.2 t -98.77 131.58 45.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -119.94 134.23 55.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 173.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.485 ' H ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -104.49 25.48 10.17 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.109 0.964 . . . . 0.0 110.597 -178.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.21 123.26 5.22 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.43 -64.99 3.15 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 117.885 0.842 . . . . 0.0 113.376 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -126.22 172.73 9.82 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.244 1.018 . . . . 0.0 111.93 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -67.46 164.86 17.86 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.179 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -128.7 -57.37 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.815 1.646 . . . . 0.0 108.813 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -140.11 171.29 14.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.565 1.546 . . . . 0.0 109.729 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -160.08 147.83 16.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.5 150.4 33.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.08 144.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.62 162.41 37.85 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.603 0.557 . . . . 0.0 112.565 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.76 131.26 38.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.553 0.741 . . . . 0.0 110.534 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.37 149.5 48.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.05 155.48 33.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.676 2.251 . . . . 0.0 114.003 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -46.03 -52.47 11.82 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 125.404 1.482 . . . . 0.0 109.771 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.83 -45.85 50.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.281 0.633 . . . . 0.0 110.612 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -49.19 68.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.8 mt -53.04 -58.81 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.9 t -52.42 -55.5 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 110.318 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.09 -47.43 78.03 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.506 0.594 . . . . 0.0 110.967 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.3 m -59.87 -42.27 93.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.96 0.504 . . . . 0.0 110.575 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.19 -57.18 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -45.32 -58.54 3.23 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.933 1.293 . . . . 0.0 111.342 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -18.59 25.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -80.51 -23.66 39.93 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 120.013 1.279 . . . . 0.0 110.722 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.0 mt -98.86 -43.24 6.82 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.271 1.428 . . . . 0.0 111.863 -177.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 117.297 -1.335 . . . . 0.0 109.853 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -122.19 -44.88 2.26 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.611 0.764 . . . . 0.0 110.839 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.14 122.93 17.79 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.02 166.79 52.12 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.907 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.51 119.65 37.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -111.56 161.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.734 0.813 . . . . 0.0 109.671 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -138.04 171.7 14.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -39.82 -45.46 1.79 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.001 1.32 . . . . 0.0 111.468 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.68 -77.76 0.06 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.253 0.621 . . . . 0.0 110.974 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.7 p -46.69 -38.65 10.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.133 1.373 . . . . 0.0 112.744 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -39.71 -46.39 1.86 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.522 1.529 . . . . 0.0 110.819 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -48.76 -56.79 7.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.519 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -78.34 -33.57 49.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.871 -0.518 . . . . 0.0 112.017 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.4 t -92.5 -26.13 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -169.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.91 -51.25 4.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 C-N-CA 124.747 1.219 . . . . 0.0 111.519 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.63 -61.86 1.69 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -77.51 33.22 0.16 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.029 0.932 . . . . 0.0 112.1 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 m -91.09 132.65 35.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.42 1.088 . . . . 0.0 111.133 -178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 p -78.79 -53.29 7.27 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.711 1.604 . . . . 0.0 107.158 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.94 152.56 79.91 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.02 166.61 29.09 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 N-CA-C 108.658 -1.324 . . . . 0.0 108.658 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.487 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -152.48 134.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.428 HD21 HG23 ' A' ' 77' ' ' ILE . 9.0 tt -99.06 115.35 28.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.987 1.715 . . . . 0.0 108.864 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.0 t -100.91 114.16 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.72 116.51 24.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -78.64 110.77 14.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 56' ' ' LYS . 9.0 p-90 -124.17 -172.71 2.6 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.792 0.806 . . . . 0.0 112.111 -172.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -172.42 151.84 2.55 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 125.239 1.416 . . . . 0.0 107.426 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.55 -42.11 35.5 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.552 2.168 . . . . 0.0 110.044 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.477 ' CH2' HD11 ' A' ' 74' ' ' ILE . 34.6 p-90 -67.35 -17.32 64.7 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.878 0.471 . . . . 0.0 111.355 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.9 t -80.02 87.52 5.41 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.208 -0.933 . . . . 0.0 110.794 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.49 -61.63 1.49 Allowed Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.521 1.058 . . . . 0.0 113.712 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.73 -19.94 56.15 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.096 1.864 . . . . 0.0 113.21 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.0 m -82.75 -50.79 8.31 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -50.2 -47.4 54.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.567 1.547 . . . . 0.0 110.832 -178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -70.21 -18.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.929 -0.558 . . . . 0.0 112.415 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -88.74 -28.32 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.464 1.029 . . . . 0.0 110.052 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -39.08 -47.31 3.83 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.704 1.602 . . . . 0.0 113.266 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.25 -38.26 21.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.948 1.766 . . . . 0.0 110.884 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.4 t -69.75 -57.4 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.707 1.203 . . . . 0.0 109.452 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.519 HG22 ' SG ' ' A' ' 54' ' ' CYS . 3.2 p -54.02 -42.86 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.96 -56.24 23.45 Favored 'General case' 0 N--CA 1.461 0.123 0 O-C-N 121.59 -0.693 . . . . 0.0 112.427 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -59.38 -41.39 89.24 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 122.008 -0.433 . . . . 0.0 110.435 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.7 mt -55.67 -44.42 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.34 -53.6 54.09 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -44.65 -44.43 8.38 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.249 0.452 . . . . 0.0 112.422 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.76 -41.84 96.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -121.92 9.76 10.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -39.85 -41.4 1.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.008 2.123 . . . . 0.0 113.752 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -42.84 -40.7 2.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.46 1.904 . . . . 0.0 112.991 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -132.47 -54.26 0.95 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HG ' ' HG3' ' A' ' 53' ' ' LYS . 12.6 tp -83.44 170.83 14.07 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' CB ' ' HA ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -75.36 93.75 2.96 Favored 'General case' 0 N--CA 1.433 -1.323 2 N-CA-C 122.993 4.442 . . . . 0.0 122.993 -164.05 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.519 ' SG ' HG22 ' A' ' 41' ' ' VAL . 11.1 t -151.2 122.2 7.65 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 118.96 -2.338 . . . . 0.0 114.794 174.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.08 165.68 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.599 1.16 . . . . 0.0 110.202 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HB3' ' CD1' ' A' ' 27' ' ' TRP . 7.4 mtmp? -132.73 122.81 25.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.732 1.213 . . . . 0.0 111.576 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 tp -104.82 120.51 41.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.829 0.823 . . . . 0.0 110.21 177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -69.45 109.51 4.26 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 124.775 1.23 . . . . 0.0 113.42 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -82.61 47.59 1.2 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.428 1.491 . . . . 0.0 110.347 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.19 -46.59 0.1 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -82.43 -23.01 35.04 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.669 1.988 . . . . 0.0 109.705 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.47 53.24 5.65 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 112.542 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.55 -38.78 7.76 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 124.88 3.72 . . . . 0.0 109.493 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -49.46 -67.31 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.892 1.277 . . . . 0.0 110.528 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.1 t -58.09 -45.53 88.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.93 -39.77 66.16 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.059 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.8 m -72.73 -41.55 65.06 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 124.144 0.978 . . . . 0.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -55.39 -43.23 75.02 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.09 -32.29 44.61 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.89 35.24 6.86 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.12 1.343 . . . . 0.0 111.622 177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.5 mt -80.84 62.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.329 1.452 . . . . 0.0 109.37 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -81.59 57.73 3.45 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.551 -0.718 . . . . 0.0 110.355 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 163.3 150.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.963 2.505 . . . . 0.0 107.585 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.477 HD11 ' CH2' ' A' ' 30' ' ' TRP . 13.3 pt -152.85 155.24 32.13 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.12 134.53 28.6 Favored 'Cis proline' 0 N--CA 1.453 -0.859 0 CA-C-N 120.362 1.165 . . . . 0.0 112.857 1.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 m -132.8 106.21 7.6 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.428 HG23 HD21 ' A' ' 23' ' ' LEU . 36.1 mt -94.75 130.51 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.138 1.375 . . . . 0.0 107.698 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.5 mtt -130.62 152.22 50.22 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.46 141.35 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.22 167.28 20.08 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 110.623 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.65 152.2 3.75 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.746 2.018 . . . . 0.0 106.712 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.21 41.25 8.07 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.484 1.038 . . . . 0.0 115.675 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.5 11.49 68.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.427 -1.207 . . . . 0.0 115.103 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -138.38 167.85 21.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.441 1.62 . . . . 0.0 110.421 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.44 160.2 25.38 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.546 0.738 . . . . 0.0 110.139 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.3 t -115.94 -53.7 2.54 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 125.569 1.548 . . . . 0.0 109.455 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 -177.0 5.81 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.724 1.21 . . . . 0.0 108.834 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.9 t -158.35 151.8 23.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 0.0 109.48 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.3 mm -135.84 155.88 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 127.549 2.34 . . . . 0.0 105.55 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.1 mt -138.95 145.48 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.01 155.13 20.75 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.46 135.58 45.76 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 m -139.65 152.31 68.22 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.63 160.09 47.28 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.007 1.805 . . . . 0.0 112.409 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -43.41 -51.34 6.57 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 126.136 1.774 . . . . 0.0 111.276 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.95 -45.93 60.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.847 0.459 . . . . 0.0 110.948 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 m -66.28 -48.02 71.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.1 mt -55.72 -55.52 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.34 -51.84 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 C-N-CA 123.496 0.718 . . . . 0.0 110.147 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.81 -46.86 81.34 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.996 0.816 . . . . 0.0 110.445 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 96.1 m -57.31 -43.32 83.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.294 0.638 . . . . 0.0 109.782 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.6 t -62.98 -58.91 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.996 0.816 . . . . 0.0 109.213 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -44.16 -51.89 7.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.835 1.254 . . . . 0.0 112.289 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.47 -26.28 30.19 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -80.59 -14.68 57.98 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.379 -0.825 . . . . 0.0 111.328 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.47 -43.5 5.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.237 1.415 . . . . 0.0 110.216 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.184 0 CA-C-O 117.079 -1.439 . . . . 0.0 109.911 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 ttm . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.51 170.13 14.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.21 148.78 35.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.41 111.6 4.1 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 112.2 -0.36 . . . . 0.0 112.2 -177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.65 115.5 19.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.55 165.07 12.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 122.282 1.039 . . . . 0.0 111.361 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -138.2 170.89 15.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 127.451 2.3 . . . . 0.0 106.408 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -38.81 -52.86 1.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.219 1.808 . . . . 0.0 111.428 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.69 -73.34 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.567 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -52.28 -38.12 57.44 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.511 1.125 . . . . 0.0 111.769 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -42.91 -45.08 4.84 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.313 1.845 . . . . 0.0 111.356 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -55.55 -51.95 65.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.856 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -75.11 -50.43 16.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.306 0.574 . . . . 0.0 111.655 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -74.57 -39.81 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.747 1.219 . . . . 0.0 112.825 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -107.38 -54.67 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 112.763 -170.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 mt -64.54 -64.53 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -77.81 49.61 0.78 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 110.432 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.0 p -84.13 121.91 28.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.565 1.546 . . . . 0.0 111.373 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.3 p -79.77 -61.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.8 m -77.88 153.88 80.5 Favored Pre-proline 0 N--CA 1.456 -0.145 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.78 149.86 67.31 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.517 -0.993 . . . . 0.0 109.517 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.484 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -149.96 127.22 2.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 N-CA-C 115.011 1.485 . . . . 0.0 115.011 -178.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.38 121.15 30.46 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.29 114.97 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 171.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -99.31 136.83 38.68 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.498 ' CD2' HD12 ' A' ' 57' ' ' LEU . 5.9 m-85 -87.85 111.9 21.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.418 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 14.3 p-90 -117.63 -174.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.21 1.004 . . . . 0.0 110.433 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.02 152.66 5.3 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -56.69 -39.59 90.27 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.237 1.958 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -70.52 -16.11 62.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.158 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.3 t -73.61 102.3 3.86 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.216 1.371 . . . . 0.0 111.408 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.8 -62.36 3.37 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.034 1.302 . . . . 0.0 114.018 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -48.64 -42.62 35.73 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.137 2.558 . . . . 0.0 111.674 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.7 m -63.14 -50.31 70.94 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -55.42 -49.76 71.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.134 -0.354 . . . . 0.0 111.098 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.24 -32.9 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 118.066 -0.969 . . . . 0.0 111.844 -175.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.8 pt -80.51 -28.62 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 120.646 1.567 . . . . 0.0 111.42 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.54 -49.39 5.13 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.12 -37.34 75.89 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.983 1.789 . . . . 0.0 110.043 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.56 -44.48 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 108.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.2 t -53.14 -53.28 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -59.85 -49.3 78.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.769 -0.582 . . . . 0.0 112.184 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -60.06 -43.63 95.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.968 0.804 . . . . 0.0 109.493 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.1 -41.44 80.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.34 -48.64 76.35 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.27 -44.28 57.77 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.791 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -58.52 -53.94 52.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.591 1.195 . . . . 0.0 110.409 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.483 ' CG ' ' HB3' ' A' ' 52' ' ' LEU . 60.3 m-85 -82.98 53.57 2.47 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.0 -21.59 66.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.861 1.665 . . . . 0.0 108.227 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 5.3 m-20 -62.16 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 168.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.516 ' CE ' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -161.17 110.41 1.61 Allowed 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 164.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.765 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 7.1 tp -151.02 -177.35 5.96 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 116.858 -1.937 . . . . 0.0 112.067 159.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.765 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.29 66.26 1.73 Allowed 'General case' 0 N--CA 1.419 -1.996 2 N-CA-C 123.845 4.757 . . . . 0.0 123.845 -157.341 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -133.32 109.75 9.59 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 117.742 -1.583 . . . . 0.0 113.81 -177.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.3 t -146.43 163.43 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.464 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 27' ' ' TRP . 36.3 pttt -153.76 121.54 5.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.005 0.431 . . . . 0.0 110.256 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD12 ' CD2' ' A' ' 26' ' ' PHE . 2.4 tm? -89.13 118.91 29.18 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.821 0.849 . . . . 0.0 110.243 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -72.49 105.64 4.25 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 m -69.51 -31.72 70.15 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.797 1.239 . . . . 0.0 111.567 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -66.1 -39.2 89.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.931 0.893 . . . . 0.0 109.483 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -86.76 -26.08 24.34 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.734 2.013 . . . . 0.0 111.722 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.405 ' CB ' HD21 ' A' ' 57' ' ' LEU . 14.6 t -126.21 55.96 14.9 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.571 1.548 . . . . 0.0 112.463 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.62 -31.2 70.42 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.508 2.805 . . . . 0.0 108.056 174.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -40.78 -75.23 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.485 1.914 . . . . 0.0 111.715 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -51.88 -48.14 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.849 1.26 . . . . 0.0 110.266 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.64 -41.26 69.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.731 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.0 m -72.27 -42.89 65.05 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.752 0.821 . . . . 0.0 110.389 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -56.04 -42.18 76.17 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.677 0.391 . . . . 0.0 110.085 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -78.41 -36.38 45.75 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.15 45.64 3.01 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.36 0.981 . . . . 0.0 111.219 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.82 130.07 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -79.09 -38.8 35.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.941 0.496 . . . . 0.0 111.683 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.2 t -163.62 -173.53 3.33 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 pt -129.42 156.27 78.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 124.558 1.143 . . . . 0.0 109.267 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.99 157.66 82.64 Favored 'Cis proline' 0 C--N 1.349 0.564 0 CA-C-N 120.127 1.081 . . . . 0.0 112.621 2.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 m -160.99 142.32 11.81 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-O 122.213 1.006 . . . . 0.0 109.679 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.599 ' HB ' ' N ' ' A' ' 89' ' ' ILE 0.607 0.8 OUTLIER -75.2 13.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.438 2 N-CA-C 138.996 10.369 . . . . 0.0 138.996 -160.967 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 65.1 mtt -80.87 128.61 33.86 Favored 'General case' 0 C--N 1.318 -0.801 1 CA-C-N 126.526 4.239 . . . . 0.0 114.708 -162.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.6 137.04 33.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -129.29 160.62 32.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.093 0.957 . . . . 0.0 109.744 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.16 167.81 6.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.576 1.95 . . . . 0.0 105.916 172.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 51.34 34.12 32.99 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.81 9.9 66.73 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-O 117.88 -1.511 . . . . 0.0 115.409 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -147.81 169.14 20.42 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.469 2.134 . . . . 0.0 112.795 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -67.69 149.4 50.06 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 127.765 2.426 . . . . 0.0 109.993 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.3 m -150.59 -80.17 0.12 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.028 0.531 . . . . 0.0 111.58 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.59 175.36 7.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.961 0.8 . . . . 0.0 111.49 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.5 p -143.16 116.01 8.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.433 1.093 . . . . 0.0 111.389 -175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.599 ' N ' ' HB ' ' A' ' 77' ' ' ILE . 23.5 mt -118.88 122.57 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.43 1.492 . . . . 0.0 112.934 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.5 mt -84.25 155.95 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 119.327 -2.108 . . . . 0.0 106.32 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.5 -158.33 7.12 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.35 -16.61 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.62 152.84 80.95 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 120.081 1.31 . . . . 0.0 108.883 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.32 131.73 21.03 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 N-CA-C 105.172 -2.665 . . . . 0.0 105.172 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -57.89 -29.12 64.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -169.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.21 -38.65 18.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.387 0.994 . . . . 0.0 110.474 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -60.01 -51.92 67.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.609 1.164 . . . . 0.0 109.076 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.72 -49.07 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.352 1.461 . . . . 0.0 110.474 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -52.3 -55.25 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -57.91 -50.14 74.35 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.177 -0.327 . . . . 0.0 110.83 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.2 m -55.61 -41.26 73.21 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.116 0.567 . . . . 0.0 111.567 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.6 p -80.72 -45.24 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.888 0.767 . . . . 0.0 110.513 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -54.55 -35.02 62.8 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.422 0.689 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -44.9 -50.99 10.12 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.462 0.648 . . . . 0.0 109.465 171.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -81.43 50.18 1.42 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.111 0.964 . . . . 0.0 110.923 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 106' ' ' LEU . 10.6 mt -156.16 102.7 2.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.065 1.746 . . . . 0.0 106.64 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.291 0 C-N-CA 128.222 2.609 . . . . 0.0 104.37 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 tpp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -78.9 162.36 26.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.919 0.888 . . . . 0.0 109.265 176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.79 67.48 1.19 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.226 0.61 . . . . 0.0 111.198 -177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.82 140.73 38.82 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.67 92.36 5.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -81.79 161.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.589 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -160.0 -178.95 7.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -38.27 -56.53 1.21 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.0 1.72 . . . . 0.0 112.888 -170.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -61.05 -71.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.203 0.601 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 p -49.6 -43.41 46.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.891 1.276 . . . . 0.0 111.695 -175.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -39.94 -50.85 2.51 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.266 1.826 . . . . 0.0 112.248 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.1 mmtm -49.7 -50.45 43.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.947 0.899 . . . . 0.0 111.405 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -79.61 -56.89 3.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.939 0.895 . . . . 0.0 112.058 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.26 -32.05 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 125.449 1.5 . . . . 0.0 113.073 -169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.29 -52.38 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 C-N-CA 123.133 0.573 . . . . 0.0 112.432 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -73.6 -73.01 0.23 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.631 0.651 . . . . 0.0 111.293 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -79.62 47.09 0.81 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.206 0.602 . . . . 0.0 111.956 -174.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 m -90.42 151.35 21.46 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.566 1.147 . . . . 0.0 109.442 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -78.85 -57.06 3.95 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 m -78.42 150.98 77.39 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.52 162.61 39.57 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 121.491 1.461 . . . . 0.0 109.217 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.422 ' HA ' ' CB ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -150.16 134.39 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -177.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 tt -95.12 99.09 11.13 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 126.229 1.812 . . . . 0.0 108.125 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 p -94.9 125.9 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -94.32 121.51 35.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.54 108.17 12.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -124.35 -172.88 2.65 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.787 0.803 . . . . 0.0 110.913 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.48 152.26 3.2 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.25 -40.07 78.79 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.134 1.889 . . . . 0.0 112.455 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -73.2 -12.17 60.78 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.4 t -73.83 86.65 1.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.084 -1.01 . . . . 0.0 110.84 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -31.74 -66.5 0.17 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.299 1.428 . . . . 0.0 115.284 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -59.46 -45.27 27.19 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.001 1.8 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.5 m -56.4 -46.09 80.32 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -57.02 -50.92 71.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.17 1.388 . . . . 0.0 110.329 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.9 pt -68.36 -36.92 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.408 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.9 pt -76.82 -25.47 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 120.178 1.354 . . . . 0.0 111.444 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -38.99 -45.81 3.14 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -64.6 -38.19 33.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.855 2.37 . . . . 0.0 110.241 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -39.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.682 1.593 . . . . 0.0 108.522 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.6 t -58.86 -50.93 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -58.92 -52.07 67.33 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.179 0.592 . . . . 0.0 111.865 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.45 -41.63 94.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.12 0.873 . . . . 0.0 110.469 -176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.14 -44.03 97.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . . . -57.76 -38.62 75.73 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.649 -0.657 . . . . 0.0 110.206 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.59 44.52 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -49.11 -54.38 16.44 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.421 0.688 . . . . 0.0 111.346 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -103.66 33.66 3.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -51.8 -45.45 63.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -33.35 -50.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 128.897 2.879 . . . . 0.0 113.401 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -149.88 -58.89 0.2 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.487 1.115 . . . . 0.0 113.5 -170.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.663 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 15.8 tp -78.59 179.14 7.28 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -155.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.663 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.23 92.06 2.7 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 123.196 4.517 . . . . 0.0 123.196 -157.097 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.43 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 39.6 t -152.97 120.98 6.14 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 119.949 -1.719 . . . . 0.0 112.584 173.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.59 171.98 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.711 0.804 . . . . 0.0 110.515 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -143.5 114.3 7.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.5 118.45 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.764 0.711 . . . . 0.0 110.195 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.11 106.49 5.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.9 m -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.667 1.587 . . . . 0.0 111.456 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -34.08 77.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.181 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -87.05 -15.37 38.8 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 110.972 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -138.53 64.34 37.15 Favored Pre-proline 0 CA--C 1.531 0.219 0 O-C-N 120.239 -1.538 . . . . 0.0 112.687 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.75 -26.91 32.25 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.173 3.249 . . . . 0.0 108.582 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -47.37 -70.51 0.09 Allowed 'General case' 0 C--O 1.228 -0.065 0 C-N-CA 125.535 1.534 . . . . 0.0 110.611 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -51.22 -49.97 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 125.541 1.536 . . . . 0.0 109.481 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.48 -45.79 69.75 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.524 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.2 m -68.92 -41.57 77.99 Favored 'General case' 0 C--O 1.227 -0.085 0 C-N-CA 123.739 0.815 . . . . 0.0 111.014 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.03 -42.2 76.16 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.183 0.593 . . . . 0.0 109.724 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.67 -32.92 47.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.575 -0.158 . . . . 0.0 110.575 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.15 36.23 5.78 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.261 0.934 . . . . 0.0 110.797 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -74.45 107.72 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -77.73 -27.34 50.51 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.838 0.455 . . . . 0.0 110.923 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -155.34 159.04 39.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.6 pt -115.02 156.86 44.7 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.59 161.73 81.88 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 120.608 1.253 . . . . 0.0 114.175 3.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.9 m -160.63 124.86 3.6 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.8 mt -116.82 106.32 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.665 1.186 . . . . 0.0 108.327 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.7 mtt -103.85 132.01 50.51 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.737 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 69.1 t -100.71 110.53 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -92.98 143.86 25.82 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 50.61 1.83 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.45 77.98 1.3 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.79 -61.82 2.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.94 0.781 . . . . 0.0 112.201 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.08 163.07 22.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.962 0.905 . . . . 0.0 111.058 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -89.4 151.24 22.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.94 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.8 t -109.17 -57.12 2.2 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.759 1.623 . . . . 0.0 107.765 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -124.36 159.48 30.26 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.798 1.239 . . . . 0.0 109.367 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.1 m -152.4 93.34 1.78 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -103.82 146.87 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 125.229 1.412 . . . . 0.0 108.46 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 90' ' ' ILE . 3.4 mp -80.01 151.45 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.32 -158.48 5.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.52 46.56 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.951 0.9 . . . . 0.0 110.504 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.05 153.18 80.27 Favored Pre-proline 0 C--O 1.233 0.204 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -71.16 139.22 35.01 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 N-CA-C 105.4 -2.577 . . . . 0.0 105.4 170.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -67.11 -19.67 65.67 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 118.773 -1.171 . . . . 0.0 109.918 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.23 -49.9 68.39 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.801 1.182 . . . . 0.0 109.221 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -55.86 -48.11 76.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.518 1.127 . . . . 0.0 109.687 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.67 -49.02 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.018 0.527 . . . . 0.0 109.81 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.88 -56.82 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -51.79 -45.65 63.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.369 0.531 . . . . 0.0 110.793 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.2 m -60.41 -33.07 71.98 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.589 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.6 t -76.75 -47.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 120.408 1.458 . . . . 0.0 109.988 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -49.35 -45.04 45.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.079 0.952 . . . . 0.0 111.063 -175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -53.86 -27.67 31.41 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -98.82 -12.31 20.96 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 112.131 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -157.39 87.26 0.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.642 0.656 . . . . 0.0 109.889 -170.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.283 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 tpp . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 71.71 -63.03 0.44 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 -166.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.59 128.93 37.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 167.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.25 175.46 54.66 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.83 136.13 54.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.93 164.36 30.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 122.346 1.07 . . . . 0.0 112.775 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.9 170.26 16.04 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 128.033 2.533 . . . . 0.0 104.433 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -39.12 -46.87 1.49 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.281 1.832 . . . . 0.0 112.735 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -55.13 -66.28 0.43 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.33 1.052 . . . . 0.0 111.723 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 p -67.21 -41.59 85.51 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.711 1.204 . . . . 0.0 111.641 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -39.52 -47.84 1.94 Allowed 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 127.524 2.33 . . . . 0.0 110.996 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -41.62 -66.67 0.32 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.006 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -42.96 65.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 111.364 -177.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.0 t -73.51 -18.39 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.121 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.15 -51.18 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 124.333 1.053 . . . . 0.0 112.272 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -76.71 -70.86 0.43 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.121 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.01 40.22 0.4 Allowed 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.973 -1.08 . . . . 0.0 112.22 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.4 m -91.12 137.87 32.03 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.734 1.213 . . . . 0.0 110.645 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 p -78.78 -55.62 5.02 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.404 1.482 . . . . 0.0 108.66 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -77.93 156.38 79.82 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.59 167.17 19.71 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 N-CA-C 108.871 -1.242 . . . . 0.0 108.871 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.5 t -136.7 144.77 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 126.595 1.958 . . . . 0.0 109.21 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 tt -124.69 98.37 5.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.348 1.859 . . . . 0.0 106.494 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.31 120.29 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 119.183 0.901 . . . . 0.0 110.323 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -90.93 117.21 29.35 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.743 0.817 . . . . 0.0 109.143 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.45 108.67 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -127.41 -174.75 3.25 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 121.717 0.77 . . . . 0.0 111.075 -174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.62 149.01 4.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -53.91 -44.05 52.64 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.526 2.151 . . . . 0.0 112.448 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.512 ' CH2' HD11 ' A' ' 74' ' ' ILE . 40.5 p-90 -68.83 -18.33 64.15 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.146 -0.346 . . . . 0.0 111.823 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 37.9 t -77.89 85.14 4.16 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.21 -60.24 1.38 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.649 1.119 . . . . 0.0 114.088 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.12 -17.24 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.84 1.82 . . . . 0.0 112.509 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -81.43 -48.11 12.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.07 -49.93 59.68 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.308 1.443 . . . . 0.0 110.244 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 pt -63.19 -36.52 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.275 -0.869 . . . . 0.0 112.393 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.1 pt -80.04 -25.32 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.741 1.155 . . . . 0.0 111.401 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.87 -48.27 5.55 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 120.071 1.305 . . . . 0.0 114.497 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.72 -39.37 53.71 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.974 2.449 . . . . 0.0 110.026 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.69 -47.07 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.02 -42.56 90.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -58.06 -56.28 24.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.02 0.528 . . . . 0.0 110.37 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -62.84 -37.84 88.42 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.917 -1.114 . . . . 0.0 111.108 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.21 -45.79 67.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.1 -51.89 66.26 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -46.18 -42.52 12.64 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 112.199 -0.361 . . . . 0.0 112.199 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -71.61 -54.54 10.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.675 0.738 . . . . 0.0 112.351 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -92.47 9.03 36.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -45.33 148.94 0.57 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.318 1.447 . . . . 0.0 111.831 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.1 t70 74.61 -50.09 0.67 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.626 1.97 . . . . 0.0 111.569 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -77.56 -29.02 51.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.73 1.212 . . . . 0.0 111.141 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 tp -141.76 121.42 13.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.136 1.374 . . . . 0.0 108.319 -177.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -79.45 94.12 5.51 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 53.8 t -79.45 133.34 36.53 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.279 -0.888 . . . . 0.0 108.978 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.84 168.54 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.301 0.572 . . . . 0.0 112.053 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -134.56 111.1 9.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.341 1.456 . . . . 0.0 109.517 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 tt -89.56 118.51 29.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.764 0.792 . . . . 0.0 109.966 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -71.93 100.2 2.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 109.208 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 m -85.36 52.82 2.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.753 1.621 . . . . 0.0 110.081 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -148.28 -46.3 0.16 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -79.93 -25.44 40.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.528 2.331 . . . . 0.0 110.062 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 t -132.58 55.47 17.72 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.06 -23.59 29.25 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.994 3.796 . . . . 0.0 109.264 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -44.55 -58.6 2.91 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.784 1.634 . . . . 0.0 109.211 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.32 -53.25 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.027 0.931 . . . . 0.0 109.967 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.51 -40.32 62.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.975 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 m -69.79 -47.73 61.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.058 0.943 . . . . 0.0 110.567 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -55.55 -44.68 77.0 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.016 0.927 . . . . 0.0 110.437 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.01 -31.93 44.94 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.83 50.19 3.38 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.3 mt -78.16 139.36 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 109.554 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -41.21 29.02 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.967 0.507 . . . . 0.0 111.403 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -167.11 -170.94 1.63 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.512 HD11 ' CH2' ' A' ' 30' ' ' TRP . 24.6 pt -130.32 152.65 80.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 124.774 1.23 . . . . 0.0 108.384 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.39 157.04 99.45 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 119.95 1.018 . . . . 0.0 113.478 2.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -160.15 114.43 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.8 mt -97.38 107.92 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.9 mtt -97.43 142.62 29.06 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 119.108 0.867 . . . . 0.0 109.0 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.22 129.56 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -132.92 162.11 32.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.862 0.865 . . . . 0.0 110.663 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.64 152.94 3.95 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.012 1.325 . . . . 0.0 108.151 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 45.47 44.8 11.49 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 169.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.55 8.17 70.85 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.837 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -138.39 163.05 32.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 119.597 1.698 . . . . 0.0 111.031 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -90.17 148.29 23.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.5 t -100.07 -60.69 1.48 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.266 1.027 . . . . 0.0 109.167 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.47 -168.5 1.53 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.013 1.725 . . . . 0.0 107.159 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -150.95 172.16 16.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.599 0.76 . . . . 0.0 109.056 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.2 mt -144.29 142.04 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 125.564 1.546 . . . . 0.0 106.835 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.9 mt -79.71 140.75 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.29 -145.7 4.06 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.48 38.7 28.67 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.793 0.796 . . . . 0.0 111.232 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.22 157.55 60.8 Favored Pre-proline 0 C--N 1.341 0.215 0 C-N-CA 124.158 0.983 . . . . 0.0 111.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -70.5 140.07 39.08 Favored 'Trans proline' 0 N--CA 1.44 -1.661 0 N-CA-C 105.704 -2.46 . . . . 0.0 105.704 163.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -58.0 -25.15 60.7 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.799 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.3 -44.66 34.11 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.156 0.889 . . . . 0.0 109.918 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -50.49 73.42 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.467 1.107 . . . . 0.0 109.53 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.02 -52.38 50.69 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.869 0.868 . . . . 0.0 109.783 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.2 t -53.57 -58.88 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.653 0.661 . . . . 0.0 109.806 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -52.32 -53.07 49.02 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.6 m -53.71 -47.6 70.38 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.156 0.285 . . . . 0.0 111.64 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.4 t -58.63 -50.0 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 C-N-CA 123.543 0.737 . . . . 0.0 109.279 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -57.6 -44.88 85.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.86 -51.5 60.81 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.055 0.942 . . . . 0.0 109.337 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -67.87 -45.18 75.29 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.277 -0.265 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.94 71.25 10.94 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 123.164 1.459 . . . . 0.0 109.361 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-N 111.479 -2.601 . . . . 0.0 107.485 179.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -61.95 -44.56 96.51 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.1 125.03 28.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.08 163.23 54.05 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.05 121.24 44.08 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.42 162.37 14.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 122.136 0.97 . . . . 0.0 110.572 -178.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -140.61 168.42 19.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.469 2.308 . . . . 0.0 105.778 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -39.87 -49.29 2.39 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.444 1.497 . . . . 0.0 110.787 176.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.74 -66.8 0.33 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.436 178.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -66.16 -41.38 90.44 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.436 1.095 . . . . 0.0 112.229 -174.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -38.93 -47.51 1.45 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 128.201 2.6 . . . . 0.0 111.237 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -44.41 -59.66 2.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.537 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.12 -46.04 18.81 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.884 0.849 . . . . 0.0 110.844 -176.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.0 -34.07 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.031 -168.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -115.29 -59.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.445 1.098 . . . . 0.0 111.657 -172.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.63 -68.02 0.37 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -175.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -79.61 41.69 0.49 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.556 -0.715 . . . . 0.0 111.762 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.2 t -90.18 139.6 30.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -78.52 -54.89 5.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -78.85 157.29 76.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.69 152.68 81.05 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 111.758 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 76.5 t -146.74 124.3 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.357 1.063 . . . . 0.0 113.757 -177.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' N ' ' HB2' ' A' ' 53' ' ' LYS . 4.2 tt -107.72 123.77 49.02 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 125.35 1.46 . . . . 0.0 108.341 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.07 133.38 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -96.59 123.37 40.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CE2' HD23 ' A' ' 57' ' ' LEU . 33.8 m-85 -78.78 110.94 14.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 175.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -123.15 -173.68 2.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.886 0.851 . . . . 0.0 111.045 -176.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.84 157.9 4.36 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 175.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.33 -38.53 84.16 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.136 1.891 . . . . 0.0 110.576 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.444 ' CH2' HD11 ' A' ' 74' ' ' ILE . 51.0 p-90 -73.78 -8.68 56.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.947 0.499 . . . . 0.0 111.422 176.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -80.11 85.44 5.67 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.28 -1.512 . . . . 0.0 109.617 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.58 -61.6 1.81 Allowed Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.675 1.131 . . . . 0.0 113.151 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.42 -49.34 13.32 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.798 2.999 . . . . 0.0 112.04 177.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 55.8 m -57.6 -50.93 71.52 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.013 0.925 . . . . 0.0 109.304 -178.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -59.25 -45.87 90.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.186 -0.435 . . . . 0.0 112.152 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.9 pt -67.34 -38.61 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.23 -178.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.84 -23.35 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.66 1.118 . . . . 0.0 111.939 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.51 4.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -176.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -69.78 -29.41 23.79 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 122.666 1.988 . . . . 0.0 109.866 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -44.44 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.12 -44.49 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -54.3 41.91 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.36 -40.16 81.48 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.979 -1.076 . . . . 0.0 110.302 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.6 mt -58.21 -45.79 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.04 -44.98 64.5 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.455 0.571 . . . . 0.0 109.546 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 -57.1 10.39 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -50.09 -51.18 44.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.573 0.702 . . . . 0.0 111.288 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -88.26 19.94 3.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -56.4 153.1 10.32 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.075 0.852 . . . . 0.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.3 -52.1 0.7 Allowed 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.799 2.039 . . . . 0.0 111.485 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -78.57 -51.84 9.34 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -173.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.41 -158.32 0.89 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -158.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HB2' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.21 82.12 3.01 Favored 'General case' 0 N--CA 1.441 -0.883 2 N-CA-C 127.687 6.18 . . . . 0.0 127.687 -156.729 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.6 t -148.29 121.7 9.07 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 118.938 -2.351 . . . . 0.0 114.974 172.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.92 167.35 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.382 1.073 . . . . 0.0 109.88 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -134.18 113.48 12.08 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.853 1.261 . . . . 0.0 109.758 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' A' ' 26' ' ' PHE . 20.2 tp -93.36 114.77 27.27 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.043 0.937 . . . . 0.0 110.413 -178.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -72.68 109.78 6.55 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.8 m -70.12 -33.51 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.031 1.333 . . . . 0.0 111.18 -174.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.54 -37.96 89.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.483 1.113 . . . . 0.0 109.43 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -87.35 -27.01 23.09 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.731 2.012 . . . . 0.0 111.758 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.2 t -121.01 52.8 3.01 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.275 1.83 . . . . 0.0 111.741 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.46 -38.16 65.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.642 2.894 . . . . 0.0 108.97 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -38.33 -69.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.657 1.983 . . . . 0.0 110.839 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.7 t -53.93 -54.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.746 1.218 . . . . 0.0 109.957 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.18 -37.46 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.835 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -68.69 -48.09 64.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.414 0.685 . . . . 0.0 109.162 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.62 -42.9 75.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.796 0.438 . . . . 0.0 110.009 177.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -79.51 -25.62 41.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.49 13.47 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.723 0.678 . . . . 0.0 111.649 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.5 mt -79.85 90.29 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' CD ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.53 -10.74 59.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.621 1.169 . . . . 0.0 112.978 -175.221 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.9 m -159.38 161.98 35.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.444 HD11 ' CH2' ' A' ' 30' ' ' TRP . 22.2 pt -132.75 154.92 81.64 Favored Pre-proline 0 N--CA 1.455 -0.214 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.77 161.88 74.81 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.661 1.272 . . . . 0.0 114.424 4.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -160.85 122.04 2.94 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 102.966 -2.976 . . . . 0.0 102.966 174.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.96 99.14 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.967 0.907 . . . . 0.0 108.62 -172.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.3 mtt -96.83 138.86 33.75 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.586 0.63 . . . . 0.0 110.079 -178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.3 t -114.19 131.1 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -129.31 167.57 17.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.743 1.617 . . . . 0.0 111.174 -177.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.17 151.67 3.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.752 2.021 . . . . 0.0 105.955 173.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 47.4 42.3 18.46 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 116.251 1.26 . . . . 0.0 116.251 170.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.1 10.33 68.62 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.691 178.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -141.76 170.75 15.14 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.561 1.68 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -86.89 162.85 17.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.471 1.109 . . . . 0.0 111.262 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 45.2 t -130.53 -50.9 1.07 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.384 1.874 . . . . 0.0 110.012 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -138.88 167.38 22.14 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.468 -177.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.7 m -151.81 89.02 1.43 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 126.234 1.814 . . . . 0.0 106.24 175.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.08 -175.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.567 1.947 . . . . 0.0 106.615 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.43 156.65 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.66 -150.16 2.09 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.9 -43.71 0.57 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.466 1.506 . . . . 0.0 112.166 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.86 151.95 79.73 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.03 149.25 53.87 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.621 1.547 . . . . 0.0 112.543 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -59.19 -37.24 76.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.014 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.2 -50.47 38.05 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.722 0.409 . . . . 0.0 110.074 175.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -56.86 -48.41 78.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.615 1.166 . . . . 0.0 110.095 178.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.1 mt -59.41 -53.01 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.43 -53.56 23.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -52.22 -42.26 63.43 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.328 0.513 . . . . 0.0 111.143 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.1 m -59.94 -47.72 84.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.58 -38.49 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 O-C-N 122.034 -0.417 . . . . 0.0 112.076 -178.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -45.68 -42.49 11.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.699 1.2 . . . . 0.0 112.304 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -45.84 -39.09 8.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.846 1.258 . . . . 0.0 111.734 176.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -99.3 30.04 3.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.972 2.109 . . . . 0.0 110.556 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 -47.25 0.25 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.645 0.378 . . . . 0.0 111.571 -170.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.394 -1.289 . . . . 0.0 107.678 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 tpt . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -157.44 167.3 30.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -178.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . . . -62.99 116.8 5.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.613 0.642 . . . . 0.0 111.03 -177.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.19 148.31 36.99 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 174.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.46 100.81 10.05 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 171.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.421 HG23 ' CB ' ' A' ' 57' ' ' LEU . 12.7 m -103.6 161.59 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.852 0.834 . . . . 0.0 109.432 -176.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -151.34 172.89 15.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.93 2.092 . . . . 0.0 105.494 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.79 -48.41 15.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.073 0.949 . . . . 0.0 112.317 -176.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.22 -72.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.867 0.867 . . . . 0.0 110.77 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -51.7 -36.58 47.26 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.539 1.135 . . . . 0.0 112.491 -174.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -39.8 -49.67 2.35 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 126.28 1.832 . . . . 0.0 110.863 177.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -49.98 -56.92 8.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.552 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -74.02 -45.15 51.61 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.678 -175.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.3 t -74.91 -43.7 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.574 -168.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.5 t -95.9 -64.65 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.22 1.008 . . . . 0.0 111.007 -173.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -64.31 -59.05 4.85 Favored 'General case' 0 N--CA 1.458 -0.063 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.36 41.98 0.41 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.162 0.585 . . . . 0.0 111.312 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t -89.75 -171.13 3.06 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 p -128.2 -65.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.799 2.039 . . . . 0.0 106.973 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 m -79.1 158.97 74.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.6 159.84 46.15 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.419 1.185 . . . . 0.0 111.347 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.24 123.95 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 126.178 1.791 . . . . 0.0 109.007 -177.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 tt -98.84 101.33 12.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.76 137.76 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -110.74 118.08 35.19 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.499 ' CE2' HD21 ' A' ' 57' ' ' LEU . 34.1 m-85 -78.25 112.29 15.08 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 177.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -125.31 -174.82 3.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.172 0.987 . . . . 0.0 111.158 -175.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.41 142.73 1.78 Allowed Pre-proline 0 C--O 1.224 -0.287 0 C-N-CA 126.527 1.931 . . . . 0.0 106.165 171.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -37.98 -53.5 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.148 3.232 . . . . 0.0 117.708 179.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 47.6 p-90 -61.27 -15.96 40.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.449 0.568 . . . . 0.0 112.458 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -73.0 80.91 1.2 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.191 0.596 . . . . 0.0 111.022 -177.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -38.15 -56.75 1.8 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.642 1.115 . . . . 0.0 112.691 176.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -50.96 -48.64 20.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.176 2.584 . . . . 0.0 112.585 177.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.6 m -58.61 -47.51 84.1 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -61.42 -45.66 93.39 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.3 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.05 -25.47 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 117.654 -1.165 . . . . 0.0 111.331 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.33 -27.99 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 120.867 1.667 . . . . 0.0 110.391 174.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 41' ' ' VAL . . . -38.68 -45.54 2.79 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 178.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.98 -40.24 73.22 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 CA-C-N 122.346 1.874 . . . . 0.0 109.855 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -74.18 -47.67 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.523 1.129 . . . . 0.0 108.668 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' SG ' ' A' ' 54' ' ' CYS . 0.4 OUTLIER -52.01 -36.08 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.422 1.089 . . . . 0.0 108.165 175.728 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 3' ' ' ALA . 16.9 t70 -70.1 -58.63 3.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 121.797 -0.565 . . . . 0.0 110.709 173.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -49.29 -41.46 38.2 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 119.347 -0.359 . . . . 0.0 111.757 -175.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mm -52.76 -42.98 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 118.482 0.583 . . . . 0.0 110.433 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.71 66.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.671 0.669 . . . . 0.0 111.171 178.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.93 -46.01 14.85 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 174.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -76.06 -65.75 0.88 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.355 1.062 . . . . 0.0 113.104 -176.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -82.91 19.16 1.42 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.498 1.119 . . . . 0.0 112.805 -174.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -39.41 -42.02 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 128.204 2.602 . . . . 0.0 112.057 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -36.17 -46.89 0.54 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 127.719 2.408 . . . . 0.0 111.748 177.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.96 -55.04 1.3 Allowed 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.687 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 tp -84.35 113.57 21.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -163.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -87.89 91.48 8.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 41' ' ' VAL . 7.7 t -79.23 142.09 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 120.752 -1.218 . . . . 0.0 109.454 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -156.73 176.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.828 0.74 . . . . 0.0 110.744 -178.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -142.13 137.74 31.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.846 0.858 . . . . 0.0 110.843 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.499 HD21 ' CE2' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -114.87 122.26 45.77 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.71 1.204 . . . . 0.0 112.824 -179.268 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.66 105.79 5.92 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-O 122.071 0.939 . . . . 0.0 109.809 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.1 m -59.89 -39.8 86.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.665 1.986 . . . . 0.0 111.94 -173.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.33 -38.27 74.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.67 0.788 . . . . 0.0 110.709 -177.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -80.09 -27.17 39.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.27 1.428 . . . . 0.0 110.995 177.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.4 m -134.57 62.83 56.88 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 124.813 1.245 . . . . 0.0 111.342 -177.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.08 -34.33 28.95 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 109.533 177.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -37.25 -69.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.764 2.026 . . . . 0.0 110.663 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -61.01 -45.33 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 122.822 0.449 . . . . 0.0 110.753 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.9 -37.11 60.24 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.13 0.172 . . . . 0.0 111.049 177.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.1 m -74.41 -46.42 40.25 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.248 1.019 . . . . 0.0 109.859 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -55.04 -45.45 75.22 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.197 0.599 . . . . 0.0 110.501 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -79.27 -33.33 43.53 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.905 0.482 . . . . 0.0 110.51 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.57 53.58 2.41 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 176.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.9 mm -67.52 130.13 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.15 -42.4 26.26 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.934 -0.479 . . . . 0.0 110.783 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.8 m -166.09 174.95 8.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.799 2.04 . . . . 0.0 106.042 179.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 pt -120.35 150.75 52.4 Favored Pre-proline 0 N--CA 1.455 -0.202 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.33 144.8 81.59 Favored 'Cis proline' 0 N--CA 1.457 -0.654 0 CA-C-N 119.905 1.002 . . . . 0.0 113.355 1.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -143.12 111.67 6.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 174.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.05 138.77 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.3 mtt -130.51 128.19 40.68 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 173.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.6 97.2 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -79.34 125.99 30.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.09 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -137.29 0.31 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.03 77.82 0.42 Allowed Glycine 0 CA--C 1.531 1.031 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 176.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.25 -63.3 4.15 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -79.66 167.84 20.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.47 0.708 . . . . 0.0 109.448 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -87.36 149.3 24.58 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.59 -55.19 3.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.351 1.06 . . . . 0.0 109.127 170.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -137.18 163.7 30.24 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.577 1.151 . . . . 0.0 112.808 -176.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.3 t -138.71 128.69 25.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 173.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 mt -140.21 137.27 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -173.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 79.3 mt -78.64 140.03 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 174.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.11 -137.71 0.72 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.12 -31.1 0.21 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.448 1.499 . . . . 0.0 112.44 -177.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -77.06 149.5 79.87 Favored Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -56.95 144.99 87.43 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 120.988 1.125 . . . . 0.0 110.387 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -55.86 -31.6 62.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.341 0.656 . . . . 0.0 110.189 -178.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.84 -37.87 60.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.021 0.828 . . . . 0.0 111.087 175.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -61.64 -49.55 76.12 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.355 1.062 . . . . 0.0 108.341 178.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 53.4 mt -62.77 -43.23 98.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.569 1.148 . . . . 0.0 109.817 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.92 -55.03 22.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 124.127 0.971 . . . . 0.0 108.865 177.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -55.07 -48.19 73.84 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.994 -0.441 . . . . 0.0 110.289 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.1 m -59.76 -44.67 93.74 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.637 -178.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.68 -44.75 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 CA-C-N 119.067 0.849 . . . . 0.0 110.636 -176.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -46.65 -47.27 20.23 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.342 1.057 . . . . 0.0 110.731 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -44.48 -39.96 5.21 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.567 1.147 . . . . 0.0 111.818 176.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -101.58 9.55 41.08 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.796 1.238 . . . . 0.0 113.224 -175.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.54 66.11 0.86 Allowed 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttm . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 9.7 pt-20 -83.77 164.5 19.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.541 0.736 . . . . 0.0 109.316 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.45 74.61 0.16 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.02 157.74 51.53 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 177.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.55 117.57 33.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -105.58 160.15 5.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 122.187 0.994 . . . . 0.0 109.87 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -152.1 174.53 13.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.736 2.414 . . . . 0.0 106.774 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -37.72 -58.36 0.9 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 126.549 1.94 . . . . 0.0 112.653 -174.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -56.26 -67.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.538 0.685 . . . . 0.0 111.446 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.1 p -53.67 -45.59 70.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.145 0.978 . . . . 0.0 111.928 -175.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -42.07 -50.42 4.7 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 127.14 2.176 . . . . 0.0 111.447 -178.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -48.52 -48.06 38.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.791 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -81.05 -59.81 2.52 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.367 0.667 . . . . 0.0 111.456 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.31 -31.49 54.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 126.332 1.853 . . . . 0.0 113.116 -172.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.42 -56.51 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.449 0.699 . . . . 0.0 112.009 -173.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.4 mt -71.76 -60.0 2.46 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.867 0.758 . . . . 0.0 109.815 -176.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.84 42.32 0.54 Allowed 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.9 p -90.16 148.42 22.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 121.902 -0.499 . . . . 0.0 109.832 -178.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 p -87.57 -62.93 1.39 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.778 1.231 . . . . 0.0 107.964 177.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 151.38 75.7 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.033 1.333 . . . . 0.0 108.192 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.44 160.49 48.42 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 120.942 1.095 . . . . 0.0 109.585 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.435 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -151.14 133.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -172.049 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.551 HD21 HG23 ' A' ' 77' ' ' ILE . 8.3 tt -92.3 109.46 20.84 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.07 110.14 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -87.15 113.39 22.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 174.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -79.11 109.81 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 177.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -130.47 -173.6 3.11 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 121.723 0.773 . . . . 0.0 111.44 -173.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -169.04 150.73 4.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.72 -40.2 85.73 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.042 1.828 . . . . 0.0 112.422 178.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.604 ' CH2' HD11 ' A' ' 74' ' ' ILE . 41.1 p-90 -70.19 -14.22 62.53 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.904 -0.498 . . . . 0.0 111.789 177.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 84.18 3.54 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.119 -0.988 . . . . 0.0 112.127 -177.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -39.52 -62.06 1.42 Allowed Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.772 -1.016 . . . . 0.0 114.059 175.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 -23.54 74.57 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.214 1.942 . . . . 0.0 113.222 -178.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.8 m -77.39 -58.55 3.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -43.45 -52.59 5.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.53 2.332 . . . . 0.0 111.602 -177.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.69 -22.79 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 118.814 -0.612 . . . . 0.0 112.247 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.88 -27.29 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.488 1.04 . . . . 0.0 110.831 176.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.71 -44.97 3.9 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 117.023 -1.465 . . . . 0.0 114.005 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.71 -37.25 88.5 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.532 2.155 . . . . 0.0 110.215 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.5 -43.4 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 176.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 t -59.97 -41.95 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 67.9 m-20 -65.05 -48.66 73.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.402 0.681 . . . . 0.0 110.599 178.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -60.76 -40.44 92.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.354 0.525 . . . . 0.0 109.719 -179.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mt -53.35 -47.29 58.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.519 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . . . -56.88 -52.42 65.2 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.81 -41.72 28.07 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.61 1.1 . . . . 0.0 112.129 178.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.47 -70.27 0.26 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.335 0.654 . . . . 0.0 110.046 177.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -86.86 48.46 1.65 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 122.427 1.108 . . . . 0.0 111.28 -174.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.7 -52.02 61.38 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 127.595 2.358 . . . . 0.0 115.011 -168.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -70.08 -72.44 0.2 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.821 0.82 . . . . 0.0 111.834 -177.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 -39.47 34.64 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -164.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 8.7 tp -105.48 -171.84 1.98 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -155.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.559 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.7 pptp? -76.34 91.67 3.28 Favored 'General case' 0 N--CA 1.431 -1.389 2 N-CA-C 123.585 4.661 . . . . 0.0 123.585 -160.933 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 52.4 t -153.82 121.89 6.07 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.492 -1.38 . . . . 0.0 113.2 172.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.59 163.68 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.395 1.478 . . . . 0.0 108.744 173.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.86 115.08 16.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.514 1.126 . . . . 0.0 110.864 -175.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -92.74 110.22 21.66 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.98 103.83 2.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 122.231 1.015 . . . . 0.0 108.699 177.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -84.53 54.1 2.9 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.492 2.317 . . . . 0.0 108.987 -177.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -150.89 -48.67 0.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.23 -26.25 30.94 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.212 1.405 . . . . 0.0 111.238 172.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.87 53.13 0.94 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 126.97 2.108 . . . . 0.0 115.042 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -67.59 -25.75 40.51 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.683 3.589 . . . . 0.0 108.79 174.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -49.14 -70.56 0.09 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.897 1.279 . . . . 0.0 109.951 178.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.6 t -51.56 -49.44 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.232 1.413 . . . . 0.0 108.856 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.89 67.14 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.51 -179.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.8 m -69.68 -45.79 67.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.28 0.632 . . . . 0.0 110.335 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.4 -46.05 76.61 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.245 0.618 . . . . 0.0 110.62 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.44 -31.36 42.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.478 0.311 . . . . 0.0 111.155 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.72 52.46 2.63 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.79 115.61 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -78.4 -33.65 48.63 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.94 0.496 . . . . 0.0 111.091 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -163.29 -173.39 3.35 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.604 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.3 pt -142.14 149.05 50.71 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.22 139.27 60.45 Favored 'Cis proline' 0 N--CA 1.452 -0.942 0 CA-C-N 119.394 0.819 . . . . 0.0 113.304 2.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.3 m -130.15 118.89 22.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 102.04 -3.318 . . . . 0.0 102.04 172.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.551 HG23 HD21 ' A' ' 23' ' ' LEU . 45.2 mt -112.49 100.45 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 108.272 -172.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.4 mtt -94.29 138.39 32.34 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 118.136 0.426 . . . . 0.0 110.287 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.5 104.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 175.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -82.82 147.69 28.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.44 21.57 3.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.396 1.078 . . . . 0.0 109.618 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.06 127.23 6.04 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -177.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.5 -52.06 1.86 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.828 1.68 . . . . 0.0 114.116 178.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -138.48 -179.88 6.06 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.248 1.019 . . . . 0.0 110.649 -177.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.04 152.71 21.04 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.778 1.231 . . . . 0.0 109.832 176.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 52.5 t -110.82 -71.06 0.78 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.404 1.482 . . . . 0.0 107.883 177.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -96.6 162.91 13.25 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.693 0.797 . . . . 0.0 109.691 177.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.4 m -153.27 108.58 3.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.347 1.059 . . . . 0.0 108.177 175.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.31 160.65 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 176.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt -142.98 147.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.67 169.34 45.65 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 121.495 0.497 . . . . 0.0 112.33 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.85 82.71 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.989 0.515 . . . . 0.0 111.122 -178.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.61 151.54 77.29 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 119.337 -0.363 . . . . 0.0 110.746 -178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -82.38 149.3 14.88 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.405 2.737 . . . . 0.0 106.76 170.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.01 -42.45 72.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 121.806 -0.559 . . . . 0.0 112.31 -177.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -43.54 -51.73 6.62 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.98 0.912 . . . . 0.0 111.253 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 m -61.5 -50.23 73.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.161 0.584 . . . . 0.0 110.481 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.1 mt -53.96 -56.37 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.594 0.758 . . . . 0.0 109.016 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.0 t -49.88 -64.08 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 125.741 1.617 . . . . 0.0 108.885 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -51.62 -47.3 63.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.188 0.449 . . . . 0.0 111.824 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -58.35 -45.34 88.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.207 -178.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -44.79 46.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 CA-C-N 119.262 0.937 . . . . 0.0 111.589 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -48.7 -44.33 37.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.244 1.018 . . . . 0.0 110.074 -178.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -44.26 -44.04 7.71 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.125 0.97 . . . . 0.0 111.717 174.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -94.32 -7.0 43.09 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.423 1.489 . . . . 0.0 112.755 -177.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -157.65 85.58 0.91 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.009 0.822 . . . . 0.0 110.31 -169.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.3 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 178.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.99 -45.76 73.21 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 171.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.61 135.71 33.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 171.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.16 -173.56 41.76 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.84 139.25 52.25 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.93 167.98 22.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 122.499 1.142 . . . . 0.0 111.514 -178.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -146.71 175.9 10.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.706 2.402 . . . . 0.0 106.419 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -38.54 -58.78 0.99 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.5 1.52 . . . . 0.0 112.793 -176.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.98 -57.45 11.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.623 1.169 . . . . 0.0 111.908 -177.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -65.11 -40.01 93.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.526 0.73 . . . . 0.0 111.658 -173.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -41.02 -47.13 3.03 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.471 1.908 . . . . 0.0 110.866 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -54.96 -62.99 1.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.656 178.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -63.21 -32.59 74.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.213 1.005 . . . . 0.0 112.314 -176.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.9 t -92.55 -54.72 6.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.19 0.596 . . . . 0.0 111.968 -171.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.6 t -83.59 -57.35 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.255 1.022 . . . . 0.0 110.854 -175.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.1 mt -70.23 -54.97 10.51 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.06 0.391 . . . . 0.0 111.238 -174.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -79.44 48.7 0.92 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.73 -0.606 . . . . 0.0 110.622 -177.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.4 p -90.47 158.51 17.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.21 1.404 . . . . 0.0 111.151 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 p -91.26 -72.05 0.6 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.93 1.292 . . . . 0.0 107.569 176.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -79.39 160.63 69.87 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -54.22 166.15 1.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.114 1.876 . . . . 0.0 111.771 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.4 t -138.64 145.05 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.738 1.215 . . . . 0.0 109.944 -176.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 tt -122.33 105.77 10.49 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 m -101.25 150.9 5.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 118.626 0.648 . . . . 0.0 109.489 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -115.07 119.9 38.01 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.526 0.73 . . . . 0.0 109.321 174.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.472 ' CD2' HD12 ' A' ' 57' ' ' LEU . 23.1 m-85 -80.76 111.31 17.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -128.84 -173.23 2.92 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.47 0.708 . . . . 0.0 111.608 -174.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -164.63 154.75 12.4 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.532 1.133 . . . . 0.0 108.158 174.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.46 -43.41 40.21 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.367 2.711 . . . . 0.0 112.07 -176.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.428 ' CH2' HD11 ' A' ' 74' ' ' ILE . 55.6 p-90 -70.9 -13.13 61.91 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.177 0.591 . . . . 0.0 111.262 177.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.23 80.68 3.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.209 -0.932 . . . . 0.0 111.061 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -42.39 -55.9 4.27 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 123.907 0.765 . . . . 0.0 112.812 176.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.55 -27.95 78.95 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.55 2.167 . . . . 0.0 112.715 178.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.54 -56.38 4.9 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -48.71 -48.57 40.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.091 1.357 . . . . 0.0 111.727 -177.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -70.45 -21.94 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 118.889 -0.577 . . . . 0.0 112.222 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.4 mm -89.54 -26.58 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 119.461 1.028 . . . . 0.0 110.012 177.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.92 -48.56 5.74 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.66 -36.88 83.17 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.106 1.871 . . . . 0.0 110.174 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -67.9 -45.02 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.565 1.146 . . . . 0.0 108.292 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.5 -53.39 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 176.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.82 -53.53 57.17 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.832 0.853 . . . . 0.0 111.943 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -63.65 -40.48 96.96 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.068 -1.02 . . . . 0.0 110.604 -177.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.5 mt -58.42 -46.7 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.85 68.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.57 -51.44 52.07 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 176.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -61.93 -49.22 77.04 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.91 10.43 41.32 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -38.42 -56.94 1.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 126.62 1.968 . . . . 0.0 112.45 -175.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.58 -44.91 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.533 1.933 . . . . 0.0 113.44 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.42 -9.8 19.97 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.216 1.006 . . . . 0.0 112.458 -176.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.7 tp -151.08 113.99 4.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -166.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -78.65 160.91 27.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 171.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 22.8 t -141.85 142.78 33.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.793 -179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.06 162.42 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -130.12 111.9 12.9 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.2 0.6 . . . . 0.0 110.087 -176.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.472 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.2 tm? -88.77 117.21 27.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.572 0.749 . . . . 0.0 109.383 -178.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -74.41 100.94 3.95 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.0 m -58.92 -39.71 82.36 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.122 1.769 . . . . 0.0 112.422 -175.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.14 -37.64 75.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.236 1.014 . . . . 0.0 110.343 -173.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -86.34 -28.83 23.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.66 1.584 . . . . 0.0 111.332 177.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.0 t -123.43 54.85 7.48 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 126.464 1.906 . . . . 0.0 110.609 -177.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -59.71 -40.22 66.42 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.942 3.094 . . . . 0.0 109.006 177.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -29.09 -75.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.404 2.281 . . . . 0.0 111.804 178.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.7 t -53.37 -49.57 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.049 1.34 . . . . 0.0 109.879 -178.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.92 68.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.949 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -80.3 -42.11 23.65 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.562 1.145 . . . . 0.0 108.957 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.18 -41.39 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -78.64 -30.09 46.17 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.427 0.691 . . . . 0.0 110.666 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.49 49.32 6.76 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.236 0.922 . . . . 0.0 111.24 176.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -133.28 79.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.661 1.584 . . . . 0.0 109.95 -178.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -31.69 46.67 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.236 -0.915 . . . . 0.0 110.468 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.57 145.3 54.09 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.428 HD11 ' CH2' ' A' ' 30' ' ' TRP . 13.4 pt -148.05 154.52 43.12 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -177.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.88 140.08 58.76 Favored 'Cis proline' 0 N--CA 1.454 -0.826 0 CA-C-N 119.812 0.968 . . . . 0.0 112.273 1.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.6 m -130.1 107.27 9.2 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.7 mt -88.78 137.85 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 16.5 mtt -131.59 135.57 47.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.07 141.15 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -127.93 155.45 44.2 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.949 1.3 . . . . 0.0 108.277 174.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.05 56.42 1.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.884 1.674 . . . . 0.0 107.836 -178.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.49 -153.56 16.93 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 107.353 -2.299 . . . . 0.0 107.353 -173.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.2 35.84 1.3 Allowed Glycine 0 CA--C 1.528 0.879 0 O-C-N 121.794 -0.827 . . . . 0.0 114.546 -177.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -151.27 155.26 38.41 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.624 1.569 . . . . 0.0 108.044 177.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -89.84 145.81 24.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.14 1.376 . . . . 0.0 108.323 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.3 t -112.32 -55.85 2.47 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.357 1.063 . . . . 0.0 111.062 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -133.56 170.78 15.02 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 111.061 -175.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.5 m -156.23 140.62 16.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.115 1.366 . . . . 0.0 108.932 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.4 mm -136.6 153.34 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mt -133.53 144.01 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.97 148.49 24.29 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.028 0.823 . . . . 0.0 112.698 176.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.06 72.76 1.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.357 0.663 . . . . 0.0 110.941 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.4 m -78.91 147.03 69.56 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -56.66 158.19 17.08 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.901 2.401 . . . . 0.0 114.556 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -46.68 -51.63 15.58 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 125.832 1.653 . . . . 0.0 110.581 177.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.36 -49.42 44.5 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.445 0.698 . . . . 0.0 110.799 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -49.7 73.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.068 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.02 -54.44 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.86 -56.78 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.562 1.145 . . . . 0.0 110.377 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -55.25 -47.47 75.36 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.3 m -56.92 -44.76 82.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.484 0.714 . . . . 0.0 110.415 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.94 -56.26 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 118.949 0.795 . . . . 0.0 109.52 176.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -52.51 -45.51 66.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.204 1.002 . . . . 0.0 112.745 -175.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -60.28 -30.75 69.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.568 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -81.09 -48.04 12.7 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.47 -99.98 0.44 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.755 1.222 . . . . 0.0 109.692 -174.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 -179.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 tpp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 70.56 -66.51 0.28 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -168.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.41 130.7 43.24 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 167.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.56 175.14 54.35 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.878 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.6 129.5 56.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.67 162.24 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 122.171 0.986 . . . . 0.0 110.094 -177.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -139.34 175.36 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.572 2.349 . . . . 0.0 106.952 175.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -46.9 -55.26 8.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.0 111.521 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.15 -52.27 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.196 1.398 . . . . 0.0 111.442 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 p -75.94 -37.76 58.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.579 0.751 . . . . 0.0 112.132 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -41.2 -46.56 3.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.767 2.027 . . . . 0.0 110.644 -177.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.34 -50.12 60.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.847 -1.524 . . . . 0.0 112.417 178.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -78.03 -52.97 7.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.62 1.2 . . . . 0.0 110.877 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.81 -35.18 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.205 -169.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.3 -59.71 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 124.115 0.966 . . . . 0.0 111.747 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.3 mt -66.4 -73.57 0.13 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -174.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -82.93 57.95 4.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.726 0.81 . . . . 0.0 108.924 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.4 p -87.6 -139.5 0.1 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.098 0.959 . . . . 0.0 109.964 -178.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -160.68 -68.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 m -77.79 158.34 78.21 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 104.959 -2.238 . . . . 0.0 104.959 171.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 165.29 21.9 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 N-CA-C 108.55 -1.365 . . . . 0.0 108.55 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.4 146.01 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 125.419 1.488 . . . . 0.0 108.916 -173.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tt -126.25 103.76 7.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -99.09 145.08 10.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -113.36 113.21 24.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 57' ' ' LEU . 52.7 m-85 -78.59 111.26 14.48 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.61 -173.84 2.78 Favored 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.716 0.635 . . . . 0.0 110.719 -178.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.38 141.46 0.92 Allowed Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.754 1.221 . . . . 0.0 110.499 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.07 110.69 3.0 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.445 2.096 . . . . 0.0 108.919 176.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 137.31 -29.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 131.61 3.964 . . . . 0.0 105.684 -173.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.5 t -68.78 88.53 0.37 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.352 0.596 . . . . 0.0 111.933 -177.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -35.65 -67.3 0.34 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.233 1.873 . . . . 0.0 113.388 177.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.28 -46.54 29.82 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 119.6 1.7 . . . . 0.0 112.268 179.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.3 m -54.22 -42.44 69.8 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.308 0.503 . . . . 0.0 110.293 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -55.57 -53.34 57.59 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 122.802 0.441 . . . . 0.0 111.065 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 pt -74.1 -27.46 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.878 -178.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.24 -38.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.11 0.964 . . . . 0.0 110.683 177.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.64 -48.33 5.15 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -178.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -60.36 -37.6 80.72 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.929 2.419 . . . . 0.0 110.435 178.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 t -64.49 -45.52 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.32 -44.55 88.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -58.15 -61.46 2.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.64 0.776 . . . . 0.0 110.011 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.91 -37.51 82.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.633 0.652 . . . . 0.0 111.309 -176.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mm -51.41 -40.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 176.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -59.29 -43.82 92.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 118.443 0.565 . . . . 0.0 110.097 175.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.36 -39.86 84.08 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.96 -51.14 42.7 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 178.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -99.91 10.11 41.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -171.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -46.4 147.49 1.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 112.078 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 72.18 -46.53 0.65 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.945 2.098 . . . . 0.0 111.91 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -77.87 -19.48 54.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.099 0.959 . . . . 0.0 110.709 -178.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.2 tp -155.3 128.83 8.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 107.338 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 tmtp? -90.16 97.85 11.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 54.0 t -79.55 133.91 36.47 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.534 -0.729 . . . . 0.0 109.517 -179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.28 169.85 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.427 0.632 . . . . 0.0 111.865 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -133.5 131.28 39.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.983 1.713 . . . . 0.0 110.438 -178.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -119.47 133.89 55.48 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 179.098 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -81.52 111.15 17.58 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.107 0.956 . . . . 0.0 111.257 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.6 m -84.22 49.86 1.74 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.238 2.215 . . . . 0.0 111.13 -174.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.12 -42.15 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -80.7 -24.1 39.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.748 2.019 . . . . 0.0 108.981 169.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.2 m -144.18 62.73 10.58 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.607 1.563 . . . . 0.0 110.985 178.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -80.26 -26.67 4.03 Favored 'Trans proline' 0 N--CA 1.445 -1.37 1 C-N-CA 126.397 4.732 . . . . 0.0 109.079 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -38.79 -61.26 0.75 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.938 1.695 . . . . 0.0 109.647 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.9 t -56.79 -52.88 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.765 1.226 . . . . 0.0 110.047 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.16 -35.25 64.57 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.501 -179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 m -73.65 -46.1 48.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.603 1.161 . . . . 0.0 109.701 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.52 -43.61 75.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.528 0.731 . . . . 0.0 109.944 177.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.99 -32.53 45.26 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.66 -0.21 . . . . 0.0 110.721 179.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.87 51.92 2.54 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 123.75 0.69 . . . . 0.0 111.533 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.9 mt -79.92 112.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.46 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.07 -27.42 43.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.118 0.567 . . . . 0.0 112.142 -177.62 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -157.72 161.89 38.54 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.76 154.88 81.09 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.3 135.18 38.22 Favored 'Cis proline' 0 N--CA 1.449 -1.098 0 CA-C-N 119.282 0.779 . . . . 0.0 113.074 1.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -121.84 102.48 8.22 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 173.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -79.58 137.2 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 175.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.0 mtt -130.22 148.27 52.03 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.34 128.32 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -116.31 144.91 43.64 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.2 12.59 3.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.168 -176.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.35 -154.41 25.12 Favored Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 105.655 -2.978 . . . . 0.0 105.655 -176.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.25 20.09 0.59 Allowed Glycine 0 CA--C 1.533 1.165 0 CA-C-N 118.041 0.921 . . . . 0.0 114.866 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -153.9 162.58 41.11 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 125.587 1.555 . . . . 0.0 108.595 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -78.84 -179.48 6.59 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.77 178.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.8 t -138.9 -66.08 0.48 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.403 1.081 . . . . 0.0 108.962 177.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -120.94 170.31 9.63 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.601 1.56 . . . . 0.0 109.784 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 t -156.86 152.25 26.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.758 0.823 . . . . 0.0 108.943 178.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.41 150.15 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.794 1.238 . . . . 0.0 107.788 -177.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.7 mt -79.78 119.85 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 171.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.75 -35.42 86.27 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.135 -0.814 . . . . 0.0 113.973 -173.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.94 66.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.252 1.021 . . . . 0.0 113.017 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.41 154.68 53.44 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 126.06 1.744 . . . . 0.0 106.958 176.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -58.04 155.13 35.3 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.441 2.094 . . . . 0.0 113.952 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.07 -42.54 63.27 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.339 1.056 . . . . 0.0 109.542 177.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.97 -49.0 66.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.948 0.499 . . . . 0.0 109.985 178.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m -61.14 -47.8 84.56 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 45.1 mm -54.11 -56.73 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.5 t -49.32 -58.55 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 125.183 1.393 . . . . 0.0 109.724 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -54.34 -48.31 71.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.881 0.31 . . . . 0.0 111.218 -178.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.0 m -61.36 -38.99 88.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.945 0.498 . . . . 0.0 110.604 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.4 t -65.67 -55.4 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 119.153 0.888 . . . . 0.0 108.778 176.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -43.86 -57.58 3.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 111.671 -177.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -52.84 -26.77 15.6 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -83.26 -21.37 33.34 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.414 -0.804 . . . . 0.0 110.976 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 84.1 mt -95.38 -39.68 9.89 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.709 1.204 . . . . 0.0 111.144 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 116.946 -1.502 . . . . 0.0 109.926 -177.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.76 -39.94 94.46 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.61 148.26 23.45 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.02 162.94 42.07 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.592 1.567 . . . . 0.0 113.601 177.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.65 122.21 35.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 103.87 -2.641 . . . . 0.0 103.87 172.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.3 163.97 29.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.862 0.839 . . . . 0.0 111.492 -176.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -149.25 170.5 18.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.469 1.907 . . . . 0.0 107.242 177.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -77.31 80.53 3.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 125.112 2.387 . . . . 0.0 111.713 -176.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 172.76 -76.83 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.052 2 CA-C-N 107.644 -4.344 . . . . 0.0 107.415 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.7 p -51.8 -39.34 58.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.616 1.167 . . . . 0.0 110.581 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -43.58 -45.54 6.73 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.584 1.553 . . . . 0.0 111.271 175.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -54.17 -52.16 62.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.289 0.566 . . . . 0.0 110.096 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -70.35 -52.5 22.15 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 111.052 -177.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.6 -46.23 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.721 1.209 . . . . 0.0 112.804 -172.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.2 -61.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.92 0.888 . . . . 0.0 111.169 -174.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.0 mt -68.04 -56.81 7.53 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.706 -172.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.59 43.75 0.58 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.267 0.485 . . . . 0.0 111.357 -178.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.8 t -90.16 -174.62 4.26 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.76 0.79 . . . . 0.0 109.361 177.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.3 p -120.34 -73.34 0.65 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.58 1.952 . . . . 0.0 106.409 176.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -78.74 158.83 75.11 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.19 159.27 15.81 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.563 1.509 . . . . 0.0 112.791 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.2 t -133.72 118.0 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.282 1.433 . . . . 0.0 109.778 -176.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -84.96 104.17 14.66 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.49 116.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -96.06 109.96 22.28 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.505 ' CD2' HD12 ' A' ' 57' ' ' LEU . 31.9 m-85 -78.8 110.89 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 177.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -126.69 -174.36 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.082 0.953 . . . . 0.0 111.119 -174.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.06 149.32 3.31 Favored Pre-proline 0 N--CA 1.456 -0.175 0 C-N-CA 124.979 1.312 . . . . 0.0 108.007 172.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -54.99 -38.34 93.35 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.706 2.271 . . . . 0.0 113.888 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -76.35 -12.21 60.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.399 0.545 . . . . 0.0 112.111 179.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 15.3 t -77.91 100.46 6.4 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.286 -0.884 . . . . 0.0 110.865 -176.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -41.92 -64.8 1.37 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.628 1.585 . . . . 0.0 114.544 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -56.52 -45.44 37.21 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 CA-C-N 119.596 1.698 . . . . 0.0 110.876 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.6 m -52.79 -50.48 63.49 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.22 0.608 . . . . 0.0 109.612 -178.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -56.24 -48.85 75.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.154 0.582 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.46 -29.28 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.776 -177.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 pt -81.7 -24.54 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 120.608 1.549 . . . . 0.0 110.853 176.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.13 -48.61 4.26 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.47 -41.01 35.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.088 1.858 . . . . 0.0 109.97 179.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.54 -49.67 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.979 1.312 . . . . 0.0 107.926 178.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.7 -44.13 57.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.479 0.177 . . . . 0.0 111.479 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -56.59 -33.79 66.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -51.07 -35.79 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.308 0.643 . . . . 0.0 109.504 176.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . . . -56.17 -38.35 70.79 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.313 0.506 . . . . 0.0 110.919 177.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.42 -43.4 45.59 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -55.82 -52.15 65.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -107.58 34.09 3.71 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -58.79 161.84 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.806 0.442 . . . . 0.0 110.172 176.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 t70 74.92 -55.44 0.65 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.613 1.965 . . . . 0.0 111.429 178.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -77.87 -31.67 51.52 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 -177.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.47 152.24 49.33 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.761 0.824 . . . . 0.0 109.906 -178.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -106.17 152.08 23.92 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 168.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 54.1 t -132.97 140.41 47.77 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 177.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 m -154.64 176.4 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 119.033 0.833 . . . . 0.0 109.461 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.72 134.61 26.98 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.442 . . . . 0.0 111.851 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 26' ' ' PHE . 3.2 tm? -99.76 119.35 38.0 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.338 1.855 . . . . 0.0 110.047 -177.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.23 104.06 4.87 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.3 m -66.96 -29.64 69.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.684 1.594 . . . . 0.0 111.631 -173.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.2 -42.03 84.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.869 0.842 . . . . 0.0 109.778 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -83.76 -31.63 25.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.281 1.832 . . . . 0.0 111.687 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 70.1 m -125.85 60.1 31.83 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.608 1.563 . . . . 0.0 111.329 -178.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.42 -34.9 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 124.723 3.615 . . . . 0.0 109.779 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -38.46 -72.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.545 1.938 . . . . 0.0 111.626 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.64 -44.78 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 124.026 0.93 . . . . 0.0 110.487 -178.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.67 -39.15 70.55 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.538 178.198 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -71.52 -43.8 65.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.663 0.785 . . . . 0.0 109.749 178.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -56.59 -41.51 77.12 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.618 0.367 . . . . 0.0 110.437 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -78.19 -33.49 50.06 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.91 47.38 2.1 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 123.725 0.678 . . . . 0.0 111.827 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.5 mt -78.71 112.41 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.45 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.37 -29.55 47.48 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.12 -0.362 . . . . 0.0 110.908 -177.345 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -160.85 155.01 22.95 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.4 pt -108.58 156.53 38.59 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -66.75 161.23 75.97 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.503 1.215 . . . . 0.0 112.595 2.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.8 m -158.37 102.02 1.73 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 175.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.4 pt -85.81 133.83 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 174.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.7 mtt -121.25 153.37 37.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.81 117.73 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 176.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -112.22 156.39 22.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.144 0.977 . . . . 0.0 109.103 178.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 153.85 8.82 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.363 1.465 . . . . 0.0 107.316 176.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 46.96 37.72 9.77 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.005 0.821 . . . . 0.0 114.69 175.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.3 20.51 65.38 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.702 -179.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -141.6 166.03 25.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.332 1.453 . . . . 0.0 109.573 179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -90.54 155.22 19.04 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.34 0.656 . . . . 0.0 109.598 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 46.0 t -108.65 -62.46 1.46 Allowed 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 125.603 1.561 . . . . 0.0 108.941 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.31 179.41 8.99 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.861 1.265 . . . . 0.0 108.846 177.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 t -155.45 151.4 27.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.631 1.173 . . . . 0.0 109.544 -178.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -146.81 157.25 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.757 1.623 . . . . 0.0 108.208 -179.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 68.3 mt -79.6 114.35 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.82 -12.53 21.57 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 116.543 1.377 . . . . 0.0 116.543 -174.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.1 63.38 0.33 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.915 . . . . 0.0 111.96 -179.419 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.97 157.06 58.3 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.434 1.494 . . . . 0.0 107.792 177.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -58.48 155.52 35.79 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.638 2.225 . . . . 0.0 113.729 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -47.12 -51.81 17.04 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.832 1.653 . . . . 0.0 110.744 178.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.73 -51.88 35.56 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.598 178.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.7 m -59.47 -46.51 88.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 118.776 -0.631 . . . . 0.0 109.874 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.22 -52.02 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.811 0.732 . . . . 0.0 109.366 177.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.3 -57.45 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 123.055 0.542 . . . . 0.0 109.678 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -53.35 -47.76 69.11 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.984 0.357 . . . . 0.0 110.681 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 m -54.12 -49.29 69.52 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.209 1.003 . . . . 0.0 110.09 178.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -61.65 -55.18 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 121.518 -0.739 . . . . 0.0 109.746 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -51.32 -48.41 62.36 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.434 0.693 . . . . 0.0 112.325 -175.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -57.82 -22.29 46.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.782 0.719 . . . . 0.0 112.593 -179.117 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -93.64 9.07 38.41 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.754 0.706 . . . . 0.0 111.404 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 77.3 mt -129.6 -56.27 1.14 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.222 1.409 . . . . 0.0 109.786 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.049 0 C-N-CA 126.851 2.061 . . . . 0.0 106.682 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 118.689 -0.672 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 10.1 pt-20 -95.66 163.61 13.12 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.541 1.136 . . . . 0.0 109.131 177.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.65 70.55 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.574 1.15 . . . . 0.0 113.126 -177.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.2 151.28 41.84 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.71 104.47 16.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -92.89 158.73 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.104 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -143.26 174.93 10.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 177.337 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -39.37 -49.71 2.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.329 1.452 . . . . 0.0 112.295 -176.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.33 -78.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.129 177.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.8 p -45.95 -41.33 11.48 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.256 1.422 . . . . 0.0 112.632 -175.052 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -39.71 -46.05 1.81 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.162 1.785 . . . . 0.0 111.38 175.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -49.83 -65.85 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.852 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -65.78 -35.94 82.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.254 0.622 . . . . 0.0 112.196 -176.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.93 -13.09 9.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -170.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.49 -66.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 119.026 0.83 . . . . 0.0 109.475 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.0 mt -57.45 -35.12 69.72 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -93.69 -5.19 49.08 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.99 0.916 . . . . 0.0 111.817 178.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.2 m -77.26 132.51 38.71 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 120.712 -1.243 . . . . 0.0 111.909 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 p -79.37 -52.9 7.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.809 1.244 . . . . 0.0 109.553 178.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.59 152.8 83.41 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -64.34 154.51 70.96 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 120.925 1.084 . . . . 0.0 113.049 -175.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.461 ' HA ' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -147.85 127.27 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 124.626 1.204 . . . . 0.0 113.541 178.609 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.11 95.49 9.46 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.26 113.2 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -86.9 114.52 23.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -79.0 102.89 8.59 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 175.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -120.32 -171.5 2.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.252 1.021 . . . . 0.0 110.519 -173.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.67 152.93 3.97 Favored Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 172.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -56.59 -35.73 97.36 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.847 1.698 . . . . 0.0 112.237 177.056 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CH2' HD11 ' A' ' 74' ' ' ILE . 24.6 p-90 -76.84 -3.92 40.93 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.798 -0.564 . . . . 0.0 111.985 177.392 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.7 t -82.06 85.37 6.76 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.587 -1.321 . . . . 0.0 112.125 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.1 -57.88 2.46 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.374 0.988 . . . . 0.0 114.055 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -65.97 -24.04 53.53 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 120.035 1.917 . . . . 0.0 112.311 -178.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 75.4 m -66.92 -49.49 65.37 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.022 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -46.93 -45.55 20.76 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.836 0.854 . . . . 0.0 111.481 -178.01 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 pp -77.48 -19.59 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.794 -177.261 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.16 -22.75 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 121.064 1.756 . . . . 0.0 109.752 171.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.37 -43.03 2.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.421 -1.276 . . . . 0.0 114.041 177.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.39 -40.96 36.28 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.228 1.952 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.5 t -64.21 -47.66 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.2 t -56.88 -54.58 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -176.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 68.9 m-20 -60.7 -49.78 76.13 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.326 0.65 . . . . 0.0 110.894 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -53.85 -52.56 60.03 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -54.34 -43.76 63.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 2' ' ' GLU . . . -52.16 -46.27 65.38 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.12 -60.68 8.43 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 175.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -39.9 -49.49 2.43 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.235 1.414 . . . . 0.0 112.789 -177.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -118.24 24.65 10.84 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -174.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -40.87 -46.62 2.79 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.133 1.773 . . . . 0.0 112.303 -177.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.19 -44.76 1.25 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.068 2.547 . . . . 0.0 113.4 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -140.22 -55.51 0.53 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 122.148 0.975 . . . . 0.0 112.832 179.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.697 ' HG ' ' H ' ' A' ' 53' ' ' LYS . 46.3 tp -78.57 -169.13 1.59 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 113.72 -1.582 . . . . 0.0 114.322 -155.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.697 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 3.4 pttp -75.79 99.88 4.56 Favored 'General case' 0 N--CA 1.432 -1.354 1 N-CA-C 127.605 6.15 . . . . 0.0 127.605 -153.504 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 52.3 t -160.02 127.8 4.68 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 120.304 -1.498 . . . . 0.0 112.719 168.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.23 167.95 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.906 0.882 . . . . 0.0 109.081 171.022 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -136.39 109.31 7.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.352 0.661 . . . . 0.0 110.456 -177.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.47 118.29 31.14 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 122.986 0.514 . . . . 0.0 109.877 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -72.46 111.86 8.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.5 m -67.97 -33.71 75.15 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.615 1.166 . . . . 0.0 111.423 -173.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -67.84 -37.4 81.85 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.529 1.132 . . . . 0.0 109.322 -179.655 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.88 -27.82 39.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 125.504 1.521 . . . . 0.0 111.375 177.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 m -119.19 51.03 1.5 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.67 1.588 . . . . 0.0 114.014 -176.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -60.03 -36.25 90.16 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 124.326 3.351 . . . . 0.0 108.419 175.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -44.34 -72.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.405 1.882 . . . . 0.0 109.93 175.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.76 -50.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.593 1.157 . . . . 0.0 109.738 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.28 -40.92 62.39 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.282 -178.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.4 m -75.84 -41.12 53.36 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.194 0.998 . . . . 0.0 110.731 179.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -56.26 -45.2 80.15 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.148 0.579 . . . . 0.0 109.758 178.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -79.11 -35.22 42.59 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.26 50.74 2.93 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.416 1.008 . . . . 0.0 112.53 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.18 -169.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.248 0.619 . . . . 0.0 110.032 178.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -158.8 -84.81 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.576 0.75 . . . . 0.0 109.096 177.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -57.57 153.84 12.37 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 110.351 178.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.525 HD11 ' CH2' ' A' ' 30' ' ' TRP . 19.1 pt -140.84 155.14 69.23 Favored Pre-proline 0 N--CA 1.448 -0.528 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.03 140.05 45.43 Favored 'Cis proline' 0 N--CA 1.453 -0.903 0 CA-C-N 120.252 1.126 . . . . 0.0 112.879 2.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 m -127.84 104.84 8.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 173.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.0 mt -101.61 102.6 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 125.661 1.584 . . . . 0.0 108.244 -173.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.6 mtt -102.26 151.62 22.02 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -112.76 130.03 67.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 171.835 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -121.37 148.73 43.97 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 175.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.61 153.88 13.3 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 175.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.18 35.98 80.22 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 118.058 -2.02 . . . . 0.0 108.172 -174.199 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.18 -53.2 1.43 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.58 1.562 . . . . 0.0 113.997 -175.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -79.24 165.84 22.8 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -172.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -80.97 152.8 27.81 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 127.137 2.175 . . . . 0.0 110.833 -178.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 18.8 t -138.46 -80.39 0.33 Allowed 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.401 ' H ' HG12 ' A' ' 79' ' ' VAL . 30.5 mm-40 -72.09 149.5 44.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.773 0.321 . . . . 0.0 110.343 178.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.12 75.34 1.29 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.28 1.832 . . . . 0.0 106.72 179.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.0 mm -81.24 154.21 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.2 mt -138.02 147.87 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -175.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.39 175.1 48.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.608 0.623 . . . . 0.0 111.567 178.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.66 153.2 44.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.54 156.08 45.43 Favored Pre-proline 0 C--O 1.232 0.165 0 C-N-CA 123.484 0.714 . . . . 0.0 109.207 -178.272 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -73.88 143.97 33.92 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 N-CA-C 105.885 -2.39 . . . . 0.0 105.885 166.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -38.46 76.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.239 0.542 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.57 -52.66 28.54 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.238 179.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 m -58.86 -49.29 78.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.363 0.665 . . . . 0.0 110.065 179.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mm -54.21 -53.09 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.006 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.9 t -52.15 -56.73 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.533 0.733 . . . . 0.0 109.254 179.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -52.7 -45.87 67.08 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.264 0.554 . . . . 0.0 111.706 178.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.8 m -58.93 -38.95 80.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.156 -177.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -81.63 -36.2 14.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 119.026 0.83 . . . . 0.0 111.334 178.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -55.75 -35.11 65.84 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 118.491 0.587 . . . . 0.0 110.437 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -46.48 -37.96 8.55 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.006 0.522 . . . . 0.0 110.704 171.284 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -102.88 14.48 31.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.089 2.156 . . . . 0.0 112.741 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.0 mt -157.59 96.61 1.53 Allowed 'General case' 0 C--N 1.338 0.104 0 C-N-CA 125.174 1.39 . . . . 0.0 108.383 177.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.089 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -69.83 -53.6 17.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 172.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.51 141.86 51.91 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.642 169.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.88 -165.41 31.57 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 176.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.83 141.69 48.58 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.54 166.08 23.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 122.316 1.055 . . . . 0.0 111.09 -178.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -141.5 169.31 17.84 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 174.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -39.33 -46.09 1.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.794 1.638 . . . . 0.0 111.986 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -57.38 -70.55 0.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.871 177.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.9 p -61.07 -38.2 85.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 112.256 -175.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -39.34 -46.17 1.55 Allowed 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 127.905 2.482 . . . . 0.0 111.107 178.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -42.65 -66.29 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 111.954 175.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -45.05 60.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.933 -174.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.4 t -70.42 -38.26 73.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.001 -171.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -108.69 -69.46 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.492 1.117 . . . . 0.0 111.706 -174.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.7 mt -54.51 -50.78 67.02 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.99 0.359 . . . . 0.0 111.148 -172.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -88.07 17.06 5.3 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.614 -178.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.17 154.21 37.79 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.12 1.327 . . . . 0.0 111.132 -178.127 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -86.71 -58.63 2.53 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.617 1.567 . . . . 0.0 109.665 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.07 161.03 72.33 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.719 1.208 . . . . 0.0 108.01 178.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.41 164.67 8.63 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.659 1.573 . . . . 0.0 109.697 173.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.6 t -145.88 115.83 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 110.98 -174.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tp -89.06 98.78 11.96 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.32 110.6 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 123.33 0.652 . . . . 0.0 110.549 -175.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -89.11 115.31 26.55 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.435 ' CD2' HD12 ' A' ' 57' ' ' LEU . 7.9 m-85 -80.05 111.39 16.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -131.11 -171.86 2.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.744 0.783 . . . . 0.0 111.035 -173.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -170.98 150.35 2.96 Favored Pre-proline 0 N--CA 1.451 -0.388 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 172.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.4 -42.26 69.31 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.281 1.987 . . . . 0.0 112.177 178.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 36.8 p-90 -66.24 -21.09 66.28 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 122.077 -0.389 . . . . 0.0 111.757 178.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.0 t -76.26 83.45 3.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.615 -0.678 . . . . 0.0 111.345 -176.166 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.73 -57.18 2.89 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.697 -1.057 . . . . 0.0 113.599 173.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.9 -20.53 67.25 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.977 1.785 . . . . 0.0 112.654 -179.658 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.2 m -82.06 -59.0 2.72 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 175.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -40.13 -53.0 2.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 127.569 2.347 . . . . 0.0 112.154 -178.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.93 -22.32 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.47 -33.78 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.347 1.059 . . . . 0.0 110.26 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.88 -43.39 3.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 127.311 2.244 . . . . 0.0 115.512 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -67.43 -36.25 20.88 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.822 1.681 . . . . 0.0 108.86 -179.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -40.2 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 C-N-CA 127.166 2.186 . . . . 0.0 107.748 179.032 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.82 -47.77 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 172.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -60.39 -53.19 60.58 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.715 0.406 . . . . 0.0 111.692 -178.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.31 -41.16 96.53 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.16 -0.962 . . . . 0.0 110.813 -179.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.98 -42.8 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' A' ' 54' ' ' CYS . . . -53.84 -46.84 71.33 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.46 -52.52 36.83 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 176.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -47.35 -41.75 20.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.546 0.673 . . . . 0.0 112.159 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -112.71 31.3 6.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.016 0.926 . . . . 0.0 112.192 -178.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -57.05 154.71 9.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.523 0.678 . . . . 0.0 110.49 -178.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 71.64 -48.45 0.68 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 128.093 2.557 . . . . 0.0 112.028 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -78.37 -13.17 59.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.206 0.457 . . . . 0.0 110.742 179.134 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.62 119.7 6.28 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -80.97 167.73 19.5 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 173.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.409 ' CB ' ' HB2' ' A' ' 45' ' ' ALA . 45.6 t -146.9 147.5 30.86 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.93 161.46 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -125.81 110.61 13.89 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.02 0.928 . . . . 0.0 109.086 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.435 HD12 ' CD2' ' A' ' 26' ' ' PHE . 2.9 tm? -89.56 112.43 23.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.38 1.472 . . . . 0.0 109.242 -178.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -71.89 107.98 4.93 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.0 m -60.58 -43.18 97.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.147 1.779 . . . . 0.0 111.665 -174.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.21 -33.77 75.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.901 0.881 . . . . 0.0 110.506 -177.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -80.8 -27.42 36.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.566 1.146 . . . . 0.0 110.425 175.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.427 ' HB2' HD11 ' A' ' 57' ' ' LEU . 1.4 m -122.86 52.81 4.6 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 125.914 1.686 . . . . 0.0 113.492 -176.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.23 -31.34 63.97 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 124.403 3.402 . . . . 0.0 107.985 177.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -50.43 -60.12 3.32 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.369 1.068 . . . . 0.0 109.457 177.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.59 -55.41 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 123.8 0.84 . . . . 0.0 109.374 -178.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.43 -45.38 36.19 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.933 179.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -65.59 -50.23 65.88 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.13 0.572 . . . . 0.0 110.715 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -56.61 -44.06 80.78 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.752 0.421 . . . . 0.0 111.305 -179.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -79.29 -32.22 43.52 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 119.607 -0.235 . . . . 0.0 111.579 -178.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.49 60.8 0.98 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.5 mt -129.11 152.37 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.274 1.43 . . . . 0.0 107.77 -178.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -148.67 -71.08 0.21 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.19 151.11 41.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 pt -146.27 154.77 50.09 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -179.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.74 151.23 74.86 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 120.656 1.27 . . . . 0.0 113.825 2.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -156.72 100.37 1.92 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.444 -3.169 . . . . 0.0 102.444 176.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 tt -100.7 123.1 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -178.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.0 mtt -106.02 144.19 33.08 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.413 1.085 . . . . 0.0 110.066 -177.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.9 t -95.87 101.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 176.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -95.89 156.36 16.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.787 0.803 . . . . 0.0 111.178 179.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.31 -154.9 0.55 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 171.325 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -33.56 95.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.301 1.429 . . . . 0.0 114.261 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.02 -76.83 0.16 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.919 0.771 . . . . 0.0 113.913 179.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -79.88 169.71 17.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 122.097 0.951 . . . . 0.0 113.429 -171.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.59 157.41 17.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.255 171.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 15.9 t -109.36 -60.45 1.77 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.832 1.253 . . . . 0.0 110.113 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -132.86 179.08 6.39 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.602 1.561 . . . . 0.0 109.097 -178.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -160.34 163.78 33.01 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.979 0.512 . . . . 0.0 110.055 179.133 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.6 mt -137.18 146.53 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.8 mp -135.71 151.1 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.269 1.428 . . . . 0.0 108.52 -174.146 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.99 152.78 10.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.2 67.92 2.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.707 . . . . 0.0 110.77 -179.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.87 144.3 63.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -53.75 155.65 13.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.593 2.195 . . . . 0.0 113.896 -178.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -49.28 -43.76 43.37 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.064 0.946 . . . . 0.0 111.323 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.32 65.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 110.625 179.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -45.91 86.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.1 mt -55.05 -54.68 21.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -50.3 -57.45 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 124.442 1.097 . . . . 0.0 110.187 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -54.73 -47.33 73.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.623 0.249 . . . . 0.0 111.044 -178.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.9 m -64.3 -41.31 96.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.517 0.327 . . . . 0.0 110.86 -179.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.2 t -60.2 -50.96 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -57.43 -50.77 71.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -48.01 -50.19 28.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.699 0.8 . . . . 0.0 109.976 176.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -75.62 -22.36 56.92 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -153.32 83.88 1.19 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.404 0.682 . . . . 0.0 110.857 -166.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.284 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 176.827 . . . . . . . . 1 1 . 1 stop_ save_